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FOREWORD  
 
This toxicological profile is prepared in accordance with guidelines developed by the Agency for Toxic 
Substances and Disease Registry (ATSDR) and the Environmental Protection Agency (EPA).  The 
original guidelines were published in the Federal Register on April 17, 1987.  Each profile will be revised 
and republished as necessary. 
 
The ATSDR toxicological profile succinctly characterizes the toxicologic and adverse health effects 
information for these toxic substances described therein.  Each peer-reviewed profile identifies and 
reviews the key literature that describes a substance's toxicologic properties.  Other pertinent literature is 
also presented, but is described in less detail than the key studies.  The profile is not intended to be an 
exhaustive document; however, more comprehensive sources of specialty information are referenced. 
 
The focus of the profiles is on health and toxicologic information; therefore, each toxicological profile 
begins with a relevance to public health discussion which would allow a public health professional to 
make a real-time determination of whether the presence of a particular substance in the environment 
poses a potential threat to human health.  The adequacy of information to determine a substance's health 
effects is described in a health effects summary.  Data needs that are of significance to the protection of 
public health are identified by ATSDR and EPA. 
 
Each profile includes the following: 
(A) The examination, summary, and interpretation of available toxicologic information and 
epidemiologic evaluations on a toxic substance to ascertain the levels of significant human 
exposure for the substance and the associated acute, intermediate, and chronic health effects; 
 
(B) A determination of whether adequate information on the health effects of each substance is 
available or in the process of development to determine the levels of exposure that present a 
significant risk to human health due to acute, intermediate, and chronic duration exposures; 
and 
 
(C) Where appropriate, identification of toxicologic testing needed to identify the types or levels 
of exposure that may present significant risk of adverse health effects in humans. 
 
The principal audiences for the toxicological profiles are health professionals at the Federal, State, and 
local levels; interested private sector organizations and groups; and members of the public.  ATSDR plans 
to revise these documents in response to public comments and as additional data become available.  
Therefore, we encourage comments that will make the toxicological profile series of the greatest use. 
 
Electronic comments may be submitted via: www.regulations.gov.  Follow the on-line instructions for 
submitting comments. 
 
Written comments may also be sent to:  Agency for Toxic Substances and Disease Registry 
     Division of Toxicology and Human Health Sciences 
     Environmental Toxicology Branch 
1600 Clifton Road, N.E. 
Mail Stop S102-1 
Atlanta, Georgia 30329-4027 
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The toxicological profiles are developed under the Comprehensive Environmental Response, 
Compensation, and Liability Act of 1980, as amended (CERCLA or Superfund).  CERCLA section 
104(i)(1) directs the Administrator of ATSDR to “…effectuate and implement the health related 
authorities” of the statute.  This includes the preparation of toxicological profiles for hazardous 
substances most commonly found at facilities on the CERCLA National Priorities List (NPL) and that 
pose the most significant potential threat to human health, as determined by ATSDR and the EPA.  
Section 104(i)(3) of CERCLA, as amended, directs the Administrator of ATSDR to prepare a 
toxicological profile for each substance on the list.  In addition, ATSDR has the authority to prepare 
toxicological profiles for substances not found at sites on the NPL, in an effort to “…establish and 
maintain inventory of literature, research, and studies on the health effects of toxic substances” under 
CERCLA Section 104(i)(1)(B), to respond to requests for consultation under section 104(i)(4), and as 
otherwise necessary to support the site-specific response actions conducted by ATSDR.  
 
This profile reflects ATSDR’s assessment of all relevant toxicologic testing and information that has been 
peer-reviewed.  Staffs of the Centers for Disease Control and Prevention and other Federal scientists have 
also reviewed the profile.  In addition, this profile has been peer-reviewed by a nongovernmental panel 
and is being made available for public review.  Final responsibility for the contents and views expressed 
in this toxicological profile resides with ATSDR. 
 
 
 
 
 
 
Patrick N. Breysse, Ph.D., CIH 
Director, National Center for Environmental Health and 
Agency for Toxic Substances and Disease Registry 
Centers for Disease Control and Prevention 
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CHAPTER 1.  RELEVANCE TO PUBLIC HEALTH.  
1.1   OVERVIEW AND U.S. EXPOSURES 
DDT is an organochlorine insecticide that has found a broad range of agricultural and nonagricultural 
applications in the United States and worldwide beginning in 1939.  In 1972, DDT use was banned in the 
United States and in many parts of the world.  Since the adoption of the Stockholm Convention in 2004, 
uses have continued to decline.  Under the Stockholm Convention, use of DDT is primarily restricted to 
controlling vector-borne diseases, such as malaria and leishmaniasis; a small number of countries 
continue to use DDT for these purposes.  In 2006, the World Health Organization (WHO) approved the 
use of indoor residual spraying as a measure to control disease in areas where malaria and other vector-
borne pathogens remain a major health problem.  DDD and DDE are both degradation products and 
metabolites of DDT.  DDD was also manufactured and used as an insecticide, but to a much lesser extent 
than DDT.  DDE is not manufactured commercially, but can be produced by the dehydrochlorination of 
DDT in alkaline solution and is commonly detected at concentrations in the environment that often 
exceed those measured for DDT.  Different forms of DDT, DDE, and DDD called isomers can be found 
in the environment.  Many of these isomers are described in human and animal studies; the six most 
common isomers that are detected or used in studies that might be seen throughout this profile include 
commercial or technical DDT, p,p’-DDT, o,p’-DDT, p,p’-DDE, o,p’-DDE, technical DDD, and 
o,p’-DDD.   
Upon introduction into the environment, DDT will enter soil, water, or air.  The long-range transport of 
DDT has resulted in the wide dispersion of DDT and its metabolites throughout the world, even into 
remote areas, such as the Arctic or Antarctic regions.  The biodegradation of DDT and its metabolites is 
slow, and these compounds can bioaccumulate (increasing concentration of a chemical in an organism 
that exceeds that in its environment) in fatty tissues.  The ban on DDT use in the early 1970s in the 
United States and most of the world has contributed to a decrease in the levels of these compounds in the 
environment over the past 40 years.  Except for areas where production and use are still active, exposure 
of the general public to DDT, DDE, DDD, and their isomers has also been declining since the ban on the 
use of DDT. 
The predominant route of exposure to DDT and its metabolites is through the consumption of foods either 
obtained from areas of the world where DDT is still used or that have the potential to contain 
bioaccumulated residues of DDT and its metabolites (e.g., meat, fish, poultry, dairy products).  Although 
DDT and its metabolites are ubiquitous in the atmosphere, they have not been shown to significantly 
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contribute to body burden; however, this has not been well studied.  Exposure to DDT in drinking water 
is considered negligible because of the extremely low water solubility of DDT and the efficiency of 
standard drinking water processing methods.  With the ban on the use of DDT, occupational exposures 
that result from formulation, packaging, and application activities should be negligible, except in areas 
where DDT use remains.  Activities that result in the mobilization of DDT (e.g., site remediation) may 
increase exposure of workers to DDT and its metabolites.   
 
Since the ban on DDT was instituted in the United States and most of the world in 1972 and the adoption 
of the Stockholm Convention, the environmental concentrations of DDT and its metabolites have been 
decreasing.  Average adult intakes of DDT were estimated to be 62 μg/person/day in 1965 and 
240 μg/person/day in 1970, before the DDT ban was instituted (Coulston 1985).  The U.S. Food and Drug 
Administration (FDA) Total Diet Studies showed that the daily intakes of total DDT have fallen since the 
ban, with daily intakes (for a 16-year-old, 70-kg male) averaging 6.51, 2.38, 1.49, and 0.97 μg/person/day 
for 1978–1979, 1979–1980, 1984–1986, and 1986–1991, respectively (Gunderson 1995a, 1995b).  As 
would be expected from the decline in the concentrations of DDT in the environment, the levels of DDT, 
DDE, and DDD measured in foodstuffs have also fallen over the last 45 years.  Yet, there are still 
measurable quantities of DDT, DDE, and DDD in some commodities.  p,p’-DDE was the most frequently 
detected isomer in studies of U.S. food samples (FDA 2006; USDA 2016).  Some of the foods with 
detectable levels of DDT and metabolites include American cheese, butter, catfish, carrots, summer 
squash, celery, and salmon (FDA 2006; Huang et al. 2006; USDA 2016).   
 
Exposures of the general public to DDT and its metabolites result in the accumulation of these 
compounds in adipose tissue and breast milk.  Due to the persistence of DDT and its metabolites in the 
environment and their slow elimination from the body, the concentrations of these compounds in adipose 
tissue and breast milk are determined by both past and current exposures.  Body burdens of DDT and its 
metabolites are decreasing, due to declining environmental levels.  The average levels of DDT in human 
breast milk fat were about 2,000–5,000 ppb in the United States in the early 1970s, but have steadily 
declined at a rate of 11–21% per year since 1975.  For example, Norén (1988) reported concentrations of 
p,p’-DDT in breast milk fat of 710, 360, 180, and 61 ppb for the years 1972, 1976, 1980, and 1984–1985, 
respectively.  These investigators also reported concentrations of p,p’-DDE of 2,420, 1,530, 999, and 
500 ppb for these same years, respectively.  More recently, ΣDDT concentrations in pooled U.S. human 
breast milk samples collected in 2000–2003 were approximately 110 ppb on a lipid basis.  Serum levels 
of p,p’-DDE, the main metabolite of p,p’-DDT, also have dropped appreciably in the last several decades, 
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showing a 5-fold decrease in concentration in U.S. National Health and Nutrition Examination Survey 
(NHANES) samples collected between 1976 and 2004 (Wattigney et al. 2015). 
 
1.2  SUMMARY OF HEALTH EFFECTS  
 
Information on the toxicity of DDT, DDE, DDD, and their isomers comes from numerous epidemiology 
studies examining possible associations between levels of DDT, DDE, or DDD in human tissues or fluids 
and occurrence of various noncancer and cancer health outcomes, as well as from over 150 oral toxicity 
studies in laboratory animals.  A few early controlled-exposure studies of human subjects are available, 
and very few inhalation or dermal studies, in either humans or animals, were identified.   
 
Inconsistent evidence (some studies reported associations, others did not) has been provided by the 
epidemiological studies of most of the noncancer and cancer outcomes, with the exception of studies 
providing consistent evidence for: 
• associations with abortion or preterm births; 
• associations with prevalence for wheeze in infant or child offspring;  
• no associations with male birth defects; 
• associations with prevalence of Type 2 diabetes mellitus (DMT2);  
• associations with liver cancer; and  
• no associations with breast cancer in women, pancreatic cancer, or endometrial cancer. 
 
Although the epidemiological studies provided consistent evidence of associations for some health 
effects, these studies are observational and do not establish causality; the observed statistical association 
may be due to effects of other factors, such as exposure to other pollutants.  Likewise, the absence of an 
association does not necessarily imply the absence of a causal relationship.  The available 
epidemiological studies do not provide sufficient data to describe exposure-response relationships for 
potential health outcomes associated with exposure to DDT, DDD, or DDE.  Another limitation of the 
epidemiological database is that most studies lacked statistical control for exposure to other compounds, 
particularly highly lipophilic compounds such as polychlorinated biphenyls (PCBs), chlorodibenzo-p-
dioxins (CDDs), and chlorodibenzofurans (CDFs), which may co-migrate with DDT and could be the 
causative agent. 
 
As illustrated in Figure 1-1, toxicity studies of laboratory animals provide sufficient evidence to identify 
neurological effects including neurodevelopmental effects, liver effects, reproductive and developmental 
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reproductive effects, and immunological effects as sensitive toxicity targets of acute-, intermediate-, and 
chronic-duration oral exposure to isomers of DDT, DDE, or DDD.  Figure 1-1 also illustrates the chronic-
duration oral exposure levels associated with liver tumors in laboratory animals.  In most cases, the doses 
associated with adverse effects in laboratory animals are higher than could be reasonably anticipated from 
background exposure in the United States (see Section 1.1). 
Figure 1-1.  Health Effects Following Oral Exposure to DDT, DDE, and DDD 
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Hepatic Effects.  Inconsistent evidence for liver effects has been provided by epidemiological studies 
examining possible associations between levels of DDT or DDE in blood and serum or urinary markers of 
liver damage or dysfunction (i.e., some studies reported associations and others reported no associations).  
Two studies found no significant associations with indicators of liver damage (e.g., increased aspartate 
aminotransferase [AST], alanine aminotransferase [ALT], or bilirubin) in subjects from a heavily 
contaminated region and a group of U.S. agricultural workers (Freire et al. 2015a, 2015b; Morgan and Lin 
1978).  However, but significant associations with indicators of liver damage were found in analyses for 
serum indicators from the U.S. general population (Serdar et al. 2014) and of urinary porphyrin levels in a 
group of children from a contaminated region (Sunyer et al. 2008). 
In contrast, results from numerous studies of orally-exposed laboratory animals indicate that the liver is a 
sensitive toxicity target of DDT, DDE, and DDD isomers.  Acute-, intermediate-, and chronic-duration 
oral exposures have been shown to cause dose-related, mild-to-severe hepatic effects in numerous animal 
studies.   
After acute oral exposure to technical DDT or unspecified DDT, p,p’-DDT, p,p’-DDE, unspecified DDE, 
or unspecified DDD, a number of hepatic effects have been observed including induction of liver 
microsomal xenobiotic metabolizing enzymes often associated with increased liver weight, increased 
serum levels of liver enzymes (suggestive of liver injury), and histological changes in the liver including 
cellular hypertrophy and necrosis (Agarwal et al. 1978; de Waziers and Azais 1987; Garcia and Mourelle 
1984; Kang et al. 2004; Kostka et al. 2000; Leavens et al. 2002; Nims et al. 1998; Pasha 1981; Tomiyama 
et al. 2003, 2004). After intermediate-duration exposure to technical DDT, p,p’-DDT, or p,p’-DDE, an 
array of hepatic effects, similar to those observed after acute exposure, have been observed in rats and 
mice (Gupta et al. 1989; Harada et al. 2003, 2006; Hojo et al. 2006; Jonsson et al. 1981; Laug et al. 1950; 
Orberg and Lundberg 1974; Ortega 1956; Yamasaki et al. 2009; Tomiyama et al. 2004).  The lowest 
reliable intermediate-duration animal lowest-observe-adverse effect level (LOAEL) for liver effects is 
0.17 mg p,p’-DDT/kg/day in the diet reported for cellular hypertrophy in rats exposed for 26 weeks; the 
no-observed-adverse-effect level (NOAEL) from this study was 0.17 mg/kg/day (Harada et al. 2003, 
2006).  Nonneoplastic liver lesions have been observed in rats, mice, hamsters, monkeys, and dogs after 
chronic oral exposure to DDT and related compounds (Cabral et al. 1982a; Deichmann et al. 1967; 
Durham et al. 1963; Fitzhugh and Nelson 1947; Graillot et al. 1975; Harada et al. 2003, 2006; Hojo et al. 
2006; Laug et al. 1950; Lehman et al. 1965; NCI 1978; Rossi et al. 1983; Takayama et al. 1999).  The 
lowest reliable chronic-duration animal LOAEL for nonneoplastic histological changes in the liver is 
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0.17 mg p,p’-DDT/kg/day for hepatocellular hypertrophy in male rats exposed in the diet for 2 years 
(Harada et al. 2003, 2006).   
 
Neurological and Neurodevelopmental Effects.  In controlled-exposure studies of adult volunteers and 
reports of accidental or intentional ingestion, the nervous system appears to be one of the primary target 
systems for acute high-dose DDT toxicity, producing reversible perspiration, headache, and nausea at 
doses ≥16 mg DDT/kg, progressing to reversible convulsions or tremors at dose levels of about 22 mg 
DDT/kg and higher (Francone et al. 1952; Garrett 1947; Hayes 1982; Hsieh 1954; Mulhens 1946; 
Velbinger 1947a, 1947b).  However, these types of neurological symptoms were not reported in adult 
volunteers who ingested low dose levels of about 0.05 or 0.5 mg DDT/kg/day for 12–18 months (Hayes et 
al. 1956).   
 
Inconsistent evidence has been provided by epidemiological studies examining possible associations 
between serum levels of DDT, DDE, or DDD in adults or adolescents and deficits in cognitive or mental 
status tests or risks for neurological conditions, such as Alzheimer’s disease, Parkinson’s disease, or 
attention deficient disorder (Kim et al. 2015a, 2015b, 2015c; Lee et al. 2007a, 2016a, 2016b; 
Medehouenou et al. 2014; Richardson et al. 2014; Rocha-Amador et al. 2009; Steenland et al. 2014; 
Weisskopf et al. 2010).  Inconsistent evidence also has been provided by epidemiological studies that 
evaluated possible associations between DDT, DDE, or DDD levels in maternal serum, milk, or cord 
blood and various neurodevelopmental endpoints, including: 
• neurobehavioral endpoints in infants ≤2 years of age (Engel et al. 2007; Eskenazi et al. 2006; 
Fenster et al. 2007; Forns et al. 2012b; Gascon et al. 2013; Gladen and Rogan 1991; Gladen et al. 
1988; Hoyer et al. 2015; Jusko et al. 2012; Pan et al. 2009; Ribas-Fito et al. 2003; Bahena-
Medina et al. 2011; Sagiv et al. 2008; Stewart et al. 2000; Torres-Sanchez et al. 2007, 2013); 
• behavioral problems, attention and ADHD in offspring (Forns et al. 2012a, 2016; Kyriklaki et al. 
2016; Sagiv et al. 2010; Sioen et al. 2013; Strom et al. 2014);  
• neurobehavioral endpoints (including IQ) in older children (Gaspar et al. 2015a, 2015b; Gladen 
and Rogan 1991; Jusko et al. 2012; Kyriklaki et al. 2016; Lyall et al. 2016; Orenstein et al. 2014; 
Osorio-Valencia et al. 2015; Ribas-Fito et al. 2006, 2007; Sagiv et al. 2012; Torres-Sanchez et al. 
2013); and 
• other neurological endpoints in children, such as visual evoked potential deficits (Ren et al. 
2011; Riva et al. 2004) and neural tube defects (Cartier et al. 2014). 
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Tremors, hyperirritability, convulsions, and intermittent myoclonic movements have been described in 
mature laboratory animals following oral exposure to technical DDT, p,p’-DDT, or p,p’-DDE at acute 
doses ≥50 mg/kg/day (Herr and Tilson 1987; Herr et al. 1985; Hietanen and Vainio 1976; Hong et al. 
1986; Hudson et al. 1985; Hwang and Van Woert 1978; Pranzatelli and Tkach 1992; Pratt et al. 1986; 
Tilson et al. 1987; Tomiyama et al. 2003), intermediate doses ≥28 mg/kg/day (Cranmer et al. 1972; Hojo 
et al. 2006; NCI 1978; Rossi et al. 1977), or chronic-duration doses ≥7 mg/kg/day (Harada et al. 2003, 
2006; NCI 1978; Rossi et al. 1983; Takayama et al. 1999), but no tremors were observed in acute- or 
chronic-duration studies of laboratory animals orally exposed to technical DDD at doses as high as 
231 mg/kg/day (NCI 1978).  
 
Acute oral exposure of adult laboratory animals to DDT also has been associated with increases in brain 
biogenic amine and neurotransmitter levels at doses ≥50 mg p,p’-DDT/kg (Hong et al. 1986; Hrdina et al. 
1973; Hudson et al. 1985; Hwang and Van Woert 1978; Tilson et al. 1986).  Young laboratory mice 
appear to be particularly sensitive to brain neurochemical changes and associated behavioral changes 
from exposure to low doses of technical DDT during critical windows of neurodevelopment.  Increased 
spontaneous motor activity (reduced habituation) and decreased cerebral cortex muscarinic receptors were 
observed in 4–7-month-old mice exposed to 0.5 mg/kg/day technical DDT on postnatal day (PND) 10, 
but not on PND 3 or 18 (Eriksson and Nordberg 1986; Eriksson et al. 1990a, 1990b, 1992, 1993; 
Johansson et al. 1995, 1996, supported by Talts et al. 1998). 
 
Reproductive and Developmental Reproductive Effects.  Possible associations between exposure to DDT 
(isomers and metabolites), as assessed by levels in biological media (mostly serum), and human 
reproductive outcomes have been examined in numerous epidemiological studies.   
 
The available studies provide inconsistent evidence for associations with each of the reproductive effects 
evaluated in adults (time to pregnancy [Axmon et al. 2006; Buck Louis et al. 2013, 2014; Chevrier et al. 
2013; Cohn et al. 2003; Harley et al. 2008; Law et al. 2005], uterine alterations such as endometriosis 
[Cooney et al. 2010; Porpora et al. 2009; Trabert et al. 2015; Upson et al. 2013], menstrual cycle changes 
[Cooper et al. 2005; Denham et al. 2005; Gallo et al. 2016; Ouyang et al. 2005; Toft et al. 2008; 
Windham et al. 2005), early age at menopause [Cooper et al. 2002; Grindler et al. 2015], levels of 
reproductive sex hormones [Blanco-Muñoz et al. 2012; Emeville et al. 2013; Ferguson et al. 2012; Freire 
et al. 2014; Giwercman et al. 2006; Goncharov et al. 2009; Hagmar et al. 2001; Haugen et al. 2011; 
Martin et al. 2002; Perry et al. 2006; Rignell-Hydbom et al. 2004; Rylander et al. 2006; Schell et al. 2014; 
Turyk et al. 2006; Windham et al. 2005], and semen parameters [Aneck-Hahn et al. 2007; Charlier and 
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Foidart 2005; Dallinga et al. 2002; De Hauser et al. 2003; Jaeger et al. 2006; Messaros et al. 2009; Pant et 
al. 2007; Rignell-Hydbom et al. 2005b; Toft et al. 2006]). 
 
Additionally, there is inconsistent evidence for associations between DDT, DDE, or DDD dosimetrics and 
puberty onset outcomes in studies of preadolescents/adolescents (Croes et al. 2015; Den Hond et al. 2011; 
Dhooge et al. 2011; Lam et al. 2014, 2015).  In contrast, there is consistent evidence from studies of 
adults suggesting that serum levels of DDT, DDD, or DDE currently found in the U.S. general 
populations may not present increased risks for abortion or premature delivery, but increased risk may 
exist in countries where DDT is still being used (Korrick et al. 2001; Longnecker et al. 2005; Ouyang et 
al. 2014; Torres-Arreola et al. 2003; Venners et al. 2005; Wood et al. 2007).  In epidemiological studies 
of possible associations between DDT, DDE, or DDD levels in maternal serum, cord blood, breast milk, 
or placenta and reproductive outcomes in human offspring, no consistent evidence was found for 
associations for increased risk for the male birth defects, cryptorchidism or hypospadias (Bhatia et al. 
2005; Brucker-Davis et al. 2008; Damgaard et al. 2006; Fernandez et al. 2007; Giordano et al. 2010; 
Longnecker et al. 2002) and for reproductive outcomes in adult offspring, such as sex hormone levels and 
menstrual cycle in adult daughters or sex hormone levels and sperm parameters in adult sons (Han et al. 
2016; Kristensen et al. 2016; Vasiliu et al. 2004; Vested et al. 2014). 
 
Reproductive effects of DDT and related compounds in mature and developing laboratory animals have 
been observed at relatively high dose levels (>1 mg/kg/day). 
 
After acute-duration exposure, decreased male reproductive tissue weight was observed at doses of DDT 
(not specified [NS]), p,p’-DDT, or p,p’-DDE ≥50 mg/kg/day (Kang et al. 2004; Kelce et al. 1995, 1997) 
and increased weight of the uterus was observed at ≥100 mg o,p’-DDT/kg/day (Clement and Okey 1972; 
Diel et al. 2000).  Decreased fertility has been observed after intermediate-duration exposure to doses of 
technical DDT ≥5.1 mg/kg/day (Bernard and Gaertner 1964; Jonsson et al. 1976; Ledoux et al. 1977).  In 
chronic multi-generation-exposure-duration studies, no adverse effects on reproduction functions were 
observed in rats fed up to 18.6 mg technical-grade DDT/kg/day (Ottoboni 1969) and 27.7 mg 
p,p’-DDT/kg/day (Hojo et al. 2006) and dogs fed up to 10 mg technical DDT/kg/day (Ottoboni et al. 
1977), but decreased fertility was reported in a 3-generation study of mice fed 20 mg technical 
DDT/kg/day (Keplinger et al. 1970).  No treatment-related histopathological effects on the ovaries, 
uterus, mammary gland, or prostate were found in rats fed for 78 weeks with doses up to 45 mg technical 
DDT/kg/day, 59 mg p,p’-DDE/kg/day, or 231 mg technical DDD/kg/day, or mice fed up 30.2 mg 
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technical DDT/kg/day, 49 mg p,p’-DDE/kg/day, or 142 mg technical DDD/kg/day (NCI 1978).  
Reproductive function (e.g., fertility) was not evaluated in the NCI (1978) study.   
 
Gestational exposure of laboratory animals to p,p’-DDT or p,p’-DDE has been associated with decreased 
prostate weight and decreased anogenital distance (AGD) in male offspring at doses ≥10 mg/kg/day (Gray 
1999; Kelce et al. 1995; Loeffler and Peterson, 1999; You et al. 1998); decreased fertility in male and 
female offspring exposed to 50 mg/kg/day on gestation days (GDs) 6–20 (Yamasaki et al. 2009); and 
increased resorptions after impregnation of female offspring exposed to ≥10 mg/kg/day on GDs 7–9 (Hart 
et al. 1971, 1972).  Gestational exposure to o,p’-DDD or p,p’-DDT also has been associated with delayed 
vaginal opening and increased ovary weight in female offspring exposed to 28 mg/kg/day on GDs 15–19, 
but not after GD 15–19 exposure to o,p’-DDT or o,p’-DDE at the same dose level (Gellert and Heinrichs, 
1975).  
 
Exposure during gestation and lactation was associated with decreased fertility in female offspring at a 
high dose level of o,p’-DDT (128 mg/kg/day), but not at ~5–6-fold lower doses of o,p’-DDT 
(26 mg/kg/day) or p,p’-DDT (16.8 mg/kg/day) (Clement and Okey 1974).  
 
Immunological Effects.  Inconsistent evidence for associations between serum levels of p,p’-DDE or 
p,p’-DDT and immune function biomarkers (e.g., immunoglobulin serum levels or counts of white blood 
cell or lymphocyte subtypes) or immune-related conditions (e.g., asthma, bronchitis, eczema) has been 
provided by epidemiological studies of adults (Cooper et al. 2004; Miyake et al. 2011; Vine et al. 2001) 
and children (Karmaus et al. 2001, 2003, 2005a, 2005b; Meng et al. 2016; Perla et al. 2015).  Consistent 
evidence comes from several studies of associations between levels of DDE in cord blood or maternal 
serum during pregnancy and prevalence of wheeze (or airway obstruction) in infant or child offspring 
(Gascon et al. 2012, 2014; Hansen et al. 2016; Sunyer et al. 2005, 2006).  In other epidemiological 
studies, however, inconsistent evidence was provided for associations between maternal DDE exposure 
biometrics (cord blood, maternal serum, or breast milk) and prevalence of asthma, blood levels of 
biomarkers associated with asthma, and prevalence of infections in offspring (Cupul-Uicab et al. 2014; 
Dallaire et al. 2004; Dewailly et al. 2000; Gascon et al. 2012; Glynn et al. 2008; Hansen et al. 2014; Jusko 
et al. 2016a, 2016b; Sunyer et al. 2006, 2010).  
 
A single acute study in hamsters exposed to 4.3 mg DDT (NS)/kg/day for 10 days found no effect on 
antibody titers to Salmonella typhi (Shiplov et al. 1972).  In contrast, the potential for intermediate-
duration exposures to technical DDT, p,p’-DDT, p,p’-DDE, p,p’-DDD, or o,p’-DDD in the diet to 
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suppress or stimulate various immune responses has been examined in rats, mice, and rabbits, with doses 
associated with immune system perturbations, such as decreased immunoglobulin serum levels and 
impaired immune response after antigen challenge, ranging from about 2.3 to 20 mg/kg/day (Banerjee 
1987a, 1987b; Banerjee et al. 1986, 1995, 1996, 1997a, 1997b; Gabliks et al. 1975; Hamid et al. 1974; 
Koner et al. 1998; Rehana and Rao 1992; Street and Sharma 1975).  In these studies, p,p’-DDT was the 
most widely used test material.   
 
Metabolic Effects/Type 2 Diabetes Mellitus (Other Noncancer Effects).  Thirty-four epidemiological 
studies have examined possible associations between human DDT exposure biometrics (e.g., serum or 
adipose levels of DDT, DDE, or DDD) and prevalence of DMT2 or biomarkers indicative of DMT2 or 
other metabolic effects (e.g., fasting blood glucose, insulin, HbA1C, homeostatic model assessment 
insulin resistance, insulin resistance, leptin, or adiponectin).  A clear majority of studies, including several 
meta-analyses, provide evidence for a positive association between DDT exposure biometrics in groups of 
humans and increased prevalence of DMT2 (e.g., Evangelou et al. 2016; Fakhri et al. 2017; Lee et al. 
2010, 2011a; Tang et al. 2014; Taylor et al. 2013; Turyk et al. 2009; Wu et al. 2013).  
 
No animal studies were identified that empirically examined whether isomers of DDT, DDE, or DDD are 
associated with DMT2; this is likely due in part to limitations in animal models for this disease.  A 
limited number of mechanistic animal studies, however, have begun to evaluate whether these compounds 
have obesogenic properties by investigating the effects of exposure to DDT and related compounds on 
energy utilization and metabolic homeostasis.  Elevated fasting blood glucose levels were observed in 
adult mice 3 weeks following 5-day oral exposure to 2 mg/kg/day p,p’-DDE, but not 0.4 mg/kg/day, but 
fasting blood glucose levels were not elevated after 4, 8, or 13 weeks of exposure (Howell et al. 2014, 
2015).  In another study, a challenge with a high-fat diet resulted in glucose intolerance, insulin 
resistance, mild dyslipidemia, and signs of compromised thermogenesis in adult mice exposed during 
gestation and early life to 1.7 mg/kg/day of a mixture of p,p’-DDT and o,p’-DDT (La Merrill et al. 2014a, 
2014b). 
 
Cancer.  Numerous studies have examined possible associations between levels of DDT, DDD, or DDE 
in serum or adipose tissues and risks of several types of cancer in groups of humans from many regions 
throughout the world, including the United States.  Consistent evidence for associations between serum 
DDT levels and increased risk of liver cancer was provided by case-control studies of three Chinese 
populations and one U.S. population (Cocco et al. 2000; McGlynn et al. 2006; Persson et al. 2012; Zhao 
et al. 2012), whereas consistent evidence for no associations with increased risk of breast cancer was 
DDT, DDE, and DDD  11 
 
1.  RELEVANCE TO PUBLIC HEALTH 
 
 
 
 
 
 
***DRAFT FOR PUBLIC COMMENT*** 
provided by 38 studies from regions throughout the world (see meta-analyses by Ingber et al. 2013; 
Lopez-Cervantes et al. 2004; Park et al. 2014).  Each of the meta-analyses noted that exposure metrics in 
most of the breast cancer case-control studies were measured in mature adult women and may not reflect 
exposure during early life periods when the breast may be vulnerable.  Cohn (2011) postulated that the 
lack of an association might be due to the lack of exposure metrics during a critical early period of life.  
Inconsistent evidence was provided for associations from >10 case-control studies of non-Hodgkin’s 
lymphoma (NHL) (Bertrand et al. 2010; Brauner et al. 2012; Cocco et al. 2008; De Roos et al. 2005; 
Engel et al. 2007; Hardell et al. 2001, 2009; Laden et al. 2010; Quintana et al. 2004; Rothman et al. 1997; 
Spinelli et al. 2007; Viel et al. 2011), 7 studies of prostate cancer (Aronson et al. 2010; Emeville et al. 
2015; Hardell et al. 2006a; Pi et al. 2016; Ritchie et al. 2003; Sawada et al. 2010; Xu et al. 2010), and 
5 studies of testicular cancer (Biggs et al. 2008; Giannandrea et al. 2011; Hardell et al. 2006b; McGlynn 
et al. 2008; Purdue et al. 2009).  Consistent evidence for no associations was found in four case-control 
studies of pancreatic cancer (Gasull et al. 2010; Hardell et al. 2007; Hoppin et al. 2000) and two case-
control studies of endometrial cancer (Hardell et al. 2004; Sturgeon et al. 1998).  No evidence for 
associations was found in single case-control studies for bladder cancer (Boada et al. 2016) and colorectal 
cancer (Howsam et al. 2004) and single studies of mortality rates from multiple myeloma (Cocco et al. 
2000) or all cancers (Austin et al. 1989).  
 
The liver and lung appear to the primary cancer targets for isomers of DDT, DDE, and DDD in laboratory 
animals orally exposed to doses that exceed anticipated human exposures.  Chronic oral exposure to 
technical DDT or p,p’-DDT increased incidences of liver tumors in several strains of mice (Innes et al. 
1969; Kashyap et al. 1977; Terracini et al. 1973; Thorpe and Walker 1973; Tomatis et al. 1972, 1974a; 
Turusov et al. 1973) and rats (Cabral et al. 1982b; Fitzhugh and Nelson 1947; Harada et al. 2003, 2006; 
Rossi et al. 1977), and increased incidences of pulmonary adenomas or lung tumors in mice (Kashyap et 
al. 1977; Shabad et al. 1973).  Long-term exposures to DDT failed to induce significant increases in 
tumors in monkeys (Adamson and Sieber 1979, 1983; Durham et al. 1963 Takayama et al. 1999) or dogs 
(Lehman 1965), and evidence of DDT carcinogenicity in hamsters is equivocal (Agthe et al. 1970; Cabral 
et al. 1982a; Graillot et al. 1975; Rossi et al. 1983).  Chronic oral exposures to p,p’-DDE induced liver 
tumors in male and female mice (NCI 1978; Tomatis et al. 1974a) and in hamsters (Rossi et al. 1983), but 
did not induce significant increases in tumor incidence in rats (NCI 1978).  Only two studies evaluated 
DDD; p,p’-DDE induced liver tumors and lung adenomas in CF-1 mice (Tomatis et al. 1974a, 1974b), 
but chronic exposure to technical DDD did not increase incidence of tumors in either mice or rats (NCI 
1978).  
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The U.S. Department of Health and Human Services (HHS) determined that DDT is “reasonably be 
anticipated to be a human carcinogen,” based on sufficient evidence of carcinogenicity in experimental 
animals (NTP 2016).  The U.S. Environmental Protection Agency (EPA) Integrated Risk Information 
System (IRIS) last revised carcinogenicity assessments for DDT, DDD, and DDE in 1988, classifying 
each as a “probable human carcinogen” (Group B2), based on sufficient evidence of carcinogenicity in 
animals (IRIS 2002a, 2002b, 2003).  The International Agency for Research on Cancer (IARC) 
determined that DDT is “probably carcinogenic to humans,” based on limited evidence in humans and 
sufficient evidence in experimental animals (IARC 2017).   
 
1.3   MINIMAL RISK LEVELS (MRLs) 
 
The inhalation database was not considered adequate for deriving inhalation MRLs due to the limited 
available inhalation data for DDT, DDE, and DDD.  The oral database was considered adequate for 
derivation of provisional acute-, intermediate-, and chronic-duration oral MRLs for DDT, DDE, and 
DDD.  The liver and early neurological development are the most sensitive targets following oral 
exposure to DDT (metabolites and isomers).  Other developmental and reproductive endpoints also have 
relatively low LOAEL values, as illustrated in Figure 1-2.  The MRL values are summarized in Table 1-1 
and discussed in greater detail in Appendix A. 
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Figure 1-2.  Summary of Sensitive Targets of DDT, DDE, and DDD – Oral 
 
Neurodevelopment and the liver are the most sensitive targets of DDT, DDE, DDD, and their 
related isomers 
Numbers in circles are the lowest LOAELs (mg/kg/day) for all health effects in animals. 
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Table 1-1.  Minimal Risk Levels (MRLs) for DDT, DDE, and DDDa 
 
Exposure 
duration MRL Critical effect 
Point of 
departure 
Uncertainty 
factor Reference 
Inhalation exposure  
 Acute Insufficient data for MRL derivation 
 Intermediate Insufficient data for MRL derivation 
 Chronic Insufficient data for MRL derivation 
Oral exposure (mg/kg/day) 
 Acute 0.0005 
(provisional) 
Increased motor 
activity (delayed 
habituation) after 
exposure on PND 10 
(neurodevelopmental) 
0.5 (LOAEL) 1,000 Eriksson and 
Norberg 1986; 
Eriksson et al. 
1990a, 1990b, 
1992, 1993; 
Johansson et 
al. 1995, 1996 
 Intermediate 0.0002 
(provisional) 
Hepatocellular 
hypertrophy 
0.17 (LOAEL) 1,000 Harada et al. 
2003, 2006 
 Chronic 0.0001 
(provisional) 
Hepatocellular 
hypertrophy 
0.01 (BMDL10) 100 Harada et al. 
2003, 2006 
 
aSee Appendix A for additional information on MRLs. 
 
BMDL = 95% lower confidence limit on the BMD associated with 10% extra risk; LOAEL = lowest observed adverse 
effect level; PND = postnatal day 
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CHAPTER 2.  HEALTH EFFECTS 
 
2.1   INTRODUCTION  
 
The primary purpose of this chapter is to provide public health officials, physicians, toxicologists, and 
other interested individuals and groups with an overall perspective on the toxicology of DDT, DDE, and 
DDD.  It contains descriptions and evaluations of toxicological studies and epidemiological investigations 
and provides conclusions, where possible, on the relevance of toxicity and toxicokinetic data to public 
health.  When available, mechanisms of action are discussed along with the health effects data; 
toxicokinetic mechanistic data are discussed in Section 3.1.   
 
A glossary and list of acronyms, abbreviations, and symbols can be found at the end of this profile. 
 
To help public health professionals and others address the needs of persons living or working near hazardous 
waste sites, the information in this section is organized by health effect.  These data are discussed in terms of 
route of exposure (inhalation, oral, and dermal) and three exposure periods:  acute (≤14 days), intermediate 
(15–364 days), and chronic (≥365 days). 
 
While this document is specifically focused on the primary forms or isomers of DDT, DDE, and DDD 
(namely p,p’-DDT, p,p’-DDE, and p,p’-DDD), data for other isomers of these compounds will be discussed 
when available and appropriate.  In some cases, the term DDT will be used to refer to the collective forms of 
DDT, DDE, and DDD.  Should this not be clear from the context, the term ΣDDT (Σ is used to mean sum of) 
will be used to indicate the total sum of DDT, DDE, and DDD.  
 
Typically, people are not exposed to DDT, DDE, or DDD individually, but rather to a mixture of all three 
compounds since DDE and DDD are degradation and metabolic products of DDT.  In addition, DDT, DDE, 
and DDD each can exist in three isomeric forms based on the relative position of the chlorine substitutions 
on the two chlorophenyl rings (Chapter 4).  The most prevalent isomer of DDT, DDE, or DDD in the 
environment is the p,p’- isomer.  Technical-grade DDT contains 65–80% p,p’-DDT, 15–21% o,p’-DDT, and 
up to 4% of p,p’-DDD (Metcalf 1995), and DDE is the principal metabolite of DDT (Chapter 3).  When the 
toxicity of the isomers of DDT, DDE, or DDD reported in the experimental data differ in an organ system, 
such as the reproductive or developmental systems, isomer-specific results are presented, when available.  
Therefore, the data presented in this document include some relevant toxicity information on the o,p’- and 
p,p’- isomers of DDT and technical-grade DDT. 
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As discussed in Appendix B, a literature search was conducted to identify relevant studies examining health 
effect endpoints.  Figure 2-1 provides an overview of the database of studies in humans or experimental 
animals included in this chapter of the profile.  These studies evaluate the potential health effects associated 
with inhalation, oral, or dermal exposure to DDT, DDE, and DDD, but may not be inclusive of the entire 
body of literature.   
 
Most laboratory animal toxicity studies of DDT, DDE, or DDD have involved oral exposure; there are only a 
small number of available inhalation or dermal contact studies (see Figure 2-1).  The most widely studied 
health effects examined in human and animal studies were reproductive, neurological and developmental 
effects, and cancer (Figure 2-1).  Considerable focus also has been given to effects on body weight and the 
liver in animal studies, endocrine, and immunological effects in human and animal studies, and human 
studies of risk for DMT2 (Figure 2-1).  The human study counts in Figure 2-1 are principally for 
epidemiological studies examining possible associations between adverse health outcomes and levels of 
DDT, DDE, or DDD in samples of tissues or body fluids.  Oral exposure through food and drinking water is 
the assumed principal route of exposure of the subjects in these studies.  Studies that looked for associations 
between adverse health outcomes and more subjective measures of exposure (e.g., self-reported exposure 
history or work history records) were not included in the analyses described in this chapter.  This chapter 
also discusses the small number of controlled-exposure human studies principally conducted in the 1940s 
through the 1950s, in which human subjects ingested, inhaled, or were dermally exposed to measured doses 
of DDT for acute or intermediate durations (principally technical DDT). 
 
Levels of significant exposure (LSEs) for each route and duration of animals orally exposed are presented 
in Table 2-1 and illustrated in Figure 2-2.  The points in the figures showing no-observed-adverse-effect 
levels (NOAELs) or lowest-observed-adverse-effect levels (LOAELs) reflect the actual doses (levels of 
exposure) used in the studies.  LOAELs have been classified into "less serious" or "serious" effects.  
"Serious" effects are those that evoke failure in a biological system and can lead to morbidity or mortality 
(e.g., acute respiratory distress or death).  "Less serious" effects are those that are not expected to cause 
significant dysfunction or death, or those whose significance to the organism is not entirely clear.  
ATSDR acknowledges that a considerable amount of judgment may be required in establishing whether 
an endpoint should be classified as a NOAEL, "less serious" LOAEL, or "serious" LOAEL, and that in 
some cases, there will be insufficient data to decide whether the effect is indicative of significant 
dysfunction.  However, the Agency has established guidelines and policies that are used to classify these 
endpoints.  ATSDR believes that there is sufficient merit in this approach to warrant an attempt at 
distinguishing between "less serious" and "serious" effects.  The distinction between "less serious" effects 
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and "serious" effects is considered to be important because it helps the users of the profiles identify levels 
of exposure at which major health effects start to appear.  LOAELs or NOAELs should also help in 
determining whether or not the effects vary with dose and/or duration, and place into perspective the 
possible significance of these effects to human health.   
 
A User's Guide has been provided at the end of this profile (see Appendix C).  This guide should aid in 
the interpretation of the tables and figures for LSEs and MRLs. 
 
The early controlled-exposure studies of human adult subjects given acute- or intermediate-duration 
exposure to oral doses of DDT provide adequate descriptions of exposure-response relationships for self-
reported neurological symptoms and NOAELs for liver effects assayed by serum enzyme levels.  In contrast, 
none of the epidemiological studies provide adequate evidence to describe LSEs to DDT, DDE, or DDD.  
For most of the health outcomes evaluated in multiple epidemiological studies, inconsistent evidence is 
available for associations with levels of DDT, DDE, or DDD in tissues or biological fluids, with the 
exception of consistent evidence for associations with:  increased risk for abortions or preterm births (see 
Section 2.16); increased prevalence for wheeze in infant or child offspring (see Section 2.14); increased 
prevalence of DMT2 (see Section 2.18); and increased risk for liver cancer (see Section 2.19).  In addition, 
consistent evidence for no associations was found in studies of breast cancer in women, pancreatic cancer, 
and endometrial cancer (see Section 2.19).  Although epidemiological studies provide consistent evidence of 
associations (or no associations) between DDT and some health outcomes, these data do not establish 
causality.  Other factors, particularly co-exposure to other highly lipophilic compounds (e.g., PCBs, CDDs, 
CDFs), may have influenced the study results.  Some of the epidemiological studies have statistically 
adjusted for exposure to one or more non-DDT compound to decrease the uncertainty; however, most studies 
did not include this adjustment. 
 
Health effects of DDT, DDE, DDD, and their related isomers have been evaluated in many animal studies 
(see Figure 2-1).  Nearly all of the studies evaluated were oral exposure studies; no animal inhalation 
studies were identified.  The most examined noncancer endpoints were reproductive, neurological, 
developmental, body weight, and hepatic effects.  The most reliable health effects data come from oral 
studies of animals administered DDT (metabolites or isomers).  Limited animal data for dermal exposure 
studies indicated that DDT and related compounds are not dermal irritants.  Results from the oral animal 
studies identify the following targets of DDT, DDE, and DDD toxicity. 
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• Hepatic effects:  Acute-, intermediate-, and chronic-duration oral exposures of laboratory 
animals to DDT, DDE, or DDD have been associated with mild-to-severe hepatic effects, such as 
induction of microsomal CYP450 xenobiotic metabolizing enzymes, liver hypertrophy, 
hepatocellular eosinophilic foci, and, less frequently, hepatocellular necrosis.   
 
• Neurological and neurodevelopmental effects:  Tremors, convulsions, and intermittent 
myoclonic movements have been observed in mature laboratory animals after acute-, 
intermediate- and chronic-duration exposure to technical DDT, p,p’-DDT, or p,p’-DDE at 
relatively high exposure levels.  Young laboratory mice appear to be particularly sensitive to 
brain neurochemical changes and associated neurobehavioral changes from acute exposure to low 
doses of technical DDT during critical windows of neurodevelopment (PND 10, but not PND 3 or 
18). 
 
• Reproductive and developmental reproductive effects:  Reproductive effects of DDT and 
related compounds in laboratory animals have been observed at relatively high dose levels.  The 
observed effects include decreased male reproductive tissue weight or increased weight of the 
uterus after acute-duration exposures and decreased fertility after intermediate- or chronic-
duration exposures.  Gestational exposure to p,p’-DDT or p,p’-DDE has been associated with 
decreased prostate weight and decreased AGD in male offspring, decreased fertility in male and 
female offspring, and increased resorptions in female offspring after impregnation.  Gestational 
exposure to o,p’-DDD or p,p’-DDT has been associated with delayed vaginal opening and 
increased ovary weight in female offspring.  Exposure during gestation and lactation was 
associated with decreased fertility in female offspring at a high dose level of o,p’-DDT, but not at 
5–6-fold lower doses of o,p’-DDT or p,p’-DDT.  
 
• Body weight effects:  Decreased body weight or body weight gain have been observed in 
laboratory animals orally exposed to DDT and related compounds after acute-, intermediate-, or 
chronic-duration exposures at relatively high dose levels. 
 
• Immunological effects:  Suppression or stimulation of various immune system responses have 
been observed in rats and mice exposed to dietary doses of technical DDT, p,p’-DDT, p,p’-DDE, 
p,p’-DDD, or o,p’-DDD, but evidence is weak for weight changes or histological changes in 
immune system organs or tissues in laboratory animals after intermediate- or chronic-duration 
exposures. 
 
• Cancer:  The liver appears to the primary cancer target for isomers of DDT, DDE, and DDD in 
laboratory animals. 
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Figure 2-1.  Overview of the Number of Studies Examining DDT, DDE, and DDD Health Effects 
Most studies examined the potential reproductive, developmental, and cancer effects of DDT, DDE, and DDD 
More studies evaluated health effects in humans than animals (counts represent studies examining endpoint) 
 
 
   
 
*Includes studies discussed in Chapter 2.  A total of 636 studies (including those finding no effect) have examined toxicity; most animal studies examined 
multiple endpoints. 
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Table 2-1.  Levels of Significant Exposure to DDT, DDE, and DDD – Oral 
 
Figure 
keya 
Species 
(strain) 
No./group 
Exposure 
parameters 
Doses 
(mg/kg/day) 
Parameters 
monitored Endpoint 
NOAEL 
(mg/kg/day) 
Less serious 
LOAEL 
(mg/kg/day) 
Serious LOAEL 
(mg/kg/day) Effects 
ACUTE EXPOSURE 
1 Human 
7 M, 4 F 
Once 
(F) 
5.1–120.5 CS Neuro 10.3  16 Convulsions 
DDT (NS) 
Hsieh 1954 
2 Monkey 
(Rhesus) 
4 NS 
Once 
(G) 
0, 150 OW GN BI Hepatic  150  Increased serum LDH, AP, and 
aminotransferases 
DDT (NS) 
Agarwal et al. 1978 
3 Monkey 
(Rhesus) 
NS M 
Once 
(G) 
0, 150 BW GN HP 
BI 
Neuro  150  Decreased CNS total lipids, phospholipids, 
and cholesterol 
DDT, technical grade 
Sanyal et al. 1986 
4 Rat (Sprague- 
Dawley)  
5–6 F 
GD 13.5–17.5 
(G) 
0, 50, 100 CS MX BI 
BW HP BC 
DX 
Bd wt 100 F    
  Repro 100 M   No change in plasma corticosterone, LH, or 
intratesticular testosterone levels 
  Develop 50 M 100 M  Fetal alterations of steroidogenic cells; 
histological and ultrastructural alterations in 
fetal-type Leydig cells on ED 19.5 
(vacuolated and reduced number of lipid 
droplets in Leydig cells, partially degenerated 
mitochondria in adrenal - incidence data not 
reported; no change in fetal plasma 
corticosterone, LH, or intratesticular 
testosterone levels; no effect on male or 
female embryo weights on ED 19.5 
p,p'-DDE 
Adamsson et al. 2009 
5 Rat  
(NS)  
NS 
Once 
(NS) 
NS LE Death   400 LD50 
DDD (NS) 
Ben-Dyke et al. 1970 
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Table 2-1.  Levels of Significant Exposure to DDT, DDE, and DDD – Oral 
 
Figure 
keya 
Species 
(strain) 
No./group 
Exposure 
parameters 
Doses 
(mg/kg/day) 
Parameters 
monitored Endpoint 
NOAEL 
(mg/kg/day) 
Less serious 
LOAEL 
(mg/kg/day) 
Serious LOAEL 
(mg/kg/day) Effects 
6 Rat  
(NS)  
NS 
Once 
(NS) 
NS LE Death   300 LD50 
DDT (NS) 
Ben-Dyke et al. 1970 
7 Rat  
(NS)  
5 NS 
Once 
(G) 
NS LE Death   800 LD50 
DDT (NS) 
Cameron and Burgess 1945 
8 Rat  
(Wistar)  
20 F 
7 days, 
PNDs 23–30 
(F) 
0, 50, 100, 
200, 300 
HP Develop 50 F 100 F  Increased uterus weight; premature vaginal 
opening 
o,p’-DDT 
Clement and Okey 1972 
9 Rat  
(Wistar)  
NS 
5 or 12 days 
(G) 
0, 40 GN OW Hepatic  40  18% increase in relative liver weight; 
increased liver GSH and AHH enzyme 
activities 
DDT (NS) 
DeWaziers and Azais 1987 
10 Rat 
(DA/Han)  
6 F 
3 days 
1 time/day 
(G) 
0, 10, 100, 
500 
OW BI Repro 10 F 100 F  Significant increase in wet uterine weight 
o,p’-DDT 
Diel et al. 2000 
11 Rat 
(Sherman) 
NS B 
Once 
(G) 
NS LE Death   4,000 LD50 
DDD-technical 
Gaines 1969 
12 Rat 
(Sherman)  
B 
Once 
(G) 
NS LE Death   880 LD50 
DDT, technical grade 
Gaines 1969 
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Table 2-1.  Levels of Significant Exposure to DDT, DDE, and DDD – Oral 
 
Figure 
keya 
Species 
(strain) 
No./group 
Exposure 
parameters 
Doses 
(mg/kg/day) 
Parameters 
monitored Endpoint 
NOAEL 
(mg/kg/day) 
Less serious 
LOAEL 
(mg/kg/day) 
Serious LOAEL 
(mg/kg/day) Effects 
13 Rat 
(Sherman)  
B 
Once 
 
NS LE Death   113 LD50 
p,p'-DDT 
Gaines 1969 
14 Rat 
(Sprague- 
Dawley)  
15 F 
GDs 15–19 
(G) 
0, 28 OW BW Develop  28 F  Delayed vaginal opening (2 days) 
o,p'-DDD 
Gellert and Heinrichs 1975 
15 Rat 
(Sprague-
Dawley)  
15 F 
GDs 15–19 
(G) 
0, 28 BW OW Develop  28  11.9% Increase in body weight and no 
effects on estrous cycle, vaginal opening, or 
ovary, adrenal, or anterior pituitary weights in 
adult offspring 
o,p'-DDE 
Gellert and Heinrichs 1975 
16 Rat 
(Sprague-
Dawley)  
15 F 
GDs 15–19 
(G) 
0, 28 BW OW Develop  28  13% increase in body weight and no effects 
on estrous cycle, vaginal opening, or ovary, 
adrenal, or anterior pituitary weights in 
offspring 
o,p’-DDT 
Gellert and Heinrichs 1975 
17 Rat 
(Sprague- 
Dawley)  
15 F 
GDs 15–19 
(G) 
0, 28 OW BW Develop  28 F  26% Decrease in ovary weight; 9% increase 
body weight in offspring; no effects on 
estrous cycle, or vaginal opening 
p,p'-DDT 
Gellert and Heinrichs 1975 
18 Rat 
(Sprague-
Dawley)  
10 M 
Once 
(GO) 
0, 25, 50, 
100, 200 
CS OF Endocr 25 50  Reduced capacity to concentrate iodine in 
thyroid 
DDT, technical grade 
Goldman 1981 
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Table 2-1.  Levels of Significant Exposure to DDT, DDE, and DDD – Oral 
 
Figure 
keya 
Species 
(strain) 
No./group 
Exposure 
parameters 
Doses 
(mg/kg/day) 
Parameters 
monitored Endpoint 
NOAEL 
(mg/kg/day) 
Less serious 
LOAEL 
(mg/kg/day) 
Serious LOAEL 
(mg/kg/day) Effects 
19 Rat  
(Long-Evans)  
8 F 
5 days 
GDs 14–18 
(GO) 
0, 100 OW HP GN 
DX 
Develop  100 M  At 10 months of age, significant decrease in 
ventral prostate weight; percent of animals 
with areolas; and mean number of retained 
nipples; no effect on pup weight or body 
weight as adults 
p,p'-DDE 
Gray et al. 1999 
20 Rat 
(Sprague- 
Dawley)  
11 F 
5 days 
GDs 14–18 
(GO) 
0, 100 OW HP DX 
GN 
Develop  100 M  At 15 months of age, decreased weight of 
glans penis, epididymis, and ventral prostate; 
reduced AGD; increased percent with areolas 
and number with retained nipples; no effect 
pup weight or body weight as adults 
p,p'-DDE 
Gray et al. 1999 
21 Rat  
32 M 
Once 
(G) 
0, 75  Neuro   75 Tremors 
DDT (NS) 
Herr and Tilson 1987 
22 Rat  
12 M 
Once 
(G) 
0, 50, 75, 
100 
 Neuro   50 Tremors 
DDT (NS) 
Herr et al. 1985 
23 Rat  
(Wistar)  
40 M 
Once 
(GO) 
160 GN HP BI Neuro   160 M Tremors 
DDT (NS) 
Hietanen and Vainio 1976 
24 Rat  
(Fischer-344)  
4 M 
Once 
(G) 
0, 25, 50, 
75, 100 
BI CS Neuro 25 M 50 M  Tremors, more severe at 75 and 
100 mg/kg/day; increased brain 5-HIAA, 
aspartate, and glutamate 
p,p'-DDT 
Hong et al. 1986; Hudson et al. 1985 
25 Rat  
(Albino 
Sprague-
Dawley)  
18 M 
Once 
(G) 
0, 100-600 GN BI Neuro  100 M 200 M Serious LOAEL: severe myoclonus, tremors, 
seizures; increased brain 5-HIAA 
LOAEL: intermittent myoclonic movement 
p,p'-DDT 
Hwang and Van Woert 1978 
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Figure 
keya 
Species 
(strain) 
No./group 
Exposure 
parameters 
Doses 
(mg/kg/day) 
Parameters 
monitored Endpoint 
NOAEL 
(mg/kg/day) 
Less serious 
LOAEL 
(mg/kg/day) 
Serious LOAEL 
(mg/kg/day) Effects 
26 Rat  
(Sprague- 
Dawley)  
6 M 
10 days 
(G) 
0, 25, 50, 
100 
CS OW BC 
BW 
Bd wt 100 M    
 Hepatic  25 M  Increased absolute liver weight (42%) 
   Renal 100 M    
    Repro 25 M 50 M  Inhibited regrowth of TP-inhibited accessory 
sex organs; decreased seminal vesicle 
weight (34%) 
p,p'-DDE 
Kang et al. 2004  
27 Rat  
(Long-Evans)  
8 F 
1 time/day 
GDs 14–18 
(GO) 
0, 100 DX Develop  100 M  Males: reduced AGD at birth; PND 13 
retained thoracic nipples 
p,p'-DDE 
Kelce et al. 1995 
28 Rat  
(Long-Evans)  
6 M 
1 time/day 
4 days 
(GO) 
0, 200 CS OW Bd wt  200 M  Decreased body weight (29.8%) 
   Repro  200 M  Reduced seminal vesicle and ventral prostate 
weight; no effect on serum testosterone 
p,p'-DDE 
Kelce et al. 1995 
29 Rat  
(Sprague- 
Dawley)  
10 M 
1 time/day 
5 days 
(GO) 
0, 200 CS OW Repro  200 M  Reduced seminal vesicle and ventral prostate 
weight; no effect on serum testosterone 
p,p'-DDE 
Kelce et al. 1997 
30 Rat  
(Wistar)  
6 M 
14 days 
1 time/day 
(GO) 
0, 12 BI HP OW Hepatic  12 M  Increased relative liver weight; necrotic 
changes; increased cell proliferation peaked 
at exposure day 3 
DDT, technical grade 
Kostka et al. 2000 
31 Rat  
6 M 
2 days, 
PNDs 4 and 5 
(G) 
0, 500 BW OW HP Repro  500  Decreased number of fetuses and 
implantations in non-exposed dams mated 
with exposed males 
DDT (NS) 
Krause et al. 1975 
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Figure 
keya 
Species 
(strain) 
No./group 
Exposure 
parameters 
Doses 
(mg/kg/day) 
Parameters 
monitored Endpoint 
NOAEL 
(mg/kg/day) 
Less serious 
LOAEL 
(mg/kg/day) 
Serious LOAEL 
(mg/kg/day) Effects 
32 Rat  
(Long- Evans)  
5 M 
4 days 
(G) 
0, 5, 12.5, 
25, 50, 100 
CS OW BI 
BW 
Hepatic 12.5 M 25 M  Increased relative liver weight (32%) 
 Repro 100 M   No changes in relative ventral prostate or 
seminal vesicles weight, serum testosterone, 
or dihydrotestosterone levels 
p,p'-DDE 
Leavens et al. 2002 
33 Rat 
(Sprague- 
Dawley)  
6 M 
Once or 
5 days 
(GO) 
50 OW HP OF Repro 50 M   No histopathological changes to testes or 
epididymis; no effect on testes, epididymis, 
prostate, or seminal vesicle weights, 
epididymal sperm counts, motility, or 
morphology 
p,p'-DDT 
Linder et al. 1992 
34 Rat 
(Sprague- 
Dawley)  
6 M 
Once 
(GO) 
100 OW, HP, OF Repro 100 M   No histopathological changes to testis or 
epididymis; no effect on testis, epididymis, 
prostate, or seminal vesicle weights; 
increased sperm counts in cauda only; no 
effect on sperm motility or morphology 
p,p'-DDT 
Linder et al. 1992 
35 Rat 
(Holtzman) 
3–6 F 
1 time/day 
GDs 14–18 
(GO) 
0, 1, 10, 50, 
100, 200 
DX OW BW Develop 10 M 50 M  Reduced AGD on PND 1 and relative ventral 
and dorsolateral prostate weights on 
PND 21; increased nipple retention starting 
at 100 mg/kg/day; delayed age at preputial 
separation at 200 mg/kg/day; no effect on 
weights of seminal vesicles, testes, or 
epididymides; prostate weight changes were 
transient; no effect on sperm production 
p,p'-DDE 
Loeffler and Peterson 1999 
36 Rat  
(NS) 
10 B 
Once 
(G) 
346.3–553.9 LE Death   437.8  
DDT, technical grade 
Lu et al. 1965 
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Figure 
keya 
Species 
(strain) 
No./group 
Exposure 
parameters 
Doses 
(mg/kg/day) 
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NOAEL 
(mg/kg/day) 
Less serious 
LOAEL 
(mg/kg/day) 
Serious LOAEL 
(mg/kg/day) Effects 
37 Rat  
(NS) 
10 B 
4 days 
(G) 
216.8–359.2 LE Death   279.2 4-Day LD50, preweanling; cumulative dose 
DDT, technical grade 
Lu et al. 1965 
38 Rat  
(NS) 
10 B 
Once 
(G) 
4,000 LE Death   4000  
DDT, technical grade 
Lu et al. 1965 
39 Rat  
(NS) 
10 B 
Once 
(G) 
317.2–397.8 LE Death   355.2 LD50, weanling rats 
DDT, technical grade 
Lu et al. 1965 
40 Rat  
(NS) 
10 B 
4 days 
(G) 
225.6–364.8 LE Death   285.6 4-Day adult LD50; cumulative dose 
DDT, technical grade 
Lu et al. 1965 
41 Rat  
(NS)  
10 B 
Once 
(G) 
158.7–238.3 LE Death   194.5 LD50, adult rats 
DDT, technical grade 
Lu et al. 1965 
42 Rat 
(Fischer-344)  
3/dose M 
2 weeks 
(F) 
0, 0.85, 2.6, 
7.7, 23, 69, 
200 
BC BW EA 
GN BH 
Bd wt 200 M   No change in body weight or body weight 
gain 
Hepatic 69 M 200 M  Increased relative liver weight 
Neuro 200 M   No muscle tremors or hyperexcitability 
p,p'-DDD 
Nims et al. 1998 
43 Rat 
(Fischer-344)  
3/dose M 
2 weeks 
(F) 
0, 0.85, 2.5, 
7.6, 23, 69, 
200 
BC BW EA 
GN BH 
Bd wt 200 M    
 Hepatic 7.6 M 23 M  Increased relative liver weight 
 Neuro 200 M   No muscle tremors or hyperexcitability 
p,p'-DDE 
Nims et al. 1998 
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44 Rat  
(Fischer-344)  
3/dose M 
2 weeks 
(F) 
0, 0.94, 2.8, 
8.5, 25, 76, 
200 
BC BW EA 
GN BH 
Bd wt 200 M    
 Hepatic 8.5 M 25 M  Increased relative liver weight 
   Neuro 200 M   No muscle tremors or hyperexcitability 
p,p'-DDT 
Nims et al. 1998 
45 Rat  
8 M 
Once 
(GO) 
200, 600, 
1,000 
CS BI Neuro 200  600 Convulsions, myoclonus 
p,p'-DDT 
Pranzatelli and Tkach 1992 
46 Rat  
NS M 
Once 
(G) 
0, 50, 100, 
200, 400, 
600 
 Neuro 50 M 200 M 400 M LOAEL: Intermittent myoclonus 
Serious LOAEL: Continuous myoclonus 
p,p'-DDT 
Pratt et al. 1986 
47 Rat 
(Fischer-344, 
Albino) 
6 M 
Once 
(G) 
0, 75 BI Neuro  75 M  Tremors and increased brain 5-HIAA 
p,p'-DDT 
Tilson et al. 1986 
48 Rat 
(Fischer-344)  
M 
Once 
(G) 
0, 25, 50, 
100 
BH Neuro 25 M 50 M 100 M Serious LOAEL: severe tremors and death in 
some rats 
LOAEL: Hyperirritability and tremors; more 
severe at 100 mg/kg/day 
NOAEL: No tremors; no effects on learning a 
conditioned response at up to 100 mg/kg/day 
p,p'-DDT 
Tilson et al. 1987 
49 Rat 
(Fischer-344)  
5–6 M 
2 weeks 
(F) 
0, 0.5, 5.0, 
50 
HE HP BC Hemato 0.5 M 5 M  Increase in total iron binding capacity 
p,p'-DDT 
Tomita et al. 2013 
50 Rat 
(Fischer-344)  
33 M 
7 days 
(F) 
0, 106 BI BC OW 
CS 
Hepatic  106 M  Increased absolute and relative liver weight 
p,p'-DDT 
Tomiyama et al. 2003 
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51 Rat  
(Fischer-344)  
36 M 
Once 
(G) 
0, 106 BI BC OW Neuro   106 M Tremors and convulsions, hyperactivity 
p,p'-DDT 
Tomiyama et al. 2003 
52 Rat  
(Fischer-344)  
5 M 
14 days 
(F) 
0, 5, 16, 50  Hepatic  5 M   
p,p'-DDT 
Tomiyama et al. 2004 
53 Rat  
(Sprague- 
Dawley)  
8–11 F 
1 time/day 
GDs 14–18 
(GO) 
0, 10, 100 CS BI DX  Develop 100 F   No effect on postnatal body weight or AGD 
on PND 2, no effect on age of vaginal 
opening 
   Develop  10 M  PND 13 males retained thoracic nipples; no 
effect on postnatal body weights, AGD, age 
of preputial separation, no effect on 
reproductive organ weights or serum 
testosterone 
p,p'-DDE 
You et al. 1998 
54 Rat  
(Long-Evans) 
8–11 F 
1 time/day 
GDs 14–18 
(GO) 
0, 10, 100 CS BI DX Develop  100 F  No effect on postnatal body weights, AGD, or 
age of vaginal opening 
    10 M 100 M  Reduced anogenital distance on PND 2; 
retained thoracic nipples on PND 13; no 
effect on postnatal body weight, age of 
preputial separation, or AGD; no effect on 
reproductive organ weights; no change in 
serum testosterone 
p,p'-DDE 
You et al. 1998 
55 Rat  
(Long-Evans)  
5–8 M 
4 days 
(F) 
0, 70 BW OW Bd wt 70 M    
   Renal 70 M    
    Repro  70 M  Decreased ventral prostate weight (30%); 
epididymis (12.7%), and seminal vesicle 
(47%) weights on PND 85; no significant 
changes in serum testosterone or LH 
p,p'-DDE 
You et al. 1999a 
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56 Mouse 
(NMRI)  
12 M 
Once 
PND 10 
(GO) 
0, 0.5 BI Develop  0.5 Mb  7 days after exposure: increased muscarinic 
receptor binding, decreased high affinity, and 
increased low affinity binding; no effect on 
sodium-dependent choline uptake; no 
changes 24 hours after exposure 
DDT (NS) 
Eriksson and Nordberg 1986 
57 Mouse  
(NMRI) 
12 M 
Once  
PND 10 
(GO) 
0, 0.5 BH Develop  0.5 Mb  Delayed habituation observed as increased 
motor activity 
DDT (NS) 
Eriksson et al. 1990a 
58 Mouse  
(NMRI)  
12 B 
Once 
PND 10 
(GO) 
0, 0.5 DI Develop  0.5 Mb  Increased motor activity (reduced 
habituation) at 4 months; increased 
potassium evoked Ach release; reduced 
density of muscarinic receptors in cerebral 
cortex at 3 months; no change in choline 
acetyltransferase activity 
DDT (NS) 
Eriksson et al. 1990b 
59 Mouse 
(NMRI)  
12 M 
Once at either 
PND 3, 10, or 
19 
(GO) 
0, 0.5 BI CS BW 
BH 
Develop  0.5 Mb  At 4 months of age in males dosed at 
10 days: decrease in cerebral cortex 
muscarinic acetylcholine receptor binding; 
delayed habituation; no change in proportion 
of HA and LA binding sites or affinity 
constants; no differences in body weight 
gain; no changes in mice dosed on PND 3 or 
19 
DDT, technical grade 
Eriksson et al. 1992 
60 Mouse  
(NMRI)  
M 
Once 
PND 10 
(GO) 
0, 0.5 BI BH Develop  0.5 Mb  At 5 months of age: delayed habituation 
(increased motor activity); decrease in 
cortical muscarinic acetylcholine receptors; 
no change in high affinity or low affinity 
muscarinic binding sites 
DDT (NS) 
Eriksson et al. 1993 
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61 Mouse  
(albino)  
15 M 
Once 
(GO) 
0, 160 CS Neuro   160 M Tremors 
p,p'-DDT 
Hietanen and Vainio 1976 
62 Mouse 
(C57BL/6H) 10 
M/dose 
5 days 
(G) 
0, 0.4, 2 BC BW Bd wt 2 M    
     Other 
noncancer 
0.4 M 2 M  Fasting Hyperglycemia 7 days after last 
exposure; no effect on serum insulin, 
glucagon, leptin, or resistin levels of glucose 
tolerance 
p,p'-DDE 
Howell et al. 2014 
63 Mouse  
(NMRI)  
NS M 
Once 
PND 10 
(GO) 
0, 0.5 BI DX BH Develop  0.5 Mb  Decreased muscarinic receptors in cerebral 
cortex; increased spontaneous activity at 
5 months 
DDT, technical grade 
Johansson et al. 1995 
64 Mouse  
(NMRI)  
NS M 
Once 
PND 10 
(GO) 
0, 0.5 BI DX BH Develop  0.5 Mb  Decreased muscarinic receptors in cerebral 
cortex; increased spontaneous activity at 5 
and 7 months 
DDT, technical grade 
Johansson et al. 1996 
65 Mouse  
(Inbred Swiss)  
NS 
Once 
(G) 
NS LE Death   300 M LD50 
DDT, technical grade 
Kashyap et al. 1977 
66 Mouse 
(Albino)  
10 M 
Once 
(G) 
0, 200, 400, 
600 
CS BI Neuro   200 Convulsions 
p,p'-DDT 
Matin et al. 1981 
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67 Mouse  
(C3H)  
NS B 
6 days 
(F) 
M: 87.5; F: 
85.7 
LE Death   85.7 F 50% of mice died after a 6-day feeding 
period 
p,p'-DDT 
Okey and Page 1974 
68 Mouse  
(CD-1)  
NS B 
7 days 
GDs 11–17 
(GO) 
0, 0.018, 
0.18 
DX BH Develop 0.018 M   No significant effect on behavior or 
aggression 
o,p’-DDT 
Palanza et al. 1999 
69 Mouse  
(CF-1)  
6–10 F/dose 
GDs 11–17 
(G) 
0, 0.02, 0.2, 
2, 20, 100 
MX BW DX Bd wt 100 F   No effect on maternal body weight 
o,p’-DDT 
Palanza et al. 2001 
70 Mouse  
(CF1)  
8 NS 
1 week 
(F) 
0, 42.9 BW BI OW Hepatic 42   29% increase absolute liver weight; increase 
cytochrome-c reductase and P-450 
DDE (NS) 
Pasha 1981 
71 Mouse  
(CF1)  
4 M, 4 F 
Once 
(G) 
NS LE Death   251.3 F LD50 
     237 M LD50 
DDT, technical grade 
Tomatis et al. 1972 
72 Mouse  
(CF1)  
8 B 
Once 
(G) 
NS LE Death   810 LD50 
o,p'-DDE 
Tomatis et al. 1972 
73 Mouse  
(CF1)  
8 B 
Once 
(G) 
NS LE Death   1466 LD50 
p,p'-DDD 
Tomatis et al. 1972 
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74 Guinea pig 
(NS)  
5 NS 
Once 
(G) 
NS LE Death   400 LD50 
DDT (NS) 
Cameron and Burgess 1945 
75 Guinea pig 
(NS)  
10 M 
Once 
(G) 
0, 160 GN HP BI Neuro   160 Paralysis of hind legs 
DDT (NS) 
Hietanen and Vainio 1976 
76 Hamster  
(NS)  
8 F 
Once 
(G) 
0, 160 GN HP BI Neuro 160    
DDT (NS) 
Hietanen and Vainio 1976 
77 Dog  
(NS)  
NS 
14 days 0, 50 BW HP CS Cardio   50 Decrease in contractile force 
    Endocr  50  Decreased plasma glucocorticoids 
o,p'-DDD 
Cueto 1970 
78 Dog  
(NS)  
NS 
10 days 
(C) 
0, 138.5 HP BC Endocr   138.5 Adrenal hemorrhage 
o,p'-DDD 
Kirk et al. 1974 
79 Dog  
(mongrels and 
beagles) 
10 NS 
Once 
(C) 
0, 200 OW HP Endocr  200  Adrenal vacuolization and necrosis 
p,p'-DDD 
Powers et al. 1974 
80 Rabbit  
(NS)  
5 NS 
Once 
(G) 
NS LE Death   300 LD50 
DDT (NS) 
Cameron and Burgess 1945 
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81 Rabbit  
(New Zealand)  
10 F 
GDs 4–7 
(G) 
0, 1.0 BW Develop  1  On GD 28, 33% decreased fetal weight; 
decreased fetal brain and kidney weights 
DDT (NS) 
Fabro et al. 1984 
82 Rabbit  
(New Zealand)  
6–15 F 
GDs 7–9 or 
21–23 
(GO) 
0, 10, 50 BW HP OF Repro   10 F Exposure on GDs 7–9: increased 
resorptions, 1.3% in controls, 9.5% in treated; 
increased incidence of prematurity 22% 
   Develop  10 F 50 F LOAEL: 11% decreased fetal weight on 
day 28 
Serious LOAEL: GDs 7–9 exposure: 19% 
decreased fetal weight on day 28; 40% 
deliveries premature; GDs 21–23 exposure: 
no effect on prematurity, resorptions or fetal 
weight 
p,p'-DDT 
Hart et al.  1972 
83 Rabbit  
(New Zealand)  
6–15 F 
GDs 7–9 
(GO) 
0, 50 BW HP OF Repro   50 F Increased resorptions, 1.8% in controls, 25% 
in treated 
   Develop   50 F 22% decreased offspring weight 
p,p'-DDT 
Hart et al. 1971 
84 Rabbit  
(New Zealand) 
30 M 
10 days 
(G) 
0, 4.3 BC Immuno 4.3   No effect on antibody titres to Salmonella 
typhimurium 
DDT (NS) 
Shiplov et al. 1972 
INTERMEDIATE EXPOSURE 
85 Monkey 
(Squirrel) 
12 M, 18 F 
2, 4, or 
6 months 
(G) 
0, 0.05, 0.5, 
5, 50 
BC BI Death   50 Death of 6/6 in 14 weeks 
p,p'-DDT 
Cranmer et al. 1972 
86 Monkey 
(Squirrel) 
12 M, 18 F 
2, 4, or 
6 months 
(G) 
0, 0.05, 0.5, 
5, 50 
BC BI CS Neuro 5  50 Staggering, weakness, loss of equilibrium 
p,p'-DDT 
Cranmer et al. 1972 
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87 Monkey  
12–18 F 
2, 4, or  
6 months 
(G) 
0, 0.05, 0.5, 
5, 50 
BC BI CS Hemato 50 F    
  Hepatic 5 F    
p,p'-DDT 
Cranmer et al. 1972 
88 Monkey 
(Rhesus)  
M 
100 days 
(G) 
0, 10 BW GN HP 
BI 
Neuro  10  15–20% decrease in brain lipids, CNS 
phospholipids, and cholesterol 
DDT, technical grade 
Sanyal et al. 1986 
89 Rat  
(albino)  
10–12 M 
8–22 weeks 
(F) 
0, 2.2, 5.5, 
11 
BW FI BC 
CS 
Immuno 2.2 M 5.5 M  Decreased relative spleen weight (17%) at 
22 weeks; increased serum albumin/globulin 
ratio and reduced IgG titers after tetanus 
toxoid stimulation; no effect on IgM titers, 
relative thymus weight, or body weight 
p,p'-DDT 
Banerjee 1987b 
90 Rat  
(Wistar)  
10–12 M 
4 weeks 
(F) 
0, 2.3, 5.7, 
11.4 
BW CS FI 
OW LE 
Immuno 2.3 M 5.7 M  Decreased IgG and IgM, increased 
albumin/globulin ratio 
p,p'-DDT 
Banerjee et al. 1995 
91 Rat  
(Wistar)  
8–12 M 
6 weeks 
(F) 
0, 20.2 LE FI BW 
OW OF 
Hepatic 20.2 M    
  Immuno  20.2 M  After ovalbumin immunization: decreased 
serum IgG and IgM, and ovalbumin antibody 
titre; increased % migration of leucocytes and 
macrophages; decreased footpad thickness; 
decreased relative spleen weight; no effect 
on thymus weight 
p,p'-DDD 
Banerjee et al. 1996 
92 Rat  
(Wistar)  
8–12 M 
6 weeks 
(F) 
0, 20.2 LE FI BW 
OW OF 
Bd wt 20.2 M    
  Hepatic  20.2 M  Increased relative liver weight (17.1%) 
p,p'-DDE 
Banerjee et al. 1996 
DDT, DDE, and DDD  35 
 
2.  HEALTH EFFECTS 
 
 
***DRAFT FOR PUBLIC COMMENT*** 
Table 2-1.  Levels of Significant Exposure to DDT, DDE, and DDD – Oral 
 
Figure 
keya 
Species 
(strain) 
No./group 
Exposure 
parameters 
Doses 
(mg/kg/day) 
Parameters 
monitored Endpoint 
NOAEL 
(mg/kg/day) 
Less serious 
LOAEL 
(mg/kg/day) 
Serious LOAEL 
(mg/kg/day) Effects 
93 Rat  
(Wistar)  
8–12 M 
6 weeks 
(F) 
0, 20.2 LE FI BW 
OW OF 
Bd wt 20.2 M    
  Hepatic  20.2 M  Increased relative liver weight (14.2% 
increase) 
p,p'-DDT 
Banerjee et al. 1996 
94 Rat  
(Wistar)  
NS B 
7 months 
(F) 
0, 2.6, 26, 
128 
BW HP LE Repro 26 F  128 F Decreased fertility in F1 females bred with 
nonexposed males 
o,p’-DDT 
Clement and Okey 1974 
95 Rat  
(Wistar)  
NS B 
Through 
breeding 
GDs 1–21 
LDs 1–21 
(F) 
0, 1.7, 16.8, 
84 
BW LE Develop 16.8 84  Decreased body weights and growth of 
nursing pups 17% less body weight than 
controls at age 21 days; reduced fertility in F1 
females (25% produced litters versus 100% 
in control) 
o,p’-DDT 
Clement and Okey 1974 
96 Rat  
(Wistar)  
NS B 
Through 
breeding, 
GDs 1–21 
LDs 1–21 
(F) 
0, 1.7, 16.8, 
42.1 
BW LE Repro 16.8 F   No effect on fertility of F1 female progeny 
bred to nonexposed males 
  Develop 1.7 16.8 42.1 LOAEL: Decreased body weights and growth 
of nursing pups; no effect on F1 fertility 
Serious LOAEL: All F1 offspring dead by 
10 days after birth 
p,p'-DDT 
Clement and Okey 1974 
97 Rat  
(albino)  
5 F 
31 days 
24 hours/day 
(F) 
0, 2.3, 23 BW FI GN 
BC 
Immuno  2.3  Decreased severity of anaphylactic shock, 
decreased mast cells response to diphtheria 
toxoid 
DDT (NS) 
Gabliks et al. 1975 
98 Rat  
(Wistar)  
12 M 
3 weeks 
(GO) 
0, 15 BW BI OW Hepatic  15 M  Increase in liver weight and in cytochrome 
P450 enzymes 
p,p'-DDT 
Gupta et al. 1989 
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99 Rat 
(F344/DuCrj)  
20 M, 20 F 
26 weeks 
(F) 
Male: 0, 
0.17, 1.7, 
and 19.1; 
females: 0, 
0.21, 2.2, 
25.2 
HP BW FI 
CS 
Hepatic 0.21 F 2.2 F  Hepatocellular hypertrophy 
    0.17 Mc  Hepatocellular hypertrophy 
p,p'-DDT 
Harada et al. 2003, 2006 
100 Rat 
(F344/DuCrj)  
30 M 
4 weeks 
(F) 
0, 4.8, 15.4, 
45.7 
HP BW FI 
CS 
Bd wt 45.7 M    
  Hepatic  4.8 M  Increased absolute and relative liver weight; 
decreased gap junctional intercellular 
communication protein Cx32; increased 
hepatocyte proliferation (% PCNA labeling 
index) at ≥15.4 mg/kg/day 
p,p'-DDT 
Harada et al. 2003; Tomiyama et al. 2004 
101 Rat (Sprague- 
Dawley)  
P and F1, 
each 24 M, 
24 F/dose 
2-generation 
P generation: 
10 weeks from 
before mating, 
through 
lactation. 
F1 generation: 
during rearing 
for 10 weeks, 
through 
mating, 
gestation, and 
lactation 
F2 generation: 
through 
weaning 
(F) 
P- males: 0, 
0.343, 3.44, 
25;  
P- females: 
0.73, 3.75, 
27.7 
CS BW OW 
MX DX TG 
OF HP GN 
FX FI BC 
Bd wt 25 M 27.7 F  P and F1 females: decreased body weight 
Hepatic 0.73 F 3.75 F  Centrilobular hypertrophy and increased 
relative liver weights in P and F1 females 
 0.343 M 3.44 M  Centrilobular hypertrophy, fatty change of 
hepatocytes; increased absolute and relative 
liver weight in P and F1 males. 
Renal 3.44 25  Parental males and females and F1 females: 
increased kidney weight (no histopathology) 
 Neuro  27.7 F  Increased incidence of tremors in P and F1 
parental females 
     25 M   No incidence of tremors in males 
    Repro 25   Estrous cyclicity, estrous cycle length, 
reproductive capability; testicular and 
epididymal sperm parameters (males); 
reproductive organ weights 
      0.73 F 3.75 F  F0 females: decreased estradiol levels at 
3.75 and 27.7 mg/kg/day; increased 
progesterone at 27.7 mg/kg/day, but no 
effects on F0 or F1 indices of mating and 
fertility, or viability of F1 and F2 offspring in 
any exposure group 
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      25 M   No effects on F0 male sex hormone levels, 
F0 and F1 indices of mating and fertility, or 
F1 and F2 viability 
     Develop 3.75 27.7  Decreased pup viability index on PND 21 in 
F1 pups; Delayed preputial separation in F1 
males and decreased body weight; increased 
kidney weight (no histopathology) in F1 
females 
p,p'-DDT 
Hojo et al. 2006 
102 Rat  
(Sprague-
Dawley) 
6 F 
36 weeks 
7 days/week 
(F) 
0, 6.6, 13.2 GN HP BC Hepatic  6.6  Focal necrosis/regeneration 
DDT (NS) 
Jonsson et al.  1981 
103 Rat  
(Sprague-
Dawley)  
6 F 
36 weeks 
(F) 
0, 6, 12  Repro 6  12 Decreased fertility 
DDT, technical grade 
Jonsson et al. 1976 
104 Rat  
(Long-Evans) 
12 M 
PNDs 21–57 
(GO) 
0, 100 CS Bd wt  100 M  Increased body weight (18%) 
   Repro   100 M Delayed onset of puberty by 5 days; no 
changes in serum testosterone 
p,p'-DDE 
Kelce et al. 1995 
105 Rat  
(Wistar)  
8–10 M 
8 weeks 
(F) 
0, 10.3, 20.6 OF Immuno 10.3 M 20.6 M  Decreased serum antibody titer to SRBC 
DDT, technical grade 
Koner et al. 1998 
106 Rat  
(Sprague-
Dawley)  
110 F 
5 weeks, 
5 days/week 
(G) 
0, 10 CS BW OW 
HP BC 
Repro 10   No effects on reproductive functions 
(including fertility, body weights, 
development, or size of litters) 
p,p'-DDE 
Kornbrust et al. 1986 
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107 Rat  
(Wistar)  
6 M 
3 weeks 
3 times/week 
(GO) 
0, 100, 200 BW OW HP 
BC 
Repro  100  Marginal, but significant decrease in 
testosterone in the testis 
DDT (NS) 
Krause 1977 
108 Rat  
(NS)  
6 M 
PNDs 4–23 
(G) 
0, 200 BW OW HP Bd wt 200 M   No effect on body weight up to 50 days after 
exposure 
   Repro  200 M  Decreased absolute testis weight; decreased 
tubular diameter; reduced number of Sertoli 
cells, A-spermatagonia, and Leydig cells 6–
12 days after exposure; significant reduction 
in number of fetuses and implants after two 
matings 
DDT (NS) 
Krause et al. 1975 
109 Rat  
(Osborne- 
Mendel)  
15 M, 15 F 
15–27 weeks 
(F) 
0, 0.05, 
0.25, 0.5, 
2.5 
BW OW GN 
HP 
Hepatic 0.05 0.25  Minimal centrilobular hypertrophy, 
cytoplasmic oxyphilia 
DDT, technical grade 
Laug et al. 1950 
110 Rat  
(Fischer-344)  
6 M 
42 days 
(F) 
0, 10 OW BW HP 
BC BI DX FI 
Bd wt 10 M    
  Hepatic 10 M    
     Renal 10 M    
     Immuno 10 M   No significant effect on relative spleen and 
thymus weight or histology 
     Repro 10 M   No changes in sperm count, serum levels of 
sex hormones, relative testis, epididymis, 
prostate, or seminal vesicle weights 
p,p'-DDE 
Makita et al. 2003a 
111 Rat  
(Osborne- 
Mendel)  
5 M, 5 F 
6 weeks 
(F) 
M:  49, 88, 
160, 280, 
490; F: 54, 
96, 170, 
300, 540 
 Bd wt  170 F  39% reduction in body weight in females at 
170 mg/kg/day 
    160 M  Reduced body weight 10% in males at 
160 mg/kg/day 
DDD-technical 
NCI 1978  
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112 Rat  
(Osborne- 
Mendel)  
5 M, 5 F 
6 weeks 
(F) 
M: 0, 16, 28, 
50, 88, 157; 
F: 0, 17, 31, 
54, 97, 172 
BW LE Bd wt  97 F  Reduced body weight (45% in females) 
    50 M  Reduced body weight (16% in males) 
DDT, technical grade 
NCI 1978  
113 Rat  
(Osborne- 
Mendel)  
20–50 F 
26 weeks 
(GO) 
F: 0, 30, 61 CS Neuro   30 F By week 26, tremors in 8% at 30 mg/kg/day 
and 90% at 61 mg/kg/day; hunched 
appearance by week 6 at 61 mg/kg/day. 
Tremors also observed in males, but 
accurate doses could not be determined 
DDT, technical grade 
NCI 1978  
114 Rat  
(Osborne- 
Mendel)  
5 M, 5 F 
6 weeks 
(F) 
M: 0, 28, 49, 
88, 160, 
280; F: 30, 
50, 96, 170, 
300 
 Death   300 F All female rats died by 6 weeks 
   Bd wt 300 F 49 M  11% body weight depression in males 
p,p'-DDE 
NCI 1978 
115 Rat  
(Sherman)  
4–20 B 
2–6 months 
(F) 
0, 0.5, 1.7, 
5, 20, 40 
GN HP BI Hepatic 5 F 20 F  Mild hepatocellular hypertrophy, more severe 
in males than females 
   0.5 M 1.7 M  More severe effects at 5 mg/kg/day in male. 
No quantitative data provided 
DDT, technical grade 
Ortega 1956 
116 Rat  
(Sprague- 
Dawley)  
11 M (treated); 
24 M (control) 
104 days; 
14 days in 
utero, 
20 lactational 
days, 70 days 
directly 
(G) 
0, 35 DX BW OW 
HP BC 
Develop  35 M  Increased liver mass, relative liver weight; 
testicular mass and relative testis weight.  
Decreased seminiferous tubule diameter, 
epithelium thickness, and lumen diameter; 
increased serum testosterone; no effect on 
AGD, body mass, seminal vesicle or 
epididymal mass 
DDE (NS) 
Patrick et al. 2016 
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117 Rat  
(Wistar)  
36 M, 36 F 
9 weeks 
(F) 
M: 0, 34.1; 
F: 0, 37 
BW FI WI 
GN HP CS 
Neuro   34.1 F Tremors in 80% of females after 9 weeks of 
treatment 
DDT, technical grade 
Rossi et al. 1977 
118 Rat  
(Fischer-344)  
7 M 
13 and 
26 weeks 
(F) 
0, 0.17, 1.7, 
19.1 
HE HP BC Hemato 1.7 19.1  Significantly decreased hematocrit and 
hemoglobin levels (at 13 and 26 weeks) and 
erythrocyte counts (at 13 weeks only) 
coupled with increased bone marrow 
hematopoiesis on week 26 
p,p'-DDT 
Tomita et al. 2013 
119 Rat  
(Wistar)  
46 F 
20 weeks 
(F) 
0, 0.1, 1.0, 
2.0, 4.0 
BW OW Repro 4   No effects on reproductive organ weights, 
birth weights, or weaning weights, vaginal 
opening, age of first littering, body weight, 
ovarian weight, or uterus weight; no adverse 
effects on fertility, fecundity, or pup viability 
o,p’-DDT 
Wrenn et al. 1971 
120 Rat  
(Sprague- 
Dawley)  
10 F 
GD 6–PND 20 
(G) 
0, 5, 15, and 
50 
BW DX CS 
MX OW 
Bd wt 50 F    
 Hepatic 15 F 50 F  Increased relative liver weight (20%) in dams 
    Develop 15 F 50 F  Reduced weaning index and number of pups 
live on PND 21; prolonged preputial 
separation and early vaginal opening; no 
significant effects on number of litters, 
gestation index, gestational length, number 
of pups born, delivery index, birth index, or 
viability on PND 4 
p,p'-DDE 
Yamasaki et al. 2009 
121 Mouse 
(Hissar)  
12–15 M 
3–12 weeks 
(F) 
0, 4.2, 10.5, 
21 
FI GN BC 
CS BI 
Immuno 4.2 10.5  Decreased splenic PFC response to 
T-antigen independent LPS at weeks 6–12; 
decreased IgM antibody titer at 21 mg/kg/day 
DDT (NS) 
Banerjee 1987a 
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122 Mouse 
(Rockfeller)  
8–12 M 
24 weeks 
(F) 
0, 4.3, 10.7, 
21.4 
OF Immuno 4.3 10.7  Increased growth of Mycobacterium leprae in 
footpad 
p,p'-DDT 
Banerjee and Koner 1997a 
123 Mouse  
(Hissar albino)  
25–30 M 
3–12 weeks 
(F) 
0, 4, 10, 20 BW FI BC 
CS OW 
Bd wt 20    
  Hepatic 4 10  Increased relative liver weight (14.7%) 
p,p'-DDT 
Banerjee et al. 1986 
124 Mouse  
(Hissar)  
8–10 M 
4 weeks 
(F) 
0, 4.1, 10.1, 
20.3 
LE BW FI 
OW OF 
Immuno 10.1 20.3  Decreased splenic PFC response to SRBC 
(in restraint-stressed mice only) 
p,p'-DDT 
Banerjee et al. 1997b 
125 Mouse  
(C-57)  
9 B 
60–90 days 
(F) 
0, 34.3, 51.4  Repro 34.3  51.4 78% decreased fertility 
DDT, technical grade 
Bernard and Gaertner 1964 
126 Mouse  
(CF1)  
NS F 
GDs 1–21 
LDs 1–21 
(F) 
0, 34.3 DX LE BH Develop  34.3  Decreased maze performance learning at 
1 and 2 months in survivors 
DDT, technical grade 
Craig and Ogilvie 1974 
127 Mouse 
(C57BL/6H)  
30 M 
5 days, 7-day 
rest, then 
1 time weekly 
for 13 weeks 
(G) 
0, 2.0 BW FI BC 
DI OW 
Bd wt 2 M   Increased body weight compared with LFD 
animals, but no change compared to HFD-
CTL 
p,p'-DDE 
Howell et al. 2015 
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128 Mouse 
(C57BL/6J) 
14–15 F 
15 days, 
GD 12–PND 5 
(G) 
0, 1.7 DX OF BI Develop 1.7 M 1.7 F  NOAEL: No effect on timing of puberty, 
gestation length, gestation weight gain, 
number of pups/litter. body mass or fat mass 
in male offspring to 6 months, or no 
significant indication of metabolic syndromes 
after 12 weeks on a high-fat diet 
LOAEL: In female offspring on high fat diets 
for 12 weeks: Metabolic syndrome (impaired 
glucose tolerance, hyperinsulinemia, 
dyslipidemia), impaired cold tolerance, 
altered bile acid metabolism; no effect on 
timing of puberty. No effect on gestation 
length, gestation weight gain, or number of 
pups/litter 
p,p'-DDT; prepared mixture of 77.2% p,p'-DDT and 22.8% o,p'-DDT  
La Merrill et al. 2014a, 2014b  
129 Mouse 
(C57BL/6J) 
14–15 F 
15 days, 
GD 12–PND 5 
(G) 
0, 1.7 DX OF BI Develop  1.7  Increased systolic and diastolic blood 
pressure in male offspring at 5 months; 
increase systolic in males and females at 
7 months; cardiac hypertrophy (increased left 
ventricular wall thickness) in females, but not 
males; no histological effects on kidneys 
p,p'-DDT; prepared Mixture of 77.2% p,p'-DDT and 22.8% o,p'-DDT 
La Merrill et al. 2016  
130 Mouse 
(B6C3F1)  
20 M, 20 F 
86–130 days 
(F) 
0, 0.86, 1.7, 
3.4, 
5.1,10.2,20.
4 
OF Repro 3.4 5.1  Decreased number of pups/litter at birth or 
PND 1, decreased fertility 
DDT, technical grade 
Ledoux et al. 1977 
131 Mouse  
(NMRI)  
13 F 
72–74 days 
7 days/week 
(F) 
0, 2.0 BI OF Repro  2  Prolonged length of estrus cycle; decreased 
number of implants (223 versus 250 in 
controls) 
p,p'-DDT 
Lundberg 1973 
132 Mouse  
(NMRI)  
10–14 F 
28 days 
(G) 
0, 1.77 GN BI OF Repro  1.77 F  Decreased corpora lutea 17.2% 
p,p'-DDT 
Lundberg 1974 
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133 Mouse 
(B6C3F1)  
5 M, 5 F 
6 weeks 
(F) 
M: 0, 45, 72, 
114, 180, 
287;  F: 0, 
49, 78, 123, 
195, 310 
BW LE Bd wt 310 F    
   287 M    
DDD-technical 
NCI 1978  
134 Mouse 
(B6C3F1)  
5 M, 5 F 
6 weeks 
(F) 
M: 0, 3, 6, 
10, 18, 32; 
F: 0, 4, 6, 
11, 20, 35 
BW LE Death   35 F 4 out of 5 died 
  Bd wt 35 F    
    32 M    
DDT, technical grade 
NCI 1978  
135 Mouse 
(B6C3F1)  
5 M, 5 F 
6 weeks 
(F) 
M: 0, 25, 35, 
49, 66, 94; 
F: 0, 27, 38, 
53, 71, 101 
 Death   66 Death of 4/5 males and 2/5 females 
  Bd wt 101 F    
    94 M    
p,p'-DDE 
NCI 1978  
136 Mouse  
(NMRI)  
10–15 M 
28 days 
(G) 
0, 6.25 BW OW GN 
BI 
Hepatic  6.25  Increased absolute and relative liver weight 
  Repro  6.25  Reduced seminal vesicle weight (28%) in 
castrated males only 
p,p'-DDT 
Orberg and Lundberg 1974 
137 Mouse  
(CF1)  
60 B 
15–30 weeks 
(F) 
0, 42.8 BW OW GN 
HP 
Cancer   42.8 CEL:  Liver hepatomas 
p,p'-DDT 
Tomatis et al. 1974b 
138 Mouse 
(BALB/c) 
53 M, 53 F 
120 days 
(F) 
0, 1.3 OF Repro 1.3   No effects on fertility or litters per producing 
pair 
DDT, technical grade 
Ware and Good 1967 
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139 Dog  
(NS)  
14 M 
36-150 days 
(C) 
0, 50 OW HP CS Endocr   50 Adrenocortical necrosis 
p,p'-DDD 
Kirk and Jenson 1975 
140 Rabbit  
(New Zealand)  
5 F 
3 times/week 
12 weeks 
(GO) 
0, 3 OF HP Repro  3  Reduced ovulation rate and slight decrease 
circulating progesterone post-insemination 
DDT, technical grade 
Lindenau et al. 1994 
141 Rabbit  
(New Zealand)  
5 F 
12–15 weeks 
3 days/week 
(GO) 
0, 3 DX  Repro 3   No fertility effects or effects on embryonic 
development observed 
DDT, technical grade 
Seiler et al. 1994 
142 Rabbit  
8 M 
8 weeks 
(F) 
0, 0.184, 
0.92, 2.1, 
6.54 
BW HP BC Immuno 2.1    
p,p'-DDT 
Street and Sharma 1975 
CHRONIC EXPOSURE 
143 Human  
51 M 
12–18 months 
(F) 
0, 0.05, 0.5 BC CS BW Bd wt 0.5    
   Cardio 0.5    
     Hemato 0.5    
     Hepatic 0.5    
     Neuro 0.5   No effect on coordination, tremors, other 
neurological tests 
DDT, technical grade 
Hayes et al. 1956 
144 Monkey 
(Rhesus)  
22 B 
3.5–7 years 
(F) 
0, 0.1, 1, 
3.9, 98 
GN CS Hepatic  3.9  N=3 at 3.9 mg/kg/day; slight variation in liver 
cell size and mild hydropic changes 
histopathology (n=1); severe hydropic and 
hyaline changes of liver cytoplasm with focal 
acute hepatitis (n=1); no liver changes noted 
(n=1); no bromsulfalein retention in any 
animals at any dose 
DDT (NS) 
Durham et al. 1963 
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145 Monkey 
(Cynomolgus) 
13 M, 11 F 
130 months 
(F) 
0, 6.4-15.5 HP OW CS 
BW HE GN 
Death   6.9 F  
  Hepatic  6.4 F  Fatty changes in the liver 
  Neuro   6.9 F Severe tremors 
p,p'-DDT 
Takayama et al. 1999 
146 Rat  
(MRC Porton)  
30–38 B 
Life 
(F) 
0, 6, 12, 24 BW GN HP 
CS 
Bd wt 24    
  Resp 24    
    Neuro 24    
    Cancer   12 F CEL: Liver-cell tumors (6.6 and 18.4% at 
12 and 24 mg/kg/day) 
DDT, technical grade 
Cabral et al. 1982b 
147 Rat  
(Osborne 
Mendel)  
30 B 
27 months 
(F) 
0, 20 BW HP GN Resp 20    
   Hemato  20  Hemolysis in spleen 
   Hepatic  20  Focal hepato-cellular necrosis 
   Renal   20 Some tubular epithelial necrosis and 
polycystic degeneration; small hemorrhages 
DDT (NS) 
Deichmann et al. 1967 
148 Rat  
(Sprague- 
Dawley)  
F1, 5 M, 10 F 
2-generation 
(F) 
0, 0.5, 1.5 OF Repro 1.5   No effect on fertility, time of vaginal opening, 
fecundity 
DDT, technical grade 
Duby et al. 1971 
149 Rat  
(Sprague- 
Dawley)  
F1, 5 M, 10 F 
2-generation 
(F) 
0, 0.1, 0.3 OF Repro 0.3   No effect on fertility, time of vaginal opening, 
fecundity 
o,p’-DDT 
Duby et al. 1971 
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150 Rat  2-generation 0, 0.4, 1.2 OF Repro 1.2 No effect on fertility, time of vaginal opening,
(Sprague- 
Dawley)  
F1, 5 M, 10 F
(F) fecundity 
p,p'-DDT
Duby et al. 1971
151 Rat  
(Osborne- 
Mendel) 
2 years
(F) 
0, 7, 14, 28, 
42, 56 
GN Hepatic 7 Focal hepatocellular necrosis
12 M, 12 F
DDT, technical grade 
Fitzhugh and Nelson 1947
152 Rat 
(F344/DuCrj)  
40 M, 40 F
1–2 years (52, 
78, and 
104 weeks)
(F) 
Male: 0, 
0.17, 1.7, 
and 19.1; 
females: 0, 
0.21, 2.2, 
25.2
HP BW FI 
CS BI 
Bd wt 2.2 F 25.2 F 25% decreased mean body weight in 
females 
1.7 M 19.1 M 12% decreased mean body weight in males
Hepatic 0.21 F 2.2 F Increased incidence of hepatocellular 
hypertrophyclose to 100% from week 26 to 
104
0.17d M Increased incidence of hepatocellular 
hypertrophy (close to 100% from week 52 to 
104)
BMDL10 of 0.01 mg/kg/day 
Neuro 2.2 F 25.2 F Whole body tremors weeks 70–104
1.7 M 19.1 M
Cancer 1.7 M CEL: Hepatocellular adenoma in males at 
≥1.7 mg/kg/day and in females at 
25.2 mg/kg/day; hepatocellular carcinomas in 
males (19.1 mg/kg/day)
p,p'-DDT
Harada et al. 2003, 2006
153 Rat  
(Osborne- 
Mendel) 
20–50 M,  
20–50 F
78 weeks
(F) 
M: 0, 116, 
231; F: 0, 
66, 131
BW CS GN 
HP 
Bd wt 
Resp
Cardio
Gastro 
231 M
231 M
231 M
66 F 28% decrease in body weight gain
Musc/skel 231 M
Hepatic 231 M
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     Hepatic 231 M    
     Renal  66 F  Chronic inflammation of the kidney 
     Dermal 231 M    
     Endocr 231 M    
     Immuno 231 M   No histological alterations in spleen, thymus 
or lymph nodes in males or females 
     Neuro 131 F    
      231 M   No tremors or hunched appearance during 
last 6 months 
     Repro 231 M   No significant alterations in uterus, mammary 
glands, ovaries, or prostate; reproductive 
function not assessed 
     Cancer   116 CEL: thyroid follicular cell adenoma and 
carcinoma 
DDD-technical 
NCI 1978 (Rat) 
154 Rat  
(Osborne- 
Mendel)  
20–50 M,  
20–50 F 
78 weeks 
(F) 
M: 0, 23, 45; 
F: 0, 16, 32 
BW CS GN 
HP 
Bd wt  32 F  20% decrease in body weight gain in males 
and females   45 M  
 Resp 45 M    
 Cardio 45 M    
 Gastro 45 M    
     Musc/skel 45 M    
     Hepatic  23 M  Fatty metamorphosis 
     Renal 45 M    
     Dermal 45 M    
     Endocr 45 M    
     Immuno 45 M   No significant alterations in spleen, thymus, 
or lymph nodes in males or females 
immunological function not assessed 
     Repro 45 M   No significant alterations in uterus, mammary 
glands, ovaries, or prostate; reproductive 
function not assessed 
DDT, technical grade 
NCI 1978  
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155 Rat  
(Osborne- 
Mendel)  
20–50 M,  
20–50 F 
78 weeks 
(F) 
M: 0, 31, 59; 
F: 0, 19, 36 
BW CS GN 
HP LE 
Death   19 F 16% death rate compared to 0% in controls 
 Bd wt   19 F 21% decrease in body weight gain 
 Resp 59 M    
 Cardio 59 M    
 Gastro 59 M    
     Musc/skel 59 M    
     Hepatic 36 F 31 M  Fatty metamorphosis 
     Renal 59 M    
     Dermal 59 M    
     Endocr 59 M    
     Immuno 59 M   No histological alterations in spleen, thymus 
or lymph nodes 
     Repro 59 M   No histopathological effects in males or 
females 
p,p'-DDE 
NCI 1978  
156 Rat  
(Sprague- 
Dawley)  
6 M, 12 F 
2-generation 
(F) 
0, 1, 10 BW FI Repro 10   No effect on fertility, fecundity, or offspring 
viability 
DDT, technical grade 
Ottoboni 1969 
157 Rat  
(Sprague-
Dawley)  
6 M, 12 F 
2-generation 
(F) 
0, 1.9, 18.6 BW FI Repro 18.6   No effect on litter size or sex ratios; no clear 
exposure effects on fertility or pup survival 
   Develop 1.9 18.6  Tail abnormalities, constriction rings in 13.2–
25.5%; no effect on birth weights or body 
weights at weaning 
DDT, technical grade 
Ottoboni 1969 
158 Rat  
(Sprague-
Dawley)  
12 M, 12 F 
7 days/week 
life 
(F) 
0, 1.6 BW FI Repro 1.6    
DDT, technical grade 
Ottoboni 1972 
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159 Rat  
(Wistar)  
36 M, 36 F 
120 weeks 
(F) 
M: 0, 34.1; 
F: 0, 37 
BW FI WI 
GN HP CS 
Cancer   34.1 M CEL: Liver cell tumors (33.3%) 
DDT, technical grade 
Rossi et al. 1977 
160 Rat  
(Fischer-344)  
5–10 M 
Up to 
104 weeks 
(F) 
0, 0.17, 1.7, 
19.1 
HE HP BC Hemato 0.17 1.7  Reduced hemoglobin, mean corpuscular 
volume and mean corpuscular hemoglobin 
and increased hematopoiesis in bone 
marrow at week 78  
p,p'-DDT 
Tomita et al. 2013 
161 Rat  
(Sprague-
Dawley)  
F0 12 B 
3 generations 
(F) 
0, 0.13, 
0.63, 1.25 
 Repro 1.25    
DDT, technical grade 
Treon et al. 1954 
162 Mouse  
(ICR)  
400 F 
70 weeks 
(conception 
through 
death); multi-
generation 
(F) 
0, 16.5 GN Resp 16.5    
   Cardio 16.5    
    Hepatic  16.5  Acute congestion in the liver 
    Renal 16.5    
     Develop 16.5   Increased neonatal death (lactation index 
only), but decreased relative risk of 
postweaning death compared to controls 
DDT, technical grade 
Del Pup et al. 1978 
163 Mouse 
(C57BL/6N)  
36 M, 36 F 
81 weeks 
(F) 
0, 28 GN HP Cancer   28 CEL: Liver tumors - primarily in males 
p,p'-DDT 
Innes et al. 1969 
164 Mouse  
(Swiss)  
30 M, 30 F 
80 weeks 
(F) 
0, 16.5 BW GN HP 
CS OF 
Cancer   16.5 Lymphomas; lung and liver tumors NS 
DDT, technical grade 
Kashyap et al. 1977 
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165 Mouse  
(Swiss)  
30 B 
80 weeks 
(F) 
0, 16.5 BW HP CS Neuro   16.5 Tremors 
DDT, technical grade 
Kashyap et al. 1977 
166 Mouse  
(Swiss)  
30 B 
80 weeks 
(F) 
0, 13 HP CS Ocular  13  Unilateral and bilateral corneal opacity 
        
DDT, technical grade 
Kashyap et al. 1977  
167 Mouse  
(Swiss- 
Webster)  
4 M, 14 F/ 
generation 
3 generations 
(F) 
0, 5, 20, 50 OF Repro   20 Decreased fertility 
DDT (NS) 
Keplinger et al. 1970 
168 Mouse 
(B6C3F1)  
20–50 M,  
20–50 F 
78 weeks 
(F) 
M: 0, 71, 
141; F: 0, 
71, 142 
BW CS GN 
HP 
Bd wt  71 F 142 F Serious LOAEL: 28% decrease in body 
weight gain 
LOAEL: 17% decrease in body weight gain 
  141 M    
 Resp 142 F    
    Cardio 142 F    
     Gastro 142 F    
     Musc/skel 142 F    
     Hepatic 142 F    
     Renal 142 F    
     Dermal 142 F    
     Ocular 142 F    
     Endocr 142 F    
     Immuno 142 F   No histological alterations in spleen, thymus, 
or lymph nodes 
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Table 2-1.  Levels of Significant Exposure to DDT, DDE, and DDD – Oral 
 
Figure 
keya 
Species 
(strain) 
No./group 
Exposure 
parameters 
Doses 
(mg/kg/day) 
Parameters 
monitored Endpoint 
NOAEL 
(mg/kg/day) 
Less serious 
LOAEL 
(mg/kg/day) 
Serious LOAEL 
(mg/kg/day) Effects 
     Neuro 142 F   Neurological clinical signs in males and 
females were comparable to controls 
     Repro 142 F   No histological alterations in male or female 
reproductive tissues 
DDD-technical 
NCI 1978  
169 Mouse 
(B6C3F1)  
20–50 M,  
20–50 F 
78 weeks 
(F) 
M: 0, 3.7, 
7.4; F: 0, 
15.0, 30.2 
BW CS GN 
HP LE 
Death   15 F 10% mortality compared to 0% in controls 
Bd wt 30.2 F    
Resp 30.2 F    
Cardio 30.2    
Gastro 30.2 F    
Musc/skel 30.2 F    
     Hepatic 30.2 F    
     Hepatic  3.7 M  Amyloidosis 
     Renal 30.2    
     Dermal 30.2 F    
     Endocr 30.2 F    
     Immuno 30.2 F   No histological alterations in spleen, thymus 
or lymph nodes 
     Neuro 30.2 F   Neurological clinical signs in males and 
females were comparable to controls. 
     Repro 7.4 F   No histological alterations in reproductive 
tissues 
DDT, technical grade 
NCI 1978  
170 Mouse 
(B6C3F1)  
20–50 M,  
20–50 F 
78 weeks 
(F) 
M: 0, 27, 47; 
F: 0, 28, 49 
BW CS GN 
HP LE 
Death   49 F 40% death rate compared to 5% in controls 
Bd wt   28 F 29% decrease in body weight gain; no effect 
in males 
 47 M    
Resp 49 F    
     Cardio 49 F    
     Gastro 49 F    
     Musc/skel 49 F    
     Hepatic 49 F    
     Renal 49 F 27 M  Chronic inflammation of the kidney 
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Table 2-1.  Levels of Significant Exposure to DDT, DDE, and DDD – Oral 
 
Figure 
keya 
Species 
(strain) 
No./group 
Exposure 
parameters 
Doses 
(mg/kg/day) 
Parameters 
monitored Endpoint 
NOAEL 
(mg/kg/day) 
Less serious 
LOAEL 
(mg/kg/day) 
Serious LOAEL 
(mg/kg/day) Effects 
     Dermal 49 F    
     Ocular 49 F    
     Endocr 49 F    
     Immuno 49 F   No histological alterations in spleen, thymus 
or lymph nodes 
     Repro 49 F   No histological alterations in male or female 
reproductive tissues 
     Cancer   28 F CEL: hepatocellular carcinomas; 0/19, 19/47, 
34/48 
        27 M CEL: hepatocellular carcinomas; 0/19, 7/41, 
17/47 
p,p'-DDE 
NCI 1978  
171 Mouse  
(A strain)  
NS 
5 generations 
(G) 
0, 1.7, 8.7 GN HP Death   8.7 F F0 dams: 14 out of 30 animals died before 
6 months (lung adenomas in 3/14) 
   Cancer   1.7 Lung tumors, NS, lung adenomas 
DDT, technical grade 
Shabad et al. 1973 
172 Mouse 
(BALB/c) 
683 B 
Life 
6 generations 
(F) 
0, 0.4, 0.7 BW GN HP 
BC CS OF 
LE 
Cancer   0.4 Lung adeno-carcinomas in F2, leukemia in 
F3 
p,p'-DDT 
Tarjan and Kemeny 1969 
173 Mouse 
(BALB/c) 
60 M, 60 F 
Life  
2-generation 
(F) 
0, 0.4, 4, 50 BW GN HP 
OF 
Cancer   50 F Liver tumors in F0 and F1 
DDT, technical grade 
Terracini et al.  1973 
174 Mouse  
(CF1)  
30 B 
2 years 
(F) 
0, 15.8 GN HP CS Cancer   15.8 Liver tumors, NS 
p,p'-DDT 
Thorpe and Walker 1973 
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Table 2-1.  Levels of Significant Exposure to DDT, DDE, and DDD – Oral 
 
Figure 
keya 
Species 
(strain) 
No./group 
Exposure 
parameters 
Doses 
(mg/kg/day) 
Parameters 
monitored Endpoint 
NOAEL 
(mg/kg/day) 
Less serious 
LOAEL 
(mg/kg/day) 
Serious LOAEL 
(mg/kg/day) Effects 
175 Mouse  
(CF1)  
50 M, 50 F 
Life 
multi-
generation 
(F) 
M: 0, 0.38, 
1.91, 9.5, 
47.6; F: 0, 
0.36, 1.82, 
9.1, 45.5 
BW GN HP 
OF 
Cancer   45.5 F Liver tumors in F0 and F1 
   0.38 M Liver tumors in F0 and F1 
DDT, technical grade 
Tomatis et al. 1972 
176 Mouse  
(CF-1)  
20 M, 20 F 
2-generation 
(F) 
0, 0.4, 2, 10, 
50 
 Develop 10  50 Increased preweanling death at 
50 mg/kg/day; increased tremors, 
convulsions 
p,p'-DDT 
Tomatis et al. 1972 
177 Mouse  
(CF1)  
60 M, 60 F 
130 weeks 
(F) 
M: 0, 42.6; 
F: 0, 45.8 
BW GN HP 
CS 
Cancer   42.6 M CEL: lung and liver tumors 
p,p'-DDD 
Tomatis et al. 1974a 
178 Mouse  
(CF1)  
60 M, 60 F 
130 weeks 
(F) 
M: 0, 42.6; 
F: 0, 45.8 
BW OW GN 
HP LE 
Cancer   42.6 CEL: liver tumors (males: 74 versus 35% in 
controls; females: 98 versus 1% in controls) 
p,p'-DDE 
Tomatis et al. 1974a 
179 Mouse  
(CF1)  
60 NS 
6 generations 
(F) 
0, 0.33, 1.7, 
8.3, 41.3 
BW GN HP Cancer   0.33 Liver tumors, NS 
DDT, technical grade 
Turusov et al. 1973 
180 Mouse  
(CF1)  
60 B 
life 
(F) 
0, 0.33, 
1.65, 8.26, 
41.32 
GN HP CS Develop 8.3  41.3 Increased in preweanling death 
DDT, technical grade 
Turusov et al. 1973 
181 Mouse  
(CF1)  
60 B 
130-
140 weeks 
(F) 
0, 0.33, 1.7, 
8.3, 41.3 
GN HP CS Neuro 1.7  8.3 Tremors 
DDT, technical grade 
Turusov et al. 1973 
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Table 2-1.  Levels of Significant Exposure to DDT, DDE, and DDD – Oral 
 
Figure 
keya 
Species 
(strain) 
No./group 
Exposure 
parameters 
Doses 
(mg/kg/day) 
Parameters 
monitored Endpoint 
NOAEL 
(mg/kg/day) 
Less serious 
LOAEL 
(mg/kg/day) 
Serious LOAEL 
(mg/kg/day) Effects 
182 Mouse  
(NS)  
12 M, 12 F 
15 months 
(F) 
0, 0.24, 2.4 RE LE Repro 2.4    
DDT, technical grade 
Wolfe et al. 1979 
183 Hamster 
(Syrian)  
30-40 B 
Life 
(F) 
0, 10, 20, 40 BW GN HP Bd wt 40    
  Hepatic 20 F 40 F  Hepatocyte hypertrophy; fatty change 
   10 M 20 M  Focal necrosis, hepatocyte hypertrophy 
DDT, technical grade 
Cabral et al. 1982a 
184 Hamster  
(NS)  
60 B 
Life 
(F) 
0, 33, 67, 
133 
GN BI Hepatic  67  50% increase in relative liver weight 
DDT, technical grade 
Graillot et al. 1975 
185 Hamster 
(Syrian)  
48 M, 48 F 
128 weeks 
(F) 
0, 95 BW LE HP 
CS 
Bd wt  95  Decreased body weight gain 
 Neuro 95   No tremors or convulsions 
 Cancer   95 CEL: adrenal neoplasms; 14% in controls, 
34% in treated 
DDT, technical grade 
Rossi et al. 1983 
186 Hamster 
(Syrian)  
87 M, 88 F 
128 weeks 
(F) 
0, 47.5, 95 BW LE HP 
CS 
Bd wt  95 M  11% decrease in body weight gain 
Hepatic  47.5  Liver necrosis 
Neuro 95   No tremors or convulsions 
Cancer   47.5 CEL: hepatocellular tumors; 0/73, 11/69, 
14/78 
p,p'-DDE 
Rossi et al. 1983 
187 Dog  
(NS)  
1–10 NS 
39–40 months 
(F) 
0, 16, 80, 
160 
GN HP BI Hepatic 16 80 160 LOAEL: Focal or diffuse liver alterations 
Serious LOAEL: Severe liver damage 
DDT, technical grade 
Lehman 1965 
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Table 2-1.  Levels of Significant Exposure to DDT, DDE, and DDD – Oral 
Figure
keya 
Species 
(strain) 
No./group
Exposure
parameters 
Doses 
(mg/kg/day) 
Parameters 
monitored Endpoint
NOAEL 
(mg/kg/day) 
Less serious
LOAEL 
(mg/kg/day) 
Serious LOAEL 
(mg/kg/day) Effects
188 Dog 7 days/week, 0, 1, 5, 10 BW OW GN Repro 10
(Beagle) 
4 M, 7–8 F
F2 generation
(F) 
HP OF
DDT, technical grade 
Ottoboni et al.  1977
aThe number corresponds to entries in Figure 2-2; differences in levels of health effects and cancer effects between male and females are not indicated in Figure 2-2.  
Where such differences exist, only the levels of effect for the most sensitive gender are presented, with the exception of the neurological and developmental endpoints for 
which levels of effect for both males and females are presented.   
bUsed to derive a provisional acute-duration oral minimal risk level (MRL) for DDT, DDE, or DDD of 0.0005 mg/kg/day based on the LOAEL of 0.5 mg technical DDT/kg on 
PND 10 for neurodevelopmental effects and an uncertainty factor of 1,000 (10 for use of a LOAEL, 10 for extrapolation from animals to humans, and 10 for human
variability). 
cUsed to derive a provisional intermediate-duration oral MRL for DDT, DDE, or DDD of 0.0002 mg/kg/day based on the LOAEL of 0.17 mg p,p’-DDT/kg/day for hepatocyte 
hypertrophy and an uncertainty factor of 1,000 (10 for the use of a LOAEL, 10 for extrapolation from animals to humans, and 10 for human variability). 
dUsed to derive a provisional chronic-duration oral MRL for DDT, DDE, or DDD of 0.0001 mg/kg/day based on a BMDL10 of 0.01 mg p,p’-DDT /kg/day for hepatocyte
hypertrophy and an uncertainty factor of 100 (10 for extrapolation from animals to humans and 10 for human variability). 
Principal studies for the MRLs 
5-HIAA = 5-hydroxy-indoleacetic acid; AGD = anogenital distance; AP = alkaline phosphatase; b = both male, female; BC = serum (blood) chemistry; Bd Wt or BW = body 
weight; BH = behavioral; BI = biochemical changes; (C)  = capsule; cardio = cardiovascular; CEL = cancer effect level; CNS = central nervous system; CS = clinical signs; 
develop = developmental; DI = distribution; DX = developmental toxicity; EA = enzyme activity; endocr = endocrine; (F) = feed; F = female(s); FI = food intake; FX = fetal 
toxicity; (G) = gavage, not specified; GD = gestation day; gen = generation(s); GN = gross necropsy; (GO) = gavage, oil; HE = hematology; hemato = hematological; 
HP = histopathology; immuno = immunological; LD = lactation day ; LD50 = dose producing 50% death; LDH = lactate dehydrogenase; LE = lethality; LOAEL = lowest-
observed-adverse-effect-level; LPS = lipopolysaccharide; M = male(s); musc/skel = muscular/skeletal; MX = maternal toxicity; neuro = neurotoxicology; NOAEL = no-
observed-adverse-effect-level; NS = not specified; OF = organ function; OW = organ weight; PCNA = proliferating cell nuclear antigen; PFC = plaque forming cell; 
PND = postnatal day; repro = reproductive; SRBC = sheep red blood cell; TG = teratogenicity; WI = water intake
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Figure 2-2.  Levels of Significant Exposure to DDT, DDE, and DDD – Oral 
Acute (≤14 days) 
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Figure 2-2.  Levels of Significant Exposure to DDT, DDE, and DDD – Oral 
Acute (≤14 days) 
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Figure 2-2.  Levels of Significant Exposure to DDT, DDE, and DDD – Oral 
Acute (≤14 days) 
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Figure 2-2.  Levels of Significant Exposure to DDT, DDE, and DDD – Oral 
Intermediate (15-364 days) 
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Figure 2-2.  Levels of Significant Exposure to DDT, DDE, and DDD – Oral 
Intermediate (15-364 days) 
  
DDT, DDE, and DDD  61 
 
2.  HEALTH EFFECTS 
 
 
***DRAFT FOR PUBLIC COMMENT*** 
Figure 2-2.  Levels of Significant Exposure to DDT, DDE, and DDD – Oral 
Chronic (≥365 days) 
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Figure 2-2.  Levels of Significant Exposure to DDT, DDE, and DDD – Oral 
Chronic (≥365 days) 
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Figure 2-2.  Levels of Significant Exposure to DDT, DDE, and DDD – Oral 
Chronic (≥365 days) 
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2.2   DEATH 
 
Evidence of Death Effects of DDT, DDD, or DDE in Humans.  Only one case of fatal poisoning in 
humans after accidental oral exposure to DDT has been documented (Hill and Robinson 1945).  One 
ounce (approximately 30 mL) of 5% DDT in kerosene was ingested by a 1-year-old child.  Clinical signs 
included coughing and vomiting followed by convulsions, which were characterized as generalized fine 
tremors.  The child then became comatose and died 4 hours post-exposure; however, the contribution of 
the kerosene solvent to DDT toxicity was not addressed.  In 1947, kerosene, not DDT, was determined to 
be the cause of death of a patient who fatally swallowed an approximate 150 mL solution of commercial 
DDT (~4% DDT, 4% lethane, and 92% kerosene) (Reingold and Lasky 1947).  Doses as high as 285 mg 
DDT/kg body weight have been accidentally ingested by 28 men with no fatal results (Garrett 1947).  
 
A historical prospective mortality study was conducted on 3,600 white male workers employed between 
1935 and 1976 in occupations that involved exposures to various brominated compounds, organic and 
inorganic bromides, and DDT (Wong et al. 1984).  Among individuals exposed to DDT, overall 
mortality, expressed as the standardized mortality ratio (SMR), was not elevated over expected values.  
Similar results were reported by Beard et al. (2003) with no significant increase in total mortality (SMRs) 
in occupationally exposed workers compared to the general population (Beard et al. 2003); in the exposed 
group, there were increases in mortality due to ischemic heart disease, respiratory disease, and pancreatic 
cancer.  However, deaths from ischemic heart disease and respiratory disease were proposed to reflect 
smoking patterns, as comparisons with a control population of outdoor workers did not result in elevated 
deaths.  This was not the case for pancreatic cancer; increases in deaths (SMR 5.27, 95% confidence 
interval [CI] 1.09–15.40) were found for workers with <3 years of DDT exposure, as compared the 
control population; no association was found in workers exposed to DDT for ≥3 years.   
 
Brown (1992) conducted an update of a historical prospective mortality study of workers in five pesticide 
manufacturing plants.  In the plant that manufactured DDT (230 persons and 90 deaths since 1964), there 
was a significant excess of deaths (11) from cerebrovascular disease.  The SMR was 2.38.  The study is 
limited by insufficient exposure data (with the exception of DDT exposure information for 35 workers 
employed in 1967), possible confounding exposures, and relatively small numbers of deaths from stroke. 
 
A study of 4,552 male workers exposed to DDT and followed for 45 years reported no statistically 
significant increase in the relative risk of total mortality, or mortality due to various diseases or cancers in 
workers with estimated cumulative doses ranging from 0.01 to ≥2,755.1 mg DDT, between 1946 and 
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1950 (Cocco et al. 2005); the study did find lower risks of cardiovascular disease and liver cirrhosis.  A 
group of 633 women with breast cancer with available blood DDT (n=622), DDE (n=632), chlordane 
(n=622), and lipid levels; the women were followed for 15 years (Parada et al. 2016).  At year 5, 
p,p’-DDT exposure was associated with all causes of mortality and breast cancer-specific mortality.  The 
respective hazard ratios (HRs) and 95% CI for T2 (serum p,p’-DDT levels of ≥5,638–<91.2 ng/g) versus 
T1 (<56.8 ng/g) were 2.19 (1.02, 4.67) and 2.72 (1.04, 7.13), respectively.  At 15 years, there were no 
associations, other than for all-cause mortality, in women with DDT levels in the second tertile and with 
lower body mass index (BMI) values (<25 kg/m2).  The highest tertile of p,p’-DDE (≥1,058.2 ng/g) was 
inversely associated with all mortality (HR 0.66, 95% CI 0.44, 0.99) at 5 years, and no associations were 
observed at 15 years (Parada et al. 2016).  Although these data may indicate increased risk of mortality 
with DDT exposure in these subjects, no comparisons were done with a control/non-breast cancer group, 
and data may not translate to risks to the general public.  
 
Evidence of Death Effects of DDT, DDD, or DDE in Animals.  The oral LD50 values for the various 
isomers and technical-grades of DDT, DDE, and DDD, as well as exposure levels associated with 
decreased survival in repeated-dose toxicity animal studies, are recorded in Table 2-1 and plotted in 
Figure 2-2.  No acute inhalation studies were identified.  
 
The LD50 values reported in rats exposed to single oral gavage doses of p,p’-DDT ranged from 113 to 
800 mg/kg (Ben-Dyke et al. 1970; Cameron and Burgess 1945; Gaines 1969).  The LD50 values for 
guinea pigs and rabbits after oral exposure to p,p’-DDT were 400 and 300 mg/kg, respectively (Cameron 
and Burgess 1945).  The LD50 for technical-grade DDT in male Sherman rats in one study was 217 mg/kg 
(Gaines, 1969).  Results from another study by Lu et al. (1965) revealed age-dependent LD50 values for 
technical-grade DDT in rats.  The LD50 values in newborn, preweanling, weanling, and adult rats were 
>4,000, 438, 355, and 195 mg technical DDT/kg, respectively.  However, when preweanling and adult 
rats were administered one-quarter of the LD50 daily for 4 days, there was no significant difference in the 
4-day LD50 between the two age groups.  Lu et al. (1965) suggested that the elimination mechanism in the 
preweanling rats is less well developed, thus making them more susceptible to repeated doses than adults.  
The age-dependent susceptibility to single high oral doses of DDT in rats was confirmed by others who 
suggested that seizures and hyperthermia, observed in the adults but not in young rats, as well as less 
resistance to hypoxia, contribute to the apparent higher sensitivity of the adult rat (Henderson and Wooley 
1969, 1970).  The LD50 values for single oral doses of technical-grade DDT in mice from two studies 
were 237 and 300 mg/kg (Kashyap et al. 1977; Tomatis et al. 1972).  In a short-term feeding experiment, 
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a daily dietary dose of about 85.7 mg p,p’-DDT/kg killed 50% of a group of mice after a 6-day feeding 
period (Okey and Page 1974). 
 
In p,p’-DDE mortality studies, a LD50 values of 880 and 1,240 mg/kg were reported for male and female 
Sherman rats, respectively (Gaines 1969).  Death occurred in mice after single oral doses of o,p’-DDE 
ranging from 810 to 880 mg/kg (Tomatis et al. 1974a). 
 
In p,p’-DDD mortality studies, reported LD50 values for rats and mice ranged from about 400 to 
>4,000 mg/kg/day (Ben-Dyke et al. 1970; Gaines 1969; Tomatis et al. 1974a). 
 
In dermal exposure studies, the dermal LD50 of DDT in rats was reported by Ben-Dyke et al. (1970) and 
Cameron and Burgess (1945) as 2,500 and 3,000 mg DDT/kg, respectively.  The LD50 was 2,510 mg of 
technical-grade DDT/kg in female Sherman rats (Gaines 1969).  In guinea pigs, a single dermal dose of 
1,000 mg DDT/kg resulted in death of 50% of the animals (Cameron and Burgess 1945).  Dermal LD50 
values in rabbits were 300 mg DDT/kg (Cameron and Burgess 1945) and 4,000–5,000 mg DDD/kg (Ben-
Dyke et al. 1970).  In the study by Cameron and Burgess (1945), the animals were dermally exposed to 
various doses of DDT in solvents including kerosene, ether, dimethyl phthalate, or dibutyl phthalate.  It is 
uncertain what contribution these solvents made to the toxic effects observed; the authors stated that 
kerosene itself may have caused some deaths.   
 
After intermediate-duration oral exposure to p,p’-DDT or technical DDT, significantly increased 
mortality has been observed in animals exposed to doses ≥~25–35 mg/kg/day.  Increased mortality 
occurred shortly after mating in F0 (3/24) and F1 (6/23) female rats (not observed in males) exposed to 
27.7 mg p,p’-DDT/kg/day in the diet for 10 weeks prior to mating, and throughout mating, gestation, and 
lactation (Hojo et al. 2006).  Four out of five female B6C3F1 mice fed a diet that provided ~35 mg 
technical DDT/kg/day for 6 weeks died (NCI 1978).  Gavage exposure to 50 mg p,p’-DDT/kg/day 
produced deaths in four of six monkeys after 4 weeks of treatment; the remaining monkeys died during 
weeks 9 and 14 of treatment (Cranmer et al. 1972). 
 
After chronic-duration exposure to p,p’-DDT, p,p’-DDE, or technical DDT, reduced survival has been 
observed in monkeys, rats, and mice.  Mortality rates of 10% and 28% were observed in female B6C3F1 
mice exposed to 15 and 30.2 mg technical DDT/kg/day, respectively, in the diet for 78 weeks (NCI 1978).  
Early mortalities were not observed in male mice exposed to the same dietary concentrations of technical 
DDT (NCI 1978).  Following dietary exposure to 49 mg p,p’-DDE/kg/day in the diet for 78 weeks, 
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female B6C3F1 mice had a 40% mortality rate (NCI 1978).  A mortality rate of 16% was observed in 
female Osborne-Mendel rats exposed to 19 mg p,p’-DDE/kg/day in the diet for 78 weeks (NCI 1978).  In 
a 130-month study that administered approximately 6.4–15.5 mg of p,p’-DDT/kg/day to Rhesus and 
Cynomolgus monkeys, there were 6/24 early deaths; the lowest dose associated with death was 
approximately 6.9 mg/kg/day (Takayama et al. 1999).  Exposure-related reduced survival was not 
observed in male and female F344/DuCrj rats exposed for up to 104 weeks to 19.1 and 25.2 mg/kg/day 
p,p’-DDT, respectively, in the diet (Harada et al. 2003).  
 
2.3   BODY WEIGHT 
 
Evidence of Body Weight Effects of DDT, DDD, or DDE in Humans.  Epidemiological studies 
described in Table 2-2 examined associations between serum or adipose levels of DDT, DDE, or total 
DDT and weight status markers including BMI, abdominal obesity, or measurements of visceral or 
subcutaneous abdominal tissue in older adults ≥50 years of age (Arrebola et al. 2014; De Roos et al. 2012; 
Dhooge et al. 2010; Lee et al. 2012a, 2012b; Roos et al. 2013; Schildkraut et al. 1999), young adults 
<50 years old (Lee et al. 2011b; Perry et al. 2005), and children or adolescents (Burns et al. 2012; Dhooge 
et al. 2010; Tang-Peronard et al. 2015a).  
 
Consistent evidence for significant positive associations with BMI was found in most studies of adults 
≥50 years of age with mean serum DDE levels lower than ~500 ng/g lipid (Arrebola et al. 2014; De Roos 
et al. 2012; Dhooge et al. 2010; Lee et al. 2012a; Schildkraut et al. 1999).  Other studies of older adults 
have reported positive associations with body weight at 50 years of age and measures of intra-abdominal 
fat (but not subcutaneous fat) in a group of postmenopausal women (De Roos et al. 2012) and with 
abdominal areas of visceral and subcutaneous adipose tissue (VAT and SAT) in a group of 70-year-old 
Swedish men and women (Roos et al. 2013).  Inconsistent results were reported in studies evaluating sex 
differences in adults (Elobeid et al. 2010; Lee et al. 2012a; Tang-Peronard et al. 2015a).  For example, 
Elobeid et al. (2010) reported an inverse association between serum DDT and BMI in men and a positive 
association in women, and Lee et al. (2012a) reported no significant association with incidence of 
abdominal obesity at age 70 years in women and a significant positive association in men. 
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Table 2-2.  Summary of Studies of Associations between DDT Exposure Biometrics and Body Weight Statusa  
 
Reference Exposure metricb Outcome evaluated Resultsc Notes 
Arrebola et al. 2014 
298 adults (median age 
51 years old; 152 women, 
146 men) 
Granada Spain 
DDE, adipose BMI ↑  Adjusted betas, continuous exposure 
variable 
  
Associations with total cholesterol and 
total lipids were NS 
Burns et al. 2012 
350 peri-pubertal boys 8–
9 years old at study 
initiation; annual follow-ups 
for 4 years 
Chapaevsk Russia 
DDE, serum WHO age-adjusted BMI z-score 
WHO age-adjusted height z-score 
Change in height (cm/year over 
4 years) 
↓ (Q2–Q5) 
↓ (Q4–Q5) 
↓ (Q4–Q5) 
Adjusted betas, categorical exposure 
levels versus Q1 
 
Significant p-trends for all endpoints 
De Roos et al. 2012 
173 sedentary and 
overweight/obese, post-
menopausal women, 
~60 years old 
Seattle, Washington 
DDE, serum BMI 
Current body composition 
Fat mass (percent total body mass) 
Subcutaneous fat (per 100 units) 
Intra-abdominal fat (per 100 units) 
Waist circumference 
Hip circumference 
Waist:hip ratio 
Weight at 50 years 
Maximum weight 
Net weight change since 35 years 
Weight loss episodes 
Number of weight loss episodes 
NS 
NS 
NS 
NS 
↑ (beta 36.5) 
NS 
NS 
NS 
↑ (50 years) 
NS 
NS 
NS 
NS 
Adjusted betas, continuous exposure 
levels  
Dhooge et al. 2010 
775 men, 808 women, 50–
65 years old 
1,679 adolescents, 14–
15 years old, 887 boys, 
792 girls 
Flanders 
DDE, serum BMI (male adults) 
BMI (female adults) 
BMI (boys)  
BMI (girls) 
↑ 
↑ 
↓ 
↓ 
Adjusted betas for DDE doubling, 
continuous exposure levels 
 
Data for adolescents were not shown 
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Table 2-2.  Summary of Studies of Associations between DDT Exposure Biometrics and Body Weight Statusa  
 
Reference Exposure metricb Outcome evaluated Resultsc Notes 
Elobeid et al. 2010 
2,464 adults (BMI), 
2,448 adults (waist 
circumference) 
NHANES 1999–2002 
DDT, serum 
 
Overall adiposity: 
BMI (overall) 
Male 
Female 
Waist circumference (overall) 
Male 
Female 
 
↑ 
↓ 
↑ 
NS 
↓ 
↑ 
Adjusted betas per SD unit increase of ln 
DDT 
Lee et al. 2011b 
5,115 U.S. adults at study 
initiation (18–30 years old 
at initiation) 
DDE and DDT, 
serum; no exposure 
levels were provided 
BMI at 20-year follow-up 
(ages 38–50 years)  
 
↑ (p-trend) 
 
 
 
Increasing p-trend of adjusted means of 
BMI across exposure quartiles for both 
DDE and DDT 
  
For DDE, adjusted means increased up 
to 3rd quartile, then decreased in 4th DDE 
quartile to levels equal to the 2nd DDE 
quartile 
 
For DDT, adjusted means steadily 
increased across quartiles 
Lee et al. 2012a  
970 adults (49% men);  
age 70 years at study 
initiation 
Abdominal obesity: 
waist circumference 
>102 cm men; >88 cm 
women 
Uppsala, Sweden 
DDE, serum; serum 
levels provided in 
supplementary 
tables 
Abdominal obesity at 70 years old 
Women 
Men 
Abdominal obesity developed 
between 70 and 75 years old 
Women 
Men 
 
NS (Q2–Q5) 
↑ (Q4, Q5)  
 
 
NS 
NS 
Adjusted ORs – Categorical exposure 
levels versus Q1  
 
Significant positive p-trend across 
quintiles (women and men) for 
prevalence at 70 years old 
 
 
Lim et al. 2011 
1,099 adults ≥40 years old 
NHANES population 1999–
2002 
DDE, serum, no 
exposure levels 
were provided 
Categories of 10-year changes in 
weight: 
      --     -           0            +    ++  
Weight loss   Stable    Weight gain 
↓  Adjusted correlation coefficients  
r= -0.16 (p<0.01) for decreasing DDE 
serum across weight change categories 
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Table 2-2.  Summary of Studies of Associations between DDT Exposure Biometrics and Body Weight Statusa  
 
Reference Exposure metricb Outcome evaluated Resultsc Notes 
Perry et al. 2005 
466 nulliparous women, 
mean age ~25 years 
 
Anhui China 
Total DDT, serum 
(high exposure 
levels: mean DDE 
5,940 ng/g lipid) 
BMI ↓ Adjusted betas, continuous exposure 
levels; each kg/m2 increase in BMI was 
associated with -1.34 ng/g lipid decrease 
in serum ΣDDT 
Roos et al. 2013 
287 adults (aged 70 years) 
Uppsala, Sweden 
DDE, serum Areas of the abdomen measured by 
MRI: 
Visceral Adipose Tissue (VAT) 
Subcutaneous AT (SAT) 
VAT/SAT 
 
 
↑ 
↑ 
NS 
Adjusted betas (95% CI), continuous 
exposure variable 
Schildkraut et al. 1999 
99 Women (42 black, 
57 white) Mean age 
~57 years 
North Carolina 
DDE, serum BMI 
Waist:hip ratio (4th versus 
1st quartile) 
Weight loss in past year (>5 lbs) 
Weight gain in past year (>5 lbs) 
↑ 
NS 
NS 
NS 
Adjusted betas for lnDDE, categorical 
outcomes 
Tang-Peronard 
et al. 2015a 
509 children (8–9 years 
old) at study initiation 
Odense, Denmark 
DDE, serum At 14–16 years: 
BMI z-score 
Waist circumference 
Percent body fat  
At 20–22 years: 
BMI z-score 
Waist circumference 
Percent body fat 
 
NS (M, F) 
↓ (F) NS (M) 
NS (M, F) 
 
↓ (F) ↑ (M) 
NS (M, F) 
NS (M, F) 
Adjusted betas (95% CI), both continuous 
and categorical exposure variables 
 
aStudies in this table were selected because they: (1) measured DDT-related metrics in biological fluids or tissues in each subject, and (2) evaluated associations 
using linear regression, logistical regression, or correlation techniques, adjusting for possible confounding factors. 
bDDE = p,p’-DDE, unless otherwise specified; DDT = p,p’-DDT, unless otherwise specified.  
cArrows “↑ or ↓” indicate statistical significance (p<0.05) and direction of change observed for a given outcome (↑ association and ↓ inverse association). 
 
BMI = body mass index; CI = confidence interval; F = female(s); M = male(s); MRI = magnetic resonance imaging; NHANES = National Health and Nutrition 
Examination Survey; NS = not statistically significant; OR = odds ratio; Q = quintile(s); SAT = subcutaneous adipose tissue; SD = standard deviation; 
VAT = visceral adipose tissue; WHO = World Health Organization 
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In contrast to the consistent evidence of a positive association from studies of BMI in older adults, a 
negative (inverse) association was reported in a study of young (mean age ~25 years) Chinese women 
with very high serum levels of total DDT (32 ng/g) (Perry et al. 2005), and a positive association was 
observed in a group of U.S. adults, ages 38–50 years (Lee et al. 2011b).  Lim et al. (2011) found an 
inverse relationship between weight change over a 10-year period and increased serum DDE, albeit at 
serum levels in the range of NHANES studies.  It is possible that the apparent inverse association of very 
high serum levels on BMI in the group of Chinese women (~10-fold >500 ng/g lipid) may be an entirely 
different response to DDT or DDE, than that inferred from the studies of people with serum total DDT or 
DDE levels <500 ng/g lipid, reflecting some non-monotonic response, but this possible explanation is 
based on very limited data.  In a systematic review and meta-analysis, Cano-Sancho et al. (2017) 
concluded that there was a moderate level of epidemiological evidence for an association between 
p,p′-DDE and BMI and calculated a beta of 0.13 (95% CI 0.01–0.25).  
 
Three studies evaluating DDT biometrics in children and adolescents provide inconsistent evidence for an 
inverse association between serum DDE and weight status markers (Burns et al. 2012; Dhooge et al. 
2010; Tang-Peronard et al. 2015a).  Inverse associations were reported for BMI z-score in Russian boys 
(Burns et al. 2012) and for BMI in boys and girls from Flanders (Dhooge et al. 2010), but no significant 
associations for BMI z-scores were found in Danish boys and girls at 14–16 years of age (Tang-Peronard 
et al. 2015a); at 20–22 years, the Danish study reported a positive association in the males and an inverse 
association in the females (Tang-Peronard et al. 2015a).   
 
In a single controlled exposure study, no treatment-related effects on body weight were observed in a 
group of 51 male volunteers given daily doses of up to 0.5 mg technical DDT/kg for up to 18 months 
(Hayes et al. 1956).  
 
Evidence of Body Weight Effects of DDT, DDT, or DDE in Animals.  Effects on body weight have been 
observed in animals orally exposed to DDT and related compounds for acute, intermediate, and chronic 
durations of exposure. 
 
Following acute oral exposure of adult animals, reported body weight effects include transiently 
decreased body weight on GDs 17–21 (9–17 % decreased compared with controls; returned to control 
levels by postpartum day 1) in rat dams exposed to 200 mg p,p’-DDE/kg/day, but not 100 mg/kg/day, on 
GDs 14–18 (Loeffler and Peterson 1999), and in adult males treated for with 200 mg p,p’-DDE/kg/day for 
4 days (Kelce et al. 1995).  No significant exposure-related body weight changes were noted in rat dams 
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exposed to gavage doses of 50 or 100 mg p,p’-DDT/kg/day during pregnancy on GDs 13.5–17.5 
(Adamsson et al. 2009); mouse dams exposed by gavage to up to 100 mg o,p’-DDT/kg/day on GDs 11–
17 (Palanza et al. 2001); castrated male rats exposed to up to 100 mg p,p’-DDE/kg/day for 10 days (Kang 
et al. 2004); or male mice exposed to up to 2 mg p,p’-DDE/kg/day for 5 days (Howell et al. 2014).   
 
After intermediate duration exposure to technical DDT, p,p’-DDE, or technical DDD, decreased body 
weight or body weight gain have been observed in rats and mice.  Significantly decreased body weight or 
body weight gain (≥10% decreased, compared with control values) were reported in male albino rats 
exposed by gavage to 0.2 mg technical DDT/kg/day for 120 days (Chowdhury et al. 1990); male and 
female Osborne-Mendel rats fed ≥50 or 97 mg technical DDT/kg/day, respectively, in the diet for 6 weeks 
(NCI 1978); male Osborne-Mendel rats fed ≥49 mg p,p’-DDE/kg/day in the diet for 6 weeks (NCI 1978); 
and female and male Osborne-Mendel rats exposed to 97 or 279 mg technical DDD/kg/day, respectively, 
in the diet for 6 weeks (NCI 1978).  Increased body weight (18% increase) occurred in pubertal male 
Long-Evans rats dosed with 100 mg p,p’-DDE/kg/day from PNDs 21 to 57 (Kelce et al. 1995).  No 
significant changes in body weight (compared with control values) were observed in male and female 
B6C3F1 mice fed 35 mg technical DDT/kg/day in the diet for 6 weeks (NCI 1978); male and female 
F344/DuCrj rats exposed to up to 45.7 mg p,p’-DDE/kg/day in the diet for 4 weeks (Harada et al. 2003); 
F0 and F1 parental female Sprague-Dawley rats exposed to up to 27.7 mg p,p’-DDE/kg/day for 10 weeks 
prior to mating and then throughout gestation and lactation (Hojo et al. 2006); Sprague-Dawley rat dams 
exposed to gavage doses as high 50 mg p,p’-DDE/kg/day from GD 6 to PND 20 (Yamasaki et al. 2009) 
or in prepubertal male F344/DuCrlCrlj rats receiving dietary doses of 10 mg p,p’-DDE/kg/day for 42 days 
(Makita et al. 2003a).   
 
Following chronic-duration exposures to technical DDT, p,p’-DDT, p,p’-DDE, or technical DDD, 
decreases in body weight have been observed in rats, mice, and hamsters.  After 78-week exposures, 
consistent decreases in body weight or body weight gain ≥20% were observed in female Osborne-Mendel 
rats exposed to 32 mg technical DDT/kg/day, 66 mg technical DDD/kg/day (lowest dose tested), and 
19 mg p,p’-DDE/kg/day (lowest dose tested) (NCI 1978).  Male rats exhibited a 16% decrease in weight 
gain at 45 mg technical DDT/kg/day (NCI 1978) and a 28% decrease with 116 mg technical DDD/kg/day 
(NCI 1978).  The chronic 2-year study by Harada et al. (2003, 2006) reported a 12% decrease in body 
weight in F344/DuCrj male rats orally exposed to 19.1 mg p,p’-DDT/kg/day and a 25% decrease at 
25.5 mg/kg/day in females.  Female B6C3F1 mice exposed to 28 mg p,p’-DDE/kg/day or 71 mg technical 
DDD/kg/day in their diets for 78 weeks had decreases in body weight gain of 29 and 17%, respectively 
(NCI 1978).  Hamsters fed a diet that provided approximately 47.5 mg p,p’-DDE/kg/day for 128 weeks 
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showed an unspecified reduction in body weight gain compared with controls (Rossi et al. 1983), but 
hamsters fed 40 mg technical DDT/kg/day for life were reported to have comparable body weights to 
control hamsters (Cabral et al. 1982a). 
 
Mechanisms of Body Weight Effects of DDT, DDD, or DDE.  The human epidemiological studies are 
consistent with the hypothesis that endocrine disrupting compounds (EDCs), including DDT, may act as 
obesogens that display non-monotonic dose-response relationships, leading to weight gain at lower 
exposure levels, but to growth restriction or weight loss at higher exposure levels (Tang-Peronard et al. 
2011).  Reduced body weights in the described animal studies are likely the result of high-dose exposure 
levels.  Several studies focusing on potential mechanisms behind DDT-associated obesity and obesity-
related diseases are discussed in Section 2.18.  Further studies may increase understanding of the 
complexities between the timing of DDT exposure, differences between DDT metabolites, dose, and 
gender, as well as the influences of initial weight status and significant weight change on serum levels of 
DDT and DDT toxicity (La Merrill et al. 2013).  
 
2.4   RESPIRATORY 
 
Evidence of Respiratory Effects of DDT, DDD, or DDE in Humans.  Epidemiological evidence of 
respiratory effects that are mediated by immunological function (e.g., asthma, wheezing, bronchitis, 
respiratory tract infections, and hypersensitivity) is discussed in detail in Section 2.14.   
 
Two studies provide inconsistent evidence for associations between serum levels of p,p’-DDT or 
p,p’-DDE and measures of lung function (Hansen et al. 2016 [see Section 2.14]; Ye et al. 2015).  In a 
study of 1,696 Canadian adults, serum levels of DDT and DDE were inversely associated with forced 
vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) in models adjusted for age, sex, 
ethnicity, height, smoking status, and daily energy expenditure; associations with FEV1/FVC and forced 
expiratory flow (FEF) at 25–75% were not statistically significant (Ye et al. 2015).  In the other study, 
maternal serum levels of DDE showed no associations with reduced lung function (FEV1 percent of 
predicted value <90%), but a positive association with airway obstruction (FEV1/FVC <75%) was noted 
in offspring at 20 years of age (Hansen et al. 2016).  
 
In a single controlled exposure study, volunteers were exposed by inhalation of aerosols containing DDT 
at concentrations that left a white deposit on the nasal hair (Neal et al. 1944).  Except for moderate 
irritation of the nose, throat, and eyes, which may have been related to the vehicle to disperse DDT in an 
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aerosol, no significant changes were reported.  The investigators provided some information on exposure 
levels, but noted that the DDT quickly settled, and thus, the actual exposure levels were lower than 
predicted. 
 
Evidence of Respiratory Effects of DDT, DDD, or DDE in Animals.  No studies were located regarding 
the respiratory effects in animals after acute or intermediate oral exposure to DDT, DDD, or DDE. 
 
In chronic oral studies, rats fed a diet containing 20 mg commercial DDT/kg/day for 27 months did not 
develop adverse respiratory effects, with the exception of squamous bronchial metaplasia in one rat 
(Deichmann et al. 1967).  In the 78-week chronic bioassay conducted by the National Cancer Institute 
(NCI 1978), no adverse effects on the respiratory system were observed in Osborne-Mendel rats treated in 
the diet with up to 45 mg technical DDT/kg/day, 59 mg p,p’-DDE/kg/day, or 231 mg technical 
DDD/kg/day, or in B6C3F1 mice treated with up to 30.2 mg technical DDT/kg/day, 49 mg 
p,p’-DDE/kg/day, or 142 mg technical DDD/kg/day (NCI 1978).  No histopathological changes or tumors 
in the lung were noted at 55 weeks of age of ICR mice exposed from conception through death to 
16.5 mg/technical-DDT/kg/day (Del Pup 1978); however, development of lung tumors has been reported 
in other studies following oral exposure of mice to DDT isomers and is discussed in Section 2.19.  
 
In rats, guinea pigs, and rabbits exposed to acute dermal doses ranging from 50 to 200 mg DDT/kg, 
pulmonary edema and respiratory failure were reported (Cameron and Burgess 1945). 
 
Mechanisms of Respiratory Effects of DDT, DDE, or DDD.  There is inconsistent evidence supporting 
associations between exposures to DDT isomers and impaired lung function.  However, some mechanistic 
studies have begun to evaluate the relationship between serum levels of DDT isomers and respiratory 
effects mediated by immunological dysfunction (see Section 2.14).  
 
2.5   CARDIOVASCULAR 
 
Evidence of Cardiovascular Effects of DDT, DDD, or DDE in Humans.  A number of epidemiological 
studies have examined associations between serum or adipose levels of DDT, DDD, or DDE and 
cardiovascular outcomes, including general hypertension in adults (Arrebola et al. 2015b; Goncharov et 
al. 2011; Henriquez-Hernandez et al. 2014; Lee et al. 2007b; La Merrill et al. 2013; Lind et al. 2014; Park 
et al. 2016; Valera et al. 2013a, 2013b), gestational hypertension (Savitz et al. 2014), stroke (Lee et al. 
2012a, 2012b), cardiovascular disease (Ha et al. 2007), and peripheral arterial disease (Min et al.  2011).  
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The results provide inconsistent evidence for associations between serum or adipose levels of DDE or 
DDT and cardiovascular effects. 
 
Three out of six epidemiological studies on hypertension (Lind et al. 2014; Valera et al. 2013a, 2013b) 
and one meta-analysis (Park et al. 2016) reported some evidence for associations with serum or adipose 
levels of p,p’-DDE.  p,p’-DDE levels were associated with increased risk of hypertension in an Inuit 
community in Quebec (Valera et al. 2013a) and in a population of older adults in Sweden (Lind et al. 
2014), but not in a population of 1,614 Inuit adults in Greenland with similarly high exposure levels 
(Valera et al. 2013b).  Despite inconsistencies among individual studies, meta and random-effects 
analysis across all six studies suggested that an overall small, but significant, association between DDE 
serum levels and hypertension may exist (Park et al. 2016).  Fewer studies have looked for associations 
with levels of DDT, and report both positive (association found in 18–39 year olds, but not in adults 
≥40 years of age) (Valera et al. 2013b) and inverse relationships between p,p’-DDT serum levels and 
hypertension (Valera et al. 2013a).  A single study examined possible associations between p,p’-DDT, 
o,p’-DDT, or DDE serum levels sampled from pregnant women in 1959–1967 and incidence of 
hypertension in adult daughters (as defined as medication for the treatment of hypertension) in 2005–2008 
and found significant associations with p,p’-DDT, but not with o,p’-DDT or p,p’-DDE (La Merrill et al. 
2013).   
 
In other epidemiological studies, no statistically significant positive associations with gestational 
hypertension (Savitz et al. 2014), cardiovascular disease (Ha et al. 2007), or systolic or diastolic blood 
pressure levels (Goncharov et al. 2011; Henriquez-Hernandez et al. 2014; Valera et al. 2013a, 2013b) 
were observed (Table 2-3).  Significant associations were reported between serum DDT or DDE levels 
and incidences of stroke in elderly men (Lee et al. 2012b) and peripheral arterial disease in obese adults 
(Min et al. 2011).  Another study (Mills et al. 2009) found a significant association between DDT 
pesticide use and incidence of nonfatal myocardial infarction, although exposure levels of DDT were not 
reported; no associations were found for fatal myocardial infarction. 
 
In a controlled exposure study, no clear effects on cardiovascular performance (resting and exercise heart 
rate, systolic blood pressure, and pulse pressure) were found in male volunteers orally administered 3.5 or 
35 mg DDT/day by capsule for 12–18 months either as recrystallized DDT administered via a capsule or 
technical-grade DDT administered via a milk emulsion (about 0.05–0.063 or 0.36–0.5 mg/kg/day) (Hayes 
et al. 1956).   
DDT, DDE, and DDD  76 
 
2.  HEALTH EFFECTS 
 
 
 
 
 
 
***DRAFT FOR PUBLIC COMMENT*** 
Table 2-3.  Summary of Studies of Associations between DDT Exposure Biometrics and Cardiovascular 
Endpointsa 
 
Reference Exposure metricb Outcome evaluated Resultsc Notes 
Arrebola et al. 2015b 
297 adults (median age 
48 years)  
Granada, Spain 
DDE, adipose Hypertension  
Total  
BMI ≤26.3 
BMI >26.3 
  
NS 
NS 
NS 
Adjusted HRs (95% CI), per 1 log-unit 
increase in exposure 
 
Goncharov et al. 2011 
394 adults (median age 
47 years) 
Anniston, Alabama 
p,p’-DDT, p,p’-DDT, 
p,p’-DDE 
Systolic blood pressure 
 
Diastolic blood pressure 
NS (all 
compounds) 
NS (all 
compounds) 
Linear regression analysis, categorical 
exposure levels 
Ha et al. 2007  
889 adults  
NHANES 1999–2002 
DDE, serum Cardiovascular disease NS Adjusted ORs (95% CI), categorical 
Exposure levels (percentiles) 
 
p-trend = NS 
Henriquez-Hernandez et 
al. 2014 
428 adults (mean age 
47.2 years) 
Canary Islands 
DDE, serum Hypertension 
SBP ≥140 mmHg 
DBP ≥90 mmHg 
NS 
NS 
NS 
Adjusted OR (95% CI), categorical 
exposure levels (tertiles) 
Lee et al. 2007b  
721 adults 
NHANES 1999–2002 
DDE, serum BP ≥130/85 NS Adjusted ORs (95% CI), categorical 
exposure levels 
 
p-trend = NS 
Lee et al. 2012b 
898 adults (mean age 
70 years) 
Uppsala, Sweden 
DDE, serum Incidence of stroke ↑ (Q2, Q4) Adjusted ORs (95% CI), categorical 
exposure levels 
 
p-trend NS 
La Merrill et al. 2013  
457 normotensive, 111 adult 
women self-reporting 
hypertension, 70  adult 
women using hypertension 
medication  
San Francisco 2005–2008 
p,p’-DDT, o,p’-DDT, 
DDE, serum from 
mothers’ sampled 
during pregnancy 
(1959–1967)  
Medicated hypertension 
 
 
 
Self-reported hypertension 
↑ (T2, T3) p,p’-DDT 
NS o,p’-DDT 
NS DDE 
 
↑ (T2) NS (T3) 
p,p’-DDT 
 
Adjusted ORs (95% CI), categorical 
exposure levels 
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Table 2-3.  Summary of Studies of Associations between DDT Exposure Biometrics and Cardiovascular 
Endpointsa 
 
Reference Exposure metricb Outcome evaluated Resultsc Notes 
Lind et al. 2014 
1,016 adults (mean age 
70 years) 
Uppsala, Sweden 
DDE, serum Prevalent hypertension ↑ Adjusted ORs (95% CI), per doubling of 
DDE 
Min et al. 2011 
2,032 adults 
NHANES 1999–2004 
DDE, serum Peripheral arterial disease ↑ (obese) 
NS (non-obese) 
Adjusted ORs (95% CI) per unit increase in 
exposure in obese and non-obese subjects 
Park et al. 2016  
Meta-analysis of six studies 
(Arrebola et al. 2015b 
Heriquez-Hernandez et al. 
2014; Lee et al. 2007b; Lind 
et al. 2014; Valera et al. 
2013a, 2013b) 
DDE Hypertension ↑ Overall OR (95% CI); only one (out of six) 
individual studies (Lind et al. 2014) with 
significant OR 
Savitz et al. 2014  
1,933 women total 
364 with gestational 
hypertension; 151 with 
preeclampsia  
DDE; DDT, serum Gestational hypertension  
 
 
Preeclampsia 
↓ (DDT, Q3, Q5)  
NS (DDE) 
 
NS (DDT, DDE) 
 
Adjusted ORs (95% CI), categorical 
exposure levels 
 
Risk for gestational hypertension was 
inversely associated with increasing DDT 
Valera et al. 2013a 
315 Inuit adults; mean age 
32.7 years 
Quebec 
DDE; DDT, serum Risk of hypertension 
Model 1 
Model 2  
Model 3 
 
 
 
 
 
 
 
 
SBP (DDE or DDT) 
DBP (DDE or DDT) 
 
↓ (DDT) 
↑ (DDE) ↓ (DDT) 
↑ (DDE) ↓ (DDT) 
 
 
 
 
 
 
 
 
NS 
NS 
Adjusted ORs (95% CI) per 1 log unit 
increase in exposure levels 
 
Model 1: standard adjustments 
Model 2: additional adjustment for specific 
polyunsaturated fatty acids, 
eicosapentaenoic acid, and 
docosahexaenoic acid   
Model 3: model 1 plus additional 
adjustments for toxic metals (lead and 
mercury) 
 
Adjusted betas for change per 1 log-unit 
increase in exposure levels 
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Table 2-3.  Summary of Studies of Associations between DDT Exposure Biometrics and Cardiovascular 
Endpointsa 
 
Reference Exposure metricb Outcome evaluated Resultsc Notes 
Valera et al. 2013b 
1,614 Inuit adults; mean age 
44.6 years 
Greenland 
DDE; DDT, serum Hypertension (DDE) 
Ages 18–39 years 
Ages ≥40 years 
Hypertension (DDT) 
Ages 18–39 years 
Ages ≥40 years 
SBP (DDE or DDT) 
DBP (DDE or DDT) 
NS 
NS 
NS 
NS 
↑ 
NS 
NS 
NS 
Adjusted ORs (95% CI) per 1 log-unit 
increase in exposure levels 
 
 
 
 
Adjusted betas for change per 1 log-unit 
increase in exposure levels 
 
aStudies in this table were selected because they: (1) measured DDT-related metrics in biological fluids or tissues in each subject, and (2) evaluated associations 
using linear regression, logistical regression, or correlation techniques, adjusting for possible confounding factors. 
bDDE = p,p’-DDE, unless otherwise specified; DDT = p,p’-DDT, unless otherwise specified.  
cArrows “↑ or ↓” indicate statistical significance (p<0.05) and direction of change observed for a given outcome (positive or inverse associations, respectively). 
 
BMI = body mass index; CI = confidence interval; DBP = diastolic blood pressure; NHANES = National Health and Nutrition Examination Survey; NS = not 
statistically significant; OR = odds ratio; HR = hazard ratio; Q = quartile(s) and quintile(s); SBP = systolic blood pressure; T = tertile(s) 
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Evidence of Cardiovascular Effects of DDT, DDD, or DDE in Animals.  In a developmental toxicity 
study, increased systolic blood pressure was measured at 5 and 7 months of age in the offspring of 
C57BL/6J mice exposed to 1.7 mg/kg/day mixture of p,p’-DDT (77.2%) and o,p’-DDT (22.8%) from 
GD 12 to PND 5 (La Merrill et al. 2016).  Cardiac hypertrophy was also observed in 8.5-month-old mice.  
No other studies evaluating cardiovascular effects following acute- or intermediate-duration studies in 
rodents orally exposed to DDT, DDD, or DDE were identified.  A 14-day study in dogs exposed to 
o,p’-DDD, resulted in decreased contractile force at a LOAEL of 50 mg/kg/day (Cueto et al. 1970), but 
no effects were observed with p,p’- isomers in dogs at any exposure duration.   
 
In chronic oral exposure studies, no significant chemical-related adverse effects on the cardiovascular 
system were observed in Osborne-Mendel rats treated in the diet for up to 78 weeks with up to 45 mg 
technical DDT/kg/day, 59 mg p,p’-DDE/kg/day, or 231 mg technical DDD/kg/day or in B6C3F1 mice 
treated with up to 30.2 mg technical DDT/kg/day, 49 mg p,p’-DDE/kg/day, or 142 mg technical 
DDD/kg/day (NCI 1978).  No histopathological changes in the heart were noted at 55 weeks of age of 
ICR mice exposed from conception through death to 16.5 mg/technical-DDT/kg/day (Del Pup 1978). 
 
Cameron and Burgess (1945) exposed rats, guinea pigs, and rabbits to acute dermal doses ranging from 
50 to 200 mg DDT/kg and reported fat in the muscle fibers of the heart. 
 
Mechanisms of Cardiovascular Effects of DDT, DDD, or DDE.  In men, DDT has known anti-
androgenic effects and has been inversely associated with serum testosterone (Blanco-Muñoz et al. 2012).  
Low levels of testosterone have been linked to hypertension and is a known risk factor for the 
development of major cardiac events, supporting the hypothesis that the anti-androgenic effects of DDE 
may impact cardiac health (Lind et al. 2014); see Section 2.16 for discussion of anti-androgenic effects.  
Although plausible, more experimental studies are needed to elucidate potential mechanistic relationships 
between DDT anti-androgenic activity and cardiovascular effects.  In a mouse developmental toxicity 
study, DDT-induced increased systolic and diastolic blood pressure could be partially reversed with the 
angiotensin converting enzyme (ACE) inhibitor, captopril (La Merrill et al. 2016).  The results are 
consistent with the idea that overactivation of ACE may be involved in DDT-induced hypertension (La 
Merrill et al. 2016).  Biochemical studies on kidney tissue showed the overactivation of the renin-
angiotensin system to be associated with increased renal expression of sodium transporter mRNA (La 
Merrill et al. 2016).  Whether a similar mechanism may operate in humans is unknown.   
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2.6   GASTROINTESTINAL 
 
Evidence of Gastrointestinal Effects of DDT, DDD, or DDE in Humans.  A single human study of 
199 mother-infant pairs found no significant associations between gastrointestinal infections in 7-month-
old offspring and maternal serum levels of DDE (Dallaire et al. 2004; see Section 2.14). 
 
Evidence of Gastrointestinal Effects of DDT, DDD, or DDE in Animals.  No evaluation of 
gastrointestinal effects following acute or intermediate oral exposure studies have been reported. 
 
In chronic studies, no significant chemical-related adverse effects on the gastrointestinal system were 
observed in Osborne-Mendel rats treated for up to 78 weeks in the diet with up to 45 mg technical 
DDT/kg/day, 59 mg p,p’-DDE/kg/day, or 231 mg technical DDD/kg/day or in B6C3F1 mice treated with 
up to 30.2 mg technical DDT/kg/day, 49 mg p,p’-DDE/kg/day, or 142 mg technical DDD/kg/day (NCI 
1978). 
 
2.7   HEMATOLOGICAL 
 
Evidence of Hematological Effects of DDT, DDD, or DDE in Humans.  Epidemiological studies 
evaluating associations between hematological effects and DDT exposure biometrics are limited 
(Table 2-4).  A Brazilian study of adults with markedly high levels of serum DDE (>10-fold higher than 
the general population) found no significant associations between serum DDE levels and risks for 
abnormal distributions of various blood cell types (Freire et al. 2015a, 2015b).  Analysis of a general 
population NHANES cohort (2003–2004) found associations between serum DDT levels and increased 
number of lymphocytes and decreased number of segmented neutrophils (Serdar et al. 2014). 
 
In a controlled exposure study, 51 male volunteers were exposed to 0.05–0.063 or 0.36–0.5 mg 
DDT/kg/day for 12–18 months (Hayes et al. 1956).  Although some variation among individuals in 
hemoglobin levels, red and white blood cell counts, and percentage of polymorphonuclear leukocytes was 
noted, these variations did not correlate with increased dosage of DDT or with duration of exposure.   
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Table 2-4.  Summary of Studies of Associations between DDT Exposure Biometrics and Hematological 
Endpointsa 
 
Reference Exposure metricb Outcome evaluated Resultsc Notes 
Freire et al. 2015a, 2015b 
415 males; 432 females  
Brazil 
DDE, serum Anemia 
Leukopenia 
Leukocytosis 
Neutropenia 
Neutrophilia 
Eosinophilia 
Thrombocytopenia 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
Adjusted ORs (95% CI), continuous and 
categorical exposure variables 
 
Results NS in both males and females 
Serdar et al. 2014 
NHANES 2003–2004 
DDT, serum Lymphocyte number  
Segmented neutrophils number 
↑ (Q2, Q4) 
↓ (Q4) 
Adjusted betas (95% CI), categorical 
exposure variables 
 
aStudies in this table were selected because they: (1) measured DDT-related metrics in biological fluids or tissues in each subject, and (2) evaluated associations 
using linear regression, logistical regression, or correlation techniques, adjusting for possible confounding factors. 
bDDE = p,p’-DDE, unless otherwise specified; DDT = p,p’-DDT, unless otherwise specified.  
cArrows “↑ or ↓” indicate statistical significance (p<0.05) and direction of change observed for a given outcome (positive or inverse associations, respectively). 
  
CI = confidence interval; NHANES = National Health and Nutrition Examination Survey; NS = not statistically significant; OR = odds ratio; Q = quartile(s) 
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In a case-control study of patients with chronic debilitating fatigue, lasting at least 6 months, the mean 
concentration of p,p’-DDE in blood serum was significantly higher in case subjects (11.9 ppb; n=14) than 
in controls (5.2 ppb; n=23) (Dunstan et al. 1996).  When the 37 subjects were pooled and then re-divided 
according to high serum DDE (>6 ppb) and low serum DDE (<6 ppb), the red blood cell distribution 
width (variation in erythrocyte cell width change) was significantly greater in the high-DDE group than in 
the low-DDE group; however, the changes were within the range of normal clinical values.  No other 
differences were seen in other hematological parameters.   
 
Evidence of Hematological Effects of DDT, DDD, or DDE in Animals.  There is little evidence that 
hematological parameters are sensitive targets for DDT, DDE, or DDD toxicity.  
 
Some evidence for microcytic anemia has been reported in rats fed p,p’-DDT in the diet at doses 
≥5.0 mg/kg/day for 13–78 weeks (Tomita et al. 2013).  The changes in hematocrit, hemoglobin, and red 
blood cell counts were small (approximately 3% lower than controls), but statistically significant.  The 
magnitude of these decreases did not markedly change with longer durations of exposure and some were 
not significant at all time points.  With 2 weeks of exposure, these effects were not seen, but small, 
statistically significant decreases (compared with controls) were found only at 50 mg/kg/day for 
hemoglobin content of reticulocytes (3%) and mature erythrocytes (1%), along with a decrease in 
transferrin saturation, but no changes in plasma iron levels.  There was, however, a marked increase in 
unsaturated iron binding capacity (115% increase at 50 mg/kg/day) and total iron binding capacity (5 and 
53% at 5 and 50 mg/kg/day, respectively) (Tomita et al. 2013). 
 
In other intermediate- to chronic-duration studies, rats exposed to commercial DDT at 20 mg/kg/day for 
27 months had congestion and hemolysis of the spleen (Deichmann et al. 1967).  No hematological 
changes were observed in squirrel monkeys exposed orally to doses of 0.05–50 mg p,p’-DDT/kg/day for 
up to 6 months; however, all monkeys in the highest dose group (six animals) died by week 14 (Cranmer 
et al. 1972); the cause of death was not determined.  
 
Cameron and Burgess (1945) exposed rats, guinea pigs, and rabbits to acute dermal doses ranging from 
50 to 200 mg technical DDT/kg.  A decrease in hemoglobin and leukocytosis was reported.  
 
Mechanisms of Hematological Effects of DDT, DDD, or DDE.  Due to the lack of strong evidence that 
DDT exposure is associated with consistent hematological effects, mechanistic investigations are limited.  
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Tomita et al. (2013) hypothesized that microcytic anemia from repeated dietary DDT exposure in rats 
may be due to impaired iron utility.   
 
Several in vitro incubation studies indicated that DDT isomers can induce apoptosis in multiple blood 
cell-types including human primary peripheral blood mononuclear cells (PBMCs) (Alegria-Torres et al. 
2009; Perez-Maldonado et al. 2004, 2005, 2006).  In a preliminary study, exposed children in Chiapas, 
Mexico, had an increased percentage of PBMC apoptotic cells compared to a non-exposed group of 
controls (Perez-Maldonado et al. 2004).  In a follow-up study with more participants, significant 
correlations between DDT or DDE exposure and DNA damage were reported; however, no significant 
associations between DDT or DDE exposure and oxidative DNA damage were observed (Perez-
Maldonado et al. 2011).  A correlation between DDE exposure and PBMC apoptosis was also reported. 
 
2.8   MUSCULOSKELETAL 
 
Evidence of Musculoskeletal Effects of DDT, DDD, or DDE in Humans.  Inconsistent evidence is 
provided by a limited number of epidemiological studies for associations between serum levels of DDT, 
DDD, or DDE and bone mineral density in men (Glynn et al. 2000; Wallin et al. 2005; Table 2-5) and 
peri- or post-menopausal women (Beard et al. 2000; Bohannon et al. 2000; Rignell-Hydbom et al. 2009; 
Wallin et al. 2005; Table 2-5).  No clear evidence for associations with DDE serum levels were found in 
two studies of Swedish men (Glynn et al. 2000; Wallin et al. 2005), despite the known anti-androgenic 
effects of DDT and the association between androgen deprivation and bone loss and osteoporosis in men 
(Taylor et al. 2009).  In studies of post-menopausal women, a significant association with decreased bone 
mineral density was found in one study (Beard et al. 2000), another study found an association with 
increased bone mineral density (Rignell-Hydbom et al. 2009), and two studies found no associations with 
bone mineral density (Bohannon et al. 2000; Wallin et al. 2005).  
 
Evidence of Musculoskeletal Effects of DDT, DDD, or DDE in Animals.  Limited information exists 
from studies in animals.  In chronic-duration oral exposure studies, no significant chemical-related 
adverse musculoskeletal effects were observed in Osborne-Mendel rats treated in the diet with up to 
45 mg technical DDT/kg/day, 59 mg p,p’-DDE/kg/day, or 231 mg technical DDD/kg/day, or in B6C3F1 
mice treated with up to 30.2 mg technical DDT/kg/day, 49 mg p,p’-DDE/kg/day, or 142 mg technical 
DDD/kg/day (NCI 1978).  Fisher 344 rats treated for 104 weeks to 19.1 mg/kg/day DDT showed no 
histopathology of the femur and sternum (Tomita et al. 2013). 
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Table 2-5.  Summary of Studies of Associations between DDT Exposure Biometrics and Musculoskeletal 
Endpoints 
 
Reference Exposure metric Outcome evaluated Results Notes 
Beard et al. 2000 
68 sedentary women (mean 
52 years) 
Australia 
DDE, serum Bone Mineral Density ↓ Adjusted betas, continuous exposure 
variable (coefficients, data not shown, only 
p-values provided) 
Bohannon et al. 2000 
103 peri- and post-
menopausal women (mean 
age 54.5 years); 50 black, 
53 white 
United States 
DDE, serum Bone mineral density 
(baseline/rate of change) in lumbar 
spine and radius: 
Whites 
Blacks 
All 
 
 
 
NS/NS 
NS/NS 
NS/NS 
Adjusted betas for T1 and T3 versus T2 
DDE 
 
All p-trends = NS 
Glynn et al. 2000 
115 men (mean age 
63 years) 
Sweden 
DDE, DDT, DDD, 
serum 
Bone mineral density 
FNBMD, LSBMD, WBBMD 
 
Ultrasound bone endpoints 
BUA and SOS 
 
All NS 
 
 
↓ (DDE Q3) 
Adjusted betas (±SE) – continuous 
exposure levels 
 
Adjusted betas – categorical exposure 
levels.  Q4 versus Q1 was NS 
Rignell-Hydbom et al. 
2009 
908 women (60–70 years 
old) 
General population, Sweden 
DDE, serum  
Osteocalcin 
Bone mineral density 
 
 
NS 
↑  
 
Adjusted betas (95% CI) – Continuous 
exposure variables: 
Beta for effects on bone mineral density, 
although statistically significant, was very 
small. 
Wallin et al. 2005 
196 men (59 years old); 
184 women (62 years old) 
Sweden 
DDE, serum Bone mineral density 
  Men 
  Women 
 
NS 
NS 
Adjusted betas (95% CI) – both continuous 
and categorical exposure variables 
 
aStudies in this table were selected because they: (1) measured DDT-related metrics in biological fluids or tissues in each subject, and (2) evaluated associations 
using linear regression, logistical regression, or correlation techniques, adjusting for possible confounding factors. 
bDDE = p,p’-DDE, unless otherwise specified; DDT = p,p’-DDT, unless otherwise specified.  
cArrows “↑ or ↓” indicate statistical significance (p<0.05) and direction of change observed for a given outcome  (positive or inverse associations, respectively). 
 
BUA = broad-band attenuation; CI = confidence interval; FNBMD = femoral neck bone mineral density, LSBMD = lumbar spine bone mineral density; NS = not 
statistically significant; Q = quartile(s); SE = standard error; SOS = speed of sound in os calcis; T = tertile(s); WBBMD = whole body bone mineral density 
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2.9   HEPATIC 
 
Evidence of Hepatic Effects of DDT, DDT, or DDE in Humans.  Inconsistent evidence is provided by 
four studies examining serum or cord blood levels of DDT or DDE and serum or urinary markers of liver 
damage or dysfunction (Table 2-6).  No clearly significant associations were found with serum enzymes 
or chemicals indicative of liver damage (e.g., increased AST, ALT, or bilirubin) in subjects residing in a 
heavily contaminated region in Brazil (Freire et al. 2015a, 2015b) or in U.S. workers exposed to 
pesticides and monitored between 1969 and 1973 (Morgan and Lin 1978), but an analysis of NHANES 
data from 2003 to 2004 reported increased adjusted mean serum levels of ALT, gamma-glutamyl 
transferase (GGT), AST, and bilirubin in higher exposure quartiles, compared with the lowest exposure 
quartile (Serdar et al. 2014; see Table 2-6); however, the changes do not appear to be dose-related.  
Significant associations between cord blood DDE or DDT levels and urinary levels of total porphyrins, 
coproporphyrin I, and coproporphyrin III (indicators of altered hepatic heme synthesis in the liver) were 
reported in a group of 52 4-year-old children from Ribera D’Ebre Spain (Sunyer et al. 2008).  
 
Studies of workers involved in the manufacture and formulation of DDT for many years found no 
evidence of hepatotoxicity, hepatic enlargement, or dysfunction (as measured by the bromsulphalein test, 
also known as sulfobromophthalein sodium) in one group (Laws et al. 1973), and no changes in hepatic 
metabolism of phenylbutazone or cortisol in another group of workers (Poland et al. 1970).  
 
In a single controlled-exposure study, Hayes et al. (1956) exposed 51 male volunteers to about 0.05–
0.063 or 0.36–0.5 mg DDT/kg/day administered via a capsule for 12–18 months.  The background dose 
from concentration measured in food of both controls and test subjects was 0.0021–0.0038 mg 
DDT/kg/day.  No signs of illness or adverse hepatic effects (as measured by liver function tests) reported 
were considered to be related to DDT exposure to humans. 
 
Evidence of Hepatic Effects of DDT, DDD, or DDE in Animals.  In animals, the liver appears to be one 
of the primary targets of toxicity for DDT and related compounds.  Acute-, intermediate-, and chronic-
duration oral exposures have been shown to cause dose-related mild-to-severe hepatic effects in numerous 
animal studies, with chronic exposure leading to the development of liver tumors in some animals (see 
Section 2.19).   
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Table 2-6.  Summary of Studies of Associations between DDT Exposure Biometrics and Hepatic Endpointsa 
 
Reference Exposure metricb Outcome evaluated Resultsc Notes 
Freire et al. 2015a, 2015b 
415 men; 432 women 
Brazil (2003–2004; ages 
14–>60 years) 
DDE, serum Outcomes measured in serum 
Elevated indirect bilirubin 
 
Elevated total and direct bilirubin, 
elevated AST, ALT, and GGT  
 
↑ (women only) 
 
All NS 
Adjusted ORs (95% CI), continuous 
exposure variables 
 
Significance lost with categorical 
analysis 
Morgan and Lin 1978 
~2,480 male adults 
Nationwide United States 
(1969–1973) workers 
exposed to pesticides 
DDE and DDT, 
serum 
Serum AP, LDH 
 
Serum AST, ALT 
↑ (weak)  
 
NS 
Partial correlation coefficients, log-
transformed DDT metrics 
  
Significant trends for increased serum 
AST and LDH, but not AP or ALT, with 
increasing serum DDE 
 
No adjustments for confounding factors 
Serdar et al. 2014 
~1955 subjects, age range 
12–>60 years 
NHANES 2003–2004 
 
DDE and DDT, 
serum 
Serum ALT 
DDE 
DDT 
Serum GGT 
DDE 
DDT 
Serum AST (DDT only) 
Serum total bilirubin (DDE only) 
 
↑ (Q3, Q4) 
↑ (Q2–Q4) 
 
↑ (Q2) 
↑ (Q2, Q3) 
↑ (Q2, Q4) 
↑ (Q3, Q4) 
Adjusted means, categorical exposure 
variables 
 
Associations with increased glucose (for 
both DDT and DDE) and bilirubin (for 
DDE), data not shown 
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Table 2-6.  Summary of Studies of Associations between DDT Exposure Biometrics and Hepatic Endpointsa 
 
Reference Exposure metricb Outcome evaluated Resultsc Notes 
Sunyer et al. 2008 
52 children (4 years old) 
Ribera d’Ebre Spain, birth 
between 1997 and 1999 
DDE and DDT, cord 
blood 
(Outcomes measured in urine) 
Total porphyrins  
UPI 
CPI 
CPIII 
 
↑ (DDE, DDT) 
NS 
↑ (DDE, DDT) 
↑ (DDE, DDT) 
Adjusted betas, continuous exposure 
variables, significant for T3 only 
 
Significance for DDE remained with 
additional adjustments for other 
pollutants (DDT not reported) 
 
aStudies in this table were selected because they: (1) measured DDT-related metrics in biological fluids or tissues in each subject, and (2) evaluated associations 
using linear regression, logistical regression, or correlation techniques. 
bDDE = p,p’-DDE, unless otherwise specified; DDT = p,p’-DDT, unless otherwise specified.  
cArrows “↑ or ↓” indicate statistical significance (p<0.05) and direction of change observed for a given outcome (positive or inverse associations, respectively).  
 
AP = alkaline phosphatase; AST = aspartate amino transferase (formerly known as glutamic oxaloacetic transaminase); ALT = alanine aminotransferase (formerly 
known as glutamic pyruvic transaminase); CI = confidence interval; CPI = coproporphyrin I; CPIII = coproporphyrin III; GGT = gamma-glutamyl transferase; 
LDH = lactate dehydrogenase; NS = not statistically significant; OR = odds ratio; Q = quartile(s); T = tertile; UPI = uroporphyrin I 
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After acute oral exposure to technical DDT or unspecified DDT, p,p’-DDT, p,p’-DDE or unspecified 
DDE, or unspecified DDD, a number of liver effects in animals have been observed including induction 
of liver microsomal xenobiotic metabolizing enzymes (often associated with increased liver weight), 
increased serum levels of liver enzymes (suggestive of liver injury), changes in the appearance of the 
liver, and necrosis.  Increased liver activities of various microsomal enzymes (e.g., CYP2B, CYP2B1, 
CYP3A1, CYP3A2, GGT, glutathione-S-transferase) have been observed after acute oral exposure in rats 
given 200 mg p,p’-DDT/kg (Garcia and Mourelle 1984).  Rats given 5–50 mg p,p’-DDT/kg/day for up to 
14 days accompanied by increases in relative liver weights exceeding 10% (Tomiyama et al. 2004); rats 
given 40 mg DDT/kg/day for 12 days, accompanied with 18% increased relative liver weight (de Waziers 
and Azais 1987); rats given ≥4.2 mg DDT/kg/day, but not 0.17 mg/kg/day, for 14 days, accompanied by 
increased relative liver weight (Nims et al. 1998); and mice given 42.9 mg DDT(NS) or DDE(NS)/kg/day 
for 1 week (but not 42.9 mg DDD(NS)/kg/day), accompanied with increased liver weight after DDE 
exposure (Pasha 1981).  Increased liver weight was also reported in rats given 25 mg p,p’-DDE/kg/day 
for 4 days (Leavens et al. 2002) or 10 days (Kang et al. 2004), and rats given 106 mg p,p’-DDT/kg once 
or for 7 days (Tomiyama et al. 2003).  Rhesus monkeys exposed once to 150 mg p,p’-DDT/kg had 
increased alkaline phosphatase (AP), lactate dehydrogenase (LDH), AST, and ALT activities in serum, 
indicative of liver damage (Agarwal et al. 1978).  Necrotic liver changes, accompanied with increased 
liver weight, were observed in rats exposed to 12 mg p,p’-DDT/kg/day for 14 days (Kostka et al. 2000). 
 
After intermediate-duration exposure to technical DDT, p,p’-DDT, or p,p’-DDE, an array of liver effects, 
similar to those observed after acute exposure, have been observed in rats and mice.  The lowest reliable 
intermediate-duration LOAEL for liver effects is 0.17 mg technical DDT/kg/day in the diet reported for 
cellular hypertrophy in F344/DuCrj rats exposed for 26 weeks (Harada et al. 2003, 2006).  Observations 
of liver effects include increased liver weight and induction of CYP enzymes in Wistar rats exposed by 
gavage to 15 mg p,p’-DDT/kg/day for 3 weeks (Gupta et al. 1989) and NMRI mice exposed to 6.25 mg 
p,p’-DDT/kg/day for 28 days (Orberg and Lundberg 1974); hepatic focal necrosis and regeneration in 
Sprague-Dawley rats exposed to 6.6 mg DDT/kg/day in the diet for 36 weeks (Jonsson et al. 1981); minor 
vacuolation, hypertrophy and cell margination in livers of Sherman rats exposed to technical DDT in food 
for 2–18 months at 5 mg/kg/day in males and 20 mg/kg/day in females (Ortega 1956); increased relative 
liver weight (20% increase compared with control) in Sprague-Dawley rat dams exposed by gavage to 
50 mg p,p’-DDE/kg/day (but not 15 mg/kg/day) between GD 6 and PND 20 (Yamasaki et al. 2009); 
centrilobular hypertrophy, fatty hepatocytes, and increased liver weight in F1 and F2 Sprague-Dawley 
rats exposed to 3.44 (males) or 3.75 (females) mg p,p’-DDT/kg/day in the diet in a 2-generation 
reproductive toxicity study (NOAELs of 0.34 and 0.73 mg/kg/day), and enlarged and darkened livers in 
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F0 rats at 25 (males) or 27.7 (females) mg/kg/day, but not at 3.44 or 3.75 mg/kg/day (Hojo et al. 2006); 
and increased absolute and relative liver weight and liver levels of CYP2B1 and decreased levels of liver 
GJIC protein in male F344/DuCrj rats exposed to ≥5 mg p,p’-DDT/kg/day for 28 days (Harada et al. 
2003, 2006; Tomiyama et al. 2004).  Cellular hypertrophy and cytoplasmic eosinophilia were also 
reported in livers of Osborne-Mendel rats exposed to 0.25 mg technical DDT/kg/day (but not 
0.05 mg/kg/day) in the diet for 15–27 weeks (Laug et al. 1950).  Laug et al. (1950) however, provided no 
incidence data or statistical analysis, and only noted that at 0.25 mg/kg/day, “some of the rats were 
unaffected,” and the liver effects “were truly minimal.”  It is unknown, therefore, whether hepatic 
changes at this level would have reached statistical significance; the LOAEL for this study was therefore 
considered to be unreliable.  Minor microscopic changes in hepatocytes (cytoplasmic vacuolation, 
mitochondrial changes, and lipid droplets) were described in male C57BL/6N mice treated by gavage 
with p,p’-DDT for 8 weeks, but only qualitative data were provided (Liu et al. 2017a, 2017b).  No 
exposure-related changes in liver weight, liver histology, or serum levels of AST and ALT were reported 
in immature, prepubertal F344/DuCrl male rats exposed to 10 mg p,p’-DDE/kg/day in the diet for 42 days 
(Makita et al. 2003a).  
Nonneoplastic liver lesions, and in some cases liver tumors, have been observed in rats, mice, hamsters, 
monkeys, and dogs after chronic oral exposure to DDT and related compounds.  LSEs in the liver from 
chronic oral exposure are summarized in Table 2-1 and Figure 2-2, and the following three paragraphs, 
which first present the results for rats, followed by results for mice and then other laboratory animal 
species. 
Chronic exposure to DDT and related compounds has been associated with liver necrosis, centrilobular 
hypertrophy, hyperplasia, and fatty metamorphosis in rats (Deichmann et al. 1967; Fitzhugh and Nelson 
1947; Harada et al. 2003, 2006; NCI 1978), including effects in F1 males and females in a 2-generation 
study (Hojo et al. 2006).  In rats, the lowest reliable chronic-duration LOAELs for nonneoplastic 
histological changes in the liver are 0.17 mg p,p’-DDT/kg/day for hepatocellular hypertrophy in male 
F344/DuCrj rats exposed in the diet for 2 years (the lowest dose tested by Harada et al. 2003, 2006) and 
7 mg technical DDT/kg/day for focal hepatocellular necrosis in Osborne-Mendel rats exposed in the diet 
for 2 years (the lowest dose tested by Fitzhugh and Nelson 1947) (see Table 2-1 and Figure 2-2).  Similar 
to intermediate exposure durations, increased CYP-450 content and microsomal activities and decreased 
GJIC protein Cx32 were observed in rats (Harada et al. 2003, 2006), as well as indicators of oxidative 
stress including increased lipid peroxide at ≥1.7 mg/kg/day, and 8-hydroxydeoxyguanosine (8-OHdG) 
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levels at 19.1 mg p,p’-DDT/kg/day in males (Harada et al. 2003, 2006).  Increased incidences of liver 
tumors have been reported in rats (see Section 2.19). 
 
Noncancer liver effects have been less consistently observed in chronically exposed mice.  Liver effects 
in B6C3F1 mice exposed for 78 weeks were restricted to amyloidosis at dietary doses ≥3.7 mg technical 
DDT/kg/day (NCI 1978); however, NOAELs for noncancer liver histological changes of 49 mg 
p,p’-DDE/kg/day and 142 mg technical DDD/kg/day were reported for mice exposed for 78 weeks (NCI 
1978).  Increased incidences of liver tumors have been observed in mice (see Section 2.19). 
 
Nonneoplastic changes in the liver have also been reported in monkeys, hamsters, and dogs chronically 
exposed to DDT and related compounds.  In Rhesus and Cynomolgus monkeys exposed to p,p’-DDT in 
the diet for up to 130 months, fatty changes in the liver were observed at doses as low as 6.4 mg 
p,p’-DDT/kg/day (Takayama et al. 1999), mild to severe hydropic changes in liver cells, assessed by 
periodic biopsies, occurred in two of three Rhesus monkeys, but no functional liver changes, assessed by 
bromsulfalein retention, were observed when exposed to 3.9 mg technical DDT/kg/day in the diet for 3.5–
7 years (Durham et al. 1963).  Reported nonneoplastic liver effects in hamsters include focal necrosis 
after lifetime dietary exposure to 40, but not 20, mg technical DDT/kg/day (Cabral et al. 1982a); 
increased relative liver weight (with no increase in serum ALT, lactate dehydrogenase [LDH], or AP) 
after exposure to 67–133 mg technical DDT/kg/day in the diet for life (Graillot et al. 1975) and liver 
necrosis after 128-week dietary exposure to 47.5 mg p,p’-DDE/kg/day (Rossi et al. 1983).  Rossi et al. 
(1983) also observed increased incidences of liver tumors at levels ≥47.5 mg p,p’-DDE/kg/day, but 
increased incidences of liver tumors were not observed in the other hamster chronic-duration studies.  In 
dogs given technical DDT in the diet for 39–40 months, focal or diffuse liver changes occurred at 
80 mg/kg/day and severe liver damage at 160 mg/kg/day; no liver changes were seen at 16 mg/kg/day 
(Lehman et al. 1965).  
 
Cameron and Burgess (1945) exposed rats, rabbits, and guinea pigs to acute dermal doses of 10, 50, or 
100 mg DDT/kg and reported fatty degeneration, calcification, and necrosis of the liver.  
 
Mechanisms of Hepatic Effects of DDT, DDD, or DDE.  DDT is considered to be an animal liver 
carcinogen with a nongenotoxic mitogenic mechanism of action (see Section 2.19).  Studies in animals 
indicate that initial inductions of microsomal liver xenobiotic metabolizing enzymes (e.g., CYP 
monooxygenases) and transient bursts in DNA synthesis and cell proliferation are key initial hepatic 
responses to DDT exposure (Harada et al. 2003, 2006).  Increased liver weights, particularly in acutely 
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exposed animals, likely reflects this increased mitogenic, proliferative activity.  Although cell 
proliferation generally ceases within days, it has been hypothesized that these initiated cells may 
contribute to the generation of eosinophilic abnormal hepatic foci (AHF) whose number and size correlate 
with dose and time of exposure (Harada et al. 2003).  An observed decrease in the GJIC protein Cx32, 
which plays an important role in cell-cell communication, may contribute to the isolation of AHF cells 
from growth regulatory signals from neighboring cells (Harada et al. 2003).  Additionally, increases in 
8-OHdG and LPO are indicative of hepatic oxidative stress and damage to DNA, which may contribute to 
liver nonneoplastic changes and eventual tumor formation.   
 
In in vitro studies, increased oxidative stress and reactive oxygen species (ROS) due to DDT exposure in 
Hep2 cells is thought to activate the Jak/STAT3 pathway, ultimately resulting in impaired expression of 
E-cadherin, which is known to be associated with hepatocellular carcinogenesis and poor prognosis in 
humans (Nakagawa et al. 2014).  The induction of microsomal liver xenobiotic metabolizing enzymes 
may be involved in proliferation of smooth-surfaced endoplasmic reticulum that are observed with longer 
durations of exposure, contributing to hypertrophy (Harada et al. 2006).  In addition to CYP induction, 
DDT has been shown to activate both the constitutive androgen receptor (CAR) and ERα transcription 
factors, which increase transcription of target genes related to hepatocyte proliferation, cell-cycle 
progression, and apoptosis inhibition in the mouse liver (Kazantseva et al. 2013).  Several animal and in 
vitro studies have demonstrated activation of microsomal enzymes in response to DDT-isomer exposure, 
presumably through activation of the CAR (Harada et al. 2016).  Aberrant expression of genes within 
these functional categories were observed in micro-dissected tissues including hypertrophic tissue, 
eosinophilic AHF, and tumors in rats, from DDT-treated animals versus controls (Harada et al. 2016).  In 
vitro studies in isolated hepatocytes also showed increases in expression of genes associated with hepatic 
estrogen, lipid, and sugar metabolism (Jellali et al. 2018). 
 
2.10   RENAL 
 
Evidence of Renal Effects of DDT, DDD, or DDE in Humans.  In a case-control study of 270 chronic 
kidney disease patients and 270 age- and sex-matched controls from a hospital in Delhi India, serum 
levels of DDE, but not DDT, were significantly associated with risk for chronic kidney disease (Siddarth 
et al. 2014).  The odds ratio (OR) (95% CI) (adjusted for age, sex, BMI, and serum lipid content) for DDE 
was 2.70 (1.04–7.02) for the third tertile, compared with the first tertile.  However, no association was 
found with further adjustment for serum levels of other pesticides including endosulfan, dieldrin, aldrin, 
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and hexachlorocyclohexanes and glutathione-S-transferase (GST) genotype (e.g., further adjusted 
OR 2.15 [95% CI 0.63–6.82] for third tertile versus first tertile).   
 
No other epidemiological studies were located that examined possible associations between serum levels 
of DDT, DDD, or DDE and kidney outcomes.   
 
Evidence of Renal Effects of DDT, DDD, or DDE in Laboratory Animals.  Limited evidence is 
available for kidney effects in laboratory animals after acute- or intermediate-duration oral exposure to 
DDT and related compounds.  In a two-generation study of Wistar rats exposed to p,p’-DDT in the diet 
before mating and during mating, gestation, and lactation, increased kidney weight was observed in F0 
parental and F1 female rats at 25 mg/kg/day, but not at 3.44 mg/kg/day (Hojo et al. 2006).  No significant 
changes in kidney weight or serum levels of creatinine or urea nitrogen were found in sexually immature 
male Wistar rats (6 weeks old) fed 10 mg p,p’-DDE/kg/day in the diet for 42 days (Makita et al. 2003a).  
Significant decreases (~36%) in kidney weights were observed in the offspring of pregnant rabbits given 
gavage doses of 1 mg DDT(NS)/kg/day on GDs 4–7 (Fabro et al. 1984).  No significant changes in 
kidney weights were observed in Sprague-Dawley offspring, or their dams, exposed during GD 6–
PND 20 to up to 50 mg p,p’-DDE/kg/day (Yamasaki et al. 2009) or in male rat offspring exposed during 
GDs 14–18 and then on PNDs 80–83 to 100 mg p,p’-DDE/kg/day (You et al. 1999a); no histological 
changes were observed in kidneys of offspring from C57BL/6J mouse dams treated with DDT (77.2% 
p,p’-DDT and 22.8% o,p’-DDT) during GD 12–PND 5 (La Merrill et al. 2016).  No changes to kidney 
weight were found in castrated male Sprague-Dawley rats (Hershberger Assay) given gavage doses of 
p,p’-DDE doses up to 100 mg/kg/day for 10 days after castration, compared with control rats (Kang et al. 
2004).  Histology of the kidney was not examined in this study.   
 
The kidney does not appear to be a sensitive target for histological changes in laboratory animals 
chronically exposed to DDT and related compounds.  Histological kidney lesions were observed in 
Osborne-Mendel rats exposed to 20 mg DDT(NS)/kg/day in the diet for up to 27 months (tubular 
epithelial necrosis and polycystic degeneration; Deichmann et al. 1967) and 66 mg technical DDD/kg/day 
in the diet for 78 weeks (chronic inflammation; NCI 1978), but no histological changes in the kidney were 
reported in Osborne-Mendel rats exposed to up to 45 mg technical DDT/kg/day or 59 mg p,p’-DDE for 
78 weeks (NCI 1978).  After 78-week exposures, chronic inflammation of the kidney was observed in 
male B6C3F1 mice exposed to ≥27 mg p,p’-DDE/kg/day, but no histological kidney changes were 
observed in female B6C3F1 mice exposed to up to 49 mg p,p’-DDE/kg/day or male or female B6C3F1 
mice exposed to up to 30.2 mg technical DDT/kg/day or 142 mg technical DDD/kg/day (NCI 1978).  No 
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histopathological changes in the kidney were noted at 55 weeks of age in ICR mice exposed from 
conception through death to 16.5 mg/technical-DDT/kg/day (Del Pup 1978). 
 
Cameron and Burgess (1945) exposed rats, rabbits, and guinea pigs to acute dermal doses ranging from 
50 to 100 mg DDT/kg and reported fat deposits, tubular changes, calcification, and necrosis of the 
kidneys. 
 
2.11   DERMAL 
 
Evidence of Dermal Effects of DDT, DDD, or DDE in Humans.  No correlation was found between 
DDT exposure in clinical laboratory workers, via dermal or inhalation routes, and the frequency and 
distribution of skin abnormalities, except for a few cases of minor skin irritation (Ortelee et al. 1958).  
 
Cameron and Burgess (1945) conducted a series of experiments on volunteers wearing clothing and 
undergarments impregnated with 1% DDT for 18–26 days in order to determine whether this treatment 
would protect soldiers against body lice.  Several individuals had transient dermatitis, but no other 
symptoms were observed; however, the investigators did not attribute the dermatitis to DDT exposure.   
 
Evidence of Dermal Effects of DDT, DDD, or DDE in Animals.  No studies were located indicating 
adverse dermal effects in animals after oral exposure to DDT, DDE, or DDD. 
 
Cameron and Burgess (1945) exposed rats, rabbits, and guinea pigs to acute dermal doses of 10, 50, or 
100 mg DDT/kg and reported inflammation, edema, and destruction of the epidermis.  Guinea pigs were 
dermally dosed 5 days/week for 3 weeks with 322–400 mg DDT/kg (Kar and Dikshith 1970).  A decrease 
in skin amino acids, disruption and degeneration of the basal cell layer, and morphologic changes in the 
cells were reported. 
 
2.12   OCULAR 
 
Evidence of Ocular Effects of DDT, DDD, or DDE in Humans.  Reports of ocular effects in humans 
exposed to DDT in the air are limited to the studies by Neal et al. (1944) and Ortelee et al. (1958).  In the 
Neal et al. (1944) study, moderate, nonspecific eye irritation was reported by two volunteers exposed to 
an aerosol containing DDT.  This effect is assumed to have been caused by direct contact of the aerosol 
with the eye and not by inhalation of the aerosol.  The investigators provided limited information on 
exposure levels, but noted that the DDT quickly settled; thus, the actual exposure levels were lower than 
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predicted.  The ocular effects were only observed at the higher of the two tested concentrations.  Red, 
itching, and inflamed eyes and/or excessive tearing was reported in 8 workers involved in the 
manufacture and/or formulation of DDT and exposed to “heavy” concentrations of dust; DDT air 
concentrations associated with these effects were not reported (Ortelee et al. (1958).  The study examined 
40 workers, although DDT exposure was limited for 30 of the workers; it is unclear from the paper 
whether any of the cases of eye irritation were in the limited exposure group of workers. 
 
Evidence of Ocular Effects of DDT, DDD, or DDE in Animals.  Unilateral (11 exposed versus 
1 control) and bilateral (9 exposed versus 2 controls) corneal opacity was described in a single study in 
mice exposed to 13 mg technical-DDT/kg/day in the diet for 80 weeks (Kashyap et al. 1977).  In a second 
oral exposure study, minute darkened areas were observed during the ophthalmologic examination of the 
retina of 5 of 10 dogs administered capsules containing 50 mg/kg o,p’-DDD for 120–147 days; vision did 
not appear to be affected (Kirk and Jensen 1975).  No evidence of vascular or cellular changes were 
observed during the histologic examination of the retina, and the darkened areas were not evident.   
 
2.13.   ENDOCRINE 
 
Reported endocrine effects related to thyroid hormone dysregulation in humans and effects on endocrine-
related tissues (pituitary, adrenals, thyroid, parathyroid) in laboratory animals are discussed in this 
section.  Other possible hormonal effects of DDT, DDD, or DDE in humans and laboratory animals are 
described in Sections 2.14 (immunological effects), 2.15 (neurological effects), 2.16 (reproductive 
effects), 2.17 (developmental effects), and 2.18 (other noncancer effects). 
 
Thyroid Hormone Dysregulation, Human Studies.  Epidemiological studies provide inconsistent 
evidence for associations between levels of DDT, DDE, or DDD in biological fluids or tissues and 
changes in serum levels of thyroid hormone levels in humans (Tables 2-7 and 2-8).  Table 2-7 describes 
summary results from epidemiological studies that examined possible associations between DDT 
exposure biometrics in adolescents or adults and changes in serum levels of thyroid hormones (thyroid 
stimulating hormone [TSH]; triiodothyronine [T3]; thyroxine [T4]).  An additional study in Table 2-7 
only examined a possible association between serum DDE levels and serum levels for thyroid peroxidase 
antibody, TPOAb (Schell et al. 2009).  Table 2-8 describes results from epidemiological studies looking  
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Table 2-7.  Summary of Studies of Associations Between DDT Exposure Biometrics in Adolescents or Adults and 
Serum Thyroid Hormone Levelsa 
 
Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Studies finding at least one statistically significant association between any DDT metric and any thyroid hormone level 
Abdelouahab et al. 2008  
211 consenting adults, general 
population (124 males, 
87 females) 
 
Serum DDE quartiles, ng/g lipid 
 25th 50th 75th 
Men 139 211 387 
Women 157 240 459 
Serum levels: TSH, 
TT3, TT4  
Adjusted betas with DDE 
 Women Men 
TT3 -0.12*↓  NS 
TT4  NS  NS 
TSH  NS  0.20*↑  
Alvarez-Pedrerol et al. 2008 
259 4-year-old children, general 
population 
Serum exposure quartile ranges, 
ng/mL 
 DDE  DDT 
Q2 0.436–0.807 0.026–0.049 
Q3 0.808–1.75 0.050–0.103 
Q4 1.76–43.9 0.104–0.657 
Serum levels: TSH, 
TT3, fT4 
Adjusted TT3 betas with   
 Q2 Q3  Q4 Overall 
DDT -9.25*↓ -10.75*↓ NS -2.51*↓ 
DDE NS NS  NS NS 
 
Unadjusted betas were NS for: 
fT4 with DDE or DDT  
TSH with DDE or DDT 
ALL fT4 and TSH p-trends >0.05 (NS)  
Blanco-Muñoz et al. 2016 
84 male floriculture workers 
Serum tertiles, DDE, ng/mL  
Tertile 1: <0.37  
Tertile 2: 0.37–7.96  
Tertile 3: >7.96 
 
 
Serum levels: TSH, 
TT3, TT4  
Adjusted betas with DDE 
  Total T3 Total T4 
Overall   NS  0.08*↑ 
Tertile 2 NS  NS 
Tertile 3 0.07*↑  0.20*↑ 
p-trend  0.03*  0.03* 
 
TSH associations with DDE were NS.   
Bloom et al. 2014 
114 consenting adults, general 
population (66 males, 
48 females) 
Mean serum levels, ng/mL 
  ΣDDT (DDE + DDT) 
Men  4.50 
Women  3.59 
Serum levels: TSH, 
TT3, fT4, TT4 
Adjusted change per 2-fold change in ΣDDT 
 Men Women  
TSH NS NS 
fT4 NS NS 
TT4 NS 0.34*↑ 
TT3 NS 2.78*↑ 
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Table 2-7.  Summary of Studies of Associations Between DDT Exposure Biometrics in Adolescents or Adults and 
Serum Thyroid Hormone Levelsa 
 
Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Croes et al. 2015 
Adolescents (aged 14–
15 years) with parental consent 
FLEHS I cohort (n=1,679) 
FLEHS-II cohort (n=210) 
Serum levels of DDE. 
Geometric mean  
 FLEHS I FLEHS II 
(ng/g lipid) 94 70 
(ng/mL) 0.418 0.307  
fT4 Adjusted betas per IQR increase in DDE 
fT4: 1.003*↑ 
Freire et al. 2012 
193 children with parental 
consent, general population 
80th percentiles in serum, ng/mL 
o,p’-DDT: 2.20   
p,p’-DDT: 17.7   
p,p’-DDD: 2.63 
p,p’-DDE: 35.7 
Serum levels, TSH, 
TT3, fT4 
p-trends from adjusted quintile linear 
regression analysis  
TSH NS with all DDT metrics 
TT3  o,p’-DDT 0.05*↑ 
 p,p’-DDT <0.01*↑ 
 p,p’-DDD <0.01*↑  
  p,p’-DDE 0.02*↑ 
fT4 o,p’-DDT NS  
 p,p’-DDT NS  
 p,p’-DDD 0.04*↑ 
  p,p’-DDE NS 
Freire et al. 2013 
608 consenting adults, general 
population (303 males, 
305 females) 
Median serum levels, ng/mL 
   Men Women 
p,p’-DDE 8.32 9.64 
o,p’-DDT 0.30 0.42  
p,p’-DDT 3.09 3.20 
p,p’-DDD 0.61 0.66   
Serum levels, TSH, 
TT3, fT4, TPOAb 
Adjusted betas 
TSH: NS with all DDT metrics (M & F) 
 
TT3: 0.40*↑ with p,p’-DDT (F only) 
TT3: NS with other DDT metrics (M & F) 
 
fT4: 0.003*↓ with p,p’-DDT (M) 
fT4: 0.003*↑ with p,p’-DDT (F) 
fT4: 0.02*↑ with o,p’-DDT (F)  
fT4: NS with other DDT metrics (M & F) 
 
ORs for elevated TPOAb ≥10 U/Ml; NS for all DDT 
metrics 
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Table 2-7.  Summary of Studies of Associations Between DDT Exposure Biometrics in Adolescents or Adults and 
Serum Thyroid Hormone Levelsa 
 
Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Kim et al. 2013 
105 consenting pregnant 
women, hospital-based 
Median serum levels, ng/g lipid 
p,p’-DDE: 57.37  
p,p’-DDT: 5.20  
ΣDDT: 64.40 
 
Serum levels, TSH, 
fT3, TT3, fT4, TT4 
Adjusted betas 
 p,p’-DDE p,p’-DDT ΣDDT 
TSH NS  NS  NS 
fT3 NS  NS  -0.52*↓ 
TT3 NS  NS   -0.096*↓  
fT4 NS   -0.045*↓ NS 
TT4 NS  NS  NS 
Lopez-Espinosa et al. 2009 
157 consenting pregnant 
women, hospital-based 
 
Geometric means DDE in serum  
 2.0 ng/mL 
 200 ng/g lipid 
Serum levels, TSH, 
TT3, fT4 
Adjusted betas with DDE 
TSH: NS 
TT3: NS 
fT4: -0.03*↓ 
 
Adjusted OR (95% CI) with DDE  
TSH ≥2.5 mIU/L 2.53*↑ (1.36–4.73) 
Meeker et al. 2007 
341 consenting men, hospital-
based 
DDE in serum 
5th percentile 95th percentile  
87.7 ng/g lipid 1,230 ng/g lipid 
0.38 ng/Ml 5.94 ng/mL 
Serum levels, TSH, 
TT3, fT4 
Adjusted betas with DDE 
TSH: 0.92*↓ 
TT3: 0.033*↑ 
fT4: 0.036*↑ 
Rylander et al. 2006 
196 consenting fishermen, 
general population 
DDE in serum, ng/g lipid 
5th percentile 95th percentiles 
110  2,140 
Serum levels, TSH, 
fT3 
Adjusted betas with DDE (per 100 ng/g lipid 
increase) 
TSH: 0.03*↑  
fT3: NS 
 
Categorical linear regression analysis indicated NS 
association between DDE and TSH 
Schell et al. 2009 
115 youth with consent from 
parents, general population 
(61 males, 57 females; 
47 subjects were breastfed) 
Geometric mean DDE in serum, ng/mL 
Breastfed: 0.37 
Non-breastfed: 0.28 
Serum levels, 
TPOAb 
Adjusted betas with DDE 
Breastfed: 0.34*↑ 
Non-breastfed: NS 
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Table 2-7.  Summary of Studies of Associations Between DDT Exposure Biometrics in Adolescents or Adults and 
Serum Thyroid Hormone Levelsa 
 
Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Takser et al. 2005 
101 consenting pregnant 
women, hospital-based 
DDE, DDT in serum at delivery, ng/mL 
 5th percentile 95th percentile 
DDE 0.20  1.20 
DDT ND  0.07  
Serum levels, TSH, 
TT3, fT4 
 
Adjusted change with change in 
 DDE DDT 
TSH NS NS  
TT3 NS -0.54*↓ 
fT4 NS NS 
Turyk et al. 2006 
56 consenting male adults, 
general population  
25–29 sport-caught fish eaters 
23–27 referents 
Mean (range) DDE in serum, ng/g lipid 
Fish eaters: 602 (99–9,499)  
Referents: 290 (43–4,554) 
Serum levels, TSH, 
TT3, T4, FTI 
Adjusted correlation coefficients with DDE 
TSH NS 
TT3 NS 
T4  -0.03*↓ (adjusted for smoking) 
FTI NS 
fT4 significance lost after further adjustment for fish 
eating or serum PCBs or dioxins 
Turyk et al. 2007 
1,021 men, 740 women, 
general population 
1999–2000: 454 males, 
350 females 
2001–2002: 667 males, 
490 females 
Geometric means DDE in serum 
  ng/mL ng/g lipid 
1999–2000  1.82 293 
2001–2002 2.12 337 
Serum levels, TSH, 
TT4 
 
 
Adjusted betas with DDE 
   1999–2000 2001–2002 
TSH, all women  NS  NS 
TSH, all men  NS  NS 
TT4, all women  NS  NS 
TT4, all men  NS  NS 
TT4, women <60 years 0.33*↑  NS 
TT4, women >60 years -0.47*↓  NS  
Studies finding no associations between any DDT metric and any serum thyroid hormone level 
Alavarez-Pedrerol et al. 2009 
1,090 consenting pregnant 
women from two regions (A and 
B) 
25th, 50th, and 75th percentiles DDE in 
serum, ng/g lipid 
Region A: 69.8, 112,1, 174.8  
Region B: 59.9, 89.9, 139.4 
Serum levels, TSH 
TT3, fT4 
Adjusted betas with DDE 
TSH: NS 
TT3: NS 
fT4: NS 
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Table 2-7.  Summary of Studies of Associations Between DDT Exposure Biometrics in Adolescents or Adults and 
Serum Thyroid Hormone Levelsa 
 
Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Chevrier et al. 2008 
334 consenting pregnant 
women 
Geometric mean serum, ng/g lipid 
p,p’-DDE: 1,302.1 
p,p’-DDT: 18.8 
o,p’-DDT: 1.7 
Serum levels, TSH, 
TT3, fT4, TT4 
Adjusted betas for change per 10-fold change in 
DDT metric  
 p,p’-DDE p,p’-DDT o,p’-DDT 
TSH  NS  NS  NS 
TT3 NS  NS  NS 
fT4  NS  NS  NS 
TT4  NS  NS  NS 
Dallaire et al. 2009 
623 consenting adults, general 
population 
Geometric mean serum DDE level: 
0.478 ng/mL  
 
Serum levels, TSH, 
TT3, fT4, T4BG 
Adjusted betas with DDE 
TSH: NS 
TT3: NS 
fT4: NS 
T4BG: - 0.030*↓ 
T4BG changed to NS with further adjustment for 
alcohol consumption 
Darnerud et al. 2010 
160 infants at 3 weeks of age 
and 138 at 3 months of age; 
325 consenting primiparous 
women 
Median serum levels DDE 
3-week-old infants: 95 ng/g lipid 
Mothers: 91 ng/g lipid 
Serum levels, TSH, 
TT3, fT4 
Adjusted betas with DDE 
 3-week 3-month  
TSH NS  NS  
TT3  NS NS  
fT4 NS NS  
Unadjusted associations of DDE with mother 
thyroid hormone levels were NS 
Pelletier et al. 2002 
16 consenting men in a weight 
loss program 
Mean serum levels, ng/g lipid 
 Before After 
DDE 430 547.2 
DDT 8.4 9.2 
Serum level, TT3 Adjusted correlation coefficient 
 DDE DDT 
TT3 NS NS 
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Table 2-7.  Summary of Studies of Associations Between DDT Exposure Biometrics in Adolescents or Adults and 
Serum Thyroid Hormone Levelsa 
 
Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Schell et al. 2008 
232 youth with consent from 
parents 
Geometric mean serum DDE, ng/mL 
Breastfed: 0.31 
Non-breastfed: 0.42 
Serum level, TSH, 
fT4 
Adjusted betas with DDE 
TSH: NS 
fT4: NS 
 
aSee Table 1 in the Supporting Document for Epidemiological Studies for DDT, DDE, and DDD for more detailed descriptions of studies.  Studies in this table were 
selected from those described in Table 1, because they: (1) measured DDT-related metrics in biological fluids or tissues in each maternal subject, and 
(2) evaluated associations using linear regression, logistical regression, or correlation techniques, adjusting for possible confounding factors. 
 DDE = p,p’-DDE, unless otherwise specified; DDT = p,p’-DDT, unless otherwise specified.  
cBold text, “significant” and asterisk indicate statistically significant (p<0.05).  Adjusted OR or adjusted β indicates adjustment for standard confounding variables 
for thyroid hormone levels, such as BMI, serum lipids, medications, smoking, and age.  Further adjustments for other analyzed chlorinated compounds or 
pesticides in biological fluid samples are expressly noted in the table.  Arrows “↑ or ↓” indicate direction of change observed for a given outcome (positive or 
inverse associations, respectively).  
 
BMI = body mass index; CI = confidence interval; F = female(s); FLEHS = Flemish Environment and Health studies; fT3 = free triiodothyronine; fT4 = free 
thyroxine; FTI = free T4 index; IQR = interquartile range; M = male(s); ND = not determined; NS = not statistically significant; OR = odds ratio; 
PCB = polychlorinated biphenyl; Q = quartile or quintile; RBP = retinol-binding protein; T3 = triiodothyronine; T4 = thyroxine; T4BG = thyroxine-binding globulin (the 
major transport protein for T4); TPOAb = thyroid peroxidase antibody; TSH = thyroid stimulating hormone; TT3 = total T3; TT4 = total T4 
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Table 2-8.  Summary of Studies of Associations Between Maternal Serum, Cord Blood, or Milk DDT Exposure 
Metrics and Thyroid-Related Outcomes in Offspringa 
 
Reference and study population DDT exposure metricb Outcome evaluated Resultsc 
Arrebola et al. 2016  
200 mother-infant pairs 
 
Cord blood serum percentiles (ng/mL) 
  25th 50th 75th  
p,p’-DDE 0.26 1.01 2.52 
o,p’-DDT 0.10 0.22 0.37 
Serum levels: TSH Adjusted betas for log-dependent 
variables 
 DDE o,p’-DDT  
TSH NS NS 
Darnerud et al. 2010 
150 mother-infant pairs (3 weeks) 
115 mother-infant pairs (3 months) 
Median maternal serum, milk, infant 
serum, and calculated postnatal 
exposure levels of DDE 
 
Maternal serum: 91 ng/g lipid 
Milk: 95 ng/g lipid 
Infant serum: 113 ng/g lipid 
Postnatal exposure: 329 ng/g x days 
 
Postnatal exposure-quartiles (ng/g x 
days) 
Q1: 0–190 
Q2: 191–329 
Q3: 330–503 
Q4: 504–2,199 
TT3, fT4, and TSH 
at 3 weeks and 
3 months of age 
Adjusted 3-month means for Q2–Q4 
versus Q1 postnatal DDE (ng/g x days) 
  TSH TT3 fT4 
Q2 NS NS NS 
Q3 NS NS NS 
Q4 NS NS NS 
 
Adjusted betas for change per unit DDE in 
child’s serum at 3 weeks and 3 months 
  TSH TT3 fT4 
3 weeks NS NS NS 
3 months NS NS NS  
 
de Cock et al. 2014 
83 mother-infant pairs 
53 males, 31 females 
Mean cord blood, milk, and total 
exposure levels of DDE, mean (ng/g 
lipid) 
Cord blood: 114.48  
Milk: 2,379.58 
Total (ng/mL): 100,000  
Quartiles for total DDE 
Q1: <41.8  
Q2: 41.8–74.5 
Q3: 74.51–107.5   
Q4: 0.107.5 
T4 (4–7 days after 
birth) 
Adjusted betas for T4 change per unit total 
DDE, Q2–Q4 versus Q1 DDE 
 Boys Girls 
Q2  NS NS 
Q3 NS  NS 
Q4 NS 24.8*↑ 
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Table 2-8.  Summary of Studies of Associations Between Maternal Serum, Cord Blood, or Milk DDT Exposure 
Metrics and Thyroid-Related Outcomes in Offspringa 
 
Reference and study population DDT exposure metricb Outcome evaluated Resultsc 
Freire et al. 2011 
220 mother-infant pairs 
Geometric mean placental DDT 
metrics (ng/g placenta) 
p,p’-DDE: 2.01 
p,p’-DDT: 1.25  
o,p’-DDT: 0.86 
o,p’-DDD: 1.91  
ΣDDT: 4.16  
TSH in cord blood Adjusted betas for continuous TSH 
and ORs for TSH ≥5 mU/L  
 Adjusted betas Adjusted ORs 
p,p’-DDE NS NS 
p,p’-DDT NS NS 
o,p’-DDT NS NS 
o,p’-DDD NS NS 
ΣDDT  NS NS 
 
Kim et al. 2015d 
102 mother-infant pairs 
 
TSH measured in cord blood and in 
infant bloodspot within 2 days after birth 
Maternal serum and cord blood DDE.  
Median (IQR) (ng/g lipid) 
Serum: 55.2 (38.7–73.9) 
Cord blood: 63.0 (44.0–91.5) 
 
fT4, TT4, fT3, TT3, 
TSH in cord blood, 
or TSH in newborn 
infant blood 
Adjusted betas (95% CI) per IQR increase 
in cord blood or maternal serum DDE 
  Cord blood Serum 
fT3  NS  -0.035↓ 
TT3  -0.038↓  NS 
fT4   NS  -0.020↓ 
TT4  NS  -0.034↓ 
TSH  NS  NS 
 
TSH  
(bloodspot)  0.208*↑  0.264*↑ 
Li et al. 2014 
247 mother-infant pairs 
Median maternal serum and cord 
blood DDT and DDE (ng/g lipid) 
 Maternal Cord blood 
DDE 333.951 193.513 
DDT 7.456   <LOD 
TSH in cord blood Adjusted betas for TSH change per unit 
DDE in cord blood NS 
  
Adjusted ORs, less than median versus 
greater than median in cord blood NS  
Lopez-Espinosa et al. 2010 
453 mother-infant pairs 
Geometric mean in cord blood (ng/g 
lipid) 
p,p’ -DDE: 197 
p,p’ -DDT: 8.0  
Tertiles, DDE 
Tertile 1: <50th percentile 
Tertile 2: ≥50th –90th percentile 
Tertile 3: ≥90th percentile 
TSH in cord blood Adjusted betas for TSH change per 10-fold 
increase in DDE or for T2 or T3 versus T1 
  p,p’-DDT p,p’-DDE 
Tertile 2 NS  NS 
Tertile 3 NS  NS 
10-fold  
increase  NS   NS 
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Table 2-8.  Summary of Studies of Associations Between Maternal Serum, Cord Blood, or Milk DDT Exposure 
Metrics and Thyroid-Related Outcomes in Offspringa 
 
Reference and study population DDT exposure metricb Outcome evaluated Resultsc 
Maervoet et al. 2007 
198 mother-infant pairs 
Mean cord blood DDE 
 ng/mL ng/g lipid 
DDE  0.37 189 
fT3, fT4, and TSH in 
cord blood 
Adjusted betas for change per unit DDE in 
cord blood 
fT3: NS 
fT4: -0.10*↓ 
TSH: NS 
Ribas-Fito et al. 2003 
98 mother-infant pairs 
Median cord serum DDE 
0.85 ng/mL 
TSH Adjusted OR for TSH ≥10 mU/L per 
doubling of DDE NS  
 
aSee Table 2 in the Supporting Document for Epidemiological Studies for DDT, DDE, and DDD for more detailed descriptions of studies.  Studies in this table were 
selected from those described in Table 2, because they: (1) measured DDT-related metrics in biological fluids or tissues in each subject, and (2) evaluated 
associations using linear regression, logistical regression, or correlation techniques, adjusting for possible confounding factors. 
bDDE = p,p’-DDE, unless otherwise specified; DDT = p,p’-DDT, unless otherwise specified.  
cBold text, “significant” and asterisk indicate statistically significant (p<0.05).  Arrows indicate an increase or decrease in thyroid hormone levels.  Adjusted OR or 
adjusted β indicates adjustment for standard confounding variables for thyroid hormone or DDT exposure levels, such as age at time of sampling, sex, serum 
lipids, smoking, alcohol consumption, prematurity, maternal BMI, fish consumption, economic levels, birth weight, weight gain during pregnancy, education, parity, 
use of thyroid medication, nursing, sampling season, and small for gestational age. 
 
 
BMI = body mass index; CI = confidence interval; fT3 = free triiodothyronine; fT4 = free thyroxine; = interquartile range; LOD = limit of detection; ND = not 
determined; NS = not statistically significant; OR = odds ratio; Q = quartile(s); T = tertile(s); T3 = triiodothyronine; T4 = thyroxine; TSH = thyroid stimulating 
hormone; TT3 = total T3; TT4 = total T4 
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for associations between maternal serum, cord blood, or breast milk DDT exposure metrics and levels of 
thyroid hormones in offspring. 
 
Associations with any DDT metric in studies of adults and adolescents (Table 2-7) were found in:  
• 9/18 studies for T3 (4 with negative and 5 with positive T3 regression coefficients; 8 with no 
associations); 
• 10/18 studies with T4 (3 with negative, 6 with positive, and 1 study with age-dependent negative 
or positive T4 regression coefficients; 8 with no associations); 
• 4/18 studies with TSH (1 with negative and 3 with positive TSH regression coefficients; 14 with 
no associations).  
 
Evidence for possible associations between DDT serum biometrics and serum thyroid hormone levels in 
adolescent and adult humans is considered to be inconsistent due to: (1) the inconsistency of finding 
associations across studies; (2) the variable direction of association across those studies finding an 
association (some found increasing, and others found decreasing, levels of thyroid hormone levels with 
increasing DDT biometric level); and (3) the variability across studies in the DDT metric showing an 
association with serum thyroid hormone levels (some found associations with DDE, others with DDT). 
 
Two studies summarized in Table 2-7 used multiple logistic regression analyses to examine possible 
associations with thyroid hormone dysregulation in adults (Freire et al. 2013; Lopez-Espinoza et al. 
2009), but this statistical technique did not provide information that clarified inconsistencies in the 
available data.  No associations were found between several DDT biometrics (DDT, DDD, and DDE) and 
prevalences of adult subjects with serum levels of TPOAb ≥10 U/mL (Freire et al. 2013), but an elevated 
OR was found for DDE in pregnant subjects with TSH levels ≥2.5 mIU/L (Lopez-Espinoza et al. 2009).  
However, the Lopez-Espinoza et al. (2009) study did not find an association between DDE and TSH 
levels.  
 
The inconsistent evidence for associations between DDT, DDD, or DDE in maternal serum, cord blood, 
or breast milk and levels of thyroid hormones in offspring is presented in Table 2-8.  Associations with 
any maternal DDT metric were found in: 
• 1/3 studies for T3 (1 inverse, 0 positive, and 2 with no association); 
• 3/4 studies for T4 (2 inverse, 1 positive, and 1 with no association); and 
• 0/6 studies for TSH (no associations in all studies measuring TSH in cord blood or blood of 
newborn infants) (Table 2-8). 
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The inconsistency of the evidence is emphasized by the observations that: (1) one study reported no 
associations between changes in children’s serum DDE levels at 3 weeks or 3 months with changes in 
children’s serum levels of TSH, total T3, or free T4 (Darnerud et al. 2010) and (2) another study reported 
no associations between cord blood DDE and cord blood TSH and T4 levels, an inverse association with 
total T3 levels, and associations for increased levels of TSH in newborn infants’ blood with increasing 
levels of DDE in cord blood or maternal serum (Kim et al. 2015d). 
 
Effects on Non-Sexual, Endocrine-Related Organs in Laboratory Animals.  Non-sexual endocrine 
system organs (e.g., pituitary, adrenal gland, thyroids) do not appear to be sensitive toxicity targets in 
laboratory animals orally exposed to DDT and related compounds.   
 
No exposure-related nonneoplastic histological changes were found in three non-sexual endocrine system 
organs in the NCI (1978) studies of rats and mice exposed to technical DDT, p,p’-DDE, or technical 
DDD: pituitary, thyroid, and parathyroid.  In male and female offspring of Sprague-Dawley rats exposed 
to gavage doses of 5, 15, or 50 mg p,p’-DDE/kg/day on GD 6–PND 20, relative weights of pituitary and 
thyroid gland were not significantly different from control values; a 13% increase in relative adrenal 
weight in 50-mg/kg/day female offspring was observed (Yamasaki et al. 2009).  Histology of the pituitary 
and thyroid glands were reported to be normal, but the adrenals were not examined histologically 
(Yamasaki et al. 2009).  Adrenal gland changes were reported in dogs after administration of single oral 
doses of 200 mg technical DDD/kg via a capsule; the alterations consisted of vacuolation, inflammation, 
and necrosis (Powers et al. 1974).  In some dogs, adrenal gland biopsies were taken prior to the terminal 
sacrifice.  No histological alterations were observed 6 hours post-exposure, but were observed as early as 
26 hours post-exposure.  Powers et al. (1974) also conducted a repeated exposure study in which dogs 
were administered capsules containing 100 mg technical DDD/kg/day for 6 days or 200 mg/kg/day DDD 
every other day for 30 days.  Although the study reported vacuolation, atrophy, and necrosis of the 
adrenal gland, conclusions cannot be drawn from this repeated exposure study due to the poor reporting 
of the study design (it appears that some of the dogs received two or three 6-day exposures) and the long 
recovery period (up to 32 weeks for some animals).  Necrosis of the adrenal cortex was observed in dogs 
exposed to 138.5 mg o,p’-DDD/kg/day for 10 days (Kirk et al. 1974); adrenocortical necrosis, 
degeneration, and vacuolation also was reported in dogs exposed to 50 mg o,p’-DDD/kg/day for 120–
156 days (Kirk and Jensen 1975). 
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In a series of reports by Yaglova and Yaglov (2014, 2015a, 2015b, 2017), a very low dose of o,p’-DDT 
administered to male Wistar rats in drinking water for 6 or 10 weeks (0.0019 mg o,p’-DDT/kg/day) was 
reported to increase serum levels of total T4, free total T4, T3, and free T3, decrease serum TSH levels, 
and produce histological changes in the thyroid (e.g., enlarged follicles, increased resorption of 
thyroglobulin, and decreased height of thyrocytes in peripheral lobes of the thyroid).  The toxicological 
significance of these reports is uncertain because of the small magnitude of the changes in serum thyroid 
hormone levels and the absence of reporting of incidence data for the histological changes; thus, the 
apparent LOAEL of 0.0019 o,p’-DDE/kg/day was excluded from Table 2-1 and Figure 2-2.  The only 
other study of thyroid effects in orally exposed laboratory animals reported reduced iodine concentrating 
capacity in Sprague-Dawley rats given single doses ≥50 mg/kg technical DDT (Goldman 1981). 
 
Mechanisms of Endocrine Effects of DDT, DDE, or DDD.  Although available studies of thyroid 
histology in laboratory animals orally exposed to DDT and related compounds do not clearly identify the 
thyroid as a sensitive toxicity target, the potential disruption of thyroid hormone homeostasis by 
environmentally persistent organochlorine chemicals, such as PCBs and DDT compounds, is an active 
area of in vitro, cell biology, and epidemiological research (for reviews of mechanistic hypotheses, see 
Liu et al. 2014; Rossi et al. 2017; Yaglova and Yaglov 2015b).  To explain the observation of decreased 
serum levels of T4, T3, and TSH measured in Sprague-Dawley rats after 5 days of intraperitoneal co-
exposure to PCB153 and p,p’-DDE (32 mg PCB153 + 20, 60 or 100 mg p,p’-DDE/kg/day), Liu et al. 
(2014) proposed that disruptive mechanisms could include decreasing levels of thyroglobulin, deiodinase 
2, and serum transthyretin (TTR), inducing hepatic enzymes that metabolize thyroid hormones, and 
increasing levels of hormone receptors.  Based on in vitro and cellular studies, Rossi et al. (2017) 
proposed that DDT may disrupt thyroid hormone homeostasis via inhibitory action on the TSH receptor 
via internalization of the TSH receptor from the plasma membrane by altering the structure of membrane 
lipid subdomains and that autoimmune responses to extracellular vesicles containing the TSH receptor 
could develop (Rossi et al. 2017).  Yaglova and Yaglov (2015b) proposed that o,p’-DDT interferes with 
iodine anion transport into follicular thyrocytes, evidenced by decreased levels of the Na+/I- symporter 
(NIS) and increased thyroperoxidase (TPO) observed in exposed rats.  
 
2.14.   IMMUNOLOGICAL 
 
Evidence of Immunological Effects of DDT, DDD, or DDE in Humans.  Numerous epidemiological 
studies have examined associations between serum DDE levels and immune function biomarkers (e.g., 
immunoglobulin serum levels or counts of white blood cell or lymphocyte subtypes) or immune-related 
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conditions (e.g., asthma, bronchitis, eczema) in adults (Cooper et al. 2004; Miyake et al. 2011; Vine et al. 
2001; Table 2-9) and children (Karmaus et al. 2001, 2003, 2005a, 2005b; Meng et al. 2016; Perla et al. 
2015; Table 2-10).  Thirteen epidemiological studies have examined associations between DDE levels in 
cord blood, maternal serum, or breast milk and levels of immune function markers or prevalence of 
immune-related conditions in offspring (see Table 2-11 for references and summaries of results).   
 
The studies provide inconsistent evidence for associations between DDE serum levels and immune 
function biomarkers or immune conditions in adults or children.  Consistent evidence comes from five 
studies for associations between levels of DDE in cord blood or maternal serum during pregnancy and 
prevalences of wheeze (or airway obstruction) in infant or child offspring.  In other studies, inconsistent 
evidence was provided for associations between maternal DDE exposure biometrics (cord blood, maternal 
serum, or breast milk) and prevalence of asthma, blood levels of biomarkers associated with asthma, and 
prevalence of infections in offspring. 
 
Results from studies of adults and children.  In studies of adults (Table 2-9), increasing DDE serum levels 
were associated with decreased serum levels of IgG, but not IgA or anti-nuclear antibodies (Cooper et al. 
2004) and increased total lymphocytes, CD3s, CD56s, and levels of IgA, but not with white blood cells or 
CD4s (Vine et al. 2001).  In adult Japanese women, no significant associations were found between DDE 
levels in their breast milk and prevalences for asthma, wheeze, rhino-conjunctivitis, or eczema (Miyake et 
al. 2011).   
 
Studies examining possible associations between serum DDE levels in children and immunological 
outcomes provide inconsistent evidence across studies (Table 2-10).  Associations between increasing 
serum DDE levels and prevalence of asthma and serum IgE >200 kU/L were found in a group of German 
children, but the association was not apparent when the data were stratified by gender, breastfeeding 
status, or age, or when the logistic regression models included other organochlorine compounds analyzed 
in the children’s serum (Karmaus et al. 2001).  In a second analysis to examine the protective effects of 
breastfeeding and detrimental effects of DDE, no associations were found for increasing prevalences for 
several atopic outcomes (asthma, bronchial hyperactivity, atopic eczema, or hay fever), except for 
increased prevalence of children with serum IgE >200 kU/L (Karmaus et al. 2003).  In a third analysis, 
elevated blood or serum levels of IgG, IgA, IgE, white blood cell, eosinophilic granula and IgE counts on 
basophils, but not lymphocyte counts, were associated with high-category DDE serum levels (0.30– 
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Table 2-9.  Summary of Studies of Associations Between DDT Exposure Biometricsa in Adults and 
Immunological Endpoints  
 
Reference and Study Population DDT exposure metricb Outcome evaluated Resultsc 
Cooper et al. 2004 
Consenting African-American male adult 
farmers (n=137) 
Serum levels of DDE 
Quartiles (ng/mL)  
Q1: <3.0 
Q2: 3.0–5.9 
Q3: 6.0–11.9 
Q4: ≥12.0 
Serum IgA, IgG, and 
prevalence of anti-
nuclear antibodies 
Adjusted betas and ORs for Q2–Q4 DDE 
versus Q1, or per 1-unit increase in DDE 
(overall analysis)  
 IgA IgG  
 β OR β  OR   
Q2 NS NS NS  NS 
Q3 NS NS -0.717*↓ NS 
Q4 NS NS -0.609*↓ NS 
p -OT NS NS 0.03*↓  0.05*↓ 
p-MT NS NS NS  NS  
Overall NS NS NS  NS 
 
Associations with prevalence of anti-nuclear 
antibodies were NS 
Miyake et al. 2011 
Consenting Japanese women (n=124) 
Samples collected 1 month after delivery 
Milk levels of DDE 
Minimum–maximum (ng/g 
lipid) = 7.5–362 
 
Wheeze, asthma, 
eczema, and 
rhinoconjunctivitis 
Adjusted ORs (95% CI) for each 1 ng/g lipid 
increase in DDE in breast milk 
Wheeze: NS  
Asthma: NS  
Eczema: NS 
Rhinoconjunctivitis: NS 
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Table 2-9.  Summary of Studies of Associations Between DDT Exposure Biometricsa in Adults and 
Immunological Endpoints  
 
Reference and Study Population DDT exposure metricb Outcome evaluated Resultsc 
Vine et al. 2001 
Cross-sectional study, community based 
Consenting adults (n=302) 
Aberdeen residents (n=151); living near a 
pesticides dump sites. 
Control community outside of Aberdeen 
(n=151) 
Serum levels of DDE.  
Quintiles (ng/mL)  
Q1: ≤1.0 
Q2: >1.0–2.0 
Q3: >2.0–4.3 
Q4: >4.3–7.6 
Q5: >7.6 
 
Lymphocyte profiles 
(cell counts and % of 
total), mitogen 
induced 
lymphoproliferative 
activity (PHA, PKW, 
or ConA), IgA, IgG, 
IgM, cell mediated 
immune function 
(skin test) 
Adjusted ordinal p-trends for change with 
increasing DDE quintiles 
WBC: 0.07 
Total lymphocytes: 0.05*↑ 
CD3: 0.05*↑ 
CD4: 0.06 
CD56: 0.05*↑ 
IgA: 0.04*↑ 
PHA: 0.08 
ConA: 0.03*↓ 
 
Significance not apparent, when lymphocyte 
subsets expressed as percent of total 
 
No significant associations with other immune 
endpoints  
 
Adjusted ORs for skin test positivity were NS 
 
Clinical significance of alterations is uncertain 
due to the small magnitude of change 
 
aSee Table 3 in the Supporting Document for Epidemiological Studies for DDT, DDE, and DDD for more detailed descriptions of studies.  Studies in this table 
were selected from those described in Table 3, because they: (1) measured DDT-related metrics in biological fluids or tissues in each subject, and (2) evaluated 
associations using linear regression, logistical regression, or correlation techniques, adjusting for possible confounding factors. 
bDDE = p,p’-DDE, unless otherwise specified; DDT = p,p’-DDT, unless otherwise specified.  
cBold text, “significant” and asterisk indicate statistically significant (p<0.05).  Arrows indicate an increase or decrease in the immunological endpoint or direction 
of p-trend.  Adjusted Odds Ratio or Adjusted β indicates adjustment for standard confounding variables for Immunological outcomes, such as age, sex, serum 
lipids, smoking, and family history of allergic disorders.  
 
CD(X) = cluster of differentiation X; CI = confidence interval; ConA = concanavalin A; Ig(X) = immunoglobin X; MT = median p-trend; NS = not statistically 
significant; OR = odds ratio; OT = ordinal p-trend; PHA = phytohemagglutinin; PKW = pokeweed mitogen; Q = quartile or quintile; WBC = white blood cell 
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Table 2-10.  Summary of Studies of Associations between DDT Exposure Biometrics in Children and 
Immunological Endpointsa 
 
Reference and study 
population DDT exposure metric 
Outcome 
evaluated Resultsb 
Karmaus et al. 2001 
School-aged (second grade) 
children with parental consent 
(n=343) 
Serum DDE 
Geometric mean: 0.32 ng/mL 
Exposure categories: 
(low) <0.3 Q1: ≤0.2 
(high) ≥0.3 Q2: 0.21–0.29 
  Q3: 0.30–0.43 
  Q4: 0.44–4.02 
 
Otitis media, 
pneumonia, 
whooping cough, 
asthma, and IgE 
Adjusted ORs (95% CI) for DDE high versus low 
exposure levels 
Otitis media: NS 
Pneumonia: NS 
Whooping cough: NS 
Asthma: 3.71 (1.10–12.56)*↑ 
IgE ≥200: 2.28 (1.20–4.31)*↑ 
Associations lost in models including other 
analytes 
 
Adjusted betas for change in IgE with Q2–Q4 
DDE versus Q1 p-value 
 Q2 NS 0.49 
 Q3 NS 0.08 
 Q4 62.1*↑ 0.01 
Karmaus et al. 2003 
School-age children (second-
grade) with parental consent 
(n=323) 
 
Breastfed 1–12 weeks (n=134) 
Breastfed >12 weeks (n=142) 
Not breastfed (n=47) 
 
Serum DDE quartiles, ng/mL 
Q1: <0.21  
Q2: 0.21–0.29 
Q3: 0.29–0.44 
Q4: ≥0.44 
IgE, specific IgE 
aeroallergens, 
bronchial hyper-
reactivity, atopic 
eczema, hay fever, 
and asthma 
Adjusted ORs for atopic outcomes across DDE 
quartiles (Q1=reference <0.21 ng/mL)  
   Q2 Q3 Q4  
Asthma   NS NS NS 
BroncHR  NS NS NS 
Atopic eczema  NS NS NS 
Hay fever  NS NS NS 
IgE >200 kU/L  NS NS 5.63*  
IgE aeroallergen NS NS 3.82* 
 
In separate analyses, the beneficial effects of 
breastfeeding were shown to be countered by 
DDE levels ≥0.29 ng/mL, especially for atopic 
eczema 
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Table 2-10.  Summary of Studies of Associations between DDT Exposure Biometrics in Children and 
Immunological Endpointsa 
 
Reference and study 
population DDT exposure metric 
Outcome 
evaluated Resultsb 
Karmaus et al. 2005a, 2005b 
Children (aged 7–10 years) 
with parental consent (n=331) 
Serum DDE 
Geometric mean (ng/mL) 0.32 
Quartiles 
Q1: ≤0.2 
Q2: 0.21–0.29 
Q3: 0.30–0.43 
Q4: >0.43 
WBC count, EG 
content, IgE count 
on basophils, IgE, 
IgG, IgM, and IgA, 
and lymphocyte cell 
counts (T-cells, 
T-helper cells, 
cytotoxic T-cells, 
memory T-helper 
cells, NK, NK 
subset, and B-cells) 
Adjusted betas for Q2–Q4 DDE versus Q1 
  Q1 Q2 Q3 Q4 
IgG   NS NS NS 1,295*↑ 
IgA  NS NS 138*↑ 141*↑ 
IgM   NS NS  NS NS 
IgE  NS NS NS 80*↑ 
WBC  NS NS NS 8,564*↑ 
EG  NS NS NS 895*↓ 
IgE(bas) NS NS 896*↑ NS 
 
Associations with various lymphocyte counts were 
NS 
Meng et al. 2016 
Asthmatic cases (n=620);  
control cases (n=218); 
ages 3–6 years 
Serum DDT metrics 
Mean (ng/g lipid) 
  Controls Cases  
p,p’-DDE  36.97  166.52  
p,p’-DDT 10.13  12.13  
p,p’-DDD 42.06  33.71 
o,p’-DDT 69.42  38.32 
 
Asthma, severe 
asthma 
Adjusted ORs (95% CI) for asthma per 1 ng/g 
lipid increase in DDT exposure metric 
     p-trend 
p,p’-DDE 1.02(1.01–1.03)*↑ 0.0004 
p,p’-DDT NS   NS  
p,p’-DDD NS    NS 
o,p’-DDT NS   NS 
 
ORs for severe asthma were NS for all exposure 
metrics, but trends were significant for p,p’-DDD 
and o,p’-DDT 
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Table 2-10.  Summary of Studies of Associations between DDT Exposure Biometrics in Children and 
Immunological Endpointsa 
 
Reference and study 
population DDT exposure metric 
Outcome 
evaluated Resultsb 
Perla et al. 2015 
Consenting children (n=962); 
ages 12–15 years 
Serum levels of DDE 
Geometric mean (95% CI) (ng/g) 
105 (93.0–1,185) 
Tertiles 
T1: <40th percentile 
T2: 40th–80th percentiles 
T3: >80th percentile 
Asthma prevalence Adjusted PRRs, T2 or T3 versus T1  
 Current wheeze  Ever asthma 
T2 NS   NS 
T3 NS   NS 
p-trend NS   NS 
 
aSee Table 4 in the Supporting Document for Epidemiological Studies for DDT, DDE, and DDD for more detailed descriptions of studies.  Studies in this table 
were selected from those described in Table 4, because they: (1) measured DDT-related metrics in biological fluids or tissues in each subject, and (2) evaluated 
associations using linear regression, logistical regression, or correlation techniques, adjusting for possible confounding factors.  
bDDE = p,p’-DDE, unless otherwise specified; DDT = p,p’-DDT, unless otherwise specified.  
cBold text, “significant” and asterisk indicate statistically significant (p<0.05).  Arrows indicate an increase or decrease in the immunological endpoint.  Adjusted 
OR or adjusted β indicates adjustment for standard confounding variables for Immunological outcomes, such as age, sex, serum lipids, smoking, atopy, 
education, gestational age, and number of recent infections.  Further adjustments for other analyzed chlorinated compounds or pesticides in biological fluid 
samples are expressly noted in the table. 
 
BronHR = bronchiolar hyperactivity; CI = confidence interval; EG = eosinophilic granula; Ig(X) = immunoglobin X; NK = natural killer; NS = not statistically 
significant; OR = odds ratio; PRR = prevalence rate ratio; Q = quartile; SD = standard deviation; T = tertile 
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Table 2-11.  Summary of Studies of Associations Between Maternal Serum, Cord Blood, or Milk DDT Exposure 
Metrics and Immunological Endpoints in Offspringa 
 
Reference and study 
population DDT exposure metric Outcome evaluated Resultsb 
Ashley-Martin et al. 
2015 
Consenting mother-infant 
pairs (n=1,258) 
Immunological 
parameters measured in 
cord blood 
Maternal serum DDE (ng/mL) 
T1: ≤0.23 (referent) 
T2: 0.24–0.39 
T3: >0.39 
IgE, Ig33/TSLP ratio 
in cord blood 
Adjusted ORs (95% CI) for T2–T3 versus T1 or per 
doubling of DDE 
 IL33/TSLP IgE  
 (≥80%)  (≥1.2 ng/mL)  
Log10 0.81*↓  NS  
T2 NS  – 
T3 NS  – 
p-trend  0.06 
Bilrha et al. 2003  
Consenting mother-infant 
pairs (n=112) 
fishing group (n=47) 
Reference group (n=65) 
 
Cord blood DDE; geometric mean (ng/g 
lipid) 
(Groups) Fishing Reference 
DDE 144  84 
 
TNF-α and IL-10 in 
mitogen (PHA) 
induced CBMCs 
Pearson’s coefficient (R) for DDE  
IL-10: NS 
TNF-α: -0.289*↓ 
Adjusted betas 
Il-10: NS 
TNF-α: ** ↓ (but value not reported) 
Cupul-Uicab et al. 2014 
Consenting mother-male 
infant pairs (n=747) 
Maternal serum DDE and DDT  
Quartiles (ng/g lipid) 
 DDE  DDT 
Q1 ≤3.0  ≤0.25 
Q2 3.01–6.00 0.26–0.75 
Q3 6.01–9.00 0.76–1.99 
Q4 >9.00  ≥2.00 
IRR of LRTIs in 
children under 
2 years of age 
Adjusted IRR (CI%) of LRTIs for Q2–Q4 versus Q1 
or per interquartile increase in DDT metrics 
   DDE DDT 
Q2   NS NS 
Q3   NS NS 
Q4   NS NS 
p-trend   NS  NS 
Interquartile increase NS NS 
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Table 2-11.  Summary of Studies of Associations Between Maternal Serum, Cord Blood, or Milk DDT Exposure 
Metrics and Immunological Endpoints in Offspringa 
 
Reference and study 
population DDT exposure metric Outcome evaluated Resultsb 
Dallaire et al. 2004  
Consenting Inuit mother-
infant pairs (n=199) 
Infant plasma collected at 
7 months 
 
Maternal and infant serum DDE 
Quartiles (ng/g lipid) 
 Maternal Infant 
Q1 <183  <100 
Q2 183–281 100–355 
Q3 281–472 355–618 
Q4 >472   >618 
 
URTIs, LRTIs, otitis 
media, GI infections, 
or all infections within 
the first 12 months of 
age 
Adjusted RRs for maternal Q2–Q4 DDE versus Q1 
 6 months  12 months 
 Q2  Q3 Q4 Q2 Q3 Q4 
URTIs 1.56*↑ NS NS 1.34*↑ NS NS 
Otitis NS 1.83*↑ NS NS NS NS 
GI infections 
 NS NS NS 1.59*↑ NS NS  
LRTIs NS NS NS NS NS NS 
All Infections 
 1.38*↑ 1.33*↑ NS NS NS NS 
 
All p-trends for continuous exposure levels were NS 
Dewailly et al. 2000 
Consenting mother-infant 
pairs (n=98) 
 
Maternal milk DDE   
Tertiles (ng/g lipid) 
T1: <730 
T2: 730–1,320 
T3: >1,320 
Acute during 0–3, 4–
7, 8–12 months 
≥1 or ≥3 otitis media 
episodes during 
1st year of age 
RRs for T2–T3 versus T1 
1 year of age T2 T3 
≥1 episode 1.55*↑ 1.52*↑ 
≥3 episode 4.64*↑ NS 
 
Acute otitis media 
 0–3 months  4–7 months 8–12 months 
T2 NS NS 1.63*↑ 
T3 NS 1.87*↑ NS 
Similar results for adjustments (NR) 
Gascon et al. 2012 
Consenting mother-infant 
pairs: 
Spanish mothers (n=1,342) 
Latin-American mothers 
(n=79) 
Maternal serum DDE 
Quartiles and tertiles (ng/g lipid) 
Spanish  Latin 
Q1 <72.6  T1 <197.9 
Q2 72.6–115.9  T2 197.9–595.9 
Q3 115.9–191.7 T3 >595.9 
Q4 >191.7 
LRTI and wheezing 
during the first 12–
14 months of age 
Adjusted RRs for Q2–Q4 DDE versus Q1 
 Spanish  Latin-American 
 LRTI Wheeze LRTI Wheeze 
Q2 1.20 NS T2 2.59*↑ NS 
Q3 1.40*↑ 1.37*↑ T3 2.89*↑ 3.54*↑ 
Q4 1.28*↑ NS  
Cont. 1.11↑ 1.14*↑  NS 1.20 
 
RRs adjusted for multiple chemical 
(hexachlorobenzene and PCB) exposure for Spanish 
cohort 
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Table 2-11.  Summary of Studies of Associations Between Maternal Serum, Cord Blood, or Milk DDT Exposure 
Metrics and Immunological Endpoints in Offspringa 
 
Reference and study 
population DDT exposure metric Outcome evaluated Resultsb 
Gascon et al. 2014 
Consenting mother-infant 
cohorts. 
Duisburg (n=204) 
FLEHS I (n=133) 
HUMIS (n=386) 
PCB COHORT (n=720) 
RHEA (n=996) 
INMA, Menorca (n=395) 
INMA, Gipuzkoa (n=540) 
INMA, Sabadell (n=543) 
INMA, Valencia (n=505) 
PELAGI (n=186) 
 
Estimated cord-serum levels of DDE.  
Geometric mean (ng/mL)  
Duisburg: 0.201  
FLEHS I: 0.285  
HUMIS: 0.052  
PCB: 0.934  
RHEA: 0.641  
INMA, Menorca: 1.067  
INMA, Gipuzkoa: 0.208  
INMA, Sabadell: 0.229  
INMA, Valencia: 0.503 
PELAGIE: 0.165  
Tertile levels not reported: T1, T2, and 
T3 = low, medium, and high exposure 
levels 
Ever bronchitis (Br) 
and/or wheezing 
(Wz) before or after 
18 months of age 
(maximum age 
~3.5 years); Br/Wz 
indicates prevalence 
for bronchitis or 
wheeze 
Adjusted RRs per doubling of DDE (“Contin”) or T2–
T3 versus T1, all cohorts 
 <18 months >18 months 
 Br/Wz Br Wz Wz 
Contin 1.03*↑ 1.05*↑ NS NS 
T2 NS NS NS NS 
T3 1.14*↑ NS 1.16*↑ NS 
 
Adjusted risk estimates for bronchitis/wheezing in 
individual cohorts were NS 
 
 Glynn et al. 2008 
Consenting mother-infant 
pairs  
WBC counts group (n=81) 
Lymphocyte profile group 
(n=52) 
Infections group (n=190) 
 
Maternal serum, milk, and estimated 
postnatal DDE levels 
Median (ng/g lipid) 
 WBC Lymphocyte Infections 
Serum 85 83 88 
Milk 289 306 311 
 
Quartile levels not reported. 
Counts and percent 
total WBCs 
(neutrophils, 
eosinophils, 
lymphocytes, 
monocytes), 
lymphocyte subsets 
at 3 months of age; 
Incidence of 
respiratory infection 
during first 3 months 
after birth 
Adjusted betas for DDE with 
Eosinophil percent -1.62 (0.46)*↓ 
 
Adjusted betas for DDE with:  
all other WBC counts and % total WBCs = NS; 
all lymphocyte subsets = NS 
 
Adjusted ORs for Q2–Q4 DDE versus Q1 
Respiratory infections 
 Serum Estimated postnatal 
Q2  NS 0.18*↓ 
Q3 NS NS 
Q4  NS NS 
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Table 2-11.  Summary of Studies of Associations Between Maternal Serum, Cord Blood, or Milk DDT Exposure 
Metrics and Immunological Endpoints in Offspringa 
 
Reference and study 
population DDT exposure metric Outcome evaluated Resultsb 
Hansen et al. 2014 
Consenting mother-
offspring pairs (n=872) 
Offspring follow-up at 
20 years of age 
Maternal serum DDE 
Tertiles (ng/mL) 
T1: 0.20–1.86 
T2: >1.86–3.24 
T3: >3.25–38.77 
Asthma: hospital 
diagnosis, asthma 
medication use for 
20 years, self-
reported lifetime 
diagnosis, and self-
reported asthma 
medication use 
Adjusted ORs for T2–T3 DDE versus T1  
  Self-reported  Current 
  diagnosis medication use 
T2  NS  NS 
T3  NS  NS 
p-for trend  NS  NS  
 
Adjusted HRs for T2–T3 DDE versus T1  
Hospital diagnosis 20-year medication use 
T2  NS   NS 
T3  NS  NS 
p-for trend NS  NS  
Hansen et al. 2016 
Consenting mother-
offspring pairs (n=421) 
Offspring age 20 years 
Maternal serum DDE 
Tertiles (ng/mL)  
T1: 0.2–1.9 
T2: 1.9–3.2 
T3: 3.2–38.8 
Allergic sensitization, 
airway obstruction, 
and reduced lung 
function 
Adjusted ORs for T2–T3 DDE, versus T1 
   T2 T3 p-trend 
Allergic sensitization NS NS NS 
Airway obstruction NS 2.87*↑ 0.05*↑ 
Reduced lung function NS NS NS 
Huang et al. 2018 
(Vhembe, South Africa) 
 
Consenting mother-child 
pairs (n=674) 
Maternal serum o,p’-DDT, p,p’-DDE, and 
p,p’-DDT geometric mean:  9.18, 292.95, 
and 70.04 µg/L, respectively 
 
Maternally reported 
number of persistent 
fevers, ear infections, 
and severe sore 
throats between ages 
1 and 2 years 
IRRs (95% CI) per 10-fold increase in maternal 
serum level 
 
Persistent fever 
o,p’-DDT NR 
p,p’-DDE 1.21 (1.01-1.46) 
p,p’-DDT NR 
 
No significant associations for ear infections or 
severe sore throat  
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Table 2-11.  Summary of Studies of Associations Between Maternal Serum, Cord Blood, or Milk DDT Exposure 
Metrics and Immunological Endpoints in Offspringa 
 
Reference and study 
population DDT exposure metric Outcome evaluated Resultsb 
Jusko et al. 2016a, 
2016b 
Consenting mother-infant 
pairs (n=541) 
 
Maternal serum, cord blood, and 
estimated 6-month DDE (ng/g lipid)  
Percentiles 
   25th  75th  
Maternal   265 723 
Cord blood  259 706 
Estimate-6 months 115 847 
BCG-specific IgA and 
IgG at 6 months of 
age 
Adjusted beta per DDE increase from the 25th to 75th 
percentile  
  BCG-IgG BCG-IgA 
Maternal NS   NS 
Cord blood NS   NS 
6-months -18.2*↓  -15.6*↓ 
 
Sunyer et al. 2005 
Consenting mother-child 
pairs (n=405) 
Serum collected at 4 years 
of age for presence of IgE 
specific to house dust mite, 
cat and grass; positive 
value defined as atopy 
 
Cord blood DDE 
Quartiles (ng/mL) 
Q1: <0.57 
Q2: 0.57–1.03 
Q3: 1.03–1.90 
Q4: >1.90 
Wheezing at 4 years 
of age 
Adjusted RR (95% CI) for wheezing Q2–Q4, versus 
Q1  
  All children (4 years) Non-atopic 
Q2 NS    NS 
Q3 NS   NS 
Q4 2.63*↑   2.49*↑ 
 
Associations with wheezing in atopic children and 
with doctor diagnosed asthma were NS 
Sunyer et al. 2006 
Consenting mother-infant 
pairs (n=402) 
Blood samples from 
children at 4 years 
(n=285) 
Atopic status evaluated at 
6 years; wheezing during 
a given year defined as 
one or more episodes of 
wheezing over 12 months 
(at years 1, 2, 3, 4, 6.5) 
Cord blood and child serum (4 years) 
levels of DDE and DDT 
Minimum–maximum (ng/mL)  
 DDE  DDT 
Cord  
blood 0.043–19.54 0.008–2.283  
Serum 0.088–43.88 0.038–0.658 
  
 
Asthma, wheezing Adjusted ORs per 1 ng/mL increase in DDE  
   All Non-atopic 
Asthma 
At 6.5 years  1.18*↑ 1.25*↑ 
 
>1 wheeze event/year   
Year 1  NS  NS 
Year 2  NS  NS 
Year 3   NS NS 
Year 4   1.14*↑  NS 
Year 6.5 NS NS 
Persistent 
wheeze  
at 6.5 years NS NS 
 
No associations with DDT found 
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Table 2-11.  Summary of Studies of Associations Between Maternal Serum, Cord Blood, or Milk DDT Exposure 
Metrics and Immunological Endpoints in Offspringa 
 
Reference and study 
population DDT exposure metric Outcome evaluated Resultsb 
 Sunyer et al. 2010 
Consenting mother-infant 
pairs (n=520) 
Maternal serum DDE and DDT 
Tertiles (ng/g lipid) 
T1: <83.0 
T2: 83.0–149.5 
T3: >149.5 
LRTIs from birth to 
6 months, or 6–
14 months of age 
Adjusted RRs for T2–T3, versus T1, or per log-unit 
increase DDE 
 At 6 months At 14 months Recurrent 
T2 1.69*↑  1.59*↑  2.46*↑ 
T3 NS  1.68*↑  2.56*↑ 
Log↑ 1.29*↑  1.25*↑  1.50*↑ 
 
aSee Table 5 in the Supporting Document for Epidemiological Studies for DDT, DDE, and DDD for more detailed descriptions of studies.  Studies in this table 
were selected from those described in Table 5, because they: (1) measured DDT-related metrics in biological fluids or tissues in each subject, and (2) evaluated 
associations using linear regression, logistical regression, or correlation techniques, adjusting for possible confounding factors. 
bDDE = p,p’-DDE, unless otherwise specified; DDT = p,p’-DDT, unless otherwise specified.  
cBold text, “significant” and asterisk indicate statistically significant (p<0.05).  Arrows indicate an increase or decrease in the immunological endpoint or direction 
of p-trend.  Adjusted Odds Ratio or Adjusted β indicates adjustment for standard confounding variables for Immunological outcomes, such as age, sex, serum 
lipids, smoking, and family history of allergic disorders.  
 
BCG = Mycobacterium bovis bacilli Calmette-Guerin; Br = bronchitis; CBMC = cord blood mononucleocytes; CI = confidence interval; FLEHS = Flemish 
Environment and Health Studies; GI = gastrointestinal; HUMIS = Norwegian Human Milk Study; Ig(X) = immunoglobin X; IL-(X) = interleukin-(x); INMA = Infancia 
y Medio Ambiente; IQR = inter quartile range; IRR = incidence rate ratio; LRTI = lower respiratory tract infection; NR = not reported; NS = not statistically 
significant; OR = odds ratio; PCB = polychlorinated biphenyl; PELAGIE = Perturbateurs endocriniens, Étude Longitudinale sur les Anomalies de la Grossesse, 
l’Infertilité et l’Enfance; PHA = phytohemagglutinin; Q = quartile; RR = relative risk; T = tertile; TNF-α = tumor necrosis factor-alpha; TSLP = thymic stromal 
lymphopoietin; URTI = upper respiratory tract infection; WBC = white blood cell; Wz = wheezing 
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0.43 or >0.43 ng/mL), compared with children with low (≤0.2 ng/mL) DDE serum levels (Karmaus et al. 
2005a, 2005b).  In the other two children studies, a small, but elevated, adjusted OR for asthma 
[1.02 (95% CI 1.01–103)] for per 1 ng/g lipid increase in serum DDE was found in one study of children 
ages 3–6 years (Meng et al. 2016), and no association with asthma prevalence was found in a study of 
children ages 12–15 years (Perla et al. 2015). 
 
Results relating maternal exposure and immunological outcomes in offspring.  Consistent evidence for 
associations between levels of DDE in maternal serum and prevalence of wheeze (or airway obstruction) 
in infant or child offspring have been reported in five studies (Gascon et al. 2012, 2014; Hansen et al. 
2016; Sunyer et al. 2005, 2006; Table 2-11).  Each of these European cohort studies reported elevated 
relative risks (RRs) or ORs for this condition in infants of mothers with high DDE serum levels, 
compared with infants of mothers with low DDE levels or increasing risk for this condition in infants with 
increasing maternal serum DDE levels.  For example, the Gascon et al. (2014) meta-analysis of 
4,608 mother-infant pairs from 10 birth cohorts from 7 European countries reported elevated RRs of 
1.14 for bronchitis or wheeze and 1.16 for wheeze in young (<18 months old) infants of mothers with the 
highest category of DDE serum levels, compared with referent infants of mothers in the low DDE serum 
level category (Table 2-11).  This association was not significant with offspring older than 18 months 
(Gascon et al. 2014).   
 
Inconsistent evidence comes from studies examining associations between maternal serum or cord blood 
DDE levels and prevalence for asthma or changes in blood immune function markers associated with 
wheezing or asthma.  Hansen et al. (2014) found no association for asthma in 20-year-old offspring with 
maternal serum DDE levels at birth, but Sunyer et al. (2006) reported increased ORs for asthma in 
6.5-year-old children per 1 ng/mL increase in cord blood DDE levels.  One study (Ashley-Martin et al. 
2015) reported an association between increased maternal serum DDE levels and decreased ratio of 
interleukin-33 and thymic stromal lymphopoietin (IL-33/TSLP) in cord blood, but no associations with 
cord blood levels of IL-33 or IgE; elevated levels of each of these individual immune function markers 
have been associated with wheezing or asthma in other studies.  In other studies, associations were found 
between increasing cord blood DDE levels and decreased cord blood levels of tumor necrosis factor-alpha 
(TNF-α), but not IL-10, in 111 Canadian mother-infant pairs (Bilrha et al. 2003) and between increasing 
infant serum DDE levels and decreased IgG and IgA responses to vaccination, but no associations with 
maternal or cord blood DDE levels (Jusko et al. 2016a, 2016b).  
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Inconsistent evidence comes from five studies examining associations between maternal serum or breast 
milk levels of DDE and prevalences of infections in offspring (Table 2-11).  No associations were found 
with increased prevalences of lower respiratory tract infections in a group of 747 Mexican <2-year-old 
children (Cupul-Uicab et al. 2014) or respiratory tract infections during the first 3 months after birth in a 
group of 190 Swedish infants (Glynn et al. 2008), but associations were found for increased prevalences 
for all infections (respiratory, ear, and gastrointestinal) during the first 6 months, but not 12 months, after 
birth in a group of 199 Canadian children (Dallaire et al. 2004), ear infections between 4 and 12 months, 
but not 0–3 months, after birth in 98 Inuit infants (Dewailly et al. 2000), lower respiratory tract infections 
between 6 and 14 months after birth in a group of 520 children from Catalonia Spain (Sunyer et al. 2010); 
lower respiratory tract infections between birth and 14 months in a group of 1,342 children from 
Gipuzkoa, Sabadell, and Valencia Spain (Gascon et al. 2012); and elevated rates of persistent fever 
between 1 and 2 months were associated with p,p’-DDE, but not o,p’-DDT or p,p’-DDT and no 
associations were found for the number of ear infections or severe sore throats (Huang et al. 2018). 
 
Evidence of Immunological Effects of DDT, DDE, or DDD in Laboratory Animals 
 
Summary.  Studies of laboratory animals have provided evidence for suppression or stimulation of various 
immune system responses in rats and mice exposed to dietary doses technical DDT, p,p’-DDT, p,p’-DDE, 
p,p’-DDD, or o,p’-DDD as low as 2–20 mg/kg/day, but evidence is weak for weight changes or 
histological changes in immune system organs or tissues in laboratory animals after intermediate- or 
chronic-duration exposures. 
 
Acute-duration evidence.  Information on possible immunological effects in laboratory animals after acute 
oral exposure to DDT and related compounds is restricted to a report that gavage administration of New 
Zealand rabbits to 4.3 mg DDT(NS)/kg/day for 10 days produced no effects on serum antibody titers to 
Salmonella typhi infection (Shiplov et al. 1972).  Additionally, a study in male NOD mice administered 
p,p′-DDE via intraperitoneal injection every other day for 10 days found increases in splenocyte 
proliferation in response to Concanavalin A exposure in mice exposed to 100 mg/kg DDE, but not at 
1 mg/kg; increases in IL-6, tumor necrosis factor-α, and interferon-γ were also observed at 100 mg/kg 
(Cetkovic-Cvrlje et al. 2016).  There were no effects on splenocyte viability or splenocyte 
immunophenotype. 
 
Intermediate-duration evidence.  The potential for intermediate-duration exposures to technical DDT, 
p,p’-DDT, p,p’-DDE, p,p’-DDD, or o,p’-DDD in the diet to suppress immune responses has been 
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examined in rats (Banerjee 1987b; Banerjee et al. 1995, 1996; Gabliks et al. 1975; Hamid et al. 1974; 
Koner et al. 1998), mice (Banerjee 1987a; Banerjee et al. 1986, 1997a, 1997b; Rehana and Rao 1992), 
and rabbits (Street and Sharma 1975).  As shown in Table 2-1, Figure 2-2, and the following text, the 
lowest doses associated with immune system perturbations in intermediate-duration studies of laboratory 
animals ranged from about 2 to 20 mg/kg/day, and p,p’-DDT was the most widely used test material.   
 
Evidence of immunosuppression comes from studies evaluating the response to various antigens:      
• Response to sheep red blood cells (SRBC) 
o decreased splenic plaque forming cell (PFC) response and thymic rosette-forming cell 
response in Sprague-Dawley rats exposed to 121 mg o,p’-DDD/kg/day for 16–24 days 
(no statistical analysis performed) (Hamid et al. 1974);  
o decreased serum antibody titer response in Wistar rats exposed to 20.6 mg 
p,p’-DDT/kg/day, but not 10.3 mg/kg/day, in the diet for 8 weeks (Koner et al. 1998);  
o decreased splenic PFC response in Hissar mice fed 20 mg p,p’-DDT/kg/day, but not 4 or 
10 mg/kg/day, for 12 weeks (Banerjee et al. 1986); and  
o decreased splenic PFC response in restraint-stressed Hissar mice fed 20.3 mg 
p,p’-DDT/kg/day, but not 4.1 or 10.1 mg/kg/day, for 4 weeks (Banerjee et al. 1997b). 
• Response to tetanus or diphtheria toxoids 
o decreased antibody response to tetanus toxoid in Wistar rats exposed for 22 weeks to 
11 mg p,p’-DDT/kg/day in the diet, but not doses ≤5.5 mg/kg/day, and decreased serum 
IgG levels and decreased relative spleen weight (17–20% decreased) and increased serum 
albumin/globulin ratio resulting from decreased IgG titers in tetanus toxoid-immunized 
rats exposed to ≥5.5 mg/kg/day, but not 2.2 mg/kg/day (Banerjee 1987b); 
o decreased serum levels of IgG and IgM and antibody titers in response to tetanus toxoid 
and increased serum albumin/globulin ratio in Wistar rats fed 5.7 mg p,p’-DDT/kg/day 
(but not 2.3 mg/kg/day) in a low (3%) protein diet for 4 weeks; these effects were not 
seen in similarly exposed rats fed diets containing 12 or 20% protein (Banerjee et al. 
1995) 
o decreased severity of anaphylactic shock and number of mast cells in mesenteries in 
response to diphtheria toxoid (without effects on serum antitoxin titers) in albino rats 
exposed to 2.3 or 23 mg technical DDT/kg/day in the diet for 31 days (Gabliks et al. 
1975) 
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• Response to Escherichia coli lipopolysaccharide 
o decreased splenic PFC response and reduced secondary haemagglutination titres in Hissar 
mice fed 10.5 or 21 mg p,p’-DDT/kg/day, but not 4.2 mg/kg/day, for 6–12 weeks 
(Banerjee 1987a); 
• Response to ovalbumin 
o decreased serum levels of IgM, IgG and ovalbumin antibodies in Wistar rats exposed to 
20.2 mg p,p’-DDT, p,p’-DDE, or p,p’-DDD/kg/day in the diet for 6 weeks and increased 
serum albumin/globulin ratio in p,p’-DDT and p,p’-DDE exposed animals (Banerjee et 
al. 1996) 
• Resistance to leprosy bacilli 
o increased susceptibility to leprosy bacilli infections in Rockfeller mice exposed to 10.7 or 
21.4 mg p,p’-DDT/kg/day, but not 4.3 mg/kg/day, in the diet for 24 weeks (Banerjee et 
al. 1997a).   
• Response to tuberculin 
o Decreased skin reactivity to tuberculin challenge in New Zealand rabbits exposed for 
8 weeks to 6.54 mg p,p’-DDT/kg/day, but not to doses ≤2.10 mg/kg/day, in the diet 
(Street and Sharma 1975). 
 
Possible effects on weights or histology of immune system organs have also been examined in laboratory 
animals after intermediate-duration oral exposure to technical DDT, p,p’-DDT, p,p’-DDE, p,p’-DDD, 
o,p’-DDT, or o,p’-DDD, but the evidence from these studies for these types of immune effects is weak.  
Hamid (1974) observed decreased absolute weights of the thymus and spleen, along with decreased body 
weight and atrophy of the thymus and adrenal glands, in Sprague-Dawley rats exposed to 121 mg 
o,p’-DDD/kg/day for 16–24 weeks.  Yaglova et al. (2013) reported changes in thymus morphology, such 
as increased counts of Hassall’s corpuscles in the thymic medulla and increased 3H-thymidine 
incorporation rates in thymus of Wistar rats exposed to 0.0019 or 0.0078 mg o,p’-DDT/kg/day in drinking 
water for up to 10 weeks.  Observations from both studies were not included in Table 2-1 or Figure 2-2 
due to lack of incidence data and statistical analysis (Hamid 1974) or the lack of corroborating evidence 
for immune system effects at such low exposure levels and deficiencies in reporting of methodological 
details (Yaglova et al. 2013).  No exposure-related organ weight changes or histopathologies in the spleen 
or thymus were reported in F344/DuCrl rats exposed to 10 mg p,p’-DDE/kg/day for 42 days (Makita et al. 
2003a).  In a study of rabbits exposed to p,p’-DDT in the diet for up to 8 weeks at doses ranging from 
0.18 to 6.54 mg/kg/day, several effects were reported in all exposed groups that were of uncertain 
adversity: 23–36% increase in relative spleen weight; decreased counts of splenic germinal centers (about 
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12 centers/4-mm diameter in all exposed groups versus about 19/4-mm diameter in control); and 
increased mean severity score for thymic atrophy (means were about 0.5, 1.9, 0.7, 0.9, and 1.1 for control 
through high-dose groups) (Street and Sharma 1975).   
 
Chronic-duration evidence.  Studies of laboratory animals orally exposed to DDT, DDE, or DDD for 
chronic durations do not identify the immune system as a sensitive toxicity target, but the scope of these 
investigations did not include possible perturbations of immune system function.  In the 78-week chronic 
bioassays, no treatment-related histological changes in the thymus, spleen, or lymph nodes were observed 
in Osborne-Mendel rats treated in the diet with up to 45 mg technical DDT/kg/day, 59 mg 
p,p’-DDE/kg/day, or 231 mg technical DDD/kg/day or in B6C3F1 mice exposed to dietary doses up to 
30.2 mg technical DDT/kg/day, 49 mg p,p’-DDE/kg/day, or 142 mg technical DDD/kg/day (NCI 1978).  
Similarly, F344/DuCrl rats treated for 104 weeks to up to 19.1 mg p,p’-DDT/kg/day showed no 
histopathology of the spleen (Tomita et al. 2013).  In a 2-generation study, no exposure-related organ 
weight changes or histopathologies in the spleen or thymus were reported in Sprague-Dawley rats 
exposed to p,p’-DDT up to 25 mg/kg/day (males) or 27.7 mg/kg/day (females) (Hojo et al. 2006). 
 
No studies were located regarding immunological effects in humans or animals after dermal exposure to 
DDT, DDE, or DDD. 
 
Mechanisms of Immunological Effects of DDT, DDE, or DDD.  Although several DDT exposure-
related immunomodulatory effects have been reported, the mechanisms behind these effects are still under 
investigation.  There is currently no clear understanding of the pathophysiological mechanisms of 
immune-mediated respiratory (e.g., asthma, wheezing, bronchitis) or other immunological effects 
associated with exposure to DDT, DDE, or DDD. 
 
Disruptions to humoral and cell-mediated immune responses could be due to a variety of cellular and 
system responses that have been observed in vitro.  Exposure to DDT or to related compounds has been 
shown to increase ROS, nitric oxide (NO), or TNF-α production (Perez-Moldonado et al. 2005; Dutta et 
al. 2008); induce pro-inflammatory responses (Gaspar-Ramirez et al. 2015c; Kim et al. 2004); alter 
inflammatory mediator production (Mangum et al. 2016) and apoptotic pathways (Alegria-Torres et al. 
2009; Perez-Moldonado et al. 2004, 2005); alter immune cell morphologies and activity (Dutta et al. 
2008; Reed et al. 2004; Udoji et al. 2010); and lead to aberrant cytokine production (Alegria-Torres et al. 
2009; Kim et al. 2004; Quaranta et al. 2006) and alterations in the complement system (Dutta et al. 2008).  
Microscopic observations of peripheral blood mononuclear cells (PBMCs) exposed to 10, 50, or 100 
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µg/mL technical DDT showed characteristic signs of cells undergoing apoptosis (cytoplasmic 
vacuolization, loss of pseudopodia, and presence of lipid bodies), as well as dose-related increases in the 
inflammatory cytokine, TNF-α and NO (51.7% increase at high dose) (Dutta et al. 2008).  Other studies 
suggested that increased TNF-α, and pro-inflammatory responses following DDT exposure could be the 
result of activation of transcription factors including NF-ĸB and AP-1 (Kim et al. 2004); TNF-α in turn 
may regulate expression of the aryl hydrocarbon receptor (AhR), which can further mediate the 
inflammatory response (Gaspar-Ramirez et al. 2015c).   
 
Natural killer (NK) cells are an important first-line immune response against tumor cells and viral 
infection; correlations between plasma p,p’-DDT levels and reduction of NK cell numbers has been 
documented in fish eaters from southeast Sweden (Svensson et al. 1994).  In vitro, NK lytic function was 
decreased by 55.4% 24 hours following exposure to 2.5 µM p,p’-DDT for 60 minutes in culture (Udoji et 
al. 2010); determinations of whether DDT can interfere with the essential involvement of mitogen-
activated protein kinase (MAPK) signaling in NK cell lytic activity is under investigation (Udoji et al. 
2010).  In a follow-up study, Hurd-Brown et al. (2013) found 22, 35, and 36% decreases in binding 
function in NK cells exposed to 2.5 µM DDT for 24 hours, 48 hours, or 6 days, respectively.  Exposure to 
2.5 µM DDT for 24 or 48 hours also resulted in decreases in CD16 expression in NK cells; no alterations 
were observed in CD2, CD11a, CD18, or CD56 cell-surface protein expression.  
 
Despite several studies attempting to uncover possible mechanisms of DDT-related immunological 
effects in vitro, it is unclear whether the responses observed in various cultured cell types would occur in 
vivo, or on a scale large enough to elicit an adverse immunotoxic response.  This may be reflected in the 
inconsistencies observed in human epidemiological studies (see Tables 2-9, 2-10, and 2-11).   
 
2.15   NEUROLOGICAL 
 
Summary.  Volunteers given single oral doses of DDT reported mild neurological symptoms like 
perspiration, headache, and nausea at doses as low as 6 mg DDT/kg and transient convulsions or tremors 
at doses ≥16 mg/kg/day (Hayes 1982; Hseih 1954; Velbinger 1947a, 1947b), but no neurological effects 
were found in volunteers who ingested 0.05–0.063 or 0.36–0.5 mg/kg/day for 12–18 months (Hayes et al. 
1956).  In epidemiological studies, inconsistent evidence was provided for associations of serum levels of 
DDT, DDE, or DDD with deficits in cognitive or mental status tests or risks for neurological conditions, 
such as Alzheimer’s, Parkinson’s disease, or attention deficient disorder, in adults or adolescents or 
associations between DDT, DDE, or DDD levels in maternal serum at birth or during pregnancy, cord 
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blood, placenta tissue, or breast milk with adverse neurodevelopmental effects of offspring (for 
references, see Tables 2-12 and 2-13 and text below).   
 
In laboratory animals orally exposed to DDT or metabolites, tremors, convulsions, or myoclonus (abrupt, 
repeated involuntary contractions of skeletal muscles) and increases in brain biogenic amine and 
neurotransmitter levels have been observed at acute doses ≥50 mg DDT/kg/day (see text below for 
references).  Acute oral administration of DDT and related compounds in utero or to neonates during 
sensitive periods of neurodevelopment also has been associated with behavioral and neurochemical 
changes in mice (see Section 2.17 for references and more details).   
 
Tremors, hyperactivity, or hunched appearance have been observed in mature laboratory animals after 
intermediate- or chronic-duration oral exposure to p,p’-DDT, technical DDT, or p,p’-DDE at 
intermediate-duration doses as low as 27 mg p,p’-DDE/kg/day and chronic-duration doses as low as 
6.9 mg p,p’-DDT/kg/day, but these signs of neurological dysfunction were not observed in laboratory rats 
or mice exposed chronically to doses as high as 231 mg technical DDD/kg/day (see text below for 
references).  
 
Evidence for Neurological Effects in Controlled-Exposure Human Studies.  The nervous system 
appears to be one of the primary target systems for DDT toxicity in humans after acute, high exposures.  
Several investigators conducted experimental studies on humans in the 1940s and 1950s at controlled 
high doses that produced neurological effects (e.g., Hayes et al. 1956; Velbinger 1947a, 1947b).  Other 
data come from accidental poisonings where dose levels were crudely estimated.  Persons exposed to 
6 mg DDT/kg administered orally by capsule generally exhibited no illness, but perspiration, headache, 
and nausea were reported (Hayes 1982), and convulsions were reported at doses of 16 mg DDT/kg or 
higher (Hsieh 1954).  In a controlled exposure study with volunteers given single oral doses of DDT 
suspended in oil, reported symptoms included prickly sensation of the mouth at 250 or 500 mg; uncertain 
gait, malaise, cold moist skin, and hypersensitivity to dermal contact within 6 hours of dosing with 750 or 
1,000 mg; and prickly tongue, mouth, and nose, dizziness, confusion, tremors, headache, fatigue, and 
vomiting within 10 hours of dosing with 1,500 mg (about 22 mg/kg) (Velbinger 1947a, 1947b).  
Symptoms disappeared within 24 hours of dosing.  Similar symptoms were reported in persons after 
accidental or intentional ingestion of DDT (Francone et al. 1952; Garrett 1947; Hsieh 1954; Mulhens 
1946).  No neurological effects were noted in 51 volunteers who ingested 3.5 or 35 mg DDT/day (0.05–
0.063 or 0.36–0.5 mg/kg/day) for 12–18 months (Hayes et al. 1956).  The subjects displayed no loss of  
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Table 2-12.  Summary of Neurological Perturbations in Adult or Adolescent Humans with DDT Exposure 
Biometricsa 
 
Reference and study population DDT exposure metricb Outcome evaluated Resultsc 
Kim et al. 2015a  
Consenting elders (n=644), aged 60–
85 years, participants in 1999–2002 
NHANES 
Serum levels of DDE and DDT 
Quartile medians 
  (ng/g lipid) (ng/g serum) 
 DDE DDT DDE DDT 
Q1 280 <LOD 1.73 <LOD 
Q2 663 – 4.42 – 
Q3 1,290 12.9 8.28 0.09 
Q4 2,660 36.3 18.3  0.23 
Low DSST scores 
(<25th percentile) 
Adjusted ORs for Q2–Q4 versus Q1 
 (ng/g lipid) (ng/g serum) 
 DDE DDT  DDE DDT 
Q2 NS NS NS NS 
Q3 NS NS NS NS 
Q4 1.8*↑ 3.3*↑ 2.3*↑ 2.5*↑ 
p-trend 0.02* <0.01* <0.01* <0.01* 
(increased association with low DSST) 
Kim et al. 2015b 
Consenting elders (n=644), aged 60–
85 years 
 
Age quintiles:  
Q1: (60–63 years) (n=134)  
Q2: (64–67 years) (n=121) 
Q3: (68–72 years) (n=124)  
Q4: (73–39 years) (n=128) 
Q5: (80–85 years) (n=137) 
Serum levels of DDE and DDT 
Tertile medians (ng/g lipid) 
 DDE  DDT 
T1 324.5  5.7 
T2  940.5   9.4 
T3 2,200.0  25.6 
 
 Low DSST scores 
(<25th percentile) 
Adjusted ORs for risk of low DSST with 
Q2–Q5 versus Q1 at (T1+T2) and T3 
exposure levels 
 DDE  DDT  
 (T1+T2) (T3) (T1+T2  (T3) 
Age Q2 NS NS NS NS 
Age Q3 NS NS NS NS 
Age Q4 NS NS NS NS  
Age Q5 4.7*↑ 2.7 4.2*↑ 3.1 
p-trend <0.01 0.20 <0.01   0.25 
Kim et al. 2015c  
Consenting elders (n=644), aged 60–
85 years, participants in 1999–2002 
NHANES 
Serum levels of DDE and DDT 
Tertile medians (ng/g lipid) 
 DDE   DDT 
T1 324.5   5.7 
T2 940.5  9.4 
T3  2,200.0  25.6 
 
Low DSST scores 
(<25th percentile) 
Adjusted ORs (95% CI) for low DSST 
scores, hypertensive versus non-
hypertensive (referents), across DDE 
or DDT tertiles. 
 DDE  DDT 
T1 0.8 (0.4–1.9) 1.6 (0.7–3.9)  
T2 2.1 (0.5–5.1) 1.2 (0.5–3.0) 
T3 2.8 (1.2–6.5)* 2.5 (1.1–5.5)* 
 
Lee et al. 2016a, 2016b 
Consenting adults (n=989) aged 70 
years 
Prospective follow-up at ages 75 and 
80 years 
Serum levels of DDE tertiles 
 ng/g lipid ng/g serum 
T1 <162  <1.0 
T2 162–551 1.0–3.5 
T3 >551  >3.5 
Risk of cognitive 
impairment diagnosis 
ranging from mild to 
overt Alzheimer’s 
disease 
Adjusted HRs for cognitive impairment, 
T2–T3 versus T1 DDE 
 ng/g lipid ng/g serum 
T2 NS  NS 
T3 NS  NS 
p-trend NS  NS  
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Table 2-12.  Summary of Neurological Perturbations in Adult or Adolescent Humans with DDT Exposure 
Biometricsa 
 
Reference and study population DDT exposure metricb Outcome evaluated Resultsc 
Medehouenou et al. 2014 
Consenting adults (n=2,023) 
 
Dementia cases (n=574) 
Alzheimer’s disease (AD) cases (n=399) 
Control (normal) cases (n=1,449) 
Serum levels of DDE and DDT Median 
(IQR) (ng/mL) 
  DDE DDT 
Dementia 4.40 0.06 
AD  4.70 0.07  
Control   3.90  0.07  
Dementia, Alzheimer’s 
disease (AD) 
Adjusted ORs for diagnosis per 1-unit 
increase in log-DDT 
   DDE DDT 
Dementia  NS 0.82 
Alzheimer’s disease NS NS 
 
Richardson et al. 2014 
Consenting adults (n=165) 
Alzheimer’s disease cases (n=86) 
Control (normal) cases (n=79) 
Serum levels of DDE 
Tertiles (ng/g cholesterol) 
T1: 90–260 
T2: 270–1,640 
T3: 1,660–18,750 
Alzheimer’s diagnosis 
and MMSE score 
Adjusted OR or beta for T2–-T3 DDE 
versus T1 
  T2 T3 
Alzheimer’s  
disease (OR) 0.54 3.40*↑ 
MMSE (β) –  -0.84*↓  
 
Steenland et al. 2014 
Consenting adults (n=89) 
Serum levels of DDE and DDT 
Quartiles (ng/mL) 
 DDE   DDT 
Q1 <0.27  <0.09 
Q2  ≥0.27–0.69 ≥0.09–0.13 
Q3 >0.69–1.26 >0.13–0.17 
Q4 >1.26  >0.17 
MMSE score and 
tremor-at-rest 
Adjusted ORs for tremor-at-rest and 
betas for change in MMSE score, Q2–
Q4 versus Q1  
DDE and DDT 
 MMSE Tremor-at-rest 
Q2 NS  NS 
Q3 NS NS 
Q4 NS NS 
p-trend NS NS 
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Table 2-12.  Summary of Neurological Perturbations in Adult or Adolescent Humans with DDT Exposure 
Biometricsa 
 
Reference and study population DDT exposure metricb Outcome evaluated Resultsc 
Weisskopf et al. 2010 
Consenting adults (n=171) 
Parkinson’s disease cases (n=101) 
Matched controls (normal) (n=349) 
Serum levels of DDE and DDT 
Geometric mean (IQR) (ng/g lipid) 
DDE: 1,087 (787–1,676) 
DDT: 257.9 (191.8–359.4) 
 
Parkinson’s disease Adjusted OR’s for Parkinson’s disease 
per IQR increase in exposure 
   DDE DDT 
Confirmed cases NS NS 
Confirmed cases NS NS 
(nonsmoker)  
All cases  NS NS 
(nonsmoker) 
 
Adjusted ORs per IQR increase in 
exposure in subjects over at 66 years 
were similarly NS 
Child/adolescent exposure 
Lee et al. 2007a 
Children (n=278) aged 12–15 years 
Participating in the United States 
1999–2000 NHANES 
Learning disability cases (n=44) 
Attention deficit disorder cases (n=26) 
Serum DDT  
Median (IQR) (ng/g lipid) 
<50th: 75.3 (49.0–98.4)  
≥50th: 278 (186–528) 
 
Learning disabilities, 
attention deficit disorder 
Adjusted ORs for disorder in group 
with DDT above the (≥50th) versus 
below (<50th) median 
Learning disabilities: NS  
Attention deficit disorder: NS 
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Table 2-12.  Summary of Neurological Perturbations in Adult or Adolescent Humans with DDT Exposure 
Biometricsa 
 
Reference and study population DDT exposure metricb Outcome evaluated Resultsc 
Rocha-Amador et al. 2009 
Children with parental consent (n=73); 
ages 6–11 years living in a region in 
which DDT was used for malaria 
control 
Serum levels of DDE and DDT 
Geometric mean±SD (ng/mL) 
DDE: 57.3±6.6 
DDT: 5.5±6.4 
 
Rey-Osterrieth 
Complex Figure Test: 
copy and immediate 
recall scores 
Adjusted partial correlation coefficient 
(r) 
  DDE DDT  
Copy NS NS 
Immediate recall -0.25*↓ NS 
 
aSee Table 6 in the Supporting Document for Epidemiological Studies for DDT, DDE, and DDD for more detailed descriptions of studies.  Studies in this table 
were selected from those described in Table 6, because they: (1) measured DDT-related metrics in biological fluids or tissues in each subject, and (2) evaluated 
associations using linear regression, logistical regression, or correlation techniques, adjusting for possible confounding factors. 
bDDE = p,p’-DDE, unless otherwise specified; DDT = p,p’-DDT, unless otherwise specified. 
cBold text, “significant” and asterisk indicate statistically significant (p<0.05).  Arrows indicate an increase or decrease in the neurological endpoint or direction of 
p-trend.  Adjusted OR, adjusted β, adjusted HR, or adjusted partial correlation coefficient indicates adjustment for standard confounding variables for neurological 
outcomes, such as age, sex, serum lipids, smoking, alcohol consumption, weight loss, BMI, ethnicity, poverty, heart disease, hypertension, diabetes, and region 
of study.  
 
BMI = body mass index; CI = confidence interval; DSST = Digit Symbol Substitution Test (to assess cognitive function); HR = hazard ratio; IQR = interquartile 
range; LOD = limit of detection; MMSE = Mini Mental Status Exam (used to measure cognitive impairment); NHANES = National Health and Nutrition Examination 
Survey; NS = not statistically significant; OR = odds ratio; PIVUS = Prospective Investigation of the Vasculature in Uppsala Seniors; Q = quartile or quintile; 
SD = standard deviation; T = tertile 
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Table 2-13.  Summary of Studies of Associations between Maternal Serum, Cord Blood, Breast Milk, or Placental 
DDT Exposure Biometrics and Neurological Outcomes in Offspringa 
 
Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Early Development Assessments Such as Bayley Scales of Infant Development (BSID), the Brazleton Neonatal Behavior Assessment 
Scale (BNBAS), Mullen Scales of Early Learning (MSEL) or MacArthur Bates Communicative Development Index (CDI)  
Bahena-Medina et 
al. 2011 
Consenting maternal-
infant pairs (n=265) 
 
BSID at ~1 month 
Maternal serum DDE. Geometric Mean 
(ng/mL) 
1st trimester: 6.33 
2nd trimester: NR 
3rd trimester: 7.27 
 
NSS, AR, PDI, and 
MDI 
Adjusted betas or ORs per doubling of DDE  
 (ORs)  (betas) 
 AR NSS PDI MDI 
1st NS NS NS NS 
2nd NS NS NS NS 
3rd NS NS NS NS 
Eskenazi et al. 2006 
Consenting mother-
infant pairs (n=360) 
 
BSID assessed at 6 
(n=330), 12 (n=327), 
and 24 (n=309) 
months 
 
 
Maternal serum DDE, DDT, and o,p’-DDT 
Geometric mean (ng/g lipid) 
p,p’-DDE: 1,436  
p,p’-DDT: 22.0 
o,p’-DDT: 1.8  
 
MDI, PDI Adjusted betas for change in index per 1 log-unit 
increase in DDE metric 
  6 months 12 months 24 months 
PDI 
p,p’-DDT -1.73*↓ -2.33*↓  NS 
o,p’-DDT NS NS  NS 
p,p’-DDE -2.14*↓ NS  NS 
 
MDI 
p,p’-DDT NS -1.71*↓  -2.12*↓ 
o,p’-DDT NS -2.56*  -3.06*↓  
p,p’-DDE NS NS   NS  
 Forns et al. 2012b 
Consenting mother-
child cohort 
(n=1,391) 
 
BSID at 14 months 
Maternal serum DDE and DDT  Median 
(25th–75th percentile), ng/g lipid  
 
DDE: 119.06 (74.44–200.26) 
DDT: 6.21 (5.46–7.28) 
MDI, PDI Adjusted betas for change per 1-log unit increase in 
DDE or for DDE levels >120.42 ng/g lipid versus 
<120.42 ng/g lipid 
 Unit increase >120.42 ng/g lipid 
MDI NS  – 
PDI –  NS 
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Table 2-13.  Summary of Studies of Associations between Maternal Serum, Cord Blood, Breast Milk, or Placental 
DDT Exposure Biometrics and Neurological Outcomes in Offspringa 
 
Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Gascon et al. 2013 
Consenting mother-
infant pairs (n=1,175) 
 
BSID assessed at 
14 months 
 
 
Maternal serum DDE and postnatal 
estimates of exposure/3-month increments  
Postnatal estimates (ng/g lipid)  
 GM Median  
1st 3 months 199.17 199.79 
2nd 3 months 199.11 230.94 
3rd 3-months 177.86 213.51 
4th 3 months  159.28 192.61  
MDI and PDI  Adjusted betas for change per DDE levels >median 
versus <median   
  MDI  PDI 
1st 3 months NS NS 
2nd 3 months NS NS  
3rd 3-months NS NS 
4th 3 months NS NS 
Gladen et al. 1988 
Consenting mother-
child pairs (n=302) 
 
BSID assessed at 
6 and 12 months 
 
 
Maternal breast milk DDE exposure 
categories (ng/g lipid)  
a. 0–0.9 
b. 1–1.9  
c. 2–2.9  
d. 3–3.9  
e. 4–4.9  
f. 5–5.9  
g. 6+ 
 
Similar categories for transplacental 
exposure based on cord blood, placenta and 
maternal serum samples  
MDI and PDI at 
6 and 12 months 
Adjusted betas for change per ng/g lipid DDE  
Transplacental  6 months 12 months  
MDI   0.65*↑  NS 
PDI   NS   NS 
Milk 
MDI   NS  NS 
PDI   NS  NS 
Hoyer et al. 2015 
Consenting mother-
child cohort (n=1,103) 
Ukraine (n=492) 
Poland (n=520) 
Greenland (n=91) 
 
Assessment of early 
development 
milestones assessed 
by parental recall 
Maternal serum DDE 
Tertiles (ng/g lipid) 
 Greenland Ukraine  Poland  
T1 5–209 147–488 88–303 
T2 209–445 488–791 303–471 
T3 445–3,122 791–4,834 471–1,750 
Crawl, stand-up, 
walking, 
developmental 
coordination 
disorder score 
Adjusted betas for mean change (month) per 1 log-
unit increase in DDE, or for T2 and T3 versus T1 in 
each cohort 
 
Adjusted betas were NS for all study groups 
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Table 2-13.  Summary of Studies of Associations between Maternal Serum, Cord Blood, Breast Milk, or Placental 
DDT Exposure Biometrics and Neurological Outcomes in Offspringa 
 
Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Jusko et al. 2012 
Consenting mother-
infant pairs (n=1,100) 
 
BSID assessed at 
8 months, cognitive 
development (IQ) 
assessed at 7 years 
Maternal serum DDE and DDT  
(ng/mL)  
 DDE  DDT 
Q1 <15  <5 
Q2 15–29.9  5.0–9.9 
Q3 30–44.9 10–14.9 
Q4 45–59.9 15–19.9 
Q5 >60  >20 
MDI, PDI (at 8 
months), and IQ (at 
7 years) 
Adjusted betas (95% CI) for change in score per 
5 ng/mL increase in DDT, 15 ng/mL increase in DDE, 
or for Q2–Q5 versus Q1  
  DDT (5 ng/mL) DDE (15 ng/mL)  
MDI NS  NS 
PDI  NS  NS 
IQ NS  NS 
 
Q2–Q5 versus Q1 betas were all NS 
Pan et al. 2009 
Consenting mother-
infant pairs (n=456) 
 
MSEL and CDI 
assessed at 
12 months 
Breast milk and lactational exposure metric 
(LEM) estimates of DDE and DDT to 1 year 
Median (ng/g lipid)  
   DDE DDT 
Milk   121 5  
(ng/g lipid-month) DDE DDT 
LEM   871 33  
 
Below average 
Mullen Scales in: 
receptive language, 
expressive 
language, visual 
reception, fine 
motor, and gross 
motor early learning 
composite, and CDI 
Adjusted ORs for below average scale per 2-fold 
increase in DDT metrics LEMs 
  DDE DDT  
Fine motor NS 1.4*↑ 
Gross motor 
(all)  NS NS 
(boys) 1.9*↑ – 
(girls) NS – 
Associations for all other outcomes were NS; adjusted 
betas for each outcome were similarly NS 
Ribas-Fito et al. 
2003 
Consenting mother-
infant pairs (n=92) 
 
BSID evaluated at 
13 months of age 
 
Cord blood levels of DDE  
Median: 0.85 (ng/mL) 
 
Bayley scales (MDI 
and PDI) and Griffith 
Scales (locomotor, 
social, hearing and 
language, eye-hand 
coordination, 
performance) 
Adjusted betas for changes per doubling of DDE 
MDI: -3.44*↓ 
PDI: -3.83*↓ 
Locomotor: -4.02*↓ 
Social: -4.66*↓ 
Hearing and language: NS 
eye-hand coordination: NS 
Performance: -2.78*↓ 
DDT, DDE, and DDD  133 
 
2.  HEALTH EFFECTS 
 
 
 
 
 
 
***DRAFT FOR PUBLIC COMMENT*** 
Table 2-13.  Summary of Studies of Associations between Maternal Serum, Cord Blood, Breast Milk, or Placental 
DDT Exposure Biometrics and Neurological Outcomes in Offspringa 
 
Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Rogan and Gladen 
1991 
Consenting mother-
child pairs (n=678) 
 
BSID assessed at 
18 and 24 months 
 
 
Estimated transplacental DDE Exposure 
categories (ng/g lipid) 
1) 0–0.9 4) 3–3.9  
2) 1–1.9 5) 4–4.9  
3) 2–2.9 6) 5–5.9 
  7) 6+  
Similar exposure categories for breast milk 
DDE 
MDI and PDI at 
18 and 24 months 
Adjusted betas for PDI change per DDE 
transplacental exposure categories 2–7 versus 1 
  18 months  24 months 
2–7 versus 1 all NS  all NS 
 
Associations with MDI were also NS 
 
Associations of breast milk DDE with MDI and PDI 
were also NS 
Torres-Sanchez et 
al. 2007 
Consenting mother-
infant pairs (n=244) 
 
BSID assessments at 
1, 3, 6, and 
12 months of age 
Pre-pregnancy and trimester serum DDE 
Geometric mean (GSD) (ng/mL) 
Pre-pregnancy: 6.8 (2.8) 
1st trimester: 6.4 (2.8) 
2nd trimester: 6.8 (2.9) 
3rd trimester: 7.8 (2.8) 
PDI and MDI during 
first year of life 
Adjusted betas for change in score in 1st year per 
doubling of DDE 
   PDI  MDI 
1st trimester -0.52*↓  NS 
2nd trimester NS  NS 
3rd trimester NS   NS 
 
Torres-Sanchez et 
al. 2009 
Consenting mother-
child pairs (n=270) 
 
BSID assessments at 
12, 18, 24, and 
30 months of age 
Trimester levels of DDE and DDT. 
Geometric mean (ng/mL) 
  1st 2nd  3rd 
DDE  6.3 6.5 7.9 
DDT  0.008 0.006 0.006 
DDT/DDE 0.003 0.002 0.002 
MDI and PDI 
between 12 and 
30 months of age 
Adjusted betas for change in score after 1st year per 
2-fold increase in DDE  
  PDI MDI 
1st trimester NS NS 
2nd trimester NS  NS 
3rd trimester  NS NS 
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Table 2-13.  Summary of Studies of Associations between Maternal Serum, Cord Blood, Breast Milk, or Placental 
DDT Exposure Biometrics and Neurological Outcomes in Offspringa 
 
Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Engel et al. 2007 
Consenting mother-
infant pairs (n=151) 
 
BNBAS assessments 
before hospital 
discharge 
 
Maternal serum levels of DDE  
Median (IQR), ng/L: 0.6 (0.4–1.3) 
Habituation, 
orientation, motor, 
range of state, 
regulation of state, 
autonomic stability, 
risk for abnormal 
reflexes 
Adjusted betas per exposure level 
Habituation: NS 
Orientation: NS 
Motor: NS 
Range of state: NS 
Regulation of state: NS 
Autonomic stability: NS 
Adjusted RR for abnormal reflexes = NS 
Fenster et al. 2007 
Consenting mother-
infant pairs (n=303) 
 
BNBAS assessments 
at ≤2 months of age  
Maternal serum DDE, DDT, and o,p’-DDT 
Geometric mean (ng/g lipid) 
p,p’-DDE: 1,464  
p,p’-DDT: 23.2 
o,p’-DDT: 1.8  
Habituation, 
orientation, motor, 
range of state, 
regulation of state, 
autonomic stability, 
reflex  
Adjusted betas for score change per 10-fold increase 
in DDT metrics 
 
No significant associations were observed with any of 
the BNBAS outcomes 
Sagiv et al. 2008 
Consenting mother, 
infant pairs (n=542) 
 
BNBAS assessed in 
408 infants at 1–
3 days following birth 
and at ~2 weeks of 
age  
Cord blood DDE 
Mean±SD (range) (ng/g serum): 
0.48±0.85 (0–10.27) 
Quartile exposure levels not reported 
Alertness, quality of 
alertness, cost of 
attention, 
consolability, self-
quieting, hand-to-
mouth, irritability, 
never in state for 
orientation items, 
elicited activity, 
spontaneous 
activity, motor 
maturity 
Adjusted p-for-trend for Q2–Q4 DDE versus Q1 
(coefficients displayed graphically) 
Irritability: 0.03*↑ 
Never in state for orientation items: 0.04*↑ 
 
All other associations were NS 
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Table 2-13.  Summary of Studies of Associations between Maternal Serum, Cord Blood, Breast Milk, or Placental 
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Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Stewart et al. 2000 
Consenting mother-
child pairs (n=293) 
Fish-eating cases 
(n=141) 
Control (non-fish-
eating cases (n=152) 
 
BNBAS assessments 
at 12–24, and 25–
48 hours after birth  
Cord blood DDE 
Exposure values (percentiles) (ng/g wet)  
25th: 0.06 
50th: 0.10 
75th: 0.18 
Habituation, 
autonomic, reflexes, 
percent poor NBAS 
scores 
Adjusted betas for change in score per unit increase 
in DDE 
Habituation: NS 
Autonomic: NS 
Reflexes: NS 
% poor NBAS scores: NS 
Behavioral problems, Attention and ADHD 
Strom et al. 2014 
Consenting mother-
offspring pairs 
(n=872) 
 
22-year prospective 
follow-up: 
ADHD cases (n=27)  
Depression cases 
(n=104) 
Scholastic 
achievement below 
median cases 
(n=383) determined 
by standardized 
written examinations 
in 9th grade 
Maternal serum DDE.  
Median (IQR) (ng/mL) 
Total: 2.5(2.2) 
ADHD cases: 2.9(2.3) 
Depression cases: 2.6(2.5) 
Scholastic achievement: 2.4 (2.1) 
 
Tertiles 
T1: 0.20–1.86  
T2: >1.86–3.24 
T3: >3.24–38.77 
ADHD, depression, 
scholastic 
achievement below 
median 
Adjusted HRs for conditions, T2 and T3 DDE versus 
T1  
  T2 T3 p-trend  
ADHD   NS NS NS 
Depression NS NS NS 
 
Adjusted betas per ng/mL difference in DDE and for 
T3 versus T1 
  ng/mL difference T3 versus T1 
Scholastic  
achievement NS   NS 
<median 
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Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Forns et al. 2012a 
Consenting mother-
child pairs (n=393) 
 
Child attention 
function evaluated at 
11 years using the 
CPT-II 
Cord blood and child serum (4 years) DDE 
Percentiles (ng/mL) 
  50th  25th–75th  
Cord blood 1.08 0.56–1.85 
Serum  0.85 0.46–1.81 
tHRT (speed of 
correct response), 
errors of omission or 
commission 
Adjusted beta (95% CI) for change per 1 log-unit 
increase in DDE levels at 4 years 
tHRT: 0.051 (0.014–0.088)*↓ (indicates delayed 
response) 
Significance lost with further adjustment for serum 
PCBs and breastfeeding. 
 
Adjusted IRRs for errors of omission or commission 
per log-unit increase in DDE were NS 
Forns et al. 2016 
Consenting mother-
infant pairs (n=522) 
 
Children evaluated 
for behavioral 
problems at 12 and 
24 months using the 
ITSC 
Breast milk levels of DDE and DDT 
Mean (SD), ng/g lipid 
DDE: 62.93 (51.09) 
DDT: 2.55 (2.43) 
 
Behavioral problems Adjusted betas (95% CI) for behavioral problem score 
at 12 months per IQR increase in DDT 
Behavioral problems 
12 months: 0.62 (0.45–0.79)*↑ 
12 months: 0.35 (0.08–0.63)*↑ (with additional 
adjustments for other analytes) 
24 months: NS 
Sagiv et al. 2010 
Consenting mother-
child pairs (n=573) 
 
ADHD measured in 
children aged 7–
11 years using 
Connors’ Rating 
Scale for Teachers  
Cord blood DDE 
Mean (SD) (ng/g serum): 0.50 (1.04) 
Quartile levels not provided 
 
Conners’ ADHD 
index, DSM-IV 
inattentive, 
hyperactive impulse, 
DSM-IV-total 
Adjusted betas for log change with P95 versus P5 
DDE  
ADHD: NS  
Inattentive: NS  
Hyper-impulse: 0.02*↑  
DSM-IV Total: 0.01*↑ 
 
Adjusted Risk Ratios for atypical score Q4 DDE 
versus Q1 
Conners’ ADHD index: 1.80*↑   
DSM-IV inattentive: NS  
DSM-IV hyperactive-impulse: NS 
DSM-IV total: 1.69*↑  
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Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Sioen et al. 2013 
Consenting mother-
child pairs (n=270); 
130 males, 140 
females 
 
Child behavioral 
problems assessed 
at 7–8 years of age; 
SDQ completed by 
parents 
Cord blood DDE 
Median (25th, 75th percentile), ng/g fat 
All: 124.0 (67.2, 218.5) 
Boys: 128.0 (67.6, 226.0) 
Girls: 118.0 (66.7, 205.9) 
Emotional 
symptoms, conduct 
problems, 
hyperactivity, total 
difficulties 
Adjusted ORs for abnormal SDQ score per log-1 unit 
increase in DDE or for T3 versus T1 stratified by 
gender 
    All  Girls (T3 versus T1) 
Emotional symptoms  NS  NR  
Conduct problems NS  NR 
Hyperactivity  NS  NR  
Total difficulties  3.061*↑  9.959*↑ 
McCarthy Scales of Children’s Abilities (MSCA), MacArthur Bates Communicative Development Inventories (CDI), Wide Range 
Assessment of Memory and Learning (WRAML), or Wechsler Intelligence Scale for Children (WISC) 
Gladen and Rogan 
1991 
Consenting mother-
child pairs (n=370) 
 
MSCA assessment at 
3, 4, and 5 years 
7 DDE transplacental exposure categories 
(ng/g lipid) ranging from 0–0.9 to >6.0 
 
5 DDE postnatal exposure categories (mg) 
ranging from 0–3 to >17 
 
MSCA at 3, 4, and 5 
years 
Adjusted mean quantitative McCarthy scores: NS 
across transplacental DDE exposure categories 
 
Adjusted mean McCarthy scores at 4 years: NS 
across postnatal DDE exposure categories 
 
 Kyriklaki et al. 2016 
Consenting mother-
child cohort (n=689) 
 
MSCA assessments at 
4 years  
 
Maternal serum DDE 
Mean±SD (ng/mL) = 2.948±3.071 
Neurodevelopment 
outcomes: verbal, 
perceptual, 
quantitative, 
cognitive, memory, 
motor scale, and 
subscales: 
executive function, 
working memory, 
memory span, and 
functions of 
posterior cortex 
Adjusted betas (95% CI) for change in score, DDE 
≥90th percentile versus ≤90th percentile 
 
All adjusted betas were NS 
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Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Orenstein et al. 
2014 
Consenting mother-
child pairs (n=393) 
 
Memory and learning 
assessed at 8 years 
using WRAML 
Cord blood DDE 
Mean±SD (ng/g serum): 0.5±01.1 
 
Visual memory, 
verbal memory, 
learning indices  
Adjusted betas (95% CI) for a change in score per 
1-unit increase in DDE  
Visual memory: NS 
Verbal memory: NS  
Learning: NS 
Osorio-Valencia et 
al. 2015 
Consenting mother-
child pairs (n=167) 
 
MSCA assessments at 
5 years only for 
laterality and spatial 
orientation endpoints  
Maternal trimester serum DDE 
Percentiles (ng/g lipid) 
 1st  2nd  3rd  
10th  260.8  152.7 149.0 
50th  1,331.1  1,138.1 826.3 
90th  4,253.9  2,983.4 2,767.6 
Laterality and 
spatial orientation 
 
Adjusted OR and beta (95% CI) per 2-fold increase in 
DDE (2nd trimester) 
Laterality (OR): NS 
Spatial orientation (β): NS 
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Ribas-Fito et al. 
2006 
Consenting mother-
child pairs (n=445)  
Ribera d’Ebre cohort 
(n=40) 
Menorca cohort 
(n=405) 
 
MSCA assessed at 
4 years 
Cord blood DDE 
Median (ng/mL) 
  Ribera d’Ebre Menorca 
DDT  0.05  0.08 
DDE  0.86  1.03 
DDT/DDE 0.04  0.09 
 
DDT quartiles (ng/mL) 
Q1: ≤0.05  
Q2: >0.05–0.10 
Q3: >0.10–0.20 
Q4: >0.20 
General cognitive, 
memory, verbal, 
executive function, 
memory span, 
verbal memory 
Adjusted betas per doubling of DDE 
 DDT DDE DDT/DDE 
General cognitive -1.99*↓ NS NS 
Memory -3.79*↓ -1.93*↓ -2.67*↓ 
Verbal -2.63*↓ NS -0.98*↓ 
Executive function -2.61*↓ NS NS 
Memory span -2.82*↓ NS NS 
Verbal memory -6.10*↓ NS -4.64*↓ 
 
Adjusted betas for Q4 DDT versus Q1 
 All  Boys Girls  
General cognitive -5.87*↓ NS -8.89*↓ 
Verbal -7.86*↓ NS -12.79*↓ 
Memory -10.56*↓ NS -17.19*↓ 
 
No significant associations with Q2 and Q3 exposure 
levels 
 
Further adjustments for cord blood HCB or PCBs did 
not change significance 
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Reference and study 
population DDT exposure metricb 
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evaluated Resultsc 
Ribas-Fito et al. 
2007 
Consenting mother-
infant pairs (n=391) 
 
MSCA assessed at 
4 years 
 
Companion study to 
Ribas-Fito et al. 2006 
 
Cord blood levels of DDT  
Median (ng/mL) according to breastfeeding  
Duration (weeks) DDT DDE 
<2 (reference)  0.07 0.94 
2–20 (short-term) 0.07 1.07 
>20 (long-term)  0.06 1.01 
 
DDT exposure groups (ng/mL) 
Low (<0.05)  
Medium (0.05–0.20) 
High (>0.20) 
 
GCS, verbal scale, 
memory scale 
Adjusted betas for change in neurodevelopmental 
scales per low, medium, and high DDT exposure 
levels in different breastfeeding groups 
  DDT exposure 
GCS   Low Medium High 
2–20 weeks NS NS  NS 
>20 weeks NS NS  13.04*↑ 
Verbal scale 
2–20 weeks NS NS  NS  
>20 weeks NS NS   NS  
Memory scale 
2–20 weeks NS NS  NS  
>20 weeks NS NS  NS  
 
Results may indicate a positive effect of breastfeeding 
on infant neurodevelopment 
Torres-Sanchez et 
al. 2013  
Consenting mother-
child pairs (n=203) 
 
MSCA assessed at 
42, 48, 54, and 
60 months 
Trimester levels of DDE and DDT 
Median (ng/mL) 
   1st 2nd 3rd  
DDE  7.65 8.22 8.95  
DDT  0.0045 0.0045 0.0045 
DDT/DDE 0.001 0.001 0.001 
 
 
General cognitive 
index perceptual 
performance, 
quantitative, verbal, 
memory, and motor 
Adjusted betas for change in score per doubling of 
DDE 
   3rd trimester Average 
    (n=84)  DDE 
General cognitive index -2.01*↓  NS 
Perceptual performance  NS  NS 
Quantitative  -2.06*↓  -1.78*↓ 
Verbal    -1.14*↓  NS 
Memory  -1.26*↓  NS 
Motor   NS  NS 
 
Association with 1st and 2nd trimester exposure levels 
were NS 
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evaluated Resultsc 
Gaspar et al. 2015a, 
2015b 
Consenting mother-
child pairs (n=619) 
 
WISC assessment at 
ages 7 (n=316) and 
10.5 years (n=595)  
Maternal serum DDE and DDE 
Geometric mean (ng/g lipid) 
DDT: 21.4  
DDE: 606.4 
Working memory, 
perceptual 
reasoning, verbal 
comprehension, 
processing speed, 
full-scale IQ  
Adjusted betas for change per 10-fold increase in 
DDT metrics at 7 years 
  (ALL)  (Boys) (Girls) 
  DDT DDE DDE DDE 
Working  
memory NS NS 2.9*↑ NS 
Perceptual  
reasoning NS NS NS NS 
Verbal  
comprehension NS NS NS -3.1*↓ 
Processing  
speed  -2.4*↓ NS NS -4.2*↓ 
Full-scale IQ NS NS  NS -4.4*↓ 
 
All betas at 10.5 years and 7 and 10.5 years, 
analyzed together were NS, except for deficits in 
processing speed in girls 
Lyall et al. 2016 
Consenting mother-
infant pairs (n=1,144) 
 
Autism spectrum 
disorder cases 
(n=545); intellectual 
disability cases 
(n=181); control 
(general population) 
(n=418) 
Maternal serum DDE (ng/g lipid)  
Q1: <121.7 
Q2: 121.7–212.5 
Q3: 212.5–<505.4 
Q4: ≥505.4 
Autism spectrum 
disorder and 
intellectual disability  
Adjusted ORs (95% CI) for Q2–Q4, versus Q1 
 Autism spectrum Intellectual  
 disorder  disability 
Q2 NS   NS 
Q3 NS    1.89*↑ 
Q4 NS   NS 
p-trend = 0.57 
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Sagiv et al. 2012 
Consenting mother-
child pairs (n=584); 
254 females, 
258 males 
 
CPT and WISC 
assessed at 8 years  
Cord serum DDE 
Mean±SD (ng/g) = 0.50±1.03; IQR=0.27 
Reaction time, 
reaction time 
variability, errors of 
commission (rate 
ratio), error of 
omission, 
processing speed, 
and freedom from 
distractibility 
Adjusted betas per IQR change in DDE 
   All Girls Boys 
Reaction time   NS NS NS 
Reaction time variability NS NS NS 
Errors of commission NS NS NS 
Error of omission NS NS NS 
Processing speed NS NS NS 
Freedom from 
distractibility  NS NS NS 
 
A significant sex interaction (p<0.05) was observed 
for reaction time and errors of omission 
Other 
Cartier et al. 2014 
Children with parental 
consent (n=150) 
Child serum collected 
at 5 and 11 years of 
age 
 
VEP evaluation at 
~11 years of age 
Cord blood and child serum DDE and DDT.  
Geometric mean (ng/g lipids), cord blood 
serum (11 years) 
DDE: 509.27, 268.54 
DDT: 24.45, 6.93 
VEPs: N150 and 
N75 amplitudes, 
and P100 latency 
Adjusted betas per 1 log-unit increase in DDE from 
cord blood or 5-year serum  
N150 for DDE (cord blood): 0.721*↑ 
N75 for DDE (5 years): -1.439*↓  
P100 latency for DDT: NS 
Riva et al. 2004 
Consenting mother-
infant pairs (n=25) 
 
VEP evaluation at 
12 months 
Colostrum and milk levels of DDT and DDE 
measured in each subject, but mean values 
were not reported 
P100 wave latency After controlling for infant’s serum levels of 
polyunsaturated fat, partial correlation coefficients 
with colostrum DDT or DDE levels were NS  
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Ren et al. 2011 
Consenting mother-
infant pairs (n=130) 
 
Neural tube defect 
(NTD) cases 
(n=80 fetuses or 
newborns) 
Healthy matched 
controls 
(n=50 newborns) 
Placental levels of all DDT metrics 
Median (ng/g lipid) 
  Cases Controls 
Σo,p’-DDTs  4.3 2.7  
Σp,p’-DDTs 55 59  
Σall DDTs 60 61  
Anencephaly, spina 
bifida, any NTD 
Adjusted ORs (95% CI) for Σo,p’-DDTs levels above 
median level in control group 
Anencephaly: 9.52 (1.45–62.65)*↑ 
Spina bifida: 8.68 (1.94–38.76)*↑ 
Any NTDs: 5.19 (1.70–15.82)*↑ 
 
Adjusted OR for Q4 versus Q1 Σo,p’-DDTs 
Any NTDs: 5.10 (1.66–15.70)*↑ 
 
Associations with Q2 and Q3 exposure levels were 
NS 
 
aSee Table 7 in the Supporting Document for Epidemiological Studies for DDT, DDE, and DDD for more detailed descriptions of studies.  Studies in this table 
were selected from those described in Table 7, because they: (1) measured DDT-related metrics in biological fluids or tissues in each subject, and (2) evaluated 
associations using linear regression, logistical regression, or correlation techniques, adjusting for possible confounding factors. 
bDDE = p,p’-DDE, unless otherwise specified; DDT = p,p’-DDT, unless otherwise specified.  
cBold text, “significant” and asterisk indicate statistically significant (p<0.05).  Arrows indicate an increase or decrease in the neurological endpoint or direction of 
p-trend.  Arrows “↑ or ↓” indicate direction of change observed for a given outcome (positive or inverse associations, respectively).  Adjusted OR, adjusted beta, or 
adjusted HR indicates adjustment for standard confounding variables for neurological outcomes, such as maternal age, occupation, parity, smoking and alcohol 
during pregnancy, socio-economic status, depression, marital status, breastfeeding, birth weight, sex, type of birth, and age at evaluation.  
 
ADHD = attention deficit hyperactivity disorder; AR = abnormal reflex; BNBAS or NBAS = Brazelton Neonatal Behavioral Assessment Scale (two components for 
evaluating behavior and reflex); BSID = Bayley Scales of Infant Development (for mental and psychomotor development); CDI = MacArthur-Bates 
Communicative-Development Inventories (to measure language comprehension); CI = confidence interval; CPT = Continuous Performance Test; 
CPT-II = Cognitive Performance Test-II; CRS-T = Conners’ Rating Scale for Teachers; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, 
4th edition; GCI = general cognitive index; GM = geometric mean; GCS = General Cognitive Score; GSD = geometric standard deviation; 
HCB = hexachlorobenzene; HR = hazard ratio; HRT = hit reaction time (measures speed of visual processing); IQ = intelligence quotient; IQR = interquartile 
range; IRR = incidence rate ratio; ITSC = infant toddler symptom checklist; LEM = lactational exposure metric; MDI = mental development index; 
MSCA = McCarthy Scales of Children’s Abilities (to assess cognitive and motor development); MSEL = Mullen Scales of Early Learning; NBAS = Neonatal 
Behavioral Assessment Scale; NR = not reported; NS = not statistically significant; NSS = Neurological soft signs; NTD = Neural tube defect; OR = odds ratio; 
PBDE = polybrominated diphenyl; PCB = polychlorinated biphenyl; PDI = psychomotor developmental index; PP = perceptual performance; Q = quartile or 
quintile; RR = relative risk; SD = standard deviation; SDQ = Strengths and Difficulties Questionnaire; T= tertile; VEP = visual evoked potential (to assess visual 
brain function/visual processing); WISC = Wechsler Intelligence Scale for Children; WRAML = Wide Range Assessment of Memory and Learning 
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coordination and there was no indication of tremors.  Other tests (over 20) conducted on the volunteers 
were negative and showed no peripheral neuropathy or central nervous system functional deficits.  
Background DDT levels in food of both controls and test subjects were 0.0021–0.0038 mg DDT/kg/day. 
 
Neurological Adult or Adolescent Epidemiological Studies.  Possible associations between serum levels 
of DDT, DDE, or DDD and deficits in cognitive or mental status tests or risks for neurological conditions, 
such as Alzheimer’s, Parkinson’s disease, or attention deficient disorder have been evaluated in studies 
described in Table 2-12.  The studies provide inconsistent evidence for such associations.  In adults, 
associations were found with low Digit Symbol Substitution Test scores in U.S. adults ages 60–85 years 
participating in the 1999–2002 NHANES (Kim et al. 2015a, 2015b, 2015c) and with increased risk for 
Alzheimer’s disease and decreased Mini Mental Status Exam (MMSE) scores in a U.S. case-control study 
(Richardson et al. 2014), but no significant associations were found between serum biometrics and 
increased risk for cognitive impairment in 70-year-old Swedish adults (Lee et al. 2016a, 2016b); 
increased risk for dementia or Alzheimer’s disease in Canadian adults (Medehouenou et al. 2014); 
decreased MMSE scores or increased risk for at-rest tremors in Costa Rican adults ages >65 years 
(Steenland et al. 2014), or increased risk for Parkinson’s disease in Finnish adults ages 20–70 years 
(Weisskopf et al. 2010).  No significant associations were found between serum DDT or DDE levels and 
increased risks for learning disability or attention deficient disorder in U.S. adolescents ages 12–15 years 
participating in the NHANES (Lee et al. 2007a), but serum levels of DDE were associated with decreased 
scores for a test of visual memory in 6–11-year-olds living in a Mexican region in which DDT was used 
for malaria control (Rocha-Amador et al. 2009). 
 
Neurodevelopmental Epidemiological Studies.  Possible associations between DDT, DDE, or DDD 
levels in maternal serum at birth or during pregnancy, cord blood, placenta tissue, or breast milk with 
adverse neurodevelopmental effects in offspring have been examined in numerous epidemiological 
studies.  To date, these studies (summarized in Table 2-13) provide inconsistent evidence for such 
associations.  Studies in Table 2-13 are presented in four groups of studies evaluating associations with: 
(1) neurobehavioral endpoints in infants ≤2 years of age using the Bayley Scales of Infant Development 
(BSID), the Brazleton Neonatal Behavioral Assessment Scale (BNBAS), Mullen Scales of Early Learning 
(MSEL), or the MacArthur-Bates Communicative Development Inventories (CDI); (2) behavioral 
problems, attention and attention deficit hyperactivity disorder (ADHD) in offspring; (3) neurobehavioral 
endpoints in older children using McCarthy Scales of Children’s Abilities (MSCA), Wide Range 
Assessment of Memory and Learning (WRAML), Wechsler Intelligence Scale for Children (WISC), and 
related methods; and (4) other neurological endpoints in offspring.  The following paragraphs summarize 
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the inconsistency of the evidence relating maternal biometrics for DDT, DDE, or DDD with related 
neurological outcomes in offspring. 
 
Early neurodevelopment epidemiological studies.  Using the BSID, no associations between maternal 
DDT, DDE, or DDD biometrics and adverse early developmental scores in children up to about 30 months 
after birth were found in a North Carolina cohort (Gladen et al. 1988; Rogan and Gladen 1991), a U.S. 
12-center cohort (Jusko et al. 2012), and cohorts from Sabadell, Gipuzkoa, and Valencia Spain (Forns et 
al. 2012b; Gascon et al. 2013), but significant associations with age-dependent BSID deficits were 
reported for cohorts from Ribera d’Ebre and Menorca, Spain (Ribas-Fito et al. 2003); Salinas, California 
(Eskenazi et al. 2006); and Morelos, Mexico (Bahena-Medina et al. 2011; Torres-Sanchez et al. 2007, 
2013).  In another North Carolina birth cohort, significant associations were reported for MSEL motor 
deficits, but not for MSEL language scales or CDI scores, in 12-month-olds in a 2004–2006 North 
Carolina birth cohort (Pan et al. 2009).  No significant associations were reported with time of achieving 
early development milestones (e.g., crawling or walking) in cohorts from Ukraine, Poland, and Greenland 
(Hoyer et al. 2015).  No statistically significant associations with BNBAS deficits for infants <2 weeks of 
age were found in cohorts from New York City (Engel et al. 2007); Oswego, New York (Stewart et al. 
2000); or Salinas, California (Fenster et al. 2007), but significant associations were reported for attention-
related BNBAS deficits in a New Bedford, Massachusetts cohort (Sagiv et al. 2008).   
 
Epidemiological studies of attention, behavioral problems, or ADHD in offspring.  No associations with 
maternal biometrics were reported for prevalences of ADHD or depression in a 22-year follow-up of 
offspring from a Danish cohort (Strom et al. 2014) for scores from a Strength and Difficulties 
Questionnaire (SDQ) or ADHD test in 4-year-old children in a Greek cohort (Kyriklaki et al. 2016), or 
attention function measures in 11-year-olds from a Menorca Spain cohort (Forns et al. 2012a), but 
associations were reported for behavioral problem scores at 12 months, but not at 24 months, in infants 
from a Norwegian cohort (Forns et al. 2016); for Connors’ ADHD Index in children ages 7–11 years in a 
New Bedford Massachusetts cohort (Sagiv et al. 2010); and for SDQ scores for total behavioral 
difficulties in children ages 7–8 years in a Flemish cohort (Sioen et al. 2013).   
 
Epidemiological studies of neurological endpoints in non-infant children.  No associations with maternal 
biometrics were found for MSCA-evaluated deficits in 3–5-year-old children in a North Carolina cohort 
(Gladen and Rogan 1991); MSCA deficits in 4-year-old children in a Greek cohort (Kyriklaki et al. 2016), 
or WRAML deficits in 8-year-olds in a New Bedford, Massachusetts cohort (Orenstein et al. 2014), but 
associations were reported for MSCA cognitive deficits, but not spatial orientation deficits, in 42–
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60-month-old children in a Morelos, Mexico cohort (Osorio-Valencia et al. 2015; Torres-Sanchez et al. 
2013) and MSCA general cognitive and memory deficits in 4-year-old children in cohorts from Ribera 
d’Ebre and Menorca, Spain (Ribas-Fito et al. 2006, 2007).  In intelligence assessments, no associations 
were reported with IQ in 7-year-old children in a U.S. 12-center cohort (Jusko et al. 2012) or 8-year-old 
children in a New Bedford, Massachusetts cohort (Sagiv et al. 2012), but associations were reported with 
IQ deficits at 7 years of age, but not at 10.5 years of age, in children (especially girls) in a Salinas, 
California cohort (Gaspar et al. 2015a, 2015b) and for increased risk for intellectual disability, but not 
autism spectrum disorder, in a 2000–2003 Southern California birth cohort (Lyall et al. 2016). 
 
Epidemiological studies of other neurodevelopmental endpoints in offspring.  Associations between cord 
blood DDE levels and visual evoked potential (VEP) deficits were reported in a group of 150 11-year-old 
children (Cartier et al. 2014), but no significant associations were found for VEP deficits in a group of 
25 12-month-old children (Riva et al. 2004).  Placental levels of Σo,p’-DDTs, but not Σp,p’-DDTs, were 
significantly associated with increased risk of neural tube defects in a study of 80 cases and 50 controls 
without neural tube defects (Ren et al. 2011). 
 
Evidence for Neurological Effects in Laboratory Animals.  The nervous system appears to be one of the 
primary targets in animals after acute-, intermediate-, and chronic-duration oral exposure to technical or 
p,p’-DDT.  Several older acute- or intermediate-duration studies (Henderson and Wooley 1969; Hrdina 
and Singhal 1972; Hrdina et al. 1973; Khairy 1959; Sobotka 1971; Talts et al. 1998; vom Saal et al. 1995) 
are mentioned in the text below to reflect the breadth of supporting evidence, but were not included in 
Table 2-1 and Figure 2-2 for various reasons such as poor study design (e.g., low number of animals), 
lack of comprehensive endpoint evaluation, poor data reporting, outdated methodologies, or exposure 
levels well above exposure levels producing the most sensitive neurological endpoints.  Clinical signs of 
neurological effects also have been observed in rats and mice after chronic dietary exposure to p,p’-DDE, 
but were not observed in rats or mice after chronic exposure to technical DDD (NCI 1978). 
 
Acute oral exposure to high doses of DDT has been associated with DDT-induced tremors or myoclonus 
(abrupt, repeated involuntary contractions of skeletal muscles), hyperexcitability, or tremors and 
convulsions in several species.  These effects have been observed in rats after single high gavage doses of 
about 50–600 mg technical p,p’-DDT/kg/day (Herr and Tilson 1987; Herr et al. 1985; Hietanen and 
Vainio 1976; Hong et al. 1986; Hudson et al. 1985; Hwang and Van Woert 1978; Pranzatelli and Tkach 
1992; Pratt et al. 1986; Tilson et al. 1987; Tomiyama et al. 2003; supported by Henderson and Wooley 
1969; Hrdina and Singhal 1972; Hrdina et al. 1973).  Mice receiving single gavage doses of 160 mg 
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DDT(NS)/kg had tremors (Hietanen and Vainio 1976), and single doses of 200–600 mg p,p’-DDT/kg/day 
induced convulsions (Matin et al. 1981).  In guinea pigs and hamsters similarly dosed, no tremors were 
observed at 160 mg DDT(NS)/kg, but hind leg paralysis occurred in guinea pigs (Hietanen and Vainio 
1976).  
 
Acute oral exposure of animals to DDT and related compounds also has been associated with increases in 
brain biogenic amine and neurotransmitter levels.  Alterations in the metabolite 5-hydroxy-indoleacetic 
acid (5-HIAA), the degradation product of serotonin, have been reported to correlate with DDT-induced 
tremors; doses ≥50 mg p,p’-DDT/kg/day resulted in increases in the levels of 5-HIAA in the brain (Hong 
et al. 1986; Hudson et al. 1985; Hwang and Van Woert 1978; Tilson et al. 1986 supported by Hrdina et al. 
1973).  Alterations in the levels of other neurotransmitters have been found.  The neurotransmitter 
changes observed are consistent with a mechanistic hypothesis that DDT and metabolites influence 
membrane ion fluxes and consequently potentiate neurotransmitter release.  Acetylcholine and norepin-
ephrine decreased in rats after acute oral exposure to 400 mg/kg DDT (Hrdina et al. 1973), and aspartate 
and glutamate were statistically significantly increased in brain tissue of F344 rats after administration of 
single oral doses ≥50 mg p,p’-DDT/kg (Hong et al. 1986; Hudson et al. 1985; Tilson et al. 1986).  
 
Acute oral administration of DDT and related compounds in utero or to neonates during sensitive periods 
of neurodevelopment has been associated with behavioral and neurochemical changes in mice (see 
Section 2.17 for more details and references). 
 
Behavioral effects have been examined in only a few studies of rodents exposed to DDT as adults.  
Administration of single oral doses of as high as 100 mg p,p’-DDT/kg to male F344 rats did not markedly 
impair their ability to acquire a conditioned behavioral response, although ≥50 mg/kg doses produced 
tremors, and deaths occurred in some rats in the 100 mg/kg group (Tilson et al. 1987).  Two earlier 
reports provided inconsistent evidence of DDT effects on behavioral endpoints, but they examined 
different behavioral endpoints.  Sobotka (1971) reported an impairment of habituation in open field 
activity in adult albino mice after administration of single oral doses of 25 mg DDT(NS)/kg, but not after 
10 mg/kg.  No statistically significant differences in tests of problem solving, locomotion speed, or 
reaction to stress were found between untreated rats and rats given oral doses up to 30 mg DDT 
(NS)/kg/day in food for 21 days (Khairy 1959).  The doses in these adult animal studies were distinctly 
higher than the dose of technical DDT administered to neonates in the Eriksson (1990a, 1990b, 1992, 
1993) studies discussed in Section 2.17.   
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Other neurological effects have been reported in animal studies after intermediate-duration oral exposure 
to DDT or DDE isomers, including body tremors and/or hunched appearance in female Osborne-Mendel 
rats after 26 weeks of dietary exposure to 30 mg technical DDT/kg/day (NCI 1978), female Wistar rats 
after 9 weeks of dietary exposure to 34 mg technical DDT/kg/day (Rossi et al. 1977), male B6C3F1 mice 
after 22 week of dietary exposure to 27 p,p’-DDE/kg/day (NCI 1978); parental and F1 parental females 
(but not males) exposed to 27.7 mg/kg/day p,p’-DDT for 10 weeks before mating, through gestation and 
lactation in a 2-generation study (Hojo et al. 2006); and male Osborne-Mendel rats after 8 weeks of 
dietary exposure to 59 mg of p,p’-DDE/kg/day (NCI 1978).  Other observed effects include decreased 
brain levels of total lipids and the relative amount of cholesterol to phospholipid after oral exposure of 
Rhesus monkeys to 10 mg technical DDT/kg/day for 100 days (Sanyal et al. 1986) and staggering, 
weakness, and loss of equilibrium in monkeys treated for up to 14 weeks with a lethal dose of 50 mg 
p,p’-DDT/kg/day, but not with exposure to 5 mg/kg/day (Cranmer et al. 1972).   
 
Effects reported in animals after chronic-duration oral exposure include severe tremors in F344/DuCrj 
rats at doses of 19.1 (males) and 25.2 (females) mg p,p’-DDT/kg/d in the diet after 70–104 weeks of 
exposure (Harada et al. 2003, 2006); severe tremors in some Rhesus and Cynomolgus monkeys exposed 
in the diet to doses ≥6.9 mg of p,p’-DDT/kg/day in a 130-month study (Takayama et al. 1999); and 
hyperactivity and tremors in chronically exposed mice at dietary doses ≥8.3 mg technical DDT/kg/day 
(Kashyap et al. 1977; Turusov et al. 1973).  In contrast, no clinical signs of neurotoxicity were observed 
in hamsters fed diets at doses up to 95 mg technical DDT or p,p’-DDE/kg/day for life (Rossi et al. 1983).  
In the 78-week NCI (1978) chronic bioassays, by week 26, tremors or hunched appearance were observed 
in about 8% of female Osborne-Mendel rats exposed to 30 mg technical DDT/kg/day and in 90% of 
females exposed to 61 mg technical DDT/kg/day.  Tremors were also reported in male rats exposed to 
technical DDT and p,p’-DDE, but due to changes in dosing early in the studies, accurate exposure levels 
are unclear; tremors ceased when doses were lowered.  No tremors were observed in female rats at up to 
36 mg p,p’-DDE/kg/day or in male or female rats exposed to up to 231 mg technical DDD/kg/day.  In 
B6C3F1 mice, observations of tremors or hunched appearance in males and females were comparable to 
controls at dietary doses up to 30.2 mg technical DDT/kg/day and 142 mg technical DDD/kg/day.  Male 
mice exposed to a time-weighted average dose of 47 mg p,p’-DDE/kg/day exhibited a hunched 
appearance in a cyclic fashion throughout the exposure period, but were comparable to controls during the 
last 12 weeks; no neurological effects were observed in female mice exposed to up to 49 mg 
p,p’-DDE/kg/day (NCI 1978).   
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Cameron and Burgess (1945) exposed rats, rabbits, and guinea pigs to acute, dermal doses ranging from 
50 to 200 mg/kg DDT(NS) and reported tremors and nervousness. 
 
Mechanisms of Neurological Effects of DDT, DDE, or DDD.  There are several proposed mechanisms 
for the neurotoxic effects of DDT and its metabolites.  DDT has been shown to disrupt nerve membrane 
ion fluxes through induced closure of sodium channels (Vijverberg et al. 1982), inhibition of potassium 
transport, and by targeting Na+/K+ and Ca2+/Mg2+ ATPases (Janicki and Kinter 1971).  There is also 
evidence that DDT can potentiate neurotransmitter release through interference with calcium calmodulin 
binding, which could then lead to central nervous system excitation and induction of tremors (Harada et 
al. 2016).  
 
Evidence in vitro suggests DDT and its metabolites can also inhibit the plasma membrane dopamine 
transporter (DAT) and the vesicular monoamine transporter (VMAT2); these transporters are often 
disrupted in Parkinson’s Disease patients (Hatcher et al. 2008).  However, in vivo, mice exposed orally to 
1, 3, or 6 mg DDT/kg every 3 days for 30 days demonstrated none of the expected nigrostriatal effects or 
evidence of neuronal dysfunction and DDT was not associated with Parkinson’s Disease in a study in 
adults (Weisskopf et al. 2010).  This suggests that the effects of DDT and its metabolites on the dopamine 
system in vitro may not translate into neurotoxicological outcomes in exposed individuals (Hatcher et al. 
2008).  
 
A study exploring potential mechanisms involved in DDT associations with Alzheimer’s disease suggests 
that DDT may positively affect the amyloid-β (Aβ) synthesis pathway, and impair the clearance and 
degradation of Aβ peptides, potentially through impairment of the ATP-binding cassette transporter A1 
(ABCA1) and insulin-degrading enzyme (IDE), both of which play roles in Aβ homeostasis (Li et al. 
2015).  Epigenetic changes, particularly alterations in methylation status of neuronal cells and tissues of 
the brain, are thought to contribute to various neuronal pathologies, including Alzheimer’s disease 
(Shutoh et al. 2009).  DNA from the hypothalamus of young rats dosed with 0.06 mg/kg DDT/day for 
4 weeks was hypomethylated at CpG islands for six genes, including the estrogen-regulated neuropeptides 
Gal, Sst, and Penk1; mRNA levels of several genes including DNA methyltransferase, Dnmt1, were also 
significantly lower in exposed groups (Shutoh et al. 2009).  Whether these changes could contribute to 
any pathologies is unknown. Further neuro-specific studies looking at epigenetic changes related to DDT 
exposure could further our understanding of possible relationships with adverse neurological effects. 
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2.16   REPRODUCTIVE 
 
Evidence of Reproductive Effects in Humans.  Tables 2-14, 2-15, and 2-16 summarize results from 
epidemiological studies that examined possible associations between exposure to DDT (isomers and 
metabolites), as assessed by levels of DDT in biological media (mostly blood), and reproductive 
outcomes.  In the majority of the studies, levels of other persistent chemicals also were examined, 
including PCBs and other organochlorine pesticides.  These tables only describe studies that included 
measurements of DDT metrics in biological fluid in each subject and examined possible associations with 
reproductive outcomes using correlation, logistic regression, or linear regression statistical techniques.   
 
Not included in these tables are studies that (although they conducted analyses such as those mentioned 
previously) presented the results only textually, without providing quantitative information.  Finally, 
some studies in which the studied population was heavily exposed to DDT (i.e., areas of endemic malaria) 
and consequently had extremely high DDT body burdens were not included in the tables.  More detailed 
data regarding these studies are presented in Tables 8, 9, and 10 in the Supporting Document for 
Epidemiological Studies for DDT, DDE, and DDD. 
 
Summary of human evidence.  In epidemiological studies examining possible association between levels 
of DDT, DDE, or DDD in tissues or biological fluids (e.g., serum), inconsistent evidence across studies of 
adults was provided for associations with time to pregnancy (fecundity), menstrual cycle, uterine 
alterations, early menopause, levels of reproductive hormones in men or women, and semen parameters.  
However, consistent evidence was reported for associations for increased risk for abortions or preterm 
births in groups of women with serum levels above those currently found in samples from the U.S. 
general population (see text below and Table 2-14).  Inconsistent evidence across studies was provided 
for associations with puberty onset in preadolescents and adolescents (see text below and Table 2-15).  
Consistent evidence for no association was reported for maternal levels of DDT, DDE, or DDD in serum, 
cord blood, breast milk, or placenta with risks for male birth defects (cryptorchidism [undescended testes] 
and hypospadias [condition in which the opening of the urethra is on the underside of the penis]) or 
adverse reproductive outcomes in adult offspring (see Table 2-16).   
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Table 2-14.  Summary of Reproductive Outcomes in Adult Humans with DDT Exposure Biometricsa 
 
Reference and study 
population DDT exposure metricb Outcome evaluated Resultc 
Time to pregnancy (TTP)  
Studies providing some evidence for an association between blood DDT and TTP (n=3) 
Axmon et al. 2006 
1,505 women 
716 men 
Men and women from four 
different countries (A, B, C, and 
D) 
Participants’ age ≥18 years 
Median serum DDE (ng/g lipid) 
 Men Women 
(A) 600  300  
(B) 520 360 
(C) 920 620 
(D) 240 820   
 
Exposure categories 
Low: <370  
Medium: 370–750 
High: >750 
Fecundity, based on 
interview data 
Adjusted fecundity OR (95% CI) for high versus 
low DDE: 
Women from (A) 0.68 (0.49–0.94)*↓ 
 
Significance lost after adjustment for maternal 
age at conception 
 
ORs for women from B-D were NS 
ORs for medium versus low DDE were NS 
Buck-Louis et al. 2013 
347 couples that achieved 
pregnancy (A) 
154 couples that withdrew or did 
not achieve pregnancy (B) 
Mean age ~30 years old (men 
and women) 
DDE geometric means, serum:  
men from (A): 0.77 ng/g 
men from (B): 0.82 ng/g 
 
DDE <LOD in women 
Fecundity based on 
menstrual cycle data 
Adjusted fecundity ORs (95% CI) for males 
DDE 
Males 0.83 (0.70–0.97)*↓ 
 
PCBs in men and women were associated with 
longer TTP 
 
Chevrier et al. 2013 
332 pregnant women (mean age 
29 years) 
DDE geometric mean in cord 
blood, 0.13 ng/mL 
T1: <0.13 
T2: 0.13–0.249 
T3: >0.250 
Fecundity based on 
results from interview  
Adjusted OR for T2–T3 versus T1 (95% CI), or 
per log10 change in DDE  
 
T2: NS 
T3: 0.60 (0.42–0.85)*↓ 
Log10: 0.84 (0.71–0.99)*↓ 
p-trend: 0.003 
 
Significance lost after further adjustment for 
shellfish consumption and mercury in hair 
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Table 2-14.  Summary of Reproductive Outcomes in Adult Humans with DDT Exposure Biometricsa 
 
Reference and study 
population DDT exposure metricb Outcome evaluated Resultc 
Studies providing no evidence for a significant association between blood DDT and TTP (n=2) 
Harley et al. 2008 
289 pregnant women (median 
age 25 years) 
Geometric mean in serum (ng/g 
lipid) 
DDT: 24 
o,p’-DDT: 2 
DDE: 1,500 
 
Fecundity based on 
menstrual cycle data  
Adjusted fecundity ORs for log10 exposure 
levels 
DDT: NS 
DDE: NS 
o,p’-DDT: NS 
 
No significant association between ΣDDT and 
TTP 
Law et al. 2005 
390 pregnant women (median 
age 23 years) 
Median DDE in serum: 22.6 ng/mL 
Quintiles 
Q1: 0–14 
Q2:15–29 
Q3: 30–44 
Q4: 45–59 
Q5: ≥60 
Fecundity based on 
results from interview 
Adjusted ORs for Q2–Q5 versus Q1 or per 16.6 
ng/mL increase in DDE 
Q2–Q4: all NS 
Q5: NS 
p for trend: NS 
16.6 ng/mL: NS 
 
Associations with lipid-adjusted levels were 
similarly NS 
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Table 2-14.  Summary of Reproductive Outcomes in Adult Humans with DDT Exposure Biometricsa 
 
Reference and study 
population DDT exposure metricb Outcome evaluated Resultc 
Semen parameters-sex organ function 
Studies providing evidence for a significant association between blood DDT and sperm parameters (n=3) 
Aneck-Hahn et al. 2007 
311 adult males (23–40 years 
old) 
Median levels in serum 
DDE: 697.0 ng/mL 
DDT: 249.0 ng/mL 
Sperm parameters: 
 
Volume (β) 
Total count (β) 
Beat cross frequency (β) 
Mean motility (β) 
Head displacement (β) 
Tail defects (β) 
Round cells (β) 
Cytoplasmic droplets 
Straight-line velocity (β) 
Oligozoospermia (OR) 
Asthenozoospermia (OR) 
 
 
Adjusted betas for continuous exposures: 
DDE  DDT 
-0.0003*↓ NS 
-0.003*↓ NS 
0.0064*↑ 0.0138*↑ 
-0.0175*↓ -0.0494*↓ 
NS  -0.0003*↓ 
NS  -0.0007*↓ 
0.0005*↑  0.0013*↑ 
NS  0.0013*↑ 
NS   -0.0018*↓ 
1.001*↑   – 
–   1.003*↑ 
 
Other motility and morphological parameters, 
viability, and CASA were NS 
DDT, DDE, and DDD  154 
 
2.  HEALTH EFFECTS 
 
 
 
 
 
 
***DRAFT FOR PUBLIC COMMENT*** 
Table 2-14.  Summary of Reproductive Outcomes in Adult Humans with DDT Exposure Biometricsa 
 
Reference and study 
population DDT exposure metricb Outcome evaluated Resultc 
De Jager et al. 2006 
116 adult males (mean age 
27 years old) 
 
Arithmetic mean plasma DDE 
45,000 ng/g lipid 
Sperm parameters: 
Volume 
Count 
Concentration 
Velocity 
Mean motility 
Tail abnormalities 
Progressive motility  
Chromatin integrity 
Epididymal function 
 
 
 
 
Normal morphology 
Motility 
Crude betas (95% CI) 
NS 
NS 
NS 
NS 
-0.1 (-0.19 to -0.10)*↓ 
0.0373 (0.007–0.067)*↑ 
-0.09 (-0.18 to -0.007)*↓ 
NS 
NS 
 
Similar results using adjusted models (data not 
reported) 
 
Men with poor sperm characteristics: 
Pearson coefficient (r) = -0.408 
Pearson coefficient (r) = -0.387 
Messaros et al. 2009 
336 adult males (18–60 years 
old) 
Median levels in serum: 
DDT: 4.72 ng/g lipid 
DDE: 290.4 ng/g lipid 
ΣDDT=DDT+DDE 
Sperm parameters: 
 
Motility 
Abnormal morphology 
Concentration 
Adjusted OR (95% CI) for high ΣDDT 
(≥75th percentile) versus <75th percentile 
2.91 (1.27–6.66)*↑ 
3.23 (1.51–6.95)*↑ 
2.53 (1.0–6.95)*↑ 
75th percentile not specified 
Studies providing mainly no evidence for a significant association between blood DDT and sperm parameters (n=5) 
Charlier and Foidart 2005 
Cases: 83 subfertile/unfertile 
men (mean age 26 years) 
Controls: 75 fertile men (mean 
age 25 years) 
Arithmetic mean DDE in blood 
Cases: 1,050 ng/g lipid 
Controls: 980 ng/g lipid 
Sperm parameters: 
Concentration 
Motility 
Abnormal morphology  
Adjusted OR (95% CI) combined groups: 
NS 
NS 
NS 
 
Similar results for separate analyses 
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Table 2-14.  Summary of Reproductive Outcomes in Adult Humans with DDT Exposure Biometricsa 
 
Reference and study 
population DDT exposure metricb Outcome evaluated Resultc 
Dallinga et al. 2002  
Cases: 34 men with poor sperm 
quality (mean age 35 years) 
Controls: 31 men with normal 
sperm (mean age 37 years) 
Arithmetic mean (±SD) of DDE in 
serum (ng/g blood) 
Cases: 0.31 (0.42) 
Controls: 0.22 (0.22) 
Sperm parameters: 
Sperm count 
Progressive motility 
Overall motility 
Sperm morphology 
No significant associations between DDE 
exposure levels and sperm parameters were 
found (data not shown) 
Testing for potential confounders (smoking and 
polymorphisms) were not significant, and were 
therefore not included in the model 
Hauser et al. 2003 
212 adult males (mean age 
36 years) 
Geometric mean DDE in serum: 
275.3 ng/g lipid 
 
DDE 3rd tertile range in serum: 
302.5–8,991.8 ng/g lipid 
Sperm parameters: 
Concentration 
Motility 
Morphology 
 
Adjusted OR (95% CI) for T3 versus T1 
NS 
NS 
NS 
Rygnell-Hydbom et al. 2005a 
157 adult men (mean age 
47 years) 
 
Median serum DDE, 231 ng/g lipid  Markers of secondary 
sex organ function: 
PSA 
Neutral α-glucosidase 
Fructose 
Zinc 
Adjusted betas change in outcome with 
increasing DDE  
NS 
NS 
NS 
NS 
Toft et al. 2006 
763 men from 4 different 
countries (A, B, C, and D) (mean 
ages 28–47 years) 
Arithmetic mean serum DDE (ng/g 
lipid) 
(A) 890 
(B) 240  
(C) 1,270 
(D) 580  
 
Quintiles: 
Q1 0–250  
Q2 251–500 
Q3 501–1,000  
Q4 1,001–1,500 
Q5 >1,500 
Sperm parameters: 
 
Concentration 
Motility 
Motility 
Morphology 
Adjusted betas (95% CI) for log DDE 
 
NS in separate or combined analysis 
-3.2 (- 5.9 to -0.6)*↓ for group A 
-2.8 (-4.8 to -0.7)*↓ groups combined 
NS in separate or combined analysis 
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Table 2-14.  Summary of Reproductive Outcomes in Adult Humans with DDT Exposure Biometricsa 
 
Reference and study 
population DDT exposure metricb Outcome evaluated Resultc 
Studies of associations between sperm parameters and DDT in semen (n=1) 
Pant et al. 2007 
50 infertile men (cases) 
50 fertile men (controls) 
 
Arithmetic mean in semen (ng/mL) 
 
   Cases Controls 
DDT   2.17 3.07  
DDE  20.29 7.24 
DDD  20.74 13.14 
o,p’-DDT 2.92 0.12 
 
 
 
Sperm concentration 
Sperm motility 
Pearson’s correlation coefficient (r) 
DDE p-value DDD p-value  
-0.39*↓ <0.005 -0.38*↓ <0.01 
NS  NS 
 
Similar low correlations reported for 
hexachlorocyclohexane 
 
No statistically significant confounders were 
identified, and therefore were not included in 
the analysis 
Menstrual cycle 
Studies finding statistically significant associations between DDT biometrics and menstrual cycle (n=3) 
Ouyang et al. 2005 
466 adult women 
Arithmetic quartile means for total 
DDT in serum 
Q1: 13.5 ng/g serum 
Q2: 23.5 ng/g 
Q3: 34.0 ng/g 
Q4: 57.1 ng/g 
 
Mean total DDT=DDT, DDE, DDD: 
32 ng/g serum 
 
Age at menarche (self 
report) 
 
 
 
Short cycle 
Long cycle 
Adjusted beta for Q2–Q4 versus Q1 
Q2 Q3 Q4  p-trend 
NS NS -1.11*↓ 0.001 
Linear (per 10 ng/g) = -0.20*↓ 
 
Adjusted ORs for Q2–Q4 versus Q1 
NS NS 2.78*↑  0.016 
NS NS NS NS 
 
Linear (per 10 ng/g) for both outcomes NS 
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Toft et al. 2008 
1,494 adult women from four 
different countries (A, B, C, and 
D) 
Tertile ranges for DDE in serum 
(ng/g lipid) 
T1: <370  
T2: 370–750  
T3: >750  
 
Means ranged from 430 in C to 
2,147 in D 
 
Menstrual cycle length 
 
 
 
Long cycle 
Adjusted beta in (C) for analysis restricted to 
minor cycle deviations 
0.1 (95% CI 0.03–0.2)*↓  
 
Adjusted OR in (A) for analysis of DDE as 
continuous variable  
0.7 (95% CI 0.5–0.99)*↓  
  
Adjusted OR in (C) for T3 versus T1 analysis  
3.1 (95% CI 1.1–8.6)*↑ 
Windham et al. 2005 
49 adult women 
Arithmetic mean serum 
concentration 
DDT: 1.77 ng/mL 
DDE: 20.8 ng/mL 
 
Quartiles: 
Q1: <0.5 
Q2: 0.5–0.69 
Q3: 0.70–1.39 
Q4: >1.4 
 
 
Menstrual cycle length 
Follicular phase 
Luteal phase 
Adjusted betas for change for Q4 versus Q1 
Exposure levels 
NS (both DDE and DDT) 
NS (both DDE and DDT) 
-1.5 (95% CI -2.7 to -0.30)*↓ for DDT 
-1.4 (95% CI -2.6 to -0.20)*↓for DDE 
Studies finding no statistically significant association between DDT biometrics and menstrual cycle (n=3) 
Cooper et al. 2005 
2,314 adult women 
(Collaborative Perinatal Project) 
 
 
Quintile ranges for DDE in serum 
Q1: <15 ng/g  
Q2: 15–29 ng/g 
Q3: 30–44 ng/g 
Q4: 45–59 ng/g 
Q5: >60 ng/g 
Arithmetic mean: 30 ng/mL 
Self-report of: 
 
Bleeding duration 
Cycle irregularity 
Heavy bleeding  
Dysmenorrhea 
Cycle length  
Adjusted OR (95% CI) for Q5 versus Q1  
 
NS 
NS 
NS 
NS 
NS 
 
PCBs were associated with increasing 
menstrual cycle length 
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Denham et al. 2005 
138 young women (10–16.9 years 
old)  
Geometric mean in blood 
DDE: 0.35 ng/mL 
Self report of presence or 
absence of menarche 
Adjusted beta per doubling of DDE 
NS  
 
Associations existed for some PCBs and lead 
Gallo et al. 2016 
140 adult women  
Geometric mean in serum 
DDE: 0.30 ng/mL 
Ovulatory status based 
on levels of estradiol and 
progesterone in saliva  
Adjusted beta for ovulatory status per 1 log-unit 
increase in DDE = NS 
 
Association existed for low chlorinated PCBs 
Abortion-preterm birth 
Studies finding significant associations between DDT biometric and abortion-preterm birth (n=3) 
Korrick et al. 2001 
15 cases of spontaneous 
abortions  
15 normal term pregnancy 
 
Arithmetic mean DDE in serum 
Cases: 22 ng/g serum 
Controls: 12 ng/g serum 
 
Clinically recognized 
spontaneous abortion 
Adjusted ORs (95% CI) for increased risk of 
spontaneous abortion per ng/g increase in DDE 
and total DDT or per ng/100 g increase in other 
metrics  
 
DDE: 1.13 (1.02–1.2)*↑ 
o,p’ -DDE: 1.56 (1.08–2.25)*↑ 
Total DDT: 1.13 (1.02–1.25)*↑ 
 
Other DDT metrics were NS 
Longnecker et al. 2005 
1,717 women (Collaborative 
Perinatal Project) 
 
Quintile ranges for DDE in serum 
Q1: <15 ng/g  
Q2: 15–29 ng/g 
Q3: 30–44 ng/g 
Q4: 45–59 ng/g 
Q5: >60 ng/g 
Median: 24.5 ng/mL 
Previous pregnancy 
outcome data assessed 
by interview 
Adjusted OR (95% CI) for fetal loss for Q2–Q5 
versus Q1 or per 60 ng/mL increase in DDE 
Q2: NS 
Q3: 1.4 (1.0–1.9)*↑ 
Q4: 1.6 (1.1–2.4)*↑ 
Q5: NS 
60 ng/mL: 1.4 (1.1–1.6)*↑ 
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Venners et al. 2005  
388 newly married Chinese 
women (20–34 years old)  
 
Tertiles for ΣDDT in serum 
T1: 5.5–22.9 ng/g  
T2: 23.0–36.5 ng/g 
T3: 36.6–113.3 ng/g 
Median: 27.9 ng/g 
 
Conception monitored by 
daily urinary assay of 
human chorionic 
gonadotropin; 
pregnancies were 
followed to monitor 
losses 
Adjusted OR (95% CI) for early pregnancy loss 
T3 versus T1 ΣDDT 
2.12 (1.26–3.57)*↑ 
 
Adjusted OR (95% CI) for total pregnancy loss 
T3 versus T1 ΣDDT  
2.01 (1.23–3.28)*↑ 
Studies finding no significant associations between DDT biometric and abortion-preterm birth (n=4) 
Khanjani and Sim 2006 
815 women assessed 6–12 weeks 
postpartum 
Tertiles in breast milk 
DDT 
T1: 0–39 ng/g fat  
T2: 39–66 ng/g fat 
T3: >66 ng/g fat 
 
DDE 
T1: 0–400 ng/g fat 
T2: >400–730 ng/g fat 
T3: >730 ng/g fat 
Reproductive outcome 
data collected as part of 
a previous breast milk 
study 
Adjusted OR (95% CI) for preterm birth T3 
versus T1  
DDT: NS 
DDE: NS 
 
Adjusted OR (95% CI) for miscarriage or 
stillbirth T3 versus T1  
DDT: NS 
DDE: NS 
Ouyang et al. 2014 
291 newly married Chinese 
women (mean age 24.9 years) 
Mean ΣDDT in serum: 34.4 ng/g 
serum 
 
Women were categorized into low-
DDT and high-DDT using a 
median split of 30.7 ng/g serum 
Conception monitored by 
daily urinary assay of 
human chorionic 
gonadotropin; pregnancy 
and pregnancy loss 
confirmed clinically 
Adjusted OR (95% CI) for early pregnancy loss 
high-exposure group versus low-exposure 
group   
1.52 (0.96–2.41) = NS 
 
Torres-Arreola et al. 2003 
Cases: 100 preterm delivery 
Controls: 133 women full-term 
delivery  
Median DDE in serum collected 
≤24 hours after delivery: 
Cases: 189.5 ng/g lipid 
Controls: 152.8 ng/g lipid 
Preterm delivery 
assessed clinically 
(<37 weeks of gestation) 
Adjusted OR (95% CI) for increased risk of 
preterm delivery for T3 (>228.8 ng/g lipid) 
versus T1 (<111.6 ng/g lipid) 
1.67 (0.84–3.31) = NS 
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Wood et al. 2007 
Cases: 26 women delivering 
preterm infants (mean age 
29.2 years) 
Controls: 52 women delivering full 
term infants (mean age 
29.7 years) 
Median DDE in serum collected 
1 day postpartum 
Cases: 67.02 ng/g lipid 
Controls: 69.29 ng/g lipid  
Premature delivery 
(>23 weeks and 
<35 weeks) assessed 
clinically 
Adjusted OR (95% CI) for premature delivery 
per 1-log unit increase in DDE 
1.15 (0.47–2.78) = NS 
Uterine and ovarian alterations 
Studies finding significant associations between DDT biometrics and female sex organ alterations (n=1) 
Trabert et al. 2015 
Cases: 99 women with uterine 
fibroids  
Controls: 374 women without 
uterine fibroids 
Cohort age range:18–44 years 
Geometric mean in serum (ng/g 
serum) 
  Cases Controls 
DDE   36.95 16.90  
DDT  1.20 1.22  
o,p’-DDE 0.61 0.69  
Fibroids surgically 
diagnosed 
Adjusted ORs (95% CI) for increased risk of 
uterine fibroids per 1 SD increase in DDT 
metrics 
 
DDE: 1.37 (1.05–1.80)*↑  
DDT: NS 
o,p’-DDE: NS 
Studies finding no significant associations between DDT biometrics and female sex organ alterations (n=3) 
Cooney et al. 2010 
Cases: 29 women with 
endometriosis 
Controls: 51 women without 
endometriosis 
Cohort age range: 18–40 years 
DDE tertiles in serum 
T1: <0.63 ng/g serum  
T2: 0.63–0.94 ng/g serum 
T3: >0.94 ng/g serum 
Endometriosis diagnosed 
by laparoscopy 
Adjusted ORs (95% CI) for increased risk of 
endometriosis 
T2 versus T1: NS 
T3 versus T1: NS 
1 log-unit increase DDE: NS 
Porpora et al. 2009 
Cases: 80 women with 
endometriosis (mean age 
31.6 years) 
Controls: 78 women without 
endometriosis (mean age 
29.5 years) 
DDE tertiles in serum 
T1: ≤231 ng/g lipid  
T2: 232–492 ng/g lipid 
T3: ≥493 ng/g lipid 
Endometriosis diagnosed 
by laparoscopy 
Adjusted ORs (95% CI) for increased risk of 
endometriosis 
T2 versus T1: NS 
T3 versus T1: NS 
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Upson et al. 2013 
Cases: 248 women with 
endometriosis 
Controls: 538 women without 
endometriosis 
Cohort age range: 18–49 years old 
Quartiles in serum 
DDT 
Q1: ≤0.19 ng/g serum   
Q2: >0.19–0.28 ng/g serum 
Q3: >0.28–0.44 ng/g serum 
Q4: >0.44 ng/g serum 
DDE 
Q1: ≤0.91 ng/g serum   
Q2: >0.91–1.6 ng/g serum 
Q3: >1.6–2.8 ng/g serum 
Q4: >2.8 ng/g serum 
Endometriosis confirmed 
by direct surgical 
visualization 
Adjusted ORs (95% CI) for increased risk of 
endometriosis for Q2–Q4 versus Q1 
   DDE DDT 
Ovarian endometriosis NS NS 
All endometriosis NS NS 
 
Mirex and β-hexachlorocyclohexane were 
associated with endometriosis 
Menopause (n=2) 
Cooper et al. 2002 
Cases: 748 women with breast 
cancer (21–24 years old) 
Controls: 659 women without 
breast cancer 
 
DDE deciles in serum (ng/g lipid)  
<50th: <620  
50th–74th: 620–1,360 
75th–89th: 1,370–2,760 
≥90th: ≥2,770  
 
Median: 600 ng/g lipid 
Age at time of the last 
menstrual period was 
used to define age at 
menopause among 
women who reported that 
their periods had stopped 
by themselves 
Adjusted HR for rate of onset of menopause (all 
women) 
DDE 
50th–75th versus <50th: NS 
75th–89th versus <50th: NS 
≥90th versus <50th: NS 
1-log unit change: 1.1*↑ 
Grindler et al. 2015 
Subset of 1,442 women from 
31,575 participants in NHANES 
1999–2008 
 
Median DDE in serum: 243 ng/g 
lipid 
 
90th percentile = 1,430 ng/g lipid 
 
Age at last menstrual 
period determined by 
survey 
Adjusted beta for average change in age of 
menopause 
- per 1-log DDE  -0.67*↓ (p=0.046). 
- per serum DDE subdivided into deciles and 
analyzed as a continuous variable: -0.34*↓ 
(p=0.043). 
- per DDE >90th versus <90th percentile = NS 
 
Other organochlorine chemicals also 
associated with early menopause 
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Sex hormones 
Studies reporting mixed results for associations between DDT biometrics and sex hormones (n=8) 
Blanco-Muñoz et al. 2012 
84 men (18–52 years old) 
Geometric mean DDE in serum: 
864 ng/g lipid 
FSH, LH, prolactin, 
testosterone, E2, and 
inhibin B in serum 
Adjusted betas per doubling of DDE  
Prolactin: -0.040*↓ 
Inhibin: 0.114*↑ 
 
No significant associations between DDE and 
other outcomes measured 
Emeville et al. 2013 
277 adult men (45–69 years old)  
Geometric mean concentration of 
DDE in serum: 1.77 ng/mL 
Dehydroepiandrosterone 
(and sulfate), 
androstenedione, DHT, 
androstenediol, estrone 
(and sulfate), E2, 
testosterone (total, free, 
and bioavailable), SHBG, 
LH, and FSH in serum  
Adjusted betas per 1-ln-unit increase in DDE 
DHT: -0.063*↓ 
LH: 0.057*↑ 
Testosterone/LH: -0.061*↓ 
 
No significant associations between DDE and 
other outcomes measured 
 
Freire et al. 2014 
304 men (15–94 years old) 
300 women (17–92 years old) 
Median concentration in serum 
(ng/mL)  
DDE DDT DDD o,p’-DDT 
Men 
8.3 3.1 0.6 0.3 
Premenopausal women 
7.9  3.0 0.6 0.4 
Peri/postmenopausal women 
20.6 4.7 0.9 0.4  
 
Men: testosterone in 
serum 
Women: estradiol, 
progesterone, prolactin, 
LH, and FSH in serum 
Adjusted betas for log-transformed sex 
hormones and DDT metrics 
Peri/postmenopausal 
 Men Women 
  T  LH  FSH 
o,p’-DDT -0.02*↓  NS  NS 
DDT   NS  -0.01*↓ NS 
DDE  NS  NS NS 
DDD   NS  -0.09*↓ -0.15*↓ 
 
No significant associations with other hormones 
 
Premenopausal women: no significant 
associations between DDT isomers and 
metabolites and outcomes measured 
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Giwercman et al. 2006 
258 men from Greenland (18–
50 years old) 
198 men from Ukraine (19–
45 years old) 
113 men from Poland (20–
46 years old) 
184 men from Sweden (24–
68 years old) 
Mean serum concentrations of 
DDE (ng/g lipid) 
Greenland: 480 
Ukraine: 1,100 
Poland: 530 
Sweden: 250 
  
Free testosterone (fT), 
SHBG, E2, LH, inhibin B, 
and FSH in serum 
Adjusted betas for 1-log unit increase in DDE 
 Ukraine Greenland All  
fT 0.008*↑ 0.011*↑ NS 
SHBG 3.57*↑ NS NS 
Ln LH 0.227*↑ NS ND 
Ln inhibin B -17.0*↓ NS NS 
LN FSH NS NS 0.056*↑ 
 
No significant associations between DDE and 
E2; no significant associations in Sweden or 
Poland cohorts 
Hagmar et al. 2001 
110 men (23–79 years old) 
Plasma levels (ng/g lipid) 
 
 DDE DDT 
50th % 828 50 
90th % 3,152 185 
FSH, LH, prolactin, fT in 
serum 
Adjusted Pearson correlation coefficient: 
0.41 (p<0.001)*↑ for DDT/FSH 
0.41 (p<0.001)*↑ for DDE/FSH 
0.35 (p=0.003)*↑ for DDE/fT 
 
No significant correlation between DDT/DDE 
and LH or prolactin 
Perry et al. 2006 
287 women (24–25 years old) 
Mean serum concentration (ng/g 
serum) ΣDDT (isomers and 
metabolites) 
Low exposure group: 19.6 
High exposure group: 46.4 
Urinary concentration of 
major metabolite of 
progesterone (PdG) and 
estrogen (E1C) 
Adjusted betas per 10 ng/g increase in DDT 
metrics (two-sided p): 
  log E1C  logPdG  
  POD LD POD  LD 
Total DDT -0.04* -0.04*  -0.06↓ -0.05* 
p,p’-DDT -0.43* NS NS -0.57* 
p,p’-DDE -0.05* -0.05* -0.06*↓ -0.06* 
p,p’-DDD -5.33* NS  -10.71* -6.53* 
o,p’-DDT -4.99↓ NS NS  NS 
o,p’-DDE  -8.84*  -8.15*  ND -13.42* 
(* indicates statistical significance, inverse 
associations)  
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Rylander et al. 2006 
196 men (48–82 years old) 
Median DDE in serum: 580 ng/g 
lipid 
1st Q: 300 
2nd Q: >300–600  
3rd Q: >600–1,100  
4th Q: >1,100  
FSH, LH, E2, total 
testosterone, and SHBG 
in serum and FAI   
Adjusted β (95% CI) for change in E2 per 100 
ng/g increase in DDE or for Q2–Q4 versus Q1 
 
100 ng/g: -0.57 (-1.0 to -0.12)*↓  
Q2: NS 
Q3: -10 (-19 to -1.2)*↓  
Q4: -12 (-21 to -2.8)*↓  
 
No significant associations with other outcomes 
measured 
Windham et al. 2005 
49 women (18–40 years old) 
Arithmetic mean concentration in 
serum  
DDT: 1.8 ng/mL 
DDE: 21 ng/mL 
 
DDE quartiles 
Q2: 7–12.9 ng/mL 
Q3: 13–23.9 ng/mL 
Q4: ≥24 ng/mL 
Main urinary metabolites 
of E2 and progesterone 
monitored during 
follicular and luteal 
phases of the menstrual 
cycle 
Adjusted beta (95% CI) for change luteal phase 
length (days) and in progesterone during total 
luteal phase for Q2–Q4 DDE versus Q1 
 Luteal length Progesterone 
Q2 NS  NS  
Q3 -1.1*↓  -18.5*↓   
Q4 -1.4*↓  -25.5*↓   
 
No significant association between DDT and E2 
or progesterone  
Studies reporting inverse associations between DDT biometrics and sex hormones (n=8) 
Ferguson et al. 2012 
341 men (18–51 years old) 
Geometric mean DDE 
concentration in serum: 236 ng/g 
lipid 
FSH, LH, inhibin B, total 
testosterone, fT, E2, 
SHBG, FAI, T/E2, and 
T/LH in serum 
No significant association between DDE and 
any of the outcomes measured in adjusted 
models; data for FSH, LH, or inhibin B not 
shown 
 
Goncharov et al. 2009 
257 men (18–82 years old) 
436 women (18–95 years old) 
Arithmetic mean DDE 
concentration in serum: 2.9 ng/g 
serum  
 
Tertile interval was not provided 
Total testosterone in 
serum  
Adjusted OR (95% CI) for comparison of 
highest tertile with lowest tertile: 
1.18 (0.37–3.69) = NS 
 
PCBs were associated with lower testosterone 
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Martin et al. 2002 
137 men (30–88 years old) 
Median DDE concentration 
(interquartile range) in serum: 
1,213 (558–2,136) ng/g lipid 
tT, bT, DHT, and FAI in 
serum 
Adjusted betas for percentage change in ln-
hormone levels per increase in interquartile 
distance of ln-DDE 
tT: NS 
bT: NS 
DHT: NS 
FAI: NS 
Rignell-Hydbom et al. 2004 
194 fishermen 
Median (range) serum DDE: 
240 (33.4–2,251) ng/g lipid 
FSH, LH, E2, serum 
testosterone, inhibin B, 
and SHBG 
No significant associations between hormones 
and DDE exposure levels were observed using 
adjusted linear and logistic regression analysis 
(data was not provided)  
Rignell-Hydbom et al. 2005a 
157 fishermen 
Median (range) serum DDE: 
231 (40–2,252) ng/g lipid 
 
PSA, NAG, zinc, and 
fructose levels in semen 
Adjusted betas for change in PSA with Q1–Q4 
DDE versus Q5 (referent) 
Q1: NS 
Q2: NS 
Q3: NS 
Q4: NS 
 
Associations with other outcomes were NS 
using univariate analysis  
Schell et al. 2014 
127 young men (10–<17 years 
old) 
Arithmetic mean DDE in serum: 
0.45 ng/g serum 
tT in serum Adjusted β (95% CI) for change in tT per 10% 
increase in DDE = NS 
 
Other organochlorines compounds were 
associated with lower testosterone 
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Turyk et al. 2006 
56 men (27–70 years old) 
Geometric mean DDE 
concentration in serum 
Fish eaters: 602 ng/g lipid 
Referents: 290 ng/g lipid 
tT, fT, SHBG, SHBG-T, 
LH, FSH, and estrone 
sulfate in serum 
Pearson’s correlation coefficients (r) (p values) 
in adjusted models that included total PCBs: 
 
tT: -0.15 (0.30) = NS 
Ln fT: -0.04 (0.78) = NS 
SHBG-T: -0.17 (0.23) = NS 
Estrone sulfate: -0.32 (>0.05) = NS 
SHBG: -0.11 (0.32) = NS 
Ln LH: -0.14 (0.32) = NS  
Ln FSH: 0.14 (0.32) = NS 
 
aSee Table 8 in the Supporting Document for Epidemiological Studies for DDT, DDE, and DDD for more detailed descriptions of studies. 
bDDT, DDE, and DDD refers to the p,p’- substituted compounds, other substitutions are explicitly noted throughout the table. 
cBold text, “significant” and asterisk indicate statistically significant (p<0.05).  Arrows “↑ or ↓” indicate direction of change observed for a given outcome (positive 
or inverse associations, respectively).  Adjusted OR or adjusted β indicates adjustment for standard confounding variables for reproductive outcomes, such as 
age, BMI, serum triglycerides and cholesterol, and smoking.  Further adjustments for other analyzed chlorinated compounds or pesticides in biological fluid 
samples are expressly noted in the table. 
 
BMI = body mass index; bT = bioavailable testosterone; CASA = Computer Assisted Sperm Analysis; CI = confidence interval; DHT = dihydrotestosterone 
E2 = estradiol; FAI = free androgen index; FSH = follicle-stimulating hormone; fT = free testosterone; HR = hazard ratio; LD = luteal day; LH = luteinizing 
hormone; LOD = limit of detection; NAG = neutral α-glucosidase; NHANES = National Health and Nutrition Examination Survey; NS = not statistically significant; 
OR = odds ratio; PCB = polychlorinated biphenyl; POD = post-ovulation day; PSA = prostate specific antigen; Q = quartile or quintile; SD = standard deviation; 
SHBG = sex hormone-binding globulin; SHBG-T = SHBG-bound testosterone; T = tertile; tT = Total testosterone; TTP = time to pregnancy 
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Croes et al. 2015 
Adolescents, (aged 14–
15 years) (n=1,889) 
FLEHS I cohort (n=1,679) 
FLEHS II cohort (n=210) 
Adolescent serum DDE 
Geometric mean  
  FLEHS I FLEHS II 
(ng/g lipid) 94  70  
(ng/mL)  0.418  0.307  
Breast development 
(girls), genital 
development (boys), 
pubic hair (boys) 
Adjusted ORs (per IQR (53.3 ng/g lipid) increase 
in DDE  
FLEHSII  OR   p-value 
Breast development  0.74*↓  0.03 
(delayed breast development) 
   
FLEHSI 
Pubic hair  (ORs NR) 0.002*↑ 
Genital development (ORs NR)  0.001*↑ 
(faster sexual maturation) 
Den Hond et al. 2011 
Consenting adolescents, 
14–15 years old 
 (n=1,679) 887 males; 
792 females 
Adolescent serum DDE 
Median (ng/g lipid) 
Boys: 104 (47–404) 
Girls: 84 (39–247) 
 
Tanner genitalia growth 
(G1–G5), and Tanner 
pubic hair growth (P1–
P5) 
Adjusted ORs (95% CI) per 2-fold increase in 
DDE 
   Boys  Girls  
Reaching G3  1.52*↑  –  
Reaching P3   1.50*↑  NS  
Breast development –    NS 
(DDE associated with faster sexual maturation in 
boys) 
 
Association with G3 remained significant with 
adjustments for other pollutants (p=0.035) 
Dhooge et al. 2011 
887 male adolescents 
(14–15 years old) 
Median concentration of DDE in serum: 
104 ng/g lipid 
LH, total and free 
testosterone, FSH, 
SHBG, total and free 
E2, and aromatase 
index (total 
testosterone/E2) in 
serum 
Adjusted beta for ln E2 per doubling of DDE 
3.3 (95% CI 1.6–5.0)* 
 
No significant associations between DDE and 
other outcomes assessed (data not shown) 
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Table 2-15.  Summary of Studies of Associations between Human DDT Exposure Metrics in Child and Adolescent 
Serum and Reproductive Endpointsa 
 
Reference and study 
population DDT exposure metricb Outcome evaluated Resultsc 
Lam et al. 2014 
Boys, aged 8–9 years 
old with parental 
consent 
Prepubertal serum concentrations of DDE. 
Wet-weight quartiles (ng/g serum) 
Q1: 0.261–0.907 
Q2: 0.908–1.406 
Q3: 1.407–2.237 
Q4: 2.238–41.301 
Median: 287 ng/g lipid; 1.41 ng/g serum 
Tanner genitalia growth 
(G1–G5), and Tanner 
pubic hair growth (P1–
P5), testicular volume 
(TV) 
Adjusted mean shifts (months) for Q2–Q4 versus 
Q1 DDE 
  Q2 Q3 Q4  
G2+  NS NS NS 
TV >3 mL NS NS  NS 
P2+  NS NS NS 
p for trend NS for each outcome 
Lam et al. 2015 
Boys, aged 8–9 years 
old with parental 
consent 
Prepubertal serum concentrations of DDE. 
Wet-weight quartiles (ng/g serum)  
Q1: 0.261–0.907 
Q2: 0.908–1.406 
Q3: 1.407–2.237 
Q4: 2.238–41.301 
Median: 287 ng/g lipid; 1.41 ng/g serum 
Age at sexual maturity 
(G5, TV >20 mL, and 
P5)  
Adjusted mean shifts (months) for Q2– Q4 
versus Q1 DDE. 
  Q2 Q3 Q4 p trend 
G5   -1.68  -1.34  2.52 NS 
TV >20 mL -0.32 -0.09 2.45 NS 
P5  -0.30 1.67 6.19*↑ 0.04*↑ 
 
DDE was associated with later attainment of 
Tanner stage 5 for pubic hair growth 
 
aSee Table 9 in the Supporting Document for Epidemiological Studies for DDT, DDE, and DDD for more detailed descriptions of studies.  Studies in this table 
were selected from those described in Table 9, because they: (1) measured DDT-related metrics in biological fluids or tissues in each subject, and (2) evaluated 
associations using linear regression, logistical regression, or correlation techniques, adjusting for possible confounding factors. 
bDDE = p,p’-DDE, unless otherwise specified; DDT = p,p’-DDT, unless otherwise specified.  
cBold text, “significant” and asterisk indicate statistically significant (p<0.05).  Arrows indicate an increase or decrease in the reproductive endpoint or direction of 
p-trend.  Adjusted OR or adjusted β indicates adjustment for standard confounding variables for reproductive outcomes, such as total serum lipids, birth weight, 
blood lead levels, age of pubertal onset, smoking, BMI, and height z-scores. 
 
BMI = body mass index; CI = confidence interval; E2 = estradiol; FLEHS = Flemish Environment and Health Studies; FSH = follicle stimulating hormone; G1–
5 = Tanner genitalia growth, stages 1–5; LH = luteinizing hormone; NS = not statistically significant; OR = odds ratio; P1–5 = Tanner pubic hair growth, stages 1–
5; Q = quartile; SHBG = sex-hormone binding globulin; TV = testicular volume 
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Table 2-16.  Summary of Studies of Associations between Human DDT Exposure Metrics in Maternal Serum, 
Cord Blood, or Breast Milk and Reproductive Endpoints in Offspring Biometricsa 
 
Reference and study population DDT exposure metricb Outcome evaluated Resultsc 
Bhatia et al. 2005 
Consenting mother-child pairs  
 
Cryptorchidism cases (n=75) 
Hypospadias cases (n=66) 
Both cryptorchidism and hypospadias 
(n=4) 
Normal controls (n=283) 
Infants followed at least 2 years from 
birth 
Maternal serum DDE and DDT 
Exposure quartiles (ng/mL) 
 DDE  DDT 
Q1 <27.0  <10.0 
Q2 27.0–43.9 10.0–14.9 
Q3 44.0–60.9 15.0–19.9 
Q4 ≥61.0  ≥19.9 
Median range: 4,600–5,300 ng/g lipid 
Cryptorchidism and 
hypospadias 
Adjusted ORs for Q4 DDE and DDT 
versus Q1 
  DDE DDT 
All  NS NS 
Cryptorchidism NS NS 
Hypospadias NS NS 
 
Associations for Q2 and Q3 were also 
NS 
 
p-values for trend across exposure 
levels were NS 
Brucker-Davis et al. 2008 
Consenting mother-infant pairs (n=164) 
Infants with cryptorchidism (n=78)  
Control infants (n=86) 
Cord blood and milk DDE 
Median (ng/g lipid-milk; ng/mL cord 
blood) 
  Cord blood Milk  
Controls 0.2  80 
Cryptorchidism 0.2  119.4  
Total  0.2  98.7  
Cryptorchidism status 
at birth and 3 months 
Adjusted ORs for DDE ≥median versus 
<LOD 
Birth: NS 
3 months: NS 
Carmichael et al. 2010 
Mother-infant pairs (n=48) 
Hypospadias cases (n=20)  
Non-malformed controls (n=28) 
 
Maternal serum DDT and DDE 
Mean (ng/g lipid) 
  DDT DDE  
Cases  20.5 344.5  
Controls 34.4 624.3  
Hypospadias Adjusted ORs for a 1 ng/g lipid change 
in DDT or a 10 ng/g lipid change in 
DDE 
DDT: NS 
DDE: NS 
Cohn et al. 2003  
Consenting mother-infant pairs (n=289) 
Daughters born 1960–1963 
Maternal serum levels of p,p’-DDT, 
p,p’-DDE, and o,p’-DDT in each subject  
Median (ng/mL): 
o,p’-DDT: 0.49  
p,p’-DDT: 13.05  
p,p’-DDE: 48.19  
 
Time to pregnancy in 
daughters 
Adjusted FRs per 10 ng/mL or SD  
DDE and DDT (data are presented in 
figures): 
  DDE DDT 
Per 10 ng/mL >1.0* <1.0* 
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Table 2-16.  Summary of Studies of Associations between Human DDT Exposure Metrics in Maternal Serum, 
Cord Blood, or Breast Milk and Reproductive Endpoints in Offspring Biometricsa 
 
Reference and study population DDT exposure metricb Outcome evaluated Resultsc 
Damgaard et al. 2006 
Consenting mother-child pairs (n=130) 
Cryptorchidism boy cases (n=29 
Danish; n=33 Finnish)  
Control cases (n=36 Danish; n=32 
Finnish 
Maternal serum DDT metrics  
Mean (ng/g lipid)  
   Cases  Controls 
p,p’-DDT 4.63 3.98  
p,p’-DDE 97.32 83.76  
p,p’-DDD 0.36 0.34  
o,p’-DDT 0.35 0.34  
o,p’-DDE 0.08 0.08  
o,p’-DDD 0.03 0.03  
DDE/DDT 17.88 19.31  
ΣDDT  140.41 116.6 
Cryptorchidism Adjusted p-values from logistic 
regression analysis (cases versus 
controls; adjusted ORs were not 
reported) 
p,p’-DDT: NS 
p,p’-DDE: NS 
p,p’-DDD: NS 
o,p’-DDT: NS 
o,p’-DDE: NS 
o,p’-DDD: NS  
DDE/DDT: NS 
ΣDDT: NS 
Fernandez et al. 2007 
Cases (n=48); boys with hypospadias 
and/or cryptorchidism at 1 month of age 
Healthy control boys (n=114) 
 
Placental levels of DDT metrics 
Mean±SD (ng/g lipid) 
o,p’-DDD: 28.7±43.7  
p,p’-DDE: 10.8±28.0  
o,p’-DDT: 3.6±8.3   
p,p’-DDT: 2.0±5.2 
ΣDDT: 28.7±47.3 
Cryptorchidism and/or 
hypospadias 
Adjusted ORs for exposure levels 
≥LOD versus <LOD 
o,p’-DDT: NS 
p,p’-DDT: NS 
 
Giordano et al. 2010 
Consenting mother-child pairs (n=160) 
Hypospadias cases (n=80) 
Healthy controls (n=80)  
 
Maternal serum DDE 
Mean±SD (ng/g lipid) 
Cases (n=37): 128±0.71 
Controls (n=21): 0.96±0.56 
All subjects: 1.16±0.67 
Hypospadias Adjusted ORs for DDE 
 
≥Median versus <median: NS 
Per 10 pg/g increase: NS  
 
Han et al. 2016 
Two-generation cohort of maternal fish-
eaters 
Angler mother-daughter (aged 20–
50 years) pairs (n=151)  
Daughter pregnancies (n=288) 
Estimated birth serum DDE 
Exposure tertiles (ng/mL) 
T1: 0–2.4  
T2: 2.5–7.4  
T3: ≥7.4  
Time to pregnancy in 
daughters (stratified by: 
all times of unprotected 
intercourse (UI), time of 
unprotected intercourse 
(TUI) ≥1 month, and 
women who planned a 
baby) 
Adjusted FRs for T2 and T3 DDE 
versus T1  
  T2  T3 
All times of UI 1.61 1.67  
TUI ≥1 month 1.36 1.35  
Planned baby 1.62 1.72  
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Table 2-16.  Summary of Studies of Associations between Human DDT Exposure Metrics in Maternal Serum, 
Cord Blood, or Breast Milk and Reproductive Endpoints in Offspring Biometricsa 
 
Reference and study population DDT exposure metricb Outcome evaluated Resultsc 
Kristensen et al. 2016 
Consenting mother daughter-pairs 
(n=244) 
Follow-up of female offspring at 
~20 years of age)  
 
Users of hormonal contraceptives 
cases (n=170); non-users of hormonal 
contraceptives cases (n=74) 
 
 
Maternal serum DDE 
Median (ng/mL) = 2.466 
Tertiles (nmol/mL) 
T1: 0.00024–0.00154 
T2: 0.00154–0.00216 
T3: 0.00216–0.01097 
Cycle length, follicle 
number/ovary, and 
reproductive hormones: 
TT, SHBG, FAI, FSH, 
LH, E2, and AMH 
Adjusted betas for T2 and T3 DDE 
versus T1 
   T2 T3  
Cycle length, days NS  NS 
# follicles/ovary  NS -28*↓  
serum TT   NS NS 
SHBG   NS NS  
FAI   NS NS  
FSH   NS NS  
LH   NS NS  
E2   NS NS  
AMH    NS NS  
 
Adjusted p-values for trend were NS 
Longnecker et al. 2002 
Consenting mother-child pairs 
Control cases (n=552) 
Cryptorchidism cases (n=219) 
Hypospadias cases (n=199) 
Polythelia (extra nipples) cases 
(n=167) 
Maternal serum DDE 
Exposure categories (ng/mL) 
(1) <15.0  
(2) 15.0–29.9  
(3) 30.0–44.9  
(4) 45.0–59.9  
(5) ≥60 
 
Median ranges: 23.6–31.9 ng/mL blood 
Cryptorchidism, 
hypospadias, polythelia 
Adjusted OR per 15.0 ng/mL increase 
in DDE or for exposure categories 2–
5 versus 1   
 (5 versus 1 DDE)  (15 ng/mL↑) 
Cryptorchidism NS  NS 
Hypospadias NS   NS 
Polythelia  NS  NS 
Longnecker et al. 2007 
Consenting mother-infant pairs (n=781) 
 
Maternal serum DDE and DDT 
Median 
  ng/g lipid ng/mL 
DDT  250  1.9  
DDE   2,700  19.5   
DDT:DDE 0.12 
AGD1, AGD2, ASD, 
penis length, penis 
width 
Adjusted betas (95% CI) mm change 
per ng/g DDE  
AGD1: NS  
AGD2: NS 
ASD: NS 
Penis length: NS 
Penis width: NS 
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Table 2-16.  Summary of Studies of Associations between Human DDT Exposure Metrics in Maternal Serum, 
Cord Blood, or Breast Milk and Reproductive Endpoints in Offspring Biometricsa 
 
Reference and study population DDT exposure metricb Outcome evaluated Resultsc 
Torres-Sanchez et al. 2008 
Mother-infant pairs (n=71; 37 males 
and 34 females) 
 
Maternal trimester serum levels DDE 
and DDT 
Median (ng/g lipid) 
 Boys Girls  
Baseline 2,456.6 1,688.2 
1st  1,714.8 1,407.9 
2nd 1,276.5 1,083.0 
3rd  1,274.2 1,040.1 
 
p,p’-DDT in both boys and girls at each 
sampling time point=0.0123 (ng/g lipid) 
Anal position index, PA, 
PA/W 
Adjusted betas for a doubling of DDE 
in boys 
 Base 1st 2nd 3rd  
API NS -0.02*↓ NS NS 
PA NS NS NS NS 
PA/W NS NS NS NS 
 
No significant associations were 
observed in girls 
 
No significant associations with levels 
of DDT (data not shown) 
Vasiliu et al. 2004  
Two-generation cohort of maternal fish-
eaters 
Angler mother-daughter (aged 20–
50 years) pairs (n=151)  
Estimated maternal DDE serum 
medians at birth: 3.8–7.0 ng/mL   
Age at menarche Adjusted beta per ng/mL serum  
DDE = –0.07, p=0.038 
 
Significance was lost after controlling 
for body size at menarche 
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Table 2-16.  Summary of Studies of Associations between Human DDT Exposure Metrics in Maternal Serum, 
Cord Blood, or Breast Milk and Reproductive Endpoints in Offspring Biometricsa 
 
Reference and study population DDT exposure metricb Outcome evaluated Resultsc 
Vested et al. 2014 
Maternal-son pairs (n=166)  
Follow-up with male offspring aged 
~20 years  
 
Maternal serum DDE 
Median (ng/mL): 2.55 
Median (ng/g lipid): 288  
 
Tertile exposure levels (nmol/mL) 
T1: 0.0007–0.0063 
T2: >0.0063–0.0106 
T3: >0.0106–0.055 
Sperm concentration, 
total sperm count, 
semen volume, percent 
progressive 
spermatozoa, percent 
motile spermatozoa, 
percent morphologically 
normal spermatozoa, 
mean testicular volume, 
testosterone, free 
testosterone, E2, LH, 
FSH, inhibin B, and 
SHBG 
Adjusted betas for % difference from 
T1 DDE 
 
All adjusted beta coefficients were NS 
Adjusted trend p-values calculated 
using DDE concentrations as a 
continuous variable were NS  
 
 
aSee Table 10 in the Supporting Document for Epidemiological Studies for DDT, DDE, and DDD for more detailed descriptions of studies.  Studies in this table 
were selected from those described in Table 10, because they: (1) measured DDT-related metrics in biological fluids or tissues in each subject, and (2) evaluated 
associations using linear regression, logistical regression, or correlation techniques, adjusting for possible confounding factors. 
bDDE = p,p’-DDE, unless otherwise specified; DDT = p,p’-DDT, unless otherwise specified.  
cBold text, “significant” and asterisk indicate statistically significant (p<0.05).  Arrows indicate an increase or decrease in the reproductive endpoint or direction of 
p-trend.  Adjusted OR or adjusted β indicates adjustment for standard confounding variables for reproductive outcomes, such as total serum lipids, birth weight, 
blood lead levels, age of pubertal onset, smoking, BMI, and height z-scores. 
 
AGD = anogenital distance; AMH = anti-mullerian hormone; API = anal position index; BMI = body mass index; CI = confidence interval; FAI = free androgen 
index; FR = fecundability ratio; FSH = follicle stimulating hormone; LH = luteinizing hormone; LOD = limit of detection; NS = not statistically significant; OR = odds 
ratio; PA = perineal distance; PA/W = perineal distance/weight; Q = quartile; SD = standard deviation; SHBG = sex hormone-binding globulin; T = tertile; 
TT = total testosterone; TUI = time of unprotected intercourse; UI = unprotected intercourse 
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Reproductive Effects in Adults (Table 2-14) 
 
Time to pregnancy (TTP) (fecundity).  Inconsistent evidence comes from five studies of the association 
between serum levels of DDT, DDD, or DDE and TTP (Table 2-14).  Only one study reported an inverse 
association between serum DDE (in male partners) and longer TTP in models adjusted for potential 
confounders (Buck Louis et al. 2013).  The geometric mean concentration of DDE was relatively low, 
0.82 ng/g serum, compared with approximately 1.46 ng/g serum in contemporaneous surveys of U.S. 
adult males (CDC 2018).  DDE levels in women were below the levels of detection.  In two studies, 
inverse associations (found in preliminary analyses) lost statistical significance after models were 
adjusted for maternal age at conception (Axmon et al. 2006) or shellfish consumption and mercury in the 
women’s hair (Chevrier et al. 2013).  Relatively high levels of DDE in women’s serum (Law et al. 2005) 
and of DDE and DDT (p,p’- and o,p’- isomers) (Harley et al. 2008) were not associated with TTP.  
Recently, Buck Louis (2014) reviewed the issue of fecundity and environmental pollutants and noted that 
subtle changes in human fecundity may be easily missed without continued research specifically aimed at 
the preconception enrollment of couples for longitudinal measurement of sensitive outcomes such as TTP 
and pregnancy loss.  The investigator also noted the necessity to consider male-mediated exposures when 
assessing couple-dependent outcomes because failure to do so may lead to the wrong conclusions, 
particularly in the absence of female exposures. 
 
Menstrual cycle.  Six studies provide inconsistent evidence for associations between menstrual cycle 
changes and serum DDE or DDT levels: three reported associations and three reported no association 
(Table 2-14).  High mean total DDT levels (~20–30 ng/g serum compared with <2 ng/g serum) reported 
in contemporaneous surveys of women from the U.S. general population [CDC 2018]) were associated 
with increased prevalence of short cycles and reduced age at menarche (Ouyang et al. 2005) and reduced 
luteal phase length (Windham et al. 2005).  However, in a larger study of women with similar mean 
serum DDE levels (30 ng/mL), no association was found between DDE and menstrual cycle parameters 
(Cooper et al. 2005).  Evaluations of four different populations by Toft et al. (2008) also showed 
inconsistent results between studied groups.  In Inuit women from Greenland, DDE was associated with 
decreased prevalence of long menstrual cycles, whereas in Polish women, DDE was associated with an 
increased risk for long cycles; both cohorts had similar mean serum DDE concentrations: 430 ng/g lipid 
in Polish women and 444 ng/g lipid in the Inuit group.  In the same study, DDE was not associated with 
long cycles in a cohort of Swedish fishermen’s wives who had a significantly higher mean serum DDE 
concentration (2,147 ng/g lipid) (Toft et al. 2008).  No associations between DDE and menstrual cycle 
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parameters were reported among women with low (≤0.35 ng/mL blood) DDE levels (i.e., Denham et al. 
2005; Gallo et al. 2016). 
 
Uterine alterations.  Inconsistent evidence comes from four studies examining associations between 
serum DDE or DDT levels and uterine alterations (Table 2-14).  In one study, women with high serum 
levels of p,p’-DDE (36.95 ng/g serum) had an increased risk for uterine fibroids compared to women with 
lower levels of p,p’-DDE (16.9 ng/g serum); no association was found with p,p’-DDT (Trabert et al. 
2015).  A small study of only 18 endometriosis cases and 8 controls (not shown in Table 2-14) reported a 
higher concentration of DDE (and PCBs) in serum from cases (770 ng/g lipid) than in controls (310 ng/g 
lipid); no further analysis was conducted (Quaranta et al. 2006).  Studies of women with relatively low 
serum levels of total DDT (DDT + DDE) did not find associations between serum levels of DDE or DDT 
and prevalence of endometriosis (Cooney et al. 2010; Porpora et al. 2009; Upson et al. 2013).  
 
Abortion-preterm birth.  Evidence from seven studies suggests that serum levels of DDT, DDD, or DDE 
currently found in the U.S. general population (CDC 2018) may not present increased risks for abortion or 
premature delivery, but increased risk may exist in countries where DDT is still being used (Table 2-14).  
Early fetal loss has been associated with relatively high serum levels of DDE (Korrick et al. 2001; 
Longnecker et al. 2005; Venners et al. 2005).  However, the reported increased ORs were marginally 
significant in two of these studies (Korrick et al. 2001; Longnecker et al. 2005; see Table 2-14).  In the 
latter study, the odds for fetal loss were increased in the third and fourth DDE quintiles compared to the 
first, but not when comparing the second (15–29 ng/mL) or fifth (≥60 ng/mL) with the first quintile.  
However, in a model fitting DDE as a continuous variable, a 60 ng/mL increase in serum DDE level 
increased the risk for fetal loss (OR 1.4 [95% CI 1.1–1.6]).  Two studies from India reported higher levels 
of DDE in placental tissue from women who had preterm delivery compared with women who gave birth 
to full-term babies (Anand et al. 2015; Saxena et al. 1980; described in Table 8 in the Supporting 
Document for Epidemiological Studies for DDT, DDE, and DDD, but not in Table 2-14, because 
regression analysis was not conducted).  Serum ΣDDT was not associated with abortions or preterm birth 
in three modern studies (Ouyang et al. 2014; Torres-Arreola et al. 2003; Wood et al. 2007).  In the 
Ouyang et al. (2014) study, the mean ΣDDT serum concentration in Chinese women (34.4 ng/g serum) 
was higher than those levels measured in the studies mentioned above that reported associations between 
DDE and fetal loss (22–28 ng/g serum) (Korrick et al. 2001; Longnecker et al. 2005; Venners et al. 2005).  
Ouyang et al. (2014) noted that they classified the total DDT concentration as low and high by using a 
median split (30.7 ng/g serum), which may have influenced the results.  Serum concentrations of DDE in 
the Torres-Arreola et al. (2003) and Wood et al. (2007) studies were low (~190 and 67 ng/g lipid, 
DDT, DDE, and DDD  176 
 
2.  HEALTH EFFECTS 
 
 
 
 
 
 
***DRAFT FOR PUBLIC COMMENT*** 
respectively), and in both studies, cases and controls had comparable levels.  Neither DDT nor DDE in 
breast milk collected between 6 and 12 weeks postpartum was associated with preterm birth in a study of 
Australian women; no analysis of the pesticides in blood was conducted (Khanjani and Sim 2006).   
 
Menopause.  Inconsistent evidence for an association between serum DDE levels and early age at 
menopause comes from two studies (Table 2-14).  Cooper et al. (2002) found no association between 
serum DDE and early menopause in a study of 1,407 women when serum DDE was categorized into 
deciles; the median concentration of DDE in serum was 600 ng/g lipid.  Analysis of DDE as a continuous 
variable, however, yielded a marginally higher HR for early menopause (1.1 [95% CI 1.0–1.3]).  In an 
evaluation of 1,442 women participants in NHANES 1999–2008, with a median DDE serum 
concentration of 243 ng/g lipid, serum DDE was associated with early menopause in analyses of serum 
DDE categorized into deciles or when DDE was analyzed as a continuous variable (Grindler et al. 2015).   
 
Reproductive sex hormones.  Inconsistent evidence for associations between serum levels of DDT, DDD, 
or DDE and serum or urine levels of sex hormones or their metabolites is provided by 15 studies 
described in Table 2-14.  Most of the studies (n=13) collected data from men, and only four studies 
collected data from women (Freire et al. 2014; Goncharov et al. 2009; Perry et al. 2006; Windham et al. 
2005).  A wide variety of sex hormones and related chemicals were measured across the studies, 
including testosterone (total, free, or bioavailable), sex-hormone-binding globulin (SHBG), estradiol (E2), 
luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin, progesterone, and inhibin B 
(IHB, which inhibits synthesis and secretion of FSH), as well as androgenic/estrogenic indices such as 
free androgen index (FAI, ratio of testosterone:SHBG), testosterone/estradiol ratio (marker of aromatase 
activity) and testosterone/LH ratio (marker of Leydig cell function).  The inconsistency of the evidence is 
illustrated by Table 2-17 showing the number of studies reporting positive associations, inverse 
associations, and no associations for each examined sex hormone and related endpoints.  For example, 
among the 13 studies in men measuring serum levels of testosterone and related endpoints, 2 found 
positive associations (Giwercman et al. 2006; Hagmar et al. 2001), 2 found inverse associations (Emeville 
et al. 2013; Freire et al. 2014), and 9 found no associations (Blanco-Muñoz et al. 2012; Ferguson et al. 
2012; Goncharov et al. 2009; Haugen et al. 2011; Martin et al. 2002; Rignell-Hydbom et al. 2004; 
Rylander et al. 2006; Schell et al. 2014; Turyk et al. 2006).   
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Table 2-17.  Number of Studies Finding Statistically Significant Associations and 
No Significant Associations Between Serum Levels of DDT, DDD, or DDE and 
Levels of Sex Hormones in Serum or Urinea 
 
Men Testosteroneb SHBG E2c LH FSH PL IHB 
2 ↑ 
2 ↓ 
9 NS 
1 ↑ 
0 ↓ 
6 NS 
1 ↑ 
0 ↓ 
6 NS 
2 ↑ 
0 ↓ 
7 NS 
2 ↑ 
0 ↓ 
7 NS 
0 ↑ 
1 ↓ 
2 NS 
1 ↑ 
1↓ 
3 NS 
Women Testosteroneb E2c PGd FSH PL 
0 ↑ 
0 ↓ 
1 NS 
0 ↑ 
1 ↓ 
2 NS 
0 ↑ 
2 ↓ 
0 NS 
0 ↑ 
0 ↓ 
1 NS 
0 ↑ 
0 ↓ 
1 NS 
 
aStudies counted are from the 15 studies with results described in Table 2-14.  
bEndpoints included in this count were serum testosterone (total, free, or bioavailable), FAI (free androgen index), 
and testosterone/LH ratio.  Only one study evaluated testosterone levels in women (Goncharov et al. 2009). 
cIn all seven studies of men, serum levels of E2 were measured.  In studies of E2 in women, Freire et al. (2014) 
measured serum E2 (association NS), and the major urinary metabolite of E2 was measured by Perry et al. (2006) 
(association NS) and Windham et al. (2005) (↓ association). 
dPerry et al. (2006) and Windham et al. (2005) reported significant inverse associations with the major urinary 
metabolite of progesterone. 
 
↑ = positive association; ↓ = inverse association; E2 = estradiol; FAI = free androgen index; FSH = follicle-stimulating 
hormone; IHB = inhibin B; LH = luteinizing hormone; NS = not statistically significant; PG = progesterone; 
PL = prolactin; SHBG = sex hormone-binding globulin 
 
The inconsistency of the evidence is further illustrated by stratification of the studies into high- (mean or 
median DDE or ΣDDT >5 ng/mL or >600 ng/g lipid) and low-level categories.  Seven high-level studies 
collected data from men (Blanco-Muñoz et al. 2012; Freire et al. 2014; Giwercman et al. 2006; Hagmar et 
al. 2001; Martin et al. 2002; Rylander et al. 2006; Turyk et al. 2006) and three collected data from women 
(Freire et al. 2014; Perry et al. 2006; Windham et al. 2005).  All three high-level women studies evaluated 
E2 levels, but two found no association between serum DDE levels and E2 levels (Friere et al. 2014; 
Windham et al. 2005) and the third found an inverse association (Perry et al. 2006).  In the seven high-
level studies of men, five found associations with at least one sex hormone (Blanco-Muñoz et al. 2012; 
Freire et al. 2014; Giwercman et al. 2006; Hagmar et al. 2001; Rylander et al. 2006), but sex hormones 
showing associations differed among the studies.  For example, Blanco-Muñoz et al. (2012) found no 
association between DDE and serum testosterone, FSH, LH, or E2, an inverse association with prolactin, 
and a positive association with inhibin B in a group of Mexican men, whereas Giwercman et al. (2006) 
reported positive associations with testosterone, SHBG, and LH, inverse associations with inhibin B, and 
no associations with FSH or E2 in a group of Ukrainian men.  Two of seven high-level studies of men 
found no associations: Martin et al. (2002) evaluated several testosterone-related endpoints and Turyk et 
al. (2006) evaluated several testosterone-related endpoints, as well as SHBG, LH, FSH, and estrone 
sulfate.  Contributing to the general inconsistency of the evidence, Emeville et al. (2013), in a low-level 
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study of men, reported inverse associations between serum DDE and dihydrotestosterone and 
testosterone:LH ratio and a positive association with LH.  Other low-exposure studies reported no 
associations between DDE and reproductive sex hormones (Ferguson et al. 2012; Goncharov et al. 2009; 
Haugen et al. 2011; Rignell-Hydbom et al. 2004, 2005a; Schell et al. 2014). 
 
Semen parameters.  Inconsistent evidence for associations between serum levels of DDT, DDD, or DDE 
and changes in semen parameters (e.g., sperm count or concentrations, sperm motility) comes from results 
of nine studies described in Table 2-14.  Associations with changes in a number of sperm parameters were 
found in a study of men with high serum DDE levels (mean of 697 ng/mL) (Aneck-Hahn et al. 2007) and 
in a study of men with relatively low serum ΣDDT levels (mean of ~300 ng/g lipid) (Messaros et al. 
2009).  However, the risk for low sperm concentration was elevated in the low-level study, but not in the 
high-level study.  Charlier and Foidart (2005) found no associations in sperm parameters at serum DDE 
levels 4–5 times higher than those associated with sperm alterations in the Messaros et al. (2009) study.  
Toft et al. (2006) reported associations with decreased sperm motility in a group of men with a mean 
serum DDE concentration of 890 ng/g lipid, but not in a group whose mean serum DDE was 1,270 ng/g 
lipid.  De Jaeger et al. (2006) evaluated a wide range of sperm parameters in a Mexican population living 
in malaria endemic areas in which DDT was sprayed annually and found associations for decreasing 
sperm motility and increasing sperm tail abnormalities, but none for sperm count or concentration.  The 
mean plasma concentration of DDE in the men was 45,000 ng/g lipid, which is approximately 200 times 
higher than levels reported in the most recent survey of men from the U.S. general population (CDC 
2018).  Other low-level studies (mean or median DDE or Σ DDT <5 ng/mL or <600 ng/g lipid) did not 
find associations between DDE and changes in sperm parameters (Dallinga et al. 2002; Hauser et al. 
2003; Rignell-Hydbom et al. 2005b).  Associations between semen levels of DDE or DDD and sperm 
concentration, but not sperm motility, were reported in a single study using this biomarker of DDT 
exposure (Pant et al. 2007). 
 
Reproductive Effects in Preadolescents/Adolescents (Table 2-15).  Inconsistent evidence is provided by 
five studies examining possible associations between serum DDE levels and puberty onset outcomes in 
Russian preadolescent boys, ages 8–9 years (Lam et al. 2014, 2015) and adolescent Belgian boys and 
girls, ages 14–15 years (Croes et al. 2015; Den Hond et al. 2011; Dhooge et al. 2011).  Outcomes were 
Tanner indices of genitalia and pubic hair growth in males (Croes et al. 2015; Den Hond et al. 2011; Lam 
et al. 2014, 2015), breast development in females (Croes et al. 2015; Den Hong et al. 2011), and serum 
levels of sex hormones in male adolescents (Dhooge et al. 2011).  Belgian subjects had relatively low 
levels of serum DDE (geometric mean 105 ng/g lipid), lower or comparable to those measured in the most 
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recent survey of U.S. teenagers (CDC 2018), whereas the Russian boys had higher serum DDE levels 
(median 287 ng/g lipid).  In Russian boys, no associations were found for shifts in attaining early 
milestones for genitalia growth, testicular volume, or pubic hair growth (Lam et al. 2014), but at later 
stages of development, the highest DDE exposure quartile showed later attainment of Tanner pubic hair 
growth stage five (P5) than the first quartile (Lam et al. 2015).  In contrast, data for Belgian boys showed 
associations between DDE serum levels and faster attainment of genitalia growth and pubic hair growth 
milestones (Croes et al. 2015; Den Hond et al. 2011).  In Belgian boys, an association was found between 
DDE levels and increasing E2 levels, but no associations with other levels of reproductive sex hormones 
(Dhooge et al. 2011).  In Belgian girls, an association between DDE levels and delayed development was 
observed in one study group (Croes et al. 2015), but not in another study group (Den Hond et al. 2011). 
 
Maternal Exposure and Effects in Neonates/Infants/Adults (Table 2-16).  Results from six studies 
described in Table 2-16 provide consistent evidence for no association between maternal DDT, DDE, or 
DDD levels in serum, cord blood, breast milk, or placenta and risk for the male birth defects, 
cryptorchidism (undescended testes) or hypospadias (condition in which the opening of the urethra is on 
the underside of the penis) (Bhatia et al. 2005; Brucker-Davis et al. 2008; Damgaard et al. 2006; 
Fernandez et al. 2007; Giordano et al. 2010; Longnecker et al. 2002).  Two of these studies looked for 
associations in study groups with high maternal serum levels (Bhatia et al. 2005: mean of 5,200 ng 
DDE/g lipid; Longnecker et al. 2002: case medians of 24–32 ng DDE/mL), but reference groups for the 
statistical comparisons in these studies, although 2–4-fold lower than the high-level groups, were still 
high, compared with U.S. general population values (CDC 2018).  Markers of androgen action such as 
AGD were not associated with ΣDDT in two studies (Longnecker et al. 2007; Torres-Sanchez et al. 
2008), except for a decrease in anal position index (a non-age-dependent measurement) in boys and DDE 
from maternal serum collected in the first trimester (but not 2nd or 3rd trimesters) in the Torres-Sanchez et 
al. (2008) study.   
 
Four studies provided consistent evidence for no associations between maternal exposures to DDT and 
adverse reproductive outcomes in their adult offspring.  Two studies examined age at menarche and time 
to pregnancy (fecundity) in daughters from mothers exposed through consumption of Great Lakes fish 
(Han et al. 2016; Vasiliu et al. 2004); the other two studies measured sex hormones and menstrual cycle 
length in adult Danish daughters (Kristensen et al. 2016) and sperm parameters and sex hormones in adult 
Danish sons (Vested et al. 2014). 
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Evidence of Reproductive Effects of DDT, DDD, or DDE in Laboratory Animals 
 
Overview.  The principal reproductive effects of DDT and related compounds in laboratory animals have 
been observed at dose levels >1 mg/kg/day, and are thought to involve anti-androgenic activities (e.g., 
androgen-receptor binding and impaired male reproductive tissue development) of p,p’ isomers of DDT, 
DDE, or DDD and estrogenic activities (e.g., estrogen-receptor binding and promotion of female 
reproductive tissue development) of o,p’-DDT (see Harada et al. 2016; Hojo et al. 2006; Kelce et al. 
1995, 1997; Yamasaki et al. 2009; You et al. 1998, 1999a).   
 
Reliable acute-duration oral LOAELs for adverse effects on reproductive tissues or reproductive function 
in laboratory animals range from 50 to 200 mg/kg/day for decreased weights of male reproductive tissues 
from p,p’-DDT, technical DDT, technical DDD, or p,p’-DDE and from 100 to 500 mg/kg/day for 
increased uterine weight from o,p’-DDT (see Table 2-1, Figure 2-2, and text below).  
 
After intermediate-duration exposure, decreased fertility has been observed in adult laboratory animals at 
doses ranging from 5.1 to 51.4 mg technical DDT/kg/day (Bernard and Gaertner 1964; Jonsson et al. 
1976; Ledoux et al. 1977), but was not observed in other studies at dose levels up to 4 mg 
o,p’-DDT/kg/day (Wrenn et al. 1971), 10 mg p,p’-DDE/kg/day (Kornbrust et al. 1986), or 27.7 mg 
p,p’-DDT/kg/day (Hojo et al. 2006).  The lowest apparent intermediate-duration LOAELs for other male 
and female reproductive effects are 3.75 mg/kg/day for decreased estradiol levels in female rats (Hojo et 
al. 2006), 6.25 mg p,p’-DDT/kg/day for decreased seminal weight in castrated mice (no effects were 
found in normal mice) (Orberg and Lundberg 1974) and 2 mg p,p’-DDT/kg/day in female mice exposed 
for 72–74 days before mating to nonexposed males for small decreases in the number of implants and 
decreased corpus luteum (Lundberg 1973, 1974). 
 
No adverse effects on indices of reproduction in laboratory animals were observed in several chronic oral 
multiple generation studies, which identified NOAELs of 0.5–18.6 mg technical DDT/kg/day in rats 
(Duby 1971; Ottoboni 1969, 1972; Treon et al. 1954), 10 mg technical DDT/kg/day in dogs (Ottoboni et 
al. 1977), 0.3 mg o,p’-DDT/kg/day (Duby et al. 1977), and up to 27 mg p,p’-DDT/kg/day in rats (Duby et 
al. 1977; Hojo et al. 2006), but decreased fertility was observed in a multiple-generation study of mice at 
20 mg technical DDT/kg/day (Keplinger 1970).  Histological examination revealed no exposure-related 
abnormalities in the ovaries, uterus, mammary glands, adrenals, or prostate of Osborne-Mendel rats or 
B6C3F1 mice fed dietary doses for 78 weeks up to 45 mg technical DDT/kg/day, 59 mg 
DDT, DDE, and DDD  181 
 
2.  HEALTH EFFECTS 
 
 
 
 
 
 
***DRAFT FOR PUBLIC COMMENT*** 
p,p’-DDE/kg/day, or 231 mg technical DDD/kg/day (rats) and 30.2 mg technical DDT/kg/day, 49 mg 
p,p’-DDE/kg/day, or 142 mg technical DDD/kg/day (mice) (NCI 1978). 
 
Acute-duration studies.  As shown in Table 2-1 and Figure 2-2, decreased weights of male reproductive 
tissues (e.g., seminal vesicles and ventral prostate) and decreased reproductive function have been 
observed after acute-duration exposure of male rats to DDT (NS), p,p’-DDT or p,p’-DDE, and increased 
uterine weights have been observed after acute exposure of female rats to o,p’-DDT.  
 
Decreases in weights of seminal vesicles or ventral prostate were observed in male adult Long-Evans or 
Sprague-Dawley rats given gavage doses of 200 mg p,p’-DDE/kg/day for 4 or 5 days, without changes in 
serum testosterone levels, but not at doses up to 100 mg p,p’-DDE/kg/day (Kelce et al. 1995, 1997; 
Leavens et al. 2002); castrated Sprague-Dawley 6-week-old rats supplemented with subcutaneous 
testosterone and co-exposed to gavage doses ≥50 mg p,p’-DDT/kg/day for 10 days (Kang et al. 2004); 
and adult male rats given gavage doses of 70 mg p,p’-DDE/kg/day for 4 days (You et al. 1999a).  Other 
reported male reproductive effects include decreases in levator ani plus bulbocanvernosus muscles and 
Cowper’s gland in castrated rats supplemented with subcutaneous testosterone and administered 100 mg 
p,p’-DDT /kg/day via gavage for 10 days (Kang et al. 2004); decreased serum testosterone, but not LH or 
FHS, in male rats treated with 200 mg p,p’-DDE for 2 weeks by gavage (Krause 1977), and significantly 
decreased number of fetuses and implantations in non-exposed female rats mated with male rats given 
500 mg DDT(NS)/kg/day on PNDs 4 and 5 (Krause et al. 1975).  No significant changes in reproductive 
organ weights, histology of testis or epididymis, or sperm morphology or motility were observed in adult 
male Sprague-Dawley rats exposed once to 100 mg p,p’-DDT/kg, or to 50 mg p,p’-DDT/kg/day for 
5 days (Linder et al. 1992). 
 
Increased uterine weight as a result of o,p’-DDD exposure was observed in immature (23-day-old) female 
Wistar rats after 3 or 7 days exposure to dietary doses ≥100 mg o,p’-DDT/kg/day, accompanied by 
increased glycogen content and premature vaginal opening (Clement and Okey 1972) and in 
ovariectomized female DA/Han rats given 3 daily gavage doses ≥100 mg o,p’-DDT/kg/day, but not 
10 mg/kg/day (Diel et al. 2000).  
 
Acute-duration oral exposure of laboratory animals to p,p’-DDT, p,p’-DDE, o,p’-DDT, or o,p’-DDD 
during gestation has produced effects on developing reproductive tissues and reproductive functions in 
adults (see Section 2.17 for more details and references). 
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Intermediate-duration studies.  Fertility has been assessed in adult laboratory animals after intermediate-
duration exposures to technical DDT, p,p’-DDE, p,p’-DDT, or o,p’-DDT (see Table 2-1 and Figure 2-2).  
An early study (Green 1969) reported decreased fertility when parental male and female Sprague-Dawley 
rats were fed diets of approximately 0.56 mg DDT/kg/day (only level tested, presumably technical DDT) 
for 60 days before mating, but this apparent LOAEL for decreased fertility was not included in Table 2-1 
and Figure 2-2 due to insufficient reporting of study details.   
 
Decreased fertility after intermediate exposure to technical DDT has been reported for female Sprague-
Dawley rats exposed to 12 mg technical DDT/kg/day in food, but not to 6 mg/kg/day, for 36 weeks before 
mating to nonexposed males (Jonsson et al. 1976); female C-57 mice exposed to 51.4 mg technical 
DDT/kg/day in food, but not to 34.3 mg/kg/day, for up to 60–90 days before mating to non-exposed 
males (Bernard and Gaertner 1964); and pairs of male and female B6D2F1 mice exposed to ≥5.1 mg 
technical DDT/kg/day in food for 130 days before mating, but not in pairs exposed to up to 3.4 mg/kg/day 
for 86 days before mating (Ledoux et al. 1977).   
 
Other studies reported no effects on fertility in female Sprague-Dawley rats exposed to up to 4 mg 
o,p’-DDT/kg/day in food for up to 20 weeks before mating to nonexposed males (Wrenn et al. 1971); 
female Sprague-Dawley rats given gavage doses of 10 mg p,p’-DDE/kg/day for 5 weeks before mating to 
nonexposed males (Kornbrust et al. 1986); pairs of male and female BALB/c mice exposed to 1.3 mg 
technical DDT/kg/day in food for 30 days before mating and 90 days beyond mating (Ware and Good 
1967); New Zealand rabbits given gavage doses of 3 mg technical DDT/kg/day, 3 times/week for 12–
15 weeks before artificial insemination, but a decreased ovulation rate and slight decrease in circulating 
progesterone levels (Lindenau et al. 1994; Seiler et al. 1994); and F0 parental male and female Sprague-
Dawley rats exposed for 10 weeks before mating to dietary doses up to 25 or 27.7 mg p,p’-DDT/kg/day, 
respectively, but altered circulating levels of sex hormones in F0 females, but not in F0 males (Hojo et al. 
2006). 
   
Other findings for male reproductive effects after intermediate-duration exposure include decreased testis 
weight and Sertoli cell numbers in male rats exposed to gavage doses of 200 mg p,p’-DDT/kg/day on 
PNDs 4–23 and mated to nonexposed female rats on PND 60 or 90, as well as decreased number of 
fetuses and implants in the pregnant dams (Krause et al. 1975); and decreased seminal vesicle weight in 
castrated adult NMRI mice supplemented with testosterone and exposed to 6.25 mg p,p’-DDT/kg/day in 
food for 28 days, but not in similarly exposed nonsurgically modified mice (Orberg and Lundberg 1974).  
No significant changes in serum levels of sex hormones, sperm counts, and relative weights or histology 
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of reproductive organs were observed in sexually immature male F344 rats exposed to 10 mg p,p’-DDE 
in food from 6 to 12 weeks of age (Makita et al. 2003a). 
 
Other female reproductive effects include small (~12%) decreases in the number of implants and 
decreased number of corpus luteum in female NMRI mice exposed to 2 mg p,p’-DDT/kg/day for 72–
74 days before mating to nonexposed males (Lundberg 1974) and decreased serum estradiol levels and 
increased progesterone (with no effects on fertility) in F0 female Sprague-Dawley rats fed dietary doses 
≥3.75 or 27.7 mg p,p’-DDT/kg/day, respectively, for 10 weeks before mating with exposed males (Hojo 
et al. 2006).   
 
Chronic-duration studies.  In chronic multi-generation exposure-duration studies, no adverse effects on 
reproduction functions were observed in rats fed up to 18.6 mg technical-grade DDT/kg/day in the diet 
for 2 generations (Ottoboni 1969), 1.25 mg/kg/day for 3 generations (Treon et al. 1954), or 1.7 mg/kg/day 
for 11 breedings (Ottoboni 1972).  Duby et al. (1971) found no reproductive effects in two successive 
generations of rats fed technical-grade DDT (0.5 mg/kg/day), p,p’-DDT (1.5 mg/kg/day) or o,p’-DDT 
(0.3 mg/kg/day).  Hojo et al. (2006) found no effects on reproduction functions in F0 and F1 Sprague-
Dawley rats exposed to dietary doses up to 25 (males) and 27.7 (females) mg p,p’-DDT/kg/day.  
 
The results of a chronic-duration dietary study showed no treatment-related adverse effects on the ovaries, 
uterus, mammary glands, prostate, or adrenals of Osborne-Mendel rats treated in the diet with up to 45 mg 
technical DDT/kg/day, 59 mg p,p’-DDE/kg/day, or 231 mg technical DDD/kg/day (NCI 1978).  The same 
findings were reported for B6C3F1 mice treated with up to 30.2 mg technical DDT/kg/day, 49 mg 
p,p’-DDE/kg/day, or 142 mg technical DDD/kg/day (NCI 1978).  Reproductive function was not 
evaluated in the NCI (1978) study.   
 
In mice, no adverse effects on reproduction were observed in field mice fed 2.4 mg technical DDT/kg/day 
in food for 15 months (Wolfe et al. 1979), but in multiple-generation studies of laboratory mice, 
decreased fertility was observed in Swiss Webster mice fed 20 mg technical DDT/kg/day, but not 
5 mg/kg/day (Keplinger 1970).  No significant reproductive effects were reported in a 3-generation study 
in dogs dosed with up to 10 mg technical DDT/kg/day (Ottoboni et al. 1977). 
 
Mechanisms of Reproductive Effects of DDT, DDD, or DDE.  DDT and related compounds have been 
associated with altered reproductive outcomes in some epidemiological studies and laboratory animal 
studies.  These effects are thought to involve anti-androgenic activities (e.g., androgen-receptor binding 
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and impaired male reproductive tissue development) of p,p’-DDE, and estrogenic activities (e.g., 
estrogen-receptor binding and promotion of female reproductive tissue development) of o,p’-DDT (see 
Harada et al. 2016; Kelce et al. 1995, 1997; Yamasaki et al. 2009; You et al. 1998, 1999a).   
 
Numerous studies have shown that o,p’-DDT has estrogenic activities, albeit relatively weak properties, 
compared with 17β-estradiol.  For example, o,p’-DDT showed significantly stronger estrogenic activity 
for initiating implantation and in increasing uterine weight in young rats than p,p’-DDT (Johnson et al. 
1992; Singhal et al. 1970).  Welch et al. (1969) reported an estrogenic activity ranking of o,p’-DDT > 
technical DDT > p,p’-DDT in immature female rats treated intraperitoneally.  In various in vitro assays 
for estrogenicity, however, o,p’-DDT gave positive estrogenic responses, but with a potency that was 
several orders of magnitude weaker than 17β-estradiol and diethylstilbestrol (DES, a synthetic form of 
estrogen) (Soto et al. 1997).  In one assay, o,p’-DDT, o,p’-DDD, and p,p’-DDT were full estrogenic 
agonists, p,p’-DDE and p,p’-DDD were partial agonists, and technical DDT was a full agonist.  In another 
study, it took 107 times more o,p’-DDT, o,p’-DDD, p,p’-DDT, p,p’-DDE, p,p’-DDD, and technical DDT 
to produce an estrogenic response comparable to that of 17β-estradiol (Soto et al. 1998).  Additional 
assays that used gene expression and transcription mediated by estrogen receptor activation showed 
o,p’-DDT’s estrogenic activity to be at least 105 less potent than 17β-estradiol in inducing estrogen-
regulated gene transcription (Balaguer et al. 1999; Gaido et al. 1997; Sohoni and Sumpter 1998; Tully et 
al. 2000).  Results from in vitro studies also have shown that o,p’- isomers can compete with estradiol for 
binding to the estrogen receptor, although with a binding affinity significantly lower than 17β-estradiol 
(Danzo 1997; Kelce et al. 1995).  Experiments also showed that p,p’-DDT, p,p’-DDE, and p,p’-DDD 
were relatively ineffective in binding to the estrogen receptor (Kelce et al. 1995).   
 
Other studies have shown that the environmentally persistent metabolite, p,p’-DDE, has anti-androgenic 
activity (Kelce et al. 1995, 1997; You et al. 1998, 1999a).  In competitive androgen receptor binding 
assays of p,p’-DDT, p,p’-DDE, o,p’- DDT, and p,p’-DDD, the four chemicals showed dose-dependent 
competitive inhibition, but p,p’-DDE was the greatest competitor with an inhibition constant similar to 
that of DES and about 30 times weaker than 17β-estradiol (Kelce et al. 1995).  The other three isomers 
were 12–20-fold less effective than p,p’-DDE.  Experiments also showed that p,p’-DDT, p,p’-DDD, and 
p,p’-DDE bound the androgen receptor 14, 11, and 200 times more effectively than the estrogen receptor, 
respectively (Kelce et al. 1995).  Maness et al. (1998) also showed that among DDT compounds, 
p,p’-DDE was the most potent for inhibiting androgen receptor regulated gene expression in a human cell 
line transiently transvected with the human androgen receptor and a reporter gene linked to an androgen 
responsive promoter.  More recently, Tinwell et al. (2007) showed that the inhibitory action of p,p’-DDE 
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on the weight of the ventral prostate of immature male rats was associated with a 4.4-fold increase in 
activity of L-amino oxidase, a protein associated with apoptosis and suggested that this protein has the 
potential to be a biomarker for endocrine disruption.  
 
Results from several studies suggest that Sertoli cells may be involved in DDT (DDT, DDE, DDD)-
induced alterations in sperm parameters.  Sertoli cells facilitate the progression of germ cells to 
spermatozoa, are activated by FSH, and produce the protein complex inhibin, which inhibits FSH 
synthesis and secretion.  For example, in vitro incubation of Sertoli cells from immature rats with DDE 
resulted in decreased survival of the cells that appeared to be mediated by down-regulation of transferrin 
and up-regulation of androgen-binding protein (ABP) (Xiong et al. 2006).  Both transferrin and ABP are 
glycoproteins produced and secreted by Sertoli cell into the lumen of the tubule and play an important 
role on differentiation and maturity of sperm.  In vitro studies also have shown that DDT can reduce the 
number of FSH binding sites in Sertoli cells by triggering degradation of FSH receptors (Bernard et al. 
2007), or by affecting intercellular junctions by altering the amount or inducing aberrant localizations of 
protein components of Sertoli cell tight junctions, specifically connexin 43 (Fiorini et al. 2004).  Other 
studies have suggested that DDE can induce apoptotic Sertoli cell (and germ cell) death by mechanisms 
involving elevation of reactive oxygen species (ROS), reduction of mitochondria membrane potential, and 
induction of apoptotic activating factors, ultimately leading to altered spermatogenesis (Mota et al. 2011; 
Quan et al. 2016; Shi et al. 2009, 2013; Song et al. 2008, 2011).  Results from a study of in vivo exposure 
of rats to DDE as well as exposure of Sertoli cells to DDE in vitro showed that DDE can alter mRNA and 
protein expression of vimentin, N-cadherin, and FSH receptors (Yan et al. 2013).  Vimentin protein is an 
important component of the Sertoli cell cytoskeleton and plays a key role in anchoring germ cells to the 
seminiferous epithelium.  N-Cadherin play an important role in cell-cell adhesions and has been found in 
spermatogonia, primary spermatocytes, and Sertoli cells.  FSH receptor expression controls the magnitude 
of FSH stimulatory action on Sertoli cells.  
 
Results from a study of in vitro incubation of human sperm with DDE in a medium simulating exposure 
in the female reproductive tract showed that DDE increased intracellular levels of calcium in sperm cells, 
prematurely triggering acrosomal loss through acrosomal reaction or by damaging sperm membranes 
(Tavares et al. 2013).  Results from a more recent study from the same group of investigators suggested 
that DDE promoted mitochondrial calcium overload that in turn induced mitochondrial malfunction 
affecting sperm motility and, ultimately, male fertility (Tavares et al. 2015).  
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Leydig cells have also been shown to be potential targets for DDT via the adrenal toxicant metabolite, 
3-methylsulphonyl-DDE.  LH stimulates Leydig cells to produce testosterone; prolactin increases the 
response of Leydig cells to stimulation by LH.  Castellanos et al. (2013) reported that incubation of 
unstimulated primary neonatal porcine cells with 3-methylsulphonyl-DDE resulted in a concentration-
dependent increased secretion of testosterone and estradiol; however, in LH-stimulated cells treated with 
3-methylsulphonyl-DDE, there was decreased secretion of testosterone, estradiol, and progesterone.  In 
addition, the expression of important steroidogenesis genes was down-regulated in LH-stimulated cells.  
These results suggested that the endocrine-disruptive activity of 3-methylsulphonyl-DDE is determined 
by the physiological status of the Leydig cells.  Proteonomic analysis of unstimulated and LH-stimulated 
cells showed that 3-methylsulphonyl-DDE was acting on several pathways, including mitochondrial 
dysfunction, oxidative phosphorylation, EIF2-signaling, and glutathione-mediated detoxification 
(Kalayou et al. 2016).   
 
Studies have also assessed ovarian function in relation to DDT exposure; most of the research has been 
conducted using in vitro cell populations.  p,p’-DDE increased proliferation of porcine granulosa cells, 
decreased FSH-stimulated cAMP in these cells and in cultured Chinese hamster ovary cells, and 
decreased progesterone synthesis in granulosa cells (Chedrese and Feyles 2001).  The fact that estradiol 
could not mimic the DDE-induced decrease in progesterone suggests that DDE also possess non-
estrogenic endocrine disrupting properties.  p,p’-DDE was also shown to increase the concentration of 
calcium in human granulosa-lutein cells in culture by rapid mobilization calcium from extra- and 
intracellular sources, which could possibly affect the calcium response to FSH and human chorionic 
gonadotropin (Younglai et al. 2004a).  Similar results were obtained when cells were incubated with 
o,p’-DDE; a mechanism involving a G-protein-coupled membrane receptor in the increase in cytoplasmic 
calcium was proposed (Wu et al. 2006).  Further studies from the same group showed that p,p’-DDE can 
increase FSH stimulation of aromatase activity in human granulosa cells, which could result in 
overproduction of estradiol early in folliculogenesis and acceleration of oocyte maturation resulting 
ultimately in impaired fertilization (Younglai et al. 2004b).  Incubation of human granulosa cells with 
p,p’-DDE also resulted in significant increases in the expression of the growth factors, vascular 
endothelial growth factor and insulin-like growth factor-1, both of which appear to play a key role in 
ovarian follicular development and corpus luteum function (Holloway et al. 2007).  Similar results were 
obtained in ovarian tissue from young rats treated with a single dose of 100 µg p,p’-DDE/kg and 
sacrificed 20 days later (Holloway et al. 2007). 
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2.17   DEVELOPMENTAL 
 
This section discusses human epidemiological evidence for effects on birth outcomes and subsequent 
postnatal growth patterns and evidence in laboratory animals exposed during gestation and/or early 
postnatal periods for fetotoxicity, birth weights and postnatal growth patterns, and developmental effects 
on neurological and reproductive systems. 
 
Epidemiology Studies of Gestational or Early Life Exposures on Birth Outcomes and Subsequent 
Postnatal Growth Patterns  
 
Birth outcomes.  Inconsistent evidence is provided by 29 epidemiological studies examining possible 
associations between maternal serum or cord blood levels of DDT, DDD, or DDE and birth weight 
(Table 2-18).  Eleven of these studies reported associations with decreased birth weight or birth weight 
status (Al-Saleh et al. 2012; De Cock et al. 2016; Govarts et al. 2012; Lenters et al. 2016; Longnecker et 
al. 2001; Lopez-Espinosa et al. 2011; Robledo et al. 2015; Sharma et al. 2012; Siddiqui et al. 2003; 
Weisskopf et al. 2005; Wojtyniak et al. 2010), three studies reported associations with increased birth 
weight (Arrebola et al. 2016; Tan et al. 2009; Weihe et al. 2003), one study reported both a decrease and 
an increase in birth weight (Kezios et al. 2013), and one study reported both a decrease and no association 
with body weight (Casas et al. 2015).  The remaining 13 studies found no associations with birth weight 
or birth weight status (Bergonzi et al. 2011; Bjerregaard et al. 2000; Farhang et al. 2005; Fenster et al. 
2006; Gladen et al. 2003; Guo et al. 2014; Jusko et al. 2006; Karmaus and Zhu 2004; Khanjani and Sim 
2006; Ribas-Fito et al. 2002; Sagiv et al. 2007; Vafeiadi et al. 2014; Wolff et al. 2007).  Two meta-
analysis reports are included in Table 2-18 (Casas et al. 2015; Govarts et al. 2012).  Both of these meta-
analyses focused on birth weight data from study populations in European birth cohorts (comprising 
8,825 and 7,530 mother-infant pairs, respectively), and found no association between maternal DDT-
related biometrics and decreased infant weight at birth in the combined datasets using multiple linear 
regression techniques.   
 
Some studies in Table 2-18 also included other birth measures such as birth length or length status 
[including crown-heel length (CHL) and small length for gestational age (SLGA)], gestational age or 
length, preterm birth, and head circumference.  Evidence for associations of these birth parameters with 
maternal DDT-related biometrics also was inconsistent across studies.  For example, 12 studies evaluated 
gestational age or length: 3 found associations with decreased duration of gestation (Al-Saleh et al. 2012;  
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Table 2-18.  Summary of Studies of Associations Between Human Maternal DDT Exposure Metrics and Offspring 
Weight and Growth Endpoints at Birtha 
 
Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Birth parameters  
Al-Saleh et al. 2012 
1,571 consenting 
mother-infant pairs 
 
Mean cord blood and maternal serum 
(ng/mL), placenta (ng/g)  
 Serum Placenta Cord 
DDE 0.551 10.167 0.197   
DDT 0.008 29.620 0.005 
DDD 0.002 7.042 0.005 
HC, CHL, 
BW, BL, PI, 
SGA 
Adjusted betas for a 1-log10 unit change in DDT metrics 
 Serum  Placenta  
 DDE  DDE  DDT  DDD 
HC -0.112*↓ NS   NS  NS 
CHL -0.116*↓ -0.132*↓ -0.101*↓ -0.141*↓ 
BW -0.109*↓ -0.065*↓ NS  NS 
BL -0.121*↓ -0.055*↓ NS  NS 
PI  NS  NS  NS  NS 
Adjusted ORs  
SGA 1.494*  NS   NS  NS 
Arrebola et al. 2016 
200 mother-infant 
pairs 
Cord blood DDE and o,p’-DDT (ng/mL) 
percentiles 
  25th 50th 75th  
DDE   0.26  1.01  2.52 
o,p’-DDT 0.10 0.22 0.37 
 
BW, GA, 
BH, PI, HC  
Adjusted betas for  
 p,p’-DDE o,p’-DDT  
BW 0.008*↑  NS 
GA -0.004*↓ NS 
BH NS  NS 
HC NS   NS 
PI NS  NS 
Bergonzi et al. 2011 
70 mother-infant pairs 
Maternal serum, adipose, cord blood 
and placenta DDE and DDT 
Geometric mean (ng/g lipid) 
  DDE DDT 
Serum  130.0 ND 
Cord blood  0.26 ND 
Placenta 70.0  ND 
Adipose 236.0 7.6 
BW, BL, 
HC, SGA, 
SLGA 
Adjusted ORs for SGA or SLGA with DDE or DDT in any tissue 
or fluid: NS 
Adjusted betas for BW, BL, or HC with DDE or DDT in any tissue 
or fluid: NS 
Except increased BL with DDT in adipose (p<0.01) 
Bjerregaard et al. 
2000 
136 mother-infant 
pairs 
Maternal serum, and cord blood DDE, 
DDT, and ΣDDT 
Geometric mean (ng/mL)  
  DDE DDT ΣDDT 
Cord blood 3.7 0.1 3.8  
BW, GL  Adjusted betas for BW or GL with DDE, DDT or ΣDDT: NS 
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Table 2-18.  Summary of Studies of Associations Between Human Maternal DDT Exposure Metrics and Offspring 
Weight and Growth Endpoints at Birtha 
 
Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Casas et al. 2015 
8,825 mother-infant 
pairs from 11 
European birth cohorts 
forming 14 study 
populations 
 
See Govarts et al. 
2012 for earlier 
analysis of the data 
from the same 
datasets. 
Cord blood DDE across 14 study 
populations, ng/mL 
Mean: 0.846   
25th percentile: 0.2 
75th percentile: 1.0   
BW Adjusted betas for change in birth weight (g) per ng/mL DDE 
13 study populations: each NS 
1 study population: -0.058*↓  
Over all populations: NS  
De Cock et al. 2016 
91 mother-infant pairs 
58 males, 31 females 
Mean cord blood, milk and total DDE 
Cord blood: 0.133 
Milk: 2.381 
 
Tertile levels not provided 
BW Adjusted betas for T3 versus T1 DDE 
 Boys   Girls 
BW -325.9*↓ 401.1 (p=0.086) 
 
Farhang et al. 2005 
420 mother-infant 
pairs 
Infants with hypospadias 
or cryptorchidism 
(n=155); control infants 
(n=265) 
 
Maternal serum levels (ng/mL)  
  DDE  DDT 
Q1 ≤31.5  ≤8.1  
Q2 31.7–42.5 8.2 – 11.0 
Q3 42.6–54.7 11.1–16.2 
Q4 ≥57.5   ≥16.3 
Pre-term 
birth, SGA, 
BW, GA 
Adjusted ORs or betas for Q4 versus Q1 
  DDE DDT  
Pre-term OR NS NS  
SGA OR NS NS  
BW beta  NS  NS 
GA beta  NS NS  
Fenster et al. 2006 
385 mother-infant 
pairs 
Maternal serum levels  
geometric mean (ng/g lipid) 
DDE: 1,363.0  
DDT: 20.6  
o,p’-DDT: 1.6  
 
GL, BW, 
CHL 
Adjusted beta per 10-fold change in metric 
  GL BW CHL 
DDE  NS NS NS 
DDT  NS  NS NS 
o,p’-DDT NS  NS NS 
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Table 2-18.  Summary of Studies of Associations Between Human Maternal DDT Exposure Metrics and Offspring 
Weight and Growth Endpoints at Birtha 
 
Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Gladen et al. 2003 
197 mother-infant 
pairs 
Milk, cord blood, and placenta DDE and 
DDT (ng/g lipid).  
Milk tertiles 
 DDE DDT 
T1  1,900 257 
Median 2,457 336 
T3  3,250 425 
BW, relative 
weight (ratio 
of observed 
weight to 
mean for 
gestational 
age) 
Adjusted mean BW and relative weights by tertile (T3 versus T1) 
   DDE DDT 
Birth weight  NS NS 
Relative weight  NS NS 
Govarts et al. 2012 
7,530 mother-infant 
pairs from 
12 European birth 
cohorts (13 study 
populations) 
Mean cord blood levels for study 
populations ranged from 0.075 to 
1.708 ng/mL  
BW Adjusted betas for change in birth weight (g) per ng/mL DDE 
12 study populations: each NS 
1 study population: -0.071*↓  
Over all populations: NS  
Guo et al. 2014 
81 mother-infant pairs 
Geometric mean maternal serum and 
cord blood DDT metrics (ng/g lipid)  
 Serum Cord blood 
p,p’-DDE 203.54 116.14 
p,p’-DDT 14.68 5.41 
o,p’-DDE 0.62 0.85 
o,p’-DDT 2.51 3.39 
p,p’-DDD 1.07 0.66 
ΣDDT 245.82 146.03 
BW Adjusted betas for change in BW per unit metric 
  Serum Cord blood 
p,p’-DDE  NS  NS 
p,p’-DDT  NS  NS 
p,p’-DDD  NS  NS 
ΣDDT  NS NS 
Jusko et al. 2006 
399 mother-infant 
pairs 
Mean maternal serum DDT metrics (ng/g 
lipid)  
p,p’-DDE: 6,850 
p,p’-DDT: 1,930 
o,p’-DDT: 270  
ΣDD: 9,050 
BW, 
adjusted 
BW (z-
score), GA, 
BL, HC 
Adjusted betas comparing 75th to 25th percentiles DDT metrics 
 DDE DDT o,p’-DDT ΣDDT 
BW NS NS NS NS 
BWz NS NS NS  NS 
GA NS NS NS NS 
BL NS NS NS NS 
HC NS NS NS  NS 
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Table 2-18.  Summary of Studies of Associations Between Human Maternal DDT Exposure Metrics and Offspring 
Weight and Growth Endpoints at Birtha 
 
Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Karmaus and Zhu 
2004 
168 mother-infant 
pairs 
Maternal serum DDE ng/mL 
Q1: <5.0 
Q2: 5.0–15.0 
Q3: 15–<25 
Q4: ≥25 
BW, SGA Adjusted BWs (g) (5–95 percentiles) 
Q1: 3,278 (2,979–3,577) 
Q4: 3,278 (3,065–3,815) 
 
OR for SGA: NS 
Kezios et al. 2013 
600 mother-infant 
pairs 
Mean maternal serum DDT metrics 
(ng/mL) 
p,p’-DDE: 44.2 
p,p’-DDT: 12.9  
o,p’-DDT: 0.58 
BW, GL, 
SGA 
Adjusted betas for 1-ln unit increase in DDT metrics 
 DDE  DDT o,p’-DDT  
BW -153*↓ 274*↑ NS 
GA -0.49*↓ NS  NS 
Adjusted ORs 
SGA NS NS NS 
Khanjani and Sim 
2006 
815 mother-infant 
pairs 
Milk DDE, DDT, DDD, and ΣDDT (ng/g 
lipid) 
  DDE  DDT 
Low  0–400   0–39 
Medium  >400–730 >39–66 
High  >730  >66 
SGA, LBW, 
HC, BW 
Adjusted ORs for high (DDT metrics) compared with low 
  DDE DDT 
LBW  NS  NS 
SGA  NS NS 
 
Adjusted means HC 
  Low Medium  High 
DDE ref NS  NS 
DDT ref NS  NS 
Lenters et al. 2016 
1,298 maternal-infant 
pairs 
Greenland (n=513), 
Poland (n=180),  
Ukraine (n=557).  
Mean maternal serum DDE.   
Pooled median exposure level: 
3.39 ng/mL 
BW Adjusted betas for change in BW per 2-SD increase in ln-
transformed DDE 
 Penalized method: -47.02*↓ 
 Unpenalized method: -66.70*↓ 
 
Penalized linear regression model simultaneously adjusted for 
other measured exposure variables.  
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Table 2-18.  Summary of Studies of Associations Between Human Maternal DDT Exposure Metrics and Offspring 
Weight and Growth Endpoints at Birtha 
 
Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Longnecker et al. 
2001 
2,380 mother-infant 
pairs 
Maternal serum DDE and DDT. DDE 
Exposure groups (ng/mL) 
Group 1: ≤15  
Group 2: 15–29  
Group 3: 30–44  
Group 4: 45–59   
Group 5: ≥60 
DDT levels not shown 
 BW, BL, 
HC, SGA, 
Preterm 
birth 
Adjusted ORs versus G1 
  Preterm birth SGA 
  <37 weeks <2,500 g 
Group 1 ref   ref  
Group 2 1.5*↑  2.0*↑  
Group 3 1.6*↑  2.3*↑ 
Group 4 2.5*↑  2.9*↑ 
Group 5 3.1*↑  4.1*↑ 
Lopez-Espinosa et 
al. 2011 
494 mother-infant 
pairs 
Geometric mean cord blood p,p’-DDE 
and p,p’-DDT (ng/mL) 
p,p’-DDE: 0.495 
p,p’-DDT: 0.020 
BW, BL, HC Adjusted beta for change in growth per 10x ↑ in DDT metrics 
 p,p’-DDE p,p’-DDT 
BW -107.39*↓ -63.04*↓ 
BL NS  NS 
HC NS  NS 
Ribas-Fito et al. 2002 
70 mother-infant pairs 
Maternal serum and cord blood DDE. 
Percentile levels in cord blood (ng/mL) 
5th: 0.22 
25th: 0.49 
50th: 0.85 
75th: 1.69 
95th: 3.21 
BW, CHL, 
preterm 
birth, 
SWGA, 
SLGA 
Adjusted beta for change with doubling in DDE 
BW: NS 
CHL: NS 
Geometric means DDE (ng/mL)  
   Yes No 
Preterm birth  2.40*↑ 0.80 
SWGA (adjusted) NS NS 
SLGA (adjusted) NS NS 
Robledo et al. 2015 
234 mother-infant 
pairs 
Boys (n=90–113), 
Girls (n=91–117) 
Geometric mean maternal and paternal 
serum DDT metrics (ng/g) 
  Maternal Paternal   
p,p’-DDE 0.580  0.752 
p,p’-DDT 0.012  0.014 
o,p’-DDT  0.002  0.003  
BW, HC, PI Adjusted beta for change per 1-SD increase maternal or paternal 
in DDT metric  
 Maternal  Paternal 
 boys girls  boys girls 
o,p’-DDT  
BW NS -195.39* NS NS 
HC NS NS  NS NS 
DDE 
PI  NS NS  0.12*↑ 0.01*↑ 
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Table 2-18.  Summary of Studies of Associations Between Human Maternal DDT Exposure Metrics and Offspring 
Weight and Growth Endpoints at Birtha 
 
Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Sagiv et al. 2007 
722 mother-infant 
pairs 
Cord blood DDE (ng/g) 
Q1: 0–0.20 
Q2: 0.20–0.30 
Q3: 0.30–0.46 
Q4: 0.47–14.93 
BW, CHL, 
HC 
Adjusted betas for change per quartile of DDE  
BW: NS 
CHL: NS 
HC: NS 
Sharma et al. 2012 
100 mother-infant 
pairs 
FGR cases (n=50) 
Normal control cases 
(n=50) 
Mean maternal serum and cord blood 
DDE and DDT (ng/mL) 
 Serum  Cord blood 
 Control FGR Control FGR 
DDE 2.58 2.68 1.31 1.95 
DDT 0.73  1.67 0.36 0.83 
FGR Adjusted ORs for FGR 
   DDE DDT 
Serum   NS 1.82*↑ 
Cord blood NS 3.07*↑ 
Siddiqui et al. 2003 
54 mother-infant pairs 
IUGR cases (n=30) 
Normal control cases 
(n=24) 
Mean maternal serum, cord blood, 
placenta ng/mL 
 DDE ΣDDT  
 Control IUGR Control IUGR 
Serum 6.32 8.79 20.0 23.4 
Placenta 8.89 11.24 33.93 40.16 
Cord 5.33 7.81  25.7 33.2 
IUGR Adjusted ORs for IUGR 
  DDE  ΣDDT 
Serum  1.21*↑ NS 
Placenta NS NS 
Cord  NS NS 
 
ORs for IUGR with other DDT metrics were NS 
Tan et al. 2009 
41 mother-infant pairs 
Mean cord blood levels ng/g lipid 
p,p’-DDE: 402  
p,p’-DDT: 34.5 
p,p’-DDD: 3.83 
 
BL, BW, HC Adjusted betas 
  DDE DDT DDD 
BL NS ~0.1*↑ ~0.1*↑ 
BW NS ~0.1*↑ ~0.1*↑ 
HC NS ~0.1*↑ ~0.1*↑ 
 
Betas are estimated from graphical presentations. 
DDT, DDE, and DDD  194 
 
2.  HEALTH EFFECTS 
 
 
 
 
 
 
***DRAFT FOR PUBLIC COMMENT*** 
Table 2-18.  Summary of Studies of Associations Between Human Maternal DDT Exposure Metrics and Offspring 
Weight and Growth Endpoints at Birtha 
 
Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Vafeiadi et al. 2014 
1,117 mother-infant 
pairs 
Geometric mean maternal serum DDE 
and DDT (ng/mL) 
DDE: 2.07 
DDT: 0.043 
BW, GA, 
HC 
Adjusted betas for change in measure per log10 unit increase 
DDE 
BW: NS 
GA: NS 
HC: NS  
 
Further adjustment for gestational weight gain did not change 
statistical significance 
Weihe et al. 2003 
500 mother-infant 
pairs 
267 males, 233 
females 
Mean maternal serum, ng/mL 
p,p’-DDT: 0.175 
p,p’-DDE: 5.534 
BW, BL, HC Adjusted partial correlation coefficients 
All BW   BL  HC 
  DDE NS  -0.115*↓ NS 
  DDT NS  -0.097*↓ NS 
Boys 
  DDE NS  -0.140*↓ NS 
  DDT 0.163*↑  NS  NS 
Girls 
 DDE  NS  NS  NS 
 DDT NS  -0.130*↓ NS 
Weisskopf et al. 2005 
143 mother-infant 
pairs 
Captains cohort 
(n=119) 
Control (n=24) 
Mean maternal serum DDE (ng/mL) 
Captain cohort: 2.03 
Control: 1.0 
BW, GA Adjusted beta for change per log10 unit DDE 
BW: -146*↓ 
GA: NS 
Wojtyniak et al. 2010 
1,322 mother-infant 
pairs 
Greenland Inuit 
(n=572) 
Kharkiv (n=611) 
Warsaw (n=258) 
Geometric mean maternal serum DDE 
(ng/g lipid) 
Inuit: 273.8 
Kharkiv: 653.3 
Warsaw: 356.8 
BW, GA, 
preterm 
birth 
Adjusted betas for changes per 1-unit increase lnDDE 
  Inuit  Kharkiv  Warsaw 
BW  -56.0*↓  NS  -146.9*↓ 
GA  -0.2*↓  NS  -0.6*↓ 
Adjusted ORs for 2x increase in DDE 
Preterm NS  NS  2.44*↑ 
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Table 2-18.  Summary of Studies of Associations Between Human Maternal DDT Exposure Metrics and Offspring 
Weight and Growth Endpoints at Birtha 
 
Reference and study 
population DDT exposure metricb 
Outcome 
evaluated Resultsc 
Wolff et al. 2007 
404 mother-infant 
pairs 
Median (range) maternal serum DDE 
(ng/mL): 0.64 (0–57.3) 
BW, BL, PI, 
HC, GA 
Adjusted betas for changes per a 1-unit increase log10 DDE 
BW: NS  
BL: NS 
PI: NS 
HC: -0.69*↓ 
GA: NS 
 
aSee Table 11 in the Supporting Document for Epidemiological Studies for DDT, DDE, and DDD Supporting Document for Epidemiological studies for DDT, DDE, 
and DDD.  Studies in this table were selected from those described in Table 11, because they: (1) measured DDT-related metrics in biological fluids or tissues in 
each maternal subject, and (2) evaluated associations using linear regression, logistical regression, or correlation techniques, adjusting for possible confounding 
factors. 
bDDE = p,p’-DDE, unless otherwise specified; DDT = p,p’-DDT, unless otherwise specified. 
cBold text, “significant” and asterisk indicate statistically significant (p<0.05).  Arrows “↑ or ↓” indicate direction of change observed for a given outcome (positive 
or inverse associations, respectively). 
 
BH = birth height; BL = birth length; BW = birth weight; BWz = birth weight z-score; CHL = crown heal length; FGR = fetal growth restriction; GA = gestational age; 
GL = gestational length; HC = head circumference; IUGR = intrauterine growth retardation; LBW = low birth weight; ND = not detected; NS = not statistically 
significant; OR = odds ratio; PI = Ponderal Index; Q = quartile; SD = standard deviation; SGA = small for gestational age; SLGA = small length for gestational age; 
SWGA = Small weight for gestational age; T = tertile 
1 
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Arrebola et al. 2016; Kezios et al. 2013) and the remaining 9 found no association with duration of 
gestation (Bergonzi et al. 2011; Bjerregaard et al. 2000; Fenster et al. 2006; Jusko et al. 2006; Ribas-Fito 
et al. 2002; Sagiv et al. 2007).  Thirteen studies evaluated infant head circumference at birth:  2 reported 
associations with decreased head circumference (Al-Saleh et al. 2012; Wolff et al. 2007); 1 reported an 
association with increased head circumference (Tan et al. 2009); and 10 reported no associations with 
infant head circumference (Bergonzi et al. 2011; Jusko et al. 2006; Khanjani and Sim 2006; Longnecker 
et al. 2001; Lopez-Espinosa et al. 2011; Robledo et al. 2015; Sagiv et al. 2007; Vafeiadi et al. 2014; 
Weihe et al. 2003).  Similarly, 13 studies evaluated infant body length measures: 2 reported associations 
with decreased length (Al-Saleh et al. 2012; Weihe et al. 2003); 1 reported an association with increased 
length (Tan et al. 2009); and 10 reported no association with body length (Fenster et al. 2006; Jusko et al. 
2006; Longnecker et al. 2001; Lopez-Espinosa et al. 2011; Ribas-Fito et al. 2002; Sagiv et al. 2007; Wolff 
et al. 2007). 
 
Subsequent growth patterns.  Inconsistent evidence is provided by 24 epidemiological studies examining 
possible associations between maternal serum, cord blood, or breast milk levels of DDT, DDD, or DDE 
and changes in growth patterns of offspring (Table 2-19).  Among the 22 studies examining body weight 
endpoints in offspring (e.g., BMI, BMI z-score, overweight or obese status, rapid infant growth), 
11/22 found associations of maternal DDT biometrics with increased weight or weight status (Agay-Shay 
et al. 2015; Delvaux et al. 2014; Gladen et al. 2000; Iszatt et al. 2015; Karmaus et al. 2002, 2009; Mendez 
et al. 2011; Ribas-Fito et al. 2006; Tang-Peronard et al. 2014; Vafeiadi et al. 2015; Valvi et al. 2012, 
2014; Warner et al. 2014; Table 2-19).  Eleven of these 22 studies found no associations of maternal 
biometrics and offspring weight or weight status (Cupul-Uicab et al. 2010, 2013; Garced et al. 2012; 
Gladen et al. 2004; Heggeseth et al. 2015; Hoyer et al. 2014; Jusko et al. 2006; Karlsen et al. 2016; Pan et 
al. 2010; Verhulst et al. 2009; Warner et al. 2013; Table 2-19). 
 
Offspring height status also was assessed in 12/24 of the studies in Table 2-19; 2/12 found associations 
with decreased height in offspring (Karmaus et al. 2002; Ribas-Fito et al. 2006), but no associations were 
found in the other 10 studies assessing offspring height (Cupul-Uicab et al. 2010; Delvaux et al. 2014; 
Garced et al. 2012; Gladen et al. 2000, 2004; Jusko et al. 2006; Karmaus et al. 2009; Pan et al. 2010; 
Verhulst et al. 2009; Warner et al. 2014; Table 2-19).  More details for these studies and other related 
studies are provided in Table 12 in the Supporting Document for Epidemiological Studies for DDT, DDE, 
and DDD.   
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Table 2-19.  Summary of Studies of Associations between Human Maternal DDT Exposure Metrics  
and Post-Birth Offspring Body Weight and Growtha 
 
Reference and study 
population DDT exposure metricb Outcome evaluated Resultsc 
Studies finding at least one statistically significant association between any DDT metric and any child growth parameter 
Agay-Shay et al. 
2015 
470 consenting 
mother-child pairs 
Mean (range) maternal serum DDE ng/g lipid: 
236.4 (7.7–17,263.4) (tertiles not reported) 
Geometric mean: 126.3 
Overweight, BMIz 
at 7 years 
 RRs for overweight β for BMIz 
T1 referent   referent   
T2 2.31*↑   NS 
T3 2.21*↑   NS 
Delvaux et al. 2014 
114 children  
57 males, 57 females 
Median (range) cord blood and maternal serum 
(ng/mL)  
DDE 
Boys: 0.24 (0.14, 0.44) 
Girls: 0.23 (0.12, 0.44) 
Height, weight, sum 
of 4 skinfolds, W/H, 
BMIz, WC at 7–
9 years 
Adjusted beta for IQR increase DDE 
  All Boys Girls 
Height  NS  –  – 
BMIz  NS –  – 
Weight   NS –  – 
WC  NS  – – 
Skinfolds  NS –  – 
BMIz   NS  NS 
WC   NS 1.018*↑ 
W/H    NS 1.037*↑ 
Gladen et al. 2000  
594 mother-child 
pairs 
316 females, 
278 males 
Maternal serum, milk, cord blood, and placenta 
DDE (ng/g fat) 
Transplacental 
Group 2: 1,000–2,000 
Group 3: 2,000–3,000 
Group 4: 3,000–4,000 
Group 5: ≥4,000 
Height, weight p-values for increasing adjusted weight or 
height at 14 years with DDE transplacental 
exposure groups 
  Boys   Girls 
Height  NS  NS 
Weight  0.025*↑  0.51 
 
No significant associations found for either 
height or weight with lactational DDE exposure 
groups 
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Table 2-19.  Summary of Studies of Associations between Human Maternal DDT Exposure Metrics  
and Post-Birth Offspring Body Weight and Growtha 
 
Reference and study 
population DDT exposure metricb Outcome evaluated Resultsc 
Iszatt et al. 2015 
Consenting mother-
child cohorts: 
Duisburg (n=222); 
FLEHS (n=134) 
HUMIS (n=399); 
Michalovce (n=938); 
PELAGIE (n=171).  
Pooled (n=2,487) 
Cord blood and milk DDE (ng/g lipid) 
Estimated concentrations 
  Prenatal Postnatal 
Duisburg 141.4  255.3 
FLEHS  214.7  272.6 
HUMIS  63.4  177.3 
Michalovce 540.5  954.3 
PELAGIE 73.5  75.7 
Weight for age 
z-scores, based on 
measurements at 
birth and 24 months  
Adjusted Betas for weight for age z-score per 
total exposure IQR increase in cohorts 
Duisburg: NS 
FLEHS: NS 
HUMIS: NS 
Michalovce: NS 
PELAGIE: NS  
Pooled prenatal: 0.12*↑ 
Pooled postnatal: NS 
Karmaus et al. 2002 
343 mother-child 
pairs 
Child serum DDE (ng/mL) 
Q2: 210–290 
Q3: 300–430 
Q4: >440 
Height at birth 
through 10 years 
Trend test for decreased height across 
exposure quartiles at different ages (p-value) 
  Girls   Boys 
4–6 weeks 0.002*↓  NS 
3–4 months 0.0049*↓ NS 
6–7 months  0.012*↓  NS 
8 years  0.009*↓  NS 
9 years  NS  0.0489*↓ 
 
No significant trend at birth, 10–12, 12–24, 43–
48 months or at 10 years 
Karmaus et al. 2009 
259 consenting 
mothers 
151 consenting adult 
daughters (2001–
2002) 
129 consenting adult 
daughters (2006–
2007) 
Maternal serum DDE (ng/mL) 
Q2: 1.503–2.9  
Q3: 2.9–6.1 
Q4: 6.1–9.4  
Q5: >9.4 
Height, weight, BMI 
in adult offspring 
(20–50 years old) at 
2001–2002 and 
2006–2007  
Adjusted betas for measures in Q2 and Q3–Q5, 
versus Q1 
  Q2  Q3–Q5 
Height  NS  NS 
Weight  5.93*↑  9.22*↑ 
BMI   1.65*↑  2.88*↑ 
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Table 2-19.  Summary of Studies of Associations between Human Maternal DDT Exposure Metrics  
and Post-Birth Offspring Body Weight and Growtha 
 
Reference and study 
population DDT exposure metricb Outcome evaluated Resultsc 
Mendez et al. 2011 
Consenting mother-
child pairs 
374 normal weight 
mothers 
144 overweight 
mothers 
125 rapid growth 
children 
393 average/slow 
growth children 
Maternal serum DDE (ng/g lipid) 
Q2: 71.71–116.92 
Q3: 116.92–186.17 
Q4: >186.17 
Rapid infant growth, 
BMIz at birth, 6, 
14 months 
Adjusted RRs of infant rapid growth for Q2–Q4, 
versus Q1 
Maternal status 
 Normal weight Overweight 
Q2 2.42*↑  NS 
Q3 2.47*↑  NS 
Q4 2.47*↑  NS 
Adjusted RRs for unit ↑ in DDE  
BMIz 1.64*↑  NS 
Ribas-Fito et al. 
2006 
Consenting mother-
child pairs 
Follow-up visits at 
1 year (n=1,540); 
4 years (n=1,371); and 
7 years (n=1,371) 
Maternal serum levels of DDE (ng/mL) 
Q1: <15 
Q2: 15–29 
Q3: 30–44 
Q4: 45–59 
Q5: ≥60 
Height at 1, 4, and 
7 years  
Adjusted betas for change in height, Q5 versus 
Q1 
  1 year  4 years  7 years 
Q5  -0.76*↓  -1.24*↓  -2.43*↓ 
 
Adjusted betas for lower quintiles were NS 
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Table 2-19.  Summary of Studies of Associations between Human Maternal DDT Exposure Metrics  
and Post-Birth Offspring Body Weight and Growtha 
 
Reference and study 
population DDT exposure metricb Outcome evaluated Resultsc 
Tang-Peronard et al. 
2014 
539 mother-child 
pairs 
290 males, 
271 females 
 
Normal weight 
mothers (n=390) 
Overweight mothers 
(n=195) 
Maternal serum and milk DDE 
Serum levels (ng/g lipid): 
Q1: <340 
Q2: 340–560 
Q3: 570–920 
Q4: ≥920 
BMI, waist 
circumference, 
change in BMI and 
WC from 5 to 7 years 
old 
Adjusted betas for Q3–Q4 versus Q1 or a 10x↑ 
DDE in children of OW mothers 
 Girls  Boys 
∆ 5–7 BMI WC BMI WC 
Q3 NS  –  NS – 
Q4  1.11*↑ –  NS – 
10x  0.46*↑  –  NS – 
At 7 years old 
Q3 NS 2.20*↑ NS NS 
Q4 NS 2.21*↑ NS NS 
10x NS 0.93*↑ NS NS 
 
No significant associations at 5 years old 
  
No significant associations with BMI or WC in 
offspring of normal weight mothers 
Vafeiadi et al. 2015 
698 mother-child 
pairs 
Maternal serum DDE 
Geometric mean: 2.036 ng/mL 
Early rapid growth 
(0–6 months), BMIz, 
obesity status, WC, 
sum of four skinfolds 
at 4 years 
Adjusted betas or RR (95% CI) for a 10-fold 
increase in DDE 
Rapid growth (RR) 1.33 (0.89–1.99) 
 
4-year measures 
BMIz (beta): 0.27 (0.04–0.51)*↑  
Obesity (RR): 3.80 (1.19–12.14)*↑ 
WC ≥58.6 cm (RR): 3.76 (1.70–8.3)*↑ 
Skinfold sum (beta): 2.75 (-0.86–6.35) 
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Table 2-19.  Summary of Studies of Associations between Human Maternal DDT Exposure Metrics  
and Post-Birth Offspring Body Weight and Growtha 
 
Reference and study 
population DDT exposure metricb Outcome evaluated Resultsc 
Valvi et al. 2012 
344 mother-child 
pairs 
178 females, 
166 males 
Child serum (n=216) 
Cord blood and child serum DDE and DDT 
Cord blood (ng/mL) 
 DDE  DDT 
T1  <0.7  <0.06 
T2  0.7–1.5  0.06–0.18 
T3  >1.5  >0.18 
Overweight status at 
6 years of age 
 Adjusted RRs for overweight status, T2 or T3 
versus T1 
DDE Girls Boys Total 
T2 2.64*↑ NS 1.67*↑ 
T3 NS NS NS 
DDT 
T3  NS 1.96*↑ NS 
 
Associations lost after adjustments for other 
persistent organochlorine analytes 
Valvi et al. 2014 
1,285 mother-child 
pairs 
Valencia and 
Gipuzkoa subcohort 
(n=790) 
Maternal serum DDE (ng/g lipid)  
Q2: >73.6–118.8 
Q3: >118.8–203.1 
Q4: >203.1 
OW status at 
14 months old, ERG 
status (0–6 months) 
Adjusted RRs for Q4 versus Q1 or a 10x↑ DDE 
 Total  Subcohort 
 OW  ERG OW ERG 
Q4 1.39*↑ NS 1.38*↑ NS 
10x 1.15*↑ 1.13*↑ 1.16*↑ NS 
Warner et al. 2014 
261 mother-child 
pairs 
143 females, 
118 males 
Maternal serum p,p’-DDT, DDE, and o,p’-DDT 
Mean (ng/g serum) 
p,p’-DDT: 1.3 
DDE: 1.5 
o,p’-DDT: 2.9 
 
OW/obese status, 
increased WC status, 
BMIz, WCz, percent 
body fat; all based on 
data from 9-year-old 
children 
Adjusted betas or ORs for measures in boys 
per 10x↑ DDT metrics 
    OW/ 
  BMIz WCz obese WC  
  Beta beta OR OR  
o,p’-DDT 0.34*↑ 0.30*↑ 2.51*↑ NS 
p,p’-DDT 0.23*↑ 0.23*↑ 2.11*↑ 2.05*↑ 
p,p’-DDE NS NS NS  NS 
 
No significant associations were observed in 
girls 
 
No associations with percent body fat 
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Table 2-19.  Summary of Studies of Associations between Human Maternal DDT Exposure Metrics  
and Post-Birth Offspring Body Weight and Growtha 
 
Reference and study 
population DDT exposure metricb Outcome evaluated Resultsc 
Studies finding no associations between any DDT metric and any child growth parameters 
Cupul-Uicab et al. 
2010  
788 consenting 
mother-child pairs  
Maternal serum DDE and DDT exposure 
quartiles, ng/g lipid 
 DDE  DDT 
Q2 3,001–6,000 270–750 
Q3 6,001–9,000 760–1,990 
Q4 ≥9,000 ≥2,000 
Overweight, obese, 
BMI, height in boys 
between 14 and 
22 months  
Adjusted betas for Q2–Q4 DDE versus Q1 
 Height BMI 
Q2 NS NS 
Q3 NS NS  
Q4 NS  NS 
 
Nonsignificant trend test for height, weight and 
BMI 
Cupul-Uicab et al. 
2013 
1,833 (for DDE) and 
1,902 (for DDT) 
mother-child pairs 
Maternal serum DDE and DDT  
Percentiles (ng/mL) 
 25th  95th   
DDE 16.93 69.63 
DDT 6.46 26.57 
Overweight, obese, 
BMI at 7 years old 
Adjusted ORs for IQR increase or β 
  DDE DDT 
OW (OR) NS NS 
Obese (OR) NS NS 
BMI (β)  NS NS 
Garced et al. 2012 
253 mother-child 
pairs 
Geometric mean maternal serum DDT and DDE 
by trimester (ng/mL) 
 DDE DDT 
1st  6.3 0.00697 
2nd 6.6 0.00581 
3rd 7.6 0.00591 
Weight, length, BMI, 
and HC for age, 
weight for length 
from birth to 1 year of 
age 
Adjusted betas for doubling of DDT metrics
  1st  2nd 3rd 
Weight  NS NS NS 
Length   NS NS NS 
BMI  NS NS NS 
HC  NS NS NS 
W/L  NS NS NS 
Gladen et al. 2004 
304 mother-child 
pairs 
Maternal serum p,p’-DDT, DDE, o,p’-DDT, and 
ΣDDT (ng/g lipid)  
DDE 
Q2: 3,000–5,900 
Q3: 6,000–8,900 
Q4: 9,000–11,900 
Q5: ≥12,000 
Height, height ratio 
(%), BMI, triceps, 
central adiposity (%), 
skeletal age from 
birth through 
20 years 
Adjusted betas for Q4 DDE versus Q1 
Height: NS 
Height ratio: NS 
BMI: NS 
Triceps: NS 
Central adiposity: NS 
Skeletal age: NS 
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Table 2-19.  Summary of Studies of Associations between Human Maternal DDT Exposure Metrics  
and Post-Birth Offspring Body Weight and Growtha 
 
Reference and study 
population DDT exposure metricb Outcome evaluated Resultsc 
Heggeseth et al. 
2015 
249 mother-child 
pairs 
113 females, 
136 males 
Maternal serum p,p’-DDT, DDE o,p’-DDT 
Geometric mean (ng/g lipid) 
p,p’-DDT: 21.2 
p,p’-DDE: 1,428 
o,p’-DDT: 1.7 
Probability of being in 
increasing BMI 
growth pattern 
groups, compared 
with Group 4 
showing flat and 
stable BMI during 2–
9 years: 
Group 1 linear 
increase through 2–
9 years;  
Group 2 stable with 
increasing BMI at 
age 4–5 years;  
Group 3 stable with 
increasing BMI at 
age 6–7 years  
Boys showed high RRRs (>1.0) for being in BMI 
increasing groups (Group 1, Group 2, Group 3) 
with a 10-fold increase in maternal DDT 
metrics; after adjustment for baseline risk 
factors, however, the RRRs were NS  
 
For girls, RRRs were <1.0 for being in BMI-
increasing groups with or without adjustment 
Hoyer et al. 2014 
Consenting mother-
child pairs in: 
Greenland (n=525); 
Poland (n=92); 
Ukraine (n=492) 
Maternal serum and estimated postnatal 
exposure of DDE  
Median (ng/g lipid) 
  Maternal Postnatal 
Greenland 300  7,075 
Poland  385  11,627 
Ukraine  639  12,535 
 
BMIz, overweight 
status at 5–9 years 
old 
Adjusted betas for increased BMIz, T3 versus 
T1  
  Maternal  Postnatal 
Greenland  NS  NS 
Poland  NS  NS  
Ukraine  NS  NS 
Pooled  NS  NS 
 
Test for trend across exposure levels was NS 
 
Adjusted ORs for overweight status and 
maternal or postnatal DDE were reported to be 
NS 
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Table 2-19.  Summary of Studies of Associations between Human Maternal DDT Exposure Metrics  
and Post-Birth Offspring Body Weight and Growtha 
 
Reference and study 
population DDT exposure metricb Outcome evaluated Resultsc 
Jusko et al. 2006 
399 mother-child 
pairs 
Maternal serum of p,p’-DDE, o,p’-DDE, p,p’-DDT, 
o,p’-DDT and ΣDDT 
Mean (ng/g lipid) 
p,p’-DDE: 6,850 
p,p’-DDT: 1,930 
o,p’-DDT: 270 
ΣDDT: 9,050 
Sitting height, 
standing height, 
standardized height, 
standardized weight, 
HC, biacromial 
distance, chest 
breadth, and depth, 
and bi-iliac distance 
at birth and 5 years 
old 
Adjusted differences between 25th and 
75th percentile DDE values for all growth 
measures at 5 years were NS, except for a 
small difference in HC (2 mm [95% CI 0–4]) 
Karlsen et al. 2016   
371 mother-child 
pairs 
Maternal serum, cord blood, and child serum 
DDE, ng/g lipid 
 Maternal  Child  
T2  90–220  130–310 
T3  >220  >310 
Overweight status, 
BMIz at 5 years old 
Adjusted betas BMIz increase per log10-unit 
increase in maternal DDE 
18 months: NS 
5 years: NS 
 
RR <1.0 for overweight status in two highest 
tertiles, compared with T1 
Pan et al. 2010 
210 mother-child 
pairs 
Milk DDT and DDE and calculated LEM over 
12 months 
Range (ng/g lipid) 
 DDE  DDT 
Milk 15–2,140 <LOD–36 
LEM 134–19,260 1–326 
Weight, length, 
weight length and 
weight for length 
z-scores for 
measures from birth 
to 12 months 
Adjusted betas for 10 ng/g lipid ↑ in DDT 
metrics in milk 
 DDE DDT 
Weight NS NS 
Length NS  NS 
 
Adjusted betas were NS for all z-score values  
Verhulst et al. 2009 
138 mother-child 
pairs 
Mean (range) cord blood DDE: 212 (24–
1,816) ng/g lipid 
BMI standard 
deviation scores 
(BMI-SDS), weight-
SDS, length-SDS for 
1–3 years of age  
Adjusted betas for growth-SDS with DDE, 1–
3 years old 
Weight-SDS: NS 
Length-SDS: NS 
BMI-SDS: NS 
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Table 2-19.  Summary of Studies of Associations between Human Maternal DDT Exposure Metrics  
and Post-Birth Offspring Body Weight and Growtha 
 
Reference and study 
population DDT exposure metricb Outcome evaluated Resultsc 
Warner et al. 2013 
270 mother-child 
pairs 
Maternal serum p,p’-DDT, DDE, and o,p’-DDT 
Geometric mean (ng/g lipid) 
p,p’-DDT: 20.45 
DDE: 1,422.0 
o,p’-DDT: 1.66 
BMIz, obesity status, 
overweight or obesity 
status, increased WC 
status in children at 
7 years old 
Adjusted ORs for 10x↑ maternal DDT metrics 
  Obese OW or obese WC 
p,p’-DDT NS NS  NS 
p,p’-DDE  NS NS  NS 
o,p’-DDT NS NS  NS 
 
Adjusted BMIz betas were NS for 10-fold 
increase in each DDT metric 
 
aSee Table 12 in the Supporting Document for Epidemiological Studies for DDT, DDE, and DDD.  Studies in this table were selected from those described in 
Table 12, because they: (1) measured DDT-related metrics in biological fluids or tissues in each maternal subject, and (2) evaluated associations using linear 
regression, logistical regression, or correlation techniques, adjusting for possible confounding factors. 
bDDE = p,p’-DDE, unless otherwise specified; DDT = p,p’-DDT, unless otherwise specified. 
cBold text, “significant” and asterisk indicate statistically significant (p<0.05).  Arrows “↑ or ↓” indicate direction of change observed for a given outcome (positive 
or inverse associations, respectively). 
 
BMI = body mass index; BMIz = BMI z-score; CI = confidence interval; ERG = early rapid growth; FLEHS = Flemish Environment and Health Studies; HC = head 
circumference; HUMIS = Norwegian Human Milk Study; IQR = interquartile range; LEM = lactational exposure metric; LOD = limit of detection; NS = not 
statistically significant; OR = odds ratio; OW = over weight; PELAGIE = Perturbateurs endocriniens, Étude Longitudinale sur les Anomalies de la Grossesse, 
l’Infertilité et l’Enfance; Q = quartile or quintile; RR = relative risk; RRR = relative risk ratio; SDS = standard deviation score; T = tertile; WC = waist circumference; 
WCz = waist circumference z-score; W/H = waist:height 
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Developmental Toxicity in Laboratory Animals 
 
Numerous adverse developmental outcomes have been reported in the offspring of rodents exposed to 
DDT/DDE during gestation and/or lactation.  Effects include fetotoxicity, alterations in growth, 
neurodevelopmental toxicity, and impaired development of the reproductive system; these effects are 
discussed in greater detail below.  Some developmental studies also evaluated cardiovascular (La Merrill 
et al. 2016), renal (La Merrill et al. 2016), and diabetic (La Merrill et al. 2014a, 2014b) outcomes in the 
offspring of rats perinatally exposed and evaluated as adults; these effects are considered developmental 
toxicity and are discussed in Sections 2.5, 2.10, and 2.18, respectively. 
 
Fetotoxicity.  Fetotoxicity was observed in mice and rats following gestational and early postnatal 
exposure to technical DDT or p,p’-DDE at dose levels >30 mg/kg/day (Clement and Okey 1974; 
Yamasaki et al. 2009).  Exposure of pregnant mice to 34.3 mg technical DDT/kg on GDs 1–21 followed 
by cross-fostering of the pups resulted in preweaning death in 39% of the neonates exposed in utero and 
through lactation and 10% of the pups exposed only through lactation (Craig and Ogilvie 1974).  All F1 
offspring died within 10 days after birth when exposed in utero and through lactation when dams were 
treated with 41.1 mg/kg/day p,p;-DDT (Clement and Okey 1974).  No deaths occurred in pups exposed in 
utero only (Craig and Ogilvie 1974).  Reduced weaning index and decreased number of PND-21 live 
pups were observed in female Sprague-Dawley rats given gavage doses of 50 mg p,p’-DDE/kg/day, but 
not 15 mg/kg/day, on GD 6 through PND 20 (Yamasaki et al. 2009). 
 
Birth outcomes and subsequent growth patterns.  Results from developmental toxicity studies in 
laboratory animals show no consistent effects of gestational or lactational exposure to DDT and related 
compounds on birth weight or early growth parameters.  The presence of an effect appears to be 
dependent on the isomeric form, the dose, and the timing of exposure.   
 
Acute-duration exposures during gestation showed small, but significant increases (9–13%) in body 
weights in adult offspring from pregnant Sprague-Dawley rat dams orally exposed during GDs 15–19 to 
28 mg o,p’-DDT, p,p’-DDT, o,p’-DDE/kg/day (Gellert and Heinrichs 1975), but not in Long-Evans or 
Sprague-Dawley male offspring (at 2 days of age, or as adults) of rat dams exposed during GDs 14–18 of 
gestation up to 100 mg p,p’-DDE/kg/day (Gray et al. 1999; You et al. 1999a, 1998).  No clear effects on 
early life body weights were observed in offspring of CF-1 mice gavaged with doses ranging from 0.02 to 
100 mg o,p’-DDT/kg/day: small decreases at 20 mg/kg/day and small increases at 100 mg/kg/day were 
observed on PNDs 2 and 5, but no exposure-related differences from control values were observed on 
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PND 10 (Palanza et al. 2001).  In rabbits, acute exposure to doses of 1 mg DDT(NS)/kg/day on GDs 4–7 
(Fabro et al. 1984) or to dose levels ≥10 mg p,p’-DDT/kg/day by gavage on GDs 7–9 (Hart et al. 1971), 
resulted in significant reductions in fetal body weights relative to controls (up to 25%).  However, 
treatment late in gestation (GDs 21–23) did not induce such an effect (Hart et al. 1972).   
 
After intermediate-duration exposure studies, a decrease in growth was observed in Wistar rat pups 
exposed via nursing from dams receiving 16.8 or 42.1 mg p,p’-DDT/kg/day or 84 mg o,p’-DDT/kg/day, 
but the effect was reversible once they were switched to a standard diet (Clement and Okey 1974).  No 
abnormal body weights were reported in rat F1 offspring at birth, or any time point up through sacrifice at 
10 weeks of age in Sprague-Dawley rats exposed in utero through lactation with dam exposure doses up 
to 50 mg p,p’-DDE /kg/day (Yamasaki et al. 2009).  Similarly, no exposure-related birth weight changes 
or changes in growth were observed in F1 and F2 rat pups from a 2-generation study; F1 offspring were 
exposed from gestation through weaning from dams fed doses as high as 27.7 mg p,p’-DDT/kg/day, and 
then in their diets through mating, gestation, and lactation (Hojo et al. 2006).  In contrast, both CD-1 
mouse male and female F1 offspring in a 2-generation study, exposed from gestation through 18 months 
of age to doses of technical DDT as low as 0.4 mg/kg/day showed significant increases in body weights, 
relative to controls, beginning from 5–9 months of age (Tomatis et al. 1972).  
 
Neurodevelopmental effects.  Acute oral administration of DDT isomers in utero or to neonates during 
sensitive periods in nervous system development has caused behavioral and neurochemical changes in 
mice.  Observations include impaired maze learning and memory functions in surviving 1–2-month-old 
mice whose dams were exposed to 34.3 mg/kg/day technical-DDT during gestation and lactation (Craig 
and Ogilvie 1974), and increased spontaneous motor activity (reduced habituation) and decreased cerebral 
cortex muscarinic receptors in 4–7-month-old mice exposed to 0.5 mg/kg/day technical-grade DDT on 
PND 10, but not on PND 3 or 18 (Eriksson and Nordberg 1986; Eriksson et al. 1990a, 1990b, 1992, 1993; 
Johansson et al. 1995, 1996 supported by Talts et al. 1998), and increased urine marking behavior in 
70-day-old male mice whose dams were exposed to o,p’-DDT doses ≥0.018 mg/kg/day during GDs 11–
17; however, because of the lack of statistical analysis or description of the number of males observed, it 
is unclear at what doses increased urine marking behavior became significant (vom Saal et al. 1995).  No 
statistically significant differences in signs of aggression (latency to attack, number of bites, total attack 
time, and tail rattling) were observed in 30-day-old male mice from dams exposed from GDs 11–17 to 
0.018 or 0.18 mg/kg/day o,p’-DDT compared to controls (Palanza et al. 1999); however, the percent of 
attacking males approached significance, and when subgroups of attacking animals only were evaluated, 
exposed males showed lower bite frequencies, total attack times, and reduced tail rattling. Exposure 
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during GDs 11–17 to up to 100 mg o,p’-DDT/kg/day had no effect on righting reflex or cliff avoidance in 
pups on PND 2 or 5 (Palanza et al. 2001).   
 
Fetuses (28-day-old) of pregnant rabbits given gavage doses of 1 mg DDT (NS)/kg/day on GDs 4–7 were 
reported to have decreased brain weight of unspecified magnitude (Fabro et al. 1984); however, male 
Sprague-Dawley offspring, or the dams, exposed during GD 6 to PND 20 to 5 or 15 mg p,p’-DDE/kg/day 
had no significant changes in relative brain weight (Yamasaki et al. 2009). 
 
Developmental reproductive effects.  Findings for effects on developing male reproductive tissues after 
gestational exposure to p,p’-DDT or p,p’-DDE include significantly decreased ventral prostate weights in 
PND-21 male offspring of pregnant Holtzman, Long-Evans, or Sprague-Dawley rats exposed to 50–
200 mg p,p’-DDE/kg/day on GDs 14–18 (Loeffler and Peterson 1999; Gray 1999); significantly 
decreased AGD at PND 1 or 2 at ≥100 mg p,p’-DDE/kg/day or retained thoracic nipples at PND 13 in 
male rats gestationally exposed to ≥10 mg p,p’-DDE/kg/day (Gray 1999; Kelce et al. 1995; Loeffler and 
Peterson 1999; You et al. 1998); and decreased number of lipid droplets in Leydig cells, with no changes 
in testicular testosterone levels, in GD-19.5 male fetuses of Sprague-Dawley rats given 100 mg 
p,p’-DDE/kg/day on GDs 13.5–17.5 (Adamsson et al. 2009).  No significant effects on weights of testes, 
epididymides, seminal vesicles, or ventral prostate were observed in PND 21 male offspring of Sprague-
Dawley or Long-Evans rats given gavage doses up to 100 mg p,p’-DDE/kg/day on GDs 14–18 (You et al. 
1998). 
 
Other reproductive effects associated with gestational exposure to p,p’-DDT, DDT(NS), p,p’-DDE, or 
DDE(NS) include decreased fertility index in F1 male and female Sprague-Dawley rats exposed in utero 
to 50 mg p,p’-DDE/kg/day on GD 6 to PND 20 (no significant effect on fertility was reported at doses 
≤15 mg/kg/day) (Yamasaki et al. 2009); increased resorptions in pregnant New Zealand rabbits exposed 
to 10 or 50 mg p,p’-DDT/kg/day on GDs 7–9, but not when exposure occurred on GDs 21–23 (Hart et al. 
1971, 1972); and qualitatively reported histological changes to reproductive organs from adult male 
Sprague-Dawley rats exposed to gavage doses of 35 mg DDT(NS) or DDE(NS)/kg/day during gestation, 
lactation, and through PND 90 (Patrick et al. 2016).  
 
Acute, gestational exposure has been associated with delayed vaginal opening and increased ovary weight 
in female offspring of Sprague-Dawley rat dams given gavage doses of 28 mg/kg/day o,p’-DDD or 
p,p’-DDT on GDs 15–19, but these effects were not observed after GD 15–19 exposure to o,p’-DDT or 
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o,p’-DDE at the same dose level (Gellert and Heinrichs 1975).  Earlier vaginal opening was observed in 
female offspring exposed to 50 mg p,p’-DDE/kg/day on GD 6 to PND 20 (Yamasaki et al. 2009). 
 
Decreased fertility was reported in F1 female Wistar rat progeny exposed to 128 mg o,p’-DDT/kg/day in 
food during gestation and lactation and bred to nonexposed males at PND 105, but not in F1 female 
Wistar rat progeny similarly exposed to up to 26 mg p,p’-DDT/kg/day (Clement and Okey 1974).  
 
Three reports from the same group of investigators have specified several reproduction-related effects in 
adult mice after gestational exposure to very low oral doses of o,p’-DDT; significantly decreased testes 
weight in adult male CD-1 mice exposed to 0.018 mg o,p’-DDT/kg/day on GDs 11–17 (~12% decreased 
compared with control values), but not 0.18 mg/kg/day (Palanza et al. 1999); and significantly increased 
AGD at birth in female offspring of CF-1 mouse dams exposed to gavage doses ~100 mg 
o,p’-DDT/kg/day on GDs 11–17 (the highest dose tested) and in male offspring at doses of ~0.2 and 
~100 mg/kg/day, but not at ~0.02, ~2, or ~20 mg/kg/day (Palanza et al. 2001).  These observations in 
adult mice after gestational exposure to o,p’-DDT were not included in Table 2-1 and Figure 2-2 due to 
the lack of supporting evidence for reproductive or developmental effects in laboratory animals at 
gestational dose levels <10 mg o,p’- isomers/kg/day in studies conducted by other laboratories. 
 
Mechanisms of Developmental Effects of DDT, DDD, or DDE.  Effects on growth patterns from 
prenatal or early-life exposure are not a well-established target of exposure to DDT, DDD, or DDE and 
relevant mechanistic studies were not located, except for those related to associations between obesity, 
diabetes, and exposure to persistent organochlorine compounds, like DDT, as discussed in Section 2.18. 
 
As discussed in Section 2.15, DDT can disrupt nerve membrane ion fluxes through induced closure of 
sodium channels, inhibition of potassium transport, and by targeting Na+/K+ and Ca2+/Mg2+ ATPases, 
potentiate neurotransmitter release through interference with calcium calmodulin binding, and inhibit the 
plasma membrane dopamine transporter (DAT) and the vesicular monoamine transporter (VMAT2) 
(Harada et al. 2016; Hatcher et al. 2008).  It is uncertain if these actions may be involved in the increased 
spontaneous motor activity and decreased cerebral cortex muscarinic receptors observed in 4–7-month-
old mice exposed to 0.5 mg/kg/day technical-grade DDT on PND 10 (Eriksson and Nordberg 1986; 
Eriksson et al. 1990a, 1990b, 1992, 1993; Johansson et al. 1995, 1996 supported by Talts et al. 1998). 
 
Mechanistic studies were not located that explained details of male and female reproduction effects 
observed in laboratory animals following prenatal and early postnatal exposure to DDT and related 
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compounds, with the exception of studies showing that p,p’- isomers have anti-androgenic effects and 
o,p’- isomers have estrogenic effects (see Section 2.16). 
 
2.18   OTHER NONCANCER 
 
Epidemiology Studies of Diabetic Outcomes in Humans  
 
Overall summary.  Table 2-20 describes results from 35 epidemiological studies that examined possible 
associations between human DDT exposure biometrics (e.g., serum levels of DDT, DDE, or DDD) and 
prevalence of DMT2 or biomarkers indicative of DMT2.  Table 2-20 also describes single studies of 
possible associations between DDT exposure biometrics and gestational diabetes (Vafeiadi et al. 2017) 
and Type 1 diabetes (Rignell-Hydbom et al. 2010).  All located human studies examining possible 
associations between DDT exposure biometrics and diabetes outcomes are described in more detail in 
Table 13 in the Supporting Document for Epidemiological Studies for DDT, DDE, and DDD. 
 
A clear majority of studies, including several meta-analyses, provide evidence for an association between 
DDT exposure biometrics in groups of humans and increased prevalence of DMT2 (Table 2-20).  Among 
the studies evaluating associations between DDT exposure biometrics and DMT2 prevalence, 18 found 
associations, 2 found marginal associations, and 5 found no associations between DDT exposure 
biometrics and DMT2 (see Table 2-20).  There is inconsistency across eight studies evaluating 
associations with other indicators of diabetes (e.g., fasting blood glucose [FBG], insulin, HbA1C, 
homeostatic model assessment insulin resistance [HOMA-IR], insulin resistance [IR], leptin, or 
adiponectin).  Clear explanations of the inconsistency across the studies are not available, but possible 
contributors could be small case sample sizes and different distributions of age, BMI, gender, and 
exposure levels; co-exposure to varying levels of other persistent organic pollutants (e.g., PCBs, CDDs, 
etc.) may also influence the study results.  
 
Associations with DMT2.  The 18 studies reporting positive evidence for a statistically significant 
association between DDT exposure biometrics and DMT2 include five nationwide studies in the United 
States (Everett and Matheson 2010; Everett and Thompson 2015; Everett et al. 2007, 2017a; Lee et al. 
2006).  Associations were reported across a wide range of age groups starting from 18 years of age 
(Aminov et al. 2016).  Four U.S. studies examined whether or not adjustments for other organochlorine 
analytes would influence the statistical significance of the association (Table 2-20).  With adjustments for  
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Table 2-20.  Summary of Diabetes Outcomes in Humans with DDT Exposure Biometricsa 
 
Reference and study 
population DDT exposure metric Outcome evaluated Resultb 
DMT2 prevalence  
Studies providing statistically significant evidence for an association between DDT and DMT2 prevalence (n=18) 
Al-Othman et al. 2015 
136 DMT2 cases 
144 controls 
ΣDDT arithmetic means, serum  
Cases: 18.3 ng/mL 
Controls: 11.8 ng/mL 
DMT2 based on FBG Adjusted ORs (95% CI):  
M 4.8 (1.3–9.6)*↑ 
F 5.7 (1.4–10.3)*↑ 
Aminov et al. 2016 
111 DMT2 cases 
144 controls 
DDE 4th quartile range serum: 
4.02–22.51 ng/mL 
DMT2, based on self 
report or FBG 
Adjusted OR, Q4 versus Q1 (95% CI):  
2.69 (1.00–7.16, p trend 0.004)*↑ 
 
Significance lost after further adjustment for PCB 
serum levels 
Arrebola et al. 2013 
34 DMT2 cases 
352 controls 
DDE geometric means, ng/g lipid  
  Cases Controls  
Serum   243.2 152.5 
Adipose 199.5 73.7 
DMT2, based on self 
report and FBG 
Adjusted ORs, T3 versus T1 (95% CI): 
Adipose:  
4.44 (1.03–21.02*↑, p trend 0.07) 
 
Serum: adjusted ORs (T3 or T2 versus T1) not 
significantly elevated  
Codru et al. 2007 
71 DMT2 cases 
281 controls 
DDE arithmetic mean, serum 
537 ng/g lipid 
 
DMT2, based on self 
report or FBG  
Adjusted ORs, T3 versus T1 (95% CI):  
6.2 (1.8–21.9)*↑ 
 
Significance lost after further adjustment for 
serum levels of PCBs, HCB, and mirex: 2.4 (0.7–
8.3) 
Cox et al. 2007 
89 DMT2 cases 
1,214 controls 
DDT 2nd tertile range serum: 2.00–
3.70 ng/mL 
 
DDE 3rd quartile range serum: 39.1–
58.60 ng/mL 
DMT2 self reported DDT Adjusted ORs T3 versus T1 (95% CI): 
2.9 (1.2–6.8)*↑ 
 
DDE Adjusted ORs, 4th quartile versus 1st quartile 
(95% CI): 2.63 (1.2–5.8)*↑ 
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Table 2-20.  Summary of Diabetes Outcomes in Humans with DDT Exposure Biometricsa 
 
Reference and study 
population DDT exposure metric Outcome evaluated Resultb 
Eden et al. 2016 
114 DMT2 cases 
149 controls 
DDE arithmetic means, serum  
Cases: 448.2 ng/g lipid 
Controls: 197.9 ng/lipid 
DMT2 based on self 
report or medical 
records 
ORs (95% CI) by age and BMI 
Normal BMI <23.5 kg/m2 
55 years: 2.01 (1.11–3.65)*↑ 
65 years: 2.85 (1.39–5.86)*↑ 
 
ORs decreased with increasing BMI groups 
(27.5 and 31.5 kg/m2), but remained 
significantly elevated (i.e., >1.0) in the 
≥65-year groups 
Everett et al. 2007 
2,163 participants with 
DMT2 diagnosis or 
undiagnosed 
DDT tertile ranges, serum 
T1: <20.7 ng/g lipid 
T2: 20.8–26.6 ng/g lipid 
T3: >26.6 ng/g lipid 
DMT2 based on self 
report of physician 
diagnosis and HbA1c 
>6.1% (total diabetes) 
Adjusted ORs versus T1 (95% CI) 
T2: 2.69 (1.35–5.36)*↑ 
T3: 2.46 (1.45–4.15)*↑ 
 
T2 and T3 ORs remained significantly elevated 
with further adjustment for other chlorinated 
serum analytes (a dioxin and a PCB) 
Everett et al. 2017a 
76 DMT2 participants with 
total diabetes (self reported 
or with HbA1c ≥6.5%) without 
nephropathy and 52 with total 
diabetes with nephropathy 
Non-fasting serum levels  
p,p’-DDT: >14.50 ng/g lipid  
p,p′-DDE: ≥1,195.1 ng/g lipid 
Diabetes (with or without 
nephropathy) 
Adjusted OR for total diabetes 
DDT: 2.46 (1.59–3.79)*↑ 
DDE: 3.35 (1.40–8.02)*↑   
 
 Without With 
 nephropathy nephropathy 
DDT 2.14 (1.46-3.15)*↑ 3.18 (1.59-6.36)*↑ 
DDE 2.12  14.69 (2.94-73.29)*↑ 
Everett and Mathescon 
2010 
334 DMT2 cases (self 
reported or with HbA1c 
≥6.5%) 
462 cases with prediabetes 
(HbA1c 5.7-6.4%) 
DDT group range serum 
T1: <20.7 ng/g lipid  
T2: >20.7 ng/g lipid 
DDE tertiles serum 
T1: <168.6 ng/g lipid 
T2: >168.6 ng/g lipid 
DMT2 based on self 
report of physician 
diagnosis and HbA1c 
≥6.5% (total diabetes) 
Adjusted ORs versus T1 (95% CI) 
DDT T2: 1.96 (1.29–2.98)*↑  
DDE T2: 1.90 (1.13–3.18)*↑ 
 
ORs were not significantly elevated with further 
adjustment for serum levels of six other pesticides 
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Table 2-20.  Summary of Diabetes Outcomes in Humans with DDT Exposure Biometricsa 
 
Reference and study 
population DDT exposure metric Outcome evaluated Resultb 
Everett and Thompson 
2015 
341 diabetes cases 
2,204 controls 
Serum DDE and DDT exposure 
categories (ng/g blood)  
 DDE   DDT 
T1 <0.8340  <0.0860 
T2 0.8340–3.8410 ≥0.0860 
T3  ≥3.8410  – 
Diabetes (with or 
without nephropathy) 
Adjusted ORs for T2 or T3 versus T1 
 Without With 
 nephropathy nephropathy 
T2 (DDE) 2.32 0.60 
T3 (DDE) 2.66 0.78 
T3 (DDT) 1.82 2.08 (1.03–4.11)*↑ 
Lee et al. 2006 
217 DMT2 cases 
1,529 controls 
DDE 4th and 5th quintile means serum 
Q4: 1,560 ng/g lipid 
Q5: 3,700 ng/g lipid 
DMT2 based on self 
report of physician 
diagnosis or FBG 
Adjusted ORs (95% CI) versus Q1 
Q4: 2.3 (1.0–5.5)*↑ 
Q5: 4.3 (1.8–10.2) p trend <0.05*↑ 
Philibert et al. 2009 
25 DMT2 cases 
76 controls 
DDE serum percentiles 
75th: 10.65 ng/mL 
75th: 1,617 ng/g lipid 
 
DMT2 self report of 
physician diagnosis 
Adjusted OR (95% CI) >75th percentile versus 
<75th percentile 
ng/mL: 6.11 (1.37–27.30)*↑ 
ng/g lipid: 3.56 (0.97–13.08) 
Rignell-Hydbom et al. 2007 
15 DMT2 cases 
528 controls 
DDE 3rd and 4th quartile ranges serum:  
Q3: >144–240 ng/g lipid 
Q4: >240 ng/g lipid 
DMT2 self report of 
physician diagnosis 
Significant linear trend (p=0.002) for 
increasing adjusted prevalence across 
quartiles* 
 
OR (95% CI) for a 100 DDE ng/g lipid change: 
1.3 (1.2–1.5)*↑ 
Rignell-Hydbom et al. 2009 
371 DMT2 cases 
371 controls 
DDE arithmetic mean serum 
Cases: 5.68 ng/mL 
Controls: 3.89 ng/mL 
(for diagnosis >7 years after baseline) 
DMT2 based on glucose 
tolerance test 
Adjusted ORs (95% CI) for diagnoses >7 years 
after baseline examination (Q4 versus Q1): 
5.5 (1.2–25)*↑   
Rylander et al. 2005 
22 DMT2 cases 
358 controls 
DDE exposure group ranges serum, 
ng/g lipid 
M: <410; >410–850; >850 
F: <180; >180–290; >290 
DMT2 self report Linear trend for increasing prevalence across 
groups. 
(M: p=0.04*↑, F = 0.07) 
 
OR (95% CI) for a 100 DDE ng/g lipid change: 
M+F 1.05 (1.01–1.09)*↑ 
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Table 2-20.  Summary of Diabetes Outcomes in Humans with DDT Exposure Biometricsa 
 
Reference and study 
population DDT exposure metric Outcome evaluated Resultb 
Son et al. 2010 
40 DMT2 cases 
40 controls 
Mean serum ng/g lipid 
  Cases Controls 
DDE  652 376 
DDD  6.6 5.7 
p,p’-DDT 34.2 23.8 
o,p’-DDT 4.5 3.2 
DMT2 based on self 
report or FBG 
Adjusted ORs (95%), p trend 
  (T3 versus T1) 
DDE  26.6 (2.0–349.1)*↑, 0.01* 
DDD  10.8 (1.2–101.1)*↑, 0.03* 
p,p’-DDT 7.6 (1.0–57.3)*↑, 0.04*  
o,p’-DDT 10.1 (0.9–119), 0.07 
Above results with ng/mL serum   
 
Similar significant results with ng/g lipid 
serum 
Turyk et al. 2009 
61 DMT2 cases 
589 controls 
DDE 4th quartile range serum 
4.1–24.0 ng/mL 
DMT2 self report or 
HbA1c>6.3% 
Adjusted ORs (95% CI) for DMT2, Q4 versus Q1: 
3.6 (NR), trend (<0.05)↑ 
Ukropec et al. 2010 
296 DMT2 cases 
1,751 DMT2 controls 
1,269 prediabetic cases 
278 prediabetic controls 
5th quintile ranges serum 
DDE: 3,605–22,328 ng/g lipid 
DDT: 103–940 ng/g lipid 
DMT2 based on FBG 
and 2hBG 
 
PD based on FBG and 
2hBG 
Adjusted ORs (95% CI) for DMT2 versus Q1 
  DDE   DDT 
Q3 1.85 (1.06–3.21)* 1.84 (1.03–2.27)* 
Q4 1.34 (0.76–2.35) 2.51 (1.43–4.38)* 
Q5 1.94 (1.11–3.78)* 2.49 (1.42–4.35)* 
 
Similarly significant results reported for 
analysis of pre-diabetes prevalence 
Studies finding marginally statistically significant associations between DDT biometrics and DMT2 prevalence (n=2) 
Airaksinen et al. 2011 
308 DMT2 cases 
1,680 controls 
DDE quartile ranges serum, ng/g lipid 
Q1: 9.1–170; Q2: 170–470 
Q3: 470–1,200  
Q4: 1,200–10,000 
DMT2 based on FBG or 
2hBG 
Adjusted ORs (95% CI) versus Q1 
 All subjects  BMI ≥30 kg/m2  
Q2 1.00 (0.59–1.69) 0.89 (0.37–2.11) 
Q3 1.62 (0.97–2.69) 1.04 (0.46–2.36) 
Q4 1.75 (0.96–3.19) 1.82 (0.71–4.65) 
p-trend 0.02*   0.087 
 
p-trends BMI <25 BMI 25–30 
  0.99 (NS) 0.15 (NS) 
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Table 2-20.  Summary of Diabetes Outcomes in Humans with DDT Exposure Biometricsa 
 
Reference and study 
population DDT exposure metric Outcome evaluated Resultb 
Kim et al. 2014 
25 DMT2 cases 
25 controls 
Subcutaneous (SAT) or visceral (VAT) 
adipose tissue 
~Median ng/g lipid 
  DDD DDE  DDT 
SAT 4 150 22 
VAT 21 120 3  
DMT2 based on self 
report or FBG 
Adjusted ORs for ∑DDT in SAT or VAT in 2nd or 
3rd tertiles (versus T1) were not significantly 
elevated 
 
Adjusted ORs (95% CI) for DDE in VAT: T2: 
2.3 (NR)*  
T3: 7.8 (1.2–49.3, p trend 0.03)* 
 
Adjusted ORs for other single DDT metrics in 
either tissue were not significantly elevated  
Studies finding no statistically significant association between DDT biometrics and DMT2 prevalence (n=5) 
Grandjean et al. 2011 
168 DMT2 cases 
78 IFG cases 
466 controls 
DDE geometric means serum 
DMT2: 3,200 ng/g lipid 
IFG: 3,100 ng/g lipid 
Controls: 2,800 ng/g lipid 
DMT2 based on 
physician diagnosis, 
FBG or HbA1c >6.4%; 
IFG based on FBG 
Adjusted ORs (95% CI) for DMT2 or IFG were not 
significantly elevated 
DMT2: 1.01 (0.87–1.16) 
IFG: 1.13 (0.92–1.37) 
Gasull et al. 2012 
143 DMT2 cases 
202 Prediabetic cases 
541 controls 
Quartile ranges serum, ng/mL 
DDT: Q3 0.179–0.349 
DDE: Q3 2.64–5.56 
DMT2 based on FBG or 
self report 
Prediabetic based on 
FBG 
Fully adjusted ORs (95% CI) versus Q1 
  DMT2 
DDT Q4 0.6 (0.3–1.2) 
DDE Q4 1.0 (0.5–2.1) 
  Prediabetic 
DDT Q4 0.6 (0,.4–1.1)  
DDE Q4 1.0 (0.5–1.9) 
All p-trends >0.05  
Lee et al. 2011a  
112 DMT2 cases at age 
70 years 
877 controls at age 70 years 
36 DMT2 cases at age 
75 years 
689 controls at age 75 years 
DDE 5th quintile range serum 
At 70 years old: 4.04–23.27 ng/mL 
DMT2 based on self 
report of FBG 
At age 70: adjusted ORs for Q2–Q5 were not 
significantly elevated versus Q1; p trend 0.11 
 
At age 75: no significant trend across quintile 
adjusted ORs  
Lee et al. 2010 
90 DMT2 cases 
90 controls 
DDE 3rd and 4th quartile range serum 
Q3: 3.313–5.731 ng/mL 
Q4: >5.731 ng/mL 
DMT2 based on self 
report or FBG 
Adjusted ORs for DDE Q2–Q4 or DDT Q2–Q4 
(versus Q1) were not significantly elevated  
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Table 2-20.  Summary of Diabetes Outcomes in Humans with DDT Exposure Biometricsa 
 
Reference and study 
population DDT exposure metric Outcome evaluated Resultb 
Wu et al. 2013 
Study 1: 24 DMT2 cases, 
398 controls 
Study 2: 24 DMT2 cases; 
649 controls 
Median 3rd tertile serum, ng/g lipid
  DDE  DDT 
Study 1  2,099.5  83.3 
Study 2  1,535.3  120.9 
DMT2 self report of 
physician diagnosis 
Adjusted ORs (95% CI) from individual study or 
pooled analysis (T3 versus T1) were not 
significantly elevated   
Pooled results 
DDE: 1.53 (0.66–3.53), p trend 0.31 
DDT: 1.05 (0.48–2.28), p trend 0.90 
Diabetes indicators (n=9) 
Arrebola et al. 2015c 
109 women with gestational 
diabetes 
DDE 1.54 ng/mL serum (arithmetic 
mean of 50th percentile)  
 
 
2h IRI 
Adjusted β (95% CI) 
7.90 (4.67–11.14)* 
ISI-gly -0.05 (-0.08 to -0.02)* 
HOMA-IR NS  
Fasting IRI NS 
FBG NS 
2hBG NS 
HbA1C NS 
Burns et al. 2014 
~300 boys examined at 8–9, 
10–11, and 12–13 years old 
DDE 1st and 5th quintile ranges, ng/mL 
Q1: 0.26–0.52  
Q5: 2.7–41.3  
 
Leptin Q2 versus Q1 
Leptin Q3 versus Q1 
Leptin Q4 versus Q1 
Leptin Q5 versus Q1 
Adjusted% change (95% CI) p-trend 
-39.2 (-55.3 to -17.3)  
-43.8 (-57.7 to -25.4) 
-49.7 (-65.5 to -32.4)  
-68.8 (71.7 to -48.4), <0.001 
Insulin Q2–Q4  
Insulin Q5 versus Q1 
NS 
-23.1 (-36.4 to -7.0), 0.02  
HOMA-IR Q2–Q4 
HOMA-IR Q5 versus 
Q1 
 
 
IR 
NS 
-22.3 (-36.2 to -5.4), 0.04 
 
Insulin and HOMA-IR not significant with further 
adjustment for BMI z-score 
Adjusted ORs for T2–T3 versus T1 were NS 
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Table 2-20.  Summary of Diabetes Outcomes in Humans with DDT Exposure Biometricsa 
 
Reference and study 
population DDT exposure metric Outcome evaluated Resultb 
Debost-Legrand et al. 
2016a, 2016b 
268 mother-child pairs 
 
 
DDE quartile ranges in cord blood 
Q1: ≤0.100 
Q2: 0.100–0.180 
Q3: 0.180–0.290 
Q4: >0.290 
Log-insulin and 
adiponectin in cord 
blood 
Adjusted betas for Q2–Q4 versus Q1 
  (boys, girls, and total) 
  Insulin  Adiponectin 
Q2  NS  NS 
Q3  NS  NS 
Q4  NS  NS 
p-trend  NS (girls only) 0.03*↓ 
Dirinck et al. 2014 
195 participants  
DDE arithmetic means serum 
Obese: 120.3 ng/g lipid 
Lean: 99.4 ng/g lipid 
Abnormal glucose 
tolerance 
Adjusted ORs (95% CI) 
Serum: 3.47 (1.08–11.15, p trend 0.037)*↑ 
Adipose: 81.69 (1.18–5,665.89, p trend 0.04)*↑ 
Langer et al. 2014 
Adults general population 
Young (21–40 years old): 
248 males, 330 females 
Old (41–75 years old): 
568 males, 889 females 
DDE 50th percentile serum, ng/g lipid 
Young: 872 males, 926 females 
Old: 2,340 males, 2,173 females 
 p for correlation 
FBG Young males: <0.01 
Young females: <0.01 
Old males: <0.01 
Old females: <0.01 
Insulin Old males: <0.01 
Other groups: NS 
Lee et al. 2007b  
Adults, general population 
(n=721) 
Metabolic syndrome cases 
(n=175) 
 
Serum levels of DDE 
Exposure percentiles: 
<25th 
25th–50th 
50th–75th 
≥75th 
 
 
 
Metabolic syndrome  
Waist circumference 
Triacylglycerol 
HDL 
Blood pressure  
FBG 
Adjusted ORs for metabolic factors per DDE 
percentiles versus <25th 
25th–50th 50th–75th >75th p-trend 
NS   NS  NS NS 
NS  NS   NS NS 
NS  NS  NS NS 
NS  NS  NS NS 
NS  NS  NS NS 
4.4*↑  3.7*↑  6.6*↑ <0.01* 
Lee et al. 2011b 
5,115 U.S. adults at study 
initiation (18–30 years old at 
initiation) 
DDE and DDT, serum; no exposure 
levels were provided 
HOMA-IR at 20-year 
follow-up 
(ages 38–50 years)  
 
  DDT  DDE 
Q2  NS  NS 
Q3  NS  NS 
Q4  NS  NS 
p-trend  NS  NS 
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Table 2-20.  Summary of Diabetes Outcomes in Humans with DDT Exposure Biometricsa 
 
Reference and study 
population DDT exposure metric Outcome evaluated Resultb 
Tang-Peronard et al. 2015b 
520 mother-child pairs 
273 males, 247 females 
Median maternal serum DDE (ng/g 
lipid) 
Boys: 600 
Girls: 600 
 
 
 
Insulin >75th %  
Leptin >75th % 
Adjusted ORs for Q2–Q4 versus Q1 
Girls   Boys 
Q2 Q3 Q4 Q2 Q3 Q4 
NS NS 2.74*↑ NS NS NS 
NS NS NS NS NS NS 
 
p-trends in all cases were NS 
Teeyapant et al. 2014 
1,137 adults, general 
population 
Means serum ng/g lipid 
 Males Females 
DDE 1,539 1,547   
DDT 135 133 
FBG Significant positive correlation 
between DDE and FBG 
 
DDT and FBG not significantly correlated 
Type 1 diabetes or gestational diabetes prevalence (n=2) 
Rignell-Hydbom et al. 2010 
150 Type 1 children 
150 controls 
DDE quartile ranges in maternal 
serum, 
ng/mL 
Q1: <5.8  
Q2: 5.8–9.6 
Q3: 9.7–16.8  
Q4: >16.8  
Type 1 diabetes in 
children based on 
parental report of 
physician diagnosis 
Adjusted ORs (95% CI) versus Q1 
Q2: 0.58 (0.28–1.20) 
Q3: 0.51 (0.24–1.07) 
Q4: 0.64 (0.28–1.46) 
Vafeiadi et al. 2017 
68 gestational diabetes cases 
871 controls 
DDE tertile ranges serum, ng/mL 
T1: 0.15–1.40;  
T2: >1.40–2.85 
T3: >2.85–32.47  
Gestational diabetes 
based on glucose 
tolerance test 
Adjusted ORs (95% CI) versus T1 
T2: 0.83 (0.38–1.82) 
T3: 0.65 (0.28–1.47) 
p-trend: 0.297  
 
aSee Table 13 in the Supporting Document for Epidemiological Studies for DDT, DDE, and DDD for more detailed descriptions of studies. 
bBold text, “significant” and asterisk indicate statistically significant (p<0.05).  Arrows “↑ or ↓” indicate direction of change observed for a given outcome (positive 
or inverse associations, respectively).  Adjusted OR or adjusted β indicates adjustment for standard confounding variables for diabetes, such as BMI, serum 
triglycerides and cholesterol, and age.  Further adjustments for other analyzed chlorinated compounds or pesticides in biological fluid samples are expressly 
noted in the table. 
 
2hBG = 2-h blood glucose (in glucose tolerance test); BMI = body mass index; CI = confidence interval; DMT2 = diabetes mellitus type 2; F = female(s); 
FBG = fasting blood glucose; HbA1c = hemoglobin A1C; HDL = high-density lipoprotein; HOMA-IR = Homeostasis Model Assessment for Insulin Resistance; 
IFG = impaired fasting glycemia; IR = insulin resistance; IRI = immunoreactive insulin; ISI-gly = Insulin Sensitivity Index; M = male(s); NR = not reported; NS = not 
statistically significant; OR = odds ratio; Q = quartile or quintile; SAT = subcutaneous adipose tissue; T = tertile; VAT = visceral adipose tissue 
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other analytes in the biological samples, statistical significance was lost in three of these studies (Aminov 
et al. 2016; Codru et al. 2007; Everett and Matheson 2010) and not influenced in the fourth (Everett et al. 
2007).  Two studies with marginal associations with DMT2 include a study by Airaksinen et al. (2011) 
that reports a significant trend for increasing ORs across DDE exposure quartiles, but individual ORs 
were not elevated for quartiles 2–4, compared with quartile 1 (Table 2-20).  Kim et al. (2014) reported no 
significant elevation in ORs for DMT2 prevalence for the sum of measured DDT analytes (∑DDT) in 
subcutaneous or visceral adipose tissues in the two highest exposure tertiles, compared with the first 
tertile, but found elevated ORs for DDE in visceral adipose tissue in the highest exposure groups (Table 
2-20). 
 
Several published meta-analyses provide support for the association between DDT exposure biometrics 
and DMT2 prevalence.  From a consideration of 22 ORs (from 18 studies), Tang et al. (2014) calculated a 
total OR of 1.33 (95% CI 1.15–1.54) indicative of an association between DDE serum levels and DMT2 
prevalence.  This analysis also reported significantly elevated ORs for other analytes in these studies: 
PCB-153 and PCBs (Tang et al. 2014).  Evangelou et al. (2016) considered ORs from 14 studies of 
DMT2 prevalence and calculated a total OR of 1.95 (95% CI 1.44–2.66) for DDE and statistically 
significant ORs for other analytes included in the evaluated studies (e.g., DDT, dieldrin, heptachlor, 
hexachlorobenzene).  Another analysis of 72 epidemiological studies evaluating associations between 
persistent organochlorine compounds and DMT2 concluded that heterogeneity of the studies precluded a 
meta-analysis, but noted that the overall evidence was sufficient to demonstrate an association (but not 
causality) between several persistent organochlorines (including DDE, PCBs, and dioxins) and DMT2 
prevalence (Taylor et al. 2013).  Wu et al. (2013) pooled results from their U.S. Nurse’s Health study of 
DMT2 prevalence with data from four other studies (Lee et al. 2010, 2011b; Rignell-Hydbom et al. 2009; 
Turyk et al. 2009) and reported a marginally elevated total ORs for DDE (OR 1.25 [95% CI 0.94–1.66]).  
Fakhri et al. (2017) evaluated ORs from six prospective and seven cross-sectional studies; a total OR of 
1.52 (1.26–1.84; p<0.001) indicates an association between increasing concentrations of p,p’-DDE in 
serum and adipose tissue with increased risk of DMT2. 
 
Associations with diabetes indicators.  Eight studies that examined associations between DDT biometrics 
and biomarkers of diabetes preclude definitive conclusions about possible associations with any specific 
diabetes biomarker due to the small number of studies evaluating each indicator and marked differences 
in study populations (Table 2-20; Arrebola et al. 2015c; Burns et al. 2014; Debost-Legrand et al. 2016a, 
2016b; Langer et al. 2014; Lee et al. 2007b; Tang-Peronard et al. 2015b; Teeyapant et al. 2014).  In the 
only three studies evaluating adults from the general population, correlation analysis found consistent 
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associations between DDE serum levels and elevated fasting blood glucose (FBG) levels (Langer et al. 
2014; Lee et al. 2007b; Teeyapant et al. 2014).  In a study of women with gestational diabetes, linear 
regression found no evidence of an association with FBG, HOMA-IR, or HbA1C, but significant 
associations were reported with 2-hour immunoreactive insulin levels (2-hIRI) (Arrebola et al. 2015c).  
Two studies involved mother-child pairs: Debost-Legrand et al. (2016a, 2016b) found no correlation 
between levels of DDE and insulin or adiponectin in cord blood and Tang-Peronard et al. (2015b) found 
that elevated levels of insulin in girls, but not boys, were associated with maternal serum DDE, but only 
in the highest quartile.  In a single study in children, in boys examined at 8 through 13 years of age, DDE 
serum levels were associated with leptin levels, but not with insulin serum levels or HOMA-IR, when 
further adjustments for BMI z-scores were taken into account (Burns et al. 2014). 
 
Associations with gestational or Type-1 diabetes.  Maternal levels of DDT biomarkers were not 
associated with prevalence of gestational diabetes (Vafaiadi et al. 2017) or development of Type 1 
diabetes in offspring (Rignell-Hydbom et al. 2010).  The sparse data for these types of diabetes preclude 
making definitive conclusions about possible association of gestational diabetes or Type 1 diabetes with 
levels of DDT exposure biometrics. 
 
Studies of Diabetic Outcomes in Laboratory Animals.  There are a limited number of animal studies that 
directly evaluate associations between exposures to DDT, DDE, or DDD and DMT2.  In an acute 
exposure study, mice exposed orally to 2.0 mg/kg/day p,p’-DDE, but not 0.4 mg/kg/day, for 5 days, had 
significant elevations in FBG levels that persisted for up to 21 days (Howell et al. 2014).  Glucose 
tolerance and levels of Akt phosphorylation (an indicator of insulin-induced glucose disposal) in liver and 
skeletal muscle were comparable to untreated controls.  Hyperglycemia was not associated with changes 
in measured metabolic hormones or adipokines including insulin, glucagon, leptin, resistin, IL-6, TNFα, 
or MCP-1 (Howell et al. 2014).  
 
In an intermediate-exposure duration follow-up study, Howell et al. (2015) investigated whether exposure 
to p,p’-DDE would influence the development of obesity and DMT2 using a rodent model of DMT2.  
Male mice were similarly treated orally with 2.0 mg/kg/day p,p’-DDE for 5 days; following 7 days of 
rest, animals then received 2.0 mg/kg p,p’-DDE weekly for 13 weeks, in combination with either a low-
fat (LFD) or high-fat diet (HFD) (Howell et al. 2015).  Hyperglycemia was observed at 4- and 8-week 
timepoints in HFD and DDE-HFD animals; by 13 weeks, however, all DDE-HFD exposed animals 
returned to normoglycemia.  This could partially be explained by an observed increase in Glut4 
expression in skeletal muscle of DDE-HFD mice, which facilitates insulin-stimulated glucose uptake, 
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increased insulin sensitivity, and decreased hepatic glucose production (Howell et al. 2015).  FBG levels 
of the DDE-LFD group were comparable to controls at all time points indicating the complexities of diet 
and weight influences on DDE activity.  In contrast to the hypothesis that DDE exposure may enhance the 
effects of HFDs on diabetic endpoints, prolonged DDE exposure exhibited protective effects.  Mice with 
prolonged exposure to DDE and HFD had values for these endpoints similar to values for LFD-vehicle 
controls.  Only fasting insulin levels and insulin resistance in DDE-HFD mice were slightly, but 
significantly, elevated, compared to LFD animals; the values were lower than the HDF-vehicle controls.  
No metabolic effects or other effects relating to DMT2 were observed in DDE-exposed animals on a LFD 
(Howell et al. 2015).  
 
In a gestational exposure study, mice exposed perinatally from GD 11.5 to PND 5 to a 1.7 mg/kg/day 
mixture of p,p’-DDT and o,p’-DDT had normal glucose tolerance, FBG, insulin, and lipid levels 
throughout their first 6 months of life (La Merrill et al. 2014a, 2014b).  Female mice, but not male mice, 
however, exhibited signs of compromised thermogenesis including reduced core temperature, oxygen 
consumption, and energy expenditure, and increased cold intolerance (La Merrill et al. 2014a, 2014b).  At 
6 months of age, when challenged with a low- or high-fat diet for 12 weeks, DDT gestationally-exposed-
only females on HFDs displayed significant glucose intolerance, insulin resistance, and mild dyslipidemia 
(La Merrill et al. 2014a, 2014b). 
 
An increased incidence and earlier development of diabetes occurred in pre-diabetic female NOD mice 
administered via intraperitoneal injection 50 mg/kg p,p′-DDE twice weekly for 16 weeks (Cetkovic-
Cvrlje et al. 2016).  Elevated blood glucose levels were also observed in these mice.  Exposure to a lower 
dose (25 mg/kg) did not result in significant alterations. 
 
Mechanistic Information on DDT Influence on Diabetic Outcomes.  DMT2 is a complex disease of 
metabolic dysfunction that can take years to develop.  The underlying etiologic agents include a multitude 
of both genetic and environmental factors.  Emerging evidence suggests that EDCs, including DDT, are 
capable of disrupting metabolism and inducing obesity, which then can contribute to the development of 
obesity-related diseases including DMT2 and cardiovascular disease (Lee et al. 2014; Legler et al. 2015; 
Tang-Peronard et al. 2011).  
 
There is a vast amount of mechanistic information on organochlorines, including DDT, their hormonal 
influences, and their ability to disrupt lipid and glucose homeostasis, mitochondrial function, energy 
expenditure, and insulin signaling (for reviews, see Heindel et al. 2017; Ishikawa et al. 2015; Karami-
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Mohajeri et al. 2010; Lee et al. 2014; Mrema et al. 2013).  Adipose tissue dysfunction and metabolic 
changes that contribute to obesity are believed to play a major role in the development of insulin 
resistance, leading to DMT2.  Several studies demonstrate the ability of DDT to disrupt lipid homeostasis.  
In vitro studies with p,p’-DDT or p,p’-DDE suggest there may be AhR-independent effects causing 
increased adipogenesis (Kim et al. 2016; Mangum et al. 2015; Moreno-Aliaga and Matsumuru 2002), 
adipocyte fatty acid uptake (Howell and Mangum 2011), and dipokine (adiponectin, leptin, resistin) levels 
(Howell and Mangum 2011).  In HepG2 cells treated with 1 or 10 ng/mL p,p’-DDE, Liu et al. (2017a, 
2017b) observed acceleration of lipid accumulation, a reduction in mRNA and protein levels of enzymes 
involved in hepatic fatty acid β-oxidation (Cpt1α, MCAD, SCAD), and reduced ATP turnover in the 
mitochondria.  Other in vitro studies further support the hypothesis that p,p’-DDE exposure is associated 
with effects on lipid synthesis, accumulation, degradation, and transport or secretion (Ward et al. 2016).  
Many of these observations translate to in vivo studies in mice.  Following an 8-week exposure to 1 mg 
p,p’-DDE/kg/day orally, significant increases in protein levels, but not transcripts, of key enzymes 
involved in fatty acid synthesis (Fas, Acc, Scd1) in the liver were observed, and alterations in 
metabolomic profiles relevant to fatty acid metabolism and phospholipids were also noted (Liu et al. 
2017a, 2017b).  Another in vivo study in adult female mice perinatally exposed to DDT observed changed 
gene expression in transcripts involved in lipolysis (Pnpla) and thermogenesis (Ppargc1a) (La Merrill et 
al. 2014a, 2014b).  
 
A human study, evaluating the metabolomes of 1,016 adults 70 years of age from Uppsala, Sweden with 
known serum DDE levels found evidence consistent with animal studies linking DDE exposures to 
altered metabolic effects (Salihovic et al. 2016).  DDE was significantly inversely associated with seven 
metabolites, including several lysophosphatidylcholine congeners, which have been linked to diabetes in 
other studies; an increase in monoacylglycerol (18:2), which has been associated with insulin secretion 
and obesity in mice; and increased levels of three fatty acid metabolites that play a role in lipid 
metabolism (Salihovic et al. 2016).  It is unclear, however, whether these changes in metabolite levels 
translate to functional changes that could trigger, or contribute to, obesity and DMT2.  
 
Timing of exposure may be a crucial factor in the development of DDT-related metabolic pathologies.  It 
has been hypothesized that exposure to obesogens, including DDT, during critical phases of development 
may lead to metabolic-related consequences later in life (Russ et al. 2016).  This hypothesis is supported 
by a study in mice (La Merrill et al. 2014a, 2014b), and in a limited number of epidemiological studies 
relating early exposure to obesity (see Section 2.3) and hyperinsulinemia (Tang-Peronard et al. 2015b).  
Because of the crucial roles hormones play during early development, it is hypothesized that DDT 
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disruption of hormonal activities, including its estrogenic and anti-androgenic effects, during vulnerable 
windows, could contribute to the disruption in multiple systems involved in metabolism and adipocyte 
function that contribute to diseases such as DMT2 later in life.  Additional long-term mechanistic studies 
evaluating early-life exposures that monitor effects later in life will help to further test this hypothesis.   
 
2.19   CANCER 
 
Evidence for Cancer in Humans 
 
Scope of the analysis.  Numerous studies have examined possible association between levels of DDT, 
DDD, or DDE in serum or adipose tissues and risks of several types of cancer in groups of humans from 
many regions throughout the world, including the United States.  Multiple case-control epidemiological 
studies of this type have been published for the following types of cancer, listed in order of decreasing 
number of studies: breast cancer in women, NHL, prostate cancer, testicular cancer, pancreatic cancer, 
liver cancer, and endometrial cancer.  In addition, there are single studies that examined associations with 
risks for bladder cancer and colorectal cancer or mortality rates for multiple myeloma or all cancers.  The 
oral route of exposure is the presumed principal route of exposure for the subjects in all of these studied 
groups, although small contributions from dermal or inhalation exposure cannot be excluded.  This 
section provides overviews of the evidence provided by these specific types of case-control 
epidemiological studies.  The ensuing discussion does not include published studies that examined 
possible associations between reports of DDT use and cancer risk, because reported-use exposure data are 
less reliable than internal biometric data.  Also not included are studies that compared serum or adipose 
levels of DDT, DDD, or DDE in cancer cases and controls, but did not examine associations with cancer 
risk.  
 
Overview of epidemiological results.  Consistent evidence from up to 46 case-control studies does not 
support the hypothesis that serum or adipose tissue levels of DDT, DDE, or DDE in adult women is 
associated with increased risk of breast cancer (Ingber et al. 2013; Lopez-Cervantes et al. 2004; Park et al. 
2014).  The lack of an association may be due to the paucity of exposure information during postulated 
early life periods of breast vulnerability (Cohn 2011; Cohn et al. 2007, 2015).  Other case-control studies 
provide inconsistent evidence for associations with NHL, prostate cancer, or testicular cancer; and no 
evidence for associations with pancreatic cancer or endometrial cancer (see sections below for 
references).  No evidence for associations was found in single case-control studies for bladder cancer and 
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colorectal cancer and single studies of mortality rates from multiple myeloma or all cancers.  Consistent 
evidence for associations with liver cancer was found. 
   
Breast cancer.  Many epidemiological studies have investigated the association between breast cancer 
risk in groups of women and levels of DDT or DDE in blood or adipose tissue from the subjects, mostly 
mature adult women.  Wolff et al. (1993) were the first to report a positive association between DDE 
levels (in serum) and breast cancer prevalence, but many subsequent studies did not find evidence for 
associations.  Bottom-line conclusions from the three most recent meta-analyses of case-control studies 
examining associations between DDT or DDE levels in serum or adipose tissue and breast cancer were 
similar:  the available evidence does not support the hypothesized association between DDT/DDE levels 
and risk of breast cancer (Ingber et al. 2013; Lopez-Cervantes et al. 2004; Park et al. 2014).  The meta-
analyses were based on 22 (Lopez-Cervantes et al. 2004), 46 (Ingber et al. 2013), and 35 studies (Park et 
al. 2014).   
 
The literature searches for this document identified two new breast cancer case-control studies not 
included in the meta-analyses, but the results are not expected to affect the overall meta-analytic 
conclusions (Arrebola et al. 2015a; Boada et al. 2012).  Clear associations with DDT biometrics were not 
found in a study of 69 cases and 56 controls from Tunisia (Arrebola et al. 2015a) or in a study of 
121 cases and 103 controls from the Spanish Canary Islands (Boada et al. 2012).  
 
Each of the meta-analyses noted that exposure metrics in most of the case-control studies were measured 
in mature adult women and may not reflect exposure during early life periods when the breast may be 
vulnerable (Ingber et al. 2013; Lopez-Cervantes et al. 2004; Park et al. 2014).  Cohn (2011) postulated 
that the lack of an association might be due to the lack exposure metrics during a critical early period of 
life.  Two studies provide support for this hypothesis (Cohn et al. 2007, 2015).  In a study of 129 breast 
cancer cases and 129 controls who provided blood samples shortly after giving birth in 1959–1967, Cohn 
et al. (2007) reported that the highest category of serum p,p’-DDT levels was associated with increased 
breast cancer risk in a subgroup of women exposed to DDT before 14 years of age (after 1931 when DDT 
use became widespread), but no association was found in women born before 1931 who were not 
expected to have been exposed to DDT in early life periods.  In a study of 118 breast cancer cases and 
118 controls whose mothers provided perinatal blood samples between 1959 and 1967, Cohn et al. (2015) 
reported that daughters of mothers in the highest category of serum o,p’-DDT had higher risk of breast 
cancer (adjusted OR 3.7, 95% CI 1.5–9.0, p-value 0.0004 for 4th versus 1st quartile). 
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A single study examined possible associations between DDT or DDE serum levels and increased risk of 
mortality within 5 or 15 years of breast cancer diagnosis.  In a sample of 622 breast cancer cases, Parada 
et al. (2016) reported that women with DDT levels in the highest tertile of DDT serum levels had an 
increased risk of dying within the first 5 years of diagnosis from all causes of mortality (adjusted HR 2.9, 
95% CI 1.02–4.67) and breast cancer mortality (adjusted HR 2.72, 95% CI 1.04–7.1).  At 15 years, the 
adjusted HRs (95% CI) were 1.42 (0.99–2.06) for all causes and 1.59 (0.90–2.83) for breast cancer 
mortality. 
   
Non-Hodgkin Lymphoma.  Inconsistent evidence comes from a number of case-control studies that 
examined possible associations between risk for NHL and serum or adipose levels of DDT (Brauner et al. 
2012; De Roos et al. 2005; Quintana et al. 2004; Rothman et al. 1997; Spinelli et al. 2007; Viel et al. 
2011) or DDE (Bertrand et al. 2010; Brauner et al. 2012; Cocco et al. 2008; De Roos et al. 2005; Engel et 
al. 2007; Hardell et al. 2001, 2009; Laden et al. 2010; Quintana et al. 2004; Spinelli et al. 2007; Viel et al. 
2011).  Only a few of these studies reported statistically significant associations between NHL risk and 
levels of DDE or DDT.  For example, Quintana et al. (2004) reported elevated adjusted ORs for NHL in 
the highest exposure category (compared with the lowest category) with adipose levels of DDT (1.39, not 
statistically significant) and DDE (1.99 [95% CI 1.14–3.47]), but in logistic models that included adipose 
levels of another organochlorine pesticide (heptachlor epoxide or beta-benzene hexachloride), the 
significance of the association between DDE levels and increased risk for NHL was not apparent.  In the 
only other report of an association, Viel et al. (2011) reported ORs for a 10-ng/g lipid increase of 
1.03 (95% CI 0.99–1.08) for DDE and 1.20 (95% CI 1.01–1.45) for DDT, indicative of weak 
associations. 
 
In a meta-analysis of 5 DDT datasets and 11 DDE data sets from all of the references cited above (except 
Viel et al. 2011), Luo et al. (2016) reported overall adjusted ORs of 1.02 (95% CI 0.81–1.28) for DDT 
and 1.38 (1.14–1.66) for DDE. 
 
Prostate cancer.  Inconsistent evidence is provided by seven case-control studies examining possible 
associations between serum or adipose levels of DDT, DDD, or DDE and increased risk for prostate 
cancer (Aronson et al. 2010; Emeville et al. 2015; Hardell et al. 2006a; Pi et al. 2016; Ritchie et al. 2003; 
Sawada et al. 2010; Xu et al. 2010).  No associations with increased risk of prostate cancer were found in:  
(1) a study that measured DDE in serum from 58 cases and 99 controls from Iowa (Ritchie et al. 2003); 
(2) a Japanese study that measured o,p’-DDT, p,p’-DDT, and p,p’-DDE in 201 cases and 402 controls 
(Sawada et al. 2010); (3) a Canadian study that measured DDE and DDT in serum from 79 cases and 
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135 controls (Aronson et al. 2010); (4) a Swedish study that measured adipose tissue DDE levels in 
42 cases and 20 controls (Hardell et al. 2006a); and (5) a U.S. study that used serum DDE measurements 
in 65 prostate cancer cases and 1,492 noncases from 1999–2004 NHANES data (Xu et al. 2010).  
Associations were reported in two studies (Emeville et al. 2015; Pi et al. 2016).  Pi et al. (2016) reported 
elevated adjusted ORs (95% CI) for prostate cancer in high versus low serum concentration categories in 
a study of 60 cases and 60 controls from Singapore for DDE: 5.67 (1.07–5.16), DDD: 2.35 (1.07–5,16), 
and DDT: 2.35 (1.07–5.16).  Emeville et al. (2015) reported an adjusted OR (95% CI) of 1.53 (1.02–2.30) 
for the highest versus lowest serum DDE quintiles in a study of 567 prostate cancer cases and 655 
controls from Guadaloupe in the French West Indies (Emeville et al. 2015).   
 
Published meta-analyses suggest that evidence is not strong for an association between DDT, DDD, or 
DDE concentrations in serum or adipose tissue and risk for prostate cancer.  In a meta-analysis of six of 
these seven studies (Pi et al. 2016 was not included), plus another report (Kumar et al. 2010) from which 
the meta-analysis authors calculated an ORs of 2.27 (95% CI 1.21–4.27), Lim et al. (2015) reported an 
overall OR of 1.41 (95% CI 1.12–1.78).  In a separate analysis of data from four studies (Aronson et al. 
2010; Ritchie et al. 2003; Sawada et al. 2010; Xu et al. 2010), an overall OR of 1.25 (95% CI 0.86–1.84) 
was reported for a 10 ng/g lipid increase in DDE serum concentration (Lim et al. 2015).  Another meta-
analysis reported overall ORs of 1.02 (95% CI 0.69–1.35) for DDE based on data from five studies 
(Aronson et al. 2010; Emeville et al. 2015; Hardell et al. 2006a; Ritchie et al. 2003; Sawada et al. 2010) 
and 0.81 (95% CI 0.35–1.26) for DDT based on data from Aronson et al. (2010) and Sawada et al. (2010) 
(Lewis-Mikhael 2015).  
 
Testicular cancer.  Inconsistent evidence is provided by five case-control studies examining possible 
associations between serum or adipose levels of DDT, DDE, or DDE and increased risk for testicular 
cancer (Biggs et al. 2008; Giannandrea et al. 2011; Hardell et al. 2006b; McGlynn et al. 2008; Purdue et 
al. 2009).  McGlynn et al. (2008) reported adjusted ORs of 1.71 (95% CI 1.23–2.38) for DDE and 
1.13 (0.71–1.82) for DDT, comparing risk for testicular germ cell tumors in the highest versus lowest 
quartile categories of serum concentrations, in a study of 734 cases and 912 controls who were U.S. 
military men.  No associations between maternal serum DDE levels and risks for testicular cancer were 
found in a Swedish study of 44 testicular cancer cases (diagnosed between 1997 and 2000) and 
45 controls: OR 1.3 (95% CI 0.5–3.0), comparing mother’s serum levels above the median versus below 
the median (Hardell et al. 2006b).  Likewise, no associations with concentrations in blood collected from 
each male subject were reported in studies of: (1) 246 cases and 630 controls diagnosed between 1993 to 
2003 in the U.S. state of Washington, comparing adjusted risks in the highest versus lowest tertiles of 
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serum levels of o,p’-DDT, p,p’-DDT, or p,p’-DDE (Biggs et al. 2008); (2) 49 cases and 51 controls 
diagnosed through 1999 in Norway, comparing adjusted risks in the highest versus lowest tertiles of 
serum levels of o,p’-DDT, p,p’-DDT, or p,p’-DDE (Purdue et al. 2009); and (3) 50 cases and 48 controls 
diagnosed between 2006 and 2008 in Rome, Italy, comparing adjusted risks in groups with levels above 
and below 0.2 ng DDE/mL serum (Giannandrea et al. 2011). 
 
Pancreatic cancer.  No evidence was found in three case-control studies for associations between serum 
DDE levels and risks for pancreatic cancer (Gasull et al. 2010; Hardell et al. 2007; Hoppin et al. 2000).  
In a study of 21 Swedish cases and 59 controls, Hardell et al. (2007) reported an adjusted OR of 
2.39 (95% CI 0.73–7.78) for pancreatic cancer in subjects with serum DDE levels greater than the median 
value, compared with subjects with serum DDE levels less than the median.  Hardell et al. (2007) noted 
shorter mean survival time after diagnosis, in cases with serum DDE levels above the median, compared 
with cases with serum levels below the median (208 versus 427 days).  In a study of 108 pancreatic 
cancer cases and 82 controls from the San Francisco area, an adjusted OR of 2.1 (95% CI 0.9–4.7) was 
reported for the highest serum DDE concentration tertile, compared with the lowest tertile (Hoppin et al. 
2000).  In a study of 97 pancreatic cancer cases with information about K-ras mutation in tumor tissue 
(75 with K-ras mutation and 22 with normal K-ras), no association was found between DDE serum levels 
and risk for K-ras-mutated pancreatic cancer (Gasull et al. 2010).  Likewise, Cocco et al. (2000) found no 
association between DDE levels in adipose samples collected in 1968 from subjects in 22 U.S. states and 
mortality rates from pancreatic cancer between 1974 and 1994.  In contrast, there were associations 
between serum DDT and DDD levels and pancreatic cancer deaths in workers exposed at least 10 years 
prior to death (Garabrant et al. 1992).  The RRs were 4.8 (95% CI 1.3–17.6) for DDT (6 cases, 7 controls) 
and 4.3 (95% CI 1.5–12.4) for DDD (9 cases, 12 controls). 
 
Liver cancer.  Three case-control studies of Chinese populations provide consistent evidence of 
associations between serum DDT levels and increased risk of liver cancer (McGlynn et al. 2006; Persson 
et al. 2012; Zhao et al. 2012).  Adjusted ORs (95% CI) of 3.8 (1.7–8.6) for DDT and 0.8 (0.3–1.7) for 
DDE, comparing risks in the highest and lowest serum level quintiles, were reported in a study of 
168 liver cancer cases and 385 controls from Linxian, China (McGlynn et al. 2006).  Adjusted ORs (95% 
CI) of 2.96 (1.19–7.40) for DDT and 0.81 (0.33–2.03) for DDE, comparing risks in the highest and lowest 
serum level quintiles, were reported in a study of 473 hepatocellular carcinoma cases and 492 controls 
from Haimen City, China (Persson et al. 2012).  Adjusted ORs (95% CI) of 4.07 (2.72–6.10) for DDT and 
1.96 (1.39–2.76) for DDE, comparing risks in the highest and lowest serum level quartiles, were reported 
in a study of 346 hepatocellular carcinoma cases and 961 controls from Xiamen China (Zhao et al. 2012).  
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Liver cancer mortality rate increased with adipose DDE levels in U.S. white males and females, but not 
among African Americans, in a study that examined associations between DDE levels in 1,968 adipose 
samples and age-adjusted mortality rates between 1974 and 1994 (Cocco et al. 2000). 
 
Endometrial cancer.  No associations between serum or adipose tissue levels of DDT, DDE, or o,p’-DDT 
and increased risk of endometrial cancer were found in a study of 90 endometrial cancer cases and 
90 controls from five regions of the United States that measured serum levels of DDT, DDE, and 
o,p’-DDT (Sturgeon et al. 1998) and a study of 76 endometrial cancer and 39 controls from two hospitals 
in Sweden that measured DDE levels in adipose tissue samples (Hardell et al. 2004, also reported in 
Lindstrom et al. 2004). 
 
Multiple myeloma.  Cocco et al. (2000) found no association between DDE levels in adipose samples 
collected in 1968 from subjects in 22 U.S. states and mortality rates from multiple myeloma between 
1974 and 1994. 
 
Bladder cancer.  No associations between serum levels of DDT, DDD, or DDE and increased risk of 
bladder cancer were found in a study of 140 bladder cancer cases and 206 controls from the Spanish 
Canary Islands (Boada et al. 2016). 
 
Colorectal cancer.  No associations between serum level of DDT or DDE and increased risk of colorectal 
cancer were found in a study of 132 colorectal cancer cases and 72 controls from a hospital in Barcelona 
Spain (Howsam et al. 2004). 
 
All cancer.  No association was found between serum levels of DDT + DDE (collected in 1974–1975) 
and adjusted mortality rates for any cancer between 1975 and 1985 in a study of 919 adults from 
Charleston, South Carolina (Austin et al. 1989).  
 
Animal Studies.  DDT is one of the most widely studied pesticides in laboratory animals, and data are 
available from many carcinogenicity studies in several species.   
 
Intermediate exposures, in which animals were exposed to DDT in food, caused cancer increases in mice, 
but not in rats or hamsters.  Mice that were observed for 50–105 weeks after cessation of treatment 
developed liver hepatomas following dietary exposure to 42.8 mg p,p’-DDT/kg/day for 15–30 weeks 
(Tomatis et al. 1974b).  DDT did not produce increases in the tumor incidence in rats exposed to 10–
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20 mg/kg/day in the food for up to 45 weeks (p,p’-DDT: Kimbrough et al. 1964; technical DDT: Laug 
et al. 1950; DDT(NS): Numoto et al. 1985) or in hamsters fed 50 mg p,p’-DDT/kg/day for 30 weeks 
(Tanaka et al. 1987).  
 
Chronic exposure (>1 year) to technical DDT, p,p’-DDT, or DDT(NS) caused cancer in multiple strains 
of mice and in some rat studies, but not in dogs; most studies in nonhuman primates have also been 
negative.   
 
Chronic exposure to DDT (technical DDT, p,p’-DDT, or DDT(NS)) produced predominantly liver tumors 
in several mouse strains ([C57BL/6 x C3H/Anf]F1, [C57BL/6 x AKR]F1, BALB/c, Swiss inbred, and 
CF1) fed DDT at dietary doses as low as 0.33 mg/kg/day for a minimum of 78 weeks (p,p’-DDT: Innes 
et al. 1969; Thorpe and Walker 1973; Tomatis et al. 1972, 1974a; technical DDT: Kashyap et al. 1977; 
Turusov et al. 1973; DDT(NS): Terracini et al. 1973).  An increased incidence of pulmonary adenomas 
was observed in strain A mice (a susceptible strain for lung tumors) after chronic gavage administration 
of doses ≥1.7 mg technical DDT/kg/day (Shabad et al. 1973).  Malignant lymphomas and lung and liver 
tumors were also observed in Swiss inbred mice fed 16.5 mg technical DDT/kg/day DDT in food for 
80 weeks (Kashyap et al. 1977).  No significant increases in tumor incidence were observed in ICR mice 
administered 16.5 technical DDT/kg/day for 55 weeks in several generations (Del Pup et al. 1978), 
consistent with the hypothesis that DDT-induced tumors develop in later stages of life with continued 
exposure.  No significantly increased incidences of any type of tumors were observed in B6C3F1 mice 
fed up to 30.2 mg technical DDT/kg/day for 78 weeks (NCI 1978).   
 
Several multigeneration studies have been conducted in mice.  In these studies, exposure of the F1 and 
subsequent generations to DDT was initially perinatal (i.e., in utero and through lactation) and was 
followed postweaning by oral exposure to DDT in the diet.  In a study by Tarjan and Kemeny (1969), 
exposure to 0.4 mg p,p’-DDT/kg/day resulted in significant increases in leukemia and pulmonary 
carcinomas in the F2 generation and occurred with increasing frequency with each subsequent generation 
of mice.  Liver tumors (0.3–0.4 mg/kg/day) (Tomatis et al. 1972; Turusov et al. 1973) and pulmonary 
tumors (1.7 mg/kg/day) (Shabad et al. 1973) in the F1 generation had a shorter latency period than in the 
parental generation, but the tumor incidence was comparable and did not increase with consecutive 
generations.  
 
Liver tumors also have been observed in rats chronically exposed to DDT.  Rats maintained on diets 
containing DDT for >2 years or at doses >25 mg technical DDT/kg/day developed liver tumors, primarily 
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in female rats (Cabral et al. 1982b; Fitzhugh and Nelson 1947; Rossi et al. 1977).  Increased incidences of 
liver tumors also occurred in rats at doses of 12 mg technical DDT/kg/day for 2 years (Cabral 1982b) and 
in F334 rats receiving doses ≥1.7 mg p,p’-DDT/kg/day for 2 years (Harada et al. 2003, 2006).  In contrast, 
no evidence of carcinogenicity was seen in Osborne-Mendel rats receiving up to 45 mg technical 
DDT/kg/day for 78 weeks in the NCI (1978) bioassay.   
 
Long-term exposure failed to induce significant increases in tumors in monkeys at doses of 3.9–20 mg 
DDT(NS)/kg/day for up to 5 years (Adamson and Sieber 1979, 1983; Durham et al. 1963) or in dogs at 
80 mg technical DDT/kg/day for 49 months (Lehman 1965).  A study that involved 11 Rhesus and 
13 Cynomolgus monkeys administered approximately 6.4–15.5 p,p’-DDT/kg/day in the diet for up to 
130 months reported that 2 out of 13 Cynomolgus monkeys (15%) developed malignant tumors: one 
hepatocellular carcinoma and one adenocarcinoma of the prostate (Takayama et al. 1999).  No neoplasms 
were found in a group of nine Cynomolgus and eight Rhesus untreated control monkeys. 
 
Evidence of carcinogenicity of DDT in hamsters is equivocal.  Rossi et al. (1983) reported an increased 
incidence (14% in controls, 34% in treated hamsters) of adrenal neoplasms in hamsters administered 
approximately 95 mg technical DDT/kg/day via the diet for 30 months.  At lower doses, Cabral et al. 
(1982a) did not observe a statistically significant increase in adrenal gland tumors; however, the incidence 
in males was increased compared to controls in animals receiving 71 mg technical DDT/kg/day via the 
diet for 28 months.  Other studies in hamsters did not indicate any carcinogenic effects of DDT; however, 
early deaths occurred in one study (Agthe et al. 1970) and the duration of exposure was shorter in another 
(Graillot et al. 1975). 
 
There are several studies of the potential carcinogenicity of DDE and DDD in rats, mice, and hamsters.  
DDE administered chronically in the diet produced liver tumors in male and female mice at doses of 27–
43 mg p,p’-DDE/kg/day for 30–78 weeks (NCI 1978; Tomatis et al. 1974a) and in hamsters dosed with 
approximately 48 mg p,p’-DDE/kg/day for 128 weeks (Rossi et al. 1983).  DDE did not induce significant 
increases in tumor incidence in rats at doses ranging from 12 to 42 mg, p,p’-DDE/kg/day for 78 weeks 
(NCI 1978), but doses of approximately 43 mg p,p’-DDE/kg/day for 130 weeks significantly increased 
the incidence of liver tumors in mice (Tomatis et al. 1974a).  DDD induced liver tumors and lung 
adenomas in CF-1 mice at doses of approximately 43 mg p,p’-DDD/kg/day (Tomatis et al. 1974a), but it 
was not tumorigenic in B6C3F1 mice in a 78-week study at doses of approximately 142 mg technical 
DDD/kg/day (NCI 1978).  In rats, the combined incidences of thyroid follicular cell adenoma and 
follicular cell carcinomas were 1/19, 16/49, and 11/49 in controls, low-dose (116 mg/kg/day), and high-
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dose (231 mg/kg/day) male rats exposed to technical DDD, respectively (NCI 1978).  The difference 
between the control and low-dose group was significant according to the Fisher Exact test.  However, 
NCI (1978) pointed out that the variation of these tumors in control male rats in the study did not permit a 
more conclusive interpretation of the lesion. 
 
Dermal exposure (skin painting) of mice to DDT did not result in a significant increase in tumor 
incidence when applied in a 5% solution in kerosene once weekly for 52 weeks (Bennison and Mostofi 
1950) or at 8 mg/kg twice weekly for 80 weeks (Kashyap et al. 1977).  No information on dermal 
exposure of rats or hamsters to DDT or dermal exposure to DDE or DDD was located. 
 
The HHS determined that DDT is “reasonably anticipated to be a human carcinogen”, based on sufficient 
evidence of carcinogenicity in experimental animals (NTP 2016).  EPA IRIS last revised carcinogenicity 
assessments for DDT, DDD, and DDE in 1988, classifying each as a “probable human carcinogen” 
(Group B2), based on sufficient evidence of carcinogenicity in animals (2002a, 2002b, 2003).  IARC 
determined that DDT is “probably carcinogenic to humans”, based on limited evidence in humans and 
sufficient evidence in experimental animals (IARC 2017).   
 
Mechanisms of Carcinogenicity of DDT, DDE, or DDD.  Many epidemiological studies have looked for 
associations between concentrations of DDT, DDE, or DDD in biological fluids and risks for various 
types of cancer in human populations.  Consistent evidence for positive associations has been presented 
only for liver cancer; consistent evidence for positive associations is not currently available for any other 
type of cancer.  In contrast, fairly consistent evidence is available for increased incidence of liver tumors 
in rodents exposed chronically to DDT, DDE, or DDD in food.  Harada et al. (2016) recently reviewed 
evidence that DDT and its metabolites may produce liver tumors in rodents via non-genotoxic 
mechanisms involving mitogenicity in the liver through activation of the CAR and induction of 
eosinophilic foci in liver cells as a result of oxidative DNA damage, in combination with inhibitory 
effects on GJIC.  Evidence presented included concordance between doses producing liver tumors in 
F344 rats fed p,p’-DDT for 2 years and doses producing: (1) early hepatic induction of CAR-mediated 
CYP isozymes (e.g., CYP2B1, CYP3A2); (2) persistently increased hepatic levels of markers of oxidative 
stress (lipid peroxide and 8-OHdG); (3) transiently enhanced cell proliferation in the liver; and 
(4) persistently decreased hepatic levels of GJIC protein px32.   
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2.20   GENOTOXICITY 
 
The genotoxicity of DDT and related compounds has been examined in humans and animals, and in 
isolated cell systems.  Tables 2-21 and 2-22 summarize pertinent results. 
 
Table 2-21.  Genotoxicity of DDT, DDE, and DDD In Vivo 
 
Species (exposure route) Endpoint Results Reference 
Epidemiological evidence 
Human (serum; semen) Chromosomal aberrations (sex-
chromosome aneuploidy, total 
disomy) 
+ McAuliffe et al. 2012 
Human (serum; semen) Chromosome aberrations 
(sperm aneuploidy) 
+ Perry et al. 2016 
Human (serum; semen) Chromosomal aberrations (sex 
ratio changes) 
– Tiido et al. 2005, 2006 
Human (serum; semen) Chromosomal aberrations 
(sperm chromatin integrity)  
– Rignell-Hydbom et al. 
2005b 
Human (serum; semen) Chromosomal aberrations 
(sperm chromatin integrity) 
– Spanò et al. 2005 
Human (serum; semen) Chromosomal aberrations 
(sperm chromatin integrity) 
(+) de Jager et al. 2009 
Human (lymphocytes) Chromosome aberrations (sister 
chromatid exchanges) 
+ Nagayama et al. 2003 
Human (lymphocytes) Micronuclei – Alvarado-Hernandez et al. 
2013 
Human (lymphocytes) Micronuclei – Vine et al. 2001 
Human (lymphocytes) DNA damage (comet assay) – Alvarado-Hernandez et al. 
2013  
Human (lymphocytes) DNA damage (Fpg-modified 
comet assay) 
+ Franken et al. 2017 
Human (lymphocytes) DNA damage (alkaline-modified 
comet assay) 
– Franken et al. 2017 
Human (lymphocytes) DNA damage (biomarkers in 
urine, 8-OHdG) 
– Franken et al. 2017 
Human (lymphocytes) DNA damage (comet assay) + Jasso-Pineda et al. 2015 
Human (lymphocytes) DNA damage (comet assay) (+) Yáňez et al. 2004 
Human (lymphocytes) DNA damage (methylation) + Itoh et al. 2014 
Human (lymphocytes) DNA damage (hypomethylation) (+) Kim et al. 2010 
Human (lymphocytes) DNA damage (methylation) (+) Rusiecki et al. 2008 
Human (serum; semen) DNA damage (sperm DNA 
methylation) 
– Consales et al. 2016 
Human (serum, semen) DNA damage (comet assay) – Hauser et al. 2003 
Human (serum, semen Sperm DNA fragmentation 
(TUNEL assay) 
– Stronati et al. 2006 
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Table 2-21.  Genotoxicity of DDT, DDE, and DDD In Vivo 
 
Species (exposure route) Endpoint Results Reference 
Human (peripheral 
leukocytes) 
DNA damage (telomere length) – Guzzardi et al. 2016 
Human (peripheral 
leukocytes) 
DNA damage (telomere length) (+) Shin et al. 2010 
Human (buccal cells) DNA damage (telomere length) ± Hou et al. 2013 
Laboratory animal evidence 
Mouse (spermatocytes) Chromosomal aberrations + Clark 1974 
Rat  Chromosomal aberrations – Legator et al. 1973 
Rabbit (fetus’ liver) Chromosomal aberrations – Hart et al. 1972 
Mouse (bone marrow) Chromosomal aberrations (+) Larsen and Jalal 1974 
Rat (mammary glands) Chromosomal aberrations + Uppala et al. 2005 
Rat (mammary glands) Micronuclei – Uppala et al. 2005 
Rat (buccal cells) Micronuclei + Canales-Aguirre et al. 2011 
Mouse Dominant lethal + Clark 1974 
Rat Dominant lethal (+) Palmer et al. 1973 
Rat (peripheral blood 
lymphocytes) 
DNA damage + Canales-Aguirre et al. 2011 
Rat (mammary epithelial 
cells) 
DNA damage + Canales-Aguirre et al. 2011 
Mouse (inhibition of 
testicular synthesis) 
DNA synthesis – (DDE) Seiler 1977 
Host-mediated assays 
Serratia marcescens 
(Mouse hosted-mediated) 
Gene mutation – (DDT, 
DDE) 
+ (DDD) 
Buselmaier et al. 1973 
Neurospora crassa Gene mutation – Clark 1974 
Invertebrate systems 
Drosophila melanogaster Dominant lethal + Clark 1974 
 
– = negative result; + = positive result; (+) = weakly positive results; ± = equivocal; 8-OHdG = 8-hydroxydeoxy-
guanosine; DNA = deoxyribonucleic acid 
 
Overview of Genotoxicity Results.  For the most part, the evidence for DDT-induced genotoxic effects at 
the blood levels of DDT (including different isomers and metabolites) currently found in the U.S. 
population is weak.  Genotoxicity has been reported in populations with the highest exposures, usually in 
foreign countries, and even then, the associations between DDT biomarkers and the outcomes measured 
have not been strong.  Studies in animals in vivo have not provided a clear picture, possibly due to 
differences in the studies’ protocols, such as differences in routes of exposure (inhalation, gavage, 
intraperitoneal injection) or in duration of exposure (single versus repeated doses).  Results from in vitro 
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studies in mammalian cells were also mixed, whereas in vitro studies in prokaryotic organisms were 
negative for DDT compounds. 
 
Epidemiological Evidence for Effects on Chromosomes and DNA.  Studies of humans exposed to DDT 
have provided information on effects on chromosomes and DNA using a wide variety of tests 
(Table 2-21).  For example, a study by Nagayama et al. (2003) revealed a positive association (r= -0.247, 
p=0.05) between the frequency of sister chromatid exchanges (SCEs) in cultured lymphocytes from 
10-month-old infants (n=105; 60 males, 45 females) and lactational exposure to DDT (estimated median 
exposure via maternal milk during the 2nd and 4th months postpartum was 272 mg DDT/kg/day).  The 
negative correlation coefficient reflects the fact that the authors measured the difference in response 
between negative and positive controls; therefore, as DDT in milk increased, the difference between the 
two responses became smaller.  In another study, an Fpg-modified comet assay in peripheral blood 
lymphocytes from 606 Belgian adolescents revealed a positive association (28.9% [95% CI: 0.01–66.1]) 
between increased blood concentrations of DDT (mean in serum was not reported, DDT was detected in 
only 40% of the blood samples) and DNA damage (Franken et al. 2017).  Results from two additional 
tests, an alkaline-modified comet assay and analysis of 8-OHdG levels in urine (biomarker of DNA 
damage/repair) produced no associations.  In a study of 276 Mexican children living in areas of high risk 
contamination, high levels of total DDT in blood (1,400–32,000 ng/g lipid) were positively correlated 
(r=0.59, p<0.01) with DNA damage in peripheral lymphocytes (Jasso-Pineda et al. 2015).  Yáňez et al. 
(2004) reported a correlation between DNA damage in peripheral blood mononuclear cells from 
54 healthy women who were residents in malarious communities with previous DDT spraying.  Mean 
serum concentrations of p,p’-DDT, p,p’-DDD, and p,p’-DDE were 4.57, 1.15, and 6.21 ng/mL, 
respectively; the associations remained significant after accounting for confounding factors (smoking 
habits, nutrition, alcohol consumption).  It should be noted, however, that although the associations were 
significant (p<0.05), the correlations were weak based on r2 values of 0.19, 0.11, and 0.21 for DDT, DDE, 
and DDD, respectively.  In a study by Alvarado-Hernandez et al. (2013), no significant correlation was 
found between frequency of micronuclei or DNA damage and plasma levels of p,p’-DDT and p,p’-DDE 
in maternal and umbilical cord blood collected from 50 mother-infant pairs (median levels for DDE and 
DDT in umbilical cord were 192 and 421 ng/g lipid, respectively; median maternal levels of 472 and 
204 ng/g lipid, respectively).  Similarly, a study of 302 individuals residing near a waste site in North 
Carolina found that plasma DDE levels (median 2 ng/mL) were not associated with frequency of 
micronuclei (Vine et al. 2001).   
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Epidemiological Evidence for Change in Telomere Length.  Three studies provide information 
regarding DDT and telomere length (Table 2-21).  The telomere is a region of repetitive nucleotides at the 
end of linear eukaryotic chromosomes that is essential for maintaining stability and integrity of the 
genome; it has been shown that loss (shortening) of the telomere can lead to genomic instability.  
Evaluation of participants in the Agricultural Health Study (AHS) (a prospective cohort study of nearly 
90,000 private pesticide applicators [mostly farmers], their spouses, and commercial pesticide applicators 
in Iowa and North Carolina) showed an association between shortening of relative telomere length (RTL) 
and lifetime intensity-weighted days of exposure to DDT (as well as other pesticides) in buccal cell DNA 
from pesticide sprayers (β -0.006; p for trend=0.03).  The association, however, was not significant for 
lifetime days of use of DDT (β -0.02; p for trend= 0.08) (Hou et al. 2013).  No quantitative assessment of 
exposure was conducted in the AHS.  In a cross-sectional study of 84 healthy adult males and females 
from South Korea, blood levels of p,p’-DDE were significantly correlated with increased telomere length 
in peripheral blood leukocytes (r=0.31, p<0.01 in models adjusted for age, sex, BMI, cigarette smoking, 
and alcohol consumption) (Shin et al. 2010).  However, the relatively low values for r indicate that the 
contribution of p,p’-DDE to the change in telomere length was minimal.  No significant associations were 
found with p,p’-DDD or p,p’-DDT.  Further analyses categorizing serum p,p’-DDE into quintiles showed 
that telomere length was increased at the lower concentrations of p,p’-DDE (<400 ng/g lipid) and 
decreased at higher concentrations (≥500 ng/g lipid).  Shin et al. (2010) had no explanation for the 
increase in telomere length across low p,p’-DDE concentrations, but suggested that p,p’-DDE may act as 
a tumor promoter at low doses.  In a study of an elderly population of 1,082 Finish subjects from the 
Helsinki Birth Cohort Study, there were no significant associations between circulating p,p’-DDE (mean 
concentration of p,p’-DDE in serum for all participants was 2.08 ng/mL) and telomere length (Guzzardi et 
al. 2016).  
 
Epidemiological Evidence for DNA Methylation Effects.  Several studies have examined associations 
between DDT and DNA methylation (Table 2-21).  Decreases in global methylation (hypomethylation) 
are believed to be a product of chromosomal instability and/or increased mutation events and are 
associated with an increased risk of cancer.  In a cross-sectional study, Itoh et al. (2014) reported 
significant decreases in mean global methylation levels (0.41–0.83% per quartile category, p≤0.034) in 
leukocyte DNA of 403 Japanese women (aged 20–74 years) who were previously used as controls for a 
breast cancer case-control study.  Mean blood concentrations of o,p’-DDT, p,p’-DDT and p,p’-DDE were 
1.6, 9.9, and 370 ng/g lipid, respectively.  Kim et al. (2010) reported inverse linear relationships between 
p,p’-DDT and p,p’-DDE in serum (medians: 20.2 and 393.0 ng/g lipid, respectively) and global DNA 
methylation in peripheral blood leukocytes of a population of 86 healthy South Koreans assessed by the 
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Alu assay, but not when the LINE-1 (long interspersed nucleotide element) assay was used.  Yet, Pearson 
correlation coefficients showed that the associations were weak (r values of -0.29 for p,p’-DDE and -0.22 
for p,p’-DDT).  No association was found for p,p’-DDD in either assay.  Inverse linear relationships also 
were reported between p,p’-DDT and p,p’-DDE in plasma (means of 44.03 and 1,624.1 ng/g lipid, 
respectively) and global DNA methylation in peripheral blood leukocytes in a study of 70 Greenlandic 
Inuit subjects in adjusted models using the Alu assay, but not when using the LINE-1 assay (Rusiecki et 
al. 2008).  As in the Kim et al. (2010) study, associations were weak (r values -0.26 for p,p’-DDT and -
0.38 for p,p’-DDE) even though concentrations of p,p’-DDT and p,p’-DDE were considerably higher.  
Consales et al. (2016) did not find consistent associations between plasma p,p’-DDE and DNA 
methylation changes in sperm from 607 fertile men from Greenland, Poland and the Ukraine using four 
different assays or in separate analyses of the three cohorts (the mean p,p’-DDE concentration for the 
combined cohort was 888.2 ng/g lipid).  The most notable finding was an inverse association between 
p,p’-DDE and DNA methylation for the combined cohort in an assay for DNA global methylation 
(β= -29.20 [95% CI -52.11 to -6.29), but not in tests that measured methylation at specific repetitive DNA 
sequences.   
 
Epidemiological Evidence for Effects on Sperm Genetic Material.  Results of studies concerning DDT 
and alterations in sperm genetic material were mixed (Table 2-21).  No associations were found between 
p,p’-DDE (geometric mean 254 ng/g lipid) and sperm chromatin integrity of 212 male partners of sub-
fertile couples who were previously evaluated for fertility at the Massachusetts General Hospital between 
January 2000 and April 2002 (Hauser et al. 2003).  Similarly, there were no associations between 
p,p’-DDE in serum (mean 233 ng/g lipid) and sperm chromatin integrity in a population of 176 Swedish 
fishermen with low and high consumption of fatty fish (Rignell-Hydbom et al. 2005a) or in a cross 
sectional study involving 707 adult males from Greenland, Sweden, Poland and the Ukraine (serum 
p,p’-DDE means ranged from 340 to 1,300 ng/g lipid) (Spanò et al. 2005).  There was a weak association 
(only marginally statistically significant) between lipid adjusted p,p’-DDT (mean: 109,200 ng/g; median: 
83,900 ng/g) and p,p’-DDE (mean: 246,200 ng/g; median: 177,800 ng/g) and the incidence of sperm with 
chromatin defects in a population of 209 men (aged 18–44 years) living in a malaria area in the Limpopo 
Province, South Africa where DDT is sprayed annually resulting in very high exposure, as evidenced by 
the measured levels of DDT and DDE in blood (de Jager et al. 2009).  A study conducted by Stronati et 
al. (2006) revealed no correlation between exposure to DDE and sperm DNA fragmentation or apoptotic 
markers in a group of 652 men (n=200 Inuits from Greenland, 166 from Sweden, 124 from Poland, and 
153 from the Ukraine).  Similar results were reported when the European populations were taken together 
and analyzed separately from the Inuit group.  McAuliffe et al. (2012) reported associations between 
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serum p,p’-DDE and increased rates of XX, XY, and total sex-chromosome disomy, but not YY disomy 
in sperm nuclei of 192 adult men (aged 20–54 years).  Analysis by p,p’-DDE quartiles showed that 
increases in disomy occurred between the 1st and 2nd quartile with no further increases in the 3rd or 
4th quartiles.  The adjusted incidence rate ratio (IRR) for the comparison of the 4th quartile (≥1.68 ng/g) 
with the 1st quartile (≤0.61 ng/g) was 1.27 (95% CI 1.22–1.33).  Men were from sub-fertile couples who 
had previously been evaluated at the Massachusetts General Hospital Fertility Center between January 
2000 and May 2003, the geometric mean serum p,p’-DDE concentration for the group was 1.11 ng/g 
serum (McAuliffe et al. 2012).  Perry et al. (2016) examined the association between serum p,p’-DDE and 
sperm aneuploidy in a group of 90 adult Faroese men who participated in Faroe Island health studies; 
cord blood and age-14 serum were also available for a subgroup (n=40).  Geometric mean concentrations 
of p,p’-DDE were 280 ng/g lipid, 790 ng/g lipid, and 0.45 ng/mL blood, in adults, adolescents, and cord 
blood, respectively.  Associations were found between p,p’-DDE and total disomy in adults (IRR 
1.32 [95% CI 1.25–1.35] for 3rd tertile [>390 ng/g lipid] versus referents) and in adolescents (IRR 
1.19 [95% CI 1.08–1.32) for 3rd tertile [1,080 ng/g lipid] versus referents), but not for cord blood (IRR 
0.94 [95% CI 0.86–1.03] for 3rd tertile [0.54 ng/mL blood] versus referents).  Tiido et al. (2006) examined 
the association between serum p,p’-DDE and Y/X chromosome distributions in the same populations 
studied by Rignell-Hydbom et al. (2005b) and Spanò et al. (2005) (see above).  Mean serum 
concentrations of p,p’-DDE ranged from 350 ng/lipid in Swedish fishermen to 1,300 ng/g lipid in men 
from the Ukraine.  Tiido et al. (2006) reported a positive association between Y-chromosome fractions in 
sperm of Swedish fisherman (β=0.66; 95% CI 0.30–1.02) and natural log-transformed p,p´-DDE.  
However, when p,p’-DDE was categorized into quintiles, there was no association for the comparison of 
the highest quintile (>1,500 ng/g lipid) with the lowest (≤250 ng/g lipid) (β=0.03 [95% CI -2.31–2.36]).  
No significant associations were found between p,p’-DDE and Y-chromosome fractions in populations of 
men from Greenland (n=157), Poland (n=121), or the Ukraine (n=120).  
 
Evidence for Dominant Lethal Mutations in Laboratory Animals.  Consistent evidence for dominant 
lethal mutations comes from studies in rats, mice, and Drosophila melanogaster (Table 2-21).  In a 
dominant lethal assay study, treatment of male rats with a single dose of 100 mg p,p’-DDT/kg resulted in 
a statistically significant increase in the proportion of females with one or more dead implantations only 
in animals mated during the postmeiotic stage of spermatogenesis (Palmer et al. 1973).  No such effect 
was observed in animals given intraperitoneal doses of ≤80 mg/kg for 5 consecutive days.  In another 
dominant lethal assay, DDT was administered orally to male mice at 150 mg/kg/day for 2 days (acute) or 
100 mg DDT/kg twice weekly for 10 weeks (intermediate); the final dose was given 24 hours before 
sequential mating began (Clark 1974).  Significant increases occurred in the number of dead implants per 
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female.  Acute doses resulted in maximum sensitivity in the induction of dominant lethal effects in 
week 5 and chronic doses in week 2, with continued increases above control through week 6.  Repeated 
dosing caused significant reductions in testes weight, sperm viability, and a reduction of cell numbers in 
all stages of spermatogenesis.  With acute treatment, the meiotic stage of spermatogenesis appeared to be 
the most sensitive.  Acute treatment produced a significantly increased frequency of chromosome 
aberrations (breakage, univalents, and stickiness) in spermatocytes.  Clark (1974) also investigated 
dominant lethal effects in D. melanogaster.  Male Canton-S D. melanogaster were treated with a drop 
containing 1 µg DDT to the surface of a treacle-meal-agar medium and were then mated sequentially with 
a brood interval of 3 days.  There was a significant increase in the proportion of unhatched eggs in broods 
3 and 4, which was attributed to dominant lethal mutations.  When DDE was administered in a single oral 
dose to male mice at the rate of 50 mg/kg, it did not inhibit testicular DNA synthesis (Seiler 1977).   
 
Evidence for Effects on Chromosomes and Micronuclei Induction in Laboratory Animals.  Studies 
evaluating chromosomal effects in vivo were mixed (Table 2-21).  In a study by Uppala et al. (2005), 
juvenile rats were exposed to o,p’-DDT via subcutaneous injection (50 mg/kg) on days 21, 23, 25, 27, 29, 
31, 32, and 34 postpartum; selected rats were also gavaged with 40 mg/kg 7,12-dimethylbenz-
[a]anthracene (DMBA, a prototype chemical carcinogen) on day 28.  Exposure with or without DMBA 
resulted in significant increases in the frequency of chromosomal aberrations in mammary cells (p≤0.01), 
but did not induce significant increases in micronuclei.  Cell proliferation (as measured by BrdU) in 
mammary cells was also significantly increased in rats treated with DDT and DMBA (p=0.0005); 
however, there was no significance with DDT alone.  Legator et al. (1973) reported that rats treated orally 
(by gavage) with p,p’-DDT in single doses of 50–100 mg/kg or daily doses of 20–80 mg/kg/day for 
5 days did not show a dose-related increase in the percent of chromosomal aberrations over the solvent 
control.  BALB/C mice injected intraperitoneally with 25–250 mg/kg DDT in peanut oil exhibited a 
significantly higher proportion of deletions in bone marrow cells than controls, but gaps, stickiness, and 
the mitotic index were not significantly affected (Larsen and Jalal 1974).  Administration of up to 50 mg 
p,p’-DDT/kg by gavage to rabbits on GDs 7–9 did not affect chromosomal number distribution or the 
percentage of aberrations compared with controls (Hart et al. 1972).  In addition, the distribution of 
chromosomes in liver samples from fetuses of DDT-treated rabbits and the percentage of chromosomal 
aberrations in these fetuses did not differ from controls.  In a repeated inhalation exposure study, female 
rats were exposed to approximately 7 mg/m3 DDT for 8 hours/day, 6 days/week for 5 months (Canales-
Aguirre et al. 2011).  Repeated exposure caused statistically significant increases in micronuclei of buccal 
cells, DNA damage in peripheral lymphocytes and mammary epithelial cells (measured by comet tail 
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length and tail moment), and an increase in lipid peroxidation in mammary tissue (measured by free 
radical production in tissue). 
 
Host-mediated Assays.  Host-mediated assays have also provided mixed results (Table 2-21).  Buselmaier 
et al. (1973) reported positive results for gene mutation in a mouse host-mediated assay in Serratia 
marcescens following injection of DDD; no mutation was observed after exposures to DDT or DDE 
(additional details were not provided).  Clark (1974) reported negative results in host-mediated assay to 
detect mutations in Neurospora crassa.  Mice received an initial oral dose of 150 mg/kg DDT in olive oil 
3 hours before injection with conidia of N. crassa; a second dose of 150 mg/kg was administered 10 hours 
after injection of conidia.  Results indicated that the host did not potentiate mutagenicity in this assay. 
 
Assays with Prokaryotic Cells.  As shown in Table 2-22, DDT and related compounds were non-
mutagenic and did not induce DNA damage in prokaryotic organisms under the conditions tested.  No 
evidence of gene mutation was found in Salmonella typhimurium strains TA1535, TA1537, TA98, 
TA100, G46, C3076, or D3052 or E. coli strains Pol-A, WP2 and WP2 uvrA- with or without metabolic 
activation (Fahrig 1974; Fluck et al. 1976; McCann et al. 1975; Probst et al. 1981).  Results were negative 
in recessive lethal test in Neurospora crassa (Clark 1974) and in a mitotic gene conversion test in 
Saccharomyces cerevisiae (Fahrig 1974) in the absence of metabolic activation.  In addition, tests 
assessing DNA damage in Bacillus subtilis (rec assay) and E. coli (col E1 plasmid DNA and DNA cell 
binding) in the absence of metabolic activation yielded negative results (Griffin and Hill 1978; Kubinski 
et al. 1981; Shirasu et al. 1976). 
 
Table 2-22.  Genotoxicity of DDT, DDE, and DDD In Vitro 
 
  Results  
 
Species (test system) 
 
Endpoint 
With 
activation 
Without 
activation 
 
Reference 
Prokaryotic organisms 
Salmonella typhimurium 
(TA1535, TA1537, TA98, 
TA100) 
Gene mutation – – McCann et al. 1975 
S. typhimurium 
(histidine auxotrophs G46, 
TA1535, TA1000, C3076, 
TA1537, D3052, TA1538, 
TA98)  
Gene mutation – – Probst et al. 1981 
Escherichia coli (WP2 and 
WP2 uvrA-) 
Gene mutation – – Probst et al. 1981 
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Table 2-22.  Genotoxicity of DDT, DDE, and DDD In Vitro 
 
  Results  
 
Species (test system) 
 
Endpoint 
With 
activation 
Without 
activation 
 
Reference 
E. coli (Pol-A) Gene mutation – – Fluck et al. 1976 
E. coli (Back mutation) Gene mutation – No data Fahrig 1974 
Escherichia marcescens 
(glucose prototrophy) 
Gene mutation – No data Fahrig 1974 
Bacillus subtilis (rec-assay) DNA damage – No data Shirasu et al. 1976 
E. coli (col E1 plasmid DNA) DNA damage – No data Griffin and Hill 1978 
E. coli (DNA cell binding 
assay) 
DNA damage – No data Kubinski et al. 1981 
Fungal and plant cells 
Neurospora crassa Recessive lethal – No data Clark 1974 
Saccharomyces cerevisiae Mitotic gene conversion – No data Fahrig 1974 
Mammalian cells 
Human (hepatocyte-
mediated cell) 
Gene mutation – – Tong et al. 1981 
Chinese hamster (V79 cells 
[6-thioguanine resistant 
mutation]) 
Gene mutation – No data Tsushimoto et al. 
1983 
Rat (liver epithelial cell) Gene mutation – No data Telang et al. 1981 
Mouse (L51784 lymphoma 
cells) 
Gene mutation + No data Amacher and 
Zelljadt 1984 
     
Chinese hamster ovary 
(CHO) cells 
Chromosomal 
aberrations 
+ No data Amacher and 
Zelljadt 1984 
Chinese hamster V79 cells Chromosomal 
aberrations 
+ (DDE) 
– (DDT) 
No data 
No data 
Kelly-Garvert and 
Legator 1973 
Chinese hamster (B14F28 
cells [chromosomal 
damage]) 
Chromosomal 
aberrations 
+ No data Mahr and 
Miltenburger 1976 
Kangaroo rat (cells) Chromosomal 
aberrations 
+ No data Palmer et al. 1972 
Cultured human lymphocytes Micronuclei No data + Ennaceur et al. 
2008 
Cultured human lymphocytes Micronuclei No data + Gerić et al. 2012 
Cultured human lymphocytes DNA damage No data + Gerić et al. 2012 
Cultured human lymphocytes DNA damage No data + Yáňez et al. 2004 
Rat (hepatocytes-UDS) DNA damage – – Probst et al. 1981 
Rat (hepatocytes-UDS) DNA damage No data – Probst and Hill 1980 
Mouse, rat, hamster 
(hepatocytes-UDS) 
DNA damage No data – Maslansky and 
Williams 1981 
 
+ = positive results; – = negative results; DNA = deoxyribonucleic acid; UDS = unscheduled DNA synthesis 
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Mutation Assays in Mammalian Cells.  The majority of in vitro gene mutation studies with mammalian 
cells were negative (Table 2-22).  DDT did not induce gene mutations in human hepatocyte-mediated 
cells in the presence or absence of metabolic activation (Tong et al. 1981), in Chinese hamster V79 cells 
(Tsushimoto et al. 1983), or in rat liver epithelial cells in the absence of activation (Telang et al. 1981).  
Conversely, a study by Amacher and Zelljadt (1984) reported positive results for gene mutations in mouse 
L51784 lymphoma cells exposed to p,p’-DDE at concentrations between 25 and 35 µg/mL in the absence 
of metabolic activation.  Exposure to 16–24 µg/mL was sufficient to produce a dose-related increase in 
6TG-resistant colonies.  
 
Chromosomal Effects in Mammalian Cells.  Studies assessing chromosomal aberrations in mammalian 
cells yielded positive results (Table 2-22).  Amacher and Zelljadt (1984) reported a significant increase in 
chromosome aberrations in Chinese hamster ovary cells exposed to 35–40 µg/mL p,p’-DDE for 24 hours.  
Mahr and Miltenburger (1976) reported chromosomal damage in the B14F28 Chinese hamster cell line 
after exposure to 44–88 ppm p,p’-DDT, DDE, or DDD; no effects were observed for DDA.  Palmer et al. 
(1972) also observed similar results in kangaroo rat cells (Potorus tridactylis) after exposure to 20–
50 µg/mL p,p’- and o,p’-DDT, DDE, or DDD; p,p’-DDA was toxic at 200 µg/mL.  Kelly-Garvert and 
Legator (1973) reported a significant increase in chromosomal aberrations in Chinese hamster V79 cells 
after exposure to 33–40 µg/mL DDE; no significant increases in aberrations were observed following 
exposure to similar concentrations of DDT.  Ennaceaur et al. (2008) reported a reduction in cell 
proliferation and an increase in the frequency of micronuclei in cultured human peripheral blood 
lymphocytes following exposure to 10–80 mM p,p’-DDE; however, effects were only significant at the 
highest tested concentration (80 mM).   
 
DNA Damage Assays in Mammalian Cells.  Results were mixed for DNA damage in mammalian cells 
(Table 2-22).  Gerić et al. (2012) observed significant increases in the number of micronucleated cells and 
in the frequency of DNA damage (measured in a comet assay) in cultured human peripheral blood 
lymphocytes following exposure to p,p’-DDT (0.1 µg/mL), p,p’-DDE (4.1 µg/mL), and p,p’-DDD 
(3.9 µg/mL).  Yáňez et al. (2004) also reported significant DNA damage in peripheral blood mononuclear 
cells (measured in a DNA content assay and a comet assay) from healthy human donors following 
exposure (24–72 hours) to 40, 80, or 100 µg/mL p,p’-DDT, p,p’-DDE, and p,p’-DDD.  Conversely, 
negative results were obtained in three studies evaluating unscheduled DNA synthesis (UDS) in rodents 
(Maslansky and Williams 1981; Probst and Hill 1980; Probst et al. 1981).  Probst et al. (1981) and Probst 
and Hill (1980) reported negative results for UDS in rat hepatocytes exposed to DDT at concentrations up 
to 1,000 nmoles/mL.  Similarly, Maslansky and Williams (1984) reported negative results for UDS in 
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primary cultures of mouse, rat, and hamster hepatocytes exposed to DDT, DDD, and DDE (tested up to 
10-4 M) for 18 hours. 
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CHAPTER 3.  TOXICOKINETICS, SUSCEPTIBLE POPULATIONS, 
BIOMARKERS, CHEMICAL INTERACTIONS 
 
3.1   TOXICOKINETICS  
 
Toxicokinetic data for DDT, DDE, and DDD are summarized below. 
•  DDT, DDD, and DDE are absorbed following inhalation, oral or dermal exposure, but humans 
are predominately exposed via the oral route. 
• DDT, DDE, and DDD are readily distributed in the lymph and blood to all body tissues and 
ultimately stored in proportion to the lipid content of the tissue, regardless of the route of 
exposure. 
• Metabolism of DDT is similar in humans, rats, mice, and hamsters.  The stable metabolite, 
p,p’-DDE, is found at higher tissue concentrations than DDT and DDD isomers, and DDA 
[2,2-bis(4-chlorophenyl)acetic acid] is the major urinary metabolite. 
• Excretion of DDT in the form of its metabolites is largely via the urine, but DDT excretion also 
may occur via feces and breast milk.  The excretion of DDT is slow, and DDT and DDE may 
persist in the human body for decades after exposure.  
 
3.1.1  Absorption  
 
Absorption of DDT by the lung is considered to be a minor route of entry, although evidence of DDT 
absorption after inhalation exposure was indicated by the appearance of DDA (a DDT metabolite) in the 
urine (Laws et al. 1967; Ortelee 1958), the presence of DDT in adipose tissue (Laws et al. 1967) and the 
presence of DDT and/or DDE in plasma or serum (Morgan and Lin 1978; Rabello et al. 1975).  However, 
no studies were located that quantified the rate or extent of absorption of DDT, DDE, or DDD in humans 
after inhalation exposure.  No studies were located regarding the absorption of DDT, DDE, or DDD after 
inhalation exposure in animals. 
 
Absorption following ingestion of DDT, DDE, or DDD is evident in humans both from measurements of 
serum and adipose tissue concentrations of these chemicals and from measurements of DDA in the urine 
(Hayes et al. 1956, 1971; Morgan and Roan 1971, 1974).  In subjects chronically exposed to oral doses of 
DDT up to 20 mg/day (approximately 0.3 mg/kg/day), DDT appeared in the serum and reached peak 
serum concentrations 3 hours after ingestion (Morgan and Roan 1971).  Serum levels remained elevated, 
but returned to near pre-dose values 24 hours after each dose.  
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The presence of urinary metabolites in mice, rats, and hamsters (Fawcett et al. 1987; Gold and Brunk 
1982, 1983, 1984), and the presence of DDT and its metabolites in bile collections (Jensen et al. 1957), 
provide evidence of gastrointestinal absorption.  In animals, absorption of orally administered DDT was 
enhanced when it is dissolved in digestible oils (Keller and Yeary 1980).  Approximately 70–90% of the 
administered dose was absorbed by rats after oral exposure to DDT in vegetable oils (Keller and Yeary 
1980; Rothe et al. 1957).  DDT was absorbed 1.5–10 times more effectively in laboratory animals when 
given in digestible oils than when dissolved in nonabsorbable solvents (Hayes 1982). 
 
Gastrointestinal absorption by way of the intestinal lymphatic system plays a major role in the uptake of 
DDT in animals (Jandacek et al. 2009; Noguchi et al. 1985; Palin et al 1982; Pocock and Vost 1974; 
Sieber 1976; Turner and Shanks 1980).  For example, Sieber (1976) showed that 12–24% of the 
administered dose was recovered in the 24-hour lymph after intraduodenal administration of 14C-isomers 
to thoracic duct-cannulated rats, and most of the radioactivity was attributed to parent compounds.  Other 
studies indicate that relatively little DDT is absorbed from the gastrointestinal tract directly into the blood 
(Jandacek et al. 2009; Palin et al. 1982; Rothe et al. 1957).  In studies of rats with cannulated mesenteric 
lymph ducts and portal veins, radioactivity collected in 4 hours from lymph ducts and portal veins 
accounted for 29.4 and 4.6%, respectively, of administered radioactivity delivered intraduodenally as 
14C-p,p’-DDT in olive oil (Jandacek et al. 2009).  Similar results were reported after administration of 
14C-p,p’-DDE (Jandacek et al. 2009).   
 
Dermal absorption of DDT in humans and animals is limited, but can be inferred by observation of 
toxicity after dermal application of DDT.  Acute toxicity studies in several species demonstrate that 
toxicity, expressed as an LD50, is less when DDT is applied dermally than when given by gavage or by 
injection, which reflects the difference in the amount of DDT absorbed by the dermal route.  The data 
indicate that DDT is 4 times more toxic when given by intraperitoneal injection than when administered 
orally and 40 times more potent when given by intraperitoneal injection than when administered by the 
dermal route (Hayes 1982).  Absorption of DDT from soil applied to the abdomen of monkeys, as 
extrapolated from urinary excretion data, was 3.3% of the applied dose in 24 hours (Wester et al. 1990). 
 
3.1.2   Distribution  
 
The distribution and storage of DDT in humans and animals has been extensively studied.  DDT and its 
metabolites, DDE and DDD, are lipid-soluble compounds.  Once absorbed, they are readily distributed 
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via the lymph and blood to all body tissues and are stored in these tissues generally in proportion to organ 
tissue lipid content (Morgan and Roan 1971).   
 
Hayes et al. (1971) and Morgan and Roan (1971, 1974) evaluated the distribution of orally administered 
DDT, DDE, or DDD in volunteers.  Morgan and Roan (1971, 1974) and Roan et al. (1971) measured the 
concentration of DDT, DDE, DDD, and DDA in blood, fat, and urine after oral dosing.  The administered 
doses ranged from 5 to 20 mg DDT/kg/day for up to 6 months; the ratio of concentration of DDT stored 
in adipose tissue to that present in blood was estimated to be 280:1. DDT uptake into tissues is a function 
of the blood flow, the lipid content of that tissue, and the partition coefficient for DDT between the blood 
and lipids in specific organs.  The ratio of DDT concentrations in adipose tissue to blood may remain 
relatively constant; however, the amount of DDT from past exposure cannot be determined from present 
blood levels only.  DDT, DDE, and DDD have been reported to be distributed to, and retained in, the 
adipose tissue of humans (Morgan and Roan 1971).  The affinity for storage in adipose tissue is related to 
each chemical's lipophilicity and increases in the order p,p’-DDD ≤ o,p,’-DDT < p,p’-DDT < p,p’-DDE 
(Morgan and Roan 1971).   
 
DDT and DDE selectively partition into fatty tissue and into human breast milk, which has a higher fat 
content than cow’s milk.  In a 1969–1970 U.S. national human milk study, the p,p’- isomers of DDT and 
DDE were found in 100% of the samples tested, with mean concentrations of 0.19 and 1.9 ppm (lipid-
basis), respectively (Takei et al. 1983).  Variance in levels of DDT and its metabolites in breast milk may 
be influenced by such factors as number of parity, children nursed, diet, and cigarette smoking (Bouwman 
et al. 1990; Bradt and Herrenkohl 1976; Rogan et al. 1986).  A steady decrease in the levels of DDT and 
its metabolites in human milk has been reported as a result of decreased intake of DDT in many regions 
throughout the world (Needham et al. 2011; Smith 1999; Wickstrom et al. 1983).  In recent global 
surveys of human breast milk samples between 2000 and 2010, ΣDDT concentrations ranged from 
<100 ng/g lipid in several northern European nations, 100–1,000 ng/g lipid in the United States, Brazil, 
Chile, Australia, Russia, Spain, and other countries, to >1,000 ng/g lipid in India, Haiti, Mauritius, Mali, 
the Philippines, Hong Kong, and other countries (Van den Berg et al. 2016).   
 
DDT and metabolites are known to cross the placenta from their detection in samples of maternal blood 
levels, umbilical cord blood, placenta, and newborn blood from numerous studies of mother/infant pairs.  
For example, a study of 90 mother/infant pairs from Mexico found that: (1) all 90 cord blood samples had 
detectable levels of p,p’-DDE, 9 had detectable levels of o,p’-DDT, and 44 had measurable levels of 
p,p’-DDT; (2) concentrations in maternal blood were similar to those in cord blood; and 
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(3) concentrations showed the following order: p,p’-DDE > p,p’-DDT > o,p’-DDT (Waliszewki et al. 
2000).  In a 2000–2002 study of placentas from 150 mother-infant pairs in Spain, median concentrations 
in placentas were 2.37 ng/g placenta for p,p’-DDE, 1.42 ng/g for o,p’-DDD, 1.02 ng/g for p,p’-DDT, and 
0.60 ng/g for o,p’-DDT (Lopez-Espinosa et al. 2007).  In a 2014 report on 42 placenta specimens 
collected in three regions of the United States, DDE concentrations ranged from 10 to 1,968 ng/g tissue, 
with a median of 74 ng/g (Nanes et al. 2014).  A recent review of global monitoring studies of DDE 
placental concentrations indicated a wide range from 58 pg/g lipid to 5x106 pg/g lipid, with a declining 
trend over time and high variability in recent years (Nanes et al. 2014).   
 
Results from studies of laboratory animals have demonstrated the preferential distribution of DDT and 
metabolites to fatty tissue, as well as the transplacental and lactational transfer.  For example, in rats after 
a single intravenous dose of radiolabeled 5 mg p,p’-DDE/kg, peak concentrations of DDE were observed 
before 1 hour in the liver and muscle, at 3 hours in the skin, and between 1 and 4 days in adipose tissue 
(Mühlebach et al. 1991).  Between 4 and 14 days after exposure, the tissue/blood concentration ratio was 
about 6 for liver and muscle, 35 for skin, and 400 for adipose tissue (Mühlebach et al. 1991).  Similar 
results were found in a study designed to induce diabetes in high saturated fat-fed mice, administered 
DDE for 5 days followed by weekly gavage doses of DDE for 13 weeks; the adipose/serum and 
liver/serum concentration ratios were approximately 950 and 70, respectively (Howell et al. 2015).  
Another study of rats administered DDE for 5 days showed that serum and liver DDE levels significantly 
decreased between 7 and 21 days post-exposure; in contrast, adipose levels increased (although the 
change between days 7 and 21 was not statistically significant) (Howell et al. 2014).  Evidence for 
transplacental and lactational transfer include observations that newborn rats of dams given p,p’-DDT in 
the diet before mating and throughout gestation had detectable levels of p,p’-DDT in the brain, liver, 
kidneys, and stomach, which were lower than levels in offspring sacrificed after suckling (Woolley and 
Talens 1971).  In rats dams given gavage doses of p,p’-DDE before mating and during gestation, tissue 
concentrations in dams after suckling were only about 1/3 of values immediately after exposure, 
indicating substantial transfer of stored p,p’-DDE in rat dam tissue to the milk (You et al. 1999b).  Other 
observation indicate that tissue burdens of rat offspring are influenced more by lactational exposure than 
gestational exposure.  Rat offspring of dams given gavage doses of p,p’-DDE only before mating and 
during gestation had lower tissue concentrations than tissue concentrations in offspring of dams exposed 
only during lactation (You et al. 1999b). 
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3.1.3   Metabolism  
 
The metabolism of DDT, DDE, and DDD has been studied in humans and a variety of other mammalian 
species.  Observations of higher levels of p,p’-DDE in human and animal tissues than levels of p,p’-DDT 
have identified p,p’-DDE as a principal stable metabolite (Morgan and Roan 1971; You et al. 1999c).  
Other studies with liver tissue from laboratory animals established that p,p’-DDD is a principal 
intermediate in the pathway to p,p’-DDE involving reductive dechlorination of p,p’-DDT to p,p’-DDD 
and a dehydrogenase conversion of p,p’-DDD to p,p’-DDE (Kitamura et al. 2002).  Figure 3-1 describes 
an initial metabolic pathway that proposes the formation of p,p’-DDE directly from p,p’-DDT and 
through p,p’-DDD, as well as a dehydrochlorinase step converting p,p’-DDD to p,p’-DDMU [1-chloro-
2,2-bis(4-chlorophenyl)ethylene], another principal metabolite identified in studies with rat liver 
microsomes (Kitamura et al. 2002).  After Phase I metabolism (reactions involving oxidation, reduction, 
and hydrolysis), many of the DDT metabolites ultimately are excreted in the conjugated form.  
Conjugates have been reported to include glycine, bile acid conjugates, serine, aspartic acid, and 
glucuronic acid (Gingell 1975; Pinto et al. 1965; Reif and Sinsheimer 1975).  The principal metabolite 
excreted in urine of animals is p,p’-DDA, which has been proposed to be oxidized from p,p’-DDT and 
p,p’-DDD in a postulated scheme described in Figure 3-2 (Gold and Brunk 1982). 
 
Figure 3-1.  Proposed Metabolic Pathway of p,p’-DDT by Rat Liver Microsomes 
 
 
 
 
Source: Kitamura et al. 2002 
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Figure 3-2.  Proposed Metabolic Scheme Converting DDT to DDA, the Principal 
Metabolite Excreted in Rat Urine 
 
 
 
 
Sources: Gold and Brunk 1982; Kitamura et al. 2002 
 
p,p’-DDT, p,p’-DDE, and p,p’-DDD are phenobarbital-type cytochrome P-450 (CYP) inducers in rats, 
causing induction of hepatic CYP2B and CYP3A proteins and CYP1A protein induction to a lesser extent 
(Nims et al. 1998).  Activities for the dechlorinating formation of p,p’-DDD from p,p’-DDT were much 
higher with human recombinant CYP3A4 and 2B6 (expressed in human B lymphoblast cells) than with 
CYP2D6, CYP 2A6, CYP1A1, CYP1A2, and 4A11 (Kitamura et al. 2002).  Together, these observations 
indicate that the metabolic dechlorination of p,p’-DDT may be enhanced by previous exposure to DDT 
and its metabolites (Kitamura et al. 2002; Nims et al. 1998).   
 
The metabolism of DDT can also produce methylsulfonyl metabolites, which are potent toxicants, 
particularly in the adrenal gland, after metabolic activation.  Methylsulfonyl metabolites of DDT 
(specifically 3- and 2-methylsulfonyl-DDE) were first identified in seal blubber from the Baltic Sea 
(Jensen and Jansson 1976); they were later found in several species of animals (Bergman et al. 1994) and 
in humans (Weistrand and Norén 1997).  Methylsulfonyl-DDE is formed as follows: products of the 
reaction between arene oxides, formed in phase I metabolism, and glutathione are degraded and excreted 
in the bile into the large intestine where they undergo cleavage by a microbial C-S lyase (Bakke et al. 
1982; Preston et al. 1984).  The thiols formed are methylated and reabsorbed, and the sulfur is further 
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oxidized to the corresponding methylsulfones, which are distributed by the blood (Haraguchi et al. 1989).  
Figure 3-3 shows a proposed pathway for sulfonyl metabolites.   
 
Figure 3-3.  Proposed Metabolic Pathway for the Conversion of p,p’-DDE to its 
Methylsulfone Derivative 
 
 
 
 
Sources: Bergman et al. 1994; Letcher et al. 1998; Weistrand and Norén 1997 
 
3.1.4   Excretion  
 
Excretion of DDT has been studied in humans and a variety of animals.  The major route of excretion of 
absorbed DDT in humans appears to be as DDA conjugates in the urine (Hayes et al. 1956, 1971; Roan et 
al. 1971), but some excretion also occurs by way of feces (via biliary excretion) (Jensen et al. 1957) and 
breast milk (Takei et al. 1983).  Results of studies with mice, rats, and hamsters indicate that the 
metabolites of DDT and small amounts of unmetabolized DDT are excreted primarily in the urine and to 
a lesser degree in feces (Gold and Brunk 1982, 1983, 1984).  
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The biological half-lives for the elimination of these compounds are ranked as follows: DDE > DDT > 
DDD.  This relationship, and the observation that DDT and DDE can persist for decades in the human 
body, has been explained to be collectively due to the chemical stability of each compound in the body 
(i.e., relatively low metabolic efficiencies), the relative efficiencies of excretory mechanisms, and 
transport in and out of fat depots (Morgan and Roan 1971, 1974).  As mentioned in Section 3.1.3, 
observations of higher levels of p,p’-DDE in human and animal tissues than levels of p,p’-DDT identify 
p,p’-DDE as a principal stable metabolite (Morgan and Roan 1971; You et al. 1999c). 
  
In volunteers receiving 35 mg DDT/day (approximately 0.5 mg/kg) for up to 18 months, urinary excretion 
of DDA increased rapidly for the first few days and a steady-state excretion of approximately 13–16% of 
the daily dose was reached and remained stable for 56 weeks (Hayes et al. 1971).  No DDT metabolites 
were detected in feces.  An earlier study by this group (Hayes et al. 1956) reported DDT and DDE levels 
in the feces of one volunteer receiving approximately 35 mg DDT/day; although DDA was not detected, 
the investigators did not exclude that it was present in the sample.  Another study reported that elevated 
rates of urinary excretion of DDA occurred within 24 hours of administering single oral doses of DDT (5, 
10, or 20 mg), or DDD (5 mg) to volunteers and did not return to pre-exposure rates until >4 months after 
ingestion (Roan et al. 1971) 
 
Studies with bile-cannulated laboratory animals have demonstrated that some fecal elimination of DDT 
metabolites can occur through enterohepatic circulation of conjugated DDA (Gingell 1975; Jensen et al. 
1957; Pinto 1965).  Other studies with rats given single intravenous doses of radiolabeled DDE indicated 
a body burden half-life of 120 days with 34 and 1% of the administered dose excreted in feces and urine, 
respectively, collected for 14 days after dose administration (Mühlebach et al. 1991).   
 
3.1.5   Physiologically Based Pharmacokinetic (PBPK)/Pharmacodynamic (PD) Models  
 
PBPK models use mathematical descriptions of the uptake and disposition of chemical substances to 
quantitatively describe the relationships among critical biological processes (Krishnan et al. 1994).  PBPK 
models are also called biologically based tissue dosimetry models.  PBPK models are increasingly used in 
risk assessments, primarily to predict the concentration of potentially toxic moieties of a chemical that 
will be delivered to any given target tissue following various combinations of route, dose level, and test 
species (Clewell and Andersen 1985).  Physiologically based pharmacodynamic (PBPD) models use 
mathematical descriptions of the dose-response function to quantitatively describe the relationship 
between target tissue dose and toxic endpoints.   
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PBPK models of the pharmacokinetics of p,p’-DDE, a principal metabolite of DDT, in pregnant and 
lactating rat dams and nursing pups have been developed by You et al. (1999b).  The models were based 
on experimental studies in which pregnant Sprague-Dawley rats were administered gavage doses of 
p,p’-DDE, and the kinetics of p,p’-DDE tissue and blood levels in the dams, fetuses, and pups were 
measured.  The models provide an approach to estimating tissue doses in fetuses and pups associated with 
maternal oral exposure to p,p’-DDE and can be used to explore dose-response relationships for the 
developmental effects of p,p’-DDE in the Sprague-Dawley rat, but are inadequately developed or 
calibrated to extrapolate to other physiological states, other species (most importantly humans), or other 
routes of exposure, such as the inhalation or dermal routes. 
 
Figures 3-4 and 3-5 show conceptualized representations of the gestation model and the lactation/nursing 
models, respectively.  Parameters used in the models are shown in Tables 3-1 and 3-2.  The gestation 
model simulates the kinetics of transfer of an oral dose of p,p’-DDE from the dam to the developing fetus 
and the lactation/nursing model simulates the transfer of p,p’-DDE from the dam to the nursing pup via 
mammary milk, followed by exchanges with pup fat, kidney, and other richly- and poorly-perfused 
tissues.  
 
All exchanges with blood plasma, in both models, were simulated as flow-limited processes, with the 
exception of the following.  Exchanges between maternal fat and a deep fat compartment were assumed 
to be diffusion-limited and were represented with first-order rate constants.  Exchanges between the 
embryo/fetus and placenta were modeled as diffusion-limited processes and were represented with 
diffusion coefficients (L/day).  Parameters used in the model were either taken from the literature, 
estimated by using the SIMUSOLV simulation program, or optimized by visually inspecting the fit of the 
collected pharmacokinetic data.  Elimination pathways in the maternal model included transfer from 
mammary tissue to maternal milk (in the lactation model), and fecal excretion, including transfer from the 
liver via bile to the gastrointestinal tract.  A fecal pathway from liver (through bile to the gastrointestinal 
tract) was included in the pup model.  In models for dams and pups, slow metabolism of p,p’-DDE in the 
liver was assumed to be accounted for by the rate constant for biliary excretion.  
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Figure 3-4.  Diagrammatic Representation of the Physiologically Based 
Pharmacokinetic Model for Gestation 
 
 
 
 
GI = gastrointestinal; N = number of concepti; PBPK = physiologically based pharmacokinetic 
 
Terms are defined in Tables 3-1 and 3-2. 
 
Source: You et al. 1999b 
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Figure 3-5.  Diagrammatic Representation of the Physiologically Based 
Pharmacokinetic Model for the Lactating Dam and Nursing Pup 
N = number of pups; PBPK = physiologically based pharmacokinetic 
Portal and lymphatic absorption routes for dams are not shown (see Figure 3-4); terms are defined in 
Tables 3-1 and 3-2. 
Source: You et al. 1999b 
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Table 3-1.  Tissue:Blood Partition Coefficients and Pharmacokinetic Constants 
for Modeling DDE Disposition in the Pregnant Rat 
 
Tissue:blood partition coefficients 
Liver 7 
Fat 450 
Poorly-perfused tissues 12 
Well-perfused tissues 6 
Kidney 6 
Uterus 6 
Placenta 2 
Mammary gland 12 
Pharmacokinetic constants 
KAS (L/day) Portal absorption rate constant 24 
KLY (L/day) Lymphatic absorption rate constant 74 
KFX (L/day) Fecal excretion rate constant 230 
KB (L/day) Biliary excretion rate constant 1.2 
PAF (L/day) Fat diffusion coefficient 5 
PA1 (L/day) Placenta-to-embryo/fetus diffusion coefficient 1.6 
PA2 (L/day) Embryo/fetus-to-placenta diffusion coefficient 1.9 
K12/K21 Diffusion to deep fat 1.0/0.1 
Tdel (day) Delay in time 0.1 
 
Source:  You et al. 1999b 
 
Table 3-2.  Physiological Constants Used in the PBPK Model for the 
Lactating Dam and the Nursing Pup 
 
 Dam Pup 
Body weight (kg) (BW) 0.290–0.340 0.0061–0.58 
Tissue volumes (% of body weight)   
Liver, VL 4 4 
Well-perfused tissues, VWP 8 8 
Poorly-perfused tissues, VPP 76-VMT 76 
Fat, VF 7 0.0199*pBW+1.664 
Mammary tissue, VMT 4.4–9.6  
Milk, Vmilk 0.002L  
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Table 3-2.  Physiological Constants Used in the PBPK Model for the 
Lactating Dam and the Nursing Pup 
 
 Dam Pup 
Cardiac output (L/hour) 14*pBW0.75 18*pBW0.74 
Blood flows (% of cardiac output)   
Liver, QL 25 25 
Well-perfused tissues, QWP 41-QMT 49 
Poorly perfused tissues, QPP 25 25 
Fat, QF 7 1 
Mammary tissue, QMT 9–15  
 
Source:  You et al. 1999b 
 
The models were calibrated with data from experimental studies in which pregnant Sprague-Dawley rats 
were administered gavage doses of 0, 10, or 100 mg p,p’-DDE on GDs 14–18 (You et al. 1999b).  A 
subset of the dams was sacrificed 4 hours after each dosing, and tissue levels of p,p’-DDE were measured 
in the dams, placenta, and fetuses.  A subset of pups in each dose group was cross-fostered to assess 
p,p’-DDE transfer to tissues from maternal milk.  Consistent with the collected data, the models predicted 
that lactational exposure was more important in determining pup body burden than in utero exposure. 
 
Verner et al. (2009, 2008) developed a generic human mother-infant PBPK model to estimate infant 
exposure to chlorinated persistent organic pollutants (POPs) including p,p’-DDT and p,p’-DDE via 
transplacental exposure during gestation and breast milk during 12 months of lactation, based on mothers’ 
exposure during gestation and lactation.  Figure 3-6 presents a conceptual representation of the model 
showing the mother model as a tissue network of nine compartments with ingested POCs assumed to be 
completely absorbed from contaminated food and directly transferred to the liver.  Excretion in milk was 
modeled as output from the mammary tissue.  The infant model consisted of five compartments and was 
integrated with the mother model via breast milk, which was assumed to be the only source of POC 
exposure of the infants during the first 12 months of life, and via transplacental transfer from the mother 
to the developing fetus (see Figure 3-6).  The mother and infant models described rates of metabolism in 
the liver compartment as the product of the hepatic extraction ratio, the liver blood flow and the arterial 
blood concentration of the pertinent POC; POC-specific hepatic extraction ratios were calculated from 
hepatic intrinsic clearance values, which were calculated from published half-life values.  The POC 
concentrations in model compartments were modeled with mass balance differential equations that 
included blood flow, and POC-specific tissue:blood partition coefficients estimated from ratios of lipid 
fractions in tissues and blood (Verner et al. 2008, 2009).  Predictions from the models for cord blood, 
DDT, DDE, and DDD  256 
 
3.  TOXICOKINETICS, SUSCEPTIBLE POPULATIONS, BIOMARKERS, CHEMICAL INTERACTIONS 
 
 
 
 
 
 
***DRAFT FOR PUBLIC COMMENT*** 
breast milk, and infant blood concentrations of p,p’-DDE (based on maternal inputs) were significantly 
correlated (r>0.9) with measured values from a group of Inuit mothers and infants from Northern Quebec, 
Canada, whereas correlations between predicted and observed values of p,p’-DDT concentrations were 
less strongly correlated (r=0.75–0.78).  Verner et al. (2009) proposed that use of the mother-infant model 
to predict infant exposures from maternal blood levels could reduce sampling efforts in future 
epidemiological studies of potential effects of POCs on child development (Verner et al. 2009).  Verner et 
al. (2013, 2015) used a similar generic POC human mother-infant PBPK model to predict prenatal 
exposure to p,p’-DDE or p,p’-DDT from maternal or children’s blood levels collected 9 years after 
delivery, noting that predictive tools that could back-extrapolate prenatal levels could lead to increased 
sample sizes in epidemiology studies of associations between POCs and child development endpoints.  
 
Using a generalized human PBPK model for persistent chlorinated organic chemicals developed by Cahill 
et al. (2003), Sonne et al. (2014) found that model-predicted blood levels of DDE (and other chemicals 
studied like hexachlorobenzene) based on estimated intakes from dietary sources were within a 2–3-fold 
factor of measured blood levels in members of Greenland Inuit communities with a traditional diet high in 
fish, whale, polar bear, reindeer, and musk oxen. 
 
3.1.6   Animal-to-Human Extrapolations  
 
The metabolism of DDT, DDE, or DDD in animals is similar to that in humans, but observed interspecies 
metabolic differences suggest that interspecies differences in susceptibility to the neurotoxicity or 
hepatotoxicity of these chemicals may exist.  Comparisons of elimination rates of DDT from fat showed 
that the process is faster in rats, followed by dogs and monkeys, and is slowest in humans (Morgan and 
Roan 1974).  Rats eliminated DDT 10–100 times faster than humans.  Morgan and Roan (1974) 
suggested that the differences in elimination rates could be due to differences in liver metabolism, gut 
bacterial metabolism, enterohepatic recirculation, or factors related to the accessibility of plasma-
transported pesticide to the excretory cells of the liver.   
 
Development of a human PBPK model similar to the rat dam-infant model developed by You et al. 
(1999b) may be useful to improve extrapolation from rats to humans in the development of acceptable 
exposure levels (e.g., MRLs) for DDT, DDE, and DDD.  The development of such a model or a model for 
nonpregnant humans, however, is limited by the lack of suitable kinetics data for adult humans, human 
mother-fetuses pairs, or human mother-infant pairs to calibrate the model. 
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Figure 3-6.  Conceptual Representation of the Mother-Infant Physiologically 
Based Pharmacokinetic Model 
 
 
 
 
Source: Verner et al. 2009 
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3.2   CHILDREN AND OTHER POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE 
 
This section discusses potential health effects from exposures during the period from conception to 
maturity at 18 years of age in humans.  Potential effects on offspring resulting from exposures of parental 
germ cells are considered, as well as any indirect effects on the fetus and neonate resulting from maternal 
exposure during gestation and lactation.  Children may be more or less susceptible than adults to health 
effects from exposure to hazardous substances and the relationship may change with developmental age.   
 
This section also discusses unusually susceptible populations.  A susceptible population may exhibit 
different or enhanced responses to certain chemicals than most persons exposed to the same level of these 
chemicals in the environment.  Factors involved with increased susceptibility may include genetic 
makeup, age, health and nutritional status, and exposure to other toxic substances (e.g., cigarette smoke).  
These parameters can reduce detoxification or excretion or compromise organ function.   
 
Populations at greater exposure risk to unusually high exposure levels to DDT, DDE, and DDD are 
discussed in Section 5.7, Populations with Potentially High Exposures. 
 
Available epidemiological studies provide some evidence for the potential susceptibility of developing 
fetuses, infants, or children to toxic actions of DDT, DDE, or DDD, depending on the endpoint.  Seven 
case-control studies provided consistent evidence for associations between very high maternal serum 
levels of DDT, DDE, or DDD with abortion or preterm births (see Section 2.16), and five case-control 
studies provided consistent evidence for associations between maternal levels of DDE during pregnancy 
and prevalence of wheeze in infant or child offspring (see Section 2.14).  However, inconsistent evidence 
has been provided by studies looking for associations between maternal levels of DDT, DDE, or DDD in 
biological fluids or tissues and other immune conditions in infant or child offspring, such as prevalence of 
asthma or infections (Section 2.14); adverse early neurodevelopmental effects in offspring (see 
Section 2.15); and changes in birth weight or early growth patterns in offspring (see Section 2.17).  Six 
case-control studies provided consistent evidence for no significant associations between levels of DDT, 
DDE, or DDD in maternal fluids or tissues and risk for the male birth defects, cryptorchidism, and 
hypospadias (see Section 2.16).   
 
Other case-control studies suggest that chronic exposure of older adults to DDT, DDE, or DDD may be 
associated with increased risks for elevated body mass index (BMI) or development of DMT2.  
Consistent evidence for significant positive associations between serum DDE levels and BMI was found 
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in most studies examining this endpoint in adults ≥50 years of age (see Section 2.3).  A clear majority of 
studies, including several meta-analysis, provided evidence for an association between serum levels of  
DDT, DDE, or DDD in adults and increased prevalence of DMT2 (see Section 2.18).  
 
Results from a few animal studies suggest that young and older animals exhibit different susceptibility to 
DDT toxicity, at least regarding neurotoxicity in response to relatively high doses of DDT.  For example, 
the LD50 values for DDT in newborn, preweanling, weanling, and adult rats were ≥4,000, 438, 355, and 
195 mg/kg, respectively (Lu et al. 1965).  However, when one-quarter of the daily LD50 dose was 
administered daily for 4 days to preweanling and adult rats, both groups had similar 4-day LD50 values.  
Lu et al. (1965) suggested that the elimination mechanisms in the preweaning rats is less developed than 
in the adult rats, thus making them more susceptible to repeated small doses.  In another study, 10-day-
old rats were more resistant to the acute lethal toxicity of purified p,p’-DDT than 60-day-old rats 
(Henderson and Woolley 1970).  In both groups, respiratory failure was the cause of death; however, the 
time course of DDT poisoning in the young rats was prolonged considerably as compared to the adults.  
Furthermore, the immature rats did not exhibit seizures nor the hyperthermia that preceded death in the 
older animals.  The decreased sensitivity of the younger rats was attributed to an incomplete development 
of the neural pathways involved in seizure activity and in thermoregulation.  The relevance of these 
findings to human health is unknown.   
 
In animals, DDT can cause abnormal development of sex organs, embryotoxicity, and fetotoxicity in the 
absence of maternal toxicity (Clement and Okey 1974; Fabro et al. 1984; Hart et al. 1971, 1972).  
Developmental effects, including preweanling mortality and premature puberty, have been reported in 
animals in multigeneration studies (Del Pup et al. 1978; Green 1969; Ottoboni 1969; Ottoboni et al. 1977; 
Tomatis et al. 1972; Turusov et al. 1973).  DDT has shown estrogenic properties in animals administered 
the pesticide orally or parenterally (Bitman and Cecil 1970; Clement and Okey 1972; Fabro et al. 1984; 
Gellert et al. 1972, 1974; Singhal et al. 1970).  In female neonates injected subcutaneously with o,p’-DDT 
or o,p’-DDD, there were significant alterations in the estrous cycle, decreases in ovary weight, and 
decreases in corpora lutea when the animals were evaluated as adults (Gellert et al. 1972, 1974).  In 
general, the estrogenic potency of DDT is orders of magnitude lower than that of estradiol.   
 
p,p’-DDE, a persistent metabolite of DDT, was an androgen receptor antagonist in male rats exposed in 
utero, and also as juveniles (Gray et al. 1999; Kelce et al. 1995, 1997; Krause et al. 1975; Loeffler and 
Peterson 1999; You et al. 1998, 1999a).  Rat pups from dams exposed during GDs 14–18 to 100 mg 
p,p’-DDE/kg/day and then exposed indirectly to maternally stored p,p’-DDE via breast milk had 
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significantly reduced AGD at birth and retained thoracic nipples on PND 13 (Kelce et al. 1995, 1997).  
Treatment of weanling male rats until day 57 of age with 100 mg p,p’-DDE/kg/day resulted in a 
statistically significant delayed onset of puberty by 5 days (Kelce et al. 1995, 1997).  Gray et al. (1999) 
and You et al. (1998) reported that AGD was not affected in male Sprague-Dawley rats on PND 2 after 
treating the dams with up to 100 mg p,p’-DDE/kg on GDs 14–18, but was significantly reduced in 
similarly exposed Long-Evans pups.  A 10 mg/kg dose to the dams was without effect in the Long-Evans 
pups.  AGD was not affected in female pups from either strain.  Treatment of the dams with 10 mg 
p,p’-DDE/kg resulted in retention of thoracic nipples in Sprague-Dawley pups, but only the higher dose 
(100 mg/kg) had this effect in Long-Evans pups.  An additional study from the same group showed that 
prenatal exposure to p,p’-DDE was associated with expression of TRPM-2, an androgen-repressed gene 
(You et al. 1999a).  A similar study in Holtzman rats exposed during GDs 14–18 to doses between 1 and 
200 mg p,p’-DDE/kg (offspring were exposed to p,p’-DDE in utero and via breast milk) found reduced 
AGD in males on PND 1 and reduced relative ventral prostate weight on PND 21 at 50 mg p,p’-DDE/kg, 
but not at 10 mg p,p’-DDE/kg (Loeffler and Peterson 1999).  Doses up to 100 mg/kg/day to the dams had 
no effect on onset of puberty, but 200 mg/kg/day did significantly delay puberty in males by <2 days.  
Androgen receptor staining in the ventral prostate was also reduced on PND 21.  Serum levels of 
testosterone or 3α-diol androgens were not significantly altered at any time.  This study also reported that 
at the 100 mg/kg dose level, cauda epididymal sperm number was reduced by 17% on PND 63 relative to 
controls.   
 
Alterations in learning processes and in other behavioral patterns have also been described in adult mice 
exposed to DDT perinatally (Craig and Ogilvie 1974; Palanza et al. 1999; vom Saal et al. 1995) or as 
neonates (Eriksson et al. 1990a, 1990b, 1992, 1993; Johansson et al. 1995, 1996); this endpoint is the 
basis of an acute oral MRL, which is discussed in detail in Section 1.3 and Appendix A.  These studies 
suggest that exposure of the developing fetus or newborn to DDT during critical stages in nervous system 
development can cause developmental toxicity manifested later in life.  Eriksson et al. (1990a, 1990b) 
pointed out that the dose levels that caused behavioral alterations in mice are comparable to those levels 
to which human neonates might be exposed in areas where DDT is still being used.  Behavioral 
neurotoxicity has been described in rats treated with DDT as adults (Sobotka 1971), but only at doses at 
least 50 times those that produced learning deficits in neonates. 
 
Studies in animals have demonstrated placental transfer of DDT and DDE to fetuses and also to newborns 
via mother’s milk (Fang et al. 1977; Seiler et al. 1994; Wooley and Talens 1971; You et al. 1999b).  The 
DDT, DDE, and DDD  261 
 
3.  TOXICOKINETICS, SUSCEPTIBLE POPULATIONS, BIOMARKERS, CHEMICAL INTERACTIONS 
 
 
 
 
 
 
***DRAFT FOR PUBLIC COMMENT*** 
results of these studies indicate that the amounts of chemical transferred via mother’s milk are much 
greater than the amounts that reach the fetus through the placenta.   
 
3.3   BIOMARKERS OF EXPOSURE AND EFFECT  
 
Biomarkers are broadly defined as indicators signaling events in biologic systems or samples.  They have 
been classified as biomarkers of exposure, biomarkers of effect, and biomarkers of susceptibility 
(NAS/NRC 1989). 
 
A biomarker of exposure is a xenobiotic substance or its metabolite(s) or the product of an interaction 
between a xenobiotic agent and some target molecule(s) or cell(s) that is measured within a compartment 
of an organism (NAS/NRC 1989).  The preferred biomarkers of exposure are generally the substance 
itself, substance-specific metabolites in readily obtainable body fluid(s), or excreta.  Biomarkers of 
exposure to DDT, DDE, and DDD are discussed in Section 3.3.1.  The National Report on Human 
Exposure to Environmental Chemicals provides an ongoing assessment of the exposure of a generalizable 
sample of the U.S. population to environmental chemicals using biomonitoring (see http://www.cdc.gov/
exposurereport/).  If available, biomonitoring data for DDT, DDE, and DDD from this report are 
discussed in Section 5.6, General Population Exposure.   
 
Biomarkers of effect are defined as any measurable biochemical, physiologic, or other alteration within an 
organism that (depending on magnitude) can be recognized as an established or potential health 
impairment or disease (NAS/NRC 1989).  This definition encompasses biochemical or cellular signals of 
tissue dysfunction (e.g., increased liver enzyme activity or pathologic changes in female genital epithelial 
cells), as well as physiologic signs of dysfunction such as increased blood pressure or decreased lung 
capacity.  Note that these markers are not often substance specific.  They also may not be directly 
adverse, but can indicate potential health impairment (e.g., DNA adducts).  Biomarkers of effect caused 
by DDT, DDE, and DDD are discussed in Section 3.3.2. 
 
A biomarker of susceptibility is an indicator of an inherent or acquired limitation of an organism's ability 
to respond to the challenge of exposure to a specific xenobiotic substance.  It can be an intrinsic genetic or 
other characteristic or a preexisting disease that results in an increase in absorbed dose, a decrease in the 
biologically effective dose, or a target tissue response.  If biomarkers of susceptibility exist, they are 
discussed in Section 3.2, Children and Other Populations that are Unusually Susceptible. 
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3.3.1   Biomarkers of Exposure 
 
Levels of DDT, DDE, or DDD in serum, blood, or breast milk (expressed on a lipid basis, ng/g lipid) are 
the most widely used biomarkers of exposure in modern biomonitoring and epidemiological studies (e.g., 
Axmon and Rignell-Hydbom 2006; Bonde et al. 2017; Chen et al. 2005; Everett and Matheson 2010; Jaga 
and Dharmani 2003; Kim et al. 2015a; Patterson et al. 2009; Roberts and Karr 2012; Sexton et al. 2006; 
van den Berg et al. 2016).  Some recent efforts have assessed that determination of concentrations of 
pesticides, including DDT and metabolites, in multiple sources (e.g., blood, hair, placenta) may increase 
rates of exposure detection, compared with single source determinations (Ostrea et al. 2008).   
 
For biomonitoring of DDT, DDE, and DDD, as well as other persistent halogenated organic chemicals, 
levels in breast milk are popular biomarkers of exposure, because breast milk is easily obtained through 
non-invasive techniques, extraction from the medium is not difficult due to the high lipid content, and 
levels are thought to be reflective of whole body burdens (van den Berg et al. 2016).  Recent global 
surveys of concentrations of DDT, DDE, and DDD (ΣDDT) in human breast milk samples for numerous 
countries collected from 2000 to 2010 indicate levels ranging from about 20 ng/g lipid in Finland to about 
1,400 ng/g lipid in India, with tropical countries (where DDT is still used for malaria control) representing 
the majority of the upper half of the distribution of concentrations (van den Berg et al. 2016).   
 
There are no quantitative data available that allow correlation of DDT/DDD/DDE levels in human tissue 
or fluids and exposure to specific levels of environmental contamination.  Studies of pesticide production 
workers reported that blood levels of these compounds are generally higher in persons exposed in the 
workplace.  Since the biological half-lives for elimination of these compounds are ranked as follows: 
DDE > DDT > DDD, detection of higher ratios of DDD or DDT to DDE has been proposed to indicate 
more recent exposure, while lower ratios are believed to correlate with long-term exposure and storage 
capacity (Morgan and Roan 1971).  There is a direct correlation between DDT and DDE levels in blood 
and adipose tissue when concentrations are expressed on a lipid basis (Hayes et al. 1971; Morgan and 
Roan 1971; Mussalo-Rauhamaa 1991).  On a wet tissue basis, concentrations of DDT in adipose tissue 
are approximately 280 times higher than those of blood (Anderson 1985).  However, because DDT and 
DDE are extensively stored in fatty tissue and slowly released from storage sites, there is no correlation 
between levels in tissues and the time course of exposure in short time spans.   
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3.3.2   Biomarkers of Effect 
 
The primary target organs for DDT, DDE, and DDD toxicity include the nervous system, the reproductive 
system, and the liver.  No biomarkers of effect specific for DDT, DDE, or DDD exposure alone were 
identified in the literature.  Tremors and convulsions have been observed in both humans and laboratory 
animals after DDT exposure (Hsieh 1954; Hwang and Van Woert 1978; Matin et al. 1981).  Exposure to 
DDT has been shown to induce hepatic microsomal enzymes in both humans and laboratory animals 
(Kolmodin et al. 1969; Morgan and Lin 1978; Pasha 1981; Street and Chadwick 1967).  However, these 
biomarkers of effect are not specific for DDT, DDE, or DDD exposure, and not all the body 
compartments in which these changes occur are accessible for sampling in living humans. 
 
3.4   INTERACTIONS WITH OTHER CHEMICALS  
 
DDT may have broad effects by changing the metabolism of other chemicals, both xenobiotics and 
endogenous macromolecules.  As discussed in Section 3.1.3, p,p’-DDT, p,p’-DDE, and p,p’-DDD are 
phenobarbital-type cytochrome P-450 (CYP) inducers in rats, causing induction of hepatic CYP2B and 
CYP3A proteins and CYP1A protein induction to a lesser extent (Nims et al. 1998).  For some chemicals, 
this enhancement of biotransformation produces less toxic metabolites and may inhibit toxic effects, 
whereas, for other chemicals with toxic metabolites, the metabolic enhancement could lead to 
enhancement of toxic effects.  
 
One interaction of concern is the enhanced conversion of other chemicals to active, carcinogenic forms 
mediated by microsomal enzymes induced by DDT.  Several investigations indicate that DDT 
administered to animals along with a known carcinogen may result in either an increase or a decrease in 
tumor production relative to the carcinogen tested without DDT.  A study by Walker et al. (1972) 
suggested that the liver enlargement was greater and the time to palpability of liver masses was earlier in 
mice fed dieldrin and DDT than those fed either pesticide separately.  A potentiation of carcinogenic 
activity of dieldrin was suggested but not conclusively shown.  It is possible that DDT could also promote 
the formation of hepatic tumors initiated by other carcinogens.  DDT has been reported to promote the 
tumorigenic effects of several known carcinogens, such as 3-methyl-(4-dimethylamine)-azobenzene 
(Kitagawa et al. 1984), 2-acetylaminofluorene (2-AAF) (Peraino et al. 1975), diethyl-nitrosamine (DEN) 
(Diwan et al. 1994; Nishizumi 1979), and carbon tetrachloride (CCl4) (Preat et al. 1986) when given after 
the putative carcinogen.  The promoting effect of DDT in rats was reported to act in a dose-dependent 
fashion, with DDT decreasing the latency period of tumor development and increasing the incidence and 
yield of hepatic tumors, mainly hepatocellular carcinomas. 
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Pretreatment of animals with DDT was also reported to decrease the tumorigenic effects of some 
previously determined carcinogens.  For example, pretreatment of rats with DDT significantly lowered 
the incidence of mammary tumors per rat after treatment with 7,12-dimethylbenz[a]anthracene (DMBA), 
versus DMBA-treated controls (Silinskas and Okey 1975).  The authors suggested that DDT may inhibit 
DMBA-induced mammary tumors by stimulating hepatic metabolism and accelerating the excretion of 
DMBA, so that less carcinogen is available to peripheral tissues.  Other studies also have reported the 
DDT induction of hepatic microsomal enzymes, which reduced the carcinogenicity of azo dyes and 
similar carcinogens (Williams and Weisburger 1991).   
 
Similarly, the hepatocarcinogenicity of aflatoxic B1 in mice was inhibited by pretreatment with DDT and 
by co-treatment with DDT when given throughout aflatoxin B1 dosing (Rojanapo et al. 1988, 1993).  
However, DDT acted as a hepatocarcinogenic promoter to aflatoxin B1 initiation when a 14-week DDT 
administration followed an 8-week aflatoxic B1 treatment, or when the DDT administration began 
halfway through aflatoxin B1 treatment (Rojanapo et al. 1988, 1993).  Also, in groups receiving both 
aflatoxic B1 and DDT, in any order, absolute and relative liver weights were significantly increased over 
both the vehicle control and the group receiving just aflatoxin B1; treatment with aflatoxin B1 alone 
increased liver weights, while treatment with DDT alone did not (Rojanapo et al. 1993).   
 
The effects of DDT on the nervous system can be altered when DDT is given in combination with certain 
neurologically-active pharmacological agents.  Some pharmacological agents (hydantoin, phenobarbital), 
prevent some or all of the neurological effects seen in animals treated with DDT (see Section 2.15), while 
other agents (trihexyphenidyl, haloperidol, propranolol) enhance DDT-induced neurotoxicity (Herr et al. 
1985; Hong et al. 1986; Matin et al. 1981).  One of the effects of DDT is to hold sodium channels open, 
which probably contributes to DDT-induced neurological effects (tremors and hyperexcitability).  Studies 
by Rubin et al. (1993) have shown that DDT analogues and metabolites, as well as several pyrethroids, 
modify radioligand binding of batrachotoxinin to sodium channels in mouse brain synaptosomes.  DDT 
and pyrethroids do not, by themselves, stimulate Na+ uptake, but they enhance activator-dependent 
uptake.  DDT is more efficacious than the pyrethroids tested.  Eriksson et al. (1993) have shown that the 
pyrethroid bioallethrin and DDT can interact in vivo in rats. 
 
In an immature rat uterotrophic assay, mixtures of six synthetic chemicals with demonstrated estrogenic 
activities (o,p’-DDT and five other chemicals) were shown, at low concentrations, to not alter responses 
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induced by a mixture of phytoestrogens and to act in an additive manner when exposed in the absence of 
external phytoestrogens (Charles et al. 2007). 
 
A series of studies examined the effects of oral exposure to binary mixtures of 1,4-dichlorobenzene and 
p,p’-DDE (Makita 2005, 2008a) or tributyl tin and p,p’-DDE (Makita 2008b; Makita et al. 2003b) on 
reproductive capabilities of immature male and female rats, but the designs of the studies were inadequate 
to conclude whether or not the components of these mixtures displayed joint actions that were additive, 
less-than-additive, or greater-than-additive.  
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CHAPTER 4.  CHEMICAL AND PHYSICAL INFORMATION 
4.1   CHEMICAL IDENTITY 
When we refer to DDT, we are generally referring to p,p’-DDT, which was produced and used for its 
insecticidal properties.  However, technical-grade DDT, the grade that was generally used as an 
insecticide, was composed of up to 14 chemical compounds, of which only 65–80% was the active 
ingredient, p,p’-DDT.  The other components included 15–21% of the nearly inactive o,p’-DDT, up to 4% 
of p,p’-DDD, and up to 1.5% of 1-(p-chlorophenyl)-2,2,2-trichloroethanol (Metcalf 1995). 
The chemical formulas, structures, and identification numbers for p,p’-DDT, p,p’-DDE, p,p’-DDD, 
o,p’-DDT, o,p’-DDE, and o,p’-DDD are listed in Table 4-1.  The latter five compounds are either 
impurities or metabolites of technical DDT. 
Table 4-1.  Chemical Identity of p,p’- and o,p’-DDT, DDE, and DDDa 
Characteristic Information 
Chemical name p,p’-DDT p,p’-DDE p,p’-DDD 
Synonym(s) and 
registered trade 
names 
4,4'-DDT; 1,1,1-trichloro-
2,2-bis(p-chlorophenyl)
ethane; dichlorodiphenyl 
trichloroethane; DDT; 
1,1'-(2,2,2-trichloro-
ethylidene) bis(4-chloro-
benzene); α-α-bis(p-chloro-
phenyl)-β,β,β-trichloro-
ethane; Genitox; Anofex; 
Detoxan; Neocid; Gesarol; 
Pentachlorin; Dicophane; 
Chlorophenothaneb 
4,4'-DDE; dichlorodiphenyl-
dichloroethane; 
1,1-dichloro-2,2-bis
(p-chlorophenyl) ethylene; 
1,1'-(2,2-dichloro-
ethylidene) bis(4-chloro-
benzene); DDE 
4,4'-DDD; DDD; 
1,1-dichloro-
2,2-bis(p-chlorophenyl)
ethane; 1,1-bis(4-chloro-
phenyl)-2,2-dichloro-
ethane; TDE; tetrachloro-
diphenylethane; DDD; 
Rothane; Dilene; TDE 
Chemical formula C14H9Cl5 C14H8Cl4 C14H10Cl4 
Chemical structure 
CAS Registry 
Number 
50-29-3 72-55-9 72-54-8
CCl3
ClCl
CCl2
Cl Cl
CHCl2
Cl Cl
H
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Table 4-1.  Chemical Identity of p,p’- and o,p’-DDT, DDE, and DDDa 
Characteristic Information 
Chemical name o,p’-DDT o,p’-DDE o,p’-DDD 
Synonym(s) and 
registered trade 
names 
2,4'-DDT; 1,1,1-trichloro-
2-(o-chlorophenyl)-
2-(p-chlorophenyl)ethane; 
o,p’-dichlorodiphenyl-
trichloroethane 
2,4'-DDE; 1,1-dichloro-
2-(o-chlorophenyl)-
2-(p-chlorophenyl) 
ethylene; 1-chloro-
2-(2,2-dichloro-
1-(4-chlorophenyl)ethenyl-
benzene 
2,4'-DDD; Mitotane; 
o,p’-DDD; 1,1-dichloro-
2-(o-chlorophenyl)-
2-(p-chlorophenyl)ethane; 
o,p’-TDE; Choditane; 
2-(o-chlorophenyl)-
2-(p-chlorophenyl; 
Lysodren 
Chemical formula C14H9Cl5 C14H8Cl4 C14H10Cl4 
Chemical structure 
CAS Registry 
Number 
789-02-6 3424-82-6 53-19-0
aHoward and Neal (1992) except where noted. 
bKlassen et al. 1991. 
CAS = Chemical Abstracts Service 
4.2   PHYSICAL AND CHEMICAL PROPERTIES 
Technical DDT is a white amorphous powder that melts over the range of 80–94°C (Metcalf 1995).  
Physical and chemical properties of p,p’-DDT, p,p’-DDE, p,p’-DDD, o,p’-DDT, o,p’-DDE, and 
o,p’-DDD are listed in Table 4-2. 
CCl3
Cl
H
Cl
CCl2
Cl
Cl
CHCl2
Cl
H
Cl
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Table 4-2.  Physical and Chemical Properties of p,p’- and o,p’-DDT, DDE, and 
DDDa 
 
Property p,p’-DDT p,p’-DDE p,p’-DDD 
Molecular weight 354.5 318.03b 320.05b 
Color Colorless crystals  White Colorless crystals, 
white powder 
Physical state Solid Crystalline solid Solid 
Melting point 108.5–109°C 89°Cb 109–110°Cb 
Boiling point Decomposes; 
185–187 at 
0.05 mmHg 
336°Cb 350°Cb 
Density at 20°C 1.56 g/cm3 No data 1.385 g/cm3 
Odor Odorless or weak 
aromatic odorc 
No data Odorless 
Odor threshold:    
 Water 0.35 mg/kgd No data No data 
 Air No data No data No data 
Solubility:    
 Water 0.025 mg/L at 25°Cb 0.12 mg/L at 25°Cb 0.05 mg/L at 25°C 
 Organic solvents 1,000 g/L in 
cyclohexane and 
dioxane; 850 g/L in 
dichloromethane; 
770 g/L in benzene; 
600 g/L in xylene; 
50 g/L in acetone; 
470 g/L in carbon 
tetrachloride; 310 g/L 
in chloroform; 270 g/L 
in diethyl ether; 60g/L 
in ethanol; 40 g/L in 
methanol 
Lipids and most 
organic solvents 
No data 
Partition coefficients:    
 Log Kow 6.91b 6.51b 6.02b 
 Log Koc 5.18e 4.70f 5.18g 
Vapor pressure at 20°C 1.60x10-7, torrb 6.0x10-6 at 25°C, torrb 1.35x10-6 at 25°C, 
torrb 
Henry's law constant at 25°C 8.3x10-6 atm-m3/molb 2.1x10-5 atm-m3/molb 4.0x10-6 atm-m3/molb 
Autoignition temperature No data No data No data 
Flashpoint 72.2–77.2 °C No data No data 
Flammability limits No data No data No data 
Conversion factors    
Ppm (v/v) to mg/m3 in air at 20°C Not applicableh Not applicableh Not applicableh 
mg/m3 to ppm (v/v) in air at 20°C Not applicable Not applicable Not applicable 
Explosive limits No data No data No data 
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Table 4-2.  Physical and Chemical Properties of p,p’- and o,p’-DDT, DDE, and 
DDDa 
 
Property o,p’-DDT o,p’-DDE o,p’-DDD 
Molecular weight 354.49b 318.03b 320.05b 
Color White crystalline 
powderd 
No data No data 
Physical state Solid No data Solid 
Melting point 74.2°Cc No data 76–78°C 
Boiling point No data No data No data 
Density at 20°C 0.98–0.99 g/cm3 No data No data 
Odor Odorless or weak 
aromatic odorc 
No data No data 
Odor threshold:    
 Water No data No data No data 
 Air No data No data No data 
Solubility:    
 Water 0.085 mg/L at 25°Cb 0.14 mg/L at 25°C 0.1 mg/L at 25°Cb 
 Organic solvents No dataj No dataj Soluble in ethanol, 
isooctane, carbon 
tetrachlorideh 
Partition coefficients:    
 Log Kow 6.79e 6.00b 5.87b 
 Log Koc 5.35g 5.19g 5.19g 
Vapor pressure at 20°C 1.1x10-7, torrb 6.2x10-6 at 25°C, torrb 1.94x10-6 at 30°C, 
torrb 
Henry's law constant at 25°C 5.9x10-7 atm-m3/molb 1.8x10-5 atm-m3/molb 8.17x10-6 atm-m3/molb 
Autoignition temperature No data No data No data 
Flashpoint No data No data No data 
Flammability limits No data No data No data 
Conversion factors    
ppm (v/v) to mg/m3 in air at 20°C Not applicableh Not applicableh Not applicableh 
mg/m3 to ppm (v/v) in air at 20°C Not applicable Not applicable Not applicable 
Explosive limits No data No data No data 
 
aMacbean 2011, unless otherwise noted. 
bHoward and Meylan 1997. 
cSax 1979. 
dVerschueren 1983. 
eSwann et al. 1981. 
fSabljic 1984. 
gMeylan et al. 1992 (values estimated from a fragment constant method). 
hExists partially in particulate form in air.  Conversion factors are only applicable for compounds that are entirely in 
the vapor phase. 
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CHAPTER 5.  POTENTIAL FOR HUMAN EXPOSURE 
 
5.1   OVERVIEW  
 
DDT, DDE, and DDD has been identified in at least 375, 322, and 260, respectively, of the 
1,854 hazardous waste sites that have been proposed for inclusion on the EPA National Priorities List 
(NPL) (Agency for Toxic Substances and Disease Registry 2017).  However, the number of sites 
evaluated for DDT, DDE, and DDD is not known.  The number of sites in each state is shown in 
Figure 5-1.  Of these sites, all are located within the United States, with the exception of one that is 
located in Puerto Rico (not shown). 
 
Figure 5-1.  Number of NPL Sites with DDT, DDE, and DDD Contamination 
 
 
• Food intake, especially meat, fish, and dairy products, continues to be the primary source of DDT 
exposure for the general population; however, DDT and DDE intakes have decreased over time.  
 
• Inhalation of ambient air and ingestion of drinking water are not considered major exposure 
pathways to the general population. 
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While this document is specifically focused on the primary forms or isomers of DDT, DDE, and DDD 
(namely p,p’-DDT, p,p’-DDE, and p,p’-DDD), other isomers of these compounds will be discussed when 
appropriate.  It should be noted that DDT, DDE, and DDD are also synonyms for p,p’-DDT, p,p’-DDE, 
and p,p’-DDD, respectively, and it is usually understood that when DDT, for example, is mentioned 
p,p’-DDT is being referred to and not both o,p’- and p,p’-DDT.  Technical-grade DDT, the grade that was 
generally used as an insecticide was composed of up to 14 chemical compounds, of which only 65–80% 
was the active ingredient, p,p’-DDT.  The other components included 15–21% of the nearly inactive 
o,p’-DDT, up to 4% of p,p’-DDD, and up to 1.5% of 1-(p-chlorophenyl)-2,2,2-trichloroethanol (Metcalf 
1995).  In some cases, the term DDT will be used to refer to the collective forms of DDT, DDE, and 
DDD.  Should this not be clear from the context, the term ΣDDT (Σ is used to mean sum of) will be used. 
 
DDT and its primary metabolites, DDE and DDD, are manufactured chemicals and are not known to 
occur naturally in the environment (WHO 1979).  Historically, DDT was released to the environment 
during its production, formulation, and extensive use as a pesticide in agriculture and vector control 
applications.  DDD was also used as a pesticide, but to a far lesser extent than was DDT.  Although it was 
banned for use in the United States after 1972, DDT is still being used in some areas of the world.  DDT 
and its metabolites are very persistent and bioaccumulate in the environment.  
 
DDT gets into the atmosphere as a result of spraying operations in areas of the world where it is still used.  
DDT and its metabolites also enter the atmosphere through the volatilization of residues in soil and 
surface water, much of it a result of past use.  These chemicals will be deposited on land and in surface 
water as a result of dry and wet deposition.  The process of volatilization and deposition may be repeated 
many times, and results in what has been referred to as a ‘global distillation’ from warm source areas to 
cold polar regions.  As a result, DDT and its metabolites are transported to the Arctic and Antarctic 
regions, where they are found in the air, sediment, and snow and accumulate in biota.  
 
When in the atmosphere, about 50% of DDT will be found adsorbed to particulate matter and 50% will 
exist in the vapor phase (Bidleman 1988).  A smaller proportion of DDE and DDD are adsorbed to 
particulate matter than DDT.  Vapor-phase DDT, DDE, and DDD react with photochemically-produced 
hydroxyl radicals in the atmosphere; their estimated half-lives are 37, 17, and 30 hours, respectively.  
However, based on the ability of DDT, DDE, and DDD to undergo long-range global transport, these 
estimated half-lives do not adequately reflect the actual lifetimes of these chemicals in the atmosphere. 
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The dominant fate processes in the aquatic environment are volatilization and adsorption to biota, 
suspended particulate matter, and sediments.  Transformation includes biotransformation and photolysis 
in surface waters.  The fate of DDT in the aquatic environment is illustrated by a microcosm study in 
which DDT was applied to a pond, and a material balance was performed after 30–40 days.  At this time, 
DDT concentrations in the water column had declined to below the detectable limit (EPA 1979).  It was 
found that 90% of the initial DDT was not present in the water, sediment, algae, invertebrates, or fish, and 
was presumed to have volatilized.  ΣDDT was present in water mainly as DDT during the first 30 days, as 
DDT and DDD during the next 30 days, and as DDD in the last 30 days.  ΣDDT levels rapidly rose in 
invertebrates, reaching equilibrium in 5 days and then declining as the ΣDDT content of the water 
declined.  Degradation of DDT is altered by invertebrates, with the conversion of DDT to DDMU.  ΣDDT 
levels in fish rose rapidly and reached a high equilibrium level.  In a study of a freshwater lake, DDT was 
found to accumulate to higher concentrations in fattier fish occupying high trophic levels than in leaner 
species occupying lower trophic levels (Kidd et al. 2001).  Also, accumulation of DDT was significantly 
higher in the pelagic food web than in the benthic food web. 
 
When deposited on soil, DDT, DDE, and DDD are strongly adsorbed.  However, they may also 
revolatilize into the air, which is more likely to occur from moist soils than dry soils.  They may 
photodegrade on the soil surface and biodegrade.  DDT biodegrades primarily to DDE under unflooded 
conditions (e.g., aerobic) and to DDD under flooded (e.g., anaerobic) conditions.  As a result of their 
strong binding to soil, DDT, DDE, and DDD mostly remain on the surface layers of soil; there is little 
leaching into the lower soil layers and groundwater.  DDT may be taken up by plants that are eaten by 
animals and accumulate to high levels, primarily in adipose tissue and milk of the animals.   
 
In discussing DDT and other pesticides in soil, agricultural chemists generally speak of persistence and 
degradation, but it is not always clear what mechanisms are responsible for the loss or dissipation of the 
chemical.  This issue is further complicated in the case of DDT because what is often reported is the 
disappearance of ΣDDT residues rather than just p,p’-DDT.  Many studies use first-order kinetics to 
model the dissipation of DDT in soils because a half-life for the chemical can be defined.  The half-life 
represents the calculated time for loss of the first 50% of the substance, but the time required for the loss 
of half of that which remains may be substantially longer, and the rate of disappearance may decline 
further as time progresses.  The rate and extent of disappearance may result from transport processes as 
well as degradation or transformation processes.  Initially, much of the disappearance of DDT is a result 
of volatilization losses, after which biodegradation becomes more important.  When more than one 
process is responsible for loss, the decrease in the amount of substance remaining will be nonlinear.  
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Assessments of long-term monitoring studies have indicated that even DDT biodegradation does not 
follow first-order kinetics (Alexander 1995, 1997).  The reason is that over long periods of time, DDT 
may become sequestered in soil particles and become less available to microorganisms.  The term half-
life in this document is used to indicate the estimated time for the initial disappearance of 50% of the 
compound, and does not necessarily imply that first-order kinetics were observed throughout the 
experiment unless otherwise noted.  The persistence of DDT in soil is highly variable.  Dissipation is 
much greater in tropical regions than in temperate regions.  In tropical and subtropical regions, most of 
the DDT is lost within a year; the half-life of ΣDDT in 13 countries ranged from 22 to 327 days.  The 
half-life of DDE, the primary degradation product of DDT, ranged from 151 to 271 days.  In another 
country where the soil was extremely acidic, the half-life was >672 days.  Comparable half-lives in 
temperate regions have been reported to range from 837 to 6,087 days.  One investigator concluded that 
the mean lifetime of DDT in temperate U.S. soils was about 5.3 years.  In a study of sprayed forest soils 
in Maine, the half-time for the disappearance of DDT residues was noted to be 20–30 years (Dimond and 
Owen 1996).  Highest residues are found in muck soils and in deeply plowed, unflooded fields (Aigner et 
al. 1998; Spencer et al. 1996).  Significant concentrations of DDT have been found in the atmosphere 
over agricultural plots.  Irrigating the soil dramatically increased the volatilization flux of DDT, which is 
probably related to the amount of DDT in the soil solution.  Volatilization, air transport, and redeposition 
were found to be the main avenues of contaminating forage eaten by cows. 
 
When deposited in water, DDT will adsorb strongly to particulate matter in the water column and 
primarily partition into the sediment.  Some of the DDT may revolatilize.  DDT bioconcentrates in 
aquatic organisms and bioaccumulates in the food chain.  Marine mammals in the Arctic often contain 
very high levels of DDT and DDE (Hargrave et al. 1992; Welfinger-Smith et al. 2011). 
 
Concentrations of DDT in all media have been declining since DDT was banned in the United States and 
most of the world (Arthur et al. 1977; Boul et al. 1994; Van Metre and Callender 1997; Van Metre et al. 
1997; Ware et al. 1978).  For example, the concentration of DDT in lake sediments decreased by 93% 
from 1965 to 1994 and declined by 70% in silt loam between 1960 and 1980 (Boul et al. 1994; Van Metre 
and Callender 1997; Van Metre et al. 1997).  ΣDDT levels in sea lions decreased by 2 orders of 
magnitude between 1970 and 1992 (Lieberg-Clark et al. 1995).  The Market Basket Surveys have shown 
an 86% decline in DDT levels measured in all classes of food from 1965 to 1975 (EPA 1980).  However, 
because of the extensive past use of DDT worldwide and the persistence of DDT and its metabolites, 
these chemicals are virtually ubiquitous and are continually being transformed and redistributed in the 
environment.  
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Human exposure to DDT is primarily through the diet.  Exposure via inhalation at the ambient levels in 
air (Whitmore et al. 1994) is thought to be insignificant compared with dietary intake.  The main source 
of DDT in food is meat, fish, poultry, and dairy products.  DDT residues in food have declined since it 
was banned.  Residues are more likely to occur in food imported from countries where DDT is still used.  
People eating fish from the Great Lakes were found to consume greater amounts of DDT in their diets 
(Hanrahan et al. 1999; Laden et al. 1999), but as DDT levels in Great Lakes fish continue to decline, 
exposure from consuming fish should also decline (Anderson et al. 1998; Hanrahan et al. 1999; Hovinga 
et al. 1993).  The populations having the greatest exposure to DDT are indigenous people in the Arctic 
who eat traditional foods (e.g., seals, caribou, narwhal whales, etc.) (Kuhnlein et al. 1995). 
 
Releases of DDT, DDE, or DDD are not required to be reported in the Toxics Release Inventory (TRI) 
database (EPA 2005). 
 
5.2   PRODUCTION, IMPORT/EXPORT, USE, AND DISPOSAL 
 
Figures relating to the production, import/export, use, and disposal of a pesticide generally refer to those 
of the active ingredient.  In the case of DDT, the active ingredient is p,p’-DDT.  Most DDT production 
can be assumed to have been technical-grade material that included 15–21% of the nearly inactive 
o,p’-DDT, up to 4% of p,p’-DDD, and up to 1.5% of 1-(p-chlorophenyl)-2,2,2-trichloroethanol (Metcalf 
1995).  
 
5.2.1   Production 
 
Technical DDT is made by condensing chloral hydrate with chlorobenzene in concentrated sulfuric acid 
(Metcalf 1995).  It was first synthesized in 1874, but it was not until 1939 that Müller and his coworkers 
discovered its insecticidal properties (Metcalf 1995).  Production of DDT in 1971 in the United States 
was estimated to be 2 million kg.  This represented a sharp decline from the 82 million kg produced in 
1962, and from the 56 million kg produced in 1960.  At the peak of its popularity in 1962, DDT was 
registered for use on 334 agricultural commodities and about 85,000 tons were produced (Metcalf 1995).  
Production then declined and by 1971, shortly before it was banned in the United States, production had 
dipped to about 2,000 tons.  The cumulative world production of DDT has been estimated as about 
2.8 million metric tons, with roughly half of that production attributed to the United States (UNEP 2015).  
As of January 1, 1973, all uses of DDT in the United States were canceled except emergency public 
health uses and a few other uses permitted on a case-by-case basis (Meister and Sine 1999).  Currently, no 
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companies in the United States manufacture DDT (Meister and Sine 1999).  DDT is still being produced 
by India and possibly the Democratic People’s Republic of Korea (North Korea).  China discontinued 
production in 2007 (UNEP 2015).  The average annual production in China from 2000 to 2004 was 
reported to be 4,500 metric tons; however, most of that production was used to manufacture the acaricide, 
dicofol (van den Berg 2009).  An average annual production of 160 metric tons of DDT was reported for 
North Korea.  The total DDT production for India in 2009, 2010, and 2011 was reported to be 3,315, 
3,610, and 3,192 metric tons, respectively (UNEP 2015).   
 
Analytical studies have shown that DDT compounds, including p,p’-DDT and p,p’-DDE, may be 
contaminants in technical grades of the insecticide, dicofol (Risebrough et al. 1986).  In addition, another 
DDT-related impurity in dicofol, 1,1,1,2-tetrachloro-2,2-bis(p-chlorophenyl)ethane, has been shown to 
degrade to p,p’-DDE. 
 
No information is available in the TRI database on facilities that manufacture or process DDT, DDE, and 
DDD because this chemical is not required to be reported under Section 313 of the Emergency Planning 
and Community Right-to-Know Act (Title III of the Superfund Amendments and Reauthorization Act of 
1986) (EPA 2005). 
 
5.2.2   Import/Export 
 
DDT was last imported into the United States in 1972, when imports amounted to 200 tons.  Although the 
use of DDT was banned in the United States after 1972, it was still manufactured for export.  Presently, 
there are no producers of DDT in the United States, and therefore, there are no exports of DDT. 
Currently, India is the only exporter of DDT in the world.  In 2012/2013, India exported 286 metric tons 
of 98–99% active ingredient and in 2013/2014, India exported 77 metric tons of 98–99% active 
ingredient, primarily to the nations of Botswana, Mynmar, Namibia, South Africa, and Zimbabwe (UNEP 
2015).   
 
5.2.3   Use 
 
DDT is a broad-spectrum insecticide that was very popular due its effectiveness, long residual 
persistence, low acute mammalian toxicity, and low cost (Metcalf 1989).  DDT was first used as an 
insecticide starting in 1939 and was widely used until about 1970 (Van Metre et al. 1997).  Its usage 
peaked in the United States in the early 1960s.  During World War II, it was extensively employed for the 
control of malaria, typhus, and other insect-transmitted diseases.  DDT has been widely used in 
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agriculture to control insects, such as the pink boll worm on cotton, codling moth on deciduous fruit, 
Colorado potato beetle, and European corn borer.  In 1972, 67–90% of the total U.S. consumption of 
DDT was on cotton; the remainder was primarily used on peanuts and soybeans.  DDT has been used 
extensively to eradicate forest pests, such as the gypsy moth and spruce budworm.  It was used in the 
home as a mothproofing agent and to control lice.  The amount of DDT used in U.S. agriculture was 
27 million pounds in 1966 and 14 million pounds in 1971 (Gianessi and Puffer 1992).  Since 1973, use of 
DDT in the United States has been limited to the control of emergency public health problems.  In some 
regions of the world where malaria is endemic, such as South Africa, Swaziland, and Madagascar, DDT is 
sprayed onto the interior surfaces of homes to decrease the incidence and spread of the disease by 
controlling mosquitoes (Attaran et al. 2000; Roberts et al. 1997).  Not only is DDT a contact toxin for 
mosquitoes, it is also a contact irritant and repellent.  As such, DDT has been shown to be effective in 
controlling malaria by not only limiting the survival of the mosquito, but also decreasing the odds of an 
individual being bitten within the sprayed homes.  p,p’-DDD was also used as an insecticide.  o,p’-DDD 
(Mitotane) is used medically in the treatment of cancer of the adrenal gland (PDR 1999).  DDE has no 
commercial use. 
 
As per the Stockholm Convention, DDT can still be used for vector control.  According to the United 
Nations, 4,953, 5,219, and 3,950 metric tons were used in 2003, 2005, and 2007, respectively, with the 
majority used for malaria and leishmaniasis control (UNEP 2015).  In 2009, 2010, and 2011, 6,987, 
6,779, and 6,553 metric tons of DDT were used, with consumption by India accounting for >90% each 
year (UNEP 2015).   
 
5.2.4   Disposal 
 
Under current federal guidelines, DDT and DDD are potential candidates for incineration in a rotary kiln 
at 820–1,600°C.  Disposal of DDT formulated in 5% oil solution or other solutions is mainly by using 
liquid injection incineration at 878–1,260°C, with a residence time of 0.16–1.30 seconds and 26–70% 
excess air.  Destruction efficiency with this method is reported to be >99.99%.  Multiple-chamber 
incineration is also used for 10% DDT dust and 90% inert ingredients at a temperature range of 930–
1,210°C, a residence time of 1.2–2.5 seconds, and 58–164% excess air.  DDT powder may be disposed of 
by molten salt combustion at 900°C (no residence time or excess air conditions specified).  A low 
temperature destruction method involving milling DDT with Mg, Ca, or CaO is under development on a 
laboratory scale (Rowlands et al. 1994).  Landfill disposal methods are rarely used at the present time. 
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5.3   RELEASES TO THE ENVIRONMENT  
 
The Toxics Release Inventory (TRI) data should be used with caution because only certain types of 
facilities are required to report (EPA 2005).  This is not an exhaustive list.  Manufacturing and processing 
facilities are required to report information to the TRI only if they employ 10 or more full-time 
employees; if their facility is included in Standard Industrial Classification (SIC) Codes 10 (except 1011, 
1081, and 1094), 12 (except 1241), 20–39, 4911 (limited to facilities that combust coal and/or oil for the 
purpose of generating electricity for distribution in commerce), 4931 (limited to facilities that combust 
coal and/or oil for the purpose of generating electricity for distribution in commerce), 4939 (limited to 
facilities that combust coal and/or oil for the purpose of generating electricity for distribution in 
commerce), 4953 (limited to facilities regulated under RCRA Subtitle C, 42 U.S.C. section 6921 et seq.), 
5169, 5171, and 7389 (limited S.C. section 6921 et seq.), 5169, 5171, and 7389 (limited to facilities 
primarily engaged in solvents recovery services on a contract or fee basis); and if their facility produces, 
imports, or processes ≥25,000 pounds of any TRI chemical or otherwise uses >10,000 pounds of a TRI 
chemical in a calendar year (EPA 2005). 
 
5.3.1   Air  
 
There is no information on releases of DDT, DDE, and DDD to the atmosphere from manufacturing and 
processing facilities because these releases are not required to be reported (EPA 2005). 
 
During the period when DDT was extensively used, a large source of DDT release to air occurred during 
agricultural or vector control applications.  Emissions could also have resulted during production, 
transport, and disposal.  Because use of DDT was banned in the United States after 1972, release of DDT 
in recent years should be negligible in this country.  
 
Nevertheless, DDT residues in bogs or peat lands across the midlatitudes of North America indicate that 
DDT was still released, even after it was banned for use in the United States (Rapaport et al. 1985).  
These areas are unique in that they receive all of their pollutant input from the atmosphere, and therefore, 
peat cores are important indicators of the atmospheric deposition of a substance and also of its 
atmospheric levels in the present and the past.  An analysis of peat cores, as well as rain and snow 
samples, indicated that DDT was still present in the atmosphere, although levels were lower compared to 
those in the 1960s.  The implication is that DDT is still being released to the atmosphere either from its 
current production and use in other countries and transport to the United States or from the volatilization 
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of residues resulting from previous use.  The estimated release of DDT into the atmosphere from the 
Great Lakes in 1994, excluding Lake Huron, was 14.3 kg (Hoff et al. 1996).   
 
5.3.2   Water  
 
There is no information on releases of DDT, DDE, and DDD to the water from manufacturing and 
processing facilities because these releases are not required to be reported (EPA 2005). 
 
Historically, DDT was released to surface water when it was used for vector control in the vicinity of 
open waters.  This source of release may still be occurring in countries that rely on DDT in insect pest 
control near open waters.  DDT also enters surface water as a result of dry and wet deposition from the 
atmosphere and direct gas transfer.  Atmospheric DDT deposited into tributaries will contribute to the 
loading in rivers, lakes, and oceans.  In 1994, the estimated loading of ΣDDT into the Great Lakes as a 
result of dry and wet deposition was estimated as 148 kg, down from 278 kg in 1988 (Hoff et al. 1996).  
Fluvial sources and erosion also contribute to the DDT burden, and they were the predominant source of 
DDT in many areas in the past.  This was clearly shown in a U.S. Geological Survey (USGS) study of 
sediment in reservoirs and lakes in Georgia and Texas compared with DDT levels in nearby peat bogs 
(Van Metre et al. 1997). 
 
Contaminated sediment near an outfall can act as a source of contamination in distant parts of a body of 
water.  This was clearly illustrated in a Norwegian lake that received insecticidal wastes.  Nineteen years 
after closing the outfall, DDT concentrations in pike and perch were 5–10 times those in uncontaminated 
lakes (Brevik et al. 1996).  DDT was disposed to the Joint Water Pollution Control Plant, Los Angeles 
County by Montrose Chemical Company from about 1950 to 1970, and eventually to the Palos Verdes 
Shelf via sewer pipes.  The distribution of DDT with respect to the outfall diffusers and the fact that the 
DDT concentration in the overlying water column exponentially decreased with increasing distance from 
the sea floor indicated that the main source of DDT in the water column was contaminated sediments 
(Zeng et al. 1999). 
 
5.3.3   Soil  
 
There is no information on releases of DDT, DDE, and DDD to the soil from manufacturing and 
processing facilities because these releases are not required to be reported (EPA 2005). 
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In the United States, large amounts of DDT were released to the soil during spraying operations or from 
direct or indirect releases during manufacturing, formulation, storage, or disposal.  Since almost all of the 
DDT produced was used to control insects damaging crops and trees or responsible for insect-transmitted 
diseases, it can be assumed that a large fraction of the DDT produced was released to soil during spraying 
operations.  The largest amounts of DDT released to soil were those used in agriculture which amounted 
to 27 million pounds in 1966 and 14 million pounds in 1971, shortly before it was banned (EPA 1992).  
 
5.4   ENVIRONMENTAL FATE  
 
A large proportion of the environmental fate studies on pesticides such as p,p’-DDT are performed in 
laboratory or field studies by agricultural chemists interested in the persistence of the active ingredient of 
the pesticide in the tilled layer of soil.  Therefore, studies may not reveal whether the loss of active 
ingredient is a result of volatilization, leaching, or microbial degradation.  Field studies may also report 
the occurrence of obvious metabolites remaining in surface soil months or years after a pesticide was 
applied.  Clearly, it is not possible to separate these studies into ‘Transport and Partitioning’ 
(Section 5.4.1) and ‘Transformation and Degradation’ (Section 5.4.2).  These studies are discussed in 
Section 5.4.2 with the understanding that ‘degradation’ may only account for part of the reported loss. 
 
5.4.1   Transport and Partitioning  
 
Air.    There is abundant evidence that DDT gets into the atmosphere as a result of volatilization from 
water or soil surfaces.  Because DDT is so slow to degrade in the environment, the process of 
volatilization from soil and water may be repeated many times and, consequently, DDT may be 
transported long distances in the atmosphere by what has been referred to as a ‘global distillation’ from 
warm source areas to cold polar regions (Bard 1999; Bidleman et al. 1992; Goldberg 1975; Ottar 1981; 
Wania and MacKay 1993).  As a result, DDT and its metabolites are found in arctic air, sediment, and 
snow with substantial accumulations in animals, marine mammals, and humans residing in these regions 
(Anthony et al. 1999; Harner 1997).  An analysis of sediment cores from eight remote lakes in Canada 
indicated that ΣDDT concentrations in surface sediments (0–1.3 cm depth) declined significantly with 
latitude (Muir et al. 1995).  The maximum ΣDDT concentrations in core slices in midcontinent lakes date 
from the late 1970s to 1980s, which is about 5–10 years later than the maximum for Lake Ontario. 
 
Transport of DDT in the atmosphere of central and eastern North America is facilitated by a circulation 
pattern that brings moisture from the Gulf of Mexico into the Midwest and the airflow patterns across the 
eastern seaboard (Rapaport et al. 1985).  DDT is removed from the atmosphere by wet and dry deposition 
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and diffusion into bodies of water.  The largest amount of DDT is believed to be removed from the 
atmosphere in precipitation (Woodwell et al. 1971).   
 
Water.    Volatilization of DDT, DDE, and DDD is known to account for considerable losses of these 
compounds from soil surfaces and water.  Their tendency to volatilize from water can be predicted by 
their respective Henry's law constants, which for the respective p,p’- and o,p’- isomers are 8.3x10-6, 
2.1x10-5, 4.0x10-6, 5.9x10-7, 1.8x10-5, and 8.2x10-6 atm-m3/mol (Howard and Meylan 1997).  The 
predicted volatilization half-lives from a model river 1 m deep, flowing at 1 m/second, with a wind of 
3 m/second are 8.2, 3.3, 10.5, 6.3, 3.7, and 8.2 days, respectively.  Laboratory studies of the air/water 
partition coefficient of DDE indicate that it will volatilize from seawater 10–20 times faster than from 
freshwater (Atlas et al. 1982).  The authors suggest that this process may be related to interaction at the 
bubble-water surface.   
 
Sediment and Soil.    Organic carbon partition coefficients (Koc) of 1.5x105 (Swann et al. 1981), 
5.0x104 (Sabljic 1984), and 1.5x105 (Meylan et al. 1992) reported for p,p’-DDT, p,p’-DDE, and 
p,p’-DDD, respectively, suggest that these compounds adsorb strongly to soil.  These chemicals are only 
slightly soluble in water, with solubilities of 0.025, 0.12, and 0.090 mg/L for p,p’-DDT, p,p’-DDE, and 
p,p’-DDD, respectively (Howard and Meylan 1997).  Therefore, loss of these compounds in runoff is 
primarily due to transport of particulate matter to which these compounds are bound.  For example, DDT 
and its metabolites have been found to fractionate and concentrate on the organic material that is 
transported with the clay fraction of the washload in runoff (Masters and Inman 2000).  The amount of 
DDT transported into streams as runoff is dependent on the methods of irrigation used (USGS 1999).  In 
the western United States, DDT concentrations in streambed sediment increased as the percentage of 
furrow irrigation, as opposed to sprinkler or drip irrigation, increased.  In the San Joaquin River Basin, 
more DDT was transported during winter runoff than during the irrigation season (Kratzer 1999).  Since 
the compounds are bound strongly to soil, DDT would remain in the surface layers of soil and not leach 
into groundwater.  However, DDT can adsorb to free-moving dissolved organic carbon, a soluble humic 
material that may occur in the soil solution.  This material behaves as a carrier and facilitates transport of 
DDT into subsurface soil (Ding and Wu 1997).  DDT released into water adsorbs to particulate matter in 
the water column and sediment.  Sediment is the sink for DDT released into water.  There, it is available 
for ingestion by organisms, such as bottom feeders.  Reich et al. (1986) reported that DDT, DDE, and 
DDD were still bioavailable to aquatic biota in a northern Alabama river 14 years after 432,000–
8,000,000 kg of DDT was discharged into the river.  DDT in the water column above the outfall of Los 
Angeles County’s Joint Water Pollution Control Plant’s outfall was present both in the dissolved phase 
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and the particulate phase (defined as particles size >0.7 μm) (Zeng et al. 1999).  It is interesting to note 
that more of the DDT was present in the dissolved phase than in the particulate phase, despite its high 
hydrophobicity.  
 
Volatilization from moist soil surfaces can be estimated from the Henry’s law constant divided by the 
absorptivity to soil (Dow Method) (Thomas 1990).  The predicted half-life for DDT volatilizing from soil 
with a Koc of 240,000 is 23 days, compared to an experimental half-life of 42 days.  Sleicher and Hopcraft 
(1984) estimated a volatilization half-life of 110 days for DDT from soil in Kenya based on mass transfer 
through the boundary layers, and claimed that volatilization of DDT was sufficient to account for its rapid 
disappearance from soil.  However, laboratory experiments in which 14C-p,p’-DDT was incubated in an 
acidic (pH 4.5–4.8), sandy loam soil maintained at 45°C for 6 hours/day for 6 weeks resulted in neither 
volatilization of DDT or its metabolites nor mineralization (Andrea et al. 1994).  Other studies conducted 
in Indonesia using a latosol soil (pH 5.7) found that 5.9% of the radioactivity was lost through 
volatilization during a 6-week incubation at 45°C (Sjoeib et al. 1994).  The volatilization rate of DDT 
from soil is significantly enhanced by temperature, sunlight, and flooding of the soil (Samuel and Pillai 
1989).   
 
Other Media.    DDT, DDE, and DDD are highly lipid soluble, as reflected by their log octanol-water 
partition coefficients (log Kow) of 6.91, 6.51, and 6.02, respectively for the p,p’- isomers and 6.79, 6.00, 
and 5.87, respectively, for the o,p’- isomers (Howard and Meylan 1997).  This lipophilic property, 
combined with an extremely long half-life is responsible for its high bioconcentration in aquatic 
organisms (i.e., levels in organisms exceed those levels occurring in the surrounding water).  Organisms 
also feed on other animals at lower trophic levels.  The result is a progressive biomagnification of DDT in 
organisms at the top of the food chain.  Biomagnification is the cumulative increase in the concentration 
of a persistent contaminant in successively higher trophic levels of the food chain (i.e., from algae to 
zooplankton to fish to birds).  Ford and Hill (1991) reported increased biomagnification of DDT, DDE, 
and DDD from soil sediment to mosquito fish, a secondary consumer.  No distinct pattern of 
biomagnification was evident in other secondary consumers such as carp and small mouth buffalo fish.  
The biomagnification of DDT is exemplified by the increase in DDT concentration in organisms 
representing four trophic levels sampled from a Long Island estuary.  The concentrations in plankton, 
invertebrates, fish, and fish-eating birds were 0.04, 0.3, 4.1, and 24 mg/kg, whole-body basis (Leblanc 
1995).  Evans et al. (1991) reported that DDE biomagnified 28.7 times in average concentrations from 
plankton to fish and 21 times from sediment to amphipods in Lake Michigan.  In some cases, humans 
may be the ultimate consumer of these contaminated organisms.   
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The bioconcentration factor (BCF) is defined as the ratio of the equilibrium concentration of contaminant 
in tissue compared to the concentration in ambient water, soil, or sediment to which the organism is 
exposed.  There are numerous measurements and estimates of BCF values for DDT in fish.  Oliver and 
Niimi (1985) estimated the steady-state BCF in rainbow trout as 12,000.  Other BCF values that have 
been reported include 51,000–100,000 in fish, 4,550–690,000 in mussels, and 36,000 in snails (Davies 
and Dobbs 1984; Geyer et al. 1982; Metcalf et al. 1973; Reish et al. 1978; Veith et al. 1979).  DDT 
bioconcentration studies in aquatic environments with representatives of various trophic levels 
demonstrate that bioconcentration increases with increasing trophic level (LeBlanc 1995).  Trophic level 
differences in bioconcentration are largely due to increased lipid content and decreased elimination 
efficiency among higher level organisms.  However, biomagnification also contributes to the increased 
concentration of DDT in higher trophic organisms (LeBlanc 1995). 
 
The BCF values of p,p’-DDT in brine shrimp (Artemia nauplii) exposed to a mixture containing 0.5 or 
1.0 ng/mL of four DDT analogues for 24 hours were significantly higher than for the three other 
chemicals.  The BCF values were 41, 54, 128, and 248 for p,p’-DDE, p,p’-DDD, o,p’-DDT, and 
p,p’-DDT, respectively (Wang and Simpson 1996).  The differences in BCF values are due to the 
different lipid solubility and selectivity of the compounds partitioned in the zooplanktonic organisms.  
p,p’-DDT, which has the greatest polarity of the four tested analogues, may have been adsorbed to a 
greater extent to the surface of the shrimp.  In addition to absorbing DDT directly from the water, fish 
obtain DDT from their diet (Miller 1994; Wang and Simpson 1996).  Wang and Simpson (1996) fed 
brook trout contaminated A. nauplii for 24 days followed by depuration for another 24 days during which 
the trout were fed uncontaminated A. nauplii.  Although the concentration of p,p’-DDE was the lowest of 
the four analogues in the contaminated brine shrimp, the concentration of this compound in the trout at 
day 24 was 42.5 ng/g, which was roughly 5 times more than the other analogues.  The levels of the 
p,p’- isomers initially ranged from 1.0 to 2.7 ng/g, while o,p’-DDT was absent.  The abnormal 
accumulation of p,p’-DDE in the fish suggests that mixed-function oxidases may have induced the 
dechlorination of p,p’-DDT to p,p’-DDE.  This may account for the fact that about 70% of ΣDDT in fish 
is p,p’-DDE (Schmitt et al. 1990).  After the fish were fed uncontaminated food, p,p’-DDE had the lowest 
percentage depuration.  After feeding the trout for 24 days with the more highly contaminated brine 
shrimp, 14, 62, 17, and 32% depuration were observed for p,p’-DDE, p,p’-DDD, o,p’-DDT, and 
p,p’-DDT, respectively. 
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Fish move from the Great Lakes or other bodies of water with elevated DDT levels to rivers that feed into 
these lakes.  In doing so, they transport DDT, which may represent a risk to wildlife along the tributaries 
(Giesy et al. 1994). 
 
Despite being strongly bound to soil, at least a portion of DDT, DDE, and DDD is bioavailable to plants 
and soil invertebrates.  Nash and Beall (1970) studied the DDT residues in soybean plants resulting from 
the application of [14C]DDT to the surface or subsurface soil.  They found that the major source of DDT 
contamination was due to sorption of volatilized residues from surface-treated soil.  This was 6.8 times 
greater than that obtained through root uptake and translocation after subsurface treatment.  In other 
experiments with oats and peas, root uptake of DDT was low and there was little or no evidence of 
translocation of the insecticide (Fuhremann and Lichtenstein 1980).  Verma and Pillai (1991a) reported 
that grain, maize, and rice plants accumulate DDT adsorbed to soil.  Most of the residues were found in 
the roots of the plant, and the lowest concentration of DDT residues was found in the shoots, indicating 
low translocation of DDT.  Earthworms are capable of aiding the mobilization of soil-bound DDT 
residues to readily bioavailable forms (Verma and Pillai 1991b).  DDT may collect on the leafy part of 
plants from the deposition of DDT-containing dust. 
 
5.4.2   Transformation and Degradation  
 
Air.    In the atmosphere, about 50% of DDT is adsorbed to particulate matter and 50% exists in the vapor 
phase (Bidleman 1988).  In the vapor phase, DDT reacts with photochemically produced hydroxyl 
radicals with an estimated rate constant of 3.44x10-12 cm3/molecule-second determined from a fragment 
constant estimation method (Meylan and Howard 1993).  Assuming an average hydroxyl radical 
concentration of 1.5x106 per cm3, its half-life is estimated to be 37 hours.  Both DDE and DDD have 
higher vapor pressures than DDT, and a smaller fraction of these compounds will be adsorbed to 
particulate matter.  The estimated half-lives of vapor-phase DDE and DDD are 17 and 30 hours, 
respectively.  Direct photolysis may also occur in the atmosphere. 
 
It should be noted that the estimated half-lives for vapor-phase DDT, DDE, and DDD do not necessarily 
reflect the lifetimes of these compounds in air.  DDT, DDE, and DDD can be adsorbed on particulate 
matter, where they are not expected to undergo rapid photooxidation, and therefore, may be subject to 
long-range transport.  Indeed, long-range transport through the atmosphere has been demonstrated for 
DDT and several of its metabolites (Bard 1999; Bidleman et al. 1992; Goldberg 1975; Ottar 1981; Wania 
and MacKay 1993).  The work of Bidleman (1988) suggests that 50% of DDT in the atmosphere is 
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adsorbed to particulate matter.  Further, when atmospheric sampling of pesticides was performed at nine 
localities in the United States during a time of high DDT usage, DDT was mostly present in the 
particulate phase (Stanley et al. 1971). 
 
Water.    DDT, DDE, and DDD present in water may be transformed by both photodegradation and 
biodegradation.  Since the shorter wave radiation does not penetrate far into a body of water, photolysis 
primarily occurs in surface water and is dependent on the clarity of the water.  Direct photolysis of DDT 
and DDD are very slow in aquatic systems, with estimated half-lives of >150 years (EPA 1979).  Direct 
photolysis of DDE will vary as a function of photoperiod and brightness, resulting in different half-lives 
depending on the season and latitude.  Over the United States, the direct photolysis of DDE results in a 
half-life of about 1 day in summer and 6 days in winter.  DDE also undergoes photoisomerization when 
exposed to sunlight.  Photolysis of DDE photoisomers is slower by at least one order of magnitude 
compared to DDE.  Studies with DDT at shorter wavelengths suggest that the initial reaction results in the 
dissociation of the Cl2C–Cl bond.  Some information exists on the indirect photolysis of DDT; no 
information on the indirect photolysis of DDE or DDD was located (Coulston 1985; EPA 1979; Zepp et 
al. 1977). 
  
Photo-induced 1,2 addition of DDT to a model lipid, methyl oleate, indicates that light-induced additions 
of DDT to unsaturated fatty acids of plant waxes and cutins may occur on a large scale (Schwack 1988). 
 
DDT undergoes hydrolysis by a base-catalyzed reaction resulting in a half-life of 81 days at pH 9.  The 
product formed in the hydrolysis is DDE.  Hydrolysis of DDE and DDD is not a significant fate process 
(EPA 1979). 
 
Biodegradation of DDT in water is reported to be a minor mechanism of transformation (Johnsen 1976).  
Biodegradation of DDE and DDD in the aquatic environment is slower than that of DDT (EPA 1979). 
 
Sediment and Soil.    Four mechanisms have been suggested to account for most losses of DDT 
residues from soils:  volatilization, removal by harvest (e.g., plants that have absorbed the residue), water 
runoff, and chemical transformation (Fishbein 1973).  Three of these are transport processes, and the 
fourth, chemical transformation, may occur by abiotic and biotic processes.  Photooxidation of DDT and 
DDE is known to occur on soil surfaces or when adsorbed to sediment (Baker and Applegate 1970; 
Lichtenstein and Schultz 1959; Miller and Zepp 1979).  The conversion of DDT to DDE in soil was 
enhanced by exposure to sunlight in a 90-day experiment with 91% of the initial concentration of DDT 
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remaining in the soil for an unexposed dark control and 65% remaining for the sample exposed to light 
(Racke et al. 1997).  However, UV-irradiation of 14C-p,p’-DDT on soil for 10 hours mineralized <0.1% of 
the initial amount (Vollner and Klotz 1994).  (Mineralization is the complete degradation of a chemical, 
generally to carbon dioxide and water for an organic chemical containing carbon, hydrogen, and oxygen.)  
The amount of DDT that may have been converted to DDE was not reported.  Biodegradation may occur 
under both aerobic and anaerobic conditions due to soil microorganisms including bacteria, fungi, and 
algae (Arisoy 1998; EPA 1979; Lichtenstein and Schulz 1959; Menzie 1980; Stewart and Chisholm 1971; 
Verma and Pillai 1991b).  Since biodegradation studies generally focus on the loss of the parent 
compound rather than complete degradation or mineralization, and since DDT initially biodegrades to 
DDD or DDE, there still may be dangerous compounds remaining after almost all of the DDT that was 
originally present has biodegraded.   
 
During biodegradation of DDT, both DDE and DDD are formed in soils.  Both metabolites may undergo 
further transformation, but the extent and rate are dependent on soil conditions and, possibly, microbial 
populations present in soil.  The degradation pathways of DDT under aerobic and anaerobic conditions 
have been reviewed by Zook and Feng (1999) and Aislabie et al. (1997).  Ligninolytic or lignin-degrading 
fungi have been shown to possess the biodegradative capabilities for metabolizing a large variety of 
persistent compounds, including DDT.  Mineralization of DDT and DDE was even observed in laboratory 
experiments using a member of this group of fungi, Phanerochaete chrysosporium (a white rot fungus) 
(Aislabie et al. 1997; Singh et al. 1999).  Other soil microorganisms, such as Aerobacter aerogenes, 
Pseudomonas fluorescens, E. coli, and Klebsiella pneumoniae, have also been shown to have the 
capability to degrade DDT under both aerobic and anaerobic conditions, forming 4-chlorobenzoic acid 
and DDE, respectively (Singh et al. 1999).  Biodegradation of DDT and its metabolites involves co-
metabolism, a process in which the microbes derive nutrients for growth and energy from sources other 
than the compound of concern.  DDE, the dominant DDT metabolite found, is often resistant to 
biodegradation under aerobic and anaerobic conditions (Strompl and Thiele 1997).  In laboratory 
experiments with marine sediments, DDT has been shown to degrade to DDE and DDD under anaerobic 
conditions (Kale et al. 1999).  In these same experiments, it was shown that extensive degradation of 
DDT occurred in clams, converting DDT to DDMU.  Laboratory experiments in marine sediment showed 
that DDE is dechlorinated to DDMU (1-chloro-2,2-bis[p-chlorophenyl]ethylene) under methanogenic or 
sulfidogenic conditions (Quensen et al. 2001).  The rate of DDE dechlorination to DDMU was found to 
be dependent on the presence of sulfate and temperature (Quensen et al. 2001).  DDD is also converted to 
DDMU, but at a much slower rate.  DDMU degrades further under anaerobic conditions to 2,2-bis(chloro-
phenyl)acetonitrile (DDNU) and other subsequent degradation species, such as 2,2-bis(chlorophenyl)
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ethanol (DDOH) and 2,2-bis(chlorophenyl)acetic acid (DDA), through chemical action (Heberer and 
Dünnbier 1999; Ware et al. 1980).  No evidence was found that methylsulfonyl metabolites of DDT are 
formed as a result of microbial metabolism.  The rate at which DDT is converted to DDD in flooded soils 
is dependent on the organic content of the soil (Racke et al. 1997).  In a laboratory study, Hitch and Day 
(1992) found that soils with a low metal content (e.g., Al, Ba, Cd, Co, Cr, Fe, and K were the major 
metals examined) degrade DDT to DDE much more slowly than do soils with high metal content.   
 
As mentioned earlier, the half-life represents the estimated time for the initial disappearance of 50% of 
the compound in question and does not necessarily imply that first-order kinetics were observed 
throughout the experiment unless otherwise noted.  In the case of DDT, the disappearance rate slows 
considerably so that after the initial concentration is reduced by half, the time required for the loss of half 
of that which remains is substantially longer.  This is largely because much of the initial loss of 
compound is due to volatilization, rather than biodegradation.  However, the biodegradation rate also 
slows in time.  This is because DDT migrates into micropores in soil particles where it becomes 
sequestered and unavailable to soil microorganisms (Alexander 1995, 1997).  In addition, the 
disappearance of DDT is often reported as the disappearance of ΣDDT residues, and therefore, the 
reported rate of loss is a summation of the component DDT-related chemicals.  DDT breaks down into 
DDE and DDD in soil, and the parent-to-metabolite ratio (DDT to DDE or DDD) decreases with time.  
However, this ratio may vary considerably with soil type.  In a 1995–1996 study of agricultural soils in 
the corn belt of the central United States, the ratio of p,p’-DDT/p,p’-DDE varied from 0.5 to 6.6 with 
three-quarters of the soils having ratios above 1 (Aigner et al. 1998).  In a study of forest soils in Maine, 
the half-life for the disappearance of DDT residues was noted to be 20–30 years (Dimond and Owen 
1996).  DDT was much more persistent in muck soils than in dry forest soils.  A study of DDT in 
agricultural soils in British Colombia, Canada reported that over a 19-year period, there was a 70% 
reduction of DDT in muck soils and a virtual disappearance of DDT from loamy sand soils (Aigner et al. 
1998).   
 
Land management practices also affect the persistence of DDT.  In 1971, an experiment was conducted in 
a field containing high amounts of DDT to evaluate the effect of various management tools in the 
disappearance of the insecticide (Spencer et al. 1996).  The site was revisited in 1994 to determine the 
residual concentrations of DDT and its metabolites and to measure volatilization fluxes.  Concentrations 
of DDT were reduced in all plots and the major residue was p,p’-DDE.  The highest concentrations of 
residues were found in deep plowed and unflooded plots.  Deep plowing places the DDT deeper into the 
soil profile, possibly reducing volatilization.  As was noted in Section 5.4.1, the volatilization rate of DDT 
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is enhanced by flooding the soil (Samuel and Pillai 1989).  Under flooded, reducing conditions, DDD was 
a more common degradation product of DDT than DDE.  Significant concentrations of both o,p’- and 
p,p’-DDE and p,p’-DDT were detected in the atmosphere over the plots.  Irrigating the soil dramatically 
increased the volatilization flux of all DDT analogues, especially p,p’-DDE.  This is probably related to 
the amount of DDT in the soil solution.  Volatilization, air transport, and redeposition were found to be 
the main avenues of contaminating forage eaten by cows.  In microcosm experiments, Boul (1996) found 
that increasing soil water content enhanced DDT loss from generally aerobic soil.  His results suggested 
that increased biodegradation contributed to these effects.  Boul et al. (1994) analyzed DDT residues in 
pasture soil as they were affected by long-term irrigation and superphosphate fertilizer application.  They 
found that ΣDDT residues in irrigated soil were about 40% that of unirrigated soil.  The predominant 
residue was p,p’-DDE, and these residues were much higher in unirrigated than in irrigated soil.  
p,p’-DDE is lost at a lower rate than p,p’-DDT.  p,p’-DDD residues were very low in both irrigated and 
unirrigated soil, indicating that loss of p,p’-DDD must occur at a rate at least as great as it is generated 
from p,p’-DDT.  Superphosphate treatment, which is known to increase microbial biomass, also resulted 
in lower levels of p,p’-DDT and ΣDDT than in unfertilized controls.  The distribution of ΣDDT with 
depth suggests that irrigation did not cause increased leaching of the insecticide. 
 
A set of experiments was conducted during 1982–1987 and 1989–1993 in 14 countries under the auspices 
of the International Atomic Energy Agency (IAEA) on the dissipation of 14C-DDT from soil under field 
conditions in tropical and subtropical areas (Racke et al. 1997).  After 12 months, the quantity of DDT 
and metabolites remaining in soil at tropical sites ranged from 5% of applied in Tanzania to 15% in 
Indonesia.  The half-life of ΣDDT ranged from 22 days in Sudan to 365 days in China.  One exception 
was in an extremely acidic soil (pH 4.5) in Brazil in which the half-life was >672 days.  The conclusion 
of the study was that DDT dissipated much more rapidly under tropical conditions than under temperate 
conditions.  The major mechanisms of dissipation under tropical conditions were volatilization, biological 
and chemical degradation, and to a lesser extent, adsorption.  Comparable half-lives in temperate regions 
that have been reported range from 837 to 6,087 days (Lichtenstein and Schulz 1959; Racke et al. 1997; 
Stewart and Chisholm 1971).  One investigator concluded that the mean lifetime of DDT in temperate 
U.S. soils was about 5.3 years (Racke et al. 1997).  The primary metabolite detected in tropical soil was 
DDE.  With the exception of highly acidic soil from Brazil, the half-lives for DDE ranged from 151 to 
271 days, much less than the >20 years reported for DDE in temperate areas.  The increased dissipation of 
DDT in the tropics compared with that in temperate zones is believed to be largely due to increased 
volatility under tropical conditions (Racke et al. 1997). 
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5.5   LEVELS IN THE ENVIRONMENT  
 
Reliable evaluation of the potential for human exposure to DDT, DDE, and DDD depends, in part, on the 
reliability of supporting analytical data from environmental samples and biological specimens.  
Concentrations of DDT, DDE, and DDD in unpolluted atmospheres and in pristine surface waters are 
often so low as to be near the limits of current analytical methods.  In reviewing data on DDT, DDE, and 
DDD levels monitored or estimated in the environment, it should also be noted that the amount of 
chemical identified analytically is not necessarily equivalent to the amount that is bioavailable. 
 
Table 5-1 shows the lowest limit of detections that are achieved by analytical analysis in environmental 
media.  An overview summary of the range of concentrations detected in environmental media is 
presented in Table 5-2. 
 
Table 5-1.  Lowest Limit of Detection Based on Standardsa 
 
Media Detection limit Reference 
Air 0.16 ng/m3 Bidleman et al. 1978 
Drinking water 0.012 μg/L EPA 2017 
Surface water and groundwater 0.012 μg/L EPA 2017 
Soil 0.0036 μg/kg EPA 1998 
Sediment 0.0036 μg/kg EPA 1998 
Serum 1.4 ng/g (lipid)  CDC 2018 
Human milk ~0.5 ng/g (lipid) Van den Berg et al. 2016 
 
aDetection list based on using appropriate preparation and analytics; National Health and Nutrition Examination 
Survey (NHANES) data. 
 
Table 5-2.  Summary of Environmental Levels of DDT, DDE, and DDD 
 
Media Low High Reference 
Outdoor air (μg/m3) 0.001 8.5 WHO 2004 
Surface water (μg /L) 0.01 0.84 WHO 2004 
Drinking water (μg//L) – 3  EPA 2008 
 
Detections of DDT, DDE, and DDD in air, water, and soil at NPL sites are summarized in Table 5-3.   
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Table 5-3.  DDT, DDE, and DDD Levels in Water, Soil, and Air of National Priorities 
List (NPL) Sites 
 
Medium Mediana 
Geometric 
meana 
Geometric 
standard 
deviationa 
Number of 
quantitative 
measurements NPL sites 
p,p’-DDT 
Water (ppm) 4.80x10-4 7.76x10-4 34.4 42 31 
Soil (ppm) 11 11.3 79.7 208 120 
Air (mg/m3) 1.95x10-5 9.59x10-5 46.5 13 7 
o,p’-DDT 
Water (ppm) No data 
Soil (ppm) 15.0 35.9 5.97 3 2 
Air (mg/m3) No data 
p,p’-DDE 
Water (ppm) 1.95x10-4 2.84x10-4 11.7 30 22 
Soil (ppm) 1.17 1.67 51.7 127 82 
Air (mg/m3) 1.50x10-6 1.21x10-5 38.3 7 5 
o,p’-DDE 
Water (ppm) 0.365 0.295 2.60 2 1 
Soil (ppm) 30.0 27.9 1.72 2 1 
Air (mg/m3) No data 
p,p’-DDD 
Water (ppm) 3.09x10-4 4.38x10-4 23.2 34 25 
Soil (ppm) 3.30 3.22 81.4 102 67 
Air (mg/m3) 3.50x10-5 8.49x10-5 52.0 5 4 
o,p’-DDD 
Water (ppm) 2.80 2.36 2.33 2 1 
Soil (ppm) 136 61.3 25.0 4 3 
Air (mg/m3) No data 
 
aConcentrations found in ATSDR site documents from 1981 to 2015 for 1,854 NPL sites (ATSDR 2017).  Maximum 
concentrations were abstracted for types of environmental media for which exposure is likely.   
 
5.5.1   Air  
 
DDT is transported long distances from source areas to the Arctic and Antarctic.  Mean ΣDDT levels in 
air over a period of 17 weeks at Signy Island, Antarctica in 1992 and over the ocean separating New 
Zealand and Ross Island, Antarctica between January and March 1990 were 0.07–0.40 and 0.81 pg/m3, 
respectively (Bidleman et al. 1993; Kallenborn et al. 1998).  The concentration declined with increasing 
latitudes.   
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Ten samples taken over the Gulf of Mexico in 1977 contained an average of 34 pg/m3 of DDT, with a 
range of 10–78 pg/m3 (Bidleman et al. 1981).  Iwata et al. (1993) collected and analyzed 71 samples of air 
over several oceans (18 sampling locations) from April 1989 to August 1990.  The range of mean and 
maximum concentrations of DDTs were (substance, range of means, maximum concentration):  
p,p’-DDE, 0.3–180 pg/m3, 180 pg/m3; o,p’-DDT, 0.3–180 pg/m3, 420 pg/m3; p,p’-DDT, 1.2–220 pg/m3, 
590 pg/m3; and ΣDDT, 2.4–580 pg/m3, 1,000 pg/m3.  The highest concentrations of DDT were found at 
locations near areas where DDT is still used, such as the Arabian Sea off the west coast of India.  Other 
locations with high air concentrations of DDT were the Strait of Malacca, South China Sea, and the Gulf 
of Mexico.  p,p’-DDT concentrations obtained from monthly air samples collected from Saginaw Bay, 
Sault Ste. Marie, and Traverse City, Michigan between November 1990 and October 1991 were below the 
detection limit during most of the winter months at Saginaw and Traverse City, and were above the 
detection limit at Sault Ste. Marie only in March, May, July, and August (Monosmith and Hermanson 
1996).  The highest monthly p,p’-DDT concentrations were 35 pg/m3 in Saginaw (August), 31 pg/m3 in 
Sault Ste. Marie (May), and 21 pg/m3 in Traverse City (July).  The corresponding highs for p,p’-DDE 
were 63 pg/m3 (August), 119 pg/m3 (May), and 92 pg/m3 (July).  An analysis of the results suggests that 
higher DDT and DDE levels correlated with air mass movement from the south, perhaps from areas 
where DDT is still used (i.e., Central America or Mexico).  The fact that the ratio of DDT to DDE was 
<1 in each instance suggests that there is no new DDT use in Michigan.  DDT and DDE levels over Green 
Bay, Wisconsin in 1989 were 8.7 and 15 pg/m3, and those over the four lower Great Lakes obtained 
during a cruise were 38 and 59 pg/m3 (McConnell et al. 1998).  An analysis of air masses indicated that 
the atmospheric sources were not long-range transport, but rather local or regional volatilization. 
 
Stanley et al. (1971) measured atmospheric levels of pesticides in the United States during a time of high 
DDT usage.  Nine localities were sampled representing both urban and agricultural areas.  Of 
12 pesticides evaluated, only DDT was detected at all localities.  Maximum levels of p,p’-DDT ranged 
from 2.7 ng/m3 in Iowa City, Iowa to 1,560 ng/m3 in Orlando Florida.  Maximum levels of o,p’-DDT and 
p,p’-DDE ranged from 2.4 to 131 ng/m3.  The highest levels were found in the agricultural areas of the 
South.  The pesticides were predominantly detected in the particulate phase.  Some agricultural areas in 
which DDT was extensively used have been monitored periodically since usage was halted.  Atmospheric 
conditions in the Mississippi Delta were monitored intermittently from 1972 to 1975 (Arthur et al. 1977).  
Air samples taken in 1975 from an area with extensive cotton acreage had a mean ΣDDT concentration of 
7.5 ng/m3, compared to 11.9 ng/m3 in 1974.  This represents a 36% decline in ΣDDT levels in 1 year.  
Between 1972 and 1974, the first 2 years after the use of DDT was banned, the atmospheric ΣDDT levels 
had declined by 88%.  In 3 years, the decrease in ΣDDT air levels was 92%, representing a much more 
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rapid decline than had been expected.  In a comparison of the results from a 1995 study of the occurrence 
and temporal distribution of pesticides in Mississippi with the results obtained in 1967, a decline in the 
concentration of p,p’-DDE in air over agricultural lands was also noted (Coupe et al. 2000).  
Concentrations of p,p’-DDE in air were lower in the 1995 measurements, ranging from 0.13 to 1.1 ng/m3, 
as compared to a range of 2.6–7.1 ng/m3 obtained in 1967.  However, these results also attest to the 
persistence of p,p’-DDT degradation products after >2 decades since the ban on DDT use in the United 
States (Coupe et al. 2000). 
p,p’-DDT, p,p’-DDE, and p,p’-DDD have all been detected in the dissolved and particulate phases of 
fogwater and air and in rainwater (Millet et al. 1997).  Fogwater samples were 1.5–30 times higher in 
DDT, DDE, and DDD concentration than rainwater samples, and the distribution between dissolved and 
particulate phase appeared to be governed by the solubility of the chemical.  The site of the measurements 
was a rural area in France between 1991 and 1993.  DDT had not been used in the area since the 1970s.  
Ligocki et al. (1985) conducted concurrent rain and air sampling for rain events in Portland, Oregon, in 
1984.  In rain samples, no p,p’-DDT, p,p’-DDE, or p,p’-DDD were detected.  However, in the gas phase 
associated with this rainfall, p,p’-DDE was detected in five of seven samples.  Levels detected in the 
samples ranged from nondetected to 420 pg/m3.  In another study, Poissant et al. (1997) reported the mean 
concentration of p,p’-DDT in precipitation over a rural site near the St. Lawrence river was 500 pg/L with 
a 75% frequency of detection.  Rapaport et al. (1985) measured DDT residues in rain and snow samples 
in Minnesota.  Samples of snow taken in 1981–1982, 1982–1983, and 1983–1984 contained an average of 
0.32, 0.60, and 0.18 ng/L of p,p’-DDT, respectively.  Two rain samples taken in 1983 contained 0.2 and 
0.3 ng/L of p,p’-DDT.  In rainwater samples taken from a forested region in northeast Bavaria in 1999, 
p,p’-DDT and p,p’-DDE were detected in three of six and four of six rainwater samples, respectively, 
ranging in concentration from not detected to 12.9 ng/L and not detected to 13.3 ng/L, respectively.  In 
the vapour phase, p,p’-DDT and p,p’-DDE were detected in two of five and three of five air samples, 
respectively, ranging in concentration from not detected to 0.03 ng/m3 and from not detected to 
0.055 ng/m3, respectively (Streck and Herrmann 2000). 
5.5.2   Water 
ΣDDT levels were measure in surface water of the Lauritzen Channel on the east side of San Francisco 
Bay in Richmond, California (EPA 2014).  As a result of activities of the former United Heckathorn 
facility where organochlorine pesticides had previously been produced and shipped, this waterway was 
affected by releases from this plant.  Waterway traffic continuously re-suspends DDT from the sediment 
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column to the surface water in this area.  Sampling conducted in 2012–2013 showed porewater levels 
ranging from about 10 to >1,000 ng/L and surface water levels in the range of approximately 0.1–10 ng/L 
(EPA 2014).   
Although there are numerous reports in the literature of DDT levels in specific bodies of water throughout 
the United States, there is little information providing evidence of trends in the DDT levels over time.  
EPA operates STORET (STOrage and RETrieval), a computerized water quality database.  Staples et al. 
(1985) reported limited data on priority pollutants from STORET.  Information from data collected from 
1980 to 1983 indicated that 3,500–5,700 ambient water samples were analyzed for DDT, DDE, and DDD 
with approximately 45% of the samples containing one of these compounds.  The median level reported 
for both DDT and DDE was 0.001 μg/L, while the median level reported for DDD was 0.000 μg/L.  
Approximately 50 samples of industrial effluents were sampled and showed median levels of 0.010 μg/L 
for all three compounds.  DDT, DDE, and DDD were infrequently detected in 1,092 water samples 
collected from January 1, 2015 to January 1, 2017 in STORET (WQP 2017).  Maximum levels of 
0.005 μg/L were reported for DDT in samples collected in California.  DDT was monitored in surface 
water and sediment as part of the National Surface Water Monitoring Program in 1976–1980.  The 
percent occurrence and maximum concentrations of the reported DDT-related compounds in surface 
water were:  p,p’-DDT, 0.5%, 0.70 μg/L (ppb); o,p’-DDT, 0.1%, 0.42 μg/L; p,p’-DDE, 0.7%, 0.55 μg/L; 
and o,p’-DDE, 0.3%, 0.54 μg/L (Carey and Kutz 1985).  The USGS and EPA cooperatively monitored 
levels of pesticides in water and sediment at Pesticide Monitoring Network stations between 1975 and 
1980 (Gilliom 1984).  Of the 177 stations (approximately 2,700 samples) monitored, 2.8, 0.6, and 4.0% 
contained detectible levels of DDT, DDE, and DDD in water, respectively.  Fewer than 0.4% of the 
samples contained detectable DDT-related residues.  The levels detected in water were not reported, but 
the limit of detection was 0.05 μg/L for DDT and DDD, and 0.3 μg/L for DDE.  The percentage of sites 
having detectable levels of DDT-related residues in sediment was much higher (see Section 5.5.3). 
Johnson et al. (1988) reported DDT and metabolite levels in the Yakima River basin in Washington State.  
Use of DDT was halted in this area when the 1972 ban was initiated; however, considerable residues are 
present in the river and sediments.  Whole unfiltered water samples, collected mainly from the tributaries 
between May and October 1985, were reported to contain between not detectable to 0.06 μg/L of DDT-
related compounds.  Concentrations of p,p’-DDT in water equaled or exceeded those of p,p’-DDE; an 
unexpected finding in light of what is believed concerning biological half-lives of DDT and its normal 
environmental degradation (Singh et al. 1999; Wolfe and Seiber 1993).  The authors have suggested an 
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unusually long half-life for DDT in Yakima basin soils, which would enter the river through runoff to 
explain the higher than expected p,p’-DDT/p,p’-DDE ratios. 
 
In the Malheur watershed, DDT was found to be persistent in the watershed, with estimated 
concentrations for ΣDDT ranging from 0.13–0.34 ng/L in rural regions of the watershed to 3.0–4.7 ng/L 
in urbanized areas of the Malheur River near Ontario, Oregon (Anderson and Johnson 2001).  Unlike the 
relative concentrations of DDT and DDE in the Yakima River, the concentrations of DDE in water 
samples were higher than those measured for DDT (ranges of 0.03–0.25 and 0.07–0.14 ng/L for DDE and 
DDT, respectively, in rural areas and 1.9–4.3 and 0.25–0.61 ng/L near Ontario, respectively), indicating 
that although DDT was still persistent in this watershed, it was undergoing the expected environmental 
degradation.  
 
A summary of pesticide levels in surface waters of the United States during 1967 and 1968 was reported 
by Lichtenberg et al. (1970).  During these 2 years (which were prior to the ban of DDT use), a total of 
224 samples (unfiltered) were analyzed from various sites in all regions of the country.  DDT was found 
in 27 samples at levels ranging from 0.005 to 0.316 μg/L; DDE was found in 3 samples at levels of 0.02–
0.05 μg/L; and DDD was found in 6 samples at levels of 0.015–0.840 μg/L. 
 
According to the USGS National Water Quality Assessment Plan initiated in 1991, that focuses on the 
water quality in >50 major river basins and aquifer systems, the frequency of detection of DDT and its 
metabolites in streams and groundwater was very low (USGS 1999).  The top 15 pesticides found in 
water were those with high current use. 
 
Only a few studies report levels of DDT in drinking water.  Drinking water in Oahu, Hawaii, was found to 
contain p,p’-DDT at an average level of 0.001 μg/L in 1971 (Bevenue et al. 1972).  In a study of 
Maryland drinking water during the September 1995, p,p’-DDE was detected in 22 out of 394 (5.6%) 
water samples, ranging in concentration from 0.039 to 0.133 μg/L (MacIntosh et al. 1999).  
Concentrations of p,p’-DDT and p,p’-DDD could not be measured above their limits of detection of 
0.021 and 0.028 ppb, respectively.  Keith et al. (1979) reported that DDE was found in 2-month 
equivalent (the amount of water a person would theoretically consume over a 2-month period) samples 
collected over 2 days from two of three drinking water plants in New Orleans in 1974; the DDE 
concentration was 0.05 μg/L in both samples.   
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p,p’-DDE was monitored for in drinking water as part of EPA’s first Unregulated Contaminant 
Monitoring Rule (UCMR 1) program.  DDE was only detected one time at or above the MRL of 0.8 μg/L, 
in 33,797 drinking water samples collected from 3,874 public drinking water systems across the United 
States (EPA 2008).  p,p’-DDE was measured at 3 μg/L at a large groundwater based system; however, 
there were no detections of DDE at any small public water systems (serving <10,000 people).   
 
Iwata et al. (1993) collected and analyzed 68 samples of surface water from several oceans (18 sampling 
locations) mainly affected by atmospheric deposition from April 1989 to August 1990.  The range of 
mean and maximum concentrations of DDTs were (substance, range of means, maximum concentration): 
p,p’-DDE, 0.2–3.0 pg/L, 7.9 pg/L; o,p’-DDT, <0.1–5.8 pg/L, 14 pg/L; p,p’-DDT, 0.1–7.5 pg/L, 19 pg/L; 
and ΣDDT, 0.3–16 pg/L, 41 pg/L.  The highest concentrations of DDT-related compounds were in the 
East China Sea.  Other seas with high concentrations of DDT were the Bay of Bengal, Arabian Sea, and 
South China Sea. 
 
Canter and Sabatini (1994) reviewed Records of Decision at 450 Superfund Sites and found 49 cases in 
which contaminated groundwater threatened local public water supply wells.  However, chlorinated 
organic pesticides were not found to be a major class of contaminants in these cases.  In only one of the 
six sites in which the findings were presented in any detail was a DDT analogue found at detectable 
levels.  p,p’-DDD was found in monitoring wells from the upper aquifer at Pristine, Inc., an industrial site 
in Reading, Ohio at 0–0.14 μg/L but not in the lower aquifer or in water supply samples that were taken 
from the lower aquifer.  No p,p’-DDT, or p,p’-DDE was detected in groundwater samples.  Surface water 
samples contained levels of p,p’-DDE, p,p’-DDD, and p,p’-DDE at ranges of 0–0.86, 0–0.78, and 0–
1.82 μg/L, respectively.  Even at sites where the surficial soil concentrations of p,p’-DDT are extremely 
high (29–959 mg/kg), the concentration of p,p’-DDT and its metabolites, p,p’-DDE and p,p’-DDD, in 
groundwater were close to their detection limits (≤0.05 μg/L) (Vine et al. 2000).  p,p’-DDE was detected 
in monitoring wells (depth range of 20–110 feet) set up around orchards and row crop fields in the 
Columbia Basin Irrigation Project, but was not detected in shallow domestic wells (depth range of 80–
250 feet) that were within 100 feet of these agricultural sites (Jones and Roberts 1999). 
 
5.5.3   Sediment and Soil  
 
ΣDDT levels were measure in sediment of the Lauritzen Channel on the east side of San Francisco Bay in 
Richmond, California (EPA 2014).  This area is nearby the United Heckathorn Superfund Site where 
organochlorine pesticides had previously been produced and shipped.  Average concentrations of ΣDDT 
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ranged from 969 μg/kg on the eastern side of the channel to 32,401 μg/kg near the former plant location 
(EPA 2014).   
 
Gilliom (1984) presented results of pesticide monitoring in sediment at USGS/EPA Pesticide Monitoring 
Network stations between 1975 and 1980.  Of the 171 stations (approximately 900 samples) monitored, 
26, 42, and 31 contained detectible levels of DDT, DDE, and DDD, respectively.  Fewer than 17% of the 
samples contained detectable DDT-related residues (limit of detection was 0.5 μg/kg for DDT and DDD, 
and 3 μg/kg for DDE).  The percentage of sites with detectable levels of DDT-related residues in 
sediment was much higher than in water, reflecting the preferential partitioning of DDT to sediment.  
From 1980 to 1983, approximately 1,100 samples of sediments in EPA’s STORET database were 
analyzed for DDT, DDE, and DDD (Staples et al. 1985).  The median levels for DDT, DDE, and DDD 
were 0.1, 0.1, and 0.2 μg/kg dry weight, respectively.  In order to investigate circumstances contributing 
to the high level of DDT in fish and wildlife, soil and sediment samples (n=28) were collected in 1987 
from the Upper Steele Bayou Watershed in west-central Mississippi at two depths (2.54–7.62 cm and 
25.40–30.48 cm) (Ford and Hill 1991).  The results are provided below in Table 5-4. 
 
Table 5-4.  DDD, DDE, and DDT Levels in Sediment Obtained from the Upper 
Steele Bayou Watershed 
 
Compound Depth (cm) Percent detection Mean (μg/kg) Range (μg/kg) 
p,p’-DDD 2.54–7.62 86 40 ND–410 
p,p’-DDD 25.40–30.38 64 20 ND–390 
p,p’-DDE 2.54–7.62 93 100 ND–660 
p,p’-DDE 25.40–30.38 79 40 ND–560 
p,p’-DDT 2.54–7.62 79 30 ND–600 
p,p’-DDT 25.40–30.38 64 20 ND–860 
 
ND = not detected 
 
River bed sediment samples collected in 1985 from the Yakima River basin in Washington contained 0.1–
234 µg/kg (dry weight) of ΣDDT and its metabolites (Johnson et al. 1988).  Use of DDT was halted in 
this area in 1972 when the ban was initiated.  
 
The concentrations of DDE, DDD, DDT, and ΣDDT in bed sediment from the San Joaquin River and its 
tributaries in California (7 sites) in 1992 were 1.4–115, 0.7–14, 0.4–39, and 2.2–170 ng/L, respectively 
(Pereira et al. 1996).  One of the seven sites, Orestimba Creek, had DDT levels far higher than the other 
sites.  Land use along this creek was dominated by orchards and a variety of row crops.  Runoff that 
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occurs during winter storms and the irrigation season contributes significant amounts of DDT-ladened 
sediment into the San Joaquin River and its tributaries (Kratzer 1999).  For example, during the 1994 
irrigation season, it was estimated that approximately 136 g/day of ΣDDT entered the river and its 
tributaries from runoff, totaling around 5,190–8,920 g of ΣDDT for the season.  Additionally, winter 
storm runoff can input large amounts of DDT within sediments into these surface waters in short periods 
of time.  For example, a winter storm in January 1995 sent sediment-ladened runoff into the river and its 
tributaries, carrying upwards of 4,500 g/day of ΣDDT into these surface waters for a total contribution of 
1,750–2,620 g of ΣDDT from this one storm alone.   
 
Total DDT in surface sediment collected in eight remote lakes in Canada along a midcontinental transect 
from 49°N to 82°N declined significantly with latitude from 9.7 μg/kg (dry weight) to 0.10 μg/kg (Muir et 
al. 1995).  The pattern of DDT deposition in lake sediment in the continental United States is exemplified 
by that in White Rock Lake in Dallas.  Total DDT concentrations in the lake sediment increased from the 
mid-1940s to a maximum of 27 μg/kg in about 1965 when DDT usage peaked in the United States and 
have decreased by 93% to 2 μg/kg in the samples collected in 1994 (Van Metre and Callender 1997; Van 
Metre et al. 1997).  On the average, DDE accounted for 58% of the total DDT in the lake.  DDD levels 
were about half those of DDE.  The mean concentration of ΣDDT in sediment in the Newark Bay 
Estuary, New Jersey collected between February 1990 and March 1993 ranged from about 100 to 
300 μg/kg except for the Arthur Kill, where the mean concentrations exceeded 700 μg/kg (Gillis et al. 
1995).  These levels may pose a potential threat to aquatic organisms.  The maximum concentrations of 
p,p’-DDD, p,p’-DDE, and p,p’-DDT in sediment from 168 sites sampled along the southeastern coast of 
the United States as part of the Environmental Monitoring and Trends Program (EMAP) in 1994–1995 
were 150.9, 34.2, and 35.0 μg/kg, respectively (Hyland et al. 1998).  The median concentrations of these 
compounds were below the detection limit.  DDT was monitored in surface water and sediment as part of 
the National Surface Water Monitoring Program in 1976–1980.  The percent occurrence and maximum 
concentrations of the reported DDT analogues in sediments were:  p,p’-DDT, 13.2%, 110.6 μg/kg; 
o,p’-DDT, 2.9%, 7.2 μg/kg; p,p’-DDE, 22.7%, 163.0 μg/kg; and o,p’-DDE, 0.5%, 1.3 μg/kg (Carey and 
Kutz 1985).  Results were not presented for DDD.  In 1983–1984, quarterly samples of bottom sediment 
were taken from six sites on tributaries of the Tennessee River near Huntsville, Alabama, and were 
analyzed for ΣDDT (Webber et al. 1989).  From 1947 to 1970, DDT was manufactured along the 
tributary, and DDT-contaminated waste water was discharged into the river.  The concentration of ΣDDT 
in sediment above the discharge point averaged less than 1 mg/kg dry weight.  Remaining stations 
showed a decreasing gradient of ΣDDT with annual means ranging from 2,730 mg/kg at the closed site to 
the point of discharge to 12 mg/kg where the tributary empties into the Tennessee River 18 km away.   
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According to the USGS National Water Quality Assessment Plan initiated in 1991, which focuses on the 
water quality in >50 major river basins and aquifer systems, the frequency of detection of DDT and its 
metabolites in bed sediment in the 1990s remains high (USGS 1999).  The metabolite with the highest 
frequency of detection was p,p’-DDE which was approximately 60% in urban areas, 48% in agricultural 
areas, and 46% in mixed land use areas followed by p,p’-DDD, p,p’-DDT, o,p’-DDD, o,p’-DDT, and 
o,p’-DDE.  The frequency of detection of o,p’-DDT and o,p’-DDE was <5%.  Sediments can act as 
repositories for DDT and its metabolites, serving as sources for these compounds for long periods of time, 
given the long half-lives of these compounds and their resistance to biodegradation (Sanger et al. 1999).  
Because DDT and its metabolites will fractionate and concentrate in organic material, the sediments of 
some waterways, such as salt marshes, that receive a large amount of organic content in washloads 
discharged from sources of water originating from urban and agricultural areas can act as potential DDT 
repositories (Masters and Inman 2000).  Also, the concentrations of DDT and its metabolites are high 
enough in some sediments to exceed the threshold effects level (TEL), probable effects level (PEL), and 
the effects range low and median (ER-L, ER-M) for specific biota in marine and estuarine environments 
(Carr et al. 2000; Long et al. 1995).   
 
The mean ΣDDT level in five U.S. cities ranged from 120 to 560 μg/kg in 1971 (Carey et al. 1979a).  
Urban areas generally had higher pesticide levels than did nearby agricultural areas except in some 
southern cities near which the agricultural use of pesticides was traditionally heavy.  
 
DDT was heavily used in the corn belt in the mid-central United States.  In a 1995–1996 sampling of 
38 soils in this region, ΣDDT varied from below quantitation to 11,846 μg/kg, with a geometric mean 
value of 9.63 μg/kg (Aigner et al. 1998).  The geometric mean concentrations for p,p’-DDE, p,p’-DDT, 
p,p’-DDD, and o,p’-DDT were 3.75, 4.67, 1.20, and 1.79 μg/kg, respectively.  At least one DDT analogue 
was found in 33 of the soils.  Nine of the samples contained ΣDDT above 200 μg/kg, while the 
concentrations in the rest of the samples were below 40 μg/kg.  Two garden soils had ΣDDT levels of 
30 and 1.07 μg/kg.  The soil with the high ΣDDT level was a muck soil with a concentration that was 
10 times higher than the sample next highest in concentration and 1,000 times higher than most sample 
concentrations.  o,p’-DDD was not found in any of the samples.  The DDT/DDE ratio was determined in 
21 of the samples and ranged from 0.5 to 6.6.  It is interesting to note that the geometric mean o,p’-DDT 
concentration is 38% of the p,p’-DDT concentration.  Since o,p’-DDT comprises between 15 and 21% of 
technical-grade DDT and 5.5% is comprised of other compounds, it would appear that o,p’-DDT 
degrades more slowly than p,p’-DDT.  It was shown that the residue level of p,p’-DDT decreased about 
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70% in a silt loam in New Zealand over a 30-year period (1960–1989), while the o,p’-DDT level only 
decreased by about 50% in the same time frame (Boul et al. 1994).  Most of the degradation occurred 
during the time frame of 1960–1980, with very little loss occurring from 1980–1989.  Forest soils in 
Maine that had been subject to aerial spraying with DDT had ΣDDT levels ranging from 270 to 
1,898 μg/kg compared with a maximum concentration of 11 μg/kg in unsprayed locations.  A study of 
DDT in agricultural soils in British Colombia, Canada report that ΣDDT levels ranged from 194 to 
763 μg/kg in silt loam soils and from 2,984 to 7,162 μg/kg in muck soils (Aigner et al. 1998).  The 
difference in residue levels reflects DDT’s longer persistence in muck soil. 
 
Hitch and Day (1992) reported that three soil samples taken near Dell City, Texas in 1980 contained an 
average of 4.94 and 0.46 mg/kg (dry weight) of DDT and DDE, respectively.  It was suspected that the 
higher DDT concentrations indicated the possible illegal use of DDT.  However, further analysis 
indicated that the "suspect" soil degraded DDT much slower than most soils and the high levels originally 
detected in soil were attributed to DDT persistence for many years.  DDD was not measured in this study.  
DDT was extensively used in Arizona for 18 years, after which agricultural residues were closely 
monitored following a statewide moratorium on DDT use in January 1969.  Levels of DDT plus 
metabolites in green alfalfa fell steadily from an average level of 0.22 mg/kg at the time of the ban to a 
level of 0.057 mg/kg 18 months later, and a level of 0.027 mg/kg after almost 7 years (Ware et al. 1978).  
After 3 years, residues in agricultural soils had decreased 23%.  Furthermore, the ratio of DDE to DDT 
was increasing, indicating a transformation of DDT to DDE.  Buck et al. (1983) reported similar results 
from monitoring these same sites over 12 years following the ban on DDT use.  After 12 years, residues 
in green alfalfa averaged 0.020 mg/kg.  At the end of the same period, combined DDT and DDE residues 
in agricultural soils had fallen from 1.2 to 0.39 mg/kg, while those in surrounding desert soil had fallen 
from 0.40 to 0.09 mg/kg.   
 
In 1985, DDT, DDE, and DDD levels were measured at the Baird and McGuire Superfund Site in 
Holbrook, Massachusetts.  Contamination was due to 60 years of mixing and batching of insecticides.  In 
the highly contaminated areas, the average concentrations of DDT, DDE, and DDD were 61, 10, and 
70 mg/kg, respectively.  DDT, DDE, and DDD levels in leaf litter and leaf litter invertebrates ranged from 
0.2 to 8.4, from nondetected to 60, and from 0.4 to 25 mg/kg, respectively (Menzie et al. 1992).  The high 
levels of DDT relative to DDE probably indicate that the Superfund Site is largely anaerobic, and that 
DDT is largely degrading to DDD.  In the Palos Verdes Shelf off of Los Angeles where waste from a 
large DDT manufacturer was discharged via a sewer outfall, sediments contain high levels of DDT 
isomers and metabolites.  The levels of these compounds in surface sediment (0–2 cm) at five sites in the 
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area were (chemical, concentration range): o,p’-DDE, 6–45 mg/kg; p,p’-DDE, 10–327 mg/kg; p,p’-DDD, 
1–13 mg/kg; p,p’-DDD, 9–25 mg/kg; o,p’-DDT, not detectible–2 mg/kg; and p,p’-DDT, not detectible–
6 mg/kg (Venkatesan et al. 1996). 
 
In summary, DDT, DDE, and DDD have been detected in many soil and sediment surfaces throughout the 
world.  Concentrations are highest in areas with a history of extensive DDT use and are often detected at 
concentrations close to 1 mg/kg (ppm) or more.  Even though concentrations of DDT, DDE, and DDD in 
soils are declining due to the discontinued production and use of DDT in most countries, detectable levels 
will probably exist for decades to come because of the long persistence time of these compounds.  
 
5.5.4   Other Media  
 
According to the USGS National Water Quality Assessment Plan initiated in 1991, which focuses on the 
water quality in >50 major river basins and aquifer systems, DDT and its metabolites were detected in 
94% of whole fish samples analyzed in the 1990s even though the total DDT concentration in fish 
continues to decline (USGS 1999).  This is attributed to the presence of DDT in stream beds and 
continued inputs of DDT to streams as contaminated soils erode.  The metabolite with the highest 
frequency of detection was p,p’-DDE followed by p,p’-DDD, p,p’-DDT, o,p’-DDD, o,p’-DDE, and 
o,p’-DDT.  The frequency of detection of the o,p’- isomers was <15%. 
 
ΣDDT concentrations in fish (8 species, 23 samples) collected in August and September 1990 from 
3 rivers in Michigan ranged from 4.71 to 976.92 μmol/kg, wet weight with a median of 82.1 μmol/kg 
(Giesy et al. 1994).  The range of concentrations of DDT and metabolites were (chemical, range in μg/kg 
wet weight):  p,p’-DDE, 3.54–627.13; o,p’-DDE, 0.15–37.95; p,p’-DDD, 0.43–58.82; o,p’-DDD, 0.13–
81.70; and p,p’-DDT, <0.42–89.58.  The mean ΣDDT concentrations in samples taken below dams that 
separated the rivers from the Great Lakes, 0.5–1.6 μmol/kg, were higher than those taken above, 0.05–
0.35 μmol/kg.  The relative contribution of DDE to ΣDDT was fairly constant in all three rivers both 
above and below the dams.  The ratio of DDE:DDT ranged from 5 to 758, which suggests that the 
accumulation of DDE resulted from direct exposure to DDE in the diet rather than from recent exposure 
to parent DDT.  The fact that DDT is still observed in the fish was ascribed to long-range transport and 
deposition.   
 
From 1986 to 1988, elements of the arctic marine food web near the Canadian Ice Island in the Arctic 
Ocean were sampled for DDT, DDE, and DDD (Hargrave et al. 1992).  The average concentration of 
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ΣDDT in plankton was 11.8 ng/g dry weight (43.5 μg/kg lipid), and the level increased with decreasing 
size of the plankton.  Amphipods collected under pack ice in the open sea, over the Canadian continental 
shelf (190–315 m depth), and near the bottom of the Alpha Ridge (2,075 m depth), had mean ΣDDT 
concentrations of <57, 299, and 3,769 μg/kg dry weight (<347, 1,594, and 12,511 μg/kg lipid), 
respectively.  Pelagic fish contained a mean ΣDDT of 200 μg/kg lipid, while abyssal fish (2,075 m) 
contained 819 μg/kg dry weight (1,465 μg/kg lipid).  Similar comparisons have also been conducted on 
surface and deep-sea fish caught in the North and South Atlantic oceans and northwest Pacific ocean off 
California, showing higher concentrations of ΣDDT in deep-sea fish (Atlantic 175–1,090 μg/kg lipid; 
Pacific 2,380–2,420 μg/kg lipid) in comparison to surface fish (Atlantic 59–125 μg/kg lipid; Pacific 
1,260–1,875 μg/kg lipid) (Looser et al. 2000).  The DDT levels in Arctic plankton are generally lower 
than those reported elsewhere.  It is not clear why the DDT levels are higher in organisms living at greater 
depths since DDT appears to be evenly distributed in the water column.  Since DDT adsorbs to particulate 
matter that sinks into the sediment, as with detritus from aquatic organisms, fish and other organisms 
living at the bottom of the sea may accumulate higher levels of DDT than organisms living at the surface 
because their food chain is associated with benthic feeders.  Regional differences in DDT levels in biota 
may be associated with the productivity of the ocean and greater sedimentation of detritus from aquatic 
organisms.  Arctic mammals feeding on DDT-contaminated fish bioaccumulate the chemical in their fat 
(Bard 1999).  The ringed neck seal (n=19) and polar bear (n=10) had mean ΣDDT concentrations of 
1,482 and 266 μg/kg (lipid basis) (Muir et al. 1988).  Beluga whales, ringed neck seals, and walruses near 
Baffin Island in the eastern Arctic had mean ΣDDT levels (wet weight) of 3.16, 0.33, and 1.42 μg/g, 
respectively (Kuhnlein et al. 1995). 
 
A comparison of ΣDDT concentrations between farmed-raised salmon (from eight regions in Europe, 
North America, and South America) and wild Pacific salmon found significantly higher levels of total 
DDT in farm-raised salmon versus wild salmon (Huang et al. 2006).  A comparison of total DDT levels 
across regions demonstrated significantly higher levels in Europe compared to North America and in 
North America when compared to South America. 
 
Exposure to DDT could occur to populations that consume fish from DDT-contaminated marine 
environments.  DDT in white croaker and Dover sole of the Southern California Bight, especially the 
Palos Verdes shelf area, are the highest in the United States.  This is due to the fact that this area received 
1,000,000 kg of DDT discharged into the Bight from the Montrose Chemical Company and also receives 
a large amount of sewage outfall from the southern California region (Zeng et al. 1999).  Historically, 
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DDT levels in these fish exceeded the FDA action level of 5 mg/kg wet weight of fish tissue, and fish 
intended for human consumption were confiscated to prevent human exposure to DDT (NOAA 1988). 
 
Levels of ΣDDT have declined markedly since the early 1970s in fish, shellfish, and aquatic mammals 
(Addison and Stobo 2001; Bard 1999; Lauenstein 1995; Lieberg-Clark et al. 1995; Odsjo et al. 1997; 
Schmitt et al. 1990).  Levels of DDT in fish were determined at 112 locations across the United States by 
the National Contaminant Biomonitoring Program in 1976 and 1984 (Schmitt et al. 1990).  The mean 
concentrations of p,p’-DDT, p,p’-DDE, p,p’-DDD, and ΣDDT decreased from 50, 260, 80, and 
370 μg/kg, respectively, in 1976 to 30, 190, 60, and 260 μg/kg, respectively, in 1984.  A follow-up study 
of DDT in California sea lions reported a decrease in ΣDDT and DDE of over 2 orders of magnitude 
between 1970 and 1992 (Lieberg-Clark et al. 1995).  ΣDDT concentrations in maternal grey seals 
decreased from 12 μg/g lipid in 1974 to 0.5 μg/g lipid in 1994; ΣDDT concentrations in seal pups were 
lower (60% of maternal concentrations) and decreased at similar rates over the same 20-year period 
(Addison and Stobo 2001).  ΣDDT for mussels and oysters analyzed as part of the National Oceanic and 
Atmospheric Administration’s National Status and Trends Mussel Watch Project in 1992 reported a 
geometric mean ΣDDT concentration for mussels and oysters at 51 sites of 20 μg/kg dry weight, down 
from a high of 53 μg/kg in 1977 (Lauenstein 1995).  Over 90% of the ΣDDT present was as metabolites 
rather than the parent compounds (p,p’- and o,p’-DDT).   
 
Among the metabolites of DDT are two methylsulfonyl metabolites of DDE, 2-methylsulfonyl-DDE 
(2-MeSO2-DDE) and 3-methylsulfonyl-DDE (3-MeSO2-DDE).  These DDE metabolites are known to be 
persistent and have been measured in several species of mammals, including humans (Bergman et al. 
1994).  The methylsulfonyl derivatives of DDE are formed through the action of phase I and II enzymes 
in the liver and the mercapturic acid pathway (Letcher et al. 1998; Weistrand and Norén 1997).  DDE is 
converted to an arene oxide through the action of the phase I cytochrome (CYP) P450 2B-type enzymes, 
followed by the conjugation of the arene oxide with glutathione as part of the phase II reactions.  As part 
of the mercapturic acid pathway, the glutathione function is converted to a cysteine residue, which is then 
cleaved by C-S lyase to form the thiol-substituted intermediates, 2-SH-DDE or 3-SH-DDE.  These 
thiolated DDE derivatives are methylated by adenosyl-methionine and then oxidized to the methylsufonyl 
derivatives of DDE.  The ratio of 2-MeSO2-DDE to 3-MeSO2-DDE varies between species and tissue site 
(Bergman et al. 1994).   
 
The two sulfonyl DDE metabolites have been measured in fat and various tissues of arctic mammals and 
in humans (Bergman et al. 1994; Haraguchi et al. 1989; Letcher et al. 1998; Norén et al. 1996; 
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Weinstrand and Norén 1997).  In pooled adipose tissue of polar bears from 12 Arctic regions, the 
concentration of 3-MeSO2-DDE ranged from 0.60 to 11 μg/kg lipids, and the ratio of methylsulfone to 
DDE ranged from 0.009 to 0.056 with a mean of 0.033 (Letcher et al. 1995).  These ratios may be the 
result of both biotransformation of DDE to methylsulfonyl-DDE in the animal and bioaccumulation 
(Letcher et al. 1998).  In the polar bear food chain, lipid adjusted concentrations of 3-MeSO2-DDE in 
arctic cod (<0.01 ng/g, in whole body pools), ringed seal (0.4 ng/g, in blubber), and polar bear (2.0 ng/g, 
in fat tissue) were measured, showing an increase in the concentration of 3-MeSO2-DDE as a function of 
the trophic level (Letcher et al. 1998).  In humans, methylsulfonyl-DDE has been measured in liver, lung, 
and adipose tissue at respective concentrations of 1.1, 0.3, and 6.8 ppb, wet weight (Haraguchi et al. 
1989).  In plasma, the concentration of 3-MeSO2-DDE (0.1–2 ng/g lipid) was 2–3 orders of magnitude 
lower than the concentration of DDE (0.11–0.88 μg/g lipid) (Norén et al.1999).  In a comparison of the 
concentrations of the two methylsulfonyl-DDE isomers in paired human liver and adipose tissues, 
3-MeSO2-DDE is the most abundant of the two isomers in these tissues (Weistrand and Norén 1997).  In 
human breast milk, the concentration of 3-MeSO2-DDE has been found to range between 0.4 and 5 ng/g 
lipid (Norén et al. 1996). 
 
From 1979 to 1983, a study was conducted on the presence of DDT and metabolites in wildlife, 
predominantly birds, in orchards in central Washington State (Blus et al. 1987).  Technical DDT was 
applied at very high rates to orchards in Washington between 1946 and 1970 with some areas probably 
receiving more than 1,000 kg/ha over this period.  High levels of DDE, DDT, and DDD were found in the 
wildlife.  Ninety-six percent of the wildlife samples (n=552) contained >0.01 μg/g of DDE, and 70% 
contained levels >0.1 μg/g.  In addition, many samples contained unusually low (≤10:1) DDE:DDT ratios.  
The study attempted to identify whether the residues resulted from past legal use of DDT, ongoing illegal 
use, use of dicofol and related compounds, or foreign sources.  While this matter wasn’t completely 
resolved, it was suspected that residues were from several sources.  However, residues in certain samples, 
particularly resident wildlife, apparently originated from past legal use of the insecticide.  High 
concentrations have been noted in animals from areas of historically high DDT use.  Mean ΣDDT 
concentrations were 1,188 μg/kg in spring peeper frogs living in southern Ontario, Canada (Russell et al. 
1995).  These concentrations exceed the suggested maximum concentration of 1,000 μg/kg proposed by 
the Great Lakes Water Quality Agreement of 1978.  DDT was also applied at very high rates in the Delta 
region of Mississippi.  The geometric mean concentration of p,p’-DDE residues in resident wood ducks 
decreased from 0.75 mg/kg in 1984 to 0.21 mg/kg in 1988 (Ford and Hill 1990).  This decrease also 
corresponded with the reduction of residue levels in wood duck eggshells.  Studies reporting 
concentrations of DDT and its metabolites in various biota is shown in Table 5-5.  
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Table 5-5.  Concentrations of DDT and Metabolites in Biota 
 
Species Location Year Concentration Type Reference 
Marine Mammals 
Pilot whale (n=7) North Atlantic Since 1987 3,847 (942–7,118) ng/g (f.w.) [DDE] 
7,748 (1,708–13,035) ng/g (f.w.) [ΣDDT] 
Mean (range) Becker et al. 1997a 
Harbor Porpoise 
(n=5) 
North Atlantic Since 1987 3,260 (1,880–4,900) ng/g (f.w.) [DDE] 
7,280 (4,690–11,200) ng/g (f.w.) [ΣDDT] 
Mean (range) Becker et al. 1997a 
Beluga whale (n=12) Arctic Since 1987 1,415 (142–2,230) ng/g (f.w.) [DDE] 
2,492 (332–3,820) ng/g (f.w.) [ΣDDT] 
Mean (range) Becker et al. 1997a 
Beluga whale (n=12) Cook Inlet Since 1987 624 (65.9–1,630) ng/g (f.w.) [DDE] 
1,050 (133–2,350) ng/g (f.w.) [ΣDDT] 
Mean (range) Becker et al. 1997a 
Northern fur seal 
(n=2) 
North Pacific Since 1987 1,190 (1,050–1,330) ng/g (f.w.) [DDE] 
1,280 (1,090–1,480) ng/g (f.w.) [ΣDDT] 
Mean (range) Becker et al. 1997a 
Ringed seal (n=4) Arctic Since 1987 198 (27–350) ng/g (f.w.) [DDE] 
543 (35–1,430) ng/g (f.w.) [ΣDDT] 
Mean (range) Becker et al. 1997a 
Harbour seals (n=18) Northern Sea 1987 3,161 (355–6,598) μg/kg (f.w.) [ΣDDT] Mean (range) Vetter et al. 1996 
Harbour seals (n=32) Northern Sea 1988 3,903 (1,501–11,475) μg/kg (f.w.) [ΣDDT] Mean (range) Vetter et al. 1996 
Beluga whale Canadian 
Arctic 
1988 3.16 μg/g (w.w.) [ΣDDT] Mean Kuhnlein et al. 1995 
Narwhal whale 
(n=unspecified) 
Canadian 
Arctic 
1988 2.73 μg/g (w.w.) [ΣDDT] Mean Kuhnlein et al. 1995 
Walrus 
(n=unspecified) 
Canadian 
Arctic 
1988 1.42 μg/g (w.w.) [ΣDDT] Mean Kuhnlein et al. 1995 
Ringed seal 
(n=unspecified) 
Canadian 
Arctic 
1988 0.33 μg/g (w.w.) [ΣDDT] Mean Kuhnlein et al. 1995 
Beluga whale 
(neonate) (n=1) 
St. Lawrence 
estuary near 
Quebec 
1991 702 ng/g (brain); 2,332 ng/g (kidney); 3,467 ng/g 
(liver); 2,230 ng/g (fat) [ΣDDT]  
689 ng/g (brain); 2,289 ng/g (kidney); 3,370 ng/g 
(liver); 2,106 ng/g (fat) [DDE]  
ND (brain); ND (kidney); 15 ng/g (liver); 17 ng/g 
(fat) [DDD] 
 Gauthier et al. 1998 
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Table 5-5.  Concentrations of DDT and Metabolites in Biota 
 
Species Location Year Concentration Type Reference 
Terrestrial mammals 
Polar bear (n=320) Arctic (16 
regions) 
1989–1993 219 μg/kg (f.w.) [DDE] 
52–560 μg/kg (f.w.) [DDE] 
Median range 
of geomeans 
Norstrom et al. 1998 
Arctic ground squirrel 
(n=13) 
Elusive Lake 1991–1993 6.13 (0.34–34.08) μg/kg (w.w.) (liver) [ΣDDT] 
1.51 (0.33–5.57) μg/kg (w.w.) (liver) [DDE] 
Mean (range) Allen-Gil et al. 1997 
Arctic ground squirrel 
(n=6) 
Feniak Lake 1991–1992 1.43 (0.19–5.16) μg/kg (w.w.) (liver) [ΣDDT] 
0.86 (0.19–3.10) μg/kg (w.w.) (liver) [DDE] 
Mean (range) Allen-Gil et al. 1997 
Arctic ground squirrel 
(n=17) 
Schrader Lake 1992–1993 12.25 (0.12–39.76) μg/kg (w.w.) (liver) [ΣDDT] 
4.47 (0.12–13.63) μg/kg (w.w.) (liver) [DDE] 
Mean (range) Allen-Gil et al. 1997 
Birds 
Bald eagle chicks 
(n=51) 
Great Lakes 
region 
1990–1996 ND–0.0171 mg/kg (plasma) [DDT] 
0.0036–0.1484 mg/kg (plasma) [DDE] 
Range Donaldson et al. 1999 
Bald eagle eggs 
(n=6) 
Lake Erie 1974–1980 24.4 (13.8–35.8) mg/kg [DDE] Mean (range) Donaldson et al. 1999 
Bald eagle eggs 
(n=6) 
Lake Erie 1989–1994 10.8 (2.7–22.2) mg/kg [DDE] Mean (range) Donaldson et al. 1999 
Bald eagle eggs 
(n=7) 
Lake of the 
Woods, 
Canada 
1993–1996 3.3 (0.9–12.6) mg/kg [DDE] Mean (range) Donaldson et al. 1999 
Blue heron eggs 
(n=10) 
Southern Lake 
Michigan 
1993 0.02 (ND–0.12) (μg/g) (w.w.) [DDT] 
1.58 (0.23–13.00) (μg/g) (w.w.) [DDE] 
0.03 (ND–0.12) (μg/g) (w.w.) [DDD] 
Mean (range) Custer et al. 1998 
Fish and shellfish 
Mussels and oysters United States 
(51 sites) 
1992 0.51–1,400 ng/g (d.w.) [ΣDDT] 
20 ng/g (d.w.) [ΣDDT] 
Range of sites 
geomean 
Lauenstein 1995 
Clams San Joaquin 
River 
(Orestimba 
Creek) 
1992 4,350 ng/g (w.w.) [ΣDDT] 
3,300 ng/g (w.w.) [DDE] 
390 ng/g (w.w.) [DDD] 
Mean Pereira et al. 1996 
Clams San Joaquin 
River (Dry 
Creek) 
1992 29 ng/g (w.w.) [ΣDDT] 
25 ng/g (w.w.) [DDE] 
0.5 ng/g (w.w.) [DDD] 
Mean Pereira et al. 1996 
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Table 5-5.  Concentrations of DDT and Metabolites in Biota 
 
Species Location Year Concentration Type Reference 
Clams San Joaquin 
River 
(Mokelumne 
River) 
1992 15 ng/g (w.w.) [ΣDDT] 
13 ng/g (w.w.) [DDE] 
0.5 ng/g (w.w.) [DDD] 
Mean Pereira et al. 1996 
Clams San Joaquin 
River 
(Stanislaus 
River) 
1992 24 ng/g (w.w.) [ΣDDT] 
22 ng/g (w.w.) [DDE] 
<0.5 ng/g (w.w.) [DDD] 
Mean Pereira et al. 1996 
Mountain whitefish 
(10 composites from 
7 sites) 
Yakima River 
Basin, 
Washington 
1989–1991 0.10–1.7 mg/kg (w.w.) (whole fish) [ΣDDT] Range of 
composites 
Marien and Laflamme 
1995 
Largescale sucker 
(18 composites from 
13 sites) 
Yakima River 
Basin, 
Washington 
1989–1991 0.05–4.37 mg/kg (w.w.) (whole fish) [ΣDDT] Range of 
composites 
Marien and Laflamme 
1995 
Perch (n=5) Lake Ørsjøen, 
Norway Mid-
lake 
1994 1.15 ng/g (w.w.), 1,643 ng/g (f.w.) [ΣDDT] 
0.53 ng/g (w.w.), 757 ng/g (f.w.) [DDE] 
0.26 ng/g (w.w.), 371 ng/g (f.w.) [DDD] 
0.28 ng/g (w.w.), 400 ng/g (f.w.) [DDT] 
Mean Brevik et al. 1996 
Perch (n=5) Lake Ørsjøen, 
Norway 
1994 5.59 ng/g (w.w.), 11,180 ng/g (f.w.) [ΣDDT]  
2.56 ng/g (w.w.), 5,120 ng/g (f.w.) [DDE] 
1.48 ng/g (w.w.), 2,960 ng/g (f.w.) [DDD] 
1.15 ng/g (w.w.), 2,300 ng/g (f.w.) [DDT] 
Mean Brevik et al. 1996 
Perch (n=5) Lake Ørsjøen, 
Norway Mid-
lake 
1994 7.3 ng/g (w.w.), 8,111 ng/g (f.w.) [ΣDDT]  
3.5 ng/g (w.w.), 3,888 ng/g (f.w.) [DDE] 
1.5 ng/g (w.w.), 1,667 ng/g (f.w.) [DDD] 
1.8 ng/g (w.w.), 2,000 ng/g (f.w.) [DDT] 
Mean Brevik et al. 1996 
Lake trout (n=59) Lake Ontario 1992 1.159 μg/g (w.w.) [DDE] Mean Kiriluk et al. 1995 
Rainbow smelt (n=8) Lake Ontario 1992 0.256 μg/g (w.w.) [DDE] Mean Kiriluk et al. 1995 
 
aU.S. National Biomonitoring Specimen Bank 
 
d.w. = dry weight; f.w. = fat weight basis; n = number; ND = not detected; geomean = geometric mean; w.w.= wet weight 
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Even with the reduction in the levels of DDT in the environment, there are still areas of concern where 
heavy applications of DDT during past legal uses of the pesticide have resulted in high concentrations of 
residual DDT and its metabolites that can, in turn, have potentially adverse effects on wildlife.  For 
example, the transfer of DDT, DDE, and DDD from fruit orchard soils to American robins had been 
investigated in Okanagan, British Columbia, and Ontario, Canada, showing increasing concentrations of 
these compounds in soil→earthworm→robin eggs (Harris et al. 2000).  In Okanagan, high average 
concentrations (mg/kg, dry weight) of DDE and DDT in soil (5.5 and 9.2), earthworms (52 and 21), and 
robin eggs (484 and 73) were consistent with the recorded contamination of this area.  These 
concentrations are comparable to those where mortality or reproductive effects have been observed to 
occur in field studies.  These results also illustrate one way in which DDT and its metabolites in soil can 
be mobilized and bioaccumulated by soil organisms which, in turn, are further accumulated in higher 
trophic levels. 
 
Market Basket Surveys indicated that there were decreases in the overall residue levels on a lipid basis of 
DDT and DDE in all classes of food tested from 1965 to 1975 (EPA 1980). The Market Basket Survey 
samples a broad variety of commodities commonly consumed in the United States, typically about 
280 foods and beverages purchased from different geographic regions.  These commodities are then 
tested for the presence of toxic and nutritional elements, pesticides, industrial chemicals, and 
radionuclides.  Between 1970 and 1973, DDE residues decreased only 27% compared to decreases of 
86 and 89% for DDT and DDD, respectively (EPA 1980).  A study by Duggan et al. (1983) reported the 
following average residues of p,p’-DDT and o,p’-DDT in grocery items from 1969 to 1976: domestic 
cheese, 3 ppb; ready-to-eat meat, fish, and poultry, 5 ppb; eggs, 4 ppb; domestic fruits, 13 ppb; domestic 
leaf and stem vegetables, 24 ppb; domestic grains, 7 ppb; corn and corn products, 0.7 ppb; and peanuts 
and peanut products, 11 ppb.  
 
Mean DDT residues by food group have been reported by Gartrell et al. (1985, 1986a, 1986b) as part of 
the FDA Total Diet Studies for October 1979–September 1980 and October 1980–March 1982.  The 
average DDE and DDT residues for 12 food groups and the daily intake for each of these groups obtained 
from the Total Diet Studies are shown in Table 5-6.  The highest intake of DDE is shown to come from 
meat, fish, and poultry.  Other Total Diet Studies have only reported the number of occurrences of a 
pesticide and not the concentration levels.  In the survey for 1984–1986, there were 433 findings of DDE 
out of 1,872 samples analyzed (Gunderson 1995b).  In the Total Diet Study for 1993–1994, p,p’-DDE 
was found in 115 out of 783 (15%) items analyzed (FDA 1995).  In the 1999 FDA Total Diet Study, DDT 
was found in 255 out of 1,040 (22%) items analyzed (FDA 1999).  In an FDA study, the mean 
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concentrations of p,p’-DDT and o,p’-DDT ranged from 0.0002 to 0.005 ppm.  The mean concentrations 
of p,p’-DDE ranged from 0.0001 to 0.0257 ppm, with the highest values found in dairy, fish and 
vegetable products (FDA 2001).  Analyses of samples from 10 states taken during fiscal years (FY) 1988 
(n=13,980) and 1989 (n=13,085) resulted in a frequency of detection of 0.028 and 0.12%, respectively, 
for p,p’-DDT.  DDE (any isomer) was detected in 1.5 and 0.99% of samples and p,p’-DDE in 0.18 and 
0.25% of samples in 1988 and 1989, respectively (Minyard and Roberts 1991).  Overall, these surveys 
indicate that DDT and DDE levels are very low in food commodities.   
 
Table 5-6.  Average Residues in Food Groups and Average Daily Intake from U.S. 
Food and Drug Administration (FDA) Total Diet Studies 
 
Food group 
October 1979–September 1980a October 1980–March 1982b 
DDE DDT DDE DDT 
Residue 
(ppb) 
Intake 
(μg/day) 
Residue 
(ppb) 
Intake 
(μg/day) 
Residue 
(ppb) 
Intake 
(μg/day) 
Residue 
(ppb) 
Intake 
(μg/day) 
Dairy products 0.9 0.626 0 0 1.5 1.05 0 0 
Meat, fish, and poultry 4.8 1.28 0.8 0.219 3.0 0.777 0 0 
Grains and cereal 0 0 0 0 0 0 0 0 
Potatoes 0.5 0.0847 <0.1 0.0079 0.5 0.0864 0 0 
Leafy vegetables 1.7 0.0954 0.2 0.0137 2.4 0.132 0 0.0195 
Legumes 0 0 0 0 <0.1 0.0014 0.4 0 
Root vegetables 1.0 0.0309 0 0 4.6 0.146 0 0.0192 
Garden vegetables 0.2 0.0185 0 0 0.1 0.0095 0.6 0 
Fruits 0 0 0 0 <0.1 0.0081 0 0 
Oils and fats <0.1 0.0028 0 0 <0.1 0.0018 0 0 
Sugar <0.1 0.0042 0 0 <0.1 0.0018 0 0 
Beverages 0 0 0 0 0 0 0 0 
 
aGartrell et al. 1985 
bGartrell et al. 1986b 
 
The results of the FDA Total Diet Study Market Basket Surveys from food items collected between 
October 2003 and August 2005 for DDT and related compounds are provided in Table 5-7. 
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Table 5-7.  Results of the FDA Market Basket Surveys from 2003 to 2005 for DDT, 
DDE, and DDD 
 
Description 
Number 
of 
analyses 
Number 
≥LOQa 
Number 
of tracesb 
Level in 
ppm 
(mean) 
Level in 
ppm 
(minimum) 
Level in 
ppm 
(maximum) 
p,p'-DDE       
  Milk, whole 8 0 6 0.00028 0.0001 0.0010 
  Milk, 2% 8 0 4 0.00024 0.0002 0.0009 
  Milk, chocolate, lowfat 8 0 2 0.00010 0.0004 0.0004 
  Milk, skim 8 0 1 0.00001 0.0001 0.0001 
  Milk shake, chocolate 8 0 4 0.00018 0.0001 0.0006 
  Cheese, American 8 7 1 0.00488 0.0010 0.0100 
  Cheese, cheddar 8 2 5 0.00180 0.0003 0.0060 
  Beef, ground 8 2 6 0.00171 0.0003 0.0090 
  Beef roast, chuck 8 0 5 0.00018 0.0001 0.0004 
  Pork chop 8 0 1 0.00001 0.0001 0.0001 
  Pork sausage 8 0 6 0.00020 0.0001 0.0004 
  Pork bacon 8 0 4 0.00011 0.0002 0.0003 
  Pork roast, loin 8 0 1 0.00005 0.0004 0.0004 
  Lamb chop 8 2 6 0.00151 0.0002 0.0060 
  Turkey breast 8 0 2 0.00003 0.0001 0.0001 
  Liver 8 0 3 0.00009 0.0001 0.0004 
  Frankfurter 8 0 7 0.00056 0.0003 0.0010 
  Bologna 8 0 4 0.00015 0.0002 0.0005 
  Salami, luncheon 8 0 8 0.00020 0.0001 0.0004 
  Fish, sticks/patty 8 0 1 0.00005 0.0004 0.0004 
  Eggs, scrambled 8 0 3 0.00020 0.0002 0.0010 
  Eggs, boiled 8 0 2 0.00012 0.0001 0.0009 
  Lima beans, immature 8 0 1 0.00001 0.0001 0.0001 
  Peanut butter, smooth 8 0 7 0.00095 0.0005 0.0020 
  Peanuts, dry roasted, salted 8 0 5 0.00046 0.0004 0.0010 
  Cornbread 8 0 3 0.00013 0.0001 0.0006 
  Raisin bran cereal 8 0 1 0.00001 0.0001 0.0001 
  Grapes (red/green) 8 0 2 0.00004 0.0001 0.0002 
  Raisins 8 0 7 0.00035 0.0002 0.0006 
  Spinach, fresh/frozen 8 5 2 0.00328 0.0004 0.0080 
  Collards, fresh/frozen 8 4 2 0.00299 0.0003 0.0140 
  Broccoli, fresh/frozen 8 0 5 0.00013 0.0001 0.0003 
  Celery 8 1 6 0.00054 0.0002 0.0020 
  Asparagus, fresh/frozen 8 0 2 0.00005 0.0001 0.0003 
  Tomato sauce, plain 8 0 6 0.00014 0.0001 0.0004 
  Green beans, fresh/frozen 8 0 3 0.00009 0.0002 0.0003 
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Table 5-7.  Results of the FDA Market Basket Surveys from 2003 to 2005 for DDT, 
DDE, and DDD 
 
Description 
Number 
of 
analyses 
Number 
≥LOQa 
Number 
of tracesb 
Level in 
ppm 
(mean) 
Level in 
ppm 
(minimum) 
Level in 
ppm 
(maximum) 
  Green beans, canned 8 0 1 0.00003 0.0002 0.0002 
  Summer squash, fresh/frozen 8 0 6 0.00045 0.0003 0.0010 
  Pepper, sweet, green 8 0 2 0.00003 0.0001 0.0001 
  Potato, boiled 8 0 3 0.00005 0.0001 0.0002 
  Potato, baked 8 3 4 0.00199 0.0002 0.0090 
  Potato chips 8 0 4 0.00024 0.0002 0.0010 
  Spaghetti with meat sauce 8 0 7 0.00029 0.0001 0.0010 
  Chili con carne with beans 8 0 8 0.00035 0.0001 0.0008 
  Macaroni and cheese 8 0 6 0.00039 0.0001 0.0010 
  Quarter-pound hamburger 8 1 7 0.00096 0.0002 0.0040 
  Meatloaf 8 2 5 0.00157 0.0001 0.0090 
  Butter 8 7 0 0.01600 0.0060 0.0340 
  Mayonnaise 8 0 1 0.00013 0.0010 0.0010 
  Cream, half & half 8 1 7 0.00056 0.0001 0.0020 
  Tomato catsup 8 0 6 0.00024 0.0001 0.0010 
  Ice cream, light, vanilla 8 0 4 0.00013 0.0001 0.0005 
  Sweet roll/Danish pastry 8 0 1 0.00001 0.0001 0.0001 
  Chocolate chip cookies 8 0 1 0.00006 0.0005 0.0005 
  Pie, apple, fresh/frozen 8 0 1 0.00003 0.0002 0.0002 
  Pie, pumpkin, fresh/frozen 8 0 2 0.00014 0.0004 0.0007 
  Candy bar, milk chocolate 8 0 7 0.00035 0.0002 0.0008 
  Baby food, beef and 
broth/gravy 
8 1 7 0.00069 0.0002 0.0020 
  Baby food, chicken and 
broth/gravy 
8 0 2 0.00004 0.0001 0.0002 
  Baby food, vegetables and beef 8 0 5 0.00019 0.0002 0.0004 
  Baby food, vegetables and 
chicken 
8 0 3 0.00005 0.0001 0.0002 
  Baby food, vegetables and ham 7 0 3 0.00007 0.0001 0.0003 
  Baby food, chicken noodle 
dinner 
8 0 5 0.00009 0.0001 0.0002 
  Baby food, macaroni, tomato 
and beef 
8 0 3 0.00006 0.0001 0.0003 
  Baby food, turkey and rice 8 0 1 0.00001 0.0001 0.0001 
  Baby food, green beans 8 0 2 0.00004 0.0001 0.0002 
  Yogurt, lowfat, fruit-flavored 8 0 1 0.00001 0.0001 0.0001 
  Cheese, Swiss, natural 8 2 5 0.00090 0.0003 0.0020 
  Cream cheese 8 7 1 0.00510 0.0008 0.0110 
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Table 5-7.  Results of the FDA Market Basket Surveys from 2003 to 2005 for DDT, 
DDE, and DDD 
 
Description 
Number 
of 
analyses 
Number 
≥LOQa 
Number 
of tracesb 
Level in 
ppm 
(mean) 
Level in 
ppm 
(minimum) 
Level in 
ppm 
(maximum) 
  Shrimp 8 0 3 0.00008 0.0002 0.0002 
  Graham, crackers 8 0 1 0.00001 0.0001 0.0001 
  French-fries 8 0 1 0.00011 0.0009 0.0009 
  Carrot, fresh 8 0 3 0.00009 0.0001 0.0005 
  Brussels sprouts, fresh/frozen 8 0 3 0.00010 0.0001 0.0005 
  Turnip, fresh/frozen 8 1 2 0.00036 0.0004 0.0020 
  Beef stroganoff with noodles 8 1 2 0.00034 0.0002 0.0020 
  Tuna noodle casserole 8 0 7 0.00055 0.0002 0.0010 
  Quarter-pound cheeseburger 8 4 3 0.00153 0.0004 0.0030 
  Fish sandwich 8 0 6 0.00025 0.0002 0.0007 
  Egg, cheese, and ham on 
English muffin 
8 0 6 0.00059 0.0004 0.0010 
  Taco/tostada with beef and 
cheese 
8 2 5 0.00096 0.0003 0.0020 
  Pizza, cheese and pepperoni 8 1 6 0.00076 0.0002 0.0020 
  Clam chowder, New England 8 0 5 0.00023 0.0001 0.0010 
  Ice cream, vanilla 8 3 4 0.00213 0.0003 0.0070 
  Sherbet, fruit-flavored 8 0 2 0.00009 0.0001 0.0006 
  Black olives 8 0 4 0.00008 0.0001 0.0002 
  Sour cream 8 1 7 0.00244 0.0003 0.0150 
  Baby food, teething biscuits 8 0 1 0.00006 0.0005 0.0005 
  Salmon 8 6 2 0.00650 0.0010 0.0340 
  Baby food, squash 8 0 1 0.00009 0.0007 0.0007 
  Baby food, veal with gravy 8 1 3 0.00046 0.0001 0.0030 
  Baby food, lamb with gravy 8 6 2 0.00283 0.0006 0.0090 
  Baby food, turkey with gravy 8 0 1 0.00001 0.0001 0.0001 
  Cottage cheese, 2% fat 8 1 1 0.00028 0.0002 0.0020 
  Sour cream dip 8 1 5 0.00053 0.0003 0.0020 
  Beef steak 8 1 6 0.00065 0.0002 0.0020 
  Lunch meat (chicken/turkey) 8 0 1 0.00003 0.0002 0.0002 
  Chicken thigh, oven 8 0 1 0.00003 0.0002 0.0002 
  Chicken leg, fried 8 0 1 0.00003 0.0002 0.0002 
  Catfish 8 8 0 0.01850 0.0060 0.0500 
  Tuna 8 0 3 0.00020 0.0002 0.0010 
  Macaroni salad 8 0 3 0.00006 0.0001 0.0002 
  Potato salad 8 0 4 0.00015 0.0001 0.0008 
  Potatoes, mashed 8 2 6 0.00118 0.0004 0.0020 
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Table 5-7.  Results of the FDA Market Basket Surveys from 2003 to 2005 for DDT, 
DDE, and DDD 
 
Description 
Number 
of 
analyses 
Number 
≥LOQa 
Number 
of tracesb 
Level in 
ppm 
(mean) 
Level in 
ppm 
(minimum) 
Level in 
ppm 
(maximum) 
  Coleslaw 8 0 1 0.00001 0.0001 0.0001 
  Carrot, baby, raw 8 0 2 0.00008 0.0003 0.0003 
  Lettuce, leaf, raw 8 0 7 0.00061 0.0002 0.0010 
  Tomato salsa, bottled 8 0 5 0.00010 0.0001 0.0002 
  Stew, beef and vegetable 8 0 5 0.00013 0.0001 0.0003 
  Lasagna 8 0 7 0.00060 0.0003 0.0010 
  Beef with vegetables, Chinese 8 0 2 0.00008 0.0003 0.0003 
  Chicken with vegetables, 
Chinese 
8 0 2 0.00005 0.0001 0.0003 
  Burrito with beef, beans, 
cheese 
8 0 7 0.00046 0.0002 0.0009 
  Cake, white with icing 8 0 2 0.00009 0.0002 0.0005 
  Candy, chocolate w/nuts 8 0 5 0.00048 0.0005 0.0010 
  Sweet and sour sauce 8 0 1 0.00001 0.0001 0.0001 
  Brown gravy 8 0 2 0.00005 0.0002 0.0002 
  Ranch dressing, low-calorie 8 0 1 0.00001 0.0001 0.0001 
  Olive oil 8 0 6 0.00038 0.0003 0.0007 
  Baby food, zwieback toast 8 0 1 0.00001 0.0001 0.0001 
  Baby food, chicken with rice 8 0 1 0.00005 0.0004 0.0004 
  Baby food, beef and noodles 8 0 6 0.00031 0.0001 0.0010 
  Baby food, macaroni and 
cheese 
8 0 5 0.00023 0.0001 0.0008 
o,p'-DDT 
  Spinach, fresh/frozen 8 0 3 0.00009 0.0001 0.0003 
  Collards, fresh/frozen 8 0 1 0.00006 0.0005 0.0005 
  Potato, baked 8 0 2 0.00004 0.0001 0.0002 
  Turnip, fresh/frozen 8 0 1 0.00001 0.0001 0.0001 
  Potato salad 8 0 1 0.00001 0.0001 0.0001 
  Lettuce, leaf, raw 8 0 2 0.00015 0.0002 0.0010 
p,p'-DDT 
  Milk, whole 8 0 1 0.00003 0.0002 0.0002 
  Beef, ground 8 0 1 0.00004 0.0003 0.0003 
  Spinach, fresh/frozen 8 0 4 0.00030 0.0004 0.0010 
  Collards, fresh/frozen 8 0 4 0.00015 0.0001 0.0004 
  Celery 8 0 2 0.00010 0.0001 0.0007 
  Summer squash, fresh/frozen 8 0 2 0.00005 0.0001 0.0003 
  Potato, baked 8 1 4 0.00080 0.0002 0.0050 
  Potato chips 8 0 2 0.00008 0.0002 0.0004 
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Table 5-7.  Results of the FDA Market Basket Surveys from 2003 to 2005 for DDT, 
DDE, and DDD 
 
Description 
Number 
of 
analyses 
Number 
≥LOQa 
Number 
of tracesb 
Level in 
ppm 
(mean) 
Level in 
ppm 
(minimum) 
Level in 
ppm 
(maximum) 
  Chocolate chip cookies 8 0 1 0.00004 0.0003 0.0003 
  Cream cheese 8 0 1 0.00004 0.0003 0.0003 
  Turnip, fresh/frozen 8 0 1 0.00003 0.0002 0.0002 
  Clam chowder, New England 8 0 1 0.00003 0.0002 0.0002 
  Mustard 8 0 1 0.00001 0.0001 0.0001 
  Salmon 8 0 1 0.00004 0.0003 0.0003 
  Sour cream dip 8 0 1 0.00003 0.0002 0.0002 
  Catfish 8 0 1 0.00011 0.0009 0.0009 
  Potato salad 8 0 1 0.00004 0.0003 0.0003 
  Lettuce, leaf, raw 8 1 3 0.00050 0.0001 0.0030 
 
aNumber ≥LOQ is the number of results for the residue that were greater than or equal to the method’s limit 
of quantitation (LOQ).  
bNumber of traces is the number of results for the residue that were equal to or greater than the method’s 
limit of detection (LOD), but less than the method’s LOQ.  The mean values were calculated using a value of 
0 for results below the LOD.  
 
Source: FDA 2006  
 
The USDA Pesticide Data Program tested 10,619 samples of foods produced domestically and imported 
into the United States in 2014 (USDA 2016).  Fresh and processed fruit and vegetables accounted for 
>80% of the total 10,619 samples collected, infant formula accounted for 9.9%, salmon accounted for 
3.3%, and oats and rice, accounted for 3.0% each.  The results pertaining to DDT, DDD, and DDE are 
summarized in Table 5-8. 
 
Table 5-8.  DDD, DDE, and DDT Residues in Food Items Sampled in 2014 
 
Food item Number of samples Detections Concentration (ppm) 
o,p’-DDD 
Apples 177 0 Not applicable 
Blueberries, cultivated, fresh 354 0 Not applicable 
Blueberries, frozen 5 0 Not applicable 
Celery 708 0 Not applicable 
Salmon 354 0 Not applicable 
Grape juice 531 0 Not applicable 
Green beans canned 378 0 Not applicable 
Green beans frozen 378 0 Not applicable 
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Table 5-8.  DDD, DDE, and DDT Residues in Food Items Sampled in 2014 
 
Food item Number of samples Detections Concentration (ppm) 
Infant formula, dairy based 528 0 Not detected 
Infant formula, soy based 527 0 Not detected 
Oats 314 0 Not detected 
Rice 314 0 Not detected 
Strawberries 176 0 Not detected 
Summer squash 270 1 0.003 
Sweet corn fresh 78 0 Not detected 
Sweet corn frozen 12 0 Not detected 
Tomatoes 177 0 Not detected 
Watermelon 390 0 Not detected 
p,p’-DDD  
Apples 177 0 Not detected 
Bananas 179 0 Not detected 
Blueberries, cultivated, fresh 688 0 Not detected 
Blueberries, frozen 19 0 Not detected 
Broccoli 712 0 Not detected 
Celery 708 0 Not detected 
Cherries fresh 228 0 Not detected 
Cherries frozen 282 0 Not detected 
Salmon 354 0 Not detected 
Grape juice 531 0 Not detected 
Green beans fresh 757 0 Not detected 
Green beans canned 378 0 Not detected 
Green beans frozen 378 0 Not detected 
Infant formula, dairy based 528 0 Not detected 
Infant formula, soy based 527 0 Not detected 
Oats 314 0 Not detected 
Peaches 707 0 Not detected 
Rice 314 0 Not detected 
Strawberries 176 0 Not detected 
Summer squash 531 1 0.003 
Sweet corn fresh 134 0 Not detected 
Sweet corn frozen 41 0 Not detected 
Tomatoes 177 0 Not detected 
Watermelon 390 0 Not detected 
o,p’-DDE 
Apples 177 0 Not detected 
Blueberries, cultivated, fresh 354 0 Not detected 
Blueberries, frozen 5 0 Not detected 
Carrots 708 1 0.003 
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Table 5-8.  DDD, DDE, and DDT Residues in Food Items Sampled in 2014 
 
Food item Number of samples Detections Concentration (ppm) 
Celery 348 0 Not detected 
Salmon 354 0 Not detected 
Grape juice 531 0 Not detected 
Infant formula, soy based 527 0 Not detected 
Nectarines 681 0 Not detected 
Oats 314 0 Not detected 
Rice 314 0 Not detected 
Strawberries 176 0 Not detected 
Summer squash 270 0 Not detected 
Sweet corn fresh 78 0 Not detected 
Sweet corn frozen 12 0 Not detected 
Watermelon 390 0 Not detected 
p,p’-DDE 
Apples 177 0 Not detected 
Bananas 179 0 Not detected 
Blueberries, cultivated, fresh 688 0 Not detected 
Blueberries, frozen 19 0 Not detected 
Broccoli 712 0 Not detected 
Carrots 708 175 0.003–0.066 
Celery 708 75 0.002–0.006 
Cherries fresh 228 0 Not detected 
Cherries frozen 282 0 Not detected 
Salmon 354 0 Not detected 
Grape juice 531 0 Not detected 
Green beans fresh 757 1 0.009 
Green beans canned 378 0 Not detected 
Green beans frozen 378 4 0.002 
Infant formula, dairy based 528 0 Not detected 
Infant formula, soy based 527 0 Not detected 
Oats 314 0 Not detected 
Peaches 707 0 Not detected 
Rice 314 0 Not detected 
Strawberries 176 0 Not detected 
Summer squash 531 16 0.003–0.011 
Sweet corn fresh 134 0 Not detected 
Sweet corn frozen 41 0 Not detected 
Tomatoes 157 0 Not detected 
Watermelon 390 0 Not detected 
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Table 5-8.  DDD, DDE, and DDT Residues in Food Items Sampled in 2014 
 
Food item Number of samples Detections Concentration (ppm) 
o,p’-DDT 
Blueberries, cultivated, fresh 325 0 Not detected 
Blueberries, frozen 4 0 Not detected 
Carrots 708 30 0.002–0.004 
Celery 650 0 Not detected 
Green beans canned 378 0 Not detected 
Green beans frozen 378 0 Not detected 
Infant formula, dairy based 528 0 Not detected 
Infant formula, soy based 527 0 Not detected 
Nectarines 681 0 Not detected 
Oats 314 0 Not detected 
Rice 314 0 Not detected 
Strawberries 176 0 Not detected 
Summer squash 240 5 0.003–0.012 
Sweet corn fresh 78 0 Not detected 
Sweet corn frozen 12 0 Not detected 
Tomatoes 177 0 Not detected 
p,p’-DDT 
Apples 177 0 Not detected 
Bananas 179 0 Not detected 
Blueberries, cultivated, fresh 659 0 Not detected 
Blueberries, frozen 18 0 Not detected 
Broccoli 712 0 Not detected 
Carrots 708 67 0.002–0.007 
Celery 679 2 0.001–0.003 
Cherries fresh 228 0 Not detected 
Cherries frozen 282 0 Not detected 
Salmon 354 7 0.001–0.003 
Grape juice 531 0 Not detected 
Green beans canned 378 0 Not detected 
Green beans frozen 378 0 Not detected 
Infant formula, dairy based 528 0 Not detected 
Infant formula, soy based 527 0 Not detected 
Oats 314 0 Not detected 
Nectarines 681 0 Not detected 
Peaches 707 0 Not detected 
Rice 314 0 Not detected 
Strawberries 176 0 Not detected 
Summer squash 270 13 0.003–0.011 
Sweet corn fresh 78 0 Not detected 
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Table 5-8.  DDD, DDE, and DDT Residues in Food Items Sampled in 2014 
 
Food item Number of samples Detections Concentration (ppm) 
Sweet corn frozen 12 0 Not detected 
Tomatoes 177 0 Not detected 
Watermelon 390 0 Not detected 
 
Source: USDA 2016 
 
Baking, frying, broiling, smoking, and microwaving all effectively reduce the total DDT concentration in 
fish and meat tissue (Bayarri et al. 1994; Khanna et al. 1997; Wilson et al. 1998).  The average reduction 
in fish ranged from 16 to 82% and in lamb from 37 to 56% depending on cooking method.  It is not clear 
whether residues are lost as a result of volatilization or decomposition or carried away in fat runoff.  
p,p’-DDT (but not p,p’-DDE or p,p’-DDD) decomposes on heating (see Table 4-2).  Concentrations of 
p,p’-DDT in tomatoes could be reduced by between 11.5 and 33.7% by washing the fruit with acetic acid 
and sodium chloride solutions; the concentrations of p,p’-DDT, o,p’-DDE, p,p’-DDD, and o,p’-DDD 
residues in tomatoes could be reduced by up to approximately 80% from the fruit by simply removing the 
peel (Abou-Arab 1999).  Production of tomato paste through home-canning methods reduced p,p’-DDT 
concentrations by 30.7%. 
 
Djordjevic et al. (1995) assessed the chlorinated pesticide residues in U.S. and foreign cigarettes 
manufactured from the 1960s to the 1990s.  Since 1970, the concentration of DDT analogues decreased 
by >98%.  Concentration ranges of DDT-related compounds in samples of cigarettes manufactured 
between 1961 and 1979 and between 1983 and 1994 were (chemical, 1961–1979 levels, 1983–1994 
levels): p,p’-DDD, 1,540–30,100 ng/g, 12.6–99.7 ng/g; o,p’-DDD, 396–7,150 ng/g, ND-19.0 ng/g; 
p,p’-DDT, 720–13,390 ng/g, 19.7–145 ng/g; o,p’-DDT, 105–1,940 ng/g; ND-88 ng/g; p,p’-DDE, 58–
959 ng/g, 6.6–15.8 ng/g; and p,p’-DDMU (1-chloro-2,2-bis(p-chlorophenyl)ethylene), 92.7–2,110 ng/g, 
ND–27.5 ng/g.  The transfer rate from tobacco into mainstream smoke amounts to 22% for DDD, 19% for 
DDT, and 27% for DDE. 
 
Monitoring in older homes reveal that carpeting in these homes may have high levels of DDT, DDE, and 
DDD (Lewis et al. 1994).  In one house built in 1930, the carpeting, which was believed to be at least 
25 years old, contained up to 10.8 μg/m2 or 5.7 μg/g of ΣDDT (p,p’-DDT, DDD, and DDE).  
 
Organochlorine pesticides have been detected and quantified in composting feedstocks and finished 
compost (Büyüksönmez et al. 2000).  Although banned for several decades, DDT and its metabolites have 
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been detected in lawn trimmings and municipal waste compost in 1990–1996, with concentrations of 
DDT, DDE, and DDD at 0.01–0.21, 0.01–0.11, and 0.007–0.13 ppm, respectively.  The concentrations of 
the DDT, DDE, and DDD have been found to typically decrease as composting feedstocks are converted 
to finished compost.  For example, DDT and DDE concentrations in lawn trimmings were found to 
decrease from 0.0466 and 0.0143 ppm to 0.0159 and 0.0108 ppm, respectively, after 90 days of 
composting.  However, under some compositing conditions, DDE concentrations have been observed to 
increase in the finished compost (mean concentration of 0.0807 ppm, maximum value of 0.483 ppm) 
compared to the initial feedstock (mean concentration of 0.0516 ppm, maximum value of 0.201 ppm) 
(Strom 2000). 
 
5.6   GENERAL POPULATION EXPOSURE  
 
The general population is currently exposed to DDT and its metabolites primarily in food, with smaller 
amounts coming from inhalation exposure.  As indicated in the previous section, although residue levels 
in food continue to slowly decline, there are measurable quantities in many commodities.  A 1989 
pesticide screening program of produce delivered to supermarkets in Texas, for example, found p,p’-DDE 
residues in 41 of the 6,970 produce samples tested (Schattenberg and Hsu 1992).  An FDA study of 
residues in infant foods and adult food eaten by infants and children in which over 10,000 samples of 
domestic and imported foods were analyzed during 1985–1991 was published (Yess et al. 1993). ΣDDT 
was detected in 2 of 2,464 apples at a maximum concentration of 0.08 ppm; 312 of 2,464 plain milk 
samples at a maximum concentration of 0.92 ppm; 8 of 180 vitamin D fortified milk samples at a 
maximum concentration of 0.10 ppm; and 1 of 735 imported apple juice samples at 0.18 ppm (Yess et al. 
1993).  A similar 1992–1994 Canadian survey found DDE or DDT residues in 1 of 380 domestic heads of 
lettuce; 1 of 769 domestic potatoes; 36 of 612 imported carrots; 4 of 721 imported cucumbers; 1 of 
702 imported heads of lettuce; 14 of 121 imported green onions; 7 of 17 imported parsnips; 1 of 
933 imported peppers; 5 of 264 imported spinach; 1 of 155 imported tomato pastes; and 1 of 
1,153 imported tomatoes (Neidert and Saschenbrecker 1996).  In a U.S. Market Basket study of ready to 
eat foods, o,p’-DDE was detected 8 times in 4 different food items at an average concentration of 
0.0025 μg/g; p,p’-DDE was detected 1,700 times in 142 different food items at an average concentration 
of 0.0026 μg/g; o,p’-DDT was detected 5 times in 4 different food items at an average concentration of 
0.0053 μg/g; p,p’-DDT was detected 98 times in 31 different food items at an average concentration of 
0.0045 μg/g (KAN-DO Office and Pesticide Team 1995). 
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Because of the extreme persistence of DDT and DDE, it is anticipated that low levels of residues will be 
present in commodities for decades.  In fact, depending on use and export patterns in other countries, 
levels in the diet may even increase (Coulston 1985).  Even in domestic commodities, the potential for 
low levels of dietary exposure of consumers may result from residues bioaccumulated in some food items, 
including fish. 
 
The estimated dietary intake of DDT and metabolites in the United States was 62 μg/person/day in 1965, 
240 μg/person/day in 1970, and 8 μg/person/day in 1974 (Coulston 1985).  The FDA Adult Total Diet 
Study for October 1979–September 1980 (FY 1980) found that the intakes of ΣDDT, DDE, DDT, and 
DDD were 0.034, 0.003, 0.031, and <0.001 μg/kg body weight/day, respectively, down from highs of 
0.093, 0.004, 0.087, and 0.002, respectively, in FY 1979 (Gartrell et al. 1986a).  The adult intake was 
assumed to be the diet of a 16–19-year-old male.  Analogous studies for infants and toddlers for FY 1980 
reported daily intakes of the respective DDTs as 0.034, 0.034, ND (not determined), and ND μg/kg body 
weight/day for infants and 0.049, 0.045, 0.002, and 0.002 μg/kg body weight/day for toddlers (Gartrell et 
al. 1986b).  Estimated dietary intakes of DDT determined from the FDA Total Diet Studies for June 
1984–April 1986 and July 1986–April 1991 for eight population groups appear in Table 5-9 (Gunderson 
1995a, 1995b).  To facilitate comparisons of DDT intakes from Gunderson (1995a, 1995b) with those of 
earlier estimates (Coulston 1985), the daily intake of ΣDDT for a 70 kg 16-year-old male as reported by 
Gunderson (1995a, 1995b) would have been 6.51, 2.38, 1.49, and 0.97 μg/day for 1978–1979, 1979–
1980, 1984–1986, and 1986–1991, respectively.  The acceptable daily intake of DDT established by 
WHO/FAO is 10 μg/kg/day (WHO 2000). 
 
Exposure to DDT, DDE, and DDD in imported foods is minimized due to FDA enforcement programs.  
FDA randomly collects and analyzes a wide variety of imported commodities (e.g., coffee, tropical fruits) 
to determine if pesticide residues are above EPA tolerances.  Pesticide tolerances established by EPA 
apply equally to domestic and imported food (Wessel and Yess 1991).   
 
Arctic indigenous people ingest high levels of DDT from traditional foods.  A study covering three age 
groups in communities in the eastern and western Canadian Arctic found the average daily ΣDDT intake 
of 24.2–27.8 μg/day for the eastern Arctic community and 0.51 to 1.0 μg/day for the western Arctic 
communities (Kuhnlein et al. 1995).  The foods with the highest ΣDDT concentrations were raw Beluga 
whale blubber (316 μg/g wet weight) and aged Narwhal whale blubber (273 μg/g wet weight) in the 
eastern Arctic, and baked Loch (species of fish) liver (1.85 μg/g wet weight) and smoked Canada goose 
meat (1.47 μg/g wet weight) in the western Arctic. 
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Table 5-9.  Mean Daily Intake of DDT Per Unit Body Weight (μg/kg body weight/day) for Various Age Groups in 
the United States 
 
Analyte 6–11 months 2 years 
14–16 years, 
female 
14–16 years, 
male 
25–30 years, 
female 
25–30 years, 
male 
60–65 years, 
female 
60–65 years, 
male 
1984–1986 
ΣDDT 0.0485 0.0499 0.0154 0.0213 0.0128 0.0155 0.0111 0.0124 
o,p’-DDE 0.0002 0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.0001 <0.0001 
p,p’-DDE 0.0468 0.0484 0.0149 0.0207 0.0123 0.0150 0.0105 0.0119 
p,p’-DDT 0.0004 0.0010 0.0003 0.0004 0.0003 0.0003 0.0003 0.0003 
p,p’-DDD 0.0011 0.0004 0.0002 0.0002 0.0002 0.0002 0.0002 0.0002 
1986–1991 
ΣDDTa 0.0448 0.0438 0.0138 0.0139 0.0106 0.0127 0.0090 0.0104 
o,p’-DDE <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
p,p’-DDE 0.0441 0.0420 0.0130 0.0151 0.0099 0.0119 0.0082 0.0096 
o,p’-DDT <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
p,p’-DDT 0.0004 0.0011 0.0005 0.0005 0.0005 0.0005 0.0006 0.0006 
p,p’-DDD 0.0003 0.0007 0.0003 0.0003 0.0002 0.0003 0.0002 0.0002 
 
aThe average daily ΣDDT intake of 0.8 µg/day for an adult was derived from the average intakes for 25–30-year-old males and females assuming a body weight 
of 70 kg.  The data presented in the table were derived from the June 1984 through April 1991 FDA Total Diet Studies. 
 
Source: Gunderson 1995a, 1995b 
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DDT and its metabolites are ubiquitous in the atmosphere, but are typically present in low concentrations.  
In 1986–1988, EPA collected data at two sites, Jacksonville, Florida and Springfield/Chicopee, 
Massachusetts, to assess the nonoccupational exposure to pesticides (NOPES) for residents of these cities 
(Whitmore et al. 1994).  Indoor p,p’-DDE and p,p’-DDT levels in air were higher than outdoor levels in 
these communities, and the highest number of indoor air samples with detectable DDT was observed in 
the spring season in Jacksonville (14%) and in the winter season in Springfield/Chicopee (20%), with 
estimated mean air DDE and DDT concentrations of ≤1.0 ng/m3.  Mean ΣDDT air exposures were 
estimated as 22 ng/day in Jacksonville and 94 ng/day in Springfield/Chicopee.  For comparison, dietary 
exposures in these two communities for 1982–1984 were estimated to be around 1,900 ng/day.  Nine of 
11 carpets tested in Jacksonville contained ΣDDT with median and mean levels of 0.7 and 1.2 μg/g, 
respectively.  Although the contribution of inhaled DDT to the overall body burden is expected to be 
small, this has not been adequately investigated. 
 
Until 1970, tobacco smoke contributed significantly to the intake of DDT by people, but since then, the 
amount of DDT in tobacco has dropped markedly and today, cigarette smoke is a minor source of human 
exposure (Djordjevic et al. 1995). 
 
Because of the extremely low solubility of DDT and DDE in water and the efficiency of standard water 
treatment methods in eliminating DDT-type chemical residues, intake of these compounds via drinking 
water is believed to be negligible.  The criterion cited in the EPA Ambient Water Quality Criteria 
document is 0.059 ng/L, based on ingestion of 2 L of drinking water/day plus 6.5 g of fish and shellfish 
per person (EPA 1999).  This criterion corresponds to an estimated increased cancer risk level of 1x10-7 
or 1 in 10 million.   
 
Data indicate that, even with relatively high doses, there is minimal absorption of DDT through skin 
(Gaines 1969; Wester et al. 1990; Wolfe and Armstrong 1971).  Therefore, exposure via dermal 
absorption was considered to be negligible.  However, in reviewing the literature and using a dermal 
absorption factor of 15% measured in their laboratory, Moody and Chu (1995) calculated that in the 
worst-case scenario where a swimmer was in contact with 1 ppm of DDT from a water slick or sediment 
for 1 hour, a swimmer would absorb 200 μg of DDT, equivalent to a dose from a meal of contaminated 
fish.   
 
DDT and DDE elimination from the body is not an efficient process; therefore, tissue levels will increase 
with repeated exposure if the absorbed dose is high enough.  For this reason, body burdens of DDT and 
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DDE tend to correspond with exposure levels, as indicated in long-term studies.  From July 1969 to 1975, 
residues of DDT and its metabolites were measured in human adipose tissue collected through an annual, 
national survey—the National Human Monitoring Program for Pesticides (Kutz et al. 1977).  During that 
time, levels of DDT and DDE in tissue samples declined.  However, the frequency of occurrence in lipid 
samples did not decline, indicating both a long biological half-life and the ubiquitous occurrence of these 
compounds in the population.  For FYs 1970–1974, all samples were positive for DDT and metabolites (a 
total of 1,412 samples).  Using all age groups sampled, the geometric mean lipid DDT and metabolite 
(combined) levels reported for each year from 1970–1974 were 7.88, 7.95, 6.88, 5.89, and 5.02 ppm, 
respectively.  Notable trends reported in Kutz et al. (1977) included increasing body burden with 
increasing age as well as a significant increase in residues in blacks when compared to whites.  Results 
published for 1975 showed little change compared to 1974 (Kutz et al. 1979).  Exposure to DDT in 
nonoccupationally exposed individuals, as manifested by their plasma DDE concentrations, was most 
reliably predicted by age and serum cholesterol concentration (Laden et al. 1999).  Kutz et al. (1991) 
contains a listing of studies on DDT, DDE, and DDD levels in human adipose tissue in the general 
population of various countries from the 1950s to the mid 1980s. 
 
The Second National Health and Nutrition Examination Survey (NHANES II) has served as a 
continuation of the National Human Monitoring Program.  Murphy and Harvey (1985) published selected 
results from the NHANES II survey for 1976–1980 based on data from the Northeast, Midwest, and 
South.  These results are based, not on adipose samples, but on serum samples.  For the years covered, 
3,300 serum specimens were analyzed for DDT and DDE.  In 31% of those samples p,p’-DDT was 
detected, with a median quantifiable level of 3.3 ppb whole weight (0.0033 ppm).  However, p,p’-DDE 
was detected in 99% of samples tested, with a median quantifiable level of 11.8 ppb (0.0118 ppm).  The 
limits of detectability were 2 ppb for p,p’-DDT and 1 ppb for p,p’-DDE.  These results offered further 
proof of the extensive biological half-life of DDE as compared to DDT.  Again, for both compounds, 
serum levels increased with increasing age.  Another report on NHANES II for the period of 1976–1980 
confirmed the above results on serum samples from 5,994 persons.  p,p’-DDE was detected in the serum 
of 99.5% of persons with a median level of 12.6 ppb (range:  0–379 ppb) whereas p,p’-DDT was 
quantifiable (>2 ppb) in only 10% of serum samples (Stehr-Green 1989).  Levels of p,p’-DDE increased 
with age and were higher in farm residents and in the South and West. 
 
Wattigney et al. (2015) studied the regional variation of p,p’-DDE levels in adults ≥20 years old from the 
NHANES 1999–2004 data.  They observed that levels were consistently greater in U.S. residents of 
western states as compared to residents of the midwest, south, and northeast.  The geometric means in 
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ng/g lipid (ppb lipid) were 247, 232, 311, and 476 for residents of the northeast, midwest, south, and west, 
respectively.  The authors noted that there has been approximately a 5-fold decrease in DDE serum levels 
in the U.S. population when comparing data on a lipid or whole weight basis from NHANES years 1976–
1980 to 1999–2004.  Using data from NHANES 2003–2004, Patterson et al. (2009) observed that 
p,p’-DDT levels increased with increasing age and were statistically significantly higher in Mexican 
Americans as compared to the non-Hispanic white population.  The lipid adjusted and unadjusted serum 
levels from NHANES 1999–2004 for p,p’-DDT are presented in Tables 5-10 and 5-11 and for p,p’-DDE 
in Tables 5-12 and 5-13 (CDC 2018).  The levels of o,p’-DDT were below the level of detection for the 
U.S. population.   
 
Results of EPA’s 1986 National Human Adipose Tissue Survey (NHATS) in which 671 adipose tissue 
specimens were pooled into composite samples according to age, census region, sex, and race showed 
significant differences in p,p’-DDT and p,p’-DDE levels depending on age and census region (Lordo et 
al. 1996).  The concentration of both compounds increased with age group, and while levels of p,p’-DDT 
were highest in the Northeast and lowest in the South, those of p,p’-DDE were highest in the West and 
lowest in the North Central region.  Levels of both compounds had significantly increased from the 1984 
NHATS.  The estimated national mean with relative standard error (%) p,p’-DDT concentrations for the 
1982, 1984, and 1986 NHATS were 189 (31%), 123 (11%), and 177 (20%) ng/g, respectively.  Those for 
p,p’-DDE were 1,840 (350%), 1,150 (90%), and 2,340 (270%) ng/g, respectively.  A 1985 survey of 
108 Canadian autopsy samples resulted in respective mean and maximum levels of p,p’-DDE at 811 and 
6,070 ng/g and p,p’-DDT at 48 and 250 ng/g (Mes et al. 1990).  Adeshina and Todd (1990) analyzed 
DDT isomer and metabolite levels in 35 human adipose tissue samples of North Texas residents who 
were not occupationally exposed to DDT.  The samples were obtained during autopsy in 1987 and 1988.  
The geometric mean concentrations were (substance, ng/g lipid): o,p’-DDE, 8 ng/g; p,p’-DDE, 679 ng/g; 
o,p’-DDT, 14 ng/g; p,p’-DDT, 294 ng/g; and ΣDDT, 1,031 ng/g.  The ΣDDT levels can be compared with 
those from the human adipose tissue survey which were 7,950 ng/g lipid in 1970, 5,150 ng/g lipid in 
1974, and 1,670 ng/g lipid in 1983 (Adeshina and Todd 1990).   
DDT, DDE, and DDD  323 
 
5.  POTENTIAL FOR HUMAN EXPOSURE 
 
 
 
 
 
 
***DRAFT FOR PUBLIC COMMENT*** 
Table 5-10.  Geometric Mean and Selected Percentiles of Serum p,p’-DDT (Lipid Adjusted in ng/g of Lipid or ppb 
on a Lipid-Weight Basis) for the U.S. Population from the National Health and Nutrition 
Examination Survey (NHANES) 1999–2004 
 
 
Survey yearsa 
Geometric mean 
(95% CI) 
Selected percentiles (95% confidence interval) Sample 
size 50th  75th  90th  95th 
Total 1999–2000 
2001–2002 
2003–2004 
* 
* 
* 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
11.9 (10.0–15.1) 
28.0 (21.9–34.0) 
26.6 (22.5–36.0) 
19.5 (15.1–27.5) 
1,679 
2,305 
1,965 
Age group        
 12–19 years 1999–2000 
2001–2002 
2003–2004 
* 
* 
* 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
9.10 (<LOD–12.2) 
677 
756 
595 
 ≥20 years 1999–2000 
2001–2002 
2003–2004 
* 
* 
* 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
12.9 (10.3–16.5) 
30.5 (23.0–37.3) 
28.1 (23.8–39.0) 
20.7 (15.9–28.7) 
1,002 
1,549 
1,370 
Gender        
 Males 1999–2000 
2001–2002 
2003–2004 
* 
* 
* 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
10.6 (9.10–13.7) 
25.1 (<LOD–39.3) 
21.6 (<LOD–25.8) 
15.2 (11.8–26.9) 
799 
1,073 
959 
 Females 1999–2000 
2001–2002 
2003–2004 
* 
* 
* 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
18.3 (<LOD–21.9) 
14.0 (10.8–17.5) 
29.4 (23.0–35.8) 
36.6 (25.5–54.3) 
21.0 (18.0–27.8) 
880 
1,232 
1,006 
Race/ethnicity 
 Mexican 
Americans 
1999–2000 
2001–2002 
2003–2004 
* 
* 
* 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
8.90 (<LOD–12.9) 
61.3 (27.0–155) 
83.1 (33.3–236) 
24.0 (18.6–33.3) 
155 (59.3–590) 
293 (104–541) 
48.6 (31.1–71.1) 
635 
566 
461 
 Non-
Hispanic 
blacks 
1999–2000 
2001–2002 
2003–2004 
* 
* 
* 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
9.00 (<LOD–10.4) 
22.3 (<LOD–31.5) 
23.2 (<LOD–40.9) 
17.5 (14.8–23.2) 
31.5 (23.2–65.0) 
40.9 (21.2–95.8) 
30.7 (19.0–53.4) 
356 
514 
490 
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Table 5-10.  Geometric Mean and Selected Percentiles of Serum p,p’-DDT (Lipid Adjusted in ng/g of Lipid or ppb 
on a Lipid-Weight Basis) for the U.S. Population from the National Health and Nutrition 
Examination Survey (NHANES) 1999–2004 
 
 
Survey yearsa 
Geometric mean 
(95% CI) 
Selected percentiles (95% confidence interval) Sample 
size 50th  75th  90th  95th 
 Non-
Hispanic 
whites 
1999–2000 
2001–2002 
2003–2004 
* 
* 
* 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
9.70 (8.50–11.2) 
<LOD 
17.9 (<LOD–20.7) 
12.9 (10.7–16.6) 
564 
1,061 
890 
 
Source: CDC 2018 
 
aThe LODs for survey years 1999–2000, 2001–2002, and 2003–2004 were 20.7. 17.4, and 7.8 ng/g, respectively. 
 
* = not calculated; the proportion of results below the limit of detection was too high to provide a valid result; CI = confidence interval; LOD = limit of detection 
 
Table 5-11.  Geometric Mean and Selected Percentiles of Serum p,p’-DDT (Whole Weight Lipid in ng/g of Serum 
or ppb) for the U.S. Population from the National Health and Nutrition Examination Survey (NHANES) 1999–2004  
 
 
Survey yearsa 
Geometric mean 
(95% CI) 
Selected percentiles (95% confidence interval) Sample 
size 50th  75th  90th  95th 
Total 1999–2000 
2001–2002 
2003–2004 
* 
* 
* 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
0.078 (0.065–0.097) 
0.170 (0.130–0.180) 
0.180 (0.160–0.220) 
0.128 (0.096–0.167) 
1,679 
2,305 
1,965 
Age group        
 12–19 years 1999–2000 
2001–2002 
2003–2004 
* 
* 
* 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
0.048 (<LOD–0.069) 
677 
756 
595 
 ≥20 years 1999–2000 
2001–2002 
2003–2004 
* 
* 
* 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
0.084 (0.068–0.106) 
0.190 (0.150–0.230) 
0.200 (0.170–0.260) 
0.142 (0.105–0.189) 
1,002 
1,549 
1,370 
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Table 5-11.  Geometric Mean and Selected Percentiles of Serum p,p’-DDT (Whole Weight Lipid in ng/g of Serum 
or ppb) for the U.S. Population from the National Health and Nutrition Examination Survey (NHANES) 1999–2004  
 
 
Survey yearsa 
Geometric mean 
(95% CI) 
Selected percentiles (95% confidence interval) Sample 
size 50th  75th  90th  95th 
Gender        
 Males 1999–2000 
2001–2002 
2003–2004 
* 
* 
* 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
0.071 (0.059–0.095) 
0.150 (<LOD–0.240) 
0.150 (<LOD–0.180) 
0.108 (0.078–.0180) 
799 
1,073 
959 
 Females 1999–2000 
2001–2002 
2003–2004 
* 
* 
* 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
0.130 (<LOD–0.150) 
0.087 (0.071–0.106) 
0.190 (0.150–0.230) 
0.240 (0.180–0.400) 
0.146 (0.106–0.207) 
880 
1,232 
1,006 
Race/ethnicity 
 Mexican 
Americans 
1999–2000 
2001–2002 
2003–2004 
* 
* 
* 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
0.063 (<LOD–0.079) 
0.400 (0.190–1.00) 
0.530 (0.250–1.34) 
0.146 (0.114–0.203) 
1.00 (0.330–4.26) 
1.62 (0.570–4.01) 
0.313 (0.189–0.627) 
635 
566 
461 
 Non-
Hispanic 
blacks 
1999–2000 
2001–2002 
2003–2004 
* 
* 
* 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
0.051 (<LOD–0.061) 
0.120 (<LOD–0.170) 
0.130 (<LOD–0.290) 
0.112 (0.080-0.143) 
0.180 (0.140–0.420) 
0.250 (0.120–0.530) 
0.201 (0.132–0.343) 
356 
514 
490 
 Non-
Hispanic 
whites 
1999–2000 
2001–2002 
2003–2004 
* 
* 
* 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
<LOD 
0.64 (0.054–0.075) 
<LOD 
0.130 (<LOD–0.140) 
0.086 (0.074–0.107) 
564 
1,061 
890 
 
Source: CDC 2018 
 
aThe LODs for survey years 1999–2000, 2001–2002, and 2003–2004 were 20.7. 17.4, and 7.8 ng/g, respectively. 
 
* = not calculated; the proportion of results below the limit of detection was too high to provide a valid result; CI = confidence interval; LOD = limit of detection 
 
DDT, DDE, and DDD  326 
 
5.  POTENTIAL FOR HUMAN EXPOSURE 
 
 
 
 
 
 
***DRAFT FOR PUBLIC COMMENT*** 
Table 5-12.  Geometric Mean and Selected Percentiles of p,p’-DDE (Lipid Adjusted in ng/g of Lipid or ppb on 
a Lipid-Weight Basis) for the U.S. Population from the National Health and Nutrition 
Examination Survey (NHANES) 1999–2004 
 
 Survey 
yearsa 
Geometric mean 
(95% CI) 
Selected percentiles (95% confidence interval) Sample 
size 50th  75th  90th  95th 
Total 1999–2000 
2001–2002 
2003–2004 
260 (226–298) 
295 (267–327) 
238 (195–292) 
226 (184–278) 
251 (228–278) 
203 (163–275) 
537 (476–631) 
598 (521–699) 
509 (376–655) 
1,150 (976–1,350) 
1,410 (1,210–1,500) 
1,170 (836–1,570) 
1,830 (1,410–2,300) 
2,320 (1,830–2,780) 
1,860 (1,400–2,380) 
1,964 
2,298 
1,956 
Age group        
 12–19 years 1999–2000 
2001–2002 
2003–2004 
118 (102–135) 
124 (106–146) 
105 (84.7–129) 
108 (97.7–119) 
113 (100–140) 
93.6 (81.0–114) 
185 (141–237) 
213 (172–253) 
167 (123–240) 
339 (243–479) 
319 (282–389) 
341 (211–586) 
528 (339–812) 
456 (343–722) 
522 (313–1,430) 
686 
758 
588 
 ≥20 years 1999–2000 
2001–2002 
2003–2004 
297 (256–344) 
338 (303–376) 
268 (217–332) 
269 (213–323) 
285 (249–337) 
233 (175–314) 
608 (530–693) 
695 (595–798) 
557 (420–734) 
1,260 (1,030–1,550) 
1,480 (1,310–1,700) 
1,270 (877–1,800) 
2,020 (1,520–2,730) 
2,550 (1,980–3,080) 
1,990 (1,500–2,470) 
1,278 
1,540 
1,368 
Gender        
 Males 1999–2000 
2001–2002 
2003–2004 
249 (220–283) 
285 (252–323) 
235 (193–288) 
223 (182–262) 
248 (222–285) 
200 (164–262) 
494 (380–578) 
520 (441–627) 
466 (331–653) 
1,010 (789–1,130) 
1,160 (937–1,360) 
1,000 (763–1,400) 
1,430 (1,080–2,160) 
1,900 (1,580–2,490) 
1,610 (1,210–2,320) 
937 
1,069 
955 
 Females 1999–2000 
2001–2002 
2003–2004 
270 (226–322) 
305 (273–341) 
241 (193–301) 
234 (184–302) 
256 (219–297) 
207 (161–281) 
601 (492–711) 
708 (567–844) 
539 (386–735) 
1,350 (1,040–1,720) 
1,480 (1,410–1,710) 
1,250 (813–1,900) 
2,210 (1,570–2,810) 
2,670 (1,940–3,300) 
2,010 (1,500–2,450) 
1,027 
1,229 
1,001 
Race/ethnicity 
 Mexican 
Americans 
1999–2000 
2001–2002 
2003–2004 
674 (574–792) 
652 (569–747) 
444 (362–545) 
624 (545–701) 
561 (455–690) 
373 (283–522) 
1,350 (1,090–1,660) 
1,400 (1,050–1,950) 
875 (608–1,170) 
3,090 (2,040–4,950) 
4,110 (2,520–6,550) 
2,150 (1,520–2,470) 
4,950 (3,070–9,350) 
7,080 (3,080–15,600) 
3,290 (2,380–9,240) 
657 
566 
457 
 Non–
Hispanic 
blacks 
1999–2000 
2001–2002 
2003–2004 
295 (241–362) 
324 (262–400) 
262 (233–295) 
251 (199–313) 
248 (223–296) 
216 (173–267) 
668 (492–874) 
762 (583–999) 
589 (453–747) 
1,850 (1,040–2,220) 
1,620 (1,180–2,980) 
1,620 (1,130–2,310) 
2,300 (1,560–5,680) 
3,260 (1,270–6,900) 
2,860 (1,880–3,440) 
416 
515 
487 
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Table 5-12.  Geometric Mean and Selected Percentiles of p,p’-DDE (Lipid Adjusted in ng/g of Lipid or ppb on 
a Lipid-Weight Basis) for the U.S. Population from the National Health and Nutrition 
Examination Survey (NHANES) 1999–2004 
 
 Survey 
yearsa 
Geometric mean 
(95% CI) 
Selected percentiles (95% confidence interval) Sample 
size 50th  75th  90th  95th 
 Non–
Hispanic 
whites 
1999–2000 
2001–2002 
2003–2004 
217 (189–249) 
253 (226–284) 
208 (165–263) 
194 (162–238) 
225 (203–254) 
177 (148–238) 
438 (355–507) 
463 (402–558) 
417 (302–564) 
825 (647–1,010) 
1,150 (878–1,340) 
907 (574–1,480) 
1,160 (1,010–1,350) 
1,640 (1,410–1,940) 
1,490 (909–2,300) 
732 
1,053 
888 
 
Source: CDC 2018 
 
aThe LODs for survey years 1999–2000, 2001–2002, and 2003–2004 were 18.6, 8.3, and 7.8 ng/g, respectively. 
 
CI = confidence interval; LOD = limit of detection 
 
 
Table 5-13.  Geometric Mean and Selected Percentiles of p,p’-DDE (Whole Weight in ng/g of Serum or ppb) for the 
U.S. Population from the National Health and Nutrition Examination Survey (NHANES) 1999–2004  
 
 Survey 
yearsa 
Geometric mean 
(95% CI) 
Selected percentiles (95% confidence interval) Sample 
size 50th  75th  90th  95th 
Total 1999–2000 
2001–2002 
2003–2004 
1.54 (1.33–1.79) 
1.81 (1.64–2.01) 
1.45 (1.18–1.79) 
1.31 (1.09–1.66) 
1.57 (1.37–1.72) 
1.28 (1.00-1.58) 
3.50 (2.97–4.27) 
3.97 (3.43–4.59) 
3.16 (2.40–4.21) 
7.49 (6.14–9.25) 
8.81 (7.85–10.1) 
7.07 (5.55–9.80) 
11.6 (9.25–14.8) 
15.4 (12.9–17.6) 
12.1 (8.37–16.0) 
1,964 
2,298 
1,956 
Age group        
 12–19 years 1999–2000 
2001–2002 
2003–2004 
.561 (.488–.646) 
.623 (.534–.716) 
.516 (.419–.635) 
0.520 (0.430–0.600) 
0.590 (0.500–0.730) 
0.456 (0.385–0.557) 
0.870 (0.680–1.18) 
1.00 (0.820–1.22) 
0.796 (0.611–1.19) 
1.52 (1.13–2.25) 
1.65 (1.39–2.07) 
1.69 (0.994–2.69) 
2.32 (1.76–3.56) 
2.30 (1.91–3.14) 
2.51 (1.56–6.71) 
686 
758 
588 
 ≥20 years 1999–2000 
2001–2002 
2003–2004 
1.83 (1.56–2.14) 
2.14 (1.91–2.39) 
1.69 (1.36–2.10) 
1.61 (1.26–2.07) 
1.77 (1.61–2.05) 
1.46 (1.12–1.96) 
4.17 (3.48–4.66) 
4.59 (4.10–5.26) 
3.68 (2.66–4.96) 
8.12 (6.37–10.6) 
9.75 (8.34–11.5) 
7.91 (6.01–11.0) 
12.3 (9.87–16.7) 
16.8 (13.7–19.1) 
12.8 (9.25–16.8) 
1,278 
1,540 
1,368 
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Table 5-13.  Geometric Mean and Selected Percentiles of p,p’-DDE (Whole Weight in ng/g of Serum or ppb) for the 
U.S. Population from the National Health and Nutrition Examination Survey (NHANES) 1999–2004  
 
 Survey 
yearsa 
Geometric mean 
(95% CI) 
Selected percentiles (95% confidence interval) Sample 
size 50th  75th  90th  95th 
Gender        
 Males 1999–2000 
2001–2002 
2003–2004 
1.49 (1.30–1.70) 
1.77 (1.57–2.01) 
1.46 (1.18–1.80) 
1.25 (1.10–1.44) 
1.59 (1.36–1.76) 
1.30 (1.04–1.58) 
3.02 (2.57–3.80) 
3.40 (3.03–4.10) 
2.80 (2.18–4.13) 
6.43 (5.40–8.00) 
7.48 (6.43–8.75) 
6.71 (5.51–8.54) 
9.63 (6.63–15.6) 
13.1 (9.66–17.6) 
9.93 (7.51–15.4) 
937 
1,069 
955 
 Females 1999–2000 
2001–2002 
2003–2004 
1.59 (1.32–1.92) 
1.85 (1.66–2.06) 
1.45 (1.16–1.82) 
1.38 (1.03–1.99) 
1.49 (1.32–1.75) 
1.25 (0.965–1.66) 
4.05 (3.15–4.79) 
4.57 (3.81–5.47) 
3.55 (2.43–4.59) 
8.18 (6.36–11.5) 
10.2 (9.01–11.9) 
7.87 (5.41–12.6) 
13.2 (9.81–18.5) 
16.8 (13.4–19.7) 
13.7 (8.50–17.3) 
1,027 
1,229 
1,001 
Race/ethnicity 
 Mexican 
Americans 
1999–2000 
2001–2002 
2003–2004 
3.92 (3.40–4.51) 
3.92 3.37–4.57) 
2.69 (2.18–3.32) 
3.52 (3.17–3.91) 
3.53 (2.68–4.34) 
2.24 (1.70–3.24) 
8.22 (7.26–10.4) 
9.34 (7.31–12.5) 
5.78 (4.54–7.21) 
22.0 (12.2–32.2) 
26.6 (17.9–38.3) 
13.0 (9.53–15.6) 
32.2 (19.7–48.1) 
40.9 (26.8–90.5) 
22.9 (15.3–43.4) 
657 
566 
457 
 Non–
Hispanic 
blacks 
1999–2000 
2001–2002 
2003–2004 
1.63 (1.31–2.02) 
1.82 (1.46–2.28) 
1.47 (1.30-1.65) 
1.37 (1.11–1.66) 
1.38 (1.22–1.72) 
1.20 (0.963–1.51) 
3.84 (3.01–5.69) 
4.39 (3.52–6.06) 
3.76 (2.85–4.75) 
11.2 (6.57–13.3) 
10.6 (7.24–17.6) 
9.23 (7.19–14.9) 
14.6 (8.88–35.2) 
19.4 (8.51–49.3) 
16.8 (14.7–20.6) 
416 
515 
487 
 Non–
Hispanic 
whites 
1999–2000 
2001–2002 
2003–2004 
1.32 (1.14–1.53) 
1.57 (1.39–1.76) 
1.29 (1.01–1.64) 
1.13 (1.01–1.35) 
1.41 (1.27–1.58) 
1.12 (0.890–1.49) 
2.88 (2.34–3.36) 
3.11 2.56–3.68) 
2.63 (1.84–3.90) 
5.75 (4.62–6.53) 
7.00 (6.02–8.34) 
6.36 (3.90–8.71) 
8.04 (6.32–9.81) 
11.3 (8.60–13.7) 
9.71 (6.01–15.0) 
732 
1,053 
888 
 
Source: CDC 2018 
 
aThe LODs for survey years 1999–2000, 2001–2002, and 2003–2004 were 18.6, 8.3, and 7.8 ng/g, respectively. 
 
CI = confidence interval; LOD = limit of detection 
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The results of a World Health Organization Survey for years 2000–2003 and 2005–2010 examined levels 
of ΣDDT in pooled human milk from 52 nations around the world (van den Berg et al. 2016).  The 
highest levels of ΣDDT were measured in Asian countries, particularly Tajikistan, which had levels 
nearly 3 times greater than those in India (see Figure 5-2).  Tropical countries that still use DDT for the 
prevention of malaria tended to have elevated levels in human milk, while levels in the United States and 
Europe tended to be lower.   
 
Figure 5-2.  Sum of DDT-like Compounds in µg/kg Lipid in Pooled Human 
Samples from Different Countries 
 
 
The dotted red line represents the calculated safe level of these compounds for the 
breastfed infant. 
 
Source: Van den Berg 2016 (used under http://creativecommons.org/licenses/by/4.0/; modified 
USA to United States) 
United States
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Levels of DDE and DDT in human milk, blood, and tissue appear in Table 5-14.  Correlations in the 
concentrations of DDT and its metabolites in human milk, adipose tissue, and blood serum have been 
observed.  The lipid adjusted mean concentrations of p,p’-DDT, p,p’-DDE, and p,p’-DDD in human milk 
(0.65, 4.00, and 0.01 mg/kg, respectively) have been shown to correlate well (r2=0.95, 0.89, and 0.75, 
respectively) with concentrations in adipose tissue (1.22, 4.36, and 0.02 mg/kg, respectively) 
(Waliszewski et al. 2001).  The lipid adjusted serum concentrations of p,p’-DDE were observed to 
correlate with concentrations of this compound in breast adipose tissue (Dorea et al. 2001).  The 
concentrations of p,p’-DDT and p,p’-DDE in blood serum taken from mothers in Veracruz, Mexico 
(1.848 and 4.378 mg/kg fat, respectively) have also been observed to correlate (r2=0.854 and 0.779, 
respectively) with concentrations in umbilical cord blood (2.800 and 4.676 mg/kg fat, respectively) 
(Waliszewski et al. 2000).  
 
Comparison of the concentrations of DDT and its metabolites in breast tissues and serum have been 
conducted in women with breast cancer in comparison to control subjects.  The mean concentrations 
(unadjusted for age) of p,p’-DDT and p,p’-DDD in breast tissues of U.S. women with breast cancer 
(261.6 and 9.8 ng/g lipid, respectively) did not statistically differ (p=0.23 and 0.79) from those measured 
in control subjects (267.3 and 24.0 ng/g lipid); however, the concentration of p,p’-DDE was statistically 
higher (p=0.006) in breast cancer patients (800.0 ng/g lipid) than in control subjects (709.1 ng/g lipid) 
(Bagga et al. 2000).  When the mean concentrations for p,p’-DDT, p,p’-DDE, and p,p’-DDD were 
adjusted for age, there was no statistical difference (p≤0.001) between cases and controls for all three 
compounds.  Statistically higher concentrations (p<0.05) of p,p’-DDE in serum were observed in both 
premenopausal (2.40 μg/g lipid) and postmenopausal (5.10 μg/g lipid) breast cancer patients from Mexico 
City, Mexico, in comparison to controls (1.93 and 3.12 μg/g lipid, respectively) (Romieu et al. 2000).  
The increased concentrations of p,p’-DDE in breast tissues of cancer patients has been attributed to 
increased exposures of these women to p,p’-DDE rather than to differences in the metabolism of 
p,p’-DDE by cancer cells (Romieu et al. 2000).  However, in a study of breast cancer patients and control 
subjects in the New York University Women’s Health Study, there was no statistical difference between 
the geometric means of the p,p’-DDE concentrations in serum (1,097 ng/g lipid in patients versus 
977 ng/g lipid in controls) obtained from these two groups of women (Wolff et al. 2000b).  A number of 
other studies have also found no statistical differences in the mean concentrations of DDT and/or its 
metabolites in serum or adipose tissue between cancer cases and controls (Demers et al. 2000; Dorgan et 
al. 1999; Helzlsouer et al. 1999; Krieger et al. 1994; Laden et al. 2001a; Liljegren et al. 1998; Lopez-
Carrillo et al. 1997; Mendonca et al. 1999; Moysich et al. 1998; Schecter et al. 1997; Unger et al. 1984; 
van’t Veer et al. 1997; Ward et al. 2000; Wolff et al. 2000a; Zheng et al. 1999, 2000). 
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Table 5-14.  Levels of DDT Compounds in Human Milk, Blood, and Tissues 
 
DDT 
compound Population Tissue Meana concentration 
Units as 
reported Reference 
Milk 
p,p’-DDT Maternity patients in Mexico City, 
Cuernavaca and rural Morelos 
Milk fat 0.71, 1.69, 4.84b mg/kg Elvia et al. 2000 
p,p’-DDT Mothers in Sweden Milk fat 14 μg/g Norén and 
Meironyté 2000 
p,p’-DDT Maternity patients in Mexico City Milk fat 0.162 mg/kg Torres-Arreola et 
al. 1999 
p,p’-DDT Women in Germany Milk fat 0.7 (estimated from graph) mg/kg Scheele et al. 
1995 
o,p’-DDT Maternity patients in Mexico City Milk fat 0.138 mg/kg Torres-Arreola et 
al. 1999 
p,p’-DDE Maternity patients in Mexico City, 
Cuernavaca and rural Morelos 
Milk fat 3.85, 6.51, 16.52b mg/kg Elvia et al. 2000 
p,p’-DDE Mothers in Sweden Milk fat 129 μg/g Norén and 
Meironyté 2000 
p,p’-DDE Inuit women in Canada Milk fat 962 μg/g Dewailly et al. 
2000 
p,p’-DDE Quebec women between 1989 and 1990 
(n=536) 
Milk fat 0.34 mg/kg Dewailly et al. 
1996 
p,p’-DDE Maternity patients in Mexico City Milk fat 0.594 mg/kg Torres-Arreola et 
al. 1999 
p,p’-DDE Maternity patients in Veracruz, Mexico Milk fat 5.302 mg/kg Pardio et al. 1998 
p,p’-DDE Mothers of hospitalized children in 
Zagreb, Croatia 
Milk fat 0.318 mg/kg Krauthacker et al. 
1998 
ΣDDT Canadian women, 1986 (n=412) Milk fat 0.385 mg/kg Smith 1999 
ΣDDT Arkansas women, 1986 (n=536) Milk fat 0.99 mg/kg Smith 1999 
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Table 5-14.  Levels of DDT Compounds in Human Milk, Blood, and Tissues 
 
DDT 
compound Population Tissue Meana concentration 
Units as 
reported Reference 
Blood 
p,p’-DDT Workers in Sao Paulo, Brazil 
 
Serum 13.5 (DDT appliers) 
1.5 (unexposed) 
μg/L Minelli and 
Ribeiro 1996 
o,p’-DDT Workers in Sao Paulo, Brazil Serum <0.7–4.7 (range; DDT appliers) μg/L Minelli and 
Ribeiro 1996 
p,p’-DDE Workers in Sao Paulo, Brazil Serum 64.3 (DDT appliers) 
14.3 (unexposed) 
μg/L Minelli and 
Ribeiro 1996 
p,p’-DDT Men in southeast Sweden Blood plasma 0.11 (lipid adjusted) ng/g Asplund et al. 
1994 
p,p’-DDE Woman hospital patients in New Haven, 
Connecticut 
Serum (lipid-adjusted) 967 (median), <1.0–2261.5 (range) 
(n=36) 
ng/g Archibeque-
Engle et al. 1997 
p,p’-DDE Iowa and North Carolina farmers and 
spouses 
Serum 0.39–6.51 (range) μg/L Brock et al. 1998 
o,p’-DDE Iowa and North Carolina farmers and 
spouses 
Serum 0.71–2.31 (range) μg/L Brock et al. 1998 
p,p’-DDE Women without breast cancer in Long 
Island 
Serum 4.7 μg/L Stellman et al. 
1998 
p,p’-DDE New York University Women’s Health 
Study (1985–1991) 
Serum 11.0±9.1 in cancer patients (n=58) 
  7.7±6.8 controls (n=171) 
μg/L Wolff et al. 1993 
p,p’-DDE Female hospital patients in New York 
City 
Plasma 6.93–7.29 (range of mean values) μg/L Gammon et al. 
1997 
p,p’-DDE Female hospital patients in New York 
City 
Plasma (lipid-
adjusted) 
0.963–0.997 (range of mean values) μg/mL Gammon et al. 
1997 
p,p’-DDE 191 Children from California Childhood 
Leukemia Study (1999–2007) 
Whole blood 690 (median), 1,400 (75th percentile), 
4,100 (90th percentile), 
110,000 (maximum) 
pg/mL Whitehead et al. 
2015 
p,p’-DDE Mothers in Veracruz, Mexico Serum 14.5 ng/mL Waliszewski et al. 
2001 
p,p’-DDE Men in southeast Sweden Plasma 2.4–14 (range of mean values among 
groups of men with different levels of 
fish consumption) 
ng/g Asplund et al. 
1994 
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Table 5-14.  Levels of DDT Compounds in Human Milk, Blood, and Tissues 
 
DDT 
compound Population Tissue Meana concentration 
Units as 
reported Reference 
p,p’-DDE Men in southeast Sweden Plasma (lipid-
adjusted) 
750–4,500 (range of mean values 
among groups of men with different 
levels of fish consumption) 
ng/g Asplund et al. 
1994 
DDE Controls in a case-control study nested 
within the Nurses Health Study (n=240) 
Plasma 7.09 ppbc Laden et al. 1999 
p,p’-DDE Four groups of refugees from Asia, 
‘USSR,’ Africa, ‘Yugoslavia’ (n=103); 
controls from Germany (n=34) 
Plasma 2.30–16.90 (range of median values)  
12.20–93.00 (range of maximum 
values) (refugees) 
1.14 (median), 4.97 (maximum) 
(controls) 
μg/L Schmid et al. 
1997 
p,p’-DDT Residents of Nainital, India Serum 4.46 (mean), range (0.78–14.29) mg/L Dua et al. 2001 
p,p’-DDE Residents of Nainital, India Serum 1.55 (mean), range (0.14–4.10) mg/L Dua et al. 2001 
p,p’-DDD Residents of Nainital, India Serum 0.91 (mean), range (ND–2.82) mg/L Dua et al. 2001 
p,p’-DDE New Bedford area infants Cord blood 0.493 ng/g 
serum 
Korrick et al. 
2000 
p,p’-DDE Maternity patients in Veracruz, Mexico Cord blood 6.0 ng/mL Waliszewski et al. 
2001 
p,p’-DDE Maternity patients in Nicaragua Venous blood (lipid-
adjusted) 
7.12 (mean), range (0–35.23) (n=52) ng/g Dorea et al. 2001 
p,p’-DDE Maternity patients in Nicaragua Cord blood (lipid-
adjusted) 
6.39 (mean), range (0–9.35) (n=52) ng/g Dorea et al. 2001 
p,p’-DDT Great Lakes fishermen (n=30); controls 
(n=180) 
Serum 0.3 (median), 0.05–0.8 (range) 
ND (controls) 
ppbc Anderson et al. 
1998 
o,p’-DDT Great Lakes fishermen (n=30); controls 
(n=180) 
Serum 0.06 (median), 0.03–0.3 (range) 
ND (controls) 
ppbc Anderson et al. 
1998 
p,p’-DDE Great Lakes fishermen (n=30); controls 
(n=180) 
Serum 5.2 (median), 0.6–23.9 (range) 
2.8 (median), ND–38.5 (range) 
(controls) 
ppbc Anderson et al. 
1998 
DDE Frequent GLSCF (Lake Michigan) males 
(n=98); females (n=83); male controls 
(n=23); female controls (n=22) 
Serum 6.9 (males), 2.9 (females), 
2.6 (controls, males), 1.4 (controls, 
females) (geometric means) 
ppbc Hanrahan et al. 
1999 
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Table 5-14.  Levels of DDT Compounds in Human Milk, Blood, and Tissues 
 
DDT 
compound Population Tissue Meana concentration 
Units as 
reported Reference 
DDE Frequent GLSCF (Lake Huron) males 
(n=65); females (n=37); male controls 
(n=3); female controls (n=3) 
Serum 3.5 (males), 2.3 (females), 
2.6 (controls, males), 0.6 (controls, 
females) (geometric means) 
ppbc Hanrahan et al. 
1999 
DDE Frequent GLSCF (Lake Erie) males 
(n=89); females (n=67); male controls 
(n=31); female controls (n=17) 
Serum 3.8 (males), 2.0 (females), 
2.0 (controls, males), 1.7 (controls, 
females) (geometric means) 
ppbc Hanrahan et al. 
1999 
ΣDDT 1982 Great Lakes fish eaters (n=572); 
controls (n=419) 
Serum 28.8 
10.6 (controls) 
ppbc Hovinga et al. 
1992 
ΣDDT 1982 Southern Great Lakes fish eaters 
(n=115); controls (n=95) 
Serum 25.8 
9.6 (controls) 
ppbc Hovinga et al. 
1992 
ΣDDT 1989 Southern Great Lakes fish eatersd 
(n=115); controls (n=95) 
Serum 15.6 
6.8 (controls) 
ppbc Hovinga et al. 
1992 
Adipose and other tissue 
p,p’-DDT Children in Germany Adipose 0.6 (estimated from graph) mg/kg Scheele et al. 
1995 
p,p’-DDT Children in Germany Bone marrow (lipid-
adjusted) 
1.75 (estimated from graph) mg/kg Scheele et al. 
1995 
p,p’-DDT Woman hospital patients in New Haven, 
Connecticut 
Adipose, breast (lipid-
adjusted) 
132.2 (median), 54.0–418.2 (range) 
(n=36) 
ng/g Archibeque-
Engle et al. 1997 
p,p’-DDT Maternity patients in Veracruz, Mexico Adipose, abdomenal 
(lipid-adjusted) 
1.22 (mean), 0.01–9.03 (range) (n=60) mg/kg Waliszewski et al. 
2001 
p,p’-DDE Maternity patients in Veracruz, Mexico Adipose, abdomenal 
(lipid-adjusted) 
4.36 (mean), 0.31–16.04 (range) 
(n=60) 
mg/kg Waliszewski et al. 
2001 
p,p’-DDD Maternity patients in Veracruz, Mexico Adipose, abdomenal 
(lipid-adjusted) 
0.02 (mean), ND–0.25 (range) (n=60) mg/kg Waliszewski et al. 
2001 
p,p’-DDE Woman hospital patients in New Haven, 
Connecticut 
Adipose, breast (lipid-
adjusted) 
970 (median), 240.0–2,644.1 (range) 
(n=36) 
ng/g Archibeque-
Engle et al. 1997 
p,p’-DDT Adults in Germany Bone marrow (dry 
lipid-adjusted) 
0.364 ppmc Scheele 1998 
p,p’-DDE Adults in Germany Bone marrow (dry 
lipid-adjusted) 
1.689 ppmc Scheele 1998 
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Table 5-14.  Levels of DDT Compounds in Human Milk, Blood, and Tissues 
 
DDT 
compound Population Tissue Meana concentration 
Units as 
reported Reference 
p,p’-DDE Women without breast cancer in Long 
Island 
Adipose 546.7 ng/g Stellman et al. 
1998 
p,p’-DDE Adults in Sweden who suffered sudden 
death 
Liver (lipid-adjusted) 836 ng/g Weistrand and 
Norén 1998 
p,p’-DDE Adults in Sweden who suffered sudden 
death 
Adipose, abdominal 788 ng/g Weistrand and 
Norén 1998 
p,p’-DDE FY 1986 National Adipose Tissue Survey 
Composite samples (n=50, from 
671 specimens) 
Adipose 2,340 (SE 12) (nation)  
1,710 (SE 22%) (0–14 years) 
2,150 (SE 17%) (15–44 years) 
3,080 (SE 13%) (45+ years) 
ng/g Lordo et al. 1996 
p,p’-DDT FY 1986 National Adipose Tissue Survey 
Composite samples (n=50, from 
671 specimens) 
Adipose 177 (SE 11%) (nation)  
73.0 (SE 36%) (0–14 years) 
177 (SE 16%) (15–44 years) 
252 (SE 13%) (45+ years) 
ng/g Lordo et al. 1996 
p,p’-DDE Women patients at Hartford Hospital, 
Hartford, Connecticut 
Adipose, breast (lipid 
basis) 
2,200±1,470 cancer patients (n=20)  
1,487±842 controls (n=20) 
ng/g Falck et al. 1992 
p,p’-DDT Women patients at Hartford Hospital, 
Hartford, Connecticut 
Adipose, breast (lipid-
adjusted) 
216±174 cancer patients (n=20) 
148±75 controls (n=20) 
ng/g Falck et al. 1992 
p,p’-DDE Rochester, New York; Milwaukee, 
Wisconsin; Sacramento, California 
Placenta  205 (n=169) pg/g Nanes et al. 2014 
 
aArithmetic mean concentrations are reported unless otherwise specified. 
bGeometric mean concentrations. 
cppm=μg/g; ppb=ng/g. 
dSame Southern Great Lakes fish eaters who participated in the 1982 study. 
 
FY = fiscal year; GLSCF = Great Lakes sport caught fish; ND = not detected; SE = standard error 
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Methyl sulfonyl metabolites of p,p’-DDE, primarily the 3-methylsulfone isomer, have been found in 
seven surveys of human milk in Sweden between 1972 and 1992 (Norén et al. 1996).  In that time, levels 
declined from 5.05 to 0.46 ng/g lipids and the ratio of the 3-methylsulfone metabolite to p,p’-DDE 
remained constant at 0.002. 
 
Fish from areas like the Great Lakes and Baltic Sea appear to be an important source of exposure to DDT 
and DDE, and human blood levels of these compounds have been found to correlate with the 
consumption of fish containing high levels of DDT and DDE (Anderson et al. 1998; Asplund et al. 1994; 
Hovinga et al. 1992).  A Swedish study found that the mean plasma lipid concentrations of p,p’-DDE 
were 750, 1,200, and 4,500 ng/g in groups of men eating no fish, moderate quantities of fish, and large 
quantities of fish, respectively, from the Baltic Sea (Asplund et al. 1994).  The respective lipid plasma 
concentrations of p,p’-DDT in these groups of men were 20, 45, and 130 ng/g.  The mean serum DDT 
level in individuals eating more than 20 pounds of sport-caught Great Lakes fish dropped from 25.8 to 
15.6 ppb (65% decrease) during the period from 1982 to 1989.  Mean serum DDT levels in the controls 
dropped from 9.6 to 6.8 ppb (41% decrease).  It was concluded that the decrease in serum DDT 
concentrations was due to lower levels of DDT in the fish and in the environment, rather than to a 
decrease in fish consumption (Hovinga et al. 1992). 
 
A study of residents in Triana, Alabama, living downstream from a former DDT manufacturing facility 
revealed mean serum levels of total DDT of 76.2 ppb (Kreiss et al. 1981).  This was several times higher 
than other reported levels.  Kreiss et al. (1981) also found that serum DDT levels increased with 
increasing age.  Residents living near a pesticide dump site in Aberdeen, North Carolina, known to 
contain high concentrations of DDT, have been shown to have age-adjusted mean levels of DDE in their 
blood of 4.05 ppb, which is higher than the mean value of 2.95 ppb obtained from residents of 
neighboring communities (Vine et al. 2000). 
 
Mean levels of total equivalent of DDT, DDE, and DDD in maternal blood in pregnant women in India 
(20 samples) were found to be 25.3 ppb compared to levels in placental tissue of 22.2 ppb (Saxena et al. 
1987).  Similar levels (30.8 ppb) were seen in maternal blood in Brazilian women (Procianoy and 
Schvartsman 1981).  Saxena et al. (1981, 1983) presented data on a limited number of samples of blood 
and placental tissues of women that aborted or delivered prematurely, which suggested that p,p’-DDE 
concentrations were elevated compared to control groups.  p,p’-DDE was detected in 100% of 
169 placenta specimens collected Rochester, New York; Milwaukee, Wisconsin; and Sacramento, 
California (Nanes et al. 2014).  The mean concentration was 205 pg/g (0.205 ppb) and the median level 
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was 81 pg/g (0.081 ppb).  The authors noted that higher concentrations were observed from the samples 
collected in Sacramento as compared to Rochester (p=0.03). 
 
Adipose tissue from a subgroup of 40 workers engaged in spraying DDT for malaria control in Mexico 
contained the following median and maximum levels of DDT metabolites (μg/g): ΣDDT, 114.60, 665.56; 
p,p’-DDT, 46.96, 344.98; o,p’-DDT, 2.96, 29.74; p,p’-DDE, 64.96, 298.42; and p,p’-DDD, 0.62, 
3.51 (Rivero-Rodriguez et al. 1997).  Based on these measurements and a survey of the work habits of 
other workers, a geometric mean p,p’-DDE concentration of 67.41 μg/g was predicted for the population 
of 331 workers, 80% of whom were employed in the sanitation campaign for 20 years.  Mean ΣDDT 
serum level in a group of 26 malaria control sprayers in Brazil was 76.9 μg/L and ranged from 7.5 to 
473.5 μg/L, whereas 16 unexposed workers had mean serum levels of 16.1 μg/L (range:  5.1–32.9 μg/L) 
(Minelli and Ribeiro 1996).  p,p’-DDT and p,p’-DDE serum levels in the exposed workers were 1.6–
62.9 and 5.9–405.9 μg/L, respectively. 
 
5.7   POPULATIONS WITH POTENTIALLY HIGH EXPOSURES  
 
Children are exposed to DDT through their diet.  Since the greatest dietary intake of DDT is from meat, 
fish, poultry, and dairy products, infants and young children for whom a substantial part of their food is 
milk may be exposed to DDT.  According to the FDA study of 1986–1991, the mean daily intake of DDT 
and its metabolites is 0.0448, and 0.0438 μg/kg body weight/day for a 6–11-month-old infant and 2-year-
old child, respectively (Gunderson 1995b).  This is roughly 4 times the intake per unit body weight for an 
adult (see Table 5-3). 
 
DDT and DDE selectively partition into fatty tissue and into human breast milk, which has a higher fat 
content than cow’s milk.  The concentration of DDT, or other hydrophobic pollutants, in milk is often 
expressed on a lipid basis (i.e., μg/g lipid rather than μg/mL milk) as it is a more accurate measure of 
DDT content due to the fluctuating fat content of the milk.  Generally, these compounds are found in 
human breast milk in concentrations higher than in cow’s milk or other infant foods.  As a result, 
breastfed infants may receive higher dietary exposure than those who are not breastfed.  If a woman has 
been exposed to high levels of DDT in the past, her milk may contain high levels of DDT, which would 
be transferred to her child.  Women exposed to high levels of DDT would include Eskimos and Indian 
women in Arctic regions who eat traditional foods as well as women who eat large quantities of fish from 
lakes and rivers known to have high concentrations of DDT in fish, such as the Great Lakes and the 
Yakima River, Washington (Bard 1999; Kuhnlein et al. 1995; Marien and Laflamme 1995).  Methods 
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have been proposed for estimating breast milk lipid concentrations of DDT from a mother’s daily intake 
(Marien and Laflamme 1995).  Mean levels of p,p’-DDT in human breast milk in pooled milk from the 
Mothers’ Milk Center in Stockholm steadily declined from 0.71 μg/g lipid in 1972 to 0.36, 0.18, and 
0.061 μg/g lipid in 1976, 1980, and 1984–1985, respectively (Norén 1988).  Mean levels of p,p’-DDE for 
these years were 2.42, 1.53, 0.99, and 0.50 μg/g lipid, respectively.  Between 1967 and 1985, the levels of 
p,p’-DDE and p,p’-DDT in human milk in Sweden declined by 75 and 95% (Norén 1993).  In another 
study conducted between 1972 and 1992, this same group of investigators noted a similar decline in 
p,p’-DDE and p,p’-DDT concentrations in human milk in Sweden; the rates at which the concentration of 
these two compounds have been declining has also been progressively decreasing with time during this 
same period (Norén et al. 1996).  The use of DDT was banned in Sweden in 1970.  Mean (maximum) 
p,p’-DDT concentrations in 54 samples of mothers’ milk from Hawaii (1979–1980) were 0.16 (0.52) μg/g 
lipid compared with 0.19 (1.7) μg/g lipid in 102 samples from the U.S. mainland (Takei et al. 1983).  
Mean (maximum) p,p’-DDE levels in Hawaiian and mainland samples were 2.0 (5.7) and 1.9 (11.0) μg/g 
lipid.  A 1982 Canadian survey that included 210 samples of breast milk from across the country resulted 
in mean levels of p,p’-DDE, p,p’-DDT, p,p’-DDD, and o,p’-DDT in ng/g milk (ng/g milkfat) of 34 (911), 
3 (80), 1 (27), and trace (12), respectively, down from 103, 33, 4, and 5 ng/g milk, respectively, obtained 
in a 1967 survey (Mes et al. 1986).  The maximum p,p’-DDE, p,p’-DDT, p,p’-DDD, and o,p’-DDT levels 
in the 1982 survey were 5,500, 450, 113, and 58 ng/g milkfat.  Levels of DDT in breast milk have shown 
a downward trend starting in about 1970.  In 28 studies from the United States and Canada, average DDT 
levels in breast milk were about 4,000–5,000 ng/g lipid in the early 1970s, and then steadily declined by 
1975.  For 13 studies from 1975 on, there was an 11–21% reduction in mean ΣDDT levels per year.  
Another way of viewing this is that the mean breast milk level in the population is being reduced by one-
half in 4.2–5.6 years.  Similar reductions have been observed in Western European countries.  While 
exposure of humans by eating fish from the Great Lakes has been a source of concern, in one study, Mes 
and Malcolm (1992) found that levels of DDE and DDT in breast milk were lower in women in the Great 
Lake’s Basin than in women in the rest of Canada.  Levels of DDE in cow’s milk have similarly declined.  
The mean level of DDE in milk supplies in Southern Ontario, Canada declined from 96 ng/g lipid in 
1970–1971 to 16 ng/g lipid in 1985–1986, indicating that the levels are being reduced by one-half in 
5.8 years (Frank and Braun 1989).  Since levels of DDT in food have been declining, exposure of children 
to DDT through their diet would be much less than in the past. 
 
Children may be exposed to DDT by ingesting contaminated soil or dust, from dermal contact with the 
soil, or by inhaling dust and then swallowing it after mucociliary transport up out of the lungs.  DDT is 
extremely persistent in soil and there are soils that still contain high levels of the insecticide.  No reports 
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have been found, however, concerning childhood exposures to DDT by ingesting dirt.  DDT is strongly 
adsorbed to soil, especially when the organic content of the soil is high.  No studies were found as to how 
bioavailable DDT-adsorbed soil is when ingested.  In addition, no information was found on the 
absorption of ingested DDT in any form in children.  Children may also be exposed to DDT improperly 
stored at waste sites.  One study indicated that old carpeting may contain high levels of DDT (Lewis et al. 
1994).  The DDT may have contaminated the carpet material or may have been tracked in from outside.  
Children may be exposed to this DDT while crawling around or playing on contaminated carpeting. 
 
Since DDT partitions into lipids and is not readily metabolized, levels of DDT in adipose tissue increase 
with age.  Levels of DDT and DDE in children aged 0–14 as reported in EPA’s FY 1986 National 
Adipose Tissue Survey appear in Table 5-14 (Lordo et al. 1996).   
 
Because of the ban on DDT use after 1972, fewer persons in the United States should be exposed to high 
levels of these compounds today than in the past.  Only fish and marine mammal consumption in the 
Arctic appear to be significant dietary contributors to human exposure to DDT in the general population 
(Laden et al. 1999).  A 1982 study by the Michigan Department of Public Health found that people eating 
large quantities of Great Lakes fish had significantly higher serum DDT levels compared to non-fish-
eating control populations.  A follow-up study in 1989 found that serum DDT levels were primarily a 
reflection of historic exposures and previously established body burden rather than recent exposure 
(Hovinga et al. 1993).  Other studies confirm these findings (Anderson et al. 1998; Hanrahan et al. 1999).  
The best predictors of serum DDE levels in frequent Great Lakes sport fish consumers were found to be 
age, years of eating sport caught fish, male gender, and BMI, which respectively accounted for 20, 10, 9, 
and 9% of the variance (Hanrahan et al. 1999).  In general, DDT-contaminated fish are caught by sport or 
subsistence fisherman and not purchased at the market (Laden et al. 1999).  As the levels of DDT in Great 
Lakes fish decline, fish consumption is less likely to be a source of potentially high exposure.  Because of 
the partitioning of DDT and DDE into fatty tissue and fluids, breastfed infants are likely to receive doses 
in excess of those occurring from ingestion of cow’s milk or other infant foods.  Monitoring exposure of 
infants via breast milk has been extensive and provides evidence of the persistence of DDT and DDE in 
fatty tissues.  The finding that old carpeting may contain high levels of DDT indicates that this may be an 
important, but unevaluated source of exposure, especially in small children crawling on the carpeting 
(Lewis et al. 1994).   
 
A study of Mexican Americans, born in Mexico, found elevated serum levels of p,p’-DDT that declined 
with increasing years in the United States and increased with age (Everett et al. 2017b).  Significantly 
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higher serum levels were found in Mexican Americans living in the United States for <5 years, as 
compared to those living in the United States for >30 years.  The percentage of individuals with serum 
p,p’-DDT levels >0.086 ng/g were 10.1, 55.8, 29.5, and 4.6% for 12–19, 20–39, 40–64, and ≥65 years of 
age, respectively.  The study also found a decline in serum p,p’-DDT serum levels 3–4 years after Mexico 
banned the use of DDT in 2000.    
 
Workers involved with formulation, packaging, and application of DDT in the past would be expected to 
have been exposed to levels higher than those encountered in the environment.  Persons who live near 
NPL sites containing DDT, DDE, or DDD might be exposed to higher levels than the general population. 
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CHAPTER 6.  ADEQUACY OF THE DATABASE 
 
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with the 
Administrator of EPA and agencies and programs of the Public Health Service) to assess whether 
adequate information on the health effects of DDT, DDE, and DDD is available.  Where adequate 
information is not available, ATSDR, in conjunction with NTP, is required to assure the initiation of a 
program of research designed to determine the health effects (and techniques for developing methods to 
determine such health effects) of DDT, DDE, and DDD. 
 
Data needs are defined as substance-specific informational needs that if met would reduce the 
uncertainties of human health assessment.  This definition should not be interpreted to mean that all data 
needs discussed in this section must be filled.  In the future, the identified data needs will be evaluated 
and prioritized, and a substance-specific research agenda will be proposed.  
 
6.1   INFORMATION ON HEALTH EFFECTS 
 
Studies evaluating the health effects of inhalation, oral, and dermal exposure of humans and animals to 
DDT, DDE, and DDD which are discussed in Chapter 2 are summarized in Figure 6-1.  The purpose of 
this figure is to illustrate the information concerning the health effects of DDT, DDE, and DDD.  The 
number of human and animal studies examining each endpoint is indicated regardless of whether an effect 
was found and the quality of the study or studies.   
 
As illustrated in Figure 6-1, most of the data on the toxicity of DDT, DDE, and DDD come from 
epidemiology studies with a presumed oral route of exposure and from oral exposure studies in laboratory 
animals.  A small number of studies have examined toxicity following inhalation or dermal exposure.  
Most of the oral exposure studies examined reproductive, neurological, cancer, and developmental 
endpoints.   
 
6.2   IDENTIFICATION OF DATA NEEDS 
 
Missing information in Figure 6-1 should not be interpreted as a “data need”.  A data need, as defined in 
ATSDR’s Decision Guide for Identifying Substance-Specific Data Needs Related to Toxicological 
Profiles (ATSDR 1989), is substance-specific information necessary to conduct comprehensive public 
health assessments.  Generally, ATSDR defines a data gap more broadly as any substance-specific 
information missing from the scientific literature. 
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Figure 6-1.  Summary of Existing Health Effects Studies on DDT, DDE, and DDD By Route and Endpoint* 
 
Most health effects research on DDT, DDE, and DDD focused on oral exposure 
The most studied endpoints (in humans & animals) were reproductive, neurological and developmental effects and cancer 
 
 
 
 *Includes studies discussed in Chapter 2; the number of studies include those finding no effect; 
many studies examined more than one endpoint.   
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Acute-Duration MRLs.  Information on health effects following acute inhalation of DDT, DDE, or 
DDD in humans (Neal et al. 1944) was limited.  Because of the lack of adequate inhalation data in 
humans or animals, an acute inhalation MRL for DDT, DDE, and DDD was not derived.  Additional 
inhalation data are needed to identify critical targets of toxicity and evaluate concentration-response 
relationships.  
 
With acute oral exposure to high doses, the nervous system appears to be the major target in both humans 
and animals.  Acute oral exposure has been associated with tremors or convulsions in humans (e.g., Hsieh 
1954; Velbinger 1947a, 1947b) and animals (e.g., Hong et al. 1986; Matin et al. 1981).  An acute MRL 
for DDT, DDE, and DDD was based on neurobehavioral effects observed in adult mice following acute 
perinatal exposure to technical DDT (Eriksson et al. 1990a, 1990b, 1992, 1993; Johansson et al. 1995, 
1996; Talts et al. 1998).  Further acute oral exposure studies during critical windows of embryonic, fetal, 
or neonatal development in species may provide confirmatory evidence.  Also of interest would be 
comparison of the neurodevelopmental toxicity of different isomerics of DDT, DDD, and DDE.  Of most 
interest would be studies on the isomer, p,p’-DDE, detected at the highest concentrations in 
environmental media, human tissues and fluids, and foods.  
 
Intermediate-Duration MRLs.  A single study of volunteers repeatedly exposed to oral doses up to 
0.5 mg technical DDT/kg/day reported no effects on body weight, cardiovascular performance (e.g., 
blood pressure, heart rate), liver function tests, or self-reported neurological symptoms (Hayes et al. 
1956).  Numerous animal studies have evaluated the oral toxicity of DDT, DDE, or DDD and their related 
isomers following intermediate-duration exposure.  These studies examined a wide range of potentially 
sensitive targets.  The most sensitive outcomes were hepatic, reproductive, developmental, 
immunological, and neurological effects.  A provisional intermediate-duration oral MRL was derived 
based on hepatic toxicity (hepatocellular hypertrophy) in rats fed p,p’-DDT for 26 weeks (Harada et al. 
2003, 2006).  
 
Additional inhalation data are needed to identify critical targets of toxicity and evaluate concentration-
response relationships.   
 
Chronic-Duration MRLs.  Human data suitable for deriving chronic-duration MRLs are not available.  
At least 35 animal studies have evaluated the chronic oral toxicity of DDT, DDE, or DDD and their 
related isomers. These studies examined a wide range of potentially sensitive target and provide data 
suitable for deriving a provisional chronic-duration oral MRL.  The most sensitive effects appear to be 
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hepatic, body weight, developmental, hematological, and neurological outcomes.  Liver effects were 
selected as the critical effect, because the lowest LOAEL was for liver effects and extensive supporting 
data support it as the most sensitive effect.  A chronic-duration oral MRL was derived based on 
hepatocellular hypertrophy in rats fed p,p’-DDT for 2 years (Harada et al. 2003, 2006). 
 
No chronic-duration inhalation toxicity studies in animals that could be used to establish concentration-
response relationships were located; these data are needed for derivation of a chronic-duration inhalation 
MRL.   
 
The derivation of acute, intermediate, or chronic oral MRLs based on human epidemiological data might 
be possible with additional research to develop and validate a human PBPK model that could reliably 
estimate oral intake levels from levels of DDT, DDE, or DDD in biological fluids or tissues. To date, 
limited but consistent epidemiological evidence has been provided for associations with risks for a few 
noncancer health outcomes (abortion or preterm births, wheeze in infant or child offspring, and DMT2 in 
adults).   
 
Health Effects.  Toxicity studies of laboratory animals exposed by the inhalation or dermal routes are 
very small in number.  Air monitoring data suggest that DDT and its metabolites are still present decades 
after its use was banned.  Health effect studies are needed to evaluate possible health effects associated 
with long-term exposure to low concentrations of DDT in air.   
 
Numerous epidemiological studies have examined possible associations between levels of DDT, DDE, or 
DDD in samples of biological fluids or tissues and a wide array of health outcomes.  To date, consistent 
epidemiological evidence for positive associations (across studies) was provided for only a few health 
outcomes (abortion or preterm births, wheeze in infant or child offspring, DMT2 in adults, and liver 
cancer).   
 
In contrast, numerous studies of laboratory animals orally exposed to DDT, DDE, or DDD for acute, 
intermediate, and chronic durations and a few controlled-exposure studies of volunteers have identified 
several sensitive toxicity targets.  For each of these toxicity targets, additional research comparing the 
potency of the various isomers and pertinent mixtures in various short-term in vivo or in vitro test systems 
may lead to refinements of the current MRLs, which are assumed to be applicable to exposure to any of 
the isomers or their mixtures. 
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Hepatic.  Recent mechanistic studies in rats indicate that p,p’-DDT initially induces (presumably 
through activation of the CAR) liver microsomal xenobiotic metabolizing enzymes and transient 
bursts in DNA synthesis and cell proliferation that lead to increased liver weight, hypertrophy, 
eosinophilic abnormal hepatic foci, and eventually liver tumors (Harada et al. 2003, 2006, 2016).  
Additional similar research with other isomers and other species may provide useful information 
to evaluate the relevance of DDT-induced liver effects in rodents to humans.  Studies with micro-
dissected liver tissues or liver tissue culture systems may be particularly useful, especially for 
cross-species extrapolation issues.  
 
Neurological and Neurodevelopmental.  Neurological symptoms such as tremors from 
relatively high oral doses of DDT and DDE isomers or mixtures like technical DDT have been 
observed in acutely exposed human adults and laboratory animals after acute, intermediate, or 
chronic oral exposure, but limited evidence indicates that this response does not occur in 
laboratory animals exposed to DDD (NCI 1978).  Brain chemistry changes have been associated 
with these high-dose symptoms in adult laboratory animals (Hong et al. 1986; Hrdina et al. 1973; 
Hudson et al. 1985; Hwang and Van Woert 1978; Tilson et al. 1986), but brain neurochemical 
changes and behavioral changes have been observed after acute exposure to a very low dose of 
technical DDT (0.5 mg/kg/day) on PND 10, but not on PND 3 or 18 (Eriksson and Nordberg 
1986; Eriksson et al. 1990a, 1990b, 1992, 1993; Johansson et al. 1995, 1996).  As discussed for 
the acute-duration MRL data needs, additional acute oral exposure studies during critical 
windows of embryonic, fetal, or neonatal neurodevelopment using different isomers (e.g., 
p,p’-DDE) or mixtures or species may be informative. 
 
Reproductive and Developmental Reproductive.  Epidemiological studies examining 
possible associations between levels of DDT, DDE, or DDD in biological fluids or tissues and a 
wide array of reproductive health outcomes have provided inconsistent evidence for associations 
or no evidence for association, except for studies providing consistent evidence of increased risk 
for abortions or preterm births in women with elevated levels of biomarkers (Korrick et al. 2001; 
Longnecker et al. 2005; Ouyang et al. 2014; Torres-Arreola et al. 2003; Venners et al. 2005; 
Wood et al. 2007).  Further case-control studies in regions where DDT continues to be used for 
insect control may be useful to better determine if increased risk for abortions or preterm birth is 
a human health outcome associated with DDT exposure.  Studies of mature and developing 
laboratory animals orally exposed to DDT, DDE or DDD have reported effects on reproductive 
endpoints at dose levels ≥~5 mg/kg/day.  Additional reproductive toxicity animal studies are not 
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needed, because reproductive effects in laboratory animals appear to be less sensitive effects from 
DDT, DDE, or DDD exposure than liver and neurodevelopmental effects.  
 
Immunological.  Epidemiological studies provided consistent evidence for associations 
between levels of DDE in cord blood or maternal serum during pregnancy and prevalence of 
wheeze (or airway obstruction) in infant or child offspring (Gascon et al. 2012; 2014; Hansen et 
al. 2016; Sunyer et al. 2005, 2006), but inconsistent evidence for associations with prevalence of 
asthma, blood levels of biomarkers associated with asthma, and prevalence of infections in 
offspring (Cupul-Uicab et al. 2014; Dallaire et al. 2004; Dewailly et al. 2000; Gascon et al. 2012; 
Glynn et al. 2008; Hansen et al. 2014; Jusko et al. 2016a, 2016b; Sunyer et al. 2006, 2010) and 
associations between serum levels of p,p’-DDE or p,p’-DDT and immune function biomarkers or 
immune-related conditions (Cooper et al. 2004; Miyake et al. 2011; Vine et al. 2001) and children 
(Karmaus et al. 2001, 2003, 2005a, 2005b; Meng et al. 2016; Perla et al. 2015).  Suppression or 
stimulation of various immune responses have been observed in mature laboratory animals 
exposed for intermediate durations to dietary doses of technical DDT, p,p’-DDT, p,p’-DDE, 
p,p’-DDD, or o,p’-DDD  ranging from about 2 to 20 mg/kg/day (Banerjee 1987a, 1987b; 
Banerjee et al. 1986, 1995, 1996, 1997a, 1997b; Hamid et al. 1974; Gabliks et al. 1975; Koner et 
al. 1998; Rehana and Rao 1992; Street and Sharma 1975).  Additional studies of immune 
endpoints in laboratory animal offspring following gestational or early postnatal exposure may be 
useful to determine the relative sensitivity of developmental immune system effects, compared 
with liver and neurodevelopmental effects.  
 
Metabolic/DMT2 (Other Noncancer).  Numerous epidemiological studies provided 
consistent evidence for associations between serum levels of DDT, DDE, or DDD and DMT2 in 
adults (e.g., Evangelou et al. 2016; Fakhri et al. 2017; Lee et al. 2010, 2011b; Rignell-Hydbom et 
al. 2009; Tang et al. 2014; Taylor et al. 2013; Turyk et al. 2009; Wu et al. 2013).  Results from a 
few mechanistic laboratory animal studies provided limited evidence for perturbations of energy 
metabolism and homeostasis from exposure to p,p’-DDE (Howell et al. 2014, 2015) or gestational 
and early life exposure to a mixture of p,p’-DDT and o,p’-DDT and chronic exposure to a high-
fat diet (La Merrill et al. 2014a, 2014b).  Additional research to better characterize DDT-, DDE-, 
or DDD-induced perturbations of energy-metabolism homeostasis (e.g., dependence on dose 
levels, duration of exposure, or critical windows of development) may be useful to better 
determine: (1) if exposure to DDT, DDE, or DDD is an important risk factor in the development 
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of DMT2 and (2) the relative sensitivity of DDT-induced energy-metabolism perturbations, 
compared with liver and neurodevelopmental effects. 
 
Cancer.  Numerous epidemiological provide inconsistent evidence for associations, or 
consistent evidence for no association, between DDT, DDE, or DDD levels in biological fluids or 
tissue and increased risk for many types of cancer.  In contrast, several epidemiological studies 
provide consistent evidence for association with increased risk of liver cancer, particularly in 
groups with relatively high levels of DDT, DDE, or DDD biomarkers (Cocco et al. 2000; 
McGlynn et al. 2006; Persson et al. 2012; Zhao et al. 2012).  Chronic oral exposure of laboratory 
rats and mice to DDT, DDE or DDD has produced increased incidence of liver tumors in multiple 
studies and lung tumors in a few studies.  Mechanistic studies in rats indicate that p,p’-DDT 
initially induces (presumably through activation of the CAR) liver microsomal xenobiotic 
metabolizing enzymes and transient bursts in DNA synthesis and cell proliferation that lead to 
increased liver weight, hypertrophy, eosinophilic abnormal hepatic foci, and eventually liver 
tumors (Harada et al. 2003, 2006, 2016).  Additional mechanistic research with other isomers and 
liver tissues from other species (including human tissue) may help to better determine the 
relevance of the observed rat liver tumors to humans. 
 
Epidemiology and Human Dosimetry Studies.  Considerable epidemiological research has been 
conducted within the past 15–20 years to examine possible associations between levels of DDT, DDE, or 
DDD (and other persistent halogenated chemicals) in samples of biological fluids or tissues and a wide 
array of health outcomes.  To date, consistent epidemiological evidence for positive associations (across 
studies) was provided for only a few health outcomes (abortion or preterm births, wheeze in infant or 
child offspring, DMT2 in adults, and liver cancer).  Further epidemiological studies in geographical 
regions where DDT continues to be used for insect control may be useful to better determine if increased 
risk for these adverse health outcomes are associated with biomarkers of DDT exposure.   
 
Biomarkers of Exposure and Effect.  Levels of DDT, DDE, and DDD in biological fluids and 
tissues are widely used as biomarkers of exposure.  Additional research is needed to develop and validate 
a human PBPK model that could reliably estimate oral intake levels from internal levels of DDT, DDE, or 
DDD in biological fluids or tissues.  
 
Absorption, Distribution, Metabolism, and Excretion.  The ADME and toxicokinetic properties 
of DDT, DDE, and DDD are well characterized.  However, there are limited data to evaluate potential 
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toxicokinetic differences associated with obesity or diabetes.  These data would be useful given the 
associations between DDT/DDE exposure and obesity and DMT2.  Development, calibration, and 
application of animal and human PBPK models to extrapolate human intake levels from animal intake 
levels could decrease toxicokinetic uncertainties in the current MRLs, which are based on laboratory 
animal points of departure (PODs).  A calibrated PBPK model for pregnant rats and fetuses has been 
developed by You et al. (1999c).  The development of a similar model for pregnant mothers or 
nonpregnant humans is limited by the lack of suitable kinetics data for adult humans, human mother-fetus 
pairs or human mother-infant pairs to calibrate the model.  As discussed earlier, the development of a 
human PBPK to predict intake levels from internal DDT, DDE, or DDD metrics also could aid in 
exploring the use of dose-response data from epidemiological studies to derive MRLs.  
 
Comparative Toxicokinetics.  The metabolism of DDT, DDE, or DDD in animals is similar to that in 
humans, but observed interspecies metabolic differences suggest that interspecies differences in 
susceptibility to the neurotoxicity or hepatotoxicity of these chemicals may exist.  Comparisons of 
elimination rates of DDT from fat showed that the process is faster in rats followed by dogs and monkeys 
and slowest in humans (Morgan and Roan 1974).  Rats eliminated DDT 10–100 times faster than humans.  
Morgan and Roan (1974) suggested that the differences in elimination rates could be due to differences in 
liver metabolism, gut bacterial metabolism, enterohepatic recirculation, or factors related to the 
accessibility of plasma-transported pesticide to the excretory cells of the liver.  Some of this information 
could be useful to the development of a human PBPK model for DDT, DDE, or DDD.  
 
Children’s Susceptibility.  There is little evidence about whether children or young animals differ 
from adults in their susceptibility to the toxicity of DDT, DDE, or DDD.  Some animal studies found that 
young rats are less susceptible than older ones to the acute neurotoxic effects produced by a single dose of 
DDT, but the relevance of these findings to humans is unknown (Lu et al. 1965).  Studies in animals have 
shown that DDT and related compounds can alter the development and maturation of the male and female 
reproductive system, but these effects have generally been observed at higher exposure levels than liver or 
neurodevelopmental effects (Bitman and Cecil 1970; Clement and Okey 1972; Duby et al. 1971; Gellert 
et al. 1972; Gray et al. 1999; Kelce et al. 1995, 1997; Loeffler and Peterson 1999; Singhal et al. 1970; 
You et al. 1998, 1999a).  There is evidence that acute perinatal exposure of mice to technical DDT at a 
critical developmental window (PND 10) results in altered behavioral responses measured in adulthood 
(Eriksson et al. 1992, 1993; Johansson et al. 1995, 1996; Talts et al. 1998).  Additional acute oral 
exposure studies during critical windows of embryonic, fetal, or neonatal neurodevelopment using 
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different isomers (e.g., p,p’-DDE) or mixtures or species are needed to better understand the effects of 
DDT, DDE, and DDD on early life neurodevelopment.  
 
There are no adequate data to evaluate whether pharmacokinetics of DDT in children are different from 
adults.  DDT and analogues can cross the placenta and are transferred to offspring via breast milk.  It is 
unknown whether the efficiency of gastrointestinal absorption of DDT and analogues in nursing neonates 
differs from adults and what influence the fat content of human milk might make.  Further information on 
the kinetics of DDT, DDE, or DDD during pregnancy and lactation would be useful.  Important 
information was published on estimates of body burden of DDE that result from nursing by using a model 
that incorporates a wide array of variables (LaKind et al. 2000).  The only calibrated PBPK model for 
DDT is that of You et al. (1999b), which focuses on pregnant and lactating Sprague-Dawley rats.  There 
is no information to evaluate whether metabolism of DDT is different in children than in adults since the 
specific phase I and II enzymes involved in DDT metabolism have not been identified. 
 
Physical and Chemical Properties.  The physical and chemical properties of p,p’-DDT, DDE, and 
DDD are well described in the literature although there are some gaps in data for the o,p’- isomers (see 
Table 4-2).  The p,p’- isomers are those of primary environmental concerns and the data available are 
sufficient to allow estimation of the environmental fate of DDT, DDE, and DDD.  
 
Production, Import/Export, Use, Release, and Disposal.  Since the banning of DDT in the early 
1970s in the United States, there has been little information published on the production of DDT.  DDT is 
no longer produced in the United States or in most countries in the world.  The most recent information 
indicates that it is produced in at least two countries, and is used in some underdeveloped countries for 
vector control.  However, data would be useful on the production and use of DDT worldwide.  This type 
of information is important for estimating the potential for environmental releases from various uses, as 
well as estimating the potential environmental burden.  In turn, this would provide a basis for estimating 
potential exposure and public health risk.  
 
Disposal information is equally important for determining environmental burden and areas where 
environmental exposure may be high.  Although disposal methods for DDT and its metabolites are 
reported to a limited extent, no current information on disposal sites and quantity disposed was located.  
Information on how the current users (e.g., hazardous waste clean-up crews) wash DDT equipment and 
dispose of the remaining waste would be helpful for estimating potential environmental and human 
exposure. 
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Environmental Fate.  DDT, DDE, and DDD released to the environment may be transported from one 
medium to another by the processes of solubilization, adsorption, bioaccumulation, or volatilization.  The 
transport of DDT, DDE, and DDD between environmental compartments has been predicted mostly from 
their physical and chemical properties.  Volatilization and adsorption account for loss of DDT and its 
metabolites from surface water and soil.  Monitoring studies indicate that DDT and its isomers and 
metabolites are extremely persistent in soil (EPA 1986) and substantiate their predicted environmental 
fate.  DDT, DDE, and DDD are highly lipid soluble.  This, combined with their extremely long 
persistence, contributes to bioaccumulation of DDT and its metabolites in freshwater and marine life.  
Limited data were located on the soil degradation rates of DDT and its metabolites.  Data are available for 
disappearance rates including losses due to transport processes.  While adequate data are available on the 
time for the disappearance of 50% of the DDT initially applied to a variety of soils, there is abundant 
evidence that subsequent declines in DDT in soil occur at a much slower rate largely due to an aging 
process.  More data on the biodegradation rates of DDT and its metabolites as well as how soil properties 
and aging affect these rates would be useful.  Experimental information characterizing the environmental 
fate of DDT, DDE, and DDD, particularly on those properties that govern transport to air, would be 
helpful to further confirm their predicted environmental behavior and potential human exposure. 
 
Bioavailability from Environmental Media.  Limited information was located regarding the 
bioavailability of DDT, DDE, and DDD from environmental media.  It has been shown that the 
bioavailability of DDT in soil declines with time (Alexander 1995, 1997; Robertson and Alexander 1998) 
and soil properties that influence the bioavailability of DDT and its toxicity to certain organisms have 
been studied (Peterson et al. 1971).  More information regarding the aging process of DDT in soil and its 
effect on bioavailability would be helpful in identifying potential routes of human exposure.  It is known 
that fish and some plants bioaccumulate these compounds and that those who consume these fish and 
plants will incur some exposure to these compounds.  However, because of universal body burdens of 
these compounds, the relative contribution of any particular medium, especially soil and sediment, is not 
clearly understood.  Even if DDT, DDE, and DDD concentrations in various media are known, the 
difference between the exposure level and the absorbed dose is still unknown.  
 
Food Chain Bioaccumulation.  Information was located regarding food chain biomagnification of 
total DDT in the arctic marine food web (Hargrave et al. 1992).  Extensive monitoring of fish populations 
has been performed and a bioconcentration factor in fish is available.  The steady-state BCF in rainbow 
trout was reported as 12,000, suggesting that bioconcentration in aquatic organisms is very high (Oliver 
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and Niimi 1985).  Although DDT has been detected in plants and vegetables, root uptake of DDT is 
considered low (Fuhremann and Lichtenstein 1980).  A clearer understanding of the potential for 
bioaccumulation would aid in determining how levels in the environment affect the food chain and 
potentially influence human exposure levels.  This type of information could be obtained by studying 
accumulation of these compounds in organisms from several trophic levels.   
 
Exposure Levels in Environmental Media.  Information on environmental levels of DDT, DDE, 
and DDD are abundant for the 1970s and 1980s (Blus et al. 1987; Carey et al. 1979b; Crockett et al. 1974; 
Ford and Hill 1990; Hargrave et al. 1992; Lichtenberg et al. 1970; Stanley et al. 1971).  Subsequent 
monitoring data have been more limited in scope (Aigner et al. 1998; McConnell et al. 1998; Monosmith 
and Hermanson 1996).  Continuation of data collection on environmental levels would contribute to the 
understanding of current worldwide concentrations and trends, especially in regions where DDT is 
currently used in vector control for malaria and as an agricultural pesticide. 
 
Reliable monitoring data for the levels of DDT, DDE, and DDD in contaminated media at hazardous 
waste sites are needed.  This information on levels of DDT, DDE, and DDD in the environment can be 
used in combination with the known body burden of DDT, DDE, and DDD to assess the potential risk of 
adverse health effects in populations living in the vicinity of hazardous waste sites. 
 
Estimates of human intake have been limited to dietary intakes based on current market basket surveys 
(EPA 1980; Gartrell et al. 1985, 1986a, 1986b; Gunderson 1995a).  Additional information is needed 
relating to the levels in environmental media to which the general population is exposed, particularly at or 
near hazardous waste sites, and the subsequent development of health effects. 
 
Exposure Levels in Humans.  Data are available on levels of DDT and its metabolites in adipose 
tissue, blood, and milk (CDC 2018; Hovinga et al. 1992; Lordo et al. 1996; Smith 1999). 
 
Exposures of Children.  More data are needed on the concentrations of DDT in breast milk of 
exposed women and on the DDT intake of breastfed infants.  In addition, the oral availability of DDT 
from soil and dust is lacking.  Such data would allow for the estimation of the exposure of children to 
DDT from eating soil and dust. 
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6.3   ONGOING STUDIES 
 
A number of ongoing studies were identified in the National Institutes of Health (NIH) RePORTER 
(2017); these studies are summarized in Table 6-1. 
 
Table 6-1.  Ongoing Studies on DDT, DDE, and DDD 
 
Investigator Affiliation Research description Sponsor 
Eskenazi, B University of 
California, Berkeley 
Examination of the possible association between DDT 
exposure and puberty onset and neurodevelopment in 
Mexican-American girls 
NIEHS  
Eskenazi, B University of 
California, Berkeley 
Examination of the effect of indoor residual spraying 
with DDT neurodevelopment in children in South 
Africa; the study will also examine possible 
interactions between DDT and pyrethroid insecticides 
NIEHS  
Gan, J University of 
California, Riverside 
Evaluation of aging of DDT in sediment on its 
bioavailability 
NIEHS  
Grandjean, P Harvard School of 
Public Health 
Examination of the effect of prenatal exposure to DDE 
on glucose metabolism in adults living in the Faroe 
Islands 
NIEHS  
Holland, N University of 
California, Berkeley 
Examination of possible associations between 
DDT/DDE exposure in children, DNA methylation, and 
pubertal development 
NIEHS  
LaMerrill, M University of 
California, Davis 
Examination of the effect of perinatal exposure to DDT 
and the risk of metabolic syndrome 
NIEHS  
LaMerrill, M University of 
California, Davis 
Examination of the effect of perinatal exposure on 
insulin resistance in mice 
NIEHS  
Longnecker, M NIEHS Examination of health effects associated with DDT 
exposure in Mexico 
NIEHS 
Longnecker, M NIEHS Examination of DDT exposure and pregnancy loss in 
South Africa 
NIEHS 
Narayan, K Emory University Examination possible associations between serum 
DDT or DDE levels and diabetes in adults in India 
NIEHS 
Sandler, D NIEHS Examination of risk or type 2 diabetes among farmer’s 
wives participating in the Agricultural Health Study 
NIEHS 
Sun, Q Harvard School of 
Public Health 
Examination of associations between p,p’-DDE 
exposure and type 2 diabetes among participants in 
the Nurses’ Health Study II 
NIEHS 
 
DNA = deoxyribonucleic acid; NIEHS = National Institute of Environmental Health Sciences 
 
Source:  RePORTER 2017 
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CHAPTER 7.  REGULATIONS AND GUIDELINES 
 
Pertinent international and national regulations, advisories, and guidelines regarding DDT, DDE, and 
DDD in air, water, and other media are summarized in Table 7-1.  This table is not an exhaustive list, and 
current regulations should be verified by the appropriate regulatory agency. 
 
ATSDR develops MRLs, which are substance-specific guidelines intended to serve as screening levels by 
ATSDR health assessors and other responders to identify contaminants and potential health effects that 
may be of concern at hazardous waste sites.  See Section 1.3 and Appendix A for detailed information on 
the MRLs for DDT, DDE, and DDD. 
 
Table 7-1.  Regulations and Guidelines Applicable to DDT, DDE, and DDD 
 
Agency Description Information Reference 
Air 
EPA RfC No data IRIS 2002a, 2002b, 
2003 
WHO Air quality guidelines No data WHO 2010 
Water & Food 
EPA Drinking water standards and health 
advisories  
No data EPA 2012 
National primary drinking water regulations No data EPA 2009 
RfD  
 
IRIS 2002a 
  p,p’-DDT 5x10-4 mg/kg/daya  
WHO Drinking water quality guidelines for DDT 
and metabolites 
 
WHO 2017 
  Guideline value 0.001 mg/L (1 μg/L)b,c  
  Provisional tolerable daily intake 0.01 mg/kg-body 
weightd 
 
FDA EAFUS No datae FDA 2013 
Cancer 
HHS Carcinogenicity classification 
 
NTP 2016 
  DDT Reasonably anticipated 
to be a human 
carcinogeng 
 
EPA Carcinogenicity classification 
 
IRIS 2002a, 2002b, 
2003   p,p’-DDT, p,p’-DDE, p,p’-DDD Group B2h 
 Oral slope factor   
  p,p’-DDT 3.4x10-1 per mg/kg/day IRIS 2002a 
  p,p’-DDE 3.4x10-1 per mg/kg/day IRIS 2003 
  p,p’-DDD 2.4x10-1 per mg/kg/day IRIS 2002b 
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Table 7-1.  Regulations and Guidelines Applicable to DDT, DDE, and DDD 
 
Agency Description Information Reference 
IARC Carcinogenicity classification 
 
IARC 2017 
  DDT Group 2Ai,j  
Occupational 
OSHA PEL (8-hour TWA) for general industry, 
shipyards, and construction 
 
OSHA 2017a, 2017b, 
2017c 
 DDT 1 mg/m3 k  
NIOSH REL (up to 10-hour TWA) 
 
NIOSH 2016 
  DDT 0.5 mg/m3 l  
 IDLH  NIOSH 2014 
  DDT 500 mg/m3 l,m  
Emergency Criteria 
EPA AEGLs-air No data EPA 2016 
DOE PACs-air  DOE 2016a 
  DDT   
 PAC-1n 3 mg/m3  
 PAC-2n 34 mg/m3  
 PAC-3n 210 mg/m3  
  DDE   
 PAC-1n 6.5 mg/m3  
 PAC-2n 72 mg/m3  
 PAC-3n 170 mg/m3  
  DDD   
 PAC-1n 2.4 mg/m3  
 PAC-2n 26 mg/m3  
 PAC-3n 160 mg/m3  
 
aBased on liver lesions; point of departure = NOEL = 5x10-2 mg/kg/day; composite uncertainty factor = 100; 
confidence = medium. 
bDetected in surface water at concentrations <1 μg/L; also detected in drinking-water at 100-fold lower 
concentrations.  
cBased on a 10-kg child consuming 1 L of drinking water per day, because infants and children may be exposed to 
greater amounts of chemicals in relation to their body weight and because of concern over the bioaccumulation of 
DDT. 
dBased on a NOAEL of 1 mg/kg-body weight/day for developmental toxicity in rats, applying an uncertainty factor of 
100 (for interspecies and intraspecies variation). 
eThe EAFUS list of substances contains ingredients added directly to food that FDA has either approved as food 
additives or listed or affirmed as GRAS. 
fA3: confirmed animal carcinogen with unknown relevance to humans. 
gBased on sufficient evidence of carcinogenicity from studies in experimental animals. 
hBased on sufficient evidence of carcinogenicity in animals.  DDT: liver tumors in seven mouse studies of various 
strains and three rat studies.  DDE: increased incidence of liver tumors in two strains of mice and in hamsters and 
thyroid tumors in female rats by diet.  DDD: increased incidence of lung tumors in male and female mice, liver 
tumors in male mice and thyroid tumors in male rats.  
iGroup 2A: probably carcinogenic to humans.  
jBased on sufficient evidence of cancer in experimental animals and limited evidence of carcinogenicity in humans. 
kSkin designation. 
lPotential occupational carcinogen. 
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Table 7-1.  Regulations and Guidelines Applicable to DDT, DDE, and DDD 
 
Agency Description Information Reference 
mBased on acute toxicity data in humans. 
nDefinitions of PAC terminology are available from U.S. Department of Energy (DOE 2016b). 
 
AEGL = acute exposure guideline levels; DOE = Department of Energy; EAFUS = Everything Added to Food in the 
United States; EPA = Environmental Protection Agency; FDA = Food and Drug Administration; GRAS = generally 
recognized as safe; HHS = Department of Health and Human Services; IARC = International Agency for Research 
on Cancer; IDLH = immediately dangerous to life or health concentrations; IRIS = Integrated Risk Information 
System; NIOSH = National Institute for Occupational Safety and Health; NOAEL = no-observed-adverse-effect level; 
NOEL = no-observed-effect level; NTP = National Toxicology Program; OSHA = Occupational Safety and Health 
Administration; PAC = Protective Action Criteria; PEL = permissible exposure limit; REL = recommended exposure 
limit; RfC = inhalation reference concentration; RfD = oral reference dose; TWA = time-weighted average; 
WHO = World Health Organization 
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APPENDIX A.  ATSDR MINIMAL RISK LEVEL WORKSHEETS 
 
MRLs are derived when reliable and sufficient data exist to identify the target organ(s) of effect or the 
most sensitive health effect(s) for a specific duration for a given route of exposure.  An MRL is an 
estimate of the daily human exposure to a hazardous substance that is likely to be without appreciable risk 
of adverse noncancer health effects over a specified route and duration of exposure.  MRLs are based on 
noncancer health effects only; cancer effects are not considered.  These substance-specific estimates, 
which are intended to serve as screening levels, are used by ATSDR health assessors to identify 
contaminants and potential health effects that may be of concern at hazardous waste sites.  It is important 
to note that MRLs are not intended to define clean-up or action levels. 
 
MRLs are derived for hazardous substances using the NOAEL/uncertainty factor approach.  They are 
below levels that might cause adverse health effects in the people most sensitive to such chemical-
induced effects.  MRLs are derived for acute (1–14 days), intermediate (15–364 days), and chronic 
(≥365 days) durations and for the oral and inhalation routes of exposure.  Currently, MRLs for the dermal 
route of exposure are not derived because ATSDR has not yet identified a method suitable for this route 
of exposure.  MRLs are generally based on the most sensitive substance-induced endpoint considered to 
be of relevance to humans.  Serious health effects (such as irreparable damage to the liver or kidneys, or 
birth defects) are not used as a basis for establishing MRLs.  Exposure to a level above the MRL does not 
mean that adverse health effects will occur. 
 
MRLs are intended only to serve as a screening tool to help public health professionals decide where to 
look more closely.  They may also be viewed as a mechanism to identify those hazardous waste sites that 
are not expected to cause adverse health effects.  Most MRLs contain a degree of uncertainty because of 
the lack of precise toxicological information on the people who might be most sensitive (e.g., infants, 
elderly, nutritionally or immunologically compromised) to the effects of hazardous substances.  ATSDR 
uses a conservative (i.e., protective) approach to address this uncertainty consistent with the public health 
principle of prevention.  Although human data are preferred, MRLs often must be based on animal studies 
because relevant human studies are lacking.  In the absence of evidence to the contrary, ATSDR assumes 
that humans are more sensitive to the effects of hazardous substance than animals and that certain persons 
may be particularly sensitive.  Thus, the resulting MRL may be as much as 100-fold below levels that 
have been shown to be nontoxic in laboratory animals. 
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Proposed MRLs undergo a rigorous review process:  Health Effects/MRL Workgroup reviews within the 
Division of Toxicology and Human Health Sciences, expert panel peer reviews, and agency-wide MRL 
Workgroup reviews, with participation from other federal agencies and comments from the public.  They 
are subject to change as new information becomes available concomitant with updating the toxicological 
profiles.  Thus, MRLs in the most recent toxicological profiles supersede previously published MRLs.  
For additional information regarding MRLs, please contact the Division of Toxicology and Human 
Health Sciences, Agency for Toxic Substances and Disease Registry, 1600 Clifton Road NE, Mailstop 
S102-1, Atlanta, Georgia 30329-4027. 
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INTRODUCTION 
DDT is an organochlorine insecticide that is no longer used in the United States or in most other 
countries.  However, it is persistent in the environment, and humans can be exposed to DDT and its 
metabolites, DDE and DDD.  The most common isomers found in the environment or used in 
experimental studies include commercial or technical DDT, p,p’-DDT, o,p’-DDT, p,p’-DDE, technical 
DDD, and o,p’-DDD.   
The database for these compounds consists of a large number of epidemiology and laboratory animal 
studies.  The epidemiology studies, primarily case-control studies and cross-sectional studies, examined 
possible associations between adverse health outcomes and levels of DDT, DDE, or DDD in tissues or 
body fluids; most of these studies are lacking exposure information, and it is assumed that ingestion from 
food and drinking water was the principal route of exposure.  Oral exposure was the primary route of 
exposure in the laboratory animal studies, and technical DDT (65–80% p,p’-DDT, 15–21% o,p’-DDT, 
and up to 4% of p,p’-DDD) and p,p’-DDT were the most widely examined isomers. 
The epidemiology studies have examined a wide range of potential health outcomes; for most outcomes, 
the results are inconsistent (some studies finding associations and others finding no association).  
However, consistent evidence for association has been found for several outcomes: increased risk of 
abortions or preterm births, wheezing in infants and children exposed in utero, increased prevalence of 
type 2 diabetes mellitus, and liver cancer.  In addition, there is consistent evidence for no association 
between biomarkers of DDT/DDD/DDE exposure and male birth defects and several cancer types (breast 
cancer in women, pancreatic cancer, and endometrial cancer).  Although the epidemiology studies provide 
suggestive evidence of some associations, the studies are not considered adequate for derivation of MRLs 
due to the lack of information on intake levels and/or a biokinetic model that would allow extrapolation 
from tissue/body fluid DDT/DDE/DDD levels to intake levels.   
As with epidemiology studies, laboratory animal studies have examined a wide range of health outcomes.  
These studies identified several sensitive targets of toxicity:  hepatic effects, developmental (particularly 
neurodevelopmental effects), neurological effects, reproductive effects, and cancer.  Technical DDT and 
p,p’-DDT are the most widely examined isomers in these animal toxicity studies, and the available studies 
are inadequate to describe isomer differences in toxicity target and potency, with the exceptions that 
p,p’-DDT and metabolites are recognized as anti-androgens, o,p’-DDT and metabolites are recognized as 
estrogens, and limited evidence from the NCI (1978) 78-week studies that suggests that the rodent liver 
may not be as sensitive to DDD, compared with DDT and DDE isomers.  For MRL derivation, all studies 
for a particular duration were evaluated regardless of the test compound, and the lowest LOAEL values 
were identified as potential points of departure (PODs).  Based on the lack of adequate data suggesting 
differences between the compounds, the MRLs are intended to be used for DDT, DDE, or DDD exposure.  
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MINIMAL RISK LEVEL (MRL) WORKSHEET 
Chemical Name: 
Date: 
Profile Status: 
Route: 
Duration: 
DDT, DDE, DDD, and their isomers 
December 2019 
Draft for Public Comment 
Inhalation 
Acute 
MRL Summary:  There are insufficient data for derivation of an acute-duration inhalation MRL. 
Rationale for Not Deriving an MRL:  No acute-duration inhalation studies were identified. 
Agency Contacts (Chemical Manager):  Obaid Faroon 
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MINIMAL RISK LEVEL (MRL) WORKSHEET 
Chemical Name: 
Date: 
Profile Status: 
Route: 
Duration: 
DDT, DDE, DDD, and their isomers 
December 2019 
Draft for Public Comment 
Inhalation 
Intermediate 
MRL Summary:  There are insufficient data for derivation of an intermediate-duration inhalation MRL. 
Rationale for Not Deriving an MRL:  No intermediate-duration inhalation studies were identified. 
Agency Contacts (Chemical Manager):  Obaid Faroon 
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MINIMAL RISK LEVEL (MRL) WORKSHEET 
Chemical Name: 
Date: 
Profile Status: 
Route: 
Duration: 
DDT, DDE, DDD, and their isomers 
December 2019 
Draft for Public Comment 
Inhalation 
Chronic 
MRL Summary:  There are insufficient data for derivation of a chronic-duration inhalation MRL. 
Rationale for Not Deriving an MRL:  No chronic-duration inhalation studies were identified. 
Agency Contacts (Chemical Manager): Obaid Faroon 
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MINIMAL RISK LEVEL (MRL) WORKSHEET 
Chemical Name: 
Date: 
Profile Status: 
Route: 
Duration: 
MRL: 
Critical Effect: 
Reference: 
Point of Departure: 
Uncertainty Factor: 
LSE Graph Keys: 
Species: 
DDT, DDE, DDD, and their isomers 
December 2019 
Draft for Public Comment 
Oral 
Acute 
0.0005 mg/kg/day (provisional) 
Developmental neurobehavioral and neurological effects  
Johansson et al. 1995, 1996; Eriksson and Norberg 1986; Eriksson et al. 1990a, 
1990b, 1992, 1993 
LOAEL of 0.5 mg/kg  
1,000 
56, 57, 58, 59, 60, 63, 64 
Mouse 
MRL Summary:  A provisional acute-duration oral MRL of 0.0005 mg/kg was derived for DDT, DDE, or 
DDD based on increased spontaneous motor activity, delayed habituation, and decreased density of 
muscarinic receptors in the cerebral cortex of NMRI mice at various timepoints after a single exposure to 
technical DDT on PND 10.  The provisional MRL is based on a LOAEL of 0.5 mg/kg on PND 10 and a 
total uncertainty factor of 1,000 (10 for use of a LOAEL, 10 for extrapolation from animals to humans, 
and 10 for human variability). 
Selection of the Critical Effect:  At least 30 animal studies have evaluated the acute oral toxicity of DDT, 
DDE, or DDD and their related isomers in a variety of animal models including monkeys, rats, mice, 
dogs, and rabbits.  These studies examined a wide range of potentially sensitive targets:  developmental, 
neurodevelopmental, endocrine, hepatic, neurological, reproductive, and diabetes-related effects.  The 
LOAELs for these outcomes range from 0.5 to 500 mg/kg/day.  The lowest LOAELs for these effects 
(and associated NOAELs) are summarized in Table A-1; given the number of studies, data in the table are 
limited to studies that identified LOAELs ≤50 mg/kg/day.   
A comparison of the LOAELs suggest that the neurodevelopmental outcomes are the most sensitive effect 
following acute-duration oral exposure, followed by other developmental, diabetes-related, liver, 
reproductive, neurological, and endocrine outcomes.  The lowest reliable LOAEL was 0.5 mg technical 
DDT/kg for neurodevelopmental effects in mice identified in a group of seven related studies.  Following 
a single exposure on PND 10, mice exhibited delays in habituation behaviors, increased motor activities, 
and reductions in muscarinic receptor densities in the cerebral cortex (Eriksson and Norberg 1986; 
Eriksson et al. 1990a, 1990b, 1992, 1993; Johansson et al. 1995, 1996).  Other developmental effects 
including decreases in fetal weight (Fabro et al. 1984; Hart et al. 1972), retained thoracic nipples (You et 
al. 1998), delayed vaginal opening (Gallert and Heinrichs 1975), and increases in body weight of adult 
offspring (Gellert and Heinrichs 1975) were observed at doses ≥1.0 mg/kg/day.  At 1 mg 
DDT(NS)/kg/day, a 33% decrease in fetal weight was observed in rabbits (Fabro et al. 1984); it is noted 
that changes in offspring weight status was a common effect following in utero exposure; however, the 
direction of change was not consistent across studies.  At 2 mg p,p’-DDE/kg/day, increases in fasting 
blood glucose levels were observed in mice (Howell et al. 2014); no increases in glucose tolerance or 
alterations in indicators of insulin-induced glucose disposal were observed.  Increased relative and/or 
absolute liver weights were commonly observed in rats acutely exposed to p,p’-DDT, p,p’-DDE, or 
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Table A-1.  Summary of Relevant NOAEL and LOAEL Values Following Acute Oral Exposure to DDT, DDE, and 
DDD Isomers 
Species Duration 
NOAEL 
(mg/kg/day) 
LOAEL 
(mg/kg/day) Effect Reference/compound 
Liver effects 
F344 rat 2 weeks ND 5 Increased relative liver weight Tomiyama et al. 2004 
p,p’-DDT 
Wistar rat 2 weeks ND 12 Increased relative liver weight; necrotic changes Kostka et al. 2000 
Technical DDT 
F344 rat 2 weeks 7.6 23 Increased relative liver weight Nims et al. 1998 
p,p’-DDE 
F344 rat 2 weeks 8.5 25 Increased relative liver weight Nims et al. 1998 
p,p’-DDT 
Long-Evans 
rat 
4 days 12.5 25 Increased relative liver weight Leavens et al. 2002 
p,p’-DDE 
Sprague-
Dawley rat 
10 days ND 25 Increased absolute liver weight (42%) Kang et al. 2004 
p,p’-DDE 
Wistar rat 5 or 12 days ND 40 Increased in relative liver weight DeWaziers and Azais 1987 
DDT(NS) 
Neurodevelopmental effects 
NMRI mouse Once PND 10 ND 0.5 Decreased muscarinic receptors in cerebral cortex; 
increased spontaneous activity at 5 months 
Johansson et al. 1995 
Technical DDT 
NMRI mouse Once PND 10 ND 0.5 Decreased muscarinic receptors in cerebral cortex; 
increased spontaneous activity at 5 and 7 months 
Johansson et al. 1996 
Technical DDT 
NMRI mouse Once at 
PND 3, 10, or 
19 
ND 0.5 Decrease in cerebral cortex muscarinic acetylcholine 
receptor binding; delayed habituation in males at 
4 months of age and dosed on PND 10; no change in 
proportion of HA and LA binding sites or affinity 
constants; no changes in mice dosed on PND 3 or 19 
Eriksson et al. 1992 
Technical DDT 
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Table A-1.  Summary of Relevant NOAEL and LOAEL Values Following Acute Oral Exposure to DDT, DDE, and 
DDD Isomers 
Species Duration 
NOAEL 
(mg/kg/day) 
LOAEL 
(mg/kg/day) Effect Reference/compound 
NMRI mouse Once, PND 10 ND 0.5 Increased motor activity (delayed habituation) at 
4 months, increased potassium evoked acetylcholine 
release, reduced density of muscarinic receptors in 
cerebral cortex at 3 months; no change in choline 
acetyltransferase activity 
Eriksson et al. 1990b 
Technical DDT 
NMRI mouse Once, PND 10 ND 0.5 Delayed habituation observed as increased motor 
activity at 4 months 
Eriksson et al. 1990a 
DDT(NS)  
NMRI mouse Once, PND 10 ND 0.5 At 5 months of age: delayed habituation (increased 
motor activity), decrease in cortical muscarinic 
acetylcholine receptors, no change in high affinity or low 
affinity muscarinic binding sites 
Eriksson et al. 1993 
DDT(NS) 
NMRI mouse  Once, PND 10 ND 0.5 At 7 days after exposure: increased muscarinic receptor 
binding, decreased high affinity and increased low 
affinity muscarinic binding; no effect on sodium-
dependent choline uptake; no changes 24 hours after 
exposure 
Eriksson and Norberg 1986 
DDT(NS) 
Other developmental effects 
New Zealand 
rabbit 
GDs 4–7 ND 1.0 On GD 28, 33% decreased fetal weight; decreased fetal 
brain and kidney weights  
Fabro et al. 1984 
DDT(NS) 
New Zealand 
rabbit 
GDs 7–9 ND 10 11% decreased fetal weight on day 28 Hart et al. 1972 
p,p’-DDT 
Sprague-
Dawley rat 
GDs 14–18 ND 10 PND 13 males retained thoracic nipples; no effect on 
postnatal body weights, AGD, age of preputial 
separation; no effect on reproductive organ weights or 
serum testosterone 
You et al. 1998 
p,p;-DDE 
Sprague-
Dawley rat 
GDs 15–19 ND 28 Delayed vaginal opening (2 days) Gellert and Heinrichs 1975 
o,p’-DDD 
Sprague-
Dawley rat 
GDs 15–19 ND 28 Adult offspring: 11.9% increase in body weight; No 
effects on estrous cycle, vaginal opening, or ovary, 
adrenal or anterior pituitary weights 
Gellert and Heinrichs 1975 
o,p’-DDE 
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Table A-1.  Summary of Relevant NOAEL and LOAEL Values Following Acute Oral Exposure to DDT, DDE, and 
DDD Isomers 
Species Duration 
NOAEL 
(mg/kg/day) 
LOAEL 
(mg/kg/day) Effect Reference/compound 
Sprague-
Dawley rat 
GDs 15–19 ND 28 Offspring: 13% increase in body weight; no effects on 
estrous cycle, vaginal opening, or ovary, adrenal or 
anterior pituitary weights 
Gellert and Heinrichs 1975 
o,p’-DDT 
Sprague-
Dawley rat 
GDs 15–19 ND 28 In offspring: 26% decrease in ovary weight; 9% increase 
body weight; no effects on estrous cycle or vaginal 
opening 
Gellert and Heinrichs 1975 
p,p’-DDT 
Neurological effects (adults) 
F344 rat Once 25 50 Hyperirritability and tremors; more severe at 
100 mg/kg/day 
Tilson et al. 1987 
p,p’-DDT 
F344 rat Once 25 50 Tremors, more severe at 75 and 100 mg/kg/day; 
increased brain 5-HIAA, aspartate, and glutamate 
Hong et al. 1986; Hudson et 
al. 1985 
p,p’-DDT 
Endocrine effects 
Sprague-
Dawley rat 
Once 25 50 Reduced capacity to concentrate iodine in thyroid Goldman 1981 
Technical DDT 
Dog 14 days ND 50 Decreased plasma glucocorticoids Cueto 1970 
o,p’-DDD 
Reproductive effects 
New Zealand 
rabbit 
GDs 7–9 or 
21–23 
ND 10 Increased resorptions and prematurity Hart et al. 1972 
p,p’-DDT 
New Zealand 
rabbit 
GDs 7–9 ND 50 Increased resorptions Hart et al. 1971 
p,p’-DDT 
Diabetes-related effects 
C57BL/6H 
mouse 
5 days 0.4 2 Hyperglycemia Howell et al. 2014 
p,p’-DDE 
5-HIAA = 5-hydroxyindoleacetic acid; AGD = anogenital distance; GD = gestation day; LOAEL = lowest-observed-adverse-effect level; NOAEL = no-observed-
adverse-effect level; NS = not specified; ND = not determined; PND = postnatal day
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technical DDT, at doses ≥5 mg/kg/day (Kang et al. 2004; Kostka et al. 2000; Leavens et al. 2002; Nims et 
al. 1998; Tomiyama et al. 2004).  Kostka et al. (2000) was the only study reporting histological 
alterations; necrotic liver changes were observed in rats exposed to 12 mg p,p’-DDT/kg/day for 14 days.   
Increases in resorptions were observed in rabbits exposed to 10 mg/kg/day on GDs 7–9 (Hart et al. 1972).  
Neurological and endocrine effects have been observed at higher doses (≥50 mg/kg/day).  The effects 
included tremors in adult rats after single exposures to p,p’-DDT (Hong et al. 1986; Hudson et al. 1985; 
Hwang and Van Woert 1978; Tilson et al. 1986, 1987) and decreased plasma glucocorticoids and reduced 
capacity to concentrate iodine were observed in dogs exposed to o,p’-DDD for 14 days (Cueto 1970) and 
in rats receiving a single dose to technical DDT (Goldman 1981), respectively.  Neurodevelopmental 
effects were selected as the critical effect for derivation of the acute-duration oral MRL since it occurred 
at the lowest LOAEL of 0.5 mg/kg.   
Selection of the Principal Studies: A group of seven related neurodevelopmental studies by the same 
investigators have consistently demonstrated an increase in spontaneous behaviors resulting in delayed 
habituation in 3–7-month-old mice (Eriksson and Norberg 1986; Eriksson et al. 1990a, 1990b, 1992, 
1993; Johansson et al. 1995, 1996).  Additionally, five of these studies consistently reported a decrease in 
the density of muscarinic cholinergic receptors in the cerebral cortex at various time points following 
exposure.  The seven studies were selected as co-principal studies. 
Summary of the Principal Studies:  
Eriksson P, Nordberg A.  1986.  The effects of DDT, DDOH-palmitic acid, and chlorinated paraffin on 
muscarinic receptors and the sodium-dependent choline uptake in the central nervous system of immature 
mice.  Toxicol Appl Pharmacol 85:121-127. 
Eriksson P, Archer T, Fredriksson A.  1990a.  Altered behaviour in adult mice exposed to a single low 
dose of DDT and its fatty acid conjugate as neonates.  Brain Res 514:141-142. 
Eriksson P, Nilsson-Hakansson L, Nordberg A, et al.  1990b.  Neonatal exposure to DDT and its fatty 
acid conjugate:  Effects on cholinergic and behavioural variables in the adult mouse.  Neurotoxicology 
11:345-354. 
Eriksson P, Ahlbom J, Fredriksson A.  1992.  Exposure to DDT during a defined period in neonatal life 
induces permanent changes in brain muscarinic receptors and behaviour in adult mice.  Brain Res 
582:277-281. 
Eriksson P, Johansson U, Ahlbom J, et al.  1993.  Neonatal exposure to DDT induces increased 
susceptibility to pyrethroid (bioallethrin) exposure at adult age - changes in cholinergic muscarinic 
receptor and behavioural variables.  Toxicology 77:21-30 
Johansson U, Fredriksson A, Eriksson P.  1995.  Bioallethrin causes permanent changes in behavioural 
and muscarinic acetylcholine receptor variables in adult mice exposed neonatally to DDT.  Eur J 
Pharmacol 293:159-166. 
Johansson U, Fredriksson A, Eriksson P.  1996.  Low-dose effects of paraoxon in adult mice exposed 
neonatally to DDT:  Changes in behavioural and cholinergic receptor variables.  Environ Toxicol 
Pharmacol 2:307-314. 
In each study, groups of 10-day-old male NMRI mice were treated by gavage with a single dose of 
0 (vehicle control) or 0.5 mg DDT (technical or NS)/kg in a 20% fat emulsion vehicle.  Spontaneous 
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behavior tests evaluating locomotion, rearing, and total activity were performed at either 4 (Eriksson 
1990a, 1990b, 1992), 5 (Eriksson et al. 1993; Johansson et al. 1996), or 7 months of age (Johansson et al. 
1995, 1996).  To determine the importance of exposure time during development, Eriksson et al. (1992) 
also dosed groups of mice on PND 3 or 19.  To evaluate densities of muscarinic receptors, mice were 
sacrificed 24 hours, 7 days (Eriksson and Nordberg 1986), or 4, 5, or 7 months following exposure 
(Eriksson et al. 1990b, 1992; Johansson et al. 1995, 1996).  Behavioral tests of spontaneous activity were 
conducted on 9–12 mice/group for 1 hour, and scores were summed for three 20-minute periods.  During 
the last 40 minutes of testing, mice treated on PND 10 consistently showed significantly more activity 
than untreated controls (see Table A-2).  This was interpreted as disruption of a simple, non-associative 
learning process (i.e., habituation) or a retardation in adjustment to a new environment.  Mice dosed on 
PND 3 or 19 responded similarly to vehicle controls indicating that the developmental processes 
occurring on or immediately after PND 10 is particularly sensitive to exposure to technical DDT 
(Eriksson et al. 1992).  To try to relate behavioral effects to specific neurological changes in the brain, 
several of the studies evaluated whether technical DDT affected the density of muscarinic acetylcholine 
(MACh) receptors in the brain, which are known to modulate neuronal excitability.  Mice were sacrificed 
at various time points and crude synaptosomal P2 fractions were prepared from the cerebral cortex for 
measurement of MACh receptor densities.  Details of sample preparation are less well described across 
studies; Eriksson and Nordberg (1986) reported pooling fractions from two to three animals, thereby 
generating a single biological replicate that was assayed in duplicate.  More animals were used in other 
studies, but whether these samples were also pooled is unclear.   
A summary of the results of these studies is found in Table A-2.  Increases in motor activity were 
observed in mice exposed at PND 10 and tested at ≥4 months of age.  Decreases in MACh receptor 
densities in the cerebral cortex of males dosed on PND 10 ranged between 3 and 30% (decrease) at 3, 4, 
5, or 7 months of age.  No changes in MACh densities occurred within 24 hours after exposure, and at 
7 days, a small, but significant increase in density was observed (Eriksson and Nordberg 1986).  The 
authors suggested that the changes in MACh density and behavior might be the consequence of early 
interference with muscarinic cholinergic transmission specifically around the age of 10 days (Eriksson et 
al. 1992).  Eriksson et al. (1990b) also measured MACh densities from P2 fractions prepared from the 
hippocampus and striatum, but only MACh densities within the cerebral cortex were reduced.  A few 
studies also measured proportions of muscarinic high- and low-affinity binding sites.  In 7-day-old mice, 
there was a significant increase in the percentage of low-affinity binding sites and a significant decrease 
in high-affinity binding sites (Eriksson and Nordberg 1986).  According to the authors, these low-affinity 
binding sites correspond to the M1 receptor in the cerebral cortex, which is thought to be associated with 
neuronal excitation.  At later time points, no differences in HA or LA proportions were observed.  Other 
neurological tests described in these studies that yielded no significant effects include: measurements of 
sodium dependent choline uptake in the cerebral cortex (Eriksson and Nordberg 1986); choline 
acetyltransferase (ChAT) activity and potassium evoked release of ACh from the cerebral cortex 
(Eriksson et al. 1990b); acetylcholinesterase activity; proportions of nicotinic high- and low-affinity 
binding sites; and swim maze tests (Johannsson et al. 1995, 1996).   
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Table A-2.  Spontaneous Activity Test Results After a Single Oral Exposure of 
NMRI Mice to 0.5 mg/kg Technical DDT on PND 10 
Reference 
Treatment 
(PND) 
Evaluation age 
(months)a Locomotionb Rearingb
Total 
activityb 
Muscarinic 
receptor 
density 
Eriksson and 
Nordberg 1986 
10 24 hours after 
dose 
NT NT NT - 
Eriksson and 
Nordberg 1986 
10 7 days after 
dose 
NT NT NT ↑ 
Eriksson et al. 
1990a 
10 4 - ↑ ↑ ↑ ↑ ↑ - ↑ ↑ NT 
Eriksson et al. 
1990b 
10 4 - ↑ ↑ ↑ ↑ ↑ - ↑ ↑ ↓ 
Eriksson et al. 1992 10 4 - ↑ ↑ ↑ ↑ ↑ - ↑ ↑ ↓ 
Eriksson et al. 1992 3 4 - - - - - - - - - - 
Eriksson et al. 1992 19 4 - - - - - - - - - - 
Eriksson et al. 1993 10 5 - ↑ ↑ ↑ ↑ ↑ - ↑ ↑ ↓ 
Johansson et al. 
1995 
10 7 - ↑ ↑ ↑ ↑ ↑ - ↑ ↑ ↓ 
Johansson et al. 
1996 
10 5 - ↑ ↑ ↑↑ ↑ - ↑ ↑ NT 
Johansson et al. 
1996 
10 7 - ↑ ↑ ↑ ↑ ↑ - ↑ ↑ ↓ 
aAge at evaluation expressed in months unless indicated otherwise.
bResults reported (from left to right) for the 0–20-, 20–40-, and 40–60-minute measurement periods, respectively.  
- (dashes) = no significant difference from vehicle controls; ↑ = increased at a particular time point, as compared with
controls; NT = not tested; PND = postnatal day
Within the group of studies, other tests were performed in attempts to further identify other exposure-
related neurological effects in the cerebral cortex.  Conclusions drawn from these results are that: 
(1) DDT did not significantly alter acetylcholinesterase activity; (2) none of the treatments altered the
density of nicotinic cholinergic receptors in the cortex; (3) none of the treatments altered performance in
the swim maze test; (4) DDT exposure did not alter K+-stimulated acetylcholine release; and (5) DDT did
not significantly alter sodium-dependent choline uptake in the cerebral cortex.
Selection of the Point of Departure for the MRL:  The data were not amenable to benchmark dose 
(BMD) modeling because only a single dose was evaluated.  The LOAEL of 0.5 mg/kg/day was therefore 
chosen as the POD.  
Uncertainty Factor: The LOAEL of 0.5 mg/kg was divided by a total uncertainty factor of 1,000: 
• 10 for use of a LOAEL
• 10 for animal to human extrapolation
• 10 for human variability
Other Additional Studies or Pertinent Information that Lend Support to this MRL:  Three additional 
studies by a different group of investigators evaluated neurobehavioral effects in mouse offspring after 
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exposure in utero to doses ranging from 0.018 to 100 mg o,p’-DDT/kg/day during GDs 11–17 (Palanza et 
al. 1999, 2001; vom Saal et al. 1995).  Palanza et al. (2001) reported no effects of o,p’-DDT exposure up 
to a high dose of 100 mg/kg/day on cliff avoidance or righting reflexes in postnatal pups.  Palanza et al. 
(1999) administered doses of 0.018 and 0.18 o,p’-DDT/kg/day to pregnant dams and evaluated male 
offspring territorial aggression at 3 months of age.  Compared to controls, treated males showed no 
statistically significant changes in the percent of attacking males per group or in other marks of 
aggression (latency to attack, number of bites, total attack time, tail rattling, or defensive behaviors).  
When only the attacking males from the control or the exposed groups were compared, the authors 
reported a reduction in aggressive behaviors in exposed males.  Males exposed to 0.018 mg 
o,p’-DDT/kg/day showed a significant decrease in bite frequency and total attack time, and those exposed 
to 0.18 o,p’-DDT/kg/day also showed less tail rattling (Palanza et al. 1999).  This is in contrast with a 
previous study reporting an increase in urine marking behavior, which is often considered a territorial 
behavior linked to displays of dominance and aggression (vom Saal et al. 1995).  Palanza et al. (1999) 
also reported a small (~<12%), but significant, reduction in paired testes weight in males exposed to 
0.018 mg o,p’-DDT/kg/day, but not 0.18 mg o,p’-DDT/kg/day.  These studies were not considered 
suitable for MRL derivation due to a variety of issues, including poor reporting (e.g., no description or 
inclusion of statistical analysis; vom Saal et al. 1995) and inconsistencies in results across doses (Palanza 
et al. 1999, 2001).  Since the decreased aggressive behavior effects described by Palanza et al. (1999) 
were observed only when select subsets of individuals were included in the analysis and vom Saal et al. 
(1995) reported an apparent increased aggressive behavior (e.g., increased urine marking), the collective 
interpretation of these results is unclear.  
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Chemical Name:   
Date: 
Profile Status: 
Route: 
Duration: 
MRL: 
Critical Effect: 
Reference: 
Point of Departure: 
Uncertainty Factor: 
LSE Graph Key: 
Species: 
DDT, DDE, DDD, and their isomers 
December 2019 
Draft for Public Comment 
Oral 
Intermediate 
0.0002 mg/kg/day (provisional) 
Hepatocyte hypertrophy 
Harada et al. 2003, 2006 
LOAEL of 0.17 mg/kg/day 
1,000 
99 
Rat 
MRL Summary:  A provisional intermediate-duration oral MRL of 0.0002 mg/kg/day was derived for 
DDT, DDE, and DDD based on an increased incidence of hepatocyte hypertrophy in rats administered 
p,p’-DDT in their diets for 26 weeks.  The provisional MRL is based on a LOAEL of 0.17 mg/kg/day and 
a total uncertainty factor of 1,000 (10 for the use of a LOAEL, 10 for extrapolation from animals to 
humans, and 10 for human variability). 
Selection of the Critical Effect:  Numerous animal studies have evaluated the oral toxicity of DDT, DDE, 
or DDD and their related isomers following intermediate-duration exposure.  These studies examined a 
wide range of potentially sensitive targets.  The LOAELs for these effects range from 0.25 to 
200 mg/kg/day.  The most sensitive outcomes were hepatic, reproductive, developmental, immunological, 
and neurological effects.  A summary of lowest LOAELs (and associated NOAELs) for relevant 
endpoints is presented in Table A-3; given the number of studies evaluating these endpoints, only 
LOAELs ≤20 mg/kg/day are included in the table. 
As shown in Table A-3, several effects associated with intermediate-duration exposure have been 
observed at levels ≤0.17 mg/kg/day.  These include: (1) liver effects such as hepatic hypertrophy (Harada 
et al. 2003, 2006; Laug et al. 1950) and hepatocyte cytoplasmic vacuolation, mitochondrial changes, and 
lipid droplets (Liu et al. 2017a, 2017b); (2) developmental effects including cardiac hypertension and 
hypertrophy (La Merrill et al. 2016) and metabolic effects consisting of impaired glucose tolerance, 
hyperinsulinemia, dyslipidemia, and impaired cold tolerance (La Merrill et al. 2014a, 2014b); and 
(3) reproductive effects including decreased corpora lutea and number of implants (Lundberg et al. 1974).
The lowest LOAELs for immunological effects, including decreased immunoglobulins or antibody titers
in response to antigens (Banerjee 1987a, 1987b; Banerjee and Koner 1997a; Banerjee et al. 1995, 1996,
1997, 1997b; Koner et al. 1998) and for neurological effects including decreased brain lipids (Sanyal et
al. 1986) were observed at higher doses.
The liver is considered a primary target for DDT, DDE, DDD, and their related isomers, and hepatic 
toxicity (hepatocellular hypertrophy) was chosen as the critical effect for intermediate-duration exposures.  
Sixteen intermediate-duration studies evaluated liver toxicity, including two recent multi-dose studies that 
provide incidence data for non-neoplastic lesions in the liver (Harada et al. 2003, 2006; Hojo et al. 2006).  
Observed effects include hepatocellular hypertrophy in rats at 0.17 mg/kg/day (Harada et al. 2003, 2006), 
increases in liver weight in mice exposed to 5 mg p,p’-DDT/kg/day (Tomiyama et al. 2004), fatty changes 
in hepatocytes in male rats exposed to 3.44 p,p’-DDT/kg/day (Hojo et al. 2006), and focal necrosis in rats 
at 6.6 mg DDT(NS)/kg/day (Jonsson et al. 1981).  Although several other effects also identified low 
LOAEL values, there is more supporting and consistent evidence that the liver is the critical target. 
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Table A-3.  Summary of Relevant LOAEL and NOAEL Values Following Intermediate Oral Exposure to DDT, DDE, 
or DDD Isomers 
Species Duration 
NOAEL 
(mg/kg/day) 
LOAEL 
(mg/kg/day) Effect Reference/compound 
Liver effects 
Osborne-
Mendel rat 
15–27 weeks 0.05 0.25 Cellular hypertrophy and cytoplasmic eosinophilia; 
only qualitative data reported; effects described 
appear to have been minimal 
Laug et al. 1950 
Technical DDT 
C57BL/6N 
mouse 
8 weeks ND 1.0 Cytoplasmic vacuolation in hepatocytes, 
mitochondrial changes and lipid droplets (qualitative 
data only); no change in AST, ALT, ALP 
Liu et al. 2017a, 2017b 
p,p’-DDE 
F344/DuCrj rat 26 weeks 
0.21 F 
0.17 M 
2.2 F 
Increased incidence of hepatocellular hypertrophy 
(6/6 exposed versus 0/6 controls) in both males and 
females at 1.7 and 2.2 mg/kg/day, respectively; 
2/6 males at 0.17 mg/kg/day 
Harada et al. 2003, 2006 
 p,p’-DDT 
Sherman rat 2–6 months 0.5 M 
5 F 
1.7 M 
20 F 
Mild hypertrophy, presence of lipospheres and cell 
margination; effects were dose-related and more 
pronounced at 5 mg/kg/day; qualitative data only 
Ortega 1956 
Technical DDT 
Sprague-
Dawley rat 
2 generations, 
10 weeks before 
mating, then 
through mating, 
gestation, and 
lactation 
0.343 M 
0.73 F 
3.44 M 
3.75 F 
P and F1 males: centrilobular hypertrophy, fatty 
change of hepatocytes (males only); increased 
relative liver weights 
Hojo et al. 2006 
p,p’-DDT 
F344 rat 28 days ND 5 Increased absolute and relative liver weight, no liver 
histology done 
Tomiyama et al. 2004 
p,p’-DDT 
NMRI mouse 28 days ND 6.25 increased absolute and relative liver weight Orberg and Lundberg 1974 
p,p’-DDT 
Sprague-
Dawley rat 
36 weeks ND 6.6 Hepatic focal necrosis/regeneration Jonsson et al. 1981 
DDT (NS) 
Hissar albino 
mouse 
3–12 weeks 4.0 10 Increased relative liver weight (14.7%); no liver 
histology done 
Banerjee et al. 1986 
p,p’-DDT 
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Table A-3.  Summary of Relevant LOAEL and NOAEL Values Following Intermediate Oral Exposure to DDT, DDE, 
or DDD Isomers 
Species Duration 
NOAEL 
(mg/kg/day) 
LOAEL 
(mg/kg/day) Effect Reference/compound 
Wistar rat 3 weeks ND 15 Significant increase in liver weight; no liver histology 
done 
Gupta et al. 1989 
p,p’-DDT 
Wistar rat 6 weeks ND 20.2 Increased relative liver weight (14.7%); no liver 
histology done 
Banerjee et al. 1996 
p,p’-DDT 
Wistar rat 6 weeks ND 20.2 Increased relative liver weight (17.1% increase); no 
liver histology done 
Banerjee et al. 1996 
p,p’-DDE 
Neurological effects 
Rhesus 
monkey 
100 days ND 10 15–20% decrease in brain lipids, central nervous 
system phospholipids, and cholesterol 
Sanyal et al. 1986 
Technical DDT 
Developmental effects 
C57BL/6J 
mouse 
GD 12–PND 5 ND 1.7 Cardiac hypertension: increased systolic and 
diastolic blood pressure in male offspring at 
5 months; increase systolic in males and females at 
7 months; cardiac hypertrophy (increased left 
ventricular wall thickness) in females, but not males 
La Merrill et al. 2016 
Prepared mixture of 
p,p’-DDT (77.2%) and 
o,p’-DDT (22.8%) 
C57BL/6J 
mouse 
GD 12–PND 5 ND 1.7 In females on high-fat diets for 12 weeks: metabolic 
syndrome (impaired glucose tolerance, 
hyperinsulinemia, dyslipidemia, impaired cold 
tolerance, altered bile acid metabolism); no effect 
on timing of puberty 
La Merrill et al. 2016 
Prepared mixture of 
p,p’-DDT (77.2%) and 
o,p’-DDT (22.8%) 
Sprague-
Dawley rat 
GD 6–PND 20 5 15 Increased relative liver weight (10.1%) Yamasaki et al. 2009 
p,p’-DDE 
Wistar rat GDs 1–21 and 
LDs 1–21 
1.7 16.8 Decreased body weights and growth of nursing 
pups 
Clement and Okey 1974 
o,p’-DDT 
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Table A-3.  Summary of Relevant LOAEL and NOAEL Values Following Intermediate Oral Exposure to DDT, DDE, 
or DDD Isomers 
Species Duration 
NOAEL 
(mg/kg/day) 
LOAEL 
(mg/kg/day) Effect Reference/compound 
Immunological effects 
Albino rat 31 days ND 1.9 Decreased mast cells Gablis et al. 1975 
DDT (NS) 
Albino rat 8–22 weeks 2.2 5.5 Decreased relative spleen weight (17% decrease), 
increased serum albumin/globulin ratio and reduced 
IgG titers after tetanus toxoid stimulation; no effect 
on IgM titers, relative thymus weight, or body weight 
Banerjee 1987b 
p,p’-DDT 
Wistar rat 4 weeks 2.3 5.7 Decreased IgG and IgM; increased albumin/globulin 
ratio 
Banerjee et al. 1995 
p,p’-DDT 
Hissar mouse 3–12 weeks 4.2 10.5 Decreased splenic plaque-forming cell response to 
T-antigen independent lipopolysaccharide at
weeks 6–12; decreased IgM antibody titer at
21 mg/kg/day
Banerjee 1987a 
p,p’-DDT 
Rockfeller 
mouse 
24 weeks 4.3 10.7 Increased growth of Mycobacterium leprae in 
footpad 
Banerjee and Koner 1997a 
p,p’-DDT 
Wistar rat 6 weeks ND 20.2 After ovalbumin immunization: decreased serum 
IgG and IgM, and ovalbumin antibody titre; 
increased percent migration of leucocytes and 
macrophages; decreased footpad thickness; 
decreased relative spleen weight; no effect on 
thymus weight 
Banerjee et al. 1996 
p,p’-DDT 
Reproductive effects 
NMRI mouse 28 days ND 1.67 Prolonged length of estrus cycle; decreased 
number of implants (223 versus 250 in controls) 
Lundberg 1973 
p,p’-DDT 
NMRI Mouse 72–74 days ND 2.0 Decreased corpora lutea (17.2%) and small 
decrease in implants (125 versus 128) 
Lundberg 1974 
p,p’-DDT 
New Zealand 
rabbit 
12 weeks 
(3 times/week) 
ND 3.0 Decreased ovulation rate and slight decrease 
circulating progesterone post-insemination 
Lindenau et al. 1994 
Technical DDT 
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Table A-3.  Summary of Relevant LOAEL and NOAEL Values Following Intermediate Oral Exposure to DDT, DDE, 
or DDD Isomers 
Species Duration 
NOAEL 
(mg/kg/day) 
LOAEL 
(mg/kg/day) Effect Reference/compound 
Sprague-
Dawley rat 
2-generations,
10 weeks before
mating, then
through mating,
gestation, and
lactation
0.73 3.75 F0 females: decreased estradiol levels; increased 
progesterone at 27.7 mg/kg/day, but no effects on 
F0 or F1 indices of mating and fertility, or viability of 
F1 and F2 offspring in any exposure group 
Hojo et al. 2006 
p,p’-DDT 
B6C3F1 mouse 86–130 days 3.4 5.1 Decreased number of pups/litter at birth or PND 1; 
decreased fertility 
Ledoux et al. 1977 
Technical DDT 
NMRI mouse 28 days ND 6.25 Reduced seminal vesicles weight (28% reduced) in 
castrated males only; no effect on seminal vesicles 
or testes weight in intact animals 
Orberg and Lundberg 1974 
p,p’-DDT 
Sprague-
Dawley rat 
104 days; 
14 days in utero, 
20 lactational 
days, 70 days 
directly 
ND 35 Increased serum testosterone, increased testicular 
mass and relative testes weight, and decreased 
seminiferous tubule diameter, seminiferous 
epithelium thickness, and lumen diameter 
Patrick et al. 2016 
DDE (NS) 
Sprague-
Dawley rat 
GD 6–PND 20 15 50 Significantly reduced weaning index and number of 
pups live on PND 21; no significant effects on 
number of litters, gestation index, gestational 
length, number of pups born, delivery index, birth 
index, or viability on PND 4 
Yamasaki et al. 2009 
p,p’-DDE 
ALP = alkaline phosphatase; ALT = alanine aminotransferase; AST = aspartate aminotransferase; F = female(s); GD = gestation day; LOAEL = lowest observed 
adverse effect level; M = male(s); ND = not detected; NOAEL = no observed-adverse-effect level; NS = not specified; P gen = parental generation; 
PND = postnatal day; LD = lactation day 
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Selection of the Principal Study: Harada et al. (2003, 2006) reported increases in the incidence of 
hepatocellular hypertrophy in males exposed ≥0.17 mg/kg/day p,p’-DDT.  Although the incidence (2/6) 
was not statistically different from controls (0/6), ATSDR considered this dose associated with a 33% 
increased incidence to be a LOAEL.  At the next highest dose (1.7 mg/kg/day), hypertrophy was observed 
in 6/6 males and 6/6 females.  This LOAEL is supported by the Laug et al. (1950) and Liu et al. (2017a, 
2017b) studies.  Other liver effects included microsomal enzyme activity, proliferation, inhibition of cell 
communication, and oxidative stress, in both males and females made at several timepoints between 4 and 
52 weeks.  Laug et al. (1950) reported hepatocellular hypertrophy in rats exposed to 0.25 mg technical 
DDT/kg/day for 15–27 weeks.  However, Laug et al. (1950) provided no incidence data or statistical 
analysis, and only noted that at 0.25 mg/kg/day, “some of the rats were unaffected,” and the liver effects 
“were truly minimal.”  Similarly, the Liu et al. (2017a, 2017b) studies only provided qualitative evidence 
of hepatocellular cytoplasmic vacuolation, mitochondrial changes, and lipid droplets in mice exposed to 
1.0 mg p,p’-DDE/kg/day for 8 weeks.  Hojo et al. (2006), reported quantitative hepatocyte hypertrophy 
incidence results that were consistent with the findings in Harada et al. (2003, 2006) and identified a 
LOAEL of 3.44 mg p,p’-DDT/kg/day and a NOAEL of 0.343 mg/kg/day.   
Summary of the Principal Study:  
Harada T, Yamaguchi S, Ohtsuka R, et al.  2003.  Mechanisms of promotion and progression of 
preneoplastic lesions in hepatocarcinogenesis by DDT in F344 rats.  Toxicol Pathol 31(1):87-98. 
Harada T, Ohtsuka R, Takeda M, et al.  2006.  Hepatocarcinogenesis by DDT in rats.  J Toxicol Pathol 
19:155-167. 
Groups of 20 male and 20 female Fisher (F344/DuCrj) rats, 5 weeks of age, were administered 0, 5, 50, or 
500 ppm p,p’-DDT in feed for 26 weeks (Harada et al. 2003, 2006).  The study report provided intakes of 
0, 0.17, 1.7, or 19.1 mg p,p’-DDT/kg/day (males) and 0, 0.21, 2.2, or 25.2 mg/kg/day (females), based on 
average feed consumption and body weight throughout a 2-year feeding study.  These were adopted as the 
exposure doses for the 26-week collection point and are considered accurate for the following reasons: 
(1) the reported average food consumptions at all doses were comparable between the 2-year study and a
pilot 4-week study; and (2) mean body weights of rats exposed to at least the two lowest doses were
comparable to controls.  Animals were sacrificed and livers were examined for: (1) cell proliferation
(percent proliferating cell nuclear antigen [PCNA] labeling index), (2) GJIC (number of GJIC protein
Cx32 spots), (3) microsomal enzyme induction (e.g., PROD activity and P450 isozyme contents,
(4) oxidative stress (LPO and 8-OHdG), and (5) histopathology.
No clinical signs, mortalities, or body weight changes compared with controls were noted during the first 
year of this 2-year study.  At 26 weeks, the liver lesions included: (1) hepatocellular hypertrophy at 
26 weeks in 100% (6/6) of male and female rats treated with doses of ≥1.7 and 2.2 mg/kg/day, 
respectively.  In low-dose males (0.17 mg/kg/day), 2/6 rats had hypertrophy (0/6 in controls), but the 
incidence was not statistically significantly elevated compared with controls and (2) large eosinophilic 
altered hepatocellular foci (AHF) were observed in high-dose males (19.1 mg/kg/day), but not females.  
In addition to these lesions, the following effects were noted in the livers: (1) significantly decreased 
hepatic levels of GJIC protein Cx32 spots were observed in males starting at 1.7 mg/kg/day and in 
females at 25.2 mg/kg/day, (2) statistically significantly increased hepatic levels of CYP1A2 and 
CYP3A2 protein were observed starting at 0.17 mg/kg/day and increased PROD activity and CYP2B1 
and CYP4A1 levels starting at 1.7 mg/kg/day in males.  In females, PROD activity, and CYP2B1 and 
CYP3A2 levels increased starting at 2.2 mg/kg/day, and (3) signs of oxidative stress were only observed 
at higher doses.  Hepatic LPO contents significantly increased starting at 1.7 or 2.2 mg/kg/day in males 
and females, respectively, and 8-OHdG levels increased in males only at 19.2 mg/kg/day.  No significant 
changes in cell proliferation were noted in the livers of exposed animals compared with controls. 
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Selection of the Point of Departure for the MRL:  The Harada et al. (2003, 2006) study identified a 
LOAEL of 0.17 mg/kg/day for hepatocellular hypertrophy in male rats exposed to p,p’-DDT for 
26 weeks.  The lowest LOAEL in female rats was 2.2 mg/kg/day, also for hepatocellular hypertrophy.  
BMD modeling was not considered appropriate because the small number of animals per group (six 
animals) is not enough for statistical analysis because of the large variance in the data (eight animals 
would be needed for 95% confidence).   
Uncertainty Factor: The LOAEL is divided by a total uncertainty factor of 1,000: 
• 10 for the use of a LOAEL
• 10 for extrapolation from animals to humans
• 10 for human variability
Provisional MRL = LOAEL ÷ UFs 
0.17 mg/kg/day ÷ (10 x 10 x 10) = 0.0002 mg/kg/day 
Other Additional Studies or Pertinent Information that Lend Support to this MRL:  The identification 
of the liver as the most sensitive target of toxicity is supported by a number of laboratory animal species 
reporting liver effects following intermediate-duration oral exposure to several DDT, DDE, and DDD 
isomers (Banerjee et al. 1986, 1996; Gupta et al. 1989; Harada et al. 2003, 2006; Hojo et al. 2006; 
Jonsson et al. 1981; Laug et al. 1950; Liu et al. 2017a, 2017b; Orberg and Lundberg 1974; Ortega 1956; 
Yamaski et al. 2009).  Four epidemiology studies have evaluated the possible associations between serum 
or cord blood DDT or DDE levels and serum or urinary biomarkers of liver damage or dysfunction 
(Freire et al. 2015a, 2015b; Morgan and Lin 1978; Serdar et al. 2014; Sunyer et al. 2008).  The results of 
these studies do not provide consistent evidence for associations between levels of DDT/DDE/DDD 
biomarkers and alterations in serum levels of alanine aminotransferase, aspartate aminotransferase, 
γ-glutamyl transferase, lactate dehydrogenase, or bilirubin (Freire et al. 2015a, 2015b; Morgan and Lin 
1978; Serdar et al. 2014).  One study did find an association between cord blood DDE or DDT levels and 
urinary porphyrin levels (Sunyer et al. 2008). 
Agency Contacts (Chemical Managers):  Obaid Faroon 
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MINIMAL RISK LEVEL (MRL) WORKSHEET 
Chemical Name:   
Date: 
Profile Status: 
Route: 
Duration: 
MRL: 
Critical Effect: 
Reference: 
Point of Departure: 
DDT, DDE, DDD, and their isomers 
December 2019 
Draft for Public Comment 
Oral 
Chronic 
0.0001 mg/kg/day (provisional) 
Hepatocellular hypertrophy 
Harada et al. 2003, 2006 
BMDL10 of 0.01 mg/kg/day 
Uncertainty Factor: 100 
LSE Graph Key: 152 
Species: Rat 
MRL Summary:  A provisional chronic-duration oral MRL of 0.0001 mg/kg/day was derived for DDT, 
DDE, and DDD based on an increased incidence of hepatocyte hypertrophy in rats administered 
p,p’-DDT in their diets for up to 104 weeks.  The provisional MRL is based on a BMDL10 of 
0.01 mg/kg/day and a total uncertainty factor of 100 (10 for extrapolation from animals to humans and 
10 for human variability). 
Selection of the Critical Effect:  At least 35 animal studies have evaluated the chronic oral toxicity of 
DDT, DDE, or DDD and their related isomers.  These studies examined a wide range of potentially 
sensitive targets; the most sensitive effects appear to be hepatic, body weight, developmental, 
hematological, and neurological outcomes.  A summary of the lowest reliable LOAELs (and associated 
NOAELs) for these sensitive endpoints is presented in Table A-4; the table is limited to LOAELs of 
≤27 mg/kg/day, because of the large number of chronic-duration studies.   
A comparison of the lowest LOAELs identified in animal studies suggests that the liver may be the most 
sensitive target, followed by body weight, developmental, neurological, and hematological alterations.  
Sixteen studies examined the liver in rats, mice, monkeys, hamsters, and dogs chronically exposed to 
DDT, DDE, or DDD (Cabral et al. 1982a; Deichmann et al. 1967; Del Pup et al. 1978; Durnham et al. 
1963; Fitzhugh and Nelson 1947; Graillot et al. 1975; Harada et al. 2003, 2006; Lehman 1965; NCI 1978 
[six studies]; Rossi et al. 1983; Takayama et al. 1999).  Additionally, a human study examined potential 
liver effects following 12–18-month dietary exposure to 0.5 mg/kg/day but did not find alterations in 
parameters of liver function (Hayes et al. 1956).  In laboratory animals, fatty metamorphosis, 
hepatocellular hypertrophy, necrosis, altered hepatocellular foci, or amyloidosis have been observed at 
LOAELs of 0.17–49 mg/kg for technical DDT, p,p’-DDT, or p,p’-DDE.  In contrast to these findings, 
NCI (1978) reported NOAELs of 231 and 142 mg/kg/day in rats and mice, respectively, exposed to 
technical DDD for 78 weeks, suggesting that the rodent liver may be less sensitive from chronic exposure 
to DDD, compared with DDT or DDE.  At 0.4 mg/kg/day, increases in body weight gain were observed 
in the P0 and F1 (categorized as a developmental effect) rats exposed to p,p’-DDT in a 2-generation study 
involving lifetime exposure (Tomatis et al. 1972).  The lowest LOAEL for both neurological and 
hematological effects is 19.1 mg p,p’-DDT/kg/day (Harada et al. 2003, 2006; Tomita et al. 2013); effects 
observed at this dose level included tremors, reductions in hemoglobin levels, and increased 
hematopoiesis in the bone marrow.  Liver effects were selected as the critical effect because the lowest 
LOAEL was for liver effects, and there are extensive data supporting it as a critical effect. 
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Table A-4.  Summary of Relevant LOAEL and NOAEL Values Following Chronic Oral Exposure to DDT, DDE, and 
DDD Isomers 
Species Duration 
NOAEL 
(mg/kg/day) 
LOAEL 
(mg/kg/day) Effect Reference/compound 
Hepatic effects 
F344/DuCrj rat 2 years ND 0.17 M 
2.2 F 
Increased incidence of hepatocellular hypertrophy Harada et al. 2003, 2006 
p,p’-DDT 
B6C3F1 mouse 78 weeks ND 3.7 M Amyloidosis (males only) NCI 1978  
Technical DDT 
Cynomolous 
monkey 
130 months ND 6.4 F Fatty changes Takayama et al. 1999 
p,p’-DDT 
Osborne-Mendel 
rat 
2 years ND 7 Focal hepatocellular necrosis Fitzhugh and Nelson 1947 
Technical DDT 
Osborne-Mendel 
rat 
27 months ND 20 Focal hepatocellular necrosis Deichmann et al. 1967 
DDT (NS) 
Syrian hamster Lifetime 10 M 20 M Focal necrosis, hepatocyte hypertrophy, no 
increase in tumors 
Cabral et al. 1982a 
Technical DDT 
Osborne-Mendel 
rat 
78 weeks ND 23 M Fatty metamorphosis NCI 1978  
Technical DDT 
Neurological effects 
F344/DuCrj rat 2 years 1.7 M 
2.2 F 
19.1 M 
25.2 F 
Whole body tremors weeks 70–104 Harada et al. 2003, 2006 
p,p’-DDT 
Developmental effects 
CF1 mouse 2-generation
study involving
lifetime
exposure
0.4 Increased offspring body weight: >50% increase 
at some time-points (particularly in males) 
between 5 and 18 months; no dose-dependent 
pattern 
Tomatis et al. 1972 
p,p’-DDT 
Sprague-Dawley 
rat 
2-generation 1.9 18.6 Tail abnormalities (constriction rings in 13.2–
25.5% incidence); no effect on birth weights or 
body weights at weaning 
Ottoboni 1969 
Technical DDT 
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Table A-4.  Summary of Relevant LOAEL and NOAEL Values Following Chronic Oral Exposure to DDT, DDE, and 
DDD Isomers 
Species Duration 
NOAEL 
(mg/kg/day) 
LOAEL 
(mg/kg/day) Effect Reference/compound 
Hematological effects 
F344 rat Up to 
104 weeks 
0.17 1.7 Reduced hemoglobin and mean corpuscular 
volume at week 78, but not at 104 weeks; 
increased hematopoiesis in bone marrow 
Tomita et al. 2013 
p,p’-DDT 
Osborne-Mendel 
rat 
27 months 20 Hemolysis in spleen Deichmann et al.  1967 
DDT (NS) 
Body weight effects 
CF1 mouse 2-generation
study involving
lifetime
exposure
0.4 Significant increase in body weights in P0 females 
(up to 60% increase) compared with controls 
between 3 and 18 months; largest increases at 
lowest dose 
Tomatis et al. 1972 
p,p’-DDT 
F344/DuCrj rat 2 years 1.7 19.1 12% decreased mean body weight Harada et al. 2003, 2006 
p,p’-DDT 
F = female(s); LOAEL = lowest observed adverse effect level; M = male(s); NOAEL = no observed-adverse-effect level; NS = not specified 
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Selection of the Principal Study:  The Harada et al. (2003, 2006) study was selected as the basis of the 
chronic-duration oral MRL because it identified the lowest LOAEL for liver effects and provides 
adequate data to describe the dose-response relationship at low-dose levels. 
Summary of the Principal Study:  
Harada T, Yamaguchi S, Ohtsuka R, et al.  2003.  Mechanisms of promotion and progression of 
preneoplastic lesions in hepatocarcinogenesis by DDT in F344 rats.  Toxicol Pathol 31(1):87-98. 
Harada T, Ohtsuka R, Takeda M, et al.  2006.  Hepatocarcinogenesis by DDT in rats.  J Toxicol Pathol 
19:155-167. 
Starting at 5 weeks of age, groups of 40 male and 40 female Fisher (F344/DuCrj) rats and a satellite group 
of 20 males and 20 females were fed p,p’-DDT in their diets at dietary concentrations of 0, 5, 50, or 
500 ppm (Harada et al. 2003, 2006).  The study report provided intakes of 0, 0.17, 1.7, or 19.1 mg 
p,p’-DDT/kg/day (males) and 0, 0.21, 2.2, or 25.2 mg/kg/day (females), based on average feed 
consumption and body weight throughout the 2-year feeding study.  Six males and six females from each 
dose group were sacrificed after 26, 52, and 78 weeks of treatment and the following endpoints in the 
liver were monitored: (1) cell proliferation activity in the liver (immunohistochemistry staining for 
PCNA); (2) GJIC (immunohistochemistry analysis for hepatic gap junction protein connexin 32 [Cx32]); 
(3a) hepatic microsomal enzyme activity (PROD activity) and (3b) cytochrome P450 isozyme contents; 
hepatic levels of oxidative stress markers: (4a) LPO and (4b) 8-OHdG; (5) absolute and relative liver 
weights; and (6) histopathological examination of livers with morphometry.  
Male and female rats in the high-dose group (19.1 and 25.2 mg/kg/day) had whole body tremors in 
weeks 70–104; females appeared more sensitive to tremors.  There was no treatment-related mortality 
during the study.  Mean body weight decreases of 12 and 25% were observed in males at 19.1 mg/kg/day 
and females at 25.2 mg/kg/day, respectively, but it is unclear when this was determined during the study.  
Body weights of rats at lower doses were not significantly different from controls.  There was a tendency 
for increased food intake in males at 19.1 mg/kg/day, though not statistically different from controls.  
Non-neoplastic and neoplastic lesions were observed in the liver.  Absolute and relative liver weight data 
were provided for the treated groups but not for the control group, so the magnitude of the changes 
(increases) compared with controls cannot be determined.  Centrilobular hepatocellular hypertrophy was 
reported in males at all doses and in females at 2.2 and 25.2 mg/kg/day; incidence and severity showed a 
dose-related response and were related to elevated microsomal activity.  Increased incidences of 
eosinophilic altered hepatocellular foci (AHF) were observed in males dosed with ≥1.7 mg/kg/day and 
females dosed with ≥2.2 mg/kg/day.  The number and size of AHF increased with treatment time and 
dose and appeared earlier in males; AHFs were often located close to, or within, hypertrophic regions.  
Males in the 1.7 and 19.1 mg/kg/day groups had a significantly increased incidence of hepatocellular 
adenomas first seen on week 104.  Females in the 25.2 mg/kg/day group also showed a significantly 
increased incidence of hepatocellular adenomas on week 104.  Total incidences in the 0, 0.17, 1.7, and 
19.1 mg/kg/day males were 0/40, 0/40, 5/40, and 22/40, respectively; corresponding incidences in females 
at 0, 0.21, 2.2, and 25.2 mg/kg/day were 0/40, 0/40, 0/40, and 16/40.  Significantly increased incidence of 
hepatocellular carcinomas occurred only in males at 19.1 mg/kg/day (14/40 versus 0/40 in all other 
groups). 
There was no cell proliferation in the liver (as measured by the percent PCNA LI in the liver) at any dose 
for either sex.  Significant decreases in liver GJIC (as measured by number of GJIC protein Cx32) 
occurred at the mid- and high-dose throughout the duration of the study.  A significant decrease in GJIC 
protein Cx32 was found in males in the low-dose group at 78 weeks, but not at any other time point.  
There were significant changes in hepatic microsomal enzyme activity and P450 isozyme contents.  
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Significantly increased PROD activity (males: ≥0.17 mg/kg/day; females: ≥2.2 mg/kg/day) occurred 
throughout the study; except for males at the highest dose where the increase was not significant after 
52 weeks of exposure.  Rats of both sexes in the mid- and high-dose groups showed dose-dependent 
significant increases of CYP2B1 and CYP3A2 enzymes.  There were no dose-dependent, treatment-
related changes in CYP1A2 or CYP4A1 enzymes in either sex.  Oxidative stress was evident in increased 
hepatic lipid peroxide in males at 50 and 500 ppm; females showed inconsistent increases with significant 
differences occurring at 26 and 104 weeks at the mid dose, and only at 26 weeks at the high dose.  
Increased 8-OHdG levels were significant at the highest dose in both males and females. 
Selection of the Point of Departure for the MRL:  The Harada et al. (2003, 2006) study identified a 
LOAEL of 0.17 mg/kg/day for hepatocellular hypertrophy in male rats exposed to p,p’-DDT for 78 or 
104 weeks.  The lowest LOAEL in female rats was 2.2 mg/kg/day also for hepatocellular hypertrophy.  
BMD modeling was conducted to identify a POD using incidence data for hepatocellular hypertrophy in 
males because consistent evidence across multiple studies suggest males are more sensitive to liver 
toxicity due to exposure to DDT isomers than females.  
Male rat incidence data for 78 and 104 weeks of exposure (Table A-5) were fit to all available 
dichotomous models in EPA’s BMDS (version 2.6.0) using the extra risk option.  Adequate model fit was 
judged by three criteria:  goodness-of-fit statistics (chi-square p-value >0.1), visual inspection of the dose-
response curve, and scaled residual at the data point (except the control) closest to the predefined BMR 
(0% extra risk).  Among all of the models providing adequate fit to the data, the lowest BMDL10 values 
were selected as potential PODs when the difference between the BMDL10 estimated from these models 
was >3-fold; in this case, several models resulted in equivalent BMDL10 values, and therefore, the model 
with the lowest Akaike’s Information Criterion (AIC) was chosen.  Modeling results are presented in 
Table A-6 and Figure A-1 for the 78-week dataset and in Table A-7 and Figure A-2 for the 104-week 
dataset.  To obtain an adequate fit of the 104-week incidence data, the highest dose was dropped.  A 
BMDL10 value of 0.01 mg/kg/day for hepatocyte hypertrophy was obtained for both datasets (from the 
1-degree multistage model for the 78-week data and the log-logistic model for the high-dose-dropped
104-week data) and was selected as the basis of the MRL.
Table A-5.  Incidences for Hepatic Hypertrophy in Male F344/DuCrj Rats after 
78- and 104-Week Exposure to p,p’-DDT in the Diet
Dose (mg/kg/day) Incidence at 78 weeks/N Incidence at 104 weeks/N 
0 0/8 0/35 
0.17 4/8 15/30 
1.7 8/8 33/36 
19.1 7/7 31/33 
N = total number of animals examined 
Source:  Harada et al. 2003, 2006 
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Table A-6.  Model Predictions for Hepatocyte Hypertrophy in Male F344/DuCrj 
Rats Administered p,p’-DDT in Their Diet For 78 Weeks  
Model DF χ2 
χ2 
Goodness-
of-fit 
p-valuea
Scaled residualsb 
AIC 
BMD10 
(mg/kg/
day) 
BMDL10 
(mg/kg/
day) 
Dose 
below 
BMD 
Dose 
above 
BMD 
Overall 
largest 
Gammac 2 0.00 1.00 0.00 0.00 0.00 15.09 0.07 0.01 
Logistic 2 0.01 0.99 -0.12 0.01 -0.12 15.12 0.11 0.04 
LogLogisticd 2 0.00 1.00 0.00 0.00 0.00 15.09 0.13 0.01 
LogProbitd 2 0.00 1.00 0.00 0.00 0.00 15.09 0.10 0.02 
Multistage (1-degree)e,f 3 0.01 1.00 0.00 -0.03 0.09 13.11 0.03 0.01 
Multistage (2-degree)e 2 0.00 1.00 0.00 0.00 0.01 15.09 0.03 0.01 
Multistage (3-degree)e 1 0.00 0.99 0.00 0.00 0.02 17.09 0.03 0.01 
Probit 2 0.00 1.00 0.00 0.00 0.00 15.09 0.13 0.04 
Weibullc 2 0.00 1.00 0.00 0.00 0.00 15.09 0.04 0.01 
aValues <0.1 fail to meet conventional goodness-of-fit criteria. 
bScaled residuals at doses immediately below and above the BMD; also the largest residual at any dose. 
cPower restricted to ≥1. 
dSlope restricted to ≥1. 
eBetas restricted to ≥0. 
fSelected model.  All models provided adequate fit to the data.  BMDLs for models providing adequate fit were not 
sufficiently close (differed by >three-fold).  Since several models resulted in equivalent low BMDLs, the model with 
the lowest AIC is selected. 
AIC = Akaike Information Criterion; BMD = maximum likelihood estimate of the exposure concentration associated 
with the selected benchmark response; BMDL = 95% lower confidence limit on the BMD (subscripts denote 
benchmark response: i.e., 10 = exposure concentration associated with 10% extra risk); DF = degrees of freedom;  
Source:  Harada et al. 2003, 2006 
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Figure A-1.  Observed and Multistage (1-Degree) Predicted Incidence 
of Hepatocyte Hypertrophy in Rats Administered p,p’-DDT in Their 
Diet for 78 Weeks 
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Table A-7.  Model Predictions for Hepatocyte Hypertrophy in Male F344/DuCrj 
Rats Administered p,p’-DDT in Their Diet For 104 Weeks  
Model DF χ2 
χ2 
Goodness-
of-fit 
p-valuea
Scaled residualsb 
AIC 
BMD10 
(mg/kg/
day) 
BMDL10 
(mg/kg/
day) 
Dose 
below 
BMD 
Dose 
above 
BMD 
Overall 
largest 
Full dataset 
Gammac 2.00 112.06 0.00 2.09 4.03 -8.81 139.65  ND ND 
Logistic 2.00 51.91 0.00 0.70 4.78 -5.11 149.57   ND ND 
LogLogisticd, 3.00 8.75 0.03 0.00 0.36 -2.91 83.55  ND ND 
LogProbitd 3.00 6,031.67 0.00 0.00 2.85 -77.60 115.64  ND ND 
Multistage (1-degree)e 2.00 112.06 0.00 2.09 4.03 -8.81 139.65  ND ND 
Multistage (2-degree)e 2.00 112.06 0.00 2.09 4.03 -8.81 139.65  ND ND 
Multistage (3-degree)e 2.00 112.06 0.00 2.09 4.03 -8.81 139.65  ND ND 
Probit 2.00 52.48 0.00 0.65 4.94 -5.18 150.90  ND ND 
Weibullc 2.00 112.06 0.00 2.09 4.03 -8.81 139.65  ND ND 
High dose dropped 
Gammac 2.00 9.64 0.01 0.00 2.41 2.41 72.11  ND ND 
Logistic 1.00 17.44 0.00 3.03 -0.50 3.03 88.92  ND ND 
LogLogisticd,f 1.00 0.00 1.00 0.00 0.00 0.00 66.24  0.02 0.01 
LogProbitd 2.00 7.99 0.02 0.00 1.26 -2.53 69.54  ND ND 
Multistage (1-degree)e 2.00 9.64 0.01 0.00 2.41 2.41 72.11  ND ND 
Multistage (2-degree)e 2.00 9.64 0.01 0.00 2.41 2.41 72.11  ND ND 
Probit 1.00 17.69 0.00 3.12 -0.40 3.12 88.89  ND ND 
Weibullc 2.00 9.64 0.01 0.00 2.41 2.41 72.11  ND ND 
aValues <0.1 fail to meet conventional goodness-of-fit criteria. 
bScaled residuals at doses immediately below and above the BMD; also the largest residual at any dose. 
cPower restricted to ≥1. 
dSlope restricted to ≥1. 
eBetas restricted to ≥0. 
fSelected model.  None of the models provided adequate fit to the data using the full dataset.  Using the reduced 
dataset (highest dose dropped), the only model that provided adequate fit to the data was the Log Logistic.  
AIC = Akaike Information Criterion; BMD = maximum likelihood estimate of the exposure concentration associated 
with the selected benchmark response; BMDL = 95% lower confidence limit on the BMD (subscripts denote 
benchmark response: i.e., 10 = exposure concentration associated with 10% extra risk); DF = degrees of freedom; 
ND = not determined, goodness-of-fit criteria, p<0.10  
Source:  Harada et al. 2003, 2006 
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Figure A-2.  Observed and Log-logistic Predicted Incidence of Hepatocyte 
Hypertrophy in Rats Administered p,p’-DDT in Their Diet for 104 Weeks 
Uncertainty Factor: The BMDL10 is divided by a total uncertainty factor of 100: 
• 10 for extrapolation from animals to humans
• 10 for human variability
Provisional MRL = BMDL10 ÷ UFs 
0.01 mg/kg/day ÷ (10 x 10) = 0.0001 mg/kg/day 
Other Additional Studies or Pertinent Information that Lend Support to this MRL:  The identification 
of the liver as the most sensitive target of toxicity is supported by studies in several laboratory animal 
species reporting liver effects following chronic-duration oral exposure to DDT, DDE, and DDD isomers 
(Cabral et al. 1982a; Deichmann et al. 1967; Del Pup et al. 1978; Durnham et al. 1963; Fitzhugh and 
Nelson 1947; Graillot et al. 1975; Harada et al. 2003, 2006; Lehman 1965; NCI 1978; Rossi et al. 1983; 
Takayama et al. 1999).  The observed effects included fatty metamorphosis, hepatocellular hypertrophy, 
necrosis, altered hepatocellular foci, and amyloidosis.  No liver effects (as assessed via serum liver 
enzyme levels) were observed in an experimental human study involving exposure to 0.5 mg technical 
DDT/kg/day (Hayes et al. 1956).  Similarly, environmental exposure studies did not find alterations in 
serum clinical markers of liver damage or dysfunction associated with serum blood DDT or DDE levels 
(Freire et al. 2015a, 2015b; Morgan and Lin 1978; Serdar et al. 2014).  Sunyer et al. (2008) did find an 
association between cord blood DDE or DDT levels and urinary porphyrin levels (Sunyer et al. 2008). 
Agency Contacts (Chemical Managers):  Obaid Faroon 
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APPENDIX B.  LITERATURE SEARCH FRAMEWORK FOR DDT, DDE, and 
DDD 
The objective of the toxicological profile is to evaluate the potential for human exposure and the potential 
health hazards associated with inhalation, oral, or dermal/ocular exposure to DDT, DDE, and DDD.   
B.1  LITERATURE SEARCH AND SCREEN
A literature search and screen was conducted to identify studies examining health effects, toxicokinetics, 
mechanisms of action, susceptible populations, biomarkers, chemical interactions, physical and chemical 
properties, production, use, environmental fate, environmental releases, and environmental and biological 
monitoring data for DDT, DDE, and DDD.  ATSDR primarily focused on peer-reviewed articles without 
publication date or language restrictions.  Non-peer-reviewed studies that were considered relevant to the 
assessment of the health effects of DDT, DDE, and DDD have undergone peer review by at least three 
ATSDR-selected experts who have been screened for conflict of interest.  The inclusion criteria used to 
identify relevant studies examining the health effects of DDT, DDE, and DDD are presented in 
Table B-1. 
Table B-1.  Inclusion Criteria for the Literature Search and Screen 
Health Effects 
Species 
Human 
Laboratory mammals 
Route of exposure 
Inhalation 
Oral 
Dermal (or ocular) 
Parenteral (these studies will be considered supporting data) 
Health outcome 
Death 
Systemic effects 
Body weight effects  
Respiratory effects 
Cardiovascular effects 
Gastrointestinal effects 
Hematological effects 
Musculoskeletal effects 
Hepatic effects 
Renal effects 
Dermal effects 
Ocular effects 
Endocrine effects 
Immunological effects 
Neurological effects 
Reproductive effects 
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Table B-1.  Inclusion Criteria for the Literature Search and Screen 
 
  Developmental effects 
  Other noncancer effects 
  Cancer 
Toxicokinetics 
 Absorption 
 Distribution 
 Metabolism 
 Excretion 
 PBPK models 
Biomarkers 
 Biomarkers of exposure 
 Biomarkers of effect 
Interactions with other chemicals 
Potential for human exposure 
 Releases to the environment 
  Air 
  Water 
  Soil 
 Environmental fate 
  Transport and partitioning 
  Transformation and degradation 
 Environmental monitoring 
  Air 
  Water 
  Sediment and soil 
  Other media 
 Biomonitoring 
  General populations 
  Occupation populations 
 
 
B.1.1  Literature Search 
 
The current literature search was intended to update the 2002 toxicological profile for DDT, DDE, and 
DDD; thus, the literature search was restricted to studies published between August 2000 to November 
2016.  The following main databases were searched in November 2016: 
 
• PubMed  
• National Library of Medicine’s TOXLINE 
• Scientific and Technical Information Network’s TOXCENTER 
 
The search strategy used the chemical names, Chemical Abstracts Service (CAS) numbers, 
synonyms, Medical Subject Headings (MeSH) headings, and keywords for DDT, DDE, and DDD.  
The query strings used for the literature search are presented in Table B-2.  
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The search was augmented by searching the Toxic Substances Control Act Test Submissions (TSCATS), 
NTP website, and National Institute of Health Research Portfolio Online Reporting Tools Expenditures 
and Results (NIH RePORTER) databases using the queries presented in Table B-3.  Additional databases 
were searched in the creation of various tables and figures, such as the TRI Explorer, the Substance 
Priority List (SPL) resource page, and other items as needed.  Regulations applicable to DDT, DDE, and 
DDD were identified by searching international and U.S. agency websites and documents. 
 
Review articles were identified and used for the purpose of providing background information and 
identifying additional references.  ATSDR also identified reports from the grey literature, which included 
unpublished research reports, technical reports from government agencies, conference proceedings and 
abstracts, and theses and dissertations.   
 
Table B-2.  Database Query Strings  
 
Database 
search date Query string 
PubMed  
11/2016 ((("DDT/toxicity"[mh] OR "DDT/adverse effects"[mh] OR "DDT/poisoning"[mh] OR 
"DDT/pharmacokinetics"[mh]) OR ("DDT"[mh] AND ("environmental exposure"[mh] OR 
ci[sh])) OR ("DDT"[mh] AND toxicokinetics[mh:noexp]) OR ("DDT/blood"[mh] OR 
"DDT/cerebrospinal fluid"[mh] OR "DDT/urine"[mh]) OR ("DDT"[mh] AND ("endocrine 
system"[mh] OR "hormones, hormone substitutes, and hormone antagonists"[mh] OR 
"endocrine disruptors"[mh])) OR ("DDT"[mh] AND ("computational biology"[mh] OR 
"medical informatics"[mh] OR genomics[mh] OR genome[mh] OR proteomics[mh] OR 
proteome[mh] OR metabolomics[mh] OR metabolome[mh] OR genes[mh] OR "gene 
expression"[mh] OR phenotype[mh] OR genetics[mh] OR genotype[mh] OR 
transcriptome[mh] OR ("systems biology"[mh] AND ("environmental exposure"[mh] OR 
"epidemiological monitoring"[mh] OR analysis[sh])) OR "transcription, genetic "[mh] OR 
"reverse transcription"[mh] OR "transcriptional activation"[mh] OR "transcription 
factors"[mh] OR ("biosynthesis"[sh] AND (RNA[mh] OR DNA[mh])) OR "RNA, 
messenger"[mh] OR "RNA, transfer"[mh] OR "peptide biosynthesis"[mh] OR "protein 
biosynthesis"[mh] OR "reverse transcriptase polymerase chain reaction"[mh] OR "base 
sequence"[mh] OR "trans-activators"[mh] OR "gene expression profiling"[mh])) OR 
("DDT/antagonists and inhibitors"[mh]) OR ("DDT/metabolism"[mh] AND ("humans"[mh] 
OR "animals"[mh])) OR ("DDT"[mh] AND cancer[sb]) OR ("DDT/pharmacology"[majr] AND 
(to[sh] OR po[sh] OR ae[sh] OR pk[sh] OR (me[sh] AND ("humans"[mh] OR 
"animals"[mh])) OR ci[sh] OR bl[sh] OR cf[sh] OR ur[sh]))) OR (("dichlorodiphenyl 
dichloroethylene/toxicity"[mh] OR "dichlorodiphenyl dichloroethylene/adverse effects"[mh] 
OR "dichlorodiphenyl dichloroethylene/poisoning"[mh] OR "dichlorodiphenyl 
dichloroethylene/pharmacokinetics"[mh]) OR ("dichlorodiphenyl dichloroethylene"[mh] AND 
("environmental exposure"[mh] OR ci[sh])) OR ("dichlorodiphenyl dichloroethylene"[mh] 
AND toxicokinetics[mh:noexp]) OR ("dichlorodiphenyl dichloroethylene"[mh] AND 
toxicokinetics[mh:noexp]) OR ("dichlorodiphenyl dichloroethylene/blood"[mh] OR 
"dichlorodiphenyl dichloroethylene/cerebrospinal fluid"[mh] OR "dichlorodiphenyl 
dichloroethylene/urine"[mh]) OR ("dichlorodiphenyl dichloroethylene"[mh] AND ("endocrine 
system"[mh] OR "hormones, hormone substitutes, and hormone antagonists"[mh] OR 
"endocrine disruptors"[mh])) OR ("dichlorodiphenyl dichloroethylene"[mh] AND 
("computational biology"[mh] OR "medical informatics"[mh] OR genomics[mh] OR 
genome[mh] OR proteomics[mh] OR proteome[mh] OR metabolomics[mh] OR 
metabolome[mh] OR genes[mh] OR "gene expression"[mh] OR phenotype[mh] OR 
genetics[mh] OR genotype[mh] OR transcriptome[mh] OR ("systems biology"[mh] AND 
("environmental exposure"[mh] OR "epidemiological monitoring"[mh] OR analysis[sh])) OR 
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Table B-2.  Database Query Strings  
 
Database 
search date Query string 
"transcription, genetic "[mh] OR "reverse transcription"[mh] OR "transcriptional 
activation"[mh] OR "transcription factors"[mh] OR ("biosynthesis"[sh] AND (rna[mh] OR 
dna[mh])) OR "rna, messenger"[mh] OR "rna, transfer"[mh] OR "peptide biosynthesis"[mh] 
OR "protein biosynthesis"[mh] OR "reverse transcriptase polymerase chain reaction"[mh] 
OR "base sequence"[mh] OR "trans-activators"[mh] OR "gene expression profiling"[mh])) 
OR ("dichlorodiphenyl dichloroethylene/antagonists and inhibitors"[mh]) OR 
("dichlorodiphenyl dichloroethylene/metabolism"[mh] AND ("humans"[mh] OR 
"animals"[mh])) OR ("dichlorodiphenyl dichloroethylene"[mh] AND cancer[sb]) OR 
("dichlorodiphenyl dichloroethylene/pharmacology"[majr] AND (to[sh] OR po[sh] OR ae[sh] 
OR pk[sh] OR (me[sh] AND ("humans"[mh] OR "animals"[mh])) OR ci[sh] OR bl[sh] OR 
cf[sh] OR ur[sh])) OR ("Dichlorodiphenyldichloroethane/toxicity"[mh] OR 
"Dichlorodiphenyldichloroethane/adverse effects"[mh] OR 
"Dichlorodiphenyldichloroethane/poisoning"[mh] OR 
"Dichlorodiphenyldichloroethane/pharmacokinetics"[mh]) OR 
("Dichlorodiphenyldichloroethane"[mh] AND ("environmental exposure"[mh] OR ci[sh])) OR 
("Dichlorodiphenyldichloroethane"[mh] AND toxicokinetics[mh:noexp]) OR 
("Dichlorodiphenyldichloroethane"[mh] AND toxicokinetics[mh:noexp]) OR 
("Dichlorodiphenyldichloroethane/blood"[mh] OR 
"Dichlorodiphenyldichloroethane/cerebrospinal fluid"[mh] OR 
"Dichlorodiphenyldichloroethane/urine"[mh]) OR ("Dichlorodiphenyldichloroethane"[mh] 
AND ("endocrine system"[mh] OR "hormones, hormone substitutes, and hormone 
antagonists"[mh] OR "endocrine disruptors"[mh])) OR 
("Dichlorodiphenyldichloroethane"[mh] AND ("computational biology"[mh] OR "medical 
informatics"[mh] OR genomics[mh] OR genome[mh] OR proteomics[mh] OR proteome[mh] 
OR metabolomics[mh] OR metabolome[mh] OR genes[mh] OR "gene expression"[mh] OR 
phenotype[mh] OR genetics[mh] OR genotype[mh] OR transcriptome[mh] OR ("systems 
biology"[mh] AND ("environmental exposure"[mh] OR "epidemiological monitoring"[mh] OR 
analysis[sh])) OR "transcription, genetic "[mh] OR "reverse transcription"[mh] OR 
"transcriptional activation"[mh] OR "transcription factors"[mh] OR ("biosynthesis"[sh] AND 
(rna[mh] OR dna[mh])) OR "rna, messenger"[mh] OR "rna, transfer"[mh] OR "peptide 
biosynthesis"[mh] OR "protein biosynthesis"[mh] OR "reverse transcriptase polymerase 
chain reaction"[mh] OR "base sequence"[mh] OR "trans-activators"[mh] OR "gene 
expression profiling"[mh])) OR ("Dichlorodiphenyldichloroethane/antagonists and 
inhibitors"[mh]) OR ("Dichlorodiphenyldichloroethane/metabolism"[mh] AND ("humans"[mh] 
OR "animals"[mh])) OR ("Dichlorodiphenyldichloroethane"[mh] AND cancer[sb]) OR 
("Dichlorodiphenyldichloroethane/pharmacology"[majr] AND (to[sh] OR po[sh] OR ae[sh] 
OR pk[sh] OR (me[sh] AND ("humans"[mh] OR "animals"[mh])) OR ci[sh] OR bl[sh] OR 
cf[sh] OR ur[sh])) OR ("Mitotane/toxicity"[mh] OR "Mitotane/adverse effects"[mh] OR 
"Mitotane/poisoning"[mh] OR "Mitotane/pharmacokinetics"[mh]) OR ("Mitotane"[mh] AND 
("environmental exposure"[mh] OR ci[sh])) OR ("Mitotane"[mh] AND 
toxicokinetics[mh:noexp]) OR ("Mitotane"[mh] AND toxicokinetics[mh:noexp]) OR 
("Mitotane/blood"[mh] OR "Mitotane/cerebrospinal fluid"[mh] OR "Mitotane/urine"[mh]) OR 
("Mitotane"[mh] AND ("endocrine system"[mh] OR "hormones, hormone substitutes, and 
hormone antagonists"[mh] OR "endocrine disruptors"[mh])) OR ("Mitotane"[mh] AND 
("computational biology"[mh] OR "medical informatics"[mh] OR genomics[mh] OR 
genome[mh] OR proteomics[mh] OR proteome[mh] OR metabolomics[mh] OR 
metabolome[mh] OR genes[mh] OR "gene expression"[mh] OR phenotype[mh] OR 
genetics[mh] OR genotype[mh] OR transcriptome[mh] OR ("systems biology"[mh] AND 
("environmental exposure"[mh] OR "epidemiological monitoring"[mh] OR analysis[sh])) OR 
"transcription, genetic "[mh] OR "reverse transcription"[mh] OR "transcriptional 
activation"[mh] OR "transcription factors"[mh] OR ("biosynthesis"[sh] AND (rna[mh] OR 
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Table B-2.  Database Query Strings  
 
Database 
search date Query string 
dna[mh])) OR "rna, messenger"[mh] OR "rna, transfer"[mh] OR "peptide biosynthesis"[mh] 
OR "protein biosynthesis"[mh] OR "reverse transcriptase polymerase chain reaction"[mh] 
OR "base sequence"[mh] OR "trans-activators"[mh] OR "gene expression profiling"[mh])) 
OR ("Mitotane/antagonists and inhibitors"[mh]) OR ("Mitotane/metabolism"[mh] AND 
("humans"[mh] OR "animals"[mh])) OR ("Mitotane"[mh] AND cancer[sb]) OR 
("Mitotane/pharmacology"[majr] AND (to[sh] OR po[sh] OR ae[sh] OR pk[sh] OR (me[sh] 
AND ("humans"[mh] OR "animals"[mh])) OR ci[sh] OR bl[sh] OR cf[sh] OR ur[sh])) OR 
("2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene"[nm]))) AND (2000 : 3000[dp] 
OR 2000/08/01 : 3000[mhda] OR 2000/08/01 : 3000[edat] OR 2000/08/01 : 3000[crdat]) 
 ((("DDT"[tw] OR "DDTs"[tw] OR "DDE"[tw]) OR ("2,4'-DDD"[tw] OR "4,4'-DDD"[tw] OR 
"DDD, o, p'-"[tw] OR "DDD, p, p'-"[tw] OR "o, p'-DDD"[tw] OR "p, p'-DDD"[tw]) OR 
("DDD"[tw] NOT ("ATC-DDD"[tw] OR "daily defined dose"[tw] OR "daily defined doses"[tw] 
OR "data-driven detection"[tw] OR "ddd pacemaker"[tw] OR "DDD-028"[tw] OR 
"ddd/100"[tw] OR "ddd/1000"[tw] OR "ddd/sgn"[tw] OR "defined daily dose"[tw] OR 
"defined daily doses"[tw] OR "degenerative disc disease"[tw] OR "degenerative disk 
disease"[tw] OR "dense deposit disease"[tw] OR "depersonalization/derealization 
disorder"[tw] OR "Depression due to Dementia"[tw] OR "digital differential display"[tw] OR 
"direct disk diffusion"[tw] OR "disc degenerative disease"[tw] OR "disk degenerative 
disease"[tw] OR "difference-in-difference-in-differences"[tw] OR "direct detection device" 
OR "direct detector device"[tw] OR "Direct electron detectors"[tw] OR "distal-dorsal 
difference"[tw] OR "Dowling-Degos disease"[tw] OR "Drew-Dickerson dodecamer"[tw] OR 
"drinking day"[tw] OR "Drug Discovery and Development"[tw] OR "drunk driving 
detection"[tw] OR "lumbar disc disease"[tw] OR "lumbar disk disease"[tw] OR "pacing"[tw] 
OR ("dual chamber"[tw] AND "pacemaker"[tw]) OR "DDD Study"[Corporate Author])) OR 
("(-)-1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2,2-trichloroethane"[tw] OR "(+-)-1,1-
Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane"[tw] OR "(+/-)-1-(o-Chlorophenyl)-1-
(p-chlorophenyl)-2,2,2-trichloroethane"[tw] OR "1-(2-Chlorophenyl)-1-(4-chlorophenyl)-
2,2,2-trichloroethane"[tw] OR "1-(2'-Chlorophenyl)-1-(4'-chlorophenyl)-2,2-
dichloroethane"[tw] OR "1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane"[tw] OR 
"1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2,2-trichloroethane"[tw] OR "1-(o-Chlorophenyl)-
1-(p-chlorophenyl)-2,2-dichloroethane"[tw] OR "1,1'-(2,2,2-Trichloroethylidene)bis(4-
chlorobenzene)"[tw] OR "1,1'-(2,2-Dichloroethylidene)bis(4-chlorobenzene)"[tw] OR "1,1'-
(Dichloroethenylidene)bis(4-chlorobenzene)"[tw] OR "1,1,1-Trichloro-2-(o-chlorophenyl)-2-
(p-chlorophenyl)ethane"[tw] OR "1,1,1-Trichloro-2,2-bis(4,4'-dichlorodiphenyl)ethane"[tw] 
OR "1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane"[tw] OR "1,1,1-Trichloro-2,2-bis(p-
chlorophenyl)ethane"[tw] OR "1,1,1-Trichloro-2,2-di(4-chlorophenyl)-ethane"[tw] OR "1,1,1-
Trichloro-2,2-di(p-chlorophenyl)ethane"[tw] OR "1,1,1-Trichloro-2-2,2-bis(p-
chlorophenyl)ethane"[tw] OR "1,1-Bis(4-chlorophenyl)-2,2,2-trichloroethane"[tw] OR "1,1-
Bis(4-chlorophenyl)-2,2-dichloroethane"[tw] OR "1,1-Bis(4-chlorophenyl)-2,2-
dichloroethene"[tw] OR "1,1-Bis(p-chlorophenyl)-2,2,2-trichloroethane"[tw] OR "1,1-Bis-(p-
chlorophenyl)-2,2,2-trichloroethane"[tw] OR "1,1-Bis(p-chlorophenyl)-2,2-
dichloroethane"[tw] OR "1,1-Bis(p-chlorophenyl)-2,2-dichloroethylene"[tw] OR "1,1-
Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane"[tw] OR "1,1-Dichloro-2-(o-
chlorophenyl)-2-(p-chlorophenyl)ethene"[tw] OR "1,1-Dichloro-2-(o-chlorophenyl)-2-(p-
chlorophenyl)ethylene"[tw] OR "1,1-Dichloro-2-(p-chlorophenyl)-2-(o-
chlorophenyl)ethane"[tw] OR "1,1-Dichloro-2,2-bis(2,4'-dichlorophenyl)ethane"[tw] OR 
"1,1'-Dichloro-2,2-bis(4-chlorophenyl)ethane"[tw] OR "1,1-Dichloro-2,2-bis(4-
chlorophenyl)ethane"[tw] OR "1,1-Dichloro-2,2-bis(para-chlorophenyl) ethylene"[tw] OR 
"1,1-Dichloro-2,2-bis(parachlorophenyl)ethane"[tw] OR "1,1-Dichloro-2,2-bis(p-
chlorophenyl)ethane"[tw] OR "1,1-Dichloro-2,2-bis(p-chlorophenyl)ethene"[tw] OR "1,1-
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Dichloro-2,2-bis(p-chlorophenyl)ethylene"[tw] OR "1,1-Dichloro-2,2-di(4-
chlorophenyl)ethane"[tw] OR "1,1-Dichloro-2,2-di(p-chlorophenyl)ethylene"[tw] OR "1-
Chloro-2-(2,2,2-trichloro-1-(4-chlorophenyl)ethyl)benzene"[tw] OR "1-Chloro-2-(2,2-
dichloro-1-(4-chlorophenyl)ethyl)benzene"[tw] OR "2-(2-Chlorophenyl)-2-(4-chlorophenyl)-
1,1,1-trichloroethane"[tw] OR "2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1-
dichloroethane"[tw] OR "2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1-dichloroethylene"[tw] 
OR "2-(o-Chlorophenyl)-2-(p-chlorophenyl)-1,1-dichloroethane"[tw] OR "2-(p-
Chlorophenyl)-2-(o-chlorophenyl)-1,1-dichloroethane"[tw] OR "2,2-(2-Chlorophenyl-4'-
chlorophenyl)-1,1-dichloroethene"[tw] OR "2,2,2, o, p'-
Pentachloroethylidenebisbenzene"[tw] OR "2,2,2-Trichloro-1,1-bis(4-
chlorophenyl)ethane"[tw] OR "2,2, o, p'-Tetrachlorovinylidenebisbenzene"[tw] OR "2,2-
Bis(2-chlorophenyl-4-chlorophenyl)-1,1-dichloroethane"[tw] OR "2,2-Bis(4-chlorophenyl)-
1,1-dichloroethane"[tw] OR "2,2-Bis(4-chlorophenyl)-1,1-dichloroethene"[tw] OR "2,2-Bis(4-
chlorophenyl)-1,1-dichloroethylene"[tw] OR "2,2-Bis(o, p-chlorophenyl)-1,1,1-
trichloroethane"[tw] OR "2,2-Bis(p-chlorophenyl)-1,1,1-trichloroethane"[tw] OR "2,2-Bis(p-
chlorophenyl)-1,1-dichloroethane"[tw] OR "2,2-Bis(p-chlorophenyl)-1,1-
dichloroethylene"[tw] OR "2,2-Di(p-chlorophenyl)-1,1-dichloroethane"[tw] OR "2,2-Di(p-
chlorophenyl)-1,1-dichloroethylene"[tw] OR "2,2-Dichloro-1,1-bis(4-
chlorophenyl)ethylene"[tw] OR "2,4'-Dichlorodiphenyldichloroethane"[tw] OR "2,4'-
Dichlorodiphenyldichloroethylene"[tw] OR "2,4'-Dichlorodiphenyltrichloroethane"[tw] OR 
"2,4'-Dichlorophenyldichlorethane"[tw] OR "2-o-Chlorophenyl-2-p-chlorophenyl-1,1,1-
trichloroethane"[tw] OR "4,4'-1,1-Dichloro-2,2-bis(p-chlorophenyl)ethane"[tw] OR "4,4'-
Dichlorodiphenyldichloroethane"[tw] OR "4,4'-Dichlorodiphenyldichloroethylene"[tw] OR 
"4,4'-Dichlorodiphenyltrichloroethane"[tw] OR "4,4'-TDE"[tw] OR "alpha, alpha-Bis(p-
chlorophenyl)-beta, beta, beta-trichloroethane"[tw] OR "Chlorophenothane"[tw] OR 
"Chlorophenothanum"[tw] OR "Chlorphenothan"[tw] OR "Dichlorodiphenyl 
dichloroethane"[tw] OR "Dichlorodiphenyl dichloroethene"[tw] OR "Dichlorodiphenyl 
dichloroethylene"[tw] OR "Dichlorodiphenyldichloroethane"[tw] OR 
"Dichlorodiphenyldichloroethylene"[tw] OR "Dichlorodiphenyltrichloroethane"[tw] OR 
"Mitotan"[tw] OR "Mitotane"[tw] OR "Mitotanum"[tw] OR "o, p'-1,1,1-Trichloro-2-2,2-bis(p-
chlorophenyl)ethane"[tw] OR "o, p'-Chlorophenothane"[tw] OR "o, p'-
Dichlorodiphenyldichloroethane"[tw] OR "o, p'-Dichlorodiphenyldichloroethylene"[tw] OR 
"o, p'-Dichlorodiphenyltrichloroethane"[tw] OR "o, p'-TDE"[tw] OR "o, p-TDE"[tw] OR "p, p'-
(Dichlorodiphenyl)-2,2-dichloroethylene"[tw] OR "p, p'-
Dichlorodiphenoldichloroethylene"[tw] OR "p, p'-Dichlorodiphenyl dichloroethylene"[tw] OR 
"p, p'-Dichlorodiphenyl-2,2-dichloroethylene"[tw] OR "p, p'-
Dichlorodiphenyldichloroethane"[tw] OR "p, p'-Dichlorodiphenyldichloroethylene"[tw] OR 
"p, p'-Dichlorodiphenylethylene dichloride"[tw] OR "p, p'-
Dichlorodiphenyltrichloroethane"[tw] OR "p, p'-Dichlorodiphenyltrichloromethylmethane"[tw] 
OR "p, p'-TDE"[tw] OR "Parachlorocidum"[tw] OR "Tetrachlorodiphenylethane"[tw] OR 
"Trichlorobis(4'-chlorophenyl)ethane"[tw] OR "Trichlorobis(4-chlorophenyl)ethane"[tw] OR 
"Aavero-extra"[tw] OR "Agritan"[tw] OR "Anofex"[tw] OR "Arkotine"[tw] OR "Azotox M 
33"[tw] OR "Benzochloryl"[tw] OR "Bosan supra"[tw] OR "Bovidermol"[tw] OR "CB 313"[tw] 
OR "CB313"[tw] OR "Chloditan"[tw] OR "Chlodithan"[tw] OR "Chlodithane"[tw] OR 
"Chlofenotan"[tw] OR "Chlorophenothan"[tw] OR "Chlorophenotoxum"[tw] OR 
"Chlorphenotoxum"[tw] OR "Citox"[tw] OR "Clofenotan"[tw] OR "Clofenotane"[tw] OR 
"Clofenotane technique"[tw] OR "Clofenotanum"[tw] OR "D.D.T. technique"[tw] OR 
"Deoval"[tw] OR "Detox"[tw] OR "Detoxan"[tw] OR "Dibovin"[tw] OR "Dicophane"[tw] OR 
"Dicophaner"[tw] OR "Didigam"[tw] OR "Didimac"[tw] OR "Dilene"[tw] OR "Dodat"[tw] OR 
"Dykol"[tw] OR "Estonate"[tw] OR "FWJ"[tw] OR "Genitox"[tw] OR "Gesafid"[tw] OR 
"Gesapon"[tw] OR "Gesarex"[tw] OR "Gesarol"[tw] OR "Guesapon"[tw] OR "Guesarol"[tw] 
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OR "Gyron"[tw] OR "Hildit"[tw] OR "Ivoran"[tw] OR "Ixodex"[tw] OR "Khlodithan"[tw] OR 
"Kopsol"[tw] OR "Lysodren"[tw] OR "ME 1700"[tw] OR "Me-700"[tw] OR "Mutoxan"[tw] OR 
"Neocid"[tw] OR "Neocidol"[tw] OR "OMS 0016"[tw] OR "OMS 1078"[tw] OR "OMS 16"[tw] 
OR "Opeprim"[tw] OR "PEB1"[tw] OR "Pentachlorin"[tw] OR "Pentech"[tw] OR 
"Penticidum"[tw] OR "p'-Zeidane"[tw] OR "Rhothane"[tw] OR "Rhothane D-3"[tw] OR 
"Rothane"[tw] OR "Rukseam"[tw] OR "Santobane"[tw] OR "Tafidex"[tw] OR "Zerdane"[tw])) 
AND (2000 : 3000[dp] OR 2000/08/01 : 3000[mhda] OR 2000/08/01 : 3000[edat] OR 
2000/08/01 : 3000[crdat])) NOT medline[sb] 
 ((("DDT"[tw] OR "DDTs"[tw] OR "DDE"[tw]) OR ("2,4'-DDD"[tw] OR "4,4'-DDD"[tw] OR 
"DDD, o, p'-"[tw] OR "DDD, p, p'-"[tw] OR "o, p'-DDD"[tw] OR "p, p'-DDD"[tw]) OR 
("DDD"[tw] NOT ("ATC-DDD"[tw] OR "daily defined dose"[tw] OR "daily defined doses"[tw] 
OR "data-driven detection"[tw] OR "ddd pacemaker"[tw] OR "DDD-028"[tw] OR 
"ddd/100"[tw] OR "ddd/1000"[tw] OR "ddd/sgn"[tw] OR "defined daily dose"[tw] OR 
"defined daily doses"[tw] OR "degenerative disc disease"[tw] OR "degenerative disk 
disease"[tw] OR "dense deposit disease"[tw] OR "depersonalization/derealization 
disorder"[tw] OR "Depression due to Dementia"[tw] OR "digital differential display"[tw] OR 
"direct disk diffusion"[tw] OR "disc degenerative disease"[tw] OR "disk degenerative 
disease"[tw] OR "difference-in-difference-in-differences"[tw] OR "direct detection device" 
OR "direct detector device"[tw] OR "Direct electron detectors"[tw] OR "distal-dorsal 
difference"[tw] OR "Dowling-Degos disease"[tw] OR "Drew-Dickerson dodecamer"[tw] OR 
"drinking day"[tw] OR "Drug Discovery and Development"[tw] OR "drunk driving 
detection"[tw] OR "lumbar disc disease"[tw] OR "lumbar disk disease"[tw] OR "pacing"[tw] 
OR ("dual chamber"[tw] AND "pacemaker"[tw]) OR "DDD Study"[Corporate Author])) OR 
("(-)-1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2,2-trichloroethane"[tw] OR "(+-)-1,1-
Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane"[tw] OR "(+/-)-1-(o-Chlorophenyl)-1-
(p-chlorophenyl)-2,2,2-trichloroethane"[tw] OR "1-(2-Chlorophenyl)-1-(4-chlorophenyl)-
2,2,2-trichloroethane"[tw] OR "1-(2'-Chlorophenyl)-1-(4'-chlorophenyl)-2,2-
dichloroethane"[tw] OR "1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane"[tw] OR 
"1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2,2-trichloroethane"[tw] OR "1-(o-Chlorophenyl)-
1-(p-chlorophenyl)-2,2-dichloroethane"[tw] OR "1,1'-(2,2,2-Trichloroethylidene)bis(4-
chlorobenzene)"[tw] OR "1,1'-(2,2-Dichloroethylidene)bis(4-chlorobenzene)"[tw] OR "1,1'-
(Dichloroethenylidene)bis(4-chlorobenzene)"[tw] OR "1,1,1-Trichloro-2-(o-chlorophenyl)-2-
(p-chlorophenyl)ethane"[tw] OR "1,1,1-Trichloro-2,2-bis(4,4'-dichlorodiphenyl)ethane"[tw] 
OR "1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane"[tw] OR "1,1,1-Trichloro-2,2-bis(p-
chlorophenyl)ethane"[tw] OR "1,1,1-Trichloro-2,2-di(4-chlorophenyl)-ethane"[tw] OR "1,1,1-
Trichloro-2,2-di(p-chlorophenyl)ethane"[tw] OR "1,1,1-Trichloro-2-2,2-bis(p-
chlorophenyl)ethane"[tw] OR "1,1-Bis(4-chlorophenyl)-2,2,2-trichloroethane"[tw] OR "1,1-
Bis(4-chlorophenyl)-2,2-dichloroethane"[tw] OR "1,1-Bis(4-chlorophenyl)-2,2-
dichloroethene"[tw] OR "1,1-Bis(p-chlorophenyl)-2,2,2-trichloroethane"[tw] OR "1,1-Bis-(p-
chlorophenyl)-2,2,2-trichloroethane"[tw] OR "1,1-Bis(p-chlorophenyl)-2,2-
dichloroethane"[tw] OR "1,1-Bis(p-chlorophenyl)-2,2-dichloroethylene"[tw] OR "1,1-
Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane"[tw] OR "1,1-Dichloro-2-(o-
chlorophenyl)-2-(p-chlorophenyl)ethene"[tw] OR "1,1-Dichloro-2-(o-chlorophenyl)-2-(p-
chlorophenyl)ethylene"[tw] OR "1,1-Dichloro-2-(p-chlorophenyl)-2-(o-
chlorophenyl)ethane"[tw] OR "1,1-Dichloro-2,2-bis(2,4'-dichlorophenyl)ethane"[tw] OR 
"1,1'-Dichloro-2,2-bis(4-chlorophenyl)ethane"[tw] OR "1,1-Dichloro-2,2-bis(4-
chlorophenyl)ethane"[tw] OR "1,1-Dichloro-2,2-bis(para-chlorophenyl) ethylene"[tw] OR 
"1,1-Dichloro-2,2-bis(parachlorophenyl)ethane"[tw] OR "1,1-Dichloro-2,2-bis(p-
chlorophenyl)ethane"[tw] OR "1,1-Dichloro-2,2-bis(p-chlorophenyl)ethene"[tw] OR "1,1-
Dichloro-2,2-bis(p-chlorophenyl)ethylene"[tw] OR "1,1-Dichloro-2,2-di(4-
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chlorophenyl)ethane"[tw] OR "1,1-Dichloro-2,2-di(p-chlorophenyl)ethylene"[tw] OR "1-
Chloro-2-(2,2,2-trichloro-1-(4-chlorophenyl)ethyl)benzene"[tw] OR "1-Chloro-2-(2,2-
dichloro-1-(4-chlorophenyl)ethyl)benzene"[tw] OR "2-(2-Chlorophenyl)-2-(4-chlorophenyl)-
1,1,1-trichloroethane"[tw] OR "2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1-
dichloroethane"[tw] OR "2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1-dichloroethylene"[tw] 
OR "2-(o-Chlorophenyl)-2-(p-chlorophenyl)-1,1-dichloroethane"[tw] OR "2-(p-
Chlorophenyl)-2-(o-chlorophenyl)-1,1-dichloroethane"[tw] OR "2,2-(2-Chlorophenyl-4'-
chlorophenyl)-1,1-dichloroethene"[tw] OR "2,2,2, o, p'-
Pentachloroethylidenebisbenzene"[tw] OR "2,2,2-Trichloro-1,1-bis(4-
chlorophenyl)ethane"[tw] OR "2,2, o, p'-Tetrachlorovinylidenebisbenzene"[tw] OR "2,2-
Bis(2-chlorophenyl-4-chlorophenyl)-1,1-dichloroethane"[tw] OR "2,2-Bis(4-chlorophenyl)-
1,1-dichloroethane"[tw] OR "2,2-Bis(4-chlorophenyl)-1,1-dichloroethene"[tw] OR "2,2-Bis(4-
chlorophenyl)-1,1-dichloroethylene"[tw] OR "2,2-Bis(o, p-chlorophenyl)-1,1,1-
trichloroethane"[tw] OR "2,2-Bis(p-chlorophenyl)-1,1,1-trichloroethane"[tw] OR "2,2-Bis(p-
chlorophenyl)-1,1-dichloroethane"[tw] OR "2,2-Bis(p-chlorophenyl)-1,1-
dichloroethylene"[tw] OR "2,2-Di(p-chlorophenyl)-1,1-dichloroethane"[tw] OR "2,2-Di(p-
chlorophenyl)-1,1-dichloroethylene"[tw] OR "2,2-Dichloro-1,1-bis(4-
chlorophenyl)ethylene"[tw] OR "2,4'-Dichlorodiphenyldichloroethane"[tw] OR "2,4'-
Dichlorodiphenyldichloroethylene"[tw] OR "2,4'-Dichlorodiphenyltrichloroethane"[tw] OR 
"2,4'-Dichlorophenyldichlorethane"[tw] OR "2-o-Chlorophenyl-2-p-chlorophenyl-1,1,1-
trichloroethane"[tw] OR "4,4'-1,1-Dichloro-2,2-bis(p-chlorophenyl)ethane"[tw] OR "4,4'-
Dichlorodiphenyldichloroethane"[tw] OR "4,4'-Dichlorodiphenyldichloroethylene"[tw] OR 
"4,4'-Dichlorodiphenyltrichloroethane"[tw] OR "4,4'-TDE"[tw] OR "alpha, alpha-Bis(p-
chlorophenyl)-beta, beta, beta-trichloroethane"[tw] OR "Chlorophenothane"[tw] OR 
"Chlorophenothanum"[tw] OR "Chlorphenothan"[tw] OR "Dichlorodiphenyl 
dichloroethane"[tw] OR "Dichlorodiphenyl dichloroethene"[tw] OR "Dichlorodiphenyl 
dichloroethylene"[tw] OR "Dichlorodiphenyldichloroethane"[tw] OR 
"Dichlorodiphenyldichloroethylene"[tw] OR "Dichlorodiphenyltrichloroethane"[tw] OR 
"Mitotan"[tw] OR "Mitotane"[tw] OR "Mitotanum"[tw] OR "o, p'-1,1,1-Trichloro-2-2,2-bis(p-
chlorophenyl)ethane"[tw] OR "o, p'-Chlorophenothane"[tw] OR "o, p'-
Dichlorodiphenyldichloroethane"[tw] OR "o, p'-Dichlorodiphenyldichloroethylene"[tw] OR 
"o, p'-Dichlorodiphenyltrichloroethane"[tw] OR "o, p'-TDE"[tw] OR "o, p-TDE"[tw] OR "p, p'-
(Dichlorodiphenyl)-2,2-dichloroethylene"[tw] OR "p, p'-
Dichlorodiphenoldichloroethylene"[tw] OR "p, p'-Dichlorodiphenyl dichloroethylene"[tw] OR 
"p, p'-Dichlorodiphenyl-2,2-dichloroethylene"[tw] OR "p, p'-
Dichlorodiphenyldichloroethane"[tw] OR "p, p'-Dichlorodiphenyldichloroethylene"[tw] OR 
"p, p'-Dichlorodiphenylethylene dichloride"[tw] OR "p, p'-
Dichlorodiphenyltrichloroethane"[tw] OR "p, p'-Dichlorodiphenyltrichloromethylmethane"[tw] 
OR "p, p'-TDE"[tw] OR "Parachlorocidum"[tw] OR "Tetrachlorodiphenylethane"[tw] OR 
"Trichlorobis(4'-chlorophenyl)ethane"[tw] OR "Trichlorobis(4-chlorophenyl)ethane"[tw] OR 
"Aavero-extra"[tw] OR "Agritan"[tw] OR "Anofex"[tw] OR "Arkotine"[tw] OR "Azotox M 
33"[tw] OR "Benzochloryl"[tw] OR "Bosan supra"[tw] OR "Bovidermol"[tw] OR "CB 313"[tw] 
OR "CB313"[tw] OR "Chloditan"[tw] OR "Chlodithan"[tw] OR "Chlodithane"[tw] OR 
"Chlofenotan"[tw] OR "Chlorophenothan"[tw] OR "Chlorophenotoxum"[tw] OR 
"Chlorphenotoxum"[tw] OR "Citox"[tw] OR "Clofenotan"[tw] OR "Clofenotane"[tw] OR 
"Clofenotane technique"[tw] OR "Clofenotanum"[tw] OR "D.D.T. technique"[tw] OR 
"Deoval"[tw] OR "Detox"[tw] OR "Detoxan"[tw] OR "Dibovin"[tw] OR "Dicophane"[tw] OR 
"Dicophaner"[tw] OR "Didigam"[tw] OR "Didimac"[tw] OR "Dilene"[tw] OR "Dodat"[tw] OR 
"Dykol"[tw] OR "Estonate"[tw] OR "FWJ"[tw] OR "Genitox"[tw] OR "Gesafid"[tw] OR 
"Gesapon"[tw] OR "Gesarex"[tw] OR "Gesarol"[tw] OR "Guesapon"[tw] OR "Guesarol"[tw] 
OR "Gyron"[tw] OR "Hildit"[tw] OR "Ivoran"[tw] OR "Ixodex"[tw] OR "Khlodithan"[tw] OR 
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"Kopsol"[tw] OR "Lysodren"[tw] OR "ME 1700"[tw] OR "Me-700"[tw] OR "Mutoxan"[tw] OR 
"Neocid"[tw] OR "Neocidol"[tw] OR "OMS 0016"[tw] OR "OMS 1078"[tw] OR "OMS 16"[tw] 
OR "Opeprim"[tw] OR "PEB1"[tw] OR "Pentachlorin"[tw] OR "Pentech"[tw] OR 
"Penticidum"[tw] OR "p'-Zeidane"[tw] OR "Rhothane"[tw] OR "Rhothane D-3"[tw] OR 
"Rothane"[tw] OR "Rukseam"[tw] OR "Santobane"[tw] OR "Tafidex"[tw] OR "Zerdane"[tw])) 
AND (2000 : 3000[dp] OR 2000/08/01 : 3000[mhda] OR 2000/08/01 : 3000[edat] OR 
2000/08/01 : 3000[crdat])) AND ((("pesticides/toxicity"[mh] OR "pesticides/adverse 
effects"[mh] OR "pesticides/poisoning"[mh] OR "pesticides/pharmacokinetics"[mh]) OR 
("pesticides"[mh] AND ("environmental exposure"[mh] OR ci[sh])) OR ("pesticides"[mh] 
AND toxicokinetics[mh:noexp]) OR ("pesticides/blood"[mh] OR "pesticides/cerebrospinal 
fluid"[mh] OR "pesticides/urine"[mh]) OR ("pesticides"[mh] AND ("endocrine system"[mh] 
OR "hormones, hormone substitutes, and hormone antagonists"[mh] OR "endocrine 
disruptors"[mh])) OR ("pesticides"[mh] AND ("computational biology"[mh] OR "medical 
informatics"[mh] OR genomics[mh] OR genome[mh] OR proteomics[mh] OR proteome[mh] 
OR metabolomics[mh] OR metabolome[mh] OR genes[mh] OR "gene expression"[mh] OR 
phenotype[mh] OR genetics[mh] OR genotype[mh] OR transcriptome[mh] OR ("systems 
biology"[mh] AND ("environmental exposure"[mh] OR "epidemiological monitoring"[mh] OR 
analysis[sh])) OR "transcription, genetic "[mh] OR "reverse transcription"[mh] OR 
"transcriptional activation"[mh] OR "transcription factors"[mh] OR ("biosynthesis"[sh] AND 
(RNA[mh] OR DNA[mh])) OR "RNA, messenger"[mh] OR "RNA, transfer"[mh] OR "peptide 
biosynthesis"[mh] OR "protein biosynthesis"[mh] OR "reverse transcriptase polymerase 
chain reaction"[mh] OR "base sequence"[mh] OR "trans-activators"[mh] OR "gene 
expression profiling"[mh])) OR ("pesticides/antagonists and inhibitors"[mh]) OR 
("pesticides/metabolism"[mh] AND ("humans"[mh] OR "animals"[mh])) OR 
("pesticides"[mh] AND cancer[sb]) OR ("endocrine disruptors/toxicity"[mh] OR "endocrine 
disruptors/adverse effects"[mh] OR "endocrine disruptors/poisoning"[mh] OR "endocrine 
disruptors/pharmacokinetics"[mh]) OR ("endocrine disruptors"[mh] AND ("environmental 
exposure"[mh] OR ci[sh])) OR ("endocrine disruptors"[mh] AND toxicokinetics[mh:noexp]) 
OR ("endocrine disruptors/blood"[mh] OR "endocrine disruptors/cerebrospinal fluid"[mh] 
OR "endocrine disruptors/urine"[mh]) OR ("endocrine disruptors"[mh] AND ("endocrine 
system"[mh] OR "hormones, hormone substitutes, and hormone antagonists"[mh] OR 
"endocrine disruptors"[mh])) OR ("endocrine disruptors"[mh] AND ("computational 
biology"[mh] OR "medical informatics"[mh] OR genomics[mh] OR genome[mh] OR 
proteomics[mh] OR proteome[mh] OR metabolomics[mh] OR metabolome[mh] OR 
genes[mh] OR "gene expression"[mh] OR phenotype[mh] OR genetics[mh] OR 
genotype[mh] OR transcriptome[mh] OR ("systems biology"[mh] AND ("environmental 
exposure"[mh] OR "epidemiological monitoring"[mh] OR analysis[sh])) OR "transcription, 
genetic "[mh] OR "reverse transcription"[mh] OR "transcriptional activation"[mh] OR 
"transcription factors"[mh] OR ("biosynthesis"[sh] AND (RNA[mh] OR DNA[mh])) OR "RNA, 
messenger"[mh] OR "RNA, transfer"[mh] OR "peptide biosynthesis"[mh] OR "protein 
biosynthesis"[mh] OR "reverse transcriptase polymerase chain reaction"[mh] OR "base 
sequence"[mh] OR "trans-activators"[mh] OR "gene expression profiling"[mh])) OR 
("endocrine disruptors/antagonists and inhibitors"[mh]) OR ("endocrine 
disruptors/metabolism"[mh] AND ("humans"[mh] OR "animals"[mh])) OR ("endocrine 
disruptors"[mh] AND cancer[sb]) OR ("environmental pollutants/toxicity"[mh] OR 
"environmental pollutants/adverse effects"[mh] OR "environmental 
pollutants/poisoning"[mh] OR "environmental pollutants/pharmacokinetics"[mh]) OR 
("environmental pollutants"[mh] AND ("environmental exposure"[mh] OR ci[sh])) OR 
("environmental pollutants"[mh] AND toxicokinetics[mh:noexp]) OR ("environmental 
pollutants/blood"[mh] OR "environmental pollutants/cerebrospinal fluid"[mh] OR 
"environmental pollutants/urine"[mh]) OR ("environmental pollutants"[mh] AND ("endocrine 
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system"[mh] OR "hormones, hormone substitutes, and hormone antagonists"[mh] OR 
"environmental pollutants"[mh])) OR ("environmental pollutants"[mh] AND ("computational 
biology"[mh] OR "medical informatics"[mh] OR genomics[mh] OR genome[mh] OR 
proteomics[mh] OR proteome[mh] OR metabolomics[mh] OR metabolome[mh] OR 
genes[mh] OR "gene expression"[mh] OR phenotype[mh] OR genetics[mh] OR 
genotype[mh] OR transcriptome[mh] OR ("systems biology"[mh] AND ("environmental 
exposure"[mh] OR "epidemiological monitoring"[mh] OR analysis[sh])) OR "transcription, 
genetic "[mh] OR "reverse transcription"[mh] OR "transcriptional activation"[mh] OR 
"transcription factors"[mh] OR ("biosynthesis"[sh] AND (RNA[mh] OR DNA[mh])) OR "RNA, 
messenger"[mh] OR "RNA, transfer"[mh] OR "peptide biosynthesis"[mh] OR "protein 
biosynthesis"[mh] OR "reverse transcriptase polymerase chain reaction"[mh] OR "base 
sequence"[mh] OR "trans-activators"[mh] OR "gene expression profiling"[mh])) OR 
("environmental pollutants/antagonists and inhibitors"[mh]) OR ("environmental 
pollutants/metabolism"[mh] AND ("humans"[mh] OR "animals"[mh])) OR ("environmental 
pollutants"[mh] AND cancer[sb])) OR ("Hydrocarbons, Chlorinated/toxicity"[mh] OR 
"Hydrocarbons, Chlorinated/adverse effects"[mh] OR "Hydrocarbons, 
Chlorinated/poisoning"[mh] OR "Hydrocarbons, Chlorinated/pharmacokinetics"[mh]) OR 
("Hydrocarbons, Chlorinated"[mh] AND ("environmental exposure"[mh] OR ci[sh])) OR 
(("Hydrocarbons, Chlorinated"[mh] AND toxicokinetics[mh:noexp]) OR ("Hydrocarbons, 
Chlorinated/blood"[mh] OR "Hydrocarbons, Chlorinated/cerebrospinal fluid"[mh] OR 
"Hydrocarbons, Chlorinated/urine"[mh]) OR ("Hydrocarbons, Chlorinated"[mh] AND 
("endocrine system"[mh] OR "hormones, hormone substitutes, and hormone 
antagonists"[mh] OR "endocrine disruptors"[mh])) OR ("Hydrocarbons, Chlorinated"[mh] 
AND ("computational biology"[mh] OR "medical informatics"[mh] OR genomics[mh] OR 
genome[mh] OR proteomics[mh] OR proteome[mh] OR metabolomics[mh] OR 
metabolome[mh] OR genes[mh] OR "gene expression"[mh] OR phenotype[mh] OR 
genetics[mh] OR genotype[mh] OR transcriptome[mh] OR ("systems biology"[mh] AND 
("environmental exposure"[mh] OR "epidemiological monitoring"[mh] OR analysis[sh])) OR 
"transcription, genetic "[mh] OR "reverse transcription"[mh] OR "transcriptional 
activation"[mh] OR "transcription factors"[mh] OR ("biosynthesis"[sh] AND (RNA[mh] OR 
DNA[mh])) OR "RNA, messenger"[mh] OR "RNA, transfer"[mh] OR "peptide 
biosynthesis"[mh] OR "protein biosynthesis"[mh] OR "reverse transcriptase polymerase 
chain reaction"[mh] OR "base sequence"[mh] OR "trans-activators"[mh] OR "gene 
expression profiling"[mh])) OR ("Hydrocarbons, Chlorinated/antagonists and 
inhibitors"[mh]) OR ("Hydrocarbons, Chlorinated/metabolism"[mh] AND ("humans"[mh] OR 
"animals"[mh])) OR ("Hydrocarbons, Chlorinated"[mh] AND cancer[sb]))) 
 (DDT OR DDE) AND ("environmental pollutants"[mh] OR "environmental pollution"[mh] OR 
"animals, wild"[mh] OR "ecotoxicology"[mh] OR "fishes"[mh] OR "birds"[mh] OR 
"amphibians"[mh] OR "reptiles"[mh] OR "Mammals"[Mesh:noexp] OR "Artiodactyla"[mh] 
OR "Carnivora"[mh] OR "Cetacea"[mh] OR "Chiroptera"[mh] OR "Hyraxes"[mh] OR 
"Lagomorpha"[mh] OR "Marsupialia"[mh] OR "Monotremata"[mh] OR "Perissodactyla"[mh] 
OR "Proboscidea Mammal"[mh] OR "Rodentia "[mh] OR "Scandentia"[mh] OR "Sirenia 
"[mh] OR "Xenarthra"[mh] OR "Gorilla"[mh] OR "Pan paniscus"[mh] OR "Pan 
troglodytes"[mh] OR "Pongo"[mh] OR "hominidae"[Mesh:noexp] OR "Cercopithecidae"[mh] 
OR "Hylobatidae"[mh] OR "catarrhini" OR "Platyrrhini"[mh] OR "Tarsii"[mh] OR 
"haplorhini"[mh:noexp] OR "Strepsirhini"[mh] OR "primates"[mh:noexp] OR 
"Oligochaeta"[mh] OR "Bees"[mh] OR ecotox* OR phytotox* OR ec50* OR lc50* OR 
"lethal concentration"[tw] OR aquatic OR wildlife OR Alga OR Algae OR Amphibian* OR 
Avian OR bird OR birds OR Chironomid* OR Chironomus OR Collembolan OR Daphnia 
OR Daphnid* OR Earthworm* OR Fish OR Medaka OR Minnow OR plant OR Mollusc* OR 
DDT, DDE, and DDD  B-11 
 
APPENDIX B 
 
 
***DRAFT FOR PUBLIC COMMENT*** 
Table B-2.  Database Query Strings  
 
Database 
search date Query string 
bioaccumulat* OR biomagnifica* OR biomonitor* OR biotransform* OR bioconcentrat*) 
AND 2006 : 3000[dp] Filter: Reviews 
Toxline  
11/2016 50-29-3[rn] OR 72-55-9[rn] OR 72-54-8[rn] OR 789-02-6[rn] OR 3424-82-6[rn] OR 53-19-
0[rn]  
 
"DDT" OR "DDTs" OR "DDE" OR "DDD" OR "(-)-1-(o-Chlorophenyl)-1-(p-chlorophenyl)-
2,2,2-trichloroethane" OR "(+-)-1,1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane" 
OR "(±)-1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2,2-trichloroethane" 
 
"1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2,2-trichloroethane" OR "1-(2'-Chlorophenyl)-1-
(4'-chlorophenyl)-2,2-dichloroethane" OR "1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-
dichloroethane" OR "1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2,2-trichloroethane" 
 
"1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane" OR "1,1'-(2,2,2-
Trichloroethylidene)bis(4-chlorobenzene)" OR "1,1'-(2,2-Dichloroethylidene)bis(4-
chlorobenzene)" OR "1,1'-(Dichloroethenylidene)bis(4-chlorobenzene)" 
 
"1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane" OR "1,1,1-Trichloro-2,2-
bis(4,4'-dichlorodiphenyl)ethane" OR "1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane" OR 
"1,1,1-Trichloro-2,2-bis(p-chlorophenyl)ethane" 
 
"1,1,1-Trichloro-2,2-di(4-chlorophenyl)-ethane" OR "1,1,1-Trichloro-2,2-di(p-
chlorophenyl)ethane" OR "1,1,1-Trichloro-2-2,2-bis(p-chlorophenyl)ethane" OR "1,1-Bis(4-
chlorophenyl)-2,2,2-trichloroethane" OR "1,1-Bis(4-chlorophenyl)-2,2-dichloroethane" 
 
"1,1-Bis(4-chlorophenyl)-2,2-dichloroethene" OR "1,1-Bis(p-chlorophenyl)-2,2,2-
trichloroethane" OR "1,1-Bis-(p-chlorophenyl)-2,2,2-trichloroethane" OR "1,1-Bis(p-
chlorophenyl)-2,2-dichloroethane" OR "1,1-Bis(p-chlorophenyl)-2,2-dichloroethylene" 
 
"1,1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane" OR "1,1-Dichloro-2-(o-
chlorophenyl)-2-(p-chlorophenyl)ethene" OR "1,1-Dichloro-2-(o-chlorophenyl)-2-(p-
chlorophenyl)ethylene" OR "1,1-Dichloro-2-(p-chlorophenyl)-2-(o-chlorophenyl)ethane" 
 
"1,1-Dichloro-2,2-bis(2,4'-dichlorophenyl)ethane" OR "1,1'-Dichloro-2,2-bis(4-
chlorophenyl)ethane" OR "1,1-Dichloro-2,2-bis(4-chlorophenyl)ethane" OR "1,1-Dichloro-
2,2-bis(para-chlorophenyl) ethylene" OR "1,1-Dichloro-2,2-bis(parachlorophenyl)ethane" 
 
"1,1-Dichloro-2,2-bis(p-chlorophenyl)ethane" OR "1,1-Dichloro-2,2-bis(p-
chlorophenyl)ethene" OR "1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene" OR "1,1-Dichloro-
2,2-di(4-chlorophenyl)ethane" OR "1,1-Dichloro-2,2-di(p-chlorophenyl)ethylene" 
 
"1-Chloro-2-(2,2,2-trichloro-1-(4-chlorophenyl)ethyl)benzene" OR "1-Chloro-2-(2,2-
dichloro-1-(4-chlorophenyl)ethyl)benzene" OR "2-(2-Chlorophenyl)-2-(4-chlorophenyl)-
1,1,1-trichloroethane" OR "2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1-dichloroethane" 
 
"2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1-dichloroethylene" OR "2-(o-Chlorophenyl)-2-(p-
chlorophenyl)-1,1-dichloroethane" OR "2-(p-Chlorophenyl)-2-(o-chlorophenyl)-1,1-
dichloroethane" OR "2,2-(2-Chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene" 
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"2,2,2,o,p'-Pentachloroethylidenebisbenzene" OR "2,2,2-Trichloro-1,1-bis(4-
chlorophenyl)ethane" OR "2,2,o,p'-Tetrachlorovinylidenebisbenzene" OR "2,2-Bis(2-
chlorophenyl-4-chlorophenyl)-1,1-dichloroethane" 
 
"2,2-Bis(4-chlorophenyl)-1,1-dichloroethane" OR "2,2-Bis(4-chlorophenyl)-1,1-
dichloroethene" OR "2,2-Bis(4-chlorophenyl)-1,1-dichloroethylene" OR "2,2-Bis(o,p-
chlorophenyl)-1,1,1-trichloroethane" OR "2,2-Bis(p-chlorophenyl)-1,1,1-trichloroethane" 
 
"2,2-Bis(p-chlorophenyl)-1,1-dichloroethane" OR "2,2-Bis(p-chlorophenyl)-1,1-
dichloroethylene" OR "2,2-Di(p-chlorophenyl)-1,1-dichloroethane" OR "2,2-Di(p-
chlorophenyl)-1,1-dichloroethylene" OR "2,2-Dichloro-1,1-bis(4-chlorophenyl)ethylene" 
 
"2,4'-Dichlorodiphenyldichloroethane" OR "2,4'-Dichlorodiphenyldichloroethylene" OR 
"2,4'-Dichlorodiphenyltrichloroethane" OR "2,4'-Dichlorophenyldichlorethane" OR "2-o-
Chlorophenyl-2-p-chlorophenyl-1,1,1-trichloroethane" 
 
"4,4'-1,1-Dichloro-2,2-bis(p-chlorophenyl)ethane" OR "4,4'-
Dichlorodiphenyldichloroethane" OR "4,4'-Dichlorodiphenyldichloroethylene" OR "4,4'-
Dichlorodiphenyltrichloroethane" OR "4,4'-TDE" OR "alpha,alpha-Bis(p-chlorophenyl)-
beta,beta,beta-trichloroethane" 
 
"Chlorophenothane" OR "Chlorophenothanum" OR "Chlorphenothan" OR 
"Dichlorodiphenyl dichloroethane" OR "Dichlorodiphenyl dichloroethene" OR 
"Dichlorodiphenyl dichloroethylene" OR "Dichlorodiphenyldichloroethane" 
 
"Dichlorodiphenyldichloroethylene" OR "Dichlorodiphenyltrichloroethane" OR "Mitotan" OR 
"Mitotane" OR "Mitotanum" OR "o,p'-1,1,1-Trichloro-2-2,2-bis(p-chlorophenyl)ethane" OR 
"o,p'-Chlorophenothane" OR "o,p'-Dichlorodiphenyldichloroethane" 
 
"o,p'-Dichlorodiphenyldichloroethylene" OR "o,p'-Dichlorodiphenyltrichloroethane" OR 
"o,p'-TDE" OR "o,p-TDE" OR "p,p'-(Dichlorodiphenyl)-2,2-dichloroethylene" OR "p,p'-
Dichlorodiphenoldichloroethylene" 
 
"p,p'-Dichlorodiphenyl dichloroethylene" OR "p,p'-Dichlorodiphenyl-2,2-dichloroethylene" 
OR "p,p'-Dichlorodiphenyldichloroethane" OR "p,p'-Dichlorodiphenyldichloroethylene" OR 
"p,p'-Dichlorodiphenylethylene dichloride" 
 
"p,p'-Dichlorodiphenyltrichloroethane" OR "p,p'-Dichlorodiphenyltrichloromethylmethane" 
OR "p,p'-TDE" OR "Parachlorocidum" OR "Tetrachlorodiphenylethane" OR 
"Trichlorobis(4'-chlorophenyl)ethane" OR "Trichlorobis(4-chlorophenyl)ethane" 
 
"Aavero-extra" OR "Agritan" OR "Anofex" OR "Arkotine" OR "Azotox M 33" OR 
"Benzochloryl" OR "Bosan supra" OR "Bovidermol" OR "CB 313" OR "CB313" OR 
"Chloditan" OR "Chlodithan" OR "Chlodithane" 
 
"Chlofenotan" OR "Chlorophenothan" OR "Chlorophenotoxum" OR "Chlorphenotoxum" OR 
"Citox" OR "Clofenotan" OR "Clofenotane" OR "Clofenotane technique" OR 
"Clofenotanum" OR "D.D.T. technique" OR "Deoval" 
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"Detox" OR "Detoxan" OR "Dibovin" OR "Dicophane" OR "Dicophaner" OR "Didigam" OR 
"Didimac" OR "Dilene" OR "Dodat" OR "Dykol" OR "Estonate" OR "FWJ" OR "Genitox" OR 
"Gesafid" OR "Gesapon" OR "Gesarex" 
 
"Gesarol" OR "Guesapon" OR "Guesarol" OR "Gyron" OR "Hildit" OR "Ivoran" OR "Ixodex" 
OR "Khlodithan" OR "Kopsol" OR "Lysodren" OR "ME 1700" OR "Me-700" OR "Mutoxan" 
OR "Neocid" OR "Neocidol" 
 
"OMS 0016" OR "OMS 1078" OR "OMS 16" OR "Opeprim" OR "PEB1" OR "Pentachlorin" 
OR "Pentech" OR "Penticidum" OR "p'-Zeidane" OR "Rhothane" OR "Rhothane D-3" OR 
"Rothane" OR "Rukseam" OR "Santobane" 
 
"Tafidex" OR "Zerdane" 
Toxcenter  
11/2016      (FILE 'HOME' ENTERED AT 14:38:39 ON 01 NOV 2016) 
     FILE 'TOXCENTER' ENTERED AT 14:38:47 ON 01 NOV 2016 
CHARGED TO COST=EH011.11.01.01 
L1        47504 SEA 50-29-3 OR 72-55-9 OR 72-54-8 OR 789-02-6 OR 3424-82-6 OR  
                53-19-0  
L2        16652 SEA L1 AND PY>1999  
L3        16652 SEA L2 NOT TSCATS/FS  
L4        15436 SEA L3 NOT PATENT/DT  
                ACT TOXQUERY/Q 
               --------- 
L5              QUE (CHRONIC OR IMMUNOTOX? OR NEUROTOX? OR TOXICOKIN? OR  
                BIOMARKER? OR NEUROLOG?)  
L6              QUE (PHARMACOKIN? OR SUBCHRONIC OR PBPK OR  
EPIDEMIOLOGY/ST,CT, 
                IT)  
L7              QUE (ACUTE OR SUBACUTE OR LD50# OR LD(W)50 OR LC50# OR  
                LC(W)50)  
L8              QUE (TOXICITY OR ADVERSE OR POISONING)/ST,CT,IT  
L9              QUE (INHAL? OR PULMON? OR NASAL? OR LUNG?  OR RESPIR?)  
L10             QUE ((OCCUPATION? OR WORKPLACE? OR WORKER?) AND EXPOS?)  
L11             QUE (ORAL OR ORALLY OR INGEST? OR GAVAGE? OR DIET OR DIETS 
OR DIETARY OR DRINKING(W)WATER?)  
L12             QUE (MAXIMUM AND CONCENTRATION? AND (ALLOWABLE OR 
PERMISSIBLE)) 
L13             QUE (ABORT? OR ABNORMALIT? OR EMBRYO? OR CLEFT? OR FETUS?)  
L14             QUE (FOETUS? OR FETAL? OR FOETAL? OR FERTIL? OR MALFORM? 
OR  
                OVUM?)  
L15             QUE (OVA OR OVARY OR PLACENTA? OR PREGNAN? OR PRENATAL?)  
L16             QUE (PERINATAL? OR POSTNATAL? OR REPRODUC? OR STERIL? OR  
                TERATOGEN?)  
L17             QUE (SPERM OR SPERMAC? OR SPERMAG? OR SPERMATI? OR 
SPERMAS? OR  
                SPERMATOB? OR SPERMATOC? OR SPERMATOG?)  
L18             QUE (SPERMATOI? OR SPERMATOL? OR SPERMATOR? OR 
SPERMATOX? OR  
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                SPERMATOZ? OR SPERMATU? OR SPERMI? OR SPERMO?)  
L19             QUE (NEONAT? OR NEWBORN? OR DEVELOPMENT OR 
DEVELOPMENTAL?)  
L20             QUE (ENDOCRIN? AND DISRUPT?)  
L21             QUE (ZYGOTE? OR CHILD OR CHILDREN OR ADOLESCEN? OR 
INFANT?)  
L22             QUE (WEAN? OR OFFSPRING OR AGE(W)FACTOR?)  
L23             QUE (DERMAL? OR DERMIS OR SKIN OR EPIDERM? OR CUTANEOUS?)  
L24             QUE (CARCINOG? OR COCARCINOG? OR CANCER? OR PRECANCER? 
OR NEOPLAS?)  
L25             QUE (TUMOR? OR TUMOUR? OR ONCOGEN? OR LYMPHOMA? OR 
CARCINOM?)  
L26             QUE (GENETOX? OR GENOTOX? OR MUTAGEN? OR 
GENETIC(W)TOXIC?)  
L27             QUE (NEPHROTOX? OR HEPATOTOX?)  
L28             QUE (ENDOCRIN? OR ESTROGEN? OR ANDROGEN? OR HORMON?)  
L29             QUE (OCCUPATION? OR WORKER? OR WORKPLACE? OR EPIDEM?)  
L30             QUE L5 OR L6 OR L7 OR L8 OR L9 OR L10 OR L11 OR L12 OR L13 OR  
                L14 OR L15 OR L16 OR L17 OR L18 OR L19 OR L20 OR L21 OR L22 OR  
                L23 OR L24 OR L25 OR L26 OR L27 OR L28 OR L29  
L31             QUE (RAT OR RATS OR MOUSE OR MICE OR GUINEA(W)PIG? OR 
MURIDAE OR DOG OR DOGS OR RABBIT? OR HAMSTER? OR PIG OR PIGS OR 
SWINE OR PORCINE OR MONKEY? OR MACAQUE?)  
L32             QUE (MARMOSET? OR FERRET? OR GERBIL? OR RODENT? OR 
LAGOMORPHA OR BABOON? OR CANINE OR CAT OR CATS OR FELINE OR 
MURINE)  
L33             QUE L30 OR L31 OR L32  
L34             QUE (HUMAN OR HUMANS OR HOMINIDAE OR MAMMALS OR MAMMAL? 
OR PRIMATES OR PRIMATE?)  
L35             QUE L33 OR L34  
               --------- 
L36        8041 SEA L4 AND L30  
L37        1742 SEA L36 AND MEDLINE/FS  
L38        1432 SEA L36 AND BIOSIS/FS  
L39        4834 SEA L36 AND CAPLUS/FS  
L40          33 SEA L36 NOT (MEDLINE/FS OR BIOSIS/FS OR CAPLUS/FS)  
L41        6248 DUP REM L37 L38 L40 L39 (1793 DUPLICATES REMOVED) 
                     ANSWERS '1-6248' FROM FILE TOXCENTER 
L*** DEL   1742 S L36 AND MEDLINE/FS 
L*** DEL   1742 S L36 AND MEDLINE/FS 
L42        1742 SEA L41  
L*** DEL   1432 S L36 AND BIOSIS/FS 
L*** DEL   1432 S L36 AND BIOSIS/FS 
L43        1039 SEA L41  
L*** DEL   4834 S L36 AND CAPLUS/FS 
L*** DEL   4834 S L36 AND CAPLUS/FS 
L44        3441 SEA L41  
L*** DEL     33 S L36 NOT (MEDLINE/FS OR BIOSIS/FS OR CAPLUS/FS) 
L*** DEL     33 S L36 NOT (MEDLINE/FS OR BIOSIS/FS OR CAPLUS/FS) 
L45          26 SEA L41  
L46        4506 SEA (L42 OR L43 OR L44 OR L45) NOT MEDLINE/FS  
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L43       48819 SEA FILE=TOXCENTER 50-29-3 OR 72-55-9 OR 72-54-8 OR 789-02-6  
                OR 3424-82-6 OR 53-19-0 OR DDT/TI OR DDE/TI  
L51       11655 SEA FILE=TOXCENTER L43 AND PY>2005  
L52        5118 SEA FILE=TOXCENTER L51 AND (ENVIRONMENT? OR ECOTOX? OR 
ECOLOG? OR PHYTOTOX? OR EC50? OR LC50? OR "LETHAL CONCENTRATION" 
OR AQUATIC OR WILDLIFE OR ALGA OR ALGAE OR AMPHIBIAN? OR AVIAN OR 
BIRD OR BIRDS OR CHIRONOMID? OR CHIRONOMUS OR COLLEMBOLAN)  
L53        2773 SEA FILE=TOXCENTER L51 AND (DAPHNIA OR DAPHNID? OR 
EARTHWORM?  
                OR FISH OR FISHES OR MEDAKA OR MINNOW OR PLANT OR MOLLUSC? 
OR  
                BIOACCUMULAT? OR BIOMAGNIFICA? OR BIOMONITOR? OR 
BIOTRANSFORM?  
                OR BIOCONCENTRAT?)  
L54        6321 SEA FILE=TOXCENTER L52 OR L53  
L55         836 SEA FILE=TOXCENTER L54 AND BIOSIS/FS  
L56          62 SEA FILE=TOXCENTER L55 AND (REVIEW? OR SYNTHESIS OR 
METASYNTHES 
                IS OR SEARCH? OR SYSTEMATIC? OR META-ANALY? OR METAANALY? 
OR  
                "META ANALY?" OR METANALY?)  
L57          62 DUP REM L56 (0 DUPLICATES REMOVED) 
                     ANSWERS '1-62' FROM FILE TOXCENTER 
                D SCAN L57 
 
Table B-3.  Strategies to Augment the Literature Search 
 
Source Query and number screened when available 
TSCATSa  
11/2016 Compounds searched: 50-29-3; 72-55-9; 72-54-8; 789-02-6; 3424-82-6; 53-19-0 
NTP  
11/2017 "DDT" OR "DDTs" OR "DDE" OR "2,4'-DDD" OR "4,4'-DDD" OR "DDD, o,p'-" OR 
"DDD, p,p'-" OR "o,p'-DDD" OR "p,p'-DDD" OR "DDD" OR "(-)-1-(o-Chlorophenyl)-1-(p-
chlorophenyl)-2,2,2-trichloroethane" OR "(-)-1,1-Dichloro-2-(o-chlorophenyl)-2-(p-
chlorophenyl)ethane" OR "(±)-1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2,2-
trichloroethane" OR "1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2,2-trichloroethane" OR 
"1-(2'-Chlorophenyl)-1-(4'-chlorophenyl)-2,2-dichloroethane" OR "1-(2-Chlorophenyl)-1-
(4-chlorophenyl)-2,2-dichloroethane" OR "1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2,2-
trichloroethane" OR "1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane" OR 
"1,1'-(2,2,2-Trichloroethylidene)bis(4-chlorobenzene)" OR "1,1'-(2,2-
Dichloroethylidene)bis(4-chlorobenzene)" OR "1,1'-(Dichloroethenylidene)bis(4-
chlorobenzene)" OR "1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane" OR 
"1,1,1-Trichloro-2,2-bis(4,4'-dichlorodiphenyl)ethane" OR "1,1,1-Trichloro-2,2-bis(4-
chlorophenyl)ethane" OR "1,1,1-Trichloro-2,2-bis(p-chlorophenyl)ethane" OR "1,1,1-
Trichloro-2,2-di(4-chlorophenyl)-ethane" OR "1,1,1-Trichloro-2,2-di(p-
chlorophenyl)ethane" OR "1,1,1-Trichloro-2-2,2-bis(p-chlorophenyl)ethane" OR "1,1-
Bis(4-chlorophenyl)-2,2,2-trichloroethane" OR "1,1-Bis(4-chlorophenyl)-2,2-
dichloroethane" OR "1,1-Bis(4-chlorophenyl)-2,2-dichloroethene" OR "1,1-Bis(p-
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Table B-3.  Strategies to Augment the Literature Search 
 
Source Query and number screened when available 
chlorophenyl)-2,2,2-trichloroethane" OR "1,1-Bis-(p-chlorophenyl)-2,2,2-
trichloroethane" OR "1,1-Bis(p-chlorophenyl)-2,2-dichloroethane" OR "1,1-Bis(p-
chlorophenyl)-2,2-dichloroethylene" OR "1,1-Dichloro-2-(o-chlorophenyl)-2-(p-
chlorophenyl)ethane" OR "1,1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethene" 
OR "1,1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethylene" OR "1,1-Dichloro-2-
(p-chlorophenyl)-2-(o-chlorophenyl)ethane" OR "1,1-Dichloro-2,2-bis(2,4'-
dichlorophenyl)ethane" OR "1,1'-Dichloro-2,2-bis(4-chlorophenyl)ethane" OR "1,1-
Dichloro-2,2-bis(4-chlorophenyl)ethane" OR "1,1-Dichloro-2,2-bis(para-chlorophenyl) 
ethylene" OR "1,1-Dichloro-2,2-bis(parachlorophenyl)ethane" OR "1,1-Dichloro-2,2-
bis(p-chlorophenyl)ethane" OR "1,1-Dichloro-2,2-bis(p-chlorophenyl)ethene" OR "1,1-
Dichloro-2,2-bis(p-chlorophenyl)ethylene" OR "1,1-Dichloro-2,2-di(4-
chlorophenyl)ethane" OR "1,1-Dichloro-2,2-di(p-chlorophenyl)ethylene" OR "1-Chloro-
2-(2,2,2-trichloro-1-(4-chlorophenyl)ethyl)benzene" OR "1-Chloro-2-(2,2-dichloro-1-(4-
chlorophenyl)ethyl)benzene" OR "2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1,1-
trichloroethane" OR "2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1-dichloroethane" OR "2-
(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1-dichloroethylene" OR "2-(o-Chlorophenyl)-2-
(p-chlorophenyl)-1,1-dichloroethane" OR "2-(p-Chlorophenyl)-2-(o-chlorophenyl)-1,1-
dichloroethane" OR "2,2-(2-Chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene" OR 
"2,2,2,o,p'-Pentachloroethylidenebisbenzene" OR "2,2,2-Trichloro-1,1-bis(4-
chlorophenyl)ethane" OR "2,2,o,p'-Tetrachlorovinylidenebisbenzene" OR "2,2-Bis(2-
chlorophenyl-4-chlorophenyl)-1,1-dichloroethane" OR "2,2-Bis(4-chlorophenyl)-1,1-
dichloroethane" OR "2,2-Bis(4-chlorophenyl)-1,1-dichloroethene" OR "2,2-Bis(4-
chlorophenyl)-1,1-dichloroethylene" OR "2,2-Bis(o,p-chlorophenyl)-1,1,1-
trichloroethane" OR "2,2-Bis(p-chlorophenyl)-1,1,1-trichloroethane" OR "2,2-Bis(p-
chlorophenyl)-1,1-dichloroethane" OR "2,2-Bis(p-chlorophenyl)-1,1-dichloroethylene" 
OR "2,2-Di(p-chlorophenyl)-1,1-dichloroethane" OR "2,2-Di(p-chlorophenyl)-1,1-
dichloroethylene" OR "2,2-Dichloro-1,1-bis(4-chlorophenyl)ethylene" OR "2,4'-
Dichlorodiphenyldichloroethane" OR "2,4'-Dichlorodiphenyldichloroethylene" OR "2,4'-
Dichlorodiphenyltrichloroethane" OR "2,4'-Dichlorophenyldichlorethane" OR "2-o-
Chlorophenyl-2-p-chlorophenyl-1,1,1-trichloroethane" OR "4,4'-1,1-Dichloro-2,2-bis(p-
chlorophenyl)ethane" OR "4,4'-Dichlorodiphenyldichloroethane" OR "4,4'-
Dichlorodiphenyldichloroethylene" OR "4,4'-Dichlorodiphenyltrichloroethane" OR "4,4'-
TDE" OR "alpha,alpha-Bis(p-chlorophenyl)-beta,beta,beta-trichloroethane" OR 
"Chlorophenothane" OR "Chlorophenothanum" OR "Chlorphenothan" OR 
"Dichlorodiphenyl dichloroethane" OR "Dichlorodiphenyl dichloroethene" OR 
"Dichlorodiphenyl dichloroethylene" OR "Dichlorodiphenyldichloroethane" OR 
"Dichlorodiphenyldichloroethylene" OR "Dichlorodiphenyltrichloroethane" OR "Mitotan" 
OR "Mitotane" OR "Mitotanum" OR "o,p'-1,1,1-Trichloro-2-2,2-bis(p-
chlorophenyl)ethane" OR "o,p'-Chlorophenothane" OR "o,p'-
Dichlorodiphenyldichloroethane" OR "o,p'-Dichlorodiphenyldichloroethylene" OR "o,p'-
Dichlorodiphenyltrichloroethane" OR "o,p'-TDE" OR "o,p-TDE" OR "p,p'-
(Dichlorodiphenyl)-2,2-dichloroethylene" OR "p,p'-Dichlorodiphenoldichloroethylene" 
OR "p,p'-Dichlorodiphenyl dichloroethylene" OR "p,p'-Dichlorodiphenyl-2,2-
dichloroethylene" OR "p,p'-Dichlorodiphenyldichloroethane" OR "p,p'-
Dichlorodiphenyldichloroethylene" OR "p,p'-Dichlorodiphenylethylene dichloride" OR 
"p,p'-Dichlorodiphenyltrichloroethane" OR "p,p'-
Dichlorodiphenyltrichloromethylmethane" OR "p,p'-TDE" OR "Parachlorocidum" OR 
"Tetrachlorodiphenylethane" OR "Trichlorobis(4'-chlorophenyl)ethane" OR 
"Trichlorobis(4-chlorophenyl)ethane" OR "Aavero-extra" OR "Agritan" OR "Anofex" OR 
"Arkotine" OR "Azotox M 33" OR "Benzochloryl" OR "Bosan supra" OR "Bovidermol" 
OR "CB 313" OR "CB313" OR "Chloditan" OR "Chlodithan" OR "Chlodithane" OR 
"Chlofenotan" OR "Chlorophenothan" OR "Chlorophenotoxum" OR "Chlorphenotoxum" 
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Table B-3.  Strategies to Augment the Literature Search 
 
Source Query and number screened when available 
OR "Citox" OR "Clofenotan" OR "Clofenotane" OR "Clofenotane technique" OR 
"Clofenotanum" OR "D.D.T. technique" OR "Deoval" OR "Detox" OR "Detoxan" OR 
"Dibovin" OR "Dicophane" OR "Dicophaner" OR "Didigam" OR "Didimac" OR "Dilene" 
OR "Dodat" OR "Dykol" OR "Estonate" OR "FWJ" OR "Genitox" OR "Gesafid" OR 
"Gesapon" OR "Gesarex" OR "Gesarol" OR "Guesapon" OR "Guesarol" OR "Gyron" 
OR "Hildit" OR "Ivoran" OR "Ixodex" OR "Khlodithan" OR "Kopsol" OR "Lysodren" OR 
"ME 1700" OR "Me-700" OR "Mutoxan" OR "Neocid" OR "Neocidol" OR "OMS 0016" 
OR "OMS 1078" OR "OMS 16" OR "Opeprim" OR "PEB1" OR "Pentachlorin" OR 
"Pentech" OR "Penticidum" OR "p'-Zeidane" OR "Rhothane" OR "Rhothane D-3" OR 
"Rothane" OR "Rukseam" OR "Santobane" OR "Tafidex" OR "Zerdane" 
50-29-3 OR 72-55-9 OR 72-54-8 OR 789-02-6 OR 3424-82-6 OR 53-19-0 
NIH RePORTER 
02/2017 "DDT" OR "DDTs" OR "DDE" OR "2,4'-DDD" OR "4,4'-DDD" OR "DDD, o,p'-" OR 
"DDD, p,p'-" OR "o,p'-DDD" OR "p,p'-DDD" OR "DDD" OR "(-)-1-(o-Chlorophenyl)-1-(p-
chlorophenyl)-2,2,2-trichloroethane" OR "(-)-1,1-Dichloro-2-(o-chlorophenyl)-2-(p-
chlorophenyl)ethane" OR "(±)-1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2,2-
trichloroethane" OR "1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2,2-trichloroethane" OR 
"1-(2'-Chlorophenyl)-1-(4'-chlorophenyl)-2,2-dichloroethane" OR "1-(2-Chlorophenyl)-1-
(4-chlorophenyl)-2,2-dichloroethane" OR "1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2,2-
trichloroethane" OR "1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane" OR 
"1,1'-(2,2,2-Trichloroethylidene)bis(4-chlorobenzene)" OR "1,1'-(2,2-
Dichloroethylidene)bis(4-chlorobenzene)" OR "1,1'-(Dichloroethenylidene)bis(4-
chlorobenzene)" OR "1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane" OR 
"1,1,1-Trichloro-2,2-bis(4,4'-dichlorodiphenyl)ethane" OR "1,1,1-Trichloro-2,2-bis(4-
chlorophenyl)ethane" OR "1,1,1-Trichloro-2,2-bis(p-chlorophenyl)ethane" OR "1,1,1-
Trichloro-2,2-di(4-chlorophenyl)-ethane" OR "1,1,1-Trichloro-2,2-di(p-
chlorophenyl)ethane" OR "1,1,1-Trichloro-2-2,2-bis(p-chlorophenyl)ethane" OR "1,1-
Bis(4-chlorophenyl)-2,2,2-trichloroethane" OR "1,1-Bis(4-chlorophenyl)-2,2-
dichloroethane" OR "1,1-Bis(4-chlorophenyl)-2,2-dichloroethene" OR "1,1-Bis(p-
chlorophenyl)-2,2,2-trichloroethane" OR "1,1-Bis-(p-chlorophenyl)-2,2,2-
trichloroethane" OR "1,1-Bis(p-chlorophenyl)-2,2-dichloroethane" OR "1,1-Bis(p-
chlorophenyl)-2,2-dichloroethylene" OR "1,1-Dichloro-2-(o-chlorophenyl)-2-(p-
chlorophenyl)ethane" OR "1,1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethene" 
OR "1,1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethylene" OR "1,1-Dichloro-2-
(p-chlorophenyl)-2-(o-chlorophenyl)ethane" OR "1,1-Dichloro-2,2-bis(2,4'-
dichlorophenyl)ethane" OR "1,1'-Dichloro-2,2-bis(4-chlorophenyl)ethane" OR "1,1-
Dichloro-2,2-bis(4-chlorophenyl)ethane" OR "1,1-Dichloro-2,2-bis(para-chlorophenyl) 
ethylene" OR "1,1-Dichloro-2,2-bis(parachlorophenyl)ethane" OR "1,1-Dichloro-2,2-
bis(p-chlorophenyl)ethane" OR "1,1-Dichloro-2,2-bis(p-chlorophenyl)ethene" OR "1,1-
Dichloro-2,2-bis(p-chlorophenyl)ethylene" OR "1,1-Dichloro-2,2-di(4-
chlorophenyl)ethane" OR "1,1-Dichloro-2,2-di(p-chlorophenyl)ethylene" OR "1-Chloro-
2-(2,2,2-trichloro-1-(4-chlorophenyl)ethyl)benzene" OR "1-Chloro-2-(2,2-dichloro-1-(4-
chlorophenyl)ethyl)benzene" OR "2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1,1-
trichloroethane" OR "2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1-dichloroethane" OR "2-
(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1-dichloroethylene" OR "2-(o-Chlorophenyl)-2-
(p-chlorophenyl)-1,1-dichloroethane" OR "2-(p-Chlorophenyl)-2-(o-chlorophenyl)-1,1-
dichloroethane" OR "2,2-(2-Chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene" OR 
"2,2,2,o,p'-Pentachloroethylidenebisbenzene" OR "2,2,2-Trichloro-1,1-bis(4-
chlorophenyl)ethane" OR "2,2,o,p'-Tetrachlorovinylidenebisbenzene" OR "2,2-Bis(2-
chlorophenyl-4-chlorophenyl)-1,1-dichloroethane" OR "2,2-Bis(4-chlorophenyl)-1,1-
dichloroethane" OR "2,2-Bis(4-chlorophenyl)-1,1-dichloroethene" OR "2,2-Bis(4-
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Table B-3.  Strategies to Augment the Literature Search 
 
Source Query and number screened when available 
chlorophenyl)-1,1-dichloroethylene" OR "2,2-Bis(o,p-chlorophenyl)-1,1,1-
trichloroethane" OR "2,2-Bis(p-chlorophenyl)-1,1,1-trichloroethane" OR "2,2-Bis(p-
chlorophenyl)-1,1-dichloroethane" OR "2,2-Bis(p-chlorophenyl)-1,1-dichloroethylene" 
OR "2,2-Di(p-chlorophenyl)-1,1-dichloroethane" OR "2,2-Di(p-chlorophenyl)-1,1-
dichloroethylene" OR "2,2-Dichloro-1,1-bis(4-chlorophenyl)ethylene" OR "2,4'-
Dichlorodiphenyldichloroethane" OR "2,4'-Dichlorodiphenyldichloroethylene" OR "2,4'-
Dichlorodiphenyltrichloroethane" OR "2,4'-Dichlorophenyldichlorethane" OR "2-o-
Chlorophenyl-2-p-chlorophenyl-1,1,1-trichloroethane" OR "4,4'-1,1-Dichloro-2,2-bis(p-
chlorophenyl)ethane" OR "4,4'-Dichlorodiphenyldichloroethane" OR "4,4'-
Dichlorodiphenyldichloroethylene" OR "4,4'-Dichlorodiphenyltrichloroethane" OR "4,4'-
TDE" OR "alpha,alpha-Bis(p-chlorophenyl)-beta,beta,beta-trichloroethane" OR 
"Chlorophenothane" OR "Chlorophenothanum" OR "Chlorphenothan" OR 
"Dichlorodiphenyl dichloroethane" OR "Dichlorodiphenyl dichloroethene" OR 
"Dichlorodiphenyl dichloroethylene" OR "Dichlorodiphenyldichloroethane" OR 
"Dichlorodiphenyldichloroethylene" OR "Dichlorodiphenyltrichloroethane" OR "Mitotan" 
OR "Mitotane" OR "Mitotanum" OR "o,p'-1,1,1-Trichloro-2-2,2-bis(p-
chlorophenyl)ethane" OR "o,p'-Chlorophenothane" OR "o,p'-
Dichlorodiphenyldichloroethane" OR "o,p'-Dichlorodiphenyldichloroethylene" OR "o,p'-
Dichlorodiphenyltrichloroethane" OR "o,p'-TDE" OR "o,p-TDE" OR "p,p'-
(Dichlorodiphenyl)-2,2-dichloroethylene" OR "p,p'-Dichlorodiphenoldichloroethylene" 
OR "p,p'-Dichlorodiphenyl dichloroethylene" OR "p,p'-Dichlorodiphenyl-2,2-
dichloroethylene" OR "p,p'-Dichlorodiphenyldichloroethane" OR "p,p'-
Dichlorodiphenyldichloroethylene" OR "p,p'-Dichlorodiphenylethylene dichloride" OR 
"p,p'-Dichlorodiphenyltrichloroethane" OR "p,p'-
Dichlorodiphenyltrichloromethylmethane" OR "p,p'-TDE" OR "Parachlorocidum" OR 
"Tetrachlorodiphenylethane" OR "Trichlorobis(4'-chlorophenyl)ethane" OR 
"Trichlorobis(4-chlorophenyl)ethane" OR "Aavero-extra" OR "Agritan" OR "Anofex" OR 
"Arkotine" OR "Azotox M 33" OR "Benzochloryl" OR "Bosan supra" OR "Bovidermol" 
OR "CB 313" OR "CB313" OR "Chloditan" OR "Chlodithan" OR "Chlodithane" OR 
"Chlofenotan" OR "Chlorophenothan" OR "Chlorophenotoxum" OR "Chlorphenotoxum" 
OR "Citox" OR "Clofenotan" OR "Clofenotane" OR "Clofenotane technique" OR 
"Clofenotanum" OR "D.D.T. technique" OR "Deoval" OR "Detox" OR "Detoxan" OR 
"Dibovin" OR "Dicophane" OR "Dicophaner" OR "Didigam" OR "Didimac" OR "Dilene" 
OR "Dodat" OR "Dykol" OR "Estonate" OR "FWJ" OR "Genitox" OR "Gesafid" OR 
"Gesapon" OR "Gesarex" OR "Gesarol" OR "Guesapon" OR "Guesarol" OR "Gyron" 
OR "Hildit" OR "Ivoran" OR "Ixodex" OR "Khlodithan" OR "Kopsol" OR "Lysodren" OR 
"ME 1700" OR "Me-700" OR "Mutoxan" OR "Neocid" OR "Neocidol" OR "OMS 0016" 
OR "OMS 1078" OR "OMS 16" OR "Opeprim" OR "PEB1" OR "Pentachlorin" OR 
"Pentech" OR "Penticidum" OR "p'-Zeidane" OR "Rhothane" OR "Rhothane D-3" OR 
"Rothane" OR "Rukseam" OR "Santobane" OR "Tafidex" OR "Zerdane" (Advanced), 
Search in: Projects Admin IC: All, Fiscal Year: Active Projects, 2017, 2016, 2015, 
2014, 2013, 2012 
Other Identified throughout the assessment process 
 
aSeveral versions of the TSCATS database were searched, as needed, by CASRN including TSCATS1 via Toxline 
(no date limit), TSCATS2 via https://yosemite.epa.gov/oppts/epatscat8.nsf/ReportSearch?OpenForm (date restricted 
by EPA receipt date), and TSCATS via CDAT (date restricted by ‘Mail Received Date Range’), as well as google for 
recent TSCA submissions. 
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The 2016 results were:  
• Number of records identified from PubMed, TOXLINE, and TOXCENTER (after duplicate 
removal): 9,589 
• Number of records identified from other strategies: 319 
• Total number of records to undergo literature screening: 9,908 
 
B.1.2  Literature Screening  
 
A two-step process was used to screen the literature search to identify relevant studies on DDT, DDE, and 
DDD:   
 
• Title and abstract screen 
• Full text screen 
 
Title and Abstract Screen.  Within the reference library, titles and abstracts were screened manually for 
relevance.  Studies that were considered relevant (see Table B-1 for inclusion criteria) were moved to the 
second step of the literature screening process.  Studies were excluded when the title and abstract clearly 
indicated that the study was not relevant to the toxicological profile.   
 
• Number of titles and abstracts screened:  9,908 
• Number of studies considered relevant and moved to the next step: 1,083 
 
Full Text Screen.  The second step in the literature screening process was a full text review of individual 
studies considered relevant in the title and abstract screen step.  Each study was reviewed to determine 
whether it was relevant for inclusion in the toxicological profile.   
 
• Number of studies undergoing full text review:  1,083 
• Number of studies cited in the pre-public draft of the toxicological profile:  709 
• Total number of studies cited in the profile: 1,053 
 
A summary of the results of the literature search and screening is presented in Figure B-1. 
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Figure B-1.  November 2016 Literature Search Results and Screen for DDT, DDE, 
and DDD 
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APPENDIX C.  USER'S GUIDE 
 
Chapter 1.  Relevance to Public Health 
 
This chapter provides an overview of U.S. exposures, a summary of health effects based on evaluations of 
existing toxicologic, epidemiologic, and toxicokinetic information, and an overview of the minimal risk 
levels.  This is designed to present interpretive, weight-of-evidence discussions for human health 
endpoints by addressing the following questions: 
 
 1. What effects are known to occur in humans? 
 
 2. What effects observed in animals are likely to be of concern to humans? 
 
 3. What exposure conditions are likely to be of concern to humans, especially around hazardous 
waste sites? 
 
Minimal Risk Levels (MRLs) 
 
Where sufficient toxicologic information is available, ATSDR derives MRLs for inhalation and oral 
routes of entry at each duration of exposure (acute, intermediate, and chronic).  These MRLs are not 
meant to support regulatory action, but to acquaint health professionals with exposure levels at which 
adverse health effects are not expected to occur in humans. 
 
MRLs should help physicians and public health officials determine the safety of a community living near 
a hazardous substance emission, given the concentration of a contaminant in air or the estimated daily 
dose in water.  MRLs are based largely on toxicological studies in animals and on reports of human 
occupational exposure. 
 
MRL users should be familiar with the toxicologic information on which the number is based.  
Section 1.2, Summary of Health Effects, contains basic information known about the substance.  Other 
sections, such as Section 3.2 Children and Other Populations that are Unusually Susceptible and 
Section 3.4 Interactions with Other Substances, provide important supplemental information. 
 
MRL users should also understand the MRL derivation methodology.  MRLs are derived using a 
modified version of the risk assessment methodology that the Environmental Protection Agency (EPA) 
provides (Barnes and Dourson 1988) to determine reference doses (RfDs) for lifetime exposure.   
 
To derive an MRL, ATSDR generally selects the most sensitive endpoint which, in its best judgement, 
represents the most sensitive human health effect for a given exposure route and duration.  ATSDR 
cannot make this judgement or derive an MRL unless information (quantitative or qualitative) is available 
for all potential systemic, neurological, and developmental effects.  If this information and reliable 
quantitative data on the chosen endpoint are available, ATSDR derives an MRL using the most sensitive 
species (when information from multiple species is available) with the highest no-observed-adverse-effect 
level (NOAEL) that does not exceed any adverse effect levels.  When a NOAEL is not available, a 
lowest-observed-adverse-effect level (LOAEL) can be used to derive an MRL, and an uncertainty factor 
of 10 must be employed.  Additional uncertainty factors of 10 must be used both for human variability to 
protect sensitive subpopulations (people who are most susceptible to the health effects caused by the 
substance) and for interspecies variability (extrapolation from animals to humans).  In deriving an MRL, 
these individual uncertainty factors are multiplied together.  The product is then divided into the 
inhalation concentration or oral dosage selected from the study.  Uncertainty factors used in developing a 
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substance-specific MRL are provided in the footnotes of the levels of significant exposure (LSE) tables 
that are provided in Chapter 2.  Detailed discussions of the MRLs are presented in Appendix A. 
 
Chapter 2.  Health Effects 
 
Tables and Figures for Levels of Significant Exposure (LSE) 
 
Tables and figures are used to summarize health effects and illustrate graphically levels of exposure 
associated with those effects.  These levels cover health effects observed at increasing dose 
concentrations and durations, differences in response by species and MRLs to humans for noncancer 
endpoints.  The LSE tables and figures can be used for a quick review of the health effects and to locate 
data for a specific exposure scenario.  The LSE tables and figures should always be used in conjunction 
with the text.  All entries in these tables and figures represent studies that provide reliable, quantitative 
estimates of NOAELs, LOAELs, or Cancer Effect Levels (CELs). 
 
The legends presented below demonstrate the application of these tables and figures.  Representative 
examples of LSE tables and figures follow.  The numbers in the left column of the legends correspond to 
the numbers in the example table and figure. 
 
TABLE LEGEND 
See Sample LSE Table (page C-5) 
 
(1) Route of exposure.  One of the first considerations when reviewing the toxicity of a substance 
using these tables and figures should be the relevant and appropriate route of exposure.  
Typically, when sufficient data exist, three LSE tables and two LSE figures are presented in the 
document.  The three LSE tables present data on the three principal routes of exposure 
(i.e., inhalation, oral, and dermal).  LSE figures are limited to the inhalation and oral routes.  Not 
all substances will have data on each route of exposure and will not, therefore, have all five of the 
tables and figures.  Profiles with more than one chemical may have more LSE tables and figures. 
 
(2) Exposure period.  Three exposure periods—acute (<15 days), intermediate (15–364 days), and 
chronic (≥365 days)—are presented within each relevant route of exposure.  In this example, two 
oral studies of chronic-duration exposure are reported.  For quick reference to health effects 
occurring from a known length of exposure, locate the applicable exposure period within the LSE 
table and figure. 
 
(3) Figure key.  Each key number in the LSE table links study information to one or more data points 
using the same key number in the corresponding LSE figure.  In this example, the study 
represented by key number 51 identified NOAELs and less serious LOAELs (also see the three 
"51R" data points in sample LSE Figure 2-X). 
 
(4) Species (strain) No./group.  The test species (and strain), whether animal or human, are identified 
in this column.  The column also contains information on the number of subjects and sex per 
group.  Chapter 1, Relevance to Public Health, covers the relevance of animal data to human 
toxicity and Section 3.1, Toxicokinetics, contains any available information on comparative 
toxicokinetics.  Although NOAELs and LOAELs are species specific, the levels are extrapolated 
to equivalent human doses to derive an MRL. 
 
(5) Exposure parameters/doses.  The duration of the study and exposure regimens are provided in 
these columns.  This permits comparison of NOAELs and LOAELs from different studies.  In 
this case (key number 51), rats were orally exposed to “Chemical X” via feed for 2 years.  For a 
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more complete review of the dosing regimen, refer to the appropriate sections of the text or the 
original reference paper (i.e., Aida et al. 1992). 
 
(6) Parameters monitored.  This column lists the parameters used to assess health effects.  Parameters 
monitored could include serum (blood) chemistry (BC), behavioral (BH), biochemical changes 
(BI), body weight (BW), clinical signs (CS), developmental toxicity (DX), enzyme activity (EA), 
food intake (FI), fetal toxicity (FX), gross necropsy (GN), hematology (HE), histopathology 
(HP), lethality (LE), maternal toxicity (MX), organ function (OF), ophthalmology (OP), organ 
weight (OW), teratogenicity (TG), urinalysis (UR), and water intake (WI). 
 
(7) Endpoint.  This column lists the endpoint examined.  The major categories of health endpoints 
included in LSE tables and figures are death, body weight, respiratory, cardiovascular, 
gastrointestinal, hematological, musculoskeletal, hepatic, renal, dermal, ocular, endocrine, 
immunological, neurological, reproductive, developmental, other noncancer, and cancer.  "Other 
noncancer" refers to any effect (e.g., alterations in blood glucose levels) not covered in these 
systems.  In the example of key number 51, three endpoints (body weight, hematological, and 
hepatic) were investigated. 
 
(8) NOAEL.  A NOAEL is the highest exposure level at which no adverse effects were seen in the 
organ system studied.  The body weight effect reported in key number 51 is a NOAEL at 
25.5 mg/kg/day.  NOAELs are not reported for cancer and death; with the exception of these two 
endpoints, this field is left blank if no NOAEL was identified in the study. 
 
(9) LOAEL.  A LOAEL is the lowest dose used in the study that caused an adverse health effect.  
LOAELs have been classified into "Less Serious" and "Serious" effects.  These distinctions help 
readers identify the levels of exposure at which adverse health effects first appear and the 
gradation of effects with increasing dose.  A brief description of the specific endpoint used to 
quantify the adverse effect accompanies the LOAEL.  Key number 51 reports a less serious 
LOAEL of 6.1 mg/kg/day for the hepatic system, which was used to derive a chronic exposure, 
oral MRL of 0.008 mg/kg/day (see footnote "c").  MRLs are not derived from serious LOAELs.  
A cancer effect level (CEL) is the lowest exposure level associated with the onset of 
carcinogenesis in experimental or epidemiologic studies.  CELs are always considered serious 
effects.  The LSE tables and figures do not contain NOAELs for cancer, but the text may report 
doses not causing measurable cancer increases.  If no LOAEL/CEL values were identified in the 
study, this field is left blank. 
 
(10) Reference.  The complete reference citation is provided in Chapter 8 of the profile.  
 
(11) Footnotes.  Explanations of abbreviations or reference notes for data in the LSE tables are found 
in the footnotes.  For example, footnote "c" indicates that the LOAEL of 6.1 mg/kg/day in key 
number 51 was used to derive an oral MRL of 0.008 mg/kg/day. 
 
FIGURE LEGEND 
See Sample LSE Figure (page C-6) 
 
LSE figures graphically illustrate the data presented in the corresponding LSE tables.  Figures help the 
reader quickly compare health effects according to exposure concentrations for particular exposure 
periods. 
 
(13) Exposure period.  The same exposure periods appear as in the LSE table.  In this example, health 
effects observed within the chronic exposure period are illustrated. 
DDT, DDE, and DDD  C-4 
 
APPENDIX C 
 
 
 
 
 
 
***DRAFT FOR PUBLIC COMMENT*** 
 
(14) Endpoint.  These are the categories of health effects for which reliable quantitative data exist.  
The same health effect endpoints appear in the LSE table. 
 
(15) Levels of exposure.  Concentrations or doses for each health effect in the LSE tables are 
graphically displayed in the LSE figures.  Exposure concentration or dose is measured on the log 
scale "y" axis.  Inhalation exposure is reported in mg/m3 or ppm and oral exposure is reported in 
mg/kg/day. 
 
(16) LOAEL.  In this example, the half-shaded circle that is designated 51R identifies a LOAEL 
critical endpoint in the rat upon which a chronic oral exposure MRL is based.  The key number 
51 corresponds to the entry in the LSE table.  The dashed descending arrow indicates the 
extrapolation from the exposure level of 6.1 mg/kg/day (see entry 51 in the sample LSE table) to 
the MRL of 0.008 mg/kg/day (see footnote "c" in the sample LSE table). 
 
(17) CEL.  Key number 59R is one of studies for which CELs were derived.  The diamond symbol 
refers to a CEL for the test species (rat).  The number 59 corresponds to the entry in the LSE 
table. 
 
(18) Key to LSE figure.  The key provides the abbreviations and symbols used in the figure. 
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APPENDIX D.  QUICK REFERENCE FOR HEALTH CARE PROVIDERS 
 
 
Toxicological Profiles are a unique compilation of toxicological information on a given hazardous 
substance.  Each profile reflects a comprehensive and extensive evaluation, summary, and interpretation 
of available toxicologic and epidemiologic information on a substance.  Health care providers treating 
patients potentially exposed to hazardous substances may find the following information helpful for fast 
answers to often-asked questions. 
 
 
Primary Chapters/Sections of Interest 
 
Chapter 1:  Relevance to Public Health: The Relevance to Public Health Section provides an overview 
of exposure and health effects and evaluates, interprets, and assesses the significance of toxicity 
data to human health.  A table listing minimal risk levels (MRLs) is also included in this chapter. 
 
Chapter 2:  Health Effects: Specific health effects identified in both human and animal studies are 
reported by type of health effect (e.g., death, hepatic, renal, immune, reproductive), route of 
exposure (e.g., inhalation, oral, dermal), and length of exposure (e.g., acute, intermediate, and 
chronic).   
 NOTE: Not all health effects reported in this section are necessarily observed in the clinical 
setting.   
 
Pediatrics:    
 Section 3.2 Children and Other Populations that are Unusually Susceptible 
 Section 3.3  Biomarkers of Exposure and Effect  
 
 
ATSDR Information Center  
 
 Phone:   1-800-CDC-INFO (800-232-4636) or 1-888-232-6348 (TTY)   
 Internet:  http://www.atsdr.cdc.gov 
 
The following additional materials are available online: 
 
Case Studies in Environmental Medicine are self-instructional publications designed to increase primary 
health care providers’ knowledge of a hazardous substance in the environment and to aid in the 
evaluation of potentially exposed patients (see https://www.atsdr.cdc.gov/csem/csem.html).   
 
Managing Hazardous Materials Incidents is a three-volume set of recommendations for on-scene 
(prehospital) and hospital medical management of patients exposed during a hazardous materials 
incident (see https://www.atsdr.cdc.gov/MHMI/index.asp).  Volumes I and II are planning guides 
to assist first responders and hospital emergency department personnel in planning for incidents 
that involve hazardous materials.  Volume III—Medical Management Guidelines for Acute 
Chemical Exposures—is a guide for health care professionals treating patients exposed to 
hazardous materials. 
 
Fact Sheets (ToxFAQs™) provide answers to frequently asked questions about toxic substances (see 
https://www.atsdr.cdc.gov/toxfaqs/Index.asp). 
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Other Agencies and Organizations 
 
The National Center for Environmental Health (NCEH) focuses on preventing or controlling disease, 
injury, and disability related to the interactions between people and their environment outside the 
workplace.  Contact:  NCEH, Mailstop F-29, 4770 Buford Highway, NE, Atlanta, GA 
30341-3724 • Phone:  770-488-7000 • FAX:  770-488-7015 • Web Page:  
https://www.cdc.gov/nceh/. 
 
The National Institute for Occupational Safety and Health (NIOSH) conducts research on occupational 
diseases and injuries, responds to requests for assistance by investigating problems of health and 
safety in the workplace, recommends standards to the Occupational Safety and Health 
Administration (OSHA) and the Mine Safety and Health Administration (MSHA), and trains 
professionals in occupational safety and health.  Contact: NIOSH, 395 E Street, S.W., Suite 9200, 
Patriots Plaza Building, Washington, DC 20201 • Phone:  202-245-0625 or 1-800-CDC-INFO 
(800-232-4636) • Web Page: https://www.cdc.gov/niosh/. 
 
The National Institute of Environmental Health Sciences (NIEHS) is the principal federal agency for 
biomedical research on the effects of chemical, physical, and biologic environmental agents on 
human health and well-being.  Contact:  NIEHS, PO Box 12233, 104 T.W. Alexander Drive, 
Research Triangle Park, NC 27709 • Phone:  919-541-3212 • Web Page: 
https://www.niehs.nih.gov/. 
 
 
Clinical Resources (Publicly Available Information) 
 
The Association of Occupational and Environmental Clinics (AOEC) has developed a network of clinics 
in the United States to provide expertise in occupational and environmental issues.  Contact:  
AOEC, 1010 Vermont Avenue, NW, #513, Washington, DC 20005 • Phone:  202-347-4976 
• FAX:  202-347-4950 • e-mail: AOEC@AOEC.ORG • Web Page:  http://www.aoec.org/. 
 
The American College of Occupational and Environmental Medicine (ACOEM) is an association of 
physicians and other health care providers specializing in the field of occupational and 
environmental medicine.  Contact:  ACOEM, 25 Northwest Point Boulevard, Suite 700, Elk 
Grove Village, IL 60007-1030 • Phone:  847-818-1800 • FAX:  847-818-9266 • Web Page:  
http://www.acoem.org/. 
 
The American College of Medical Toxicology (ACMT) is a nonprofit association of physicians with 
recognized expertise in medical toxicology.  Contact:  ACMT, 10645 North Tatum Boulevard, 
Suite 200-111, Phoenix AZ 85028 • Phone:  844-226-8333 • FAX:  844-226-8333 • Web Page:  
http://www.acmt.net. 
 
The Pediatric Environmental Health Specialty Units (PEHSUs) is an interconnected system of specialists 
who respond to questions from public health professionals, clinicians, policy makers, and the 
public about the impact of environmental factors on the health of children and reproductive-aged 
adults.  Contact information for regional centers can be found at http://pehsu.net/findhelp.html. 
 
The American Association of Poison Control Centers (AAPCC) provide support on the prevention and 
treatment of poison exposures.  Contact:  AAPCC, 515 King Street, Suite 510, Alexandria VA 
22314 • Phone:  701-894-1858 • Poison Help Line: 1-800-222-1222 • Web Page:  
http://www.aapcc.org/. 
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APPENDIX E.  GLOSSARY 
 
 
Absorption—The process by which a substance crosses biological membranes and enters systemic 
circulation.  Absorption can also refer to the taking up of liquids by solids, or of gases by solids or liquids. 
 
Acute Exposure—Exposure to a chemical for a duration of ≤14 days, as specified in the Toxicological 
Profiles. 
 
Adsorption—The adhesion in an extremely thin layer of molecules (as of gases, solutes, or liquids) to the 
surfaces of solid bodies or liquids with which they are in contact. 
 
Adsorption Coefficient (Koc)—The ratio of the amount of a chemical adsorbed per unit weight of 
organic carbon in the soil or sediment to the concentration of the chemical in solution at equilibrium. 
 
Adsorption Ratio (Kd)—The amount of a chemical adsorbed by sediment or soil (i.e., the solid phase) 
divided by the amount of chemical in the solution phase, which is in equilibrium with the solid phase, at a 
fixed solid/solution ratio.  It is generally expressed in micrograms of chemical sorbed per gram of soil or 
sediment. 
 
Benchmark Dose (BMD) or Benchmark Concentration (BMC)—is the dose/concentration 
corresponding to a specific response level estimate using a statistical dose-response model applied to 
either experimental toxicology or epidemiology data.  For example, a BMD10 would be the dose 
corresponding to a 10% benchmark response (BMR).  The BMD is determined by modeling the dose-
response curve in the region of the dose-response relationship where biologically observable data are 
feasible.  The BMDL or BMCL is the 95% lower confidence limit on the BMD or BMC.   
 
Bioconcentration Factor (BCF)—The quotient of the concentration of a chemical in aquatic organisms 
at a specific time or during a discrete time period of exposure divided by the concentration in the 
surrounding water at the same time or during the same period. 
 
Biomarkers—Indicators signaling events in biologic systems or samples, typically classified as markers 
of exposure, effect, and susceptibility. 
 
Cancer Effect Level (CEL)—The lowest dose of a chemical in a study, or group of studies, that 
produces significant increases in the incidence of cancer (or tumors) between the exposed population and 
its appropriate control. 
 
Carcinogen—A chemical capable of inducing cancer. 
 
Case-Control Study—A type of epidemiological study that examines the relationship between a 
particular outcome (disease or condition) and a variety of potential causative agents (such as toxic 
chemicals).  In a case-control study, a group of people with a specified and well-defined outcome is 
identified and compared to a similar group of people without the outcome. 
 
Case Report—A report that describes a single individual with a particular disease or exposure.  These 
reports may suggest some potential topics for scientific research, but are not actual research studies. 
 
Case Series—Reports that describe the experience of a small number of individuals with the same 
disease or exposure.  These reports may suggest potential topics for scientific research, but are not actual 
research studies. 
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Ceiling Value—A concentration that must not be exceeded.  
 
Chronic Exposure—Exposure to a chemical for ≥365 days, as specified in the Toxicological Profiles. 
 
Clastogen—A substance that causes breaks in chromosomes resulting in addition, deletion, or 
rearrangement of parts of the chromosome. 
 
Cohort Study—A type of epidemiological study of a specific group or groups of people who have had a 
common insult (e.g., exposure to an agent suspected of causing disease or a common disease) and are 
followed forward from exposure to outcome, and who are disease-free at start of follow-up.  Often, at 
least one exposed group is compared to one unexposed group, while in other cohorts, exposure is a 
continuous variable and analyses are directed towards analyzing an exposure-response coefficient. 
 
Cross-sectional Study—A type of epidemiological study of a group or groups of people that examines 
the relationship between exposure and outcome to a chemical or to chemicals at a specific point in time. 
 
Data Needs—Substance-specific informational needs that, if met, would reduce the uncertainties of 
human health risk assessment. 
 
Developmental Toxicity—The occurrence of adverse effects on the developing organism that may result 
from exposure to a chemical prior to conception (either parent), during prenatal development, or 
postnatally to the time of sexual maturation.  Adverse developmental effects may be detected at any point 
in the life span of the organism. 
 
Dose-Response Relationship—The quantitative relationship between the amount of exposure to a 
toxicant and the incidence of the response or amount of the response. 
  
Embryotoxicity and Fetotoxicity—Any toxic effect on the conceptus as a result of prenatal exposure to 
a chemical; the distinguishing feature between the two terms is the stage of development during which the 
effect occurs.  Effects include malformations and variations, altered growth, and in utero death. 
 
Epidemiology—The investigation of factors that determine the frequency and distribution of disease or 
other health-related conditions within a defined human population during a specified period.  
 
Excretion—The process by which metabolic waste products are removed from the body.  
  
Genotoxicity—A specific adverse effect on the genome of living cells that, upon the duplication of 
affected cells, can be expressed as a mutagenic, clastogenic, or carcinogenic event because of specific 
alteration of the molecular structure of the genome. 
 
Half-life—A measure of rate for the time required to eliminate one-half of a quantity of a chemical from 
the body or environmental media. 
 
Health Advisory—An estimate of acceptable drinking water levels for a chemical substance derived by 
EPA and based on health effects information.  A health advisory is not a legally enforceable federal 
standard, but serves as technical guidance to assist federal, state, and local officials. 
 
Immediately Dangerous to Life or Health (IDLH)—A condition that poses a threat of life or health, or 
conditions that pose an immediate threat of severe exposure to contaminants that are likely to have 
adverse cumulative or delayed effects on health. 
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Immunotoxicity—Adverse effect on the functioning of the immune system that may result from 
exposure to chemical substances.   
 
Incidence—The ratio of new cases of individuals in a population who develop a specified condition to 
the total number of individuals in that population who could have developed that condition in a specified 
time period.  
 
Intermediate Exposure—Exposure to a chemical for a duration of 15–364 days, as specified in the 
Toxicological Profiles. 
 
In Vitro—Isolated from the living organism and artificially maintained, as in a test tube. 
 
In Vivo—Occurring within the living organism. 
 
Lethal Concentration(LO) (LCLO)—The lowest concentration of a chemical in air that has been reported 
to have caused death in humans or animals. 
 
Lethal Concentration(50) (LC50)—A calculated concentration of a chemical in air to which exposure for 
a specific length of time is expected to cause death in 50% of a defined experimental animal population. 
 
Lethal Dose(LO) (LDLo)—The lowest dose of a chemical introduced by a route other than inhalation that 
has been reported to have caused death in humans or animals. 
 
Lethal Dose(50) (LD50)—The dose of a chemical that has been calculated to cause death in 50% of a 
defined experimental animal population. 
 
Lethal Time(50) (LT50)—A calculated period of time within which a specific concentration of a chemical 
is expected to cause death in 50% of a defined experimental animal population. 
 
Lowest-Observed-Adverse-Effect Level (LOAEL)—The lowest exposure level of chemical in a study, 
or group of studies, that produces statistically or biologically significant increases in frequency or severity 
of adverse effects between the exposed population and its appropriate control. 
 
Lymphoreticular Effects—Represent morphological effects involving lymphatic tissues such as the 
lymph nodes, spleen, and thymus. 
 
Malformations—Permanent structural changes that may adversely affect survival, development, or 
function. 
  
Metabolism—Process in which chemical substances are biotransformed in the body that could result in 
less toxic and/or readily excreted compounds or produce a biologically active intermediate. 
 
Minimal Risk Level (MRL)—An estimate of daily human exposure to a hazardous substance that is 
likely to be without an appreciable risk of adverse noncancer health effects over a specified route and 
duration of exposure. 
 
Modifying Factor (MF)—A value (greater than zero) that is applied to the derivation of a Minimal Risk 
Level (MRL) to reflect additional concerns about the database that are not covered by the uncertainty 
factors.  The default value for a MF is 1. 
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Morbidity—The state of being diseased; the morbidity rate is the incidence or prevalence of a disease in 
a specific population. 
 
Mortality—Death; the mortality rate is a measure of the number of deaths in a population during a 
specified interval of time. 
 
Mutagen—A substance that causes mutations, which are changes in the DNA sequence of a cell’s DNA.  
Mutations can lead to birth defects, miscarriages, or cancer. 
 
Necropsy—The gross examination of the organs and tissues of a dead body to determine the cause of 
death or pathological conditions. 
 
Neurotoxicity—The occurrence of adverse effects on the nervous system following exposure to a 
hazardous substance. 
 
No-Observed-Adverse-Effect Level (NOAEL)—The dose of a chemical at which there were no 
statistically or biologically significant increases in frequency or severity of adverse effects seen between 
the exposed population and its appropriate control.  Although effects may be produced at this dose, they 
are not considered to be adverse. 
 
Octanol-Water Partition Coefficient (Kow)—The equilibrium ratio of the concentrations of a chemical 
in n-octanol and water, in dilute solution. 
 
Odds Ratio (OR)—A means of measuring the association between an exposure (such as toxic substances 
and a disease or condition) that represents the best estimate of relative risk (risk as a ratio of the incidence 
among subjects exposed to a particular risk factor divided by the incidence among subjects who were not 
exposed to the risk factor).  An odds ratio that is greater than 1 is considered to indicate greater risk of 
disease in the exposed group compared to the unexposed group. 
 
Permissible Exposure Limit (PEL)—An Occupational Safety and Health Administration (OSHA) 
regulatory limit on the amount or concentration of a substance not to be exceeded in workplace air 
averaged over any 8-hour work shift of a 40-hour workweek. 
 
Pesticide—General classification of chemicals specifically developed and produced for use in the control 
of agricultural and public health pests (insects or other organisms harmful to cultivated plants or animals). 
 
Pharmacokinetics—The dynamic behavior of a material in the body, used to predict the fate 
(disposition) of an exogenous substance in an organism.  Utilizing computational techniques, it provides 
the means of studying the absorption, distribution, metabolism, and excretion of chemicals by the body. 
 
Pharmacokinetic Model—A set of equations that can be used to describe the time course of a parent 
chemical or metabolite in an animal system.  There are two types of pharmacokinetic models:  data-based 
and physiologically-based.  A data-based model divides the animal system into a series of compartments, 
which, in general, do not represent real, identifiable anatomic regions of the body, whereas the 
physiologically-based model compartments represent real anatomic regions of the body. 
 
Physiologically Based Pharmacodynamic (PBPD) Model—A type of physiologically based dose-
response model that quantitatively describes the relationship between target tissue dose and toxic 
endpoints.  These models advance the importance of physiologically based models in that they clearly 
describe the biological effect (response) produced by the system following exposure to an exogenous 
substance.  
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Physiologically Based Pharmacokinetic (PBPK) Model—A type of physiologically based dose-
response model that is comprised of a series of compartments representing organs or tissue groups with 
realistic weights and blood flows.  These models require a variety of physiological information, including 
tissue volumes, blood flow rates to tissues, cardiac output, alveolar ventilation rates, and possibly 
membrane permeabilities.  The models also utilize biochemical information, such as blood:air partition 
coefficients, and metabolic parameters.  PBPK models are also called biologically based tissue dosimetry 
models. 
 
Prevalence—The number of cases of a disease or condition in a population at one point in time.  
 
Prospective Study—A type of cohort study in which a group is followed over time and the pertinent 
observations are made on events occurring after the start of the study.   
 
Recommended Exposure Limit (REL)—A National Institute for Occupational Safety and Health 
(NIOSH) time-weighted average (TWA) concentration for up to a 10-hour workday during a 40-hour 
workweek. 
 
Reference Concentration (RfC)—An estimate (with uncertainty spanning perhaps an order of 
magnitude) of a continuous inhalation exposure to the human population (including sensitive subgroups) 
that is likely to be without an appreciable risk of deleterious noncancer health effects during a lifetime.  
The inhalation RfC is expressed in units of mg/m3 or ppm. 
 
Reference Dose (RfD)—An estimate (with uncertainty spanning perhaps an order of magnitude) of the 
daily oral exposure of the human population to a potential hazard that is likely to be without risk of 
deleterious noncancer health effects during a lifetime.  The oral RfD is expressed in units of mg/kg/day.   
 
Reportable Quantity (RQ)—The quantity of a hazardous substance that is considered reportable under 
the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA).  RQs are 
(1) ≥1 pound or (2) for selected substances, an amount established by regulation either under CERCLA or 
under Section 311 of the Clean Water Act.  Quantities are measured over a 24-hour period. 
 
Reproductive Toxicity—The occurrence of adverse effects on the reproductive system that may result 
from exposure to a hazardous substance.  The toxicity may be directed to the reproductive organs and/or 
the related endocrine system.  The manifestation of such toxicity may be noted as alterations in sexual 
behavior, fertility, pregnancy outcomes, or modifications in other functions that are dependent on the 
integrity of this system. 
 
Retrospective Study—A type of cohort study based on a group of persons known to have been exposed 
at some time in the past.  Data are collected from routinely recorded events, up to the time the study is 
undertaken.  Retrospective studies are limited to causal factors that can be ascertained from existing 
records and/or examining survivors of the cohort. 
 
Risk—The possibility or chance that some adverse effect will result from a given exposure to a hazardous 
substance. 
 
Risk Factor—An aspect of personal behavior or lifestyle, an environmental exposure, existing health 
condition, or an inborn or inherited characteristic that is associated with an increased occurrence of 
disease or other health-related event or condition. 
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Risk Ratio/Relative Risk—The ratio of the risk among persons with specific risk factors compared to the 
risk among persons without risk factors.  A risk ratio that is greater than 1 indicates greater risk of disease 
in the exposed group compared to the unexposed group. 
 
Short-Term Exposure Limit (STEL)—A STEL is a 15-minute TWA exposure that should not be 
exceeded at any time during a workday.   
 
Standardized Mortality Ratio (SMR)—A ratio of the observed number of deaths and the expected 
number of deaths in a specific standard population. 
 
Target Organ Toxicity—This term covers a broad range of adverse effects on target organs or 
physiological systems (e.g., renal, cardiovascular) extending from those arising through a single limited 
exposure to those assumed over a lifetime of exposure to a chemical. 
 
Teratogen—A chemical that causes structural defects that affect the development of an organism. 
 
Threshold Limit Value (TLV)—An American Conference of Governmental Industrial Hygienists 
(ACGIH) concentration of a substance to which it is believed that nearly all workers may be repeatedly 
exposed, day after day, for a working lifetime without adverse effect.  The TLV may be expressed as a 
Time-Weighted Average (TLV-TWA), as a Short-Term Exposure Limit (TLV-STEL), or as a ceiling 
limit (TLV-C). 
 
Time-Weighted Average (TWA)—An average exposure within a given time period.   
 
Toxicokinetic—The absorption, distribution, metabolism, and elimination of toxic compounds in the 
living organism. 
 
Toxics Release Inventory (TRI)—The TRI is an EPA program that tracks toxic chemical releases and 
pollution prevention activities reported by industrial and federal facilities.   
 
Uncertainty Factor (UF)—A factor used in operationally deriving the Minimal Risk Level (MRL), 
Reference Dose (RfD), or Reference Concentration (RfC) from experimental data.  UFs are intended to 
account for (1) the variation in sensitivity among the members of the human population, (2) the 
uncertainty in extrapolating animal data to the case of human, (3) the uncertainty in extrapolating from 
data obtained in a study that is of less than lifetime exposure, and (4) the uncertainty in using lowest-
observed-adverse-effect level (LOAEL) data rather than no-observed-adverse-effect level (NOAEL) data.  
A default for each individual UF is 10; if complete certainty in data exists, a value of 1 can be used; 
however, a reduced UF of 3 may be used on a case-by-case basis (3 being the approximate logarithmic 
average of 10 and 1). 
 
Xenobiotic—Any substance that is foreign to the biological system. 
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APPENDIX F.  ACRONYMS, ABBREVIATIONS, AND SYMBOLS 
 
AAPCC American Association of Poison Control Centers 
ACGIH American Conference of Governmental Industrial Hygienists 
ACOEM American College of Occupational and Environmental Medicine 
ACMT American College of Medical Toxicology 
ADI acceptable daily intake 
ADME absorption, distribution, metabolism, and excretion 
AEGL Acute Exposure Guideline Level 
AGD anogenital distance 
AIC Akaike’s information criterion  
AIHA American Industrial Hygiene Association  
ALT alanine aminotransferase 
AOEC Association of Occupational and Environmental Clinics 
AP alkaline phosphatase 
AST aspartate aminotransferase 
atm atmosphere 
ATSDR Agency for Toxic Substances and Disease Registry 
AWQC Ambient Water Quality Criteria 
BCF bioconcentration factor 
BMD/C benchmark dose or benchmark concentration 
BMDX dose that produces a X% change in response rate of an adverse effect 
BMDLX 95% lower confidence limit on the BMDX 
BMDS Benchmark Dose Software   
BMR benchmark response 
BUN  blood urea nitrogen  
C centigrade 
CAA Clean Air Act 
CAS Chemical Abstract Services 
CDC Centers for Disease Control and Prevention 
CEL cancer effect level 
CERCLA Comprehensive Environmental Response, Compensation, and Liability Act 
CFR Code of Federal Regulations 
Ci curie 
CI confidence interval 
cm centimeter 
CPSC Consumer Products Safety Commission 
CWA Clean Water Act 
ΣDDT Sum of total DDT, DDD, and DDT levels  
DMT2 Type 2 diabetes mellitus 
DNA deoxyribonucleic acid 
DOD Department of Defense 
DOE Department of Energy 
DWEL drinking water exposure level 
EAFUS  Everything Added to Food in the United States  
ECG/EKG electrocardiogram 
EEG electroencephalogram 
EPA Environmental Protection Agency 
ERPG  emergency response planning guidelines  
F Fahrenheit 
F1 first-filial generation 
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FDA Food and Drug Administration 
FIFRA Federal Insecticide, Fungicide, and Rodenticide Act 
FR Federal Register 
FSH follicle stimulating hormone 
g gram 
GC gas chromatography 
gd gestational day 
GGT γ-glutamyl transferase  
GRAS  generally recognized as safe  
HEC  human equivalent concentration  
HED  human equivalent dose  
HHS  Department of Health and Human Services  
HPLC high-performance liquid chromatography 
HR hazard ratio 
HSDB Hazardous Substance Data Bank  
IARC International Agency for Research on Cancer 
IDLH immediately dangerous to life and health 
IRIS Integrated Risk Information System   
Kd adsorption ratio 
kg kilogram 
kkg kilokilogram; 1 kilokilogram is equivalent to 1,000 kilograms and 1 metric ton 
Koc organic carbon partition coefficient 
Kow octanol-water partition coefficient 
L liter 
LC liquid chromatography 
LC50 lethal concentration, 50% kill 
LCLo lethal concentration, low 
LD50 lethal dose, 50% kill 
LDLo lethal dose, low 
LDH lactic dehydrogenase 
LH luteinizing hormone 
LOAEL lowest-observed-adverse-effect level 
LSE Level of Significant Exposure 
LT50 lethal time, 50% kill 
m meter 
mCi millicurie 
MCL maximum contaminant level 
MCLG maximum contaminant level goal 
MF modifying factor 
mg milligram 
mL milliliter 
mm millimeter 
mmHg millimeters of mercury 
mmol millimole 
MRL Minimal Risk Level 
MS mass spectrometry 
MSHA Mine Safety and Health Administration 
Mt metric ton 
NAAQS National Ambient Air Quality Standard 
NAS National Academy of Science 
NCEH National Center for Environmental Health 
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ND not detected 
ng nanogram 
NHANES National Health and Nutrition Examination Survey 
NIEHS National Institute of Environmental Health Sciences 
NIOSH National Institute for Occupational Safety and Health 
NLM National Library of Medicine 
nm nanometer 
nmol nanomole 
NOAEL no-observed-adverse-effect level 
NPL National Priorities List 
NR not reported 
NRC National Research Council 
NS not specified 
NTP National Toxicology Program 
OR odds ratio 
OSHA Occupational Safety and Health Administration 
PAC  Protective Action Criteria  
PAH polycyclic aromatic hydrocarbon 
PBPD physiologically based pharmacodynamic  
PBPK physiologically based pharmacokinetic  
PEHSU Pediatric Environmental Health Specialty Unit 
PEL permissible exposure limit 
PEL-C permissible exposure limit-ceiling value 
pg picogram 
PND postnatal day 
POD point of departure 
ppb parts per billion 
ppbv parts per billion by volume 
ppm parts per million 
ppt parts per trillion 
REL recommended exposure level/limit 
REL-C recommended exposure level-ceiling value 
RfC reference concentration 
RfD reference dose 
RNA ribonucleic acid 
ROS reactive oxygen species 
SARA Superfund Amendments and Reauthorization Act 
SCE sister chromatid exchange 
SD standard deviation 
SE standard error 
SGOT serum glutamic oxaloacetic transaminase (same as aspartate aminotransferase or AST) 
SGPT serum glutamic pyruvic transaminase (same as alanine aminotransferase or ALT) 
SIC standard industrial classification 
SMR standardized mortality ratio 
sRBC sheep red blood cell 
STEL short term exposure limit 
TLV threshold limit value 
TLV-C threshold limit value-ceiling value 
TRI Toxics Release Inventory 
TSCA Toxic Substances Control Act 
TWA time-weighted average 
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UF uncertainty factor 
U.S. United States 
USDA United States Department of Agriculture 
USGS United States Geological Survey 
USNRC U.S. Nuclear Regulatory Commission 
VOC volatile organic compound 
WBC white blood cell 
WHO World Health Organization 
 
> greater than 
≥ greater than or equal to 
= equal to 
< less than 
≤ less than or equal to 
% percent 
α alpha 
β beta 
γ gamma 
δ delta 
μm micrometer 
μg microgram 
q1* cancer slope factor 
– negative 
+ positive 
(+) weakly positive result 
(–) weakly negative result 
 
> greater than 
≥ greater than or equal to 
= equal to 
< less than 
≤ less than or equal to 
% percent 
α alpha 
β beta 
γ gamma 
δ delta 
μm micrometer 
μg microgram 
q1* cancer slope factor 
– negative 
+ positive 
(+) weakly positive result 
(–) weakly negative result 
 
